UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-
FORM 20-F
-
(Mark One)
☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OR
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2017
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
OR
☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission file number 1-10882
-
Aegon N.V.
(Exact name of Registrant as specified in its charter)
-
Not Applicable
(Translation of Registrants name into English)
The Netherlands
(Jurisdiction of incorporation or organization)
Aegonplein 50, PO Box 85, 2501 CB The Hague, The Netherlands
(Address of principal executive offices)
J.H.P.M. van Rossum
Executive Vice President and Head of Corporate Financial Center
Aegon N.V.
Aegonplein 50, 2501 CB The Hague, The Netherlands
+31-70-3445458
Jurgen.vanRossum@aegon.com
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class | Name of each exchange on which registered | |
Common shares, par value EUR 0.12 per share | New York Stock Exchange |
Securities registered or to be registered pursuant to Section 12(g) of the Act.
Not applicable
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
Not applicable
(Title of Class)
Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report: 2,074,548,842 common shares and 585,022,160 common shares B
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act
☒ Yes No ☐
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. ☐ Yes No ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days. ☒ Yes No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of large accelerated filer, accelerated filer, and emerging growth company in Rule 12b-2 of the Exchange Act
☒ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Emerging growth company
If an emerging growth company that prepares its financial statements in accordance with US GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
The term new or revised financial accounting standard refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012
Indicate by checkmark which basis of accounting the registrant has used to prepare the financial statements included in this filing
☐ U.S. GAAP ☒ International Financial Reporting Standards as issued by the International Accounting Standards Board ☐ Other
If other has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.
☐ Item 17 ☐ Item 18
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes No ☒
III | ||
Cross reference table Form 20-F
1 | Identity of Directors, Senior Management and Advisers | n/a | ||
2 | Offer Statistics and Expected Timetable | n/a | ||
3 | Key Information | |||
3A | Selected financial data |
11-12 |
||
3B | Capitalization and indebtedness | n/a | ||
3C | Reasons for the offer and use of proceeds | n/a | ||
3D | Risk factors |
13-19; 93-98; 175-202; 336-355 |
||
4 | Information on the Company | |||
4A | History and development of the Company |
10; 20-92; 294-296; 380 |
||
4B | Business overview |
20-21; 39-46; 57-72; 79-81; 87-92 |
||
4C | Organizational structure |
10; 20-21 |
||
4D | Property, plants and equipment |
356 |
||
4A | Unresolved Staff Comments | n/a | ||
5 | Operating and Financial Review and Prospects | |||
5A | Operating results |
20-92 |
||
5B | Liquidity and capital resources |
99-107; 223-225; 258-259; 270-274 |
||
5C | Research and development, patent and licenses etc. | n/a | ||
5D | Trend information |
8-9; 20-92 |
||
5E | Off-balance sheet arrangements |
287-290 |
||
5F | Tabular disclosure of contractual obligations |
201-202; 287-290; 326 |
||
5G | Safe harbor | n/a | ||
6 | Directors, Senior Management and Employees | |||
6A | Directors and senior management |
5-7; 120-122 |
||
6B | Compensation |
123-130; 216-218, 299-305 |
||
6C | Board practices |
131-136 |
||
6D | Employees |
356 |
||
6E | Share ownership |
132-134; 321-323 |
||
7 | Major Shareholders and Related Party Transactions | |||
7A | Major shareholders |
133; 321-323 |
||
7B | Related party transactions |
299-305 |
||
7C | Interest of experts and counsel | n/a | ||
8 | Financial Information | |||
8A | Consolidated Statements and Other Financial Information |
144-150; 324-331 |
||
8B | Significant Changes | n/a | ||
9 | The Offer and Listing | |||
9A | Offer and listing details |
358 |
||
9B | Plan of distribution | n/a | ||
9C | Markets |
358 |
||
9D | Selling shareholders | n/a | ||
9E | Dilution | n/a | ||
9F | Expenses of the issue | n/a | ||
10 | Additional Information | |||
10A | Share capital | n/a | ||
10B | Memorandum and articles of association |
359-360 |
||
10C | Material contracts |
360 |
||
10D | Exchange controls |
360 |
||
10E | Taxation |
361-367 |
||
10F | Dividends and paying agents | n/a | ||
10G | Statement by experts | n/a | ||
10H | Documents on display |
381 |
||
10I | Subsidiary Information | n/a | ||
11 | Quantitative and Qualitative Disclosures About Market Risk |
93-98; 143; 175-202 |
||
12 | Description of Securities Other than Equity Securities | n/a |
Annual Report on Form 20-F 2017 |
IV | ||
13 | Defaults, Dividend Arrearages and Delinquencies | n/a | ||
14 | Material Modifications to the Rights of Security Holders and Use of Proceeds | n/a | ||
15 | Controls and Procedures |
138 |
||
16A | Audit committee financial expert |
115-116 |
||
16B | Code of Ethics |
137 |
||
16C | Principal Accountant Fees and Services |
368 |
||
16D | Exemptions from the Listing Standards for Audit Committees | n/a | ||
16E | Purchases of Equity Securities by the Issuer and Affiliated Purchasers |
369 |
||
16F | Change in Registrants Certifying Accountant | n/a | ||
16G | Corporate Governance |
131-135 |
||
16H | Mine Safety Disclosure | n/a | ||
17 | Financial Statements | n/a | ||
18 | Financial Statements |
144-319 |
||
19 | Exhibits |
382 |
Annual Report on Form 20-F 2017 |
1 | ||
Strategic information | ||||
2 | ||||
3 | ||||
5 | ||||
8 | ||||
Business overview | ||||
10 | ||||
11 | ||||
13 | ||||
20 | ||||
22 | ||||
22 | ||||
31 | ||||
47 | ||||
73 | ||||
82 | ||||
89 | ||||
91 | ||||
93 | ||||
99 | ||||
108 | ||||
Governance | ||||
112 | ||||
120 | ||||
123 | ||||
131 | ||||
136 | ||||
137 | ||||
138 | ||||
Consolidated financial statements of Aegon N.V. | ||||
143 | ||||
144 | ||||
Consolidated statement of comprehensive income of Aegon N.V. |
145 | |||
146 | ||||
147 | ||||
150 | ||||
151 | ||||
299 |
Financial statements of Aegon N.V. | ||||
307 | ||||
308 | ||||
309 | ||||
Other information | ||||
320 | ||||
321 | ||||
Other financial information | ||||
324 | ||||
325 | ||||
328 | ||||
330 | ||||
331 | ||||
Auditors report on the Annual Report on Form 20-F | 332 | |||
Additional information | ||||
335 | ||||
336 | ||||
356 | ||||
356 | ||||
357 | ||||
358 | ||||
359 | ||||
360 | ||||
360 | ||||
361 | ||||
368 | ||||
Purchases of equity securities by the issuer and affiliated purchasers |
369 | |||
370 | ||||
376 | ||||
377 | ||||
378 | ||||
380 | ||||
381 | ||||
382 |
Annual Report on Form 20-F 2017 |
2 | Strategic information Introduction | |
About this report
Filing
This document contains Aegons Annual Report as filed on Form 20-F (also referred to in this document as Annual Report) with the United States Securities and Exchange Commission (SEC).
About this report
This report serves as Aegons Annual Report for the year ended December 31, 2017. It presents the consolidated financial statements of Aegon pages 144-305 and the stand-alone financial statements of Aegon N.V. pages 307-319, both prepared in accordance with the International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS), and Part 9 of Book 2 of the Dutch Civil Code.
Aegon N.V. is referred to in this document as Aegon, or the Company, and is together with its member companies referred to as Aegon Group or the Group. For such purposes, member companies means, in relation to Aegon N.V., those companies required to be consolidated in accordance with the Netherlands legislative requirements relating to consolidated accounts.
Presentation of certain information
References to the NYSE are to the New York Stock Exchange and references to the SEC are to the US Securities and Exchange Commission. Aegon uses EUR and euro when referring to the lawful currency of the member states of the European Monetary Union; USD, and US dollar when referring to the lawful currency of the United States of America; GBP, UK pound and pound sterling when referring to the lawful currency of the United Kingdom; and PLN when referring to the lawful currency of Poland.
Aegon prepares its consolidated financial statements in accordance with IFRS and with Part 9 of Book 2 of the Netherlands Civil Code for purposes of reporting with the U.S. SEC, including financial information contained in this Annual
Report on Form 20-F. Aegons accounting policies and its use of various options under IFRS are described in note 2 to the consolidated financial statements.
Other then for SEC reporting, Aegon prepared its Annual Accounts under International Financial Reporting Standards as adopted by the European Union, including the decisions Aegon made with regard to the options available under International Financial Reporting Standards as adopted by the EU (IFRS-EU). IFRS-EU differs from IFRS in respect of certain paragraphs in IAS 39 Financial Instruments: Recognition and Measurementregarding hedge accounting for portfolio hedges of interest rate risk. Under IFRS-EU, Aegon applies fair value hedge accounting for portfolio hedges of interest rate risk (fair value macro hedges) in accordance with the EU carve out version of IAS 39. Under IFRS. hedge accounting for fair value macro hedges cannot be applied to mortage loans and ineffectiveness arises whenever the revised estimate of the amount of cash flows in sceduled time buckets is either more or less than the original designated amount of that bucket.
This information is prepared by revising the hedge accounting impacts that are applied under the EU carve out version of IAS
39. Financial information under IFRS accordingly does not take account of the possibility that had Aegon applied IFRS as its primary accounting framework it might have apllied alternative hedge strategies where those alternative hedge strategies could have qualified for IFRS compliant hedge accounting. These decisions could have resulted in different shareholders equity and net income amounts compared to those indicated in this Annual Report on Form 20-F.
A reconciliation between IFRS-EU and IFRS is included in note 2.1 to the consolidated financial statements.
References
References are included on page 377 of this document.
Annual Report on Form 20-F 2017 |
3 | Strategic information CEO letter | |
2017 was a year to be proud of as we continued to grow our business profitably, strengthened our capital position, executed our strategy and helped millions of people achieve a lifetime of financial security.
Our environment
Last year saw a welcome improvement in the world economy, with the 3% pickup in global growth the highest rate recorded since 2011. For Aegon, the macroeconomic backdrop was in general positive. Economic growth improved across the majority of our markets, and this was reflected in business and consumer confidence. Inflation remained relatively low and central bank policies moved slowly onto a path of normalization globally. The rise in interest rates, be it from a very low base, was a beneficial development not only for customers wishing to save for the future, but also for Aegon and the industry as a whole.
Political events were once again followed very closely by the financial community. Indeed, political developments in Aegons three largest markets continued to make headlines, with a new President taking office in the US, the formation of a new coalition in the Netherlands, and the triggering of article 50 by the UK government to leave the EU. The regulatory world also continued to change rapidly. In the US, for instance, the Department of Labor implemented a new fiduciary rule to ensure customers best interests are served, whereas in the UK, changes to corporate tax rate policy required us to hold more capital.
Our financial performance
2017 was a very positive year for Aegon from a financial perspective, and I am pleased that we are, as a result, well positioned to achieve our 2018 financial targets. In terms of our key financial metrics, our earnings were strong, we continued to generate solid sales particularly in fee businesses, pension businesses, mutual funds and third-party asset management and we made progress on our return on equity target.
Furthermore, recapitalizing our Dutch business and strengthening our group solvency ratio means that we are able to fully focus on continuing to implement our strategy, such as executing our expense savings program, which will lead to annual EUR 350 million cost savings by year-end 2018. Most important of all, we paid out a total of close to EUR 50 billion in claims and benefits over the year, demonstrating how relevant our company is to the lives of our millions of customers
Our companys transformation
Customers needs and expectations are continuously evolving and we are therefore changing the way we serve them. In 2017, we made significant progress across our company in becoming a more innovative and digital company, positioning us well for future growth.
In our largest market, the US, we continued our work to reduce expenses in order to boost earnings and modernize our business by investing in new technology. In early January of 2018, we announced that we would outsource the administration of our life, health, annuities and benefits businesses. This decision represents a major strategic step forward, as our customers will benefit from both enhanced digital capabilities and higher service levels. In addition, the divestment of the majority of our run-off businesses marked a major milestone in the strategic transformation of our US business.
The most important development in the Netherlands over the last year was the recapitalization of our Dutch business by injecting capital from the Group and divesting Unirobe Meeùs Groep. As a result, the unit is now strongly capitalized, is expected to generate healthy cash flows, and is positioned to pay a dividend to the group in 2018, which represents a very significant turnaround from only a year ago.
In the UK, we have transformed our business into the number one retail investment platform in the market, with over 1.2 million customers. Our main focus over the last year was continuing to integrate Cofunds and BlackRocks defined contribution business, together with upgrading tens of thousands of customers from our backbook onto our state-of-the-art platform, which increased assets to more than GBP 117 billion. This growth is a direct result of our decision to reposition our UK business, and underlines the benefits of moving to a fee-based business model.
During 2017, we took the decision to implement a new structure in our European asset management business to enhance synergies, become more agile and improve earnings. Furthermore, our asset management joint ventures in China and France have proven very successful in contributing to underlying earnings and the growth of our business.
The significant progress achieved in our largest markets was also replicated in our developing markets. In Asia, for instance, our Chinese joint venture has become profit-making due to the continued success of our critical illness product. Our Asian high-net-worth business has made a meaningful contribution to the group, upstreaming a special dividend of USD 200 million for the first time. Elsewhere, our business in India is a leader in the digital insurance market, and continues to set the standard for offering life insurance online. Perhaps most pleasing of all, we have made significant progress in terms of how we share
Annual Report on Form 20-F 2017 |
4 | Strategic information CEO letter | |
ideas, information and innovation across our company. This means that customers in one market can benefit from what we have learned in another, demonstrating one of the key benefits of being active in such diverse markets.
Our communities
Being a responsible corporate citizen is a role we take very seriously. We manage over EUR 800 billion of investments and have a duty to invest responsibly. We also support our communities in other ways: raising global awareness about retirement issues; fulfilling our tax obligations; and helping to implement the UNs 2030 Sustainable Development Goals and Paris Agreement on Climate Change. Further information about all these issues, together with an overview of our strategy, can be found in our 2017 Review, which is published online.
Our employees and shareholders
I am very proud of how our team of over 28,000 colleagues continued to deliver at a time of change. I would therefore like to pay tribute to their hard work and dedication over the last 12 months, and express my gratitude for all that they do to serve our customers. Our thanks also go to our investors, without whom we would not be able to meet our purpose. I am pleased
that we increased our full year 2017 dividend to 27 euro cents, and that by paying a sustainable and growing dividend we will be able to meet our target to return EUR 2.1 billion of capital to shareholders from 2016 to 2018.
Our organization
We are this year saying farewell to Aegons Supervisory Board Chairman, Rob Routs and fellow member of the Supervisory Board. Dirk Verbeek both of whom are stepping down at the Annual General meeting in May 2018. I would like to sincerely thank Rob and Dirk for the commitment, challenge and support they have provided over the last 10 years, and wish them well for the future.
Looking ahead
Our company has every reason to look forward with confidence. We are well on track to achieve our 2018 financial targets, and we have a compelling strategy. Moreover, the need for the financial security we help provide to millions of customers has never been so great. By continuing to transform and grow our business we will therefore be even better placed to help people around the world secure their financial future.
Alex Wynaendts
Chief Executive Officer and Chairman of the Executive Board of Aegon N.V.
Annual Report on Form 20-F 2017 |
5 | Strategic information Composition of the Executive Board and the Management Board | |
Composition of the Executive Board
Alexander R. Wynaendts (1960, Dutch)
CEO and Chairman of the Executive and Management Boards of Aegon N.V.
Alex Wynaendts began his career in 1984 with ABN AMRO Bank, working in Amsterdam and London in the Dutch banks capital markets, asset management, corporate finance and private banking operations. In 1997, Mr. Wynaendts joined Aegon as Senior Vice President for Group Business Development. He was appointed as a member of Aegons Executive Board
in 2003, overseeing the Companys international growth strategy. In April 2007, Mr. Wynaendts was named Aegons Chief Operating Officer. A year later, he became CEO and Chairman of Aegons Executive Board and Management Board. His current term of office ends in 2019. Mr. Wynaendts has been an Independent Director of the Board of Air France-KLM S.A. since May 2016 and a member of the Supervisory Board of Puissance B.V. (not listed) since May 2017.
Matthew J. Rider (1963, American)
CFO and member of the Executive and Management Boards of Aegon N.V.
Matt Rider began his career at Banner Life Insurance Company and held various management positions at Transamerica, Merrill Lynch Insurance Group and ING before joining Aegon. From 2010 to 2013, he was Chief Administration Officer
and a member of the Management Board at ING Insurance, based in the Netherlands. In this role he was responsible for all of INGs insurance and asset management operations, and specifically for Finance and Risk Management. Mr. Rider joined Aegon on January 1, 2017 and was appointed as CFO and member of the Executive Board of Aegon at the Annual General Meeting of Shareholders of Aegon N.V. of May 19, 2017.
Composition of the Management Board
Alexander R. Wynaendts: see above
Matthew J. Rider: see above
Mark Bloom (1964, American)
Global Chief Technology Officer and member of the Management Board of Aegon N.V.
Mark Bloom has over 30 years experience in information technology. He joined Aegon from Citi in February 2016, where he served as Global Head of Consumer Digital and Operations Technology, responsible for digital, data and operations technology solutions and innovations. Prior to that, he held
a number of technology leadership positions in financial services and the aerospace industry. As Global Chief Technology Officer at Aegon, Mr. Bloom is responsible for leading the Companys technology and innovation activities, including leveraging technology to drive efficiency and enhancing the customer experience. Mr. Bloom was appointed as a member of Aegons Management Board in August 2016.
Adrian Grace (1963, British)
CEO of Aegon UK and member of the Management Board of Aegon N.V.
Adrian Grace held various roles at GE capital, Sage Group Inc., before joining Barclays Bank as Chief Executive of the Insurance Business in 2004, and HBOS as Managing Director of Commercial
Businesses in 2007. He joined Aegon UK in 2009, and was appointed CEO of Aegon UK in 2011 and as a member of the Management Board of Aegon in 2012. Mr. Grace is a non-executive Director at Clydesdale Bank and a member of the Financial Conduct Authority practitioners panel. He was member of the Board of Scottish Financial Enterprise until June 2013.
Annual Report on Form 20-F 2017 |
6 | Strategic information Composition of the Executive Board and the Management Board | |
Allegra van Hövell-Patrizi (1974, Italian)
Chief Risk Officer of Aegon N.V. and member of the Management Board of Aegon N.V.
Allegra van Hövell-Patrizi began her career in 1996 at McKinsey & Company, specializing in financial institutions. After several years as a partner there, she joined F&C Asset Management in 2007 as a member of the Management Committee. In 2009, she
joined Prudential plc where she became Group Risk Director, and a member of the Group Executive Risk Committee, as well as the PUSL Board (within the Prudential plc group). Ms. Van Hövell-Patrizi joined Aegon at the end of 2015. She was appointed Chief Risk Officer of Aegon N.V. and a member of Aegons Management Board in January 2016.
Marco Keim (1962, Dutch)
Head of Aegon Continental Europe and member of the Management Board of Aegon N.V.
Marco Keim began his career with accountancy firm Coopers & Lybrand / Van Dien, before moving to the aircraft manufacturer Fokker Aircraft and NS Reizigers, part of the Dutch railway company, NS Group. In 1999, he joined Swiss Life in the Netherlands as a Member of the Board, and was appointed CEO
three years later. Mr. Keim was appointed CEO of Aegon the Netherlands and member of Aegons Management Board in June 2008, and Head of Aegon Continental Europe in January 2017. Mr. Keim was a Board member at the Verbond van Verzekeraars until December 2016. Mr. Keim is a member of the Supervisory Board of Eneco Holding N.V., and holds a Management Board position at VNO-NCW.
Onno van Klinken (1969, Dutch)
General Counsel and member of the Management Board of Aegon N.V.
Onno van Klinken has over 25 years experience providing legal advice to a range of companies and leading Executive Board offices. Mr. Van Klinken started his career at Allen & Overy, and previously worked for Aegon between 2002 and 2006. He then served as Corporate Secretary for Royal Numico, before it was acquired by Groupe Danone. His next position was as General Counsel for the Dutch global mail and express group TNT,
where he served from 2008 until the legal demerger of the group in 2011. This was followed by General Counsel positions at D.E. Master Blenders 1753 and Corio N.V Mr. Van Klinken rejoined Aegon in 2014 as General Counsel responsible for Group Legal, Regulatory Compliance, the Executive Board Office, and Government and Policy Affairs. Mr. Van Klinken has been a member of Aegons Management Board since August 2016. Mr. Van Klinken was appointed member of the Board of Stichting Continuïteit SBM Offshore in December 2016.
Carla Mahieu (1959, Dutch)
Global Head Human Resources and member of the Management Board of Aegon N.V.
Carla Mahieu started her career in 1984 at Royal Dutch Shell, where she held various management positions within Human Resources, Communications and Corporate Strategy. Following several years as a consultant during which time she worked for Spencer Stuart, among other companies Ms. Mahieu was
appointed Senior Vice President Corporate Human Resource Management at Royal Philips Electronics in 2003. Ms. Mahieu joined Aegon in 2010 as Global Head Human Resources, and has been a member of Aegons Management Board since August 2016. Ms. Mahieu has been a member of the Supervisory Board of the Royal BAM Group since 2011, and the Supervisory Board of VodafoneZiggo Group B.V. since 2017.
Annual Report on Form 20-F 2017 |
7 | Strategic information Composition of the Executive Board and the Management Board | |
Mark Mullin (1963, American)
CEO of Aegon Americas and member of the Management Board of Aegon N.V.
Mark Mullin has spent more than 20 years with Aegon in various management positions in both the United States and Europe. Mr. Mullin served as President and CEO of one of Aegons US subsidiaries, Diversified Investment Advisors, and as head
of the Companys US annuity and mutual fund businesses. He was named President of Aegon Americas in 2009, and became President and CEO of Aegon Americas and a member of Aegons Management Board in 2010. Mr. Mullin was appointed Chairman of the Board of Directors of the American Council of Life Insurers in October 2017.
Sarah Russell (1962, Australian)
CEO of Aegon Asset Management and member of the Management Board of Aegon N.V.
Sarah Russell has over 25 years experience in international finance and asset management. Ms. Russell began her career at Toronto Dominion in Melbourne before joining ABN AMRO in 1994. She moved to the Netherlands in 2000, where she held a number of various roles, leading to her appointment as CEO of ABN AMROs asset management operations. Ms. Russell
joined Aegon Asset Management as CEO in 2010, and has been a member of Aegons Management Board since August 2016. Ms. Russell has been a non-executive director of Nordea Bank AB since 2010, holds a Supervisory Board member position at the Nederlandse Investeringsinstelling, and is Vice Chairman of the Supervisory Board of La Banque Postale Asset Management. Ms. Russell is also a Board member of the American Chamber of Commerce, the Netherlands since May 2017.
Annual Report on Form 20-F 2017 |
8 | Strategic information Aegons strategy | |
Long-term value creation
To prosper, companies must create long-term value for society and their stakeholders. Aegon creates value in several ways, for instance as a provider of insurance and other financial services, and a responsible employer and business partner. Aegon also makes significant social and economic contributions through its returns to shareholders, its tax payments, its support for local communities and, most importantly, through the money the Company invests both for its own account and on behalf of its customers. Aegons aim is to be a responsible corporate citizen, fully aware of the impact the Companys businesses have on its stakeholders and on society as a whole.
Aegon defines its stakeholders as: any individual or organization affected, or likely to be affected, by its business or that may, in turn, affect the environment in which we operate. Aegon recognizes five main stakeholder groups:
◆ | Customers (individual customers, group and corporate clients); |
◆ | Employees (full-time and part-time employees, tied agents, trade unions and other employee representative groups); |
◆ | Investors (institutional and retail investors); |
◆ | Business partners (distributors, joint venture partners, outsourcing partners, reinsurers, and suppliers of goods and services); and |
◆ | Wider community (charities, community groups and other NGOs, governments, regulators, academic and other public institutions). |
Most Aegon businesses operate in a highly-regulated environment. This environment may be affected by a number of factors: economic, financial, regulatory, social, environmental and employee-related. More information on the aspects relevant to Aegon can be found in the non-financial statement on page 13.
Aegons ambition
Aegons purpose - to help people achieve a lifetime of financial security - forms the basis of the Companys strategy. The central focus of the strategy is to further change the Company from a product-based to a customer need-driven company. This means serving diverse and evolving needs across the customer life cycle; aligning Aegons brand promise with being a trusted partner for financial solutions that are relevant, simple, rewarding, and convenient; and developing long-term customer relationships by providing guidance and advice, and identifying additional financial security needs at every stage of customers lives.
The aim of Aegons strategy is that the Company be a truly international enterprise with a common culture across its businesses of working together; that Aegons respective businesses learn from one another and replicate best practices to benefit customers; that it recognizes and addresses
opportunities in rapidly changing markets in a timely and agile way; and that it attracts, develops, and retains the best people who share its values and are committed to its purpose.
In order to do so, Aegon is focused on reducing complexity, eliminating duplication, improving accuracy, and increasing automation to realize cost efficiencies, allowing investments in its transformation to a digitally enabled, customer-centric company. Furthermore, the Company is focused on driving scale and establishing strong market positions in its current footprint, and strictly adhering to comprehensive standards that support the efficient use of capital by all its businesses. The different market segments, and starting positions of Aegons businesses nonetheless mean that they will experience different paths to meet the same goals. Expertise and knowledge available in Aegons established markets is utilized to position its businesses in emerging markets.
In summary, it is Aegons ambition to be regarded as a trusted partner for financial solutions at every stage of life in all its markets. That means being recognized by its customers, business partners, and society as a company that puts the interests of its customers first in all that it does; and being regarded as an employer of choice by employees, engaging and enabling them to succeed. In addition, the Company strives to meet shareholders expectations by generating strong returns, earnings and dividends.
Aegons strategic objectives
Aegon believes that it will achieve its ambition of becoming a trusted partner for financial solutions at every stage of life if it realizes the following strategic objectives:
◆ | Serving customers need for financial security throughout their lifetimes by providing digitally-enabled, omni-channel, accessible solutions and superior customer experience (Loyal Customers); |
◆ | Delivering excellent service to customers at competitive cost levels by increasing scale and improving the quality, efficiency and accuracy of processes with technology (Operational Excellence); |
◆ | Valuing and supporting Aegon employees as the Companys greatest asset by engaging and enabling them with the tools, training and culture needed to exceed customers expectations (Empowered Employees); and |
◆ | Ensuring that the Company always meets its long-term commitments to stakeholders by delivering sustainable financial results and maintaining a strong and stable balance sheet (Optimized Portfolio). |
Annual Report on Form 20-F 2017 |
9 | Strategic information Aegons strategy | |
Aegons business model
Aegons overall business model has six basic stages (though these may vary according to product, local market and distribution channel):
Acquisitions & divestments
Acquisitions can accelerate the implementation of Aegons strategy, provide it with access to new technologies and provide the scale needed in markets in which it is already active. Aegon is selective when determining which businesses it would like to acquire, generally targeting acquisitions that fit the Companys mission of securing the financial future of its customers, and that are aligned with its four strategic objectives. The Company uses several financial criteria for determining the attractiveness of acquisitions, including: return on capital, internal rate of return, capital generation, and capital fungibility. Similar strategic and financial criteria are applied when considering the potential divestment of existing activities.
Risks and opportunities for Aegon
Aegon has identified several risks to successfully executing its strategy, which are both financial and non-financial in nature. The financial underwriting and operational risks are described in the risk management section on page 94. The non-financial risks are described in the non-financial statement on page 13. Opportunities with regards to the most significant topics and issues affecting Aegons business are also described in the non-financial statement on page 13-14.
Operational and financial goals
Aegon has a number key financial targets, including:
◆ | Realize annual operating expense savings of 350 million; |
◆ | Achieve a return on equity of 10% by 2018; |
◆ | Return 2.1 billion of capital to shareholders over 2016-2018 through share buyback and dividends; |
◆ | Achieve an annual sales growth of 10% by growing fee-based businesses and expanding in Asset Management; and |
◆ | Maintain a solid capital position with a Solvency II ratio within a range of 150-200% at Group level. |
Non-financial information is further described in the non-financial statement on page 16 (Performance indicators).
Culture
Refer to page 16 for overview of cultural change program (Non-Financial Statement).
Annual Report on Form 20-F 2017 |
10 | Business overview History and development of Aegon | |
History and development of Aegon
Aegon is an international life insurance, pensions and asset management group. Its listed holding company, Aegon N.V., is a public limited liability company with its corporate seat and head office in the Netherlands.
The Companys history dates back over 170 years. Aegon N.V. was formed in 1983 through the merger of AGO and Ennia, both of which were successors to insurance companies founded in the 1800s.
Aegon is headquartered in the Netherlands, and through its subsidiaries and joint ventures it employs over 28,000 people worldwide. Aegons common shares are listed on stock exchanges in Amsterdam (Euronext) and New York (NYSE). Aegons main operating units are separate legal entities that operate under the laws of their respective countries. The shares of these legal entities are directly or indirectly held by three intermediate holding companies incorporated under Dutch law: Aegon Europe Holding B.V., the holding company for all European activities; Aegon International B.V., which serves as a holding company for the Aegon Group companies of all non-European countries; and Aegon Asset Management Holding B.V., the holding company for a number of its asset management entities.
Aegon exists to help people achieve a lifetime of financial security. It uses a multi-brand, multichannel distribution approach to meet its customers needs, and fosters an entrepreneurial spirit within its businesses, encouraging the development of innovative products and services.
Aegon has the following operating segments: the Americas, which includes the United States, Mexico and Brazil; the Netherlands; the United Kingdom; Central & Eastern Europe; Spain & Portugal; Asia and Aegon Asset Management. The separate operating segments of the Netherlands, the United Kingdom, Central & Eastern Europe and Spain & Portugal may be referred together as Europe, although Europe is not an operating segment.
Annual Report on Form 20-F 2017 |
11 | Business overview Selected financial data | |
The financial results in this Annual Report are based on Aegons consolidated financial statements, which have been prepared in accordance with International Financial Reporting Standards as issued by the IASB (IFRS).
Application of the accounting policies in the preparation of the financial statements requires management to apply judgment involving assumptions and estimates concerning future results or other developments, including the likelihood, timing or amount of future transactions or events. There can be no assurance that actual results will not differ materially from those estimates. Accounting policies that are critical to the presentation of the financial statements and that require complex estimates
or significant judgment are described in the notes to the financial statements.
A summary of historical financial data is provided in the table below. It is important to read this summary in conjunction with the consolidated financial statements and related notes (see pages 144-305) of this Annual Report.
Selected consolidated income statement information | ||||||||||||||||||||
In EUR million (except per share amount) | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||
Amounts based upon IFRS |
||||||||||||||||||||
Premium income |
22,826 | 23,453 | 22,925 | 19,864 | 19,939 | |||||||||||||||
Investment income |
7,338 | 7,788 | 8,525 | 8,148 | 7,909 | |||||||||||||||
Total revenues 1) |
32,973 | 33,655 | 33,902 | 30,157 | 29,805 | |||||||||||||||
Income/ (loss) before tax |
2,534 | 610 | (514 | ) | 916 | 1,236 | ||||||||||||||
Net income/ (loss) |
2,469 | 438 | (431 | ) | 766 | 1,003 | ||||||||||||||
Earnings per common share |
||||||||||||||||||||
Basic |
1.14 | 0.15 | (0.27 | ) | 0.29 | 0.37 | ||||||||||||||
Diluted |
1.14 | 0.15 | (0.27 | ) | 0.29 | 0.37 | ||||||||||||||
Earnings per common share B |
||||||||||||||||||||
Basic |
0.03 | - | (0.01 | ) | 0.01 | 0.01 | ||||||||||||||
Diluted |
0.03 | - | (0.01 | ) | 0.01 | 0.01 |
1 | Excluded from the income statements prepared in accordance with IFRS are receipts related to investment-type annuity products and investment contracts. |
Selected consolidated balance sheet information | ||||||||||||||||||||
In million EUR | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||
Amounts based upon IFRS |
||||||||||||||||||||
Total assets |
395,923 | 425,425 | 415,415 | 424,112 | 351,523 | |||||||||||||||
Insurance and investment contracts |
324,362 | 344,844 | 343,558 | 321,384 | 283,234 | |||||||||||||||
Borrowings including subordinated and trust pass-through securities |
14,532 | 14,076 | 13,361 | 15,049 | 12,009 | |||||||||||||||
Shareholders equity |
20,288 | 20,520 | 22,441 | 23,847 | 17,589 | |||||||||||||||
Number of common shares |
||||||||||||||||||||
In thousands | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||
Balance at January 1 |
2,074,549 | 2,147,037 | 2,145,948 | 2,131,459 | 1,972,030 | |||||||||||||||
Share issuance |
- | - | - | - | 120,713 | |||||||||||||||
Stock dividends |
21,099 | 10,629 | 1,089 | 14,489 | 38,716 | |||||||||||||||
Shares withdrawn |
- | (83,117 | ) | - | - | - | ||||||||||||||
Balance at end of period |
2,095,648 | 2,074,549 | 2,147,037 | 2,145,948 | 2,131,459 |
Annual Report on Form 20-F 2017 |
12 | Business overview Selected financial data | |
Number of common shares B | ||||||||||||||||||||
In thousands | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||
Balance at January 1 |
585,022 | 585,022 | 581,326 | 579,005 | - | |||||||||||||||
Share issuance |
- | - | 3,696 | 2,320 | 579,005 | |||||||||||||||
Balance at end of period |
585,022 | 585,022 | 585,022 | 581,326 | 579,005 |
Dividends
Aegon declared interim and final dividends on common shares for the years 2013 through 2017 in the amounts set forth in the following table. The 2017 interim dividend amounted to EUR 0.13 per common share. The interim dividend was paid in cash or stock at the election of the shareholder. The interim dividend was payable as of September 15, 2017. At the General Meeting of Shareholders on May 18, 2018, the Supervisory Board will, absent unforeseen circumstances, propose a final dividend of EUR 0.14 per common share (at each shareholders option
in cash or in stock), which will bring the total dividend for 2017 to EUR 0.27. With respect to the Common Shares B, each which has financial rights attached to it of 1/40th of a Common Share, the proposed final dividend will be EUR 0.0035. After taking the interim-dividend 2017 of EUR per Common Share B into account, this will result in a total 2017 dividend of EUR 0.00675 per Common Share B. Dividends in US dollars are calculated based on the foreign exchange reference rate (WM/Reuters closing spot exchange rate fixed at 5.00 pm Central European Summer Time (CEST)) on the US-ex dividend day.
EUR per common share 1) | USD per common share 1) | |||||||||||||||||||||||
Year | Interim | Final | Total | Interim | Final | Total | ||||||||||||||||||
2013 |
0.11 | 0.11 | 0.22 | 0.15 | 0.15 | 0.30 | ||||||||||||||||||
2014 |
0.11 | 0.12 | 0.23 | 0.15 | 0.13 | 0.28 | ||||||||||||||||||
2015 |
0.12 | 0.13 | 0.25 | 0.13 | 0.15 | 0.28 | ||||||||||||||||||
2016 |
0.13 | 0.13 | 0.26 | 0.15 | 0.15 | 0.29 | ||||||||||||||||||
2017 |
0.13 | 0.14 2) | 0.27 | 0.15 |
1 | Paid at each shareholders option in cash or in stock. |
2 | Proposed. |
Exchange rates
Fluctuations in the exchange rate between the euro and the US dollar will affect the dollar equivalent of the euro price of Aegons common shares traded on Euronext Amsterdam and, as a result, are likely to impact the market price of Aegons common shares in the United States. Such fluctuations will also affect any US dollar amounts received by holders of common shares upon conversion of any cash dividends paid in euros on Aegons common shares.
As of March 16, 2017, the USD exchange rate was EUR 1 = USD 1.2280.
The high and low exchange rates for the US dollar per euro for each of the last six months through February 2018 are set forth below:
Closing rates | Sept. 2017 | Oct. 2017 | Nov. 2017 | Dec. 2017 | Jan. 2018 | Feb. 2018 | ||||||||||||||||||
High (USD per EUR) |
1.2041 | 1.1847 | 1.1936 | 1.2022 | 1.2488 | 1.2482 | ||||||||||||||||||
Low (USD per EUR) |
1.1747 | 1.1580 | 1.1577 | 1.1725 | 1.1922 | 1.2211 |
The average exchange rates for the US dollar per euro for the five years ended December 31, 2017, calculated by using the average
of the exchange rates on the last day of each month during the period, are set forth below:
Year ended December 31, | Average rate 1) | |||
2013 |
1.3303 | |||
2014 |
1.3210 | |||
2015 |
1.1032 | |||
2016 |
1.1029 | |||
2017 |
1.1399 |
1 | The US dollar exchange rates are the noon buying rates in New York City for cable transfers in euros as certified for customs purposes by the Federal Reserve Bank of New York. |
Annual Report on Form 20-F 2017 |
13 | Business overview Non-Financial Statement | |
Introduction
To prosper, companies must create long-term value for society and their stakeholders. Its from this value that a company derives its license to operate 2 . Aegon creates value in several ways: as a provider of insurance and other financial services, and a responsible employer and business partner. Aegon also makes significant social and economic contributions through its returns to shareholders, its tax payments, its support for local communities and, most importantly, through investments for both for its own account and on behalf of its customers. Aegons aim is to be a responsible corporate citizen, fully aware of the impact the Companys businesses have on its stakeholders and on society as a whole.
Social and economic role of insurance
Insurance plays a very important role in strengthening social stability and in creating the conditions necessary for long-term economic growth. Insurance protects people, property and assets and, by doing so, allows individuals and businesses to take risks, and invest and plan for the future. By pooling risk, insurance increases social solidarity between individuals, groups and generations. Insurers are also significant long-term investors in the economy, financing both public and private sectors, creating new jobs and driving business growth.
Aegons businesses
Aegon is an international financial services, insurance, pension and asset management company. Its purpose is to help customers achieve a lifetime of financial security. Aegons main operations are located in the US, the Netherlands and the UK. The Company also has operations elsewhere in Europe, as well as in Asia and Latin America.
Aegon offers a range of financial products, including life insurance, savings and investments, retirement plans and property & casualty cover. Most of Aegons products and services are sold through brokers and other financial intermediaries, though direct-to-customer sales have been increasing in recent years.
Business model
Please refer to page 9 of Aegons Strategy to view Aegons business model.
Stakeholders
As an international business, Aegon has many stakeholders. Their relationship with the Company depends not only on the
nature of each stakeholders organization or activities, but also the value created by that relationship (both for the stakeholder and for Aegon).
Aegon defines its stakeholders as: any individual or organization affected, or likely to be affected, by its business or that may, in turn, affect the environment in which the Company operates. Aegon recognizes five main stakeholder groups:
◆ | Customers (individual customers, group and corporate clients); |
◆ | Employees (full-time and part-time employees, tied agents, trade unions and other employee representative groups); |
◆ | Investors (institutional and retail investors); |
◆ | Business partners (distributors, joint venture partners, reinsurers and suppliers of goods and services); |
◆ | Wider community (governments, regulators, charities, tax authorities, community groups and other non-governmental organizations, academic and other public institutions). |
Aegon regularly engages its stakeholders, and uses their input to improve products and services, and to ensure the Company remains accountable and relevant.
Current operating environment
Most Aegon businesses operate in a highly-regulated environment. This environment may be affected by a number of factors: economic, financial, regulatory, social, political and environmental. Over the past year, Aegons operating environment has shown signs of improvement, particularly as a result of stronger financial markets and economic growth in the US, Europe and parts of Asia. Interest rates remain low, however. Insurance sector regulation, meanwhile, has become increasingly complex. There has also been a rise in political uncertainty, and rapid social change, driven by aging and the introduction of new digital technologies.
Material issues
Every year, Aegon identifies a number of material issues. This is done through a formal materiality exercise, involving both stakeholders and the Companys senior management. Material issues are those likely to have the most impact, over the next few years, on Aegons business, profits, reputation, and its ability to continue creating long-term value for stakeholders. Results of the materiality exercise are incorporated into Aegons strategy and reporting processes 3 . For 2017, five material issues were identified; the risks and opportunities have been mapped against each issue, and actions taken are outlined below:
Annual Report on Form 20-F 2017 |
14 | Business overview Non-Financial Statement | |
1 | In 2016, Aegon set up the Blockchain Insurance Industry Initiative (B3i) with four other insurers. B3is aim is to develop uses for blockchain technology in insurance. The initiatives first project a common platform for reinsurance launched an initial prototype in December 2017. |
Annual Report on Form 20-F 2017 |
15 | Business overview Non-Financial Statement | |
Value creation
Aegon creates both short and long-term value for its stakeholders. This value is often financial through the payment
of claims and benefits to customers, for example. But it may also be economic, social or environmental:
To create this value, Aegon makes use of different resources or capitals 4 . These inputs include:
◆ | Financial capital (from the Companys investors through investment in Aegon shares, bonds and other securities). |
◆ | Human & intellectual capital (through the skills and expertise of the Companys employees in product development, pricing, marketing, investment and risk management). |
◆ | Social & relationship capital (through customers trust in Aegon and through financial intermediaries responsible for selling the Companys products and services). |
Strategy and objectives
Over the past year, Aegon has reorganized many of its businesses, reducing costs and selling operations no longer considered core. At the same time, the Company has strengthened its capital position, set out responsible business objectives, and invested in new areas that will transform customer service and bring future growth. With this strategy, the aim is to ensure Aegon remains profitable, relevant to its customers, and able to continue creating long-term financial, social and environmental value for all its stakeholders. For more details of our strategy, measures taken and performance, please see pages 8-9 and Aegons Review, available online.
Benefits and risks for stakeholders
Aegons strategy aims to create additional value for each of the Companys main stakeholder groups:
◆ | Customers: Quicker, easier access to products and services through increased investment in digital technologies and online business models; |
◆ | Employees: New skills and career opportunities through training and development (particularly in core areas, such as analytics and digital marketing); |
◆ | Investors: Increased efficiency and new business growth, mainly as a result of divestments, and management actions to reduce financial risk and strengthen the Companys capital position; |
◆ | Business partners: Further business growth through expansion of key joint ventures and distribution agreements; |
◆ | Wider Community: Better protection of the environment through targeted investments in renewable energy and green bonds; increased knowledge of the social effects of aging through the work of the Aegon Center for Longevity & Retirement. |
In implementing these measures, there are risks for stakeholders. Prominent among them is the risk of job losses for employees, particularly those working in areas that can be easily automated (claims processing, underwriting, customer service, pricing etc.). Recent restructuring at the Companys operations in the US, UK and Netherlands has brought job losses. Overall, Aegons workforce is likely to decline in the coming years. New jobs will be created in digital marketing, IT, analytics and a number of other specialized areas, but these will not be sufficient to compensate job losses elsewhere in the Company 5 . Other risks related to implementation include financial market performance (which may reduce targeted returns for investors), and changes to the scope of Aegons businesses (which may alter the Companys relationship with certain customers and distributors).
Performance indicators
Measuring value creation is not always straightforward. Most financial value can be measured, but often social and environmental value is more difficult to quantify. Aegon also recognizes that, in creating value for one stakeholder group, it may deplete value for another group (for example, reducing headcount may result in lower costs and improved profit margins, creating value for shareholders and other investors, while overall value for employees is reduced).
Annual Report on Form 20-F 2017 |
16 | Business overview Non-Financial Statement | |
Performance indicators
Stakeholder | Indicator | 2017 | 2016 | 2015 | 3-year trend | Value 1) | ||||||||||||||||
Customers |
Claims, benefits & plan withdrawals | 48 billion | 59 billion | 46 billion | + | Financial | ||||||||||||||||
Assets managed on behalf of policyholders | 194 billion | 204 billion | 200 billion | - | Social | |||||||||||||||||
Investors |
Payments to investors (in the form of | 721 million | 774 million | 824 million | - | Financial | ||||||||||||||||
dividends and interest) 2) | ||||||||||||||||||||||
Employees |
Salaries and other social benefits | 2.23 billion | 2.29 billion | 2.28 billion | - | Social | ||||||||||||||||
Spending on training and career development | 14 million | 15 million | 14 million | Social | ||||||||||||||||||
Changes in size of workforce during year (headcount) | (1,062) | (2,150) | 2,748 | Social | ||||||||||||||||||
Business partners |
Commissions paid to brokers and other financial intermediaries | 2.7 billion | 2.9 billion | 3.3 billion | - | Financial | ||||||||||||||||
Payments to suppliers of goods & services | 1.4 billion | 1.3billion | 1.3 billion | Financial | ||||||||||||||||||
Wider Community |
Impact investments with specific environmental benefit Impact investments with specific social or | 0.8 billion | 0.4 billion | 0.6 billion | + | Environmental | ||||||||||||||||
health benefits | 7.2 billion | 6.8 billion | 7.0 billion | + | Social | |||||||||||||||||
Corporate income tax paid 3) | 173 million | 116 million | 405 million | Social | ||||||||||||||||||
Tax collected on behalf of governments | 2.2 billion | 2.2 billion | NM | Social | ||||||||||||||||||
Community investment (donations and value | ||||||||||||||||||||||
of employee volunteering) | 8.9 million | 8.8 million | 8.6 million | + | Social |
1 | Value created may be financial, social or environmental (or a combination of these values). Charts shows main value created for each stakeholder group only. |
2 | Does not include impact of share buy-backs. |
3 | Negative figures denote amounts received from the tax authorities. Please note that there is often no direct correlation between tax on earnings for any given year and amounts paid or received in tax. |
Culture change
To execute its strategy successfully, Aegon realizes that it needs to adapt its corporate culture to new circumstances. In 2016, the Company introduced Future Fit. With this program, Aegons goal is to create a more flexible organization, able to adapt quickly to new ways of working and doing business. Future Fit is built on four themes:
◆ | Agility (adapting quickly to new opportunities); |
◆ | Accountability (owning both problems and solutions); |
◆ | Acting as One (building on the ideas of others); |
◆ | Customer centricity (getting closer to customers and better understanding their needs). |
These themes have been embedded into performance appraisals, training and remuneration; they also form part of Aegons leadership development, assessment and commitments. In addition, change plans aligned and connected with local business goals have been developed to drive the process of change in each of Aegons businesses. These and other actions will contribute to a culture focused on long-term value creation. The Management Board regularly discusses progress with the Supervisory Board. Implementation of Future Fit will be the responsibility primarily of Aegons local businesses. By the end of 2017, 70% of employees had attended a Future Fit workshop.
To support Future Fit, Aegon is investing in new technical skills. Aegon has identified core capabilities that it believes will be critical to future performance and value creation. These new skills will be either developed internally, through training and development programs 6 , or brought in through the creation of new jobs or partnerships with other companies.
With Future Fit, Aegons aim is to ensure employees also have the skills they will need in their future careers, whether within the Company or outside. Progress with Future Fit is currently tracked through regular employee surveys (this includes awareness of Future Fit, and performance against each of the four themes).
Policies, procedures and outcome 7
Aegons system of governance is based on checks and balances. This helps the Company manage its business responsibly, protect long-term value creation, and take the best possible decisions for both itself and its stakeholders. As part of this overall approach, Aegon embeds social, environmental and financial considerations, where possible, in both formal procedures and other internal systems and processes. Doing so helps Aegon reduce risk, and ensure better business performance and more inclusive decision-making.
Annual Report on Form 20-F 2017 |
17 | Business overview Non-Financial Statement | |
The Table below shows how various social and environmental issues are incorporated into Aegon decision-making processes,
as well as the measurement of outcomes, policies and metrics:
Social and environmental issues
Issue |
Embedding of social and environmental factors into governance |
Outcome measurement
& reference |
Performance | |||
Code of Conduct | All employees must abide by Aegons Code of Conduct . This covers a number of topics, including data protection, environmental responsibility, human rights, and money laundering. The Code of Conduct also contains provisions for reporting suspected illegal and unethical behavior. Aegon has separate global policies to address prevention of financial crime (including fraud, money laundering, economic sanctions, and bribery and corruption). |
Total number of incidents of fraud, involving employees, intermediaries and third parties. Significant fines to address cases of misselling. Percentage of employees completing training on Code of Conduct. Completion of internal risk assessment (SIRA, or Systematic Integrity Risk Assessment), and action items to address any gaps in performance. Policy attestation for bribery and corruption risk (Conflict of Interest and Gift & Entertainment Policies). |
Incidents of fraud rose last year to 551 (compared with 196 in 2016); this was due to a reported rise in incidents involving third parties. There were no significant fines to address mis-selling. All action items under SIRA for 2016 were tracked to completion. By the end of 2017, 99% of employees had completed training on the Companys Code of Conduct. | |||
Community investment | Aegons Policy for Charitable Donations covers the Companys objectives with regard to community investment, as well as priority areas, selection criteria, governance and approval. The policy also sets out Aegons approach to humanitarian aid. |
Total donations to charities and other good causes. Donations as percentage of net income. Value of employee volunteering hours granted. |
Total cash donations 8.1 million (+3.8% compared with 7.8 million in 2016). This represented 0.4% of net income, down from 1.3% (due to increase in net income for 2017). Value of volunteering 0.8 million (-20% from 1.0 million in 2016). | |||
Data protection | Aegons Global Information Security Policy sets out the Companys approach to cyber threats and data protection. The policy applies to all Aegon businesses, and is supported by mandatory training in data and cyber security. |
Percentage compliance with terms of Aegons Global Information Security Policy. Total customer complaints related to data privacy breaches. |
Customer complaints relating to data privacy 198 (down from 275 in 2016). An internal assessment showed 73% compliance with the Companys Global Information Security Policy. This is in line with expectations; most examples of non-compliance were in smaller operating units and were minor in nature. | |||
Diversity & inclusion | Aegons Statement on Diversity & Non- Discrimination applies to all its businesses |
Total number of women in workforce. |
Women in Aegons workforce 53% (unchanged); women in senior management | |||
worldwide. Diversity is also included in Aegons Code of Conduct for employees, and there are diversity targets in place for the Companys Supervisory, Executive and Management Boards. |
Percentage of women in senior management and at Supervisory, Executive or Management Board level. |
28% (up from 27%). Please note, Aegon also track internally complaints made via its Ethics Line related to diversity and discrimination issues. | ||||
Environment | Aegons Environmental Policy emphasizes the importance of minimizing damage to the environment through the Companys use of energy, water and other utilities. The policy also commits Aegon, where possible, to identifying renewable or sustainable sources of energy. |
Total CO 2 emissions from business operations. Business travel by air, consumption of gas, electricity and water. Consumption of renewable energy (as percentage of overall energy use). |
CO 2 emissions 59,491 metric tons (-14% from previous years 69,213 metric tons); business travel 80.7 million km (-26%); gas consumption 1.8 million m 3 (-20%); electricity consumption 85.7 GwH (-12%); water use 208,531 m 3 (-20%). Renewable energy represented 26% of overall energy consumption in 2017 (up from 24%). | |||
Health & safety | Aegon has a Global Health & Safety Statement . This commits the Company to upholding high health & safety standards in its offices. Aegons aim is to limit work-related injuries and illnesses to an absolute minimum. |
Number of work-related illnesses and injuries. Absentee rate (by country of operation). |
Work-related injuries and illnesses 167 (-18% from 204 the previous year); absentee rate 2.4%, up from 2.0%. |
Annual Report on Form 20-F 2017 |
18 | Business overview Non-Financial Statement | |
Issue |
Embedding of social and environmental factors into governance |
Outcome measurement
& reference |
Performance | |||
Human rights | Aegons Human Rights Policy is based on the UN Declaration of Human Rights, the core standards of the International Labor Organization and the principles of the UN Global Compact. The policy commits Aegon to upholding international human rights standards at all businesses where it has sufficient management control and, where possible, to ensure partners live up to the same standards. |
Complaints (internal and external) relating to Aegons or business partners human rights record. Results of global human rights risk assessment. |
Aegon has a global Ethics Line (which allows anonymous reporting), and an internal process to investigate any allegations of human rights abuse. All Ethics Line matters are reported to the Companys Supervisory Board Audit Committee, though specific metrics on human rights are not tracked. Aegon completed a global human rights risk assessment in 2016. This assessment showed the Companys operating environment and geographical spread created a low risk for human rights violations. Aegons profile did not change in 2017. | |||
Investment | Aegon has a Responsible Investment Policy , covering all major asset classes. This policy sets out minimum social and environmental standards for the Companys investments. Aegon also excludes investment in certain areas, including controversial weapons, tobacco, and certain coal mining companies. Aegons approach to responsible investment is overseen by a Responsible Investment Strategy Committee, supported by a technical committee, which manages all operational aspects. The Company also has an extensive program of shareholder engagement, focused mainly on social, environmental and governance issues. |
Number of companies engaged as part of Aegons approach to responsible investment. Engagements related to social and environmental topics. Number and type of companies excluded from investment. Total investments delivering social & environmental benefits (Impact Investments). |
Aegon engaged 335 companies last year as part of its approach to responsible investment; of these 40% focused on social and environmental topics, the remainder on governance issues. A total of 120 companies are currently excluded from investments (these are related primarily to involvement with controversial weapons, coal mining or tobacco). Impact investments totaled 8.0 billion (up from 7.2 billion at the end of 2016). | |||
Procurement | Aegons Sustainable Procurement policy sets out business conduct, social and environmental standards for suppliers of goods and other services. Aegon businesses regularly assess suppliers against these standards, and require leading suppliers to sign a sustainability declaration. |
Percentage of Aegon businesses regularly assessing suppliers for social, environmental and governance risk. Proportion of suppliers where risk has been identified. |
Aegon businesses assessing suppliers for environmental, social and governance risk 51% (unchanged from 2016). | |||
Product development | Aegons Pricing & Product Development Policy includes the principle of reasonable distribution. The aim is to ensure that returns are shared reasonably between customers, intermediaries and shareholders, and reduce any risk of unacceptably low returns to customers. The Pricing & Product Development Policy also contains broader market conduct principles aimed at ensuring fair treatment of customers. |
Percentage compliance with terms of the Pricing & Product Development Policy. |
An internal assessment of Aegons business and operating units showed 95% compliance with the requirements of the policy. | |||
Remuneration | Aegon has a Global Remuneration Framework that details the Companys approach to pay. The Framework is based on the principle of pay for performance. Variable pay for Aegon executives and other senior management is based on both financial and non-financial performance metrics (including employee engagement and customer loyalty). |
Percentage of workforce with non-financial metrics in performance appraisals and variable compensation. |
Currently, 65% of Aegons workforce has non-financial metrics included in appraisals and variable pay. | |||
Risk management | Aegons Operational Risk Management Framework covers social and environmental risk. Under this framework, businesses are required to set minimum tolerance levels. Risks covered include tax, processing risk, financial crime and business disruption. |
Number of social or environmental risks flagged as serious or material. |
In 2017, no social or environmental risk exceeded Aegons operational risk tolerances. The Company has taken steps to further strengthen the monitoring and reporting of market conduct risks; this will continue to be an area of attention for management. |
Annual Report on Form 20-F 2017 |
19 | Business overview Non-Financial Statement | |
Issue |
Embedding of social and environmental factors into governance |
Outcome measurement
& reference |
Performance | |||
Tax | Aegon has a Global Tax Policy. This policy is based on the principle of fair taxes which means paying the right amount of taxes in the right places. Aegon tax follows business, which means that decisions are taken for business reasons and not for tax advantages. |
Total taxes borne by Aegon (Americas, Netherlands, UK and Other). Tax collected on behalf of others. |
In 2017, Aegon paid a total of 444 million in taxes (this covers corporate income tax, wage tax, irrecoverable VAT or GST, insurance premium tax and other taxes). The Company also collected 2.2 billion in taxes on behalf of governments (including withholding tax, wage tax, insurance premium tax, and other taxes).
|
Many of Aegons internal policies and processes are based on the relevant international standards. These include: the OECD Guidelines for Multinational Enterprises, the UN Declaration of Human Rights, the UN Global Compact and the core standards of the International Labor Organization. In addition, Aegon is a signatory to other international agreements, including the
Extractives Industry Transparency Initiative, and the Principles for both Sustainable Insurance and Responsible Investment. Aegon also reports its contribution to the UN Sustainable Development Goals, adopted in 2015. Details may be found in the Companys Review.
Annual Report on Form 20-F 2017 |
20 | Business overview Business lines | |
Americas
Life
Products offering protection against mortality, morbidity and longevity risks, including traditional and universal life, in addition to endowment, term, and whole life insurance products.
Accident & health
Products offering supplemental health, accidental death and dismemberment insurance, critical illness, cancer treatment, credit/disability, income protection, travel and long-term care insurance.
Mutual funds
Wide range of specialized mutual funds, including asset allocation, US equity, global/international equity, alternative investments, hybrid allocation, fixed income and target date funds.
Retirement plans
Comprehensive and customized retirement plan services to employers across the entire spectrum of defined benefit, defined contribution and non-qualified deferred compensation plans. Includes services to individuals rolling over funds from other qualified retirement funds or Individual Retirement Accounts (IRAs).
Variable annuities
Variable annuities allow the holder to accumulate assets for retirement on a tax-deferred basis and to participate in equity or bond market performance, in addition to receiving one of many payout options designed to provide income in retirement.
Fixed annuities
Fixed annuities allow customers to make a lump-sum payment or a series of payments and receive income in the form of periodic payments that can begin immediately or after a period of time.
Stable value solutions
Synthetic Guaranteed Investment Contracts (GICs) in the United States offered primarily to tax-qualified institutional entities such as 401(k) plans and other retirement plans.
Latin America
◆ | Brazil: Life and critical illness insurance; private and company pensions; pension scheme administration; and investment funds. |
◆ | Mexico: Individual life, group life, and health insurance; saving plans; and investment funds. |
Europe
The Netherlands
◆ | Life: Products offering protection against mortality, morbidity, and longevity risks, including traditional and universal life, in addition to employer, endowment, term, whole life insurance products; mortgages; annuity products; and banking products, including saving deposits. |
◆ | Pensions: Individual and group pensions usually sponsored by, or obtained via, an employer. Administration-only services are offered to company and industry pension funds. |
◆ | Non-life: General insurance, consisting mainly of automotive, liability, disability, household insurance, and fire protection. |
◆ | Distribution: Independent distribution channel, offering both life and non-life insurance solutions. |
United Kingdom
◆ | Life: Individual protection products, such as term insurance, critical illness, income protection and international/ offshore bonds. |
◆ | Pensions: Individual pensions, including self-invested personal pensions and drawdown products, such as guaranteed income drawdown products; group pensions, sponsored by, or obtained via, an employer. Also includes the tied-agent distribution business Origen. |
Central & Eastern Europe
Activities in the Czech Republic, Hungary, Poland, Romania, Slovakia, and Turkey. Includes life insurance, individual and group pension products, savings and investments, in addition to general insurance.
Spain & Portugal
Distribution partnerships with Santander in Spain & Portugal and with Liberbank in Spain. Includes life insurance, accident and health insurance, general insurance and investment products.
Annual Report on Form 20-F 2017 |
21 | Business overview Business lines | |
Asia
High net worth businesses
Life insurance marketed to high-net-worth individuals in Hong Kong and Singapore.
Aegon Insights
Full range of direct insurance solutions from product design, customer analytics insights, marketing campaign design and
multi-channel product distribution to policy administration and claims management.
Strategic partnerships
Joint ventures in China and India offering (term) life insurance and savings products, and in Japan offering variable annuities.
Aegon Asset Management
Americas
Investment products covering third-party customers, insurance-linked solutions, and Aegons own insurance companies.
The Netherlands
Investment products covering third-party customers, insurance-linked solutions, and Aegons own insurance companies in addition to manager selection and tailored advice on balance sheet solutions for the pension market.
United Kingdom
Fixed income, equities, real estate and multi-asset solutions to Aegons own insurance companies as well as external UK and international customers.
Rest of World
Asset management activities in Central & Eastern Europe and Spain & Portugal, in addition to results of the asset management holding.
Strategic partnerships
◆ | In China, Aegon Asset Management owns 49% of the shares of Aegon Industrial Fund Management Company, a Shanghai-based asset manager. |
◆ | In France, Aegon Asset Management has a strategic asset management partnership with La Banque Postale, through a 25% equity stake in La Banque Postale Asset Management. |
Annual Report on Form 20-F 2017 |
22 | Business overview Results of operations Worldwide | |
This Annual Report includes the non-IFRS financial measure: underlying earnings before tax. The reconciliation of this measure to the most comparable IFRS measure is presented in the table below in addition to note 5 Segment information of the consolidated financial statements. This non-IFRS measure is calculated by consolidating on a proportionate basis the revenues and expenses of Aegons joint ventures in China, Japan, Mexico, the Netherlands, Portugal and Spain and Aegons associates in Brazil, India, Mexico, the Netherlands and United Kingdom.
The table also includes the non-IFRS financial measure: net underlying earnings. This is the after-tax equivalent of underlying earnings before tax. The reconciliation of net underlying earnings to the most comparable IFRS measure is presented in the table below. Aegon believes that these non-IFRS measures provides meaningful supplemental information about the underlying operating results of Aegons businesses, including insight into the financial measures that senior management uses in managing the businesses.
Aegons senior management is compensated based in part on Aegons results against targets using the non-IFRS measures presented in this report. While many other insurers in Aegons peer group present substantially similar non-IFRS measures, the non-IFRS measures presented in this document may nevertheless differ from the non-IFRS measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards and readers are cautioned to consider carefully the different ways in which Aegon and its peers present similar information before making a comparison. Aegon believes the non-IFRS measures present within this report, when read together with Aegons reported IFRS financial statements, provide meaningful supplemental information for the investing public. This enables them to evaluate Aegons businesses after eliminating the impact of current IFRS accounting policies for financial instruments and insurance contracts, which embed a number of accounting policy alternatives that companies may select in presenting their results (as companies may use different local generally accepted accounting principles (GAAPs)), and this may make the comparability difficult between time periods.
Underlying earnings geographically | ||||||||||||
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Net underlying earnings |
1,543 | 1,483 | 4 | |||||||||
Tax on underlying earnings |
559 | 429 | 30 | |||||||||
Underlying earnings before tax geographically |
||||||||||||
Americas |
1,381 | 1,249 | 11 | |||||||||
The Netherlands |
520 | 534 | (2) | |||||||||
United Kingdom |
116 | 59 | 98 | |||||||||
Central & Eastern Europe |
67 | 55 | 20 | |||||||||
Spain & Portugal |
4 | 8 | (47) | |||||||||
Europe |
707 | 655 | 8 | |||||||||
Asia |
49 | 21 | 131 | |||||||||
Asset Management |
136 | 149 | (9) | |||||||||
Holding and other activities |
(170 | ) | (162 | ) | (5) | |||||||
Underlying earnings before tax |
2,103 | 1,913 | 10 | |||||||||
Fair value items |
142 | (840 | ) | n.m. | ||||||||
Gains / (losses) on investments |
413 | 340 | 21 | |||||||||
Net impairments |
(39 | ) | (54 | ) | 28 | |||||||
Other income / (charges) |
(68 | ) | (771 | ) | 91 | |||||||
Run-off businesses |
30 | 54 | (45) | |||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
2,579 | 641 | n.m. | |||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
44 | 31 | 45 | |||||||||
Income tax |
(110 | ) | (203 | ) | 46 | |||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(44 | ) | (31 | ) | (45) | |||||||
Net income / (loss) |
2,469 | 438 | n.m. | |||||||||
Commissions and expenses |
6,309 | 6,696 | (6) | |||||||||
of which operating expenses |
3,878 | 3,764 | 3 |
Annual Report on Form 20-F 2017 |
23 | Business overview Results of operations Worldwide | |
New life sales | ||||||||||||
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Americas |
472 | 542 | (13) | |||||||||
The Netherlands |
99 | 111 | (11) | |||||||||
United Kingdom |
37 | 66 | (44) | |||||||||
Central & Eastern Europe |
88 | 83 | 6 | |||||||||
Spain & Portugal |
48 | 39 | 23 | |||||||||
Europe |
273 | 299 | (9) | |||||||||
Asia |
151 | 128 | 18 | |||||||||
Total recurring plus 1/10 single |
896 | 969 | (8) | |||||||||
Gross deposits (on and off balance) | ||||||||||||
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Americas |
38,543 | 40,881 | (6) | |||||||||
The Netherlands |
8,061 | 6,686 | 21 | |||||||||
United Kingdom |
35,896 | 5,791 | n.m. | |||||||||
Central & Eastern Europe |
323 | 265 | 22 | |||||||||
Spain & Portugal |
36 | 31 | 15 | |||||||||
Europe |
44,316 | 12,773 | n.m. | |||||||||
Asia |
222 | 304 | (27) | |||||||||
Asset Management |
61,332 | 46,366 | 32 | |||||||||
Total gross deposits |
144,412 | 100,325 | 44 | |||||||||
Net deposits (on and off balance) | ||||||||||||
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Americas |
(29,713 | ) | (1,015 | ) | n.m. | |||||||
The Netherlands |
1,067 | 1,909 | (44) | |||||||||
United Kingdom |
4,665 | (846 | ) | n.m. | ||||||||
Central & Eastern Europe |
176 | 176 | - | |||||||||
Spain & Portugal |
13 | 20 | (37) | |||||||||
Europe |
5,921 | 1,260 | n.m. | |||||||||
Asia |
129 | 259 | (50) | |||||||||
Asset Management |
6,913 | 2,964 | 133 | |||||||||
Total net deposits excluding run-off businesses |
(16,750 | ) | 3,468 | n.m. | ||||||||
Run-off businesses |
(338 | ) | (759 | ) | 55 | |||||||
Total net deposits / (outflows) |
(17,088) | 2,709 | n.m. |
Annual Report on Form 20-F 2017 |
24 | Business overview Results of operations Worldwide | |
Worldwide revenues geographically 2017 Amounts in EUR millions |
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Total life insurance gross premiums |
7,437 | 1,857 | 9,603 | 411 | 208 | 12,079 | 983 | - | (1 | ) | 20,498 | (546 | ) | 19,952 | ||||||||||||||||||||||||||||||||||
Accident and health insurance premiums |
2,115 | 203 | 32 | 1 | 83 | 319 | 97 | - | - | 2,531 | (20 | ) | 2,511 | |||||||||||||||||||||||||||||||||||
General insurance premiums |
- | 148 | - | 216 | 103 | 467 | - | - | - | 466 | (103 | ) | 363 | |||||||||||||||||||||||||||||||||||
Total gross premiums | 9,553 | 2,208 | 9,635 | 628 | 394 | 12,865 | 1,080 | - | (2 | ) | 23,496 | (670 | ) | 22,826 | ||||||||||||||||||||||||||||||||||
Investment income |
3,368 | 2,172 | 1,517 | 49 | 37 | 3,774 | 246 | 4 | 5 | 7,396 | (58 | ) | 7,338 | |||||||||||||||||||||||||||||||||||
Fees and commission income |
1,919 | 326 | 235 | 43 | 17 | 621 | 63 | 609 | (221 | ) | 2,991 | (189 | ) | 2,802 | ||||||||||||||||||||||||||||||||||
Other revenue |
5 | - | - | - | 3 | 3 | 1 | - | 4 | 13 | (5 | ) | 7 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,844 | 4,706 | 11,387 | 720 | 450 | 17,263 | 1,390 | 613 | (214 | ) | 33,895 | (922 | ) | 32,973 | ||||||||||||||||||||||||||||||||||
Number of employees, including agent employees |
10,951 | 3,089 | 3,435 | 2,337 | 610 | 9,471 | 6,025 | 1,500 | 371 | 28,318 |
Annual Report on Form 20-F 2017 |
25 | Business overview Results of operations Worldwide | |
Results 2017 worldwide
Aegons net income in 2017 improved compared with 2016 to EUR 2,469 million. Underlying earnings before tax increased by 10% compared with 2016 to EUR 2,103 million in 2017, as higher underlying earnings before tax from the Americas, Europe and Asia were only partly offset by lower Asset Management underlying earnings before tax and Holding and other activities. The net result in 2017 benefited from realized gains of EUR 413 million mainly related to normal trading in the investment portfolio, as well as a EUR 554 million benefit related to the US tax reform. The result from fair value items amounted to a gain of EUR 142 million. Other charges amounted to EUR 68 million in 2017, as the net gain from divestments was more than offset by other items, including charges related to assumption changes and model updates.
Net income
Net income amounted to EUR 2,469 million in 2017 driven by underlying earnings before tax of EUR 2,103 million, realized gains and an effective tax rate of only 4% as a result of a benefit related to US tax reform.
Underlying earnings before tax
Aegons underlying earnings before tax increased compared with 2016 to EUR 2,103 million in 2017. This was mainly driven by expense reductions, an improvement in claims experience in the Americas, and higher fee revenue resulting from favorable equity market performance.
◆ | Underlying earnings before tax from the Americas increased compared with 2016 to EUR 1,381 million in 2017. Expense reductions, an improvement in claims experience, and higher fee revenue resulting from favorable equity market performance more than offset net outflows. |
◆ | In Europe, underlying earnings before tax in 2017 increased by 8% compared with 2016 to EUR 707 million. This was mainly driven by higher fee income in the United Kingdom compared with 2016 from favorable equity markets and net inflows. In addition, the inclusion of Cofunds in 2017 led to higher underlying earnings before tax compared with 2016. |
◆ | In Asia, underlying earnings before tax increased in 2017 compared with 2016 to EUR 49 million as a result of increased underlying earnings before tax from the High Net Worth business, Aegon Insights and the Strategic Partnership in China. This was in part driven by lower expenses compared with 2016 as well as favorable mortality experience, favorable persistency and favorable intangible adjustments related to anticipated investment yields. |
◆ | Underlying earnings before tax from asset management decreased by 9% in 2017 compared with 2016 to EUR 136 million. This decline was mainly driven by lower underlying earnings before tax from the United Kingdom due to lower management fees. |
◆ | Total holding costs amounted to EUR 170 million in 2017 compared with EUR 162 million in 2016 impacted by regulatory projects. |
Fair value items
The results from fair value items amounted to a gain of EUR 142 million in 2017 compared with a loss of EUR 840 million in 2016. EUR 170 million fair value gains in the United States in 2017 were driven by positive results on hedging programs and the outperformance of real estate investments. These positive results on hedging programs were the result of favorable equity market movements and reflect changes made to the macro equity hedge program throughout 2017 to a 100% option-based program. Fair value losses in Europe amounted to EUR 52 million, as gains on real estate investments in the Netherlands and the positive result from the mismatch on an IFRS basis between interest rate hedges on the mortgage portfolio and the underlying mortgages were more than offset by a fair value loss on the guarantee provision in the Netherlands, as well as negative fair value changes on equity hedges in the United Kingdom, and interest rate hedges in the Netherlands to protect Aegons capital position. Gains on interest rate swaps were the main driver of the EUR 24 million fair value gains in 2017 at the holding.
Realized gains on investments
Realized gains on investments amounted to EUR 413 million in 2017 and were primarily related to normal trading activity, the sale of an equity investment in the United States, and gains on bonds to optimize the general account investment portfolio in the Netherlands and the United Kingdom.
Impairment charges
Net impairments of EUR 39 million in 2017 primarily related to a single commercial mortgage loan in the United States and loan loss provisions in connection to growing consumer loan origination in the Netherlands.
Other charges
Other charges amounted to EUR 68 million in 2017. The book gains on the divestments of UMG (EUR 208 million) and the majority of the run-off businesses in the Americas (EUR 231 million) were more than offset by the loss on the
Annual Report on Form 20-F 2017 |
26 | Business overview Results of operations Worldwide | |
divestment of an additional block of life reinsurance business in the Americas (EUR 105 million), charges related to assumption changes and model updates (EUR 276 million), a provision in anticipation of a possible settlement in connection with an investigation by the US Securities and Exchange Commission at Aegons Asset Management business in the United States (EUR 85 million), and restructuring and integration charges.
Run-off businesses
The results of run-off businesses declined compared with 2016 to EUR 30 million in 2017, mainly as a result of the divestment of the majority of the run-off businesses.
Income tax
Income tax amounted to a charge of EUR 110 million in 2017, and included a EUR 554 million one-time benefit from US tax reform driven by a reduction in net deferred tax liabilities. As a result of this benefit and the tax exempt gain on the sale of UMG, the effective tax rate on total income for 2017 amounted to 4%. The effective tax rate on underlying earnings before tax amounted to 27%.
Commissions and expenses
Commissions and expenses decreased by 6% compared with 2016 to EUR 6.3 billion in 2017, mainly driven by lower sales of life and annuity products in the United States. Operating expenses increased by 3% compared with 2016 to EUR 3.9 billion in 2017. Expense savings were more than offset by higher expenses associated with the acquisitions of Cofunds and BlackRocks defined contribution business in the United Kingdom.
Production
Compared with 2016, gross deposits in 2017 were up by 44% to EUR 144.4 billion, driven by higher gross deposits in Asset Management and the acquisition of Cofunds. Net outflows amounted to EUR 17.1 billion as inflows in Asset Management and the United Kingdom were more than offset by contract discontinuances from the business acquired from Mercer. These outflows were in line with the guidance provided in 2017, and are driven by the conversion of customers to the Transamerica recordkeeping platform. New life sales declined by 8% compared with 2016 to EUR 896 million in 2017, mostly driven by lower indexed universal life and term life production in the United States and the sale of the annuity business in the United Kingdom, which more than offset the increase in sales in Asia driven by the continued success of the whole life critical illness product. New premium production for accident & health and general insurance decreased by 7% compared with 2016 to EUR 885 million in 2017, mainly as product exits and lower supplemental health sales in the United States more than offset increased general insurance production supported by a portfolio acquisition in Hungary.
Capital management
During 2017, shareholders equity decreased by EUR 0.2 billion to EUR 20.3 billion, as net income was more than offset by a
weakening of the US Dollar, dividends paid to shareholders, and a reduction in revaluation reserves net of deferred tax liabilities. During the year, the revaluation reserves net of deferred tax liabilities decreased by EUR 0.5 billion to EUR 4.9 billion. The benefit from US tax reform in connection to the reduction in net deferred tax liabilities related to revaluation reserves was more than offset by the adverse impact from higher interest rates. Aegons shareholders equity, excluding revaluation reserves and defined benefit plan remeasurements, amounted to EUR 17.1 billion on December 31, 2017, or 8.33 per common share. The gross leverage ratio improved to 28.6% on December 31, 2017, compared with 29.8% at the end of 2016, which was mostly the result of retained earnings. Excess cash in the holding declined in 2017 compared with 2016 to EUR 1.4 billion, as remittances from business units were more than offset by dividends to shareholders, interest payments, operating expenses and capital injections into the units, including a EUR 1 billion injection to increase the Solvency II ratio of Aegon the Netherlands.
On December 31, 2017, Aegons estimated Solvency II ratio amounted to 201%, up from 157% at the end of 2016. This increase was driven by capital generation, divestments and an amendment of the conversion methodology for US Life insurance entities under Solvency II. This methodology is consistent with EIOPAs guidance on how to calculate group solvency in the context of equivalence. It includes a conversion factor of 150% for required capital and reducing own funds by 100% RBC requirement to reflect transferability restrictions. The methodology is subject to annual review. The RBC ratio in the United States increased from 440% at year-end 2016 to 472% on December 31, 2017. The benefit to the ratio from capital generation and the divestment of the majority of the run-off businesses more than offset remittances to the Group. In the Netherlands, the estimated Solvency II ratio at the end of 2017 amounted to 199%, up from 134% at the end of 2016. The ratio benefited from the aforementioned capital injection, model changes, derisking and the divestment of UMG. The estimated Solvency II ratio at the end of 2017 of Aegon United Kingdom amounted to 176%, up from 156% at the end of 2016. The capital generation, the completion of the Part VII transfers related to the divestment of the majority of the UK annuity book and model changes more than offset remittances to the Group.
The Solvency ratios as disclosed in this section represent Aegons estimates, are not final until filed with the regulator, and are subject to supervisory review.
Dividends from and capital contributions to business units
Aegons business units remitted over EUR 1.8 billion to the Group during 2017, including EUR 1.4 billion from the Americas, EUR 176 million from Asia and EUR 167 million from the United Kingdom. Aegon spent EUR 1.1 billion on capital injections, including EUR 1 billion into the Netherlands.
Annual Report on Form 20-F 2017 |
27 | Business overview Results of operations Worldwide | |
Results 2016 worldwide
Underlying earnings geographically | ||||||||||||
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Net underlying earnings |
1,483 | 1,481 | - | |||||||||
Tax on underlying earnings |
429 | 386 | 11 | |||||||||
Underlying earnings before tax geographically |
||||||||||||
Americas |
1,249 | 1,278 | (2) | |||||||||
The Netherlands |
534 | 537 | (1) | |||||||||
United Kingdom |
59 | (27 | ) | n.m. | ||||||||
Central & Eastern Europe |
55 | 37 | 51 | |||||||||
Spain & Portugal |
8 | 12 | (38) | |||||||||
Europe |
655 | 559 | 17 | |||||||||
Asia |
21 | 20 | 3 | |||||||||
Asset Management |
149 | 170 | (12) | |||||||||
Holding and other activities |
(162 | ) | (161 | ) | - | |||||||
Underlying earnings before tax |
1,913 | 1,867 | 2 | |||||||||
Fair value items |
(840 | ) | (651 | ) | (29) | |||||||
Gains / (losses) on investments |
340 | 346 | (2) | |||||||||
Net impairments |
(54 | ) | 49 | n.m. | ||||||||
Other income / (charges) |
(771 | ) | (2,180 | ) | 65 | |||||||
Run-off businesses |
54 | 88 | (39) | |||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
641 | (482 | ) | n.m. | ||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
31 | 33 | (6) | |||||||||
Income tax |
(203 | ) | 51 | n.m. | ||||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(31 | ) | (33 | ) | 6 | |||||||
Net income / (loss) |
438 | (431 | ) | n.m. | ||||||||
Commissions and expenses |
6,696 | 6,916 | (3) | |||||||||
of which operating expenses |
3,764 | 3,734 | 1 | |||||||||
New life sales | ||||||||||||
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Americas |
542 | 599 | (9) | |||||||||
The Netherlands |
111 | 130 | (15) | |||||||||
United Kingdom |
66 | 72 | (8) | |||||||||
Central & Eastern Europe |
83 | 91 | (9) | |||||||||
Spain & Portugal |
39 | 39 | 1 | |||||||||
Europe |
299 | 332 | (10) | |||||||||
Asia |
128 | 173 | (26) | |||||||||
Total recurring plus 1/10 single |
969 | 1,104 | (12) | |||||||||
Gross deposits (on and off balance) | ||||||||||||
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Americas |
40,881 | 36,999 | 10 | |||||||||
The Netherlands |
6,686 | 5,137 | 30 | |||||||||
United Kingdom |
5,791 | 6,096 | (5) | |||||||||
Central & Eastern Europe |
265 | 227 | 17 | |||||||||
Spain & Portugal |
31 | 29 | 8 | |||||||||
Europe |
12,773 | 11,489 | 11 | |||||||||
Asia |
304 | 408 | (25) | |||||||||
Asset Management |
46,366 | 33,722 | 37 | |||||||||
Total gross deposits |
100,325 | 82,618 | 21 |
Annual Report on Form 20-F 2017 |
28 | Business overview Results of operations Worldwide | |
Net deposits (on and off balance) | ||||||||||||
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Americas |
(1,015 | ) | 7,754 | n.m. | ||||||||
The Netherlands |
1,909 | 1,885 | 1 | |||||||||
United Kingdom |
(846 | ) | (1,096 | ) | 23 | |||||||
Central & Eastern Europe |
176 | 63 | 180 | |||||||||
Spain & Portugal |
20 | 17 | 20 | |||||||||
Europe |
1,260 | 869 | 45 | |||||||||
Asia |
259 | 353 | (27) | |||||||||
Asset Management |
2,964 | 8,235 | (64) | |||||||||
Total net deposits excluding run-off businesses |
3,468 | 17,211 | (80) | |||||||||
Run-off businesses |
(759 | ) | (833 | ) | 9 | |||||||
Total net deposits / (outflows) |
2,709 | 16,378 | (83) |
Worldwide revenues geographically 2016 Amounts in EUR millions |
||||||||||||||||||||||||||||||||||||||||||||||||
Total life insurance gross premiums |
7,363 | 2,015 | 9,888 | 399 | 191 | 12,493 | 1,121 | - | (78 | ) | 20,898 | (498 | ) | 20,400 | ||||||||||||||||||||||||||||||||||
Accident and health insurance premiums |
2,204 | 210 | 36 | 1 | 73 | 320 | 104 | - | (4 | ) | 2,624 | (15 | ) | 2,609 | ||||||||||||||||||||||||||||||||||
General insurance premiums |
- | 266 | - | 179 | 92 | 536 | - | - | - | 536 | (92 | ) | 444 | |||||||||||||||||||||||||||||||||||
Total gross premiums | 9,567 | 2,491 | 9,924 | 578 | 355 | 13,348 | 1,225 | - | (82 | ) | 24,058 | (606 | ) | 23,453 | ||||||||||||||||||||||||||||||||||
Investment income |
3,717 | 2,135 | 1,661 | 45 | 45 | 3,886 | 232 | 3 | 3 | 7,841 | (54 | ) | 7,788 | |||||||||||||||||||||||||||||||||||
Fees and commission income |
1,651 | 350 | 95 | 36 | 14 | 495 | 61 | 632 | (242 | ) | 2,596 | (188 | ) | 2,408 | ||||||||||||||||||||||||||||||||||
Other revenue |
4 | - | - | - | 2 | 2 | - | 1 | 3 | 11 | (4 | ) | 7 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,940 | 4,976 | 11,680 | 659 | 416 | 17,732 | 1,517 | 636 | (318 | ) | 34,507 | (852 | ) | 33,655 | ||||||||||||||||||||||||||||||||||
Number of employees, including agent employees |
11,943 | 4,464 | 2,673 | 2,317 | 600 | 10,054 | 5,579 | 1,474 | 330 | 29,380 |
Annual Report on Form 20-F 2017 |
29 | Business overview Results of operations Worldwide | |
Results 2016 worldwide
Aegons net income in 2016 improved to EUR 438 million compared with 2015. Underlying earnings before tax increased 2% compared with 2015 to EUR 1,913 million in 2016, primarily as a result of higher underlying earnings before tax from the United Kingdom. The net result in 2016 was impacted by a loss of EUR 840 million on fair value items, which was driven by accounting losses on hedging programs and underperformance of alternative investments. Realized gains of EUR 340 million in 2016 mainly related to normal trading in the investment portfolio. Other charges amounted to EUR 771 million in 2016, mainly driven by the EUR 682 million book loss on the divestment of the annuity portfolio in the United Kingdom.
Net income
The net income amounted to EUR 438 million in 2016 driven by underlying earnings before tax of EUR 1,913 million, and was impacted by the book loss on the divestment of the UK annuity portfolio and fair value losses, partly offset by gains on investments.
Underlying earnings before tax
Aegons underlying earnings before tax increased compared with 2015 to EUR 1,913 million in 2016. This was mainly driven by lower amortization of deferred policy acquisition costs (DPAC) in the United Kingdom following the write down of DPAC in the fourth quarter of 2015.
◆ | Underlying earnings before tax from the Americas declined compared with 2015 to EUR 1,249 million in 2016. Expense reductions and an improvement in claims experience offset lower variable annuities underlying earnings before tax compared with 2015 and the impact on recurring underlying earnings before tax of the actuarial assumption changes and model updates implemented in the third quarter of 2015. |
◆ | In Europe, underlying earnings before tax in 2016 increased by 17% compared with 2015 to EUR 655 million. This was mainly driven by lower amortization of deferred policy acquisition costs in the United Kingdom related to upgrading customers to the retirement platform compared to 2015. |
◆ | In Asia, underlying earnings before tax increased in 2016 compared with 2015 to EUR 21 million as a result of increased underlying earnings before tax from the High Net Worth business. This was partly offset by lower underlying earnings before tax from Strategic Partnerships compared with 2015 mainly a result of the increase in ownership from 26% to 49% in India, which is currently loss-making. |
◆ | Underlying earnings before tax from asset management decreased by 12% in 2016 compared with 2015 to EUR 149 million. This decline was mainly driven by lower underlying earnings before tax from Aegons Chinese asset management joint venture AIFMC due to the normalization of performance fees. |
◆ | Total holding costs remained stable compared with 2015 at EUR 162 million in 2016. |
Fair value items
The results from fair value items amounted to a loss of EUR 840 million in 2016, and were mainly driven by fair value losses in the United States. EUR 521 million fair value losses in the United States in 2016 were driven by the loss on hedging programs and the underperformance of alternative investments. Included in the loss on hedging programs in the United States is the loss on fair value hedges without accounting match in the Americas (EUR 322 million). This was mainly driven by the loss on equity hedges, which were set up to protect Aegons capital position. Underperformance of fair value investments of EUR 226 million was primarily driven by investments related to hedge funds in the United States. Fair value losses of EUR 236 million in Europe in 2016 were driven by credit spreads movements, declining interest rates as a result of a mismatch on an IFRS basis between the valuation of interest rate hedges and liabilities, and declining interest rates as a result of the mismatch on an IFRS basis between certain interest rate hedges on the mortgage portfolio and the underlying mortgages. In addition, the loss on interest rate swaps was the main driver of the EUR 74 million fair value losses in 2016 at the holding.
Realized gains on investments
Realized gains on investments amounted to EUR 340 million in 2016 and were primarily related to a rebalancing of the investment portfolio in the United Kingdom and gains resulting from asset-liability management adjustments in the Netherlands.
Impairment charges
Net impairments of EUR 54 million in 2016 primarily related to investments in the energy industry in the United States.
Other charges
Other charges amounted to EUR 771 million in 2016. These were mostly caused by the book loss on the divestment of the annuity portfolio in the United Kingdom (EUR 682 million), and assumption changes and model updates (EUR 118 million).
Annual Report on Form 20-F 2017 |
30 | Business overview Results of operations Worldwide | |
Run-off businesses
The results of run-off businesses declined to EUR 54 million in 2016 mainly as a result of an adjustment to the intangible balances for BOLI/COLI business.
Income tax
Income tax amounted to EUR 203 million in 2016, and included one-time tax benefits in the United States and the United Kingdom. The effective tax rate on underlying earnings before tax and total income for 2016 was 22% and 32%, respectively.
Commissions and expenses
Commissions and expenses decreased by 3% in 2016 compared with 2015 to EUR 6.7 billion, mainly driven by lower amortization of deferred policy acquisition costs in the United Kingdom. Operating expenses increased by 1% in 2016 compared with 2015 to EUR 3.8 billion. Increased variable personnel expenses compared with 2015 and the acquisition of the defined contribution business from Mercer more than offset expense savings.
Production
In 2016, compared with 2015, gross deposits were up 21% to EUR 100.3 billion, driven by higher gross deposits in asset management and Retirement Plans in the United States. Net deposits, excluding run-off businesses, declined to EUR 3.5 billion in 2016 compared with 2015, mostly due to lower gross deposits in variable annuities, anticipated contract discontinuances from the business acquired from Mercer, and low asset management net flows. The latter were mainly driven by market insecurity following the Brexit vote and a reduction in flows from money market funds in China. New life sales declined by 12% compared with 2015 to EUR 969 million in 2016, mostly driven by lower universal life and term life production in the United States, fewer pension buy-out sales in the Netherlands, and lower sales in Asia as a result of Aegons strict pricing policy in a low rate environment. New premium production for accident & health and general insurance decreased by 9% compared with 2015 to EUR 954 million in 2016, mainly as a result of several product exits and a lower contribution from portfolio acquisitions.
Capital management
During 2016, shareholders equity decreased by EUR 1.9 billion to EUR 20.5 billion, as a result of a EUR 400 million share buyback and the impact from higher interest rates on revaluation reserves. During the year, the revaluation reserves decreased by EUR 1.1 billion to EUR 5.4 billion. Aegons shareholders equity, excluding revaluation reserves and defined benefit plan remeasurements, amounted to EUR 17.0 billion on December 31, 2016, or 8.31 per common share. The gross leverage ratio increased to 29.8% on December 31, 2016, compared with 28.4% at the end of 2015, which was mostly the result of the issuance of EUR 500 million senior unsecured notes. Excess cash in the holding increased from EUR 1.4 billion at the end of 2015 to EUR 1.5 billion on December 31, 2016, as net remittances from business units and the aforementioned issuance of senior unsecured notes more than offset the EUR 400 million share buyback, dividends to shareholders, interest payments and operating expenses.
On December 31, 2016, Aegons estimated Solvency II ratio amounted to 157%. The RBC ratio in the United States decreased from 460% at year-end 2015 to ~440% on December 31, 2016 which primarily reflects dividends upstreamed to the holding. In the Netherlands, the estimated Solvency II ratio at the end of 2016 amounted to 135%. The estimated Solvency II ratio at the end of 2016 of Aegon United Kingdom amounted to 156%.
The Group Solvency II ratio and Aegon the Netherlands Solvency II ratio have been updated since the earlier public communications on February 17, 2017 as a result of a change in the calculation of the risk margin in the Netherlands.
The Solvency ratios as disclosed in this section represent Aegons estimates, are not final until filed with the regulator and subject to supervisory review. Solvency II capital ratios are still subject to final interpretations of Solvency II regulations including the assumptions underlying Aegons factor for the loss absorbing capacity of deferred taxes in the Netherlands of 75%.
Dividends from and capital contributions to business units
Aegon received EUR 1.1 billion of dividends from its business units during 2016 from the Americas, asset management, Central & Eastern Europe and Spain & Portugal. Aegon spent EUR 0.2 billion on capital contributions.
Annual Report on Form 20-F 2017 |
31 | Business overview Results of operations Americas | |
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2017 | 2016 | % | 2017 | 2016 | % | |||||||||||||||||||
Net underlying earnings |
1,158 | 1,059 | 9 | 1,026 | 956 | 7 | ||||||||||||||||||
Tax on underlying earnings |
401 | 323 | 24 | 355 | 292 | 22 | ||||||||||||||||||
Underlying earnings before tax by business |
||||||||||||||||||||||||
Life |
251 | 174 | 44 | 222 | 157 | 41 | ||||||||||||||||||
Accident & Health |
284 | 218 | 30 | 252 | 197 | 28 | ||||||||||||||||||
Retirement plans |
315 | 280 | 13 | 279 | 253 | 11 | ||||||||||||||||||
Mutual funds |
54 | 50 | 8 | 48 | 45 | 6 | ||||||||||||||||||
Variable annuities |
410 | 393 | 4 | 363 | 355 | 2 | ||||||||||||||||||
Fixed annuities |
145 | 172 | (15) | 129 | 155 | (17) | ||||||||||||||||||
Stable Value Solutions |
99 | 96 | 3 | 88 | 87 | 1 | ||||||||||||||||||
Latin America |
1 | 1 | 66 | 1 | 1 | 63 | ||||||||||||||||||
Underlying earnings before tax |
1,560 | 1,382 | 13 | 1,381 | 1,249 | 11 | ||||||||||||||||||
Fair value items |
192 | (577 | ) | n.m. | 170 | (521 | ) | n.m. | ||||||||||||||||
Gains / (losses) on investments |
177 | (14 | ) | n.m. | 157 | (13 | ) | n.m. | ||||||||||||||||
Net impairments |
(19 | ) | (33 | ) | 44 | (17 | ) | (30 | ) | 45 | ||||||||||||||
Other income / (charges) |
(409 | ) | (111 | ) | n.m. | (353 | ) | (100 | ) | n.m. | ||||||||||||||
Run-off businesses |
33 | 60 | (44) | 30 | 54 | (45) | ||||||||||||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
1,535 | 706 | 117 | 1,369 | 638 | 115 | ||||||||||||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
5 | 3 | 48 | 5 | 3 | 45 | ||||||||||||||||||
Income tax |
227 | (88 | ) | n.m. | 198 | (80 | ) | n.m. | ||||||||||||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(5 | ) | (3 | ) | (48) | (5 | ) | (3 | ) | (45) | ||||||||||||||
Net income / (loss) |
1,762 | 618 | 185 | 1,567 | 559 | 181 | ||||||||||||||||||
Life insurance gross premiums |
8,397 | 8,150 | 3 | 7,437 | 7,363 | 1 | ||||||||||||||||||
Accident and health insurance premiums |
2,388 | 2,440 | (2) | 2,115 | 2,204 | (4) | ||||||||||||||||||
Total gross premiums |
10,786 | 10,590 | 2 | 9,553 | 9,567 | - | ||||||||||||||||||
Investment income |
3,803 | 4,114 | (8) | 3,368 | 3,717 | (9) | ||||||||||||||||||
Fees and commission income |
2,167 | 1,828 | 19 | 1,919 | 1,651 | 16 | ||||||||||||||||||
Other revenues |
6 | 5 | 20 | 5 | 4 | 18 | ||||||||||||||||||
Total revenues |
16,761 | 16,537 | 1 | 14,844 | 14,940 | (1) | ||||||||||||||||||
Commissions and expenses |
4,071 | 4,532 | (10) | 3,606 | 4,095 | (12) | ||||||||||||||||||
of which operating expenses |
1,798 | 1,834 | (2) | 1,593 | 1,656 | (4) |
Annual Report on Form 20-F 2017 |
32 | Business overview Results of operations Americas | |
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
New life sales | 2017 | 2016 | % | 2017 | 2016 | |||||||||||||||||||
Life |
460 | 547 | (16) | 407 | 494 | (18) | ||||||||||||||||||
Latin America |
74 | 53 | 39 | 65 | 48 | 37 | ||||||||||||||||||
Total recurring plus 1/10 single |
533 | 600 | (11) | 472 | 542 | (13) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2017 | 2016 | % | 2017 | 2016 | % | |||||||||||||||||||
New premium production accident and health insurance |
818 | 895 | (9) | 725 | 808 | (10) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Gross deposits (on and off balance) | 2017 | 2016 | % | 2017 | 2016 | % | ||||||||||||||||||
Life |
7 | 8 | (22) | 6 | 8 | (23) | ||||||||||||||||||
Retirement plans |
34,235 | 35,137 | (3) | 30,321 | 31,743 | (4) | ||||||||||||||||||
Mutual funds |
5,695 | 5,467 | 4 | 5,043 | 4,939 | 2 | ||||||||||||||||||
Variable annuities |
3,190 | 4,375 | (27) | 2,825 | 3,952 | (29) | ||||||||||||||||||
Fixed annuities |
317 | 254 | 25 | 281 | 230 | 22 | ||||||||||||||||||
Latin America |
75 | 10 | n.m. | 66 | 9 | n.m. | ||||||||||||||||||
Total gross deposits |
43,518 | 45,251 | (4) | 38,543 | 40,881 | (6) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Net deposits (on and off balance) | 2017 | 2016 | % | 2017 | 2016 | % | ||||||||||||||||||
Life |
(33 | ) | (40 | ) | 19 | (29 | ) | (37 | ) | 21 | ||||||||||||||
Retirement plans |
(30,480 | ) | 268 | n.m. | (26,995 | ) | 242 | n.m. | ||||||||||||||||
Mutual funds |
377 | 38 | n.m. | 334 | 34 | n.m. | ||||||||||||||||||
Variable annuities |
(2,284 | ) | (125 | ) | n.m. | (2,023 | ) | (113 | ) | n.m. | ||||||||||||||
Fixed annuities |
(1,181 | ) | (1,265 | ) | 7 | (1,046 | ) | (1,143 | ) | 8 | ||||||||||||||
Latin America |
52 | 1 | n.m. | 46 | 1 | n.m. | ||||||||||||||||||
Total net deposits excluding run-off businesses |
(33,549 | ) | (1,123 | ) | n.m. | (29,713 | ) | (1,015 | ) | n.m. | ||||||||||||||
Run-off businesses |
(382 | ) | (841 | ) | 55 | (338 | ) | (759 | ) | 55 | ||||||||||||||
Total net deposits / (outflows) |
(33,931 | ) | (1,964 | ) | n.m. | (30,051 | ) | (1,774 | ) | n.m. |
Weighted average rate | Closing rate as of | |||||||||||||||
Exchange rates Per 1 EUR |
2017 | 2016 | December 31, 2017 | December 31, 2016 | ||||||||||||
USD |
1.1291 | 1.1069 | 1.2008 | 1.0548 |
Annual Report on Form 20-F 2017 |
33 | Business overview Results of operations Americas | |
Results 2017 Americas
The net income from the Americas amounted to USD 1.8 billion in 2017. Underlying earnings before tax in 2017 increased by 13% compared with 2016 to USD 1.6 billion as expense reductions, an improvement in claims experience, and higher fee revenue resulting from favorable equity market performance more than offset net outflows. Gross deposits decreased by 4% to USD 43.5 billion in 2017 compared with 2016, mainly as a result of lower variable annuity and retirement plans deposits. New life sales declined to USD 533 million in 2017 compared with 2016 due to lower indexed universal life and term life sales, partly as a result of not following competitors pricing changes. New premium production for accident & health insurance was down 9% to USD 0.8 billion in 2017 compared with 2016, as product exits and lower supplemental health sales more than offset higher travel sales.
Net income
The net income amounted to USD 1.8 billion in 2017, as underlying earnings before tax, gains from fair value items, realized gains, a net gain on divestments, and a benefit from US tax reform were partly offset by other charges which mainly relate to model updates and assumption changes. Underlying earnings before tax in 2017 strongly increased compared with 2016 to USD 1.6 billion. Results on fair value items amounted to a gain of USD 192 million in 2017, which was primarily related to changes to hedging programs to a 100% option based program and real estate investments. Income before tax from run-off businesses in 2017 almost halved compared with 2016 to USD 33 million following the divestment of the majority of run-off businesses in 2017, while realized gains on investments in 2017 amounted to USD 177 million. Net impairments amounted USD 19 million in 2017, primarily related to a single commercial mortgage loan. Other charges of USD 409 million in 2017 mainly related to the impact of model updates and assumption changes related to conversion of the largest block of universal life business to a new model and a provision in anticipation of a possible settlement in connection with an investigation by the US SEC (USD 51 million), which more than offset a net gain on divestments due to the sale of BOLI/COLI and Payout annuities (USD 250 million) and life reinsurance block (USD 119 million). The benefit from US tax reform amounted to USD 626 million driven by a reduction in deferred tax liabilities.
Underlying earnings before tax
Underlying earnings before tax in 2017 increased by 13% compared with 2016 to USD 1.6 billion. Expense reductions, an improvement in claims experience, and higher fee revenue resulting from favorable equity market performance more than offset net outflows.
◆ | Underlying earnings before tax from Life increased to USD 251 million in 2017 compared with USD 174 million in 2016. This increase was mainly driven by an improvement in mortality experience. |
◆ | Accident & Health underlying earnings before tax increased by 30% to USD 284 million in 2017 compared with USD 218 million in 2016, as an improvement in claims experience and expense savings more than offset the negative impact on underlying earnings before tax of product exits. |
◆ | Underlying earnings before tax from Mutual Funds increased by USD 4 million in 2017 compared with 2016 to USD 54 million. Increased fee income from higher average account balances driven by equity market performance and inflows more than offset increased expenses. |
◆ | Retirement Plans underlying earnings before tax were up 13% to USD 315 million in 2017 compared with USD 280 million in 2016, primarily driven by increased fee income compared with 2016. This was the result of higher fee revenue from higher asset balances with favorable equity market performance more than offsetting net outflows related to the conversion of the Mercer business to Transamericas platform. |
◆ | Underlying earnings before tax from Variable Annuities increased by 4% to USD 410 million in 2017 compared with USD 393 million in 2016 , primarily driven by the benefit of expense savings and increased fee income compared with 2016. This was the result of higher fee revenue from higher asset balances with favorable equity market performance more than offsetting net outflows. |
◆ | Fixed Annuity underlying earnings before tax decreased by 15% in 2017 compared with 2016 to USD 145 million, reflecting the continued balance reduction and unfavorable adjustments of deferred acquisition costs. |
◆ | Underlying earnings before tax from Stable Value Solutions amounted to USD 99 million in 2017 compared with USD 96 million in 2016 mainly due to lower hedging costs. |
◆ | Latin America remained stable at USD 1 million of underlying earnings before tax in 2017. |
Annual Report on Form 20-F 2017 |
34 | Business overview Results of operations Americas | |
Commissions and expenses
Commissions and expenses decreased by 10% compared with 2016 to USD 4.1 billion in 2017 mainly driven by lower sales of life and annuity products. Operating expenses decreased by 2% compared with 2016 to USD 1.8 billion in 2017 as a result of expense savings, which were partly offset by investments in business transformation and project expenses.
Production
Gross deposits decreased by 4% in 2017 compared with 2016 to USD 43.5 billion. Higher gross deposits in Mutual Funds and Latin Americas in 2017 were more than offset by a decline in variable annuity and retirement plan deposits compared with 2016. Decreased variable annuity deposits in 2017 compared with 2016 were caused by lower market demand following the implementation of the Department of Labor Fiduciary Rule, in addition to not following competitors pricing changes for some products and partners deciding to offer their own variable annuities solutions. Retirement plan deposits decreased in 2017 compared with 2016, as higher recurring deposits were more
than offset by lower takeover deposits. Net outflows amounted to USD 33.9 billion due to contract discontinuances from the business acquired from Mercer. These outflows were in line with guidance provided in 2017, and are driven by the conversion of customers to the Transamerica recordkeeping platform.
New life sales declined by 11% in 2017 to USD 533 million compared with 2016, as a result of lower indexed universal life and term life sales. Universal life production was down in 2017 compared with 2016, as a result of a decline in market share in indexed universal life. Sales of term life products declined in 2017 compared with 2016 as Aegon did not lower its pricing in line with a number of its competitors. New premium production for accident & health insurance was down by 9% to USD 0.8 billion in 2017 compared with 2016, as product exits and lower supplemental health sales more than offset higher travel sales.
Annual Report on Form 20-F 2017 |
35 | Business overview Results of operations Americas | |
Results 2016 Americas
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2016 | 2015 | % | 2016 | 2015 | % | |||||||||||||||||||
Net underlying earnings |
1,059 | 1,100 | (4) | 956 | 991 | (4) | ||||||||||||||||||
Tax on underlying earnings |
323 | 318 | 2 | 292 | 286 | 2 | ||||||||||||||||||
Underlying earnings before tax by business |
||||||||||||||||||||||||
Life |
174 | 207 | (16) | 157 | 186 | (16) | ||||||||||||||||||
Accident & Health |
218 | 165 | 32 | 197 | 149 | 32 | ||||||||||||||||||
Retirement plans |
280 | 261 | 7 | 253 | 235 | 7 | ||||||||||||||||||
Mutual funds |
50 | 50 | - | 45 | 45 | - | ||||||||||||||||||
Variable annuities |
393 | 503 | (22) | 355 | 453 | (22) | ||||||||||||||||||
Fixed annuities |
172 | 131 | 31 | 155 | 118 | 32 | ||||||||||||||||||
Stable Value Solutions |
96 | 101 | (4) | 87 | 91 | (4) | ||||||||||||||||||
Latin America |
1 | 1 | (41) | 1 | 1 | (41) | ||||||||||||||||||
Underlying earnings before tax |
1,382 | 1,418 | (3) | 1,249 | 1,278 | (2) | ||||||||||||||||||
Fair value items |
(577 | ) | (768 | ) | 25 | (521 | ) | (691 | ) | 25 | ||||||||||||||
Gains / (losses) on investments |
(14 | ) | (83 | ) | 83 | (13 | ) | (74 | ) | 83 | ||||||||||||||
Net impairments |
(33 | ) | 79 | n.m. | (30 | ) | 71 | n.m. | ||||||||||||||||
Other income / (charges) |
(111 | ) | (1,013 | ) | 89 | (100 | ) | (913 | ) | 89 | ||||||||||||||
Run-off businesses |
60 | 98 | (39) | 54 | 88 | (39) | ||||||||||||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
706 | (268 | ) | n.m. | 638 | (241 | ) | n.m. | ||||||||||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
3 | 5 | (32) | 3 | 5 | (32) | ||||||||||||||||||
Income tax |
(88 | ) | 7 | n.m. | (80 | ) | 6 | n.m. | ||||||||||||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(3 | ) | (5 | ) | 32 | (3 | ) | (5 | ) | 32 | ||||||||||||||
Net income / (loss) |
618 | (261 | ) | n.m. | 559 | (235 | ) | n.m. | ||||||||||||||||
Life insurance gross premiums |
8,150 | 7,821 | 4 | 7,363 | 7,046 | 5 | ||||||||||||||||||
Accident and health insurance premiums |
2,440 | 2,515 | (3) | 2,204 | 2,266 | (3) | ||||||||||||||||||
Total gross premiums |
10,590 | 10,336 | 2 | 9,567 | 9,312 | 3 | ||||||||||||||||||
Investment income |
4,114 | 4,085 | 1 | 3,717 | 3,680 | 1 | ||||||||||||||||||
Fees and commission income |
1,828 | 1,891 | (3) | 1,651 | 1,704 | (3) | ||||||||||||||||||
Other revenues |
5 | 11 | (56) | 4 | 9 | (56) | ||||||||||||||||||
Total revenues |
16,537 | 16,322 | 1 | 14,940 | 14,705 | 2 | ||||||||||||||||||
Commissions and expenses |
4,532 | 4,489 | 1 | 4,095 | 4,044 | 1 | ||||||||||||||||||
of which operating expenses |
1,834 | 1,843 | (1) | 1,656 | 1,660 | - |
Annual Report on Form 20-F 2017 |
36 | Business overview Results of operations Americas | |
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
New life sales | 2016 | 2015 | % | 2016 | 2015 | % | ||||||||||||||||||
Life |
547 | 622 | (12) | 494 | 561 | (12) | ||||||||||||||||||
Latin America |
53 | 42 | 24 | 48 | 38 | 25 | ||||||||||||||||||
Total recurring plus 1/10 single |
600 | 665 | (10) | 542 | 599 | (9) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2016 | 2015 | % | 2016 | 2015 | % | |||||||||||||||||||
New premium production accident and health insurance |
895 | 1,003 | (11) | 808 | 904 | (11) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Gross deposits (on and off balance) | 2016 | 2015 | % | 2016 | 2015 | % | ||||||||||||||||||
Life |
8 | 7 | 21 | 8 | 6 | 21 | ||||||||||||||||||
Retirement plans |
35,137 | 27,833 | 26 | 31,743 | 25,075 | 27 | ||||||||||||||||||
Mutual funds |
5,467 | 5,084 | 8 | 4,939 | 4,580 | 8 | ||||||||||||||||||
Variable annuities |
4,375 | 7,857 | (44) | 3,952 | 7,079 | (44) | ||||||||||||||||||
Fixed annuities |
254 | 276 | (8) | 230 | 249 | (8) | ||||||||||||||||||
Latin America |
10 | 12 | (14) | 9 | 10 | (13) | ||||||||||||||||||
Total gross deposits |
45,251 | 41,069 | 10 | 40,881 | 36,999 | 10 | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Net deposits (on and off balance) | 2016 | 2015 | % | 2016 | 2015 | % | ||||||||||||||||||
Life |
(40 | ) | (38 | ) | (6) | (37 | ) | (34 | ) | (7) | ||||||||||||||
Retirement plans |
268 | 7,945 | (97) | 242 | 7,158 | (97) | ||||||||||||||||||
Mutual funds |
38 | (6 | ) | n.m. | 34 | (5 | ) | n.m. | ||||||||||||||||
Variable annuities |
(125 | ) | 2,416 | n.m. | (113 | ) | 2,177 | n.m. | ||||||||||||||||
Fixed annuities |
(1,265 | ) | (1,711 | ) | 26 | (1,143 | ) | (1,541 | ) | 26 | ||||||||||||||
Latin America |
1 | - | 186 | 1 | - | 187 | ||||||||||||||||||
Total net deposits excluding run-off businesses | (1,123 | ) | 8,607 | n.m. | (1,015 | ) | 7,754 | n.m. | ||||||||||||||||
Run-off businesses |
(841 | ) | (925 | ) | 9 | (759 | ) | (833 | ) | 9 | ||||||||||||||
Total net deposits / (outflows) |
(1,964 | ) | 7,682 | n.m. | (1,774 | ) | 6,920 | n.m. |
Weighted average rate | Closing rate as of | |||||||||||||||
Exchange rates Per 1 EUR |
2016 | 2015 | December 31, 2016 | December 31, 2015 | ||||||||||||
USD |
1.1069 | 1.1100 | 1.0548 | 1.0863 |
Annual Report on Form 20-F 2017 |
37 | Business overview Results of operations Americas | |
Results 2016 Americas
The net income from the Americas amounted to USD 618 million in 2016. Underlying earnings before tax in 2016 were stable compared with 2015 at USD 1.4 billion. Expense reductions and an improvement in claims experience compared with 2015 offset lower variable annuities underlying earnings before tax and the impact on recurring underlying earnings before tax of the actuarial assumption changes and model updates implemented in the third quarter of 2015. Gross deposits increased to USD 45.3 billion in 2016 compared with 2015, as a result of the deposits from the defined contribution business acquired from Mercer in 2015, which more than offset lower variable annuity deposits. New life sales declined to USD 600 million in 2016 compared with 2015 due to a decline in the recruitment of new agents and Aegons strict pricing policy, while new premium production for accident & health insurance was down to USD 0.9 billion compared with 2015 due to lower contribution from portfolio acquisitions and several product exits.
Net income
The net income amounted to USD 618 million in 2016, as underlying earnings before tax were partly offset by losses from fair value items. Underlying earnings before tax in 2016 were stable compared with 2015 at USD 1.4 billion. Results on fair value items amounted to a loss of USD 577 million in 2016, which was primarily related to underperformance of hedge fund investments and the impact on hedging programs as a result of higher equity markets. Income before tax from run-off businesses in 2016 amounted to USD 60 million, while realized losses on investments in 2016 amounted to USD 14 million. Net impairments amounted USD 33 million in 2016, primarily related to investments in the energy industry. Other charges of USD 111 million in 2016 mainly related to the net impact of assumption changes and model updates. These charges were mainly driven by the assumption changes and model updates in the US from long-term care, primarily resulting from experience updates for morbidity, termination rates and utilization assumptions. For the other business lines, assumption and model changes largely offset each other.
Underlying earnings before tax
Underlying earnings before tax in 2016 were stable compared with 2015 at USD 1.4 billion. Expense reductions and an improvement in claims experience compared with 2015 offset lower variable annuities underlying earnings before tax and the impact on recurring underlying earnings before tax of the actuarial assumption changes and model updates implemented in the third quarter of 2015.
◆ | Underlying earnings before tax from Life decreased to USD 174 million in 2016 compared with USD 207 million in 2015. Expense savings were more than offset by unfavorable mortality, the impact of lower interest rates |
compared with 2015 and the impact on recurring underlying earnings before tax of the actuarial assumption changes and model updates implemented in the third quarter of 2015. |
◆ | Accident & Health underlying earnings before tax increased to USD 218 million in 2016 compared with USD 165 million in 2015, as an improvement in long-term care morbidity experience and expense savings more than offset the negative impact on underlying earnings before tax of product exits. |
◆ | Underlying earnings before tax from Mutual Funds were stable in 2016 compared with 2015 at USD 50 million. |
◆ | Retirement Plans underlying earnings before tax were up to USD 280 million in 2016 compared with USD 261 million in 2015, primarily driven by the benefit of expense savings and increased fee income compared with 2015. Increased fee income resulted from higher average account balances driven by equity market performance, which more than offset margin pressure arising from the competitive environment on fees. |
◆ | Underlying earnings before tax from Variable Annuities declined to USD 393 million in 2016 compared with USD 503 million in 2015 as a result of lower underlying earnings before tax from the declining closed block, lower margins on new business and adverse claims experience. |
◆ | Fixed Annuity underlying earnings before tax increased by 31% in 2016 compared with 2015 to USD 172 million, as an increase in the result from adjustments to intangible assets more than offset the continued balance reduction. |
◆ | Underlying earnings before tax from Stable Value Solutions amounted to USD 96 million in 2016 compared with USD 101 million in 2015 due to lower average account balances. |
◆ | Latin America contributed USD 1 million to underlying earnings before tax in 2016. |
Annual Report on Form 20-F 2017 |
38 | Business overview Results of operations Americas | |
Commissions and expenses
Commissions and expenses increased by 1% compared with 2015 in 2016 to USD 4.5 billion. Operating expenses decreased by 1% compared with 2015 in 2016 to USD 1.8 billion. Expense savings and lower restructuring charges compared with 2015 were partly offset by increased variable personnel expense and the acquisition of the defined contribution business acquired from Mercer.
Production
Gross deposits increased by 10% in 2016 compared with 2015 to USD 45.3 billion. Higher gross deposits in Retirement Plans more than offset a decline in variable annuity deposits compared with 2015. Increased retirement plan gross deposits were mostly driven by the acquisition of the defined contribution business acquired from Mercer. Variable annuity gross deposits were down
by 44% in 2016 compared with 2015 to USD 4.4 billion, mainly driven by product adjustments implemented last year in response to the low interest rate environment and lower market demand as a result of the upcoming implementation of the Department of Labor fiduciary rule.
New life sales declined by 10% in 2016 to USD 600 million compared with 2015, as a result of lower universal life and term life sales. Lower universal life sales resulted from a decline in the recruitment of new agents. Sales of term life products declined as Aegon did not lower its pricing in line with a number of its competitors. New premium production for accident & health insurance was down 11% to USD 0.9 billion in 2016 compared with 2015, mainly resulting from a lower contribution from portfolio acquisitions and several product exits.
Annual Report on Form 20-F 2017 |
39 | Business overview Results of operations Americas | |
Overview of Americas
Aegon Americas operates under the Transamerica brand in the United States, and has joint venture operations in Brazil and Mexico and a small operation in Canada.
Aegon in the US
Transamerica is one of the leading life insurance organizations in the United States, and the largest of Aegons operating units worldwide. Its businesses in the US serve customers in all fifty states and the District of Columbia, and employ approximately 10,000 people. Most Aegon companies in the United States operate under the Transamerica brand. Its companies have existed since the mid-19th century, and its primary offices are in Cedar Rapids, Iowa, Denver, Colorado and Baltimore, Maryland -with additional offices located throughout the United States.
Through its subsidiaries and affiliated companies, Aegon provides a wide range of life insurance, long-term care insurance, and voluntary benefits including supplemental health insurance, retirement plans, recordkeeping and advisory services, annuities and other long-term savings and investment products.
Aegon employs a variety of distribution channels to help customers access its products and services as suits their needs. These include brokerage, partner (including career/captive), institutional/workplace and wholesale distribution channels.
Aegon in Brazil
Aegon has a 50% interest in Mongeral Aegon Seguros e Previdência S.A. (hereafter referred to as Mongeral Aegon), Brazils fourth largest independent (i.e. non-bank affiliated) life insurer. To further capture growth prospects in Brazil, Mongeral Aegon and Bancoob (Banco Cooperativo do Brasil) established Sicoob Seguradora de Vida e Previdência, a new life insurance and pensions company dedicated to providing life insurance and pension products to the Sicoob system. As of December 2017, Aegon Brazil had 550 employees.
Aegon in Mexico
Aegon has a joint venture with Administradora Akaan S.A. de C.V. called Akaan-Aegon S.A.P.I. de C.V Operating as Akaan Transamerica, this Mexico City-based organization launched a series of mutual funds in October 2017, targeting family offices, high net worth individuals, and institutions. As of December 31, 2017, Aegon Mexico had 25 employees.
In 2006, Aegon acquired a 49% interest in Seguros Argos S.A. de C.V., a Mexican life insurance company (Seguros Argos); and as such acquisition was completed, In 2017, the Mexican shareholders of Seguros Argos agreed to purchase Aegons shares for an undisclosed amount and end the Afore Argos joint venture. This was a mutual decision that allows both parties to pursue new opportunities and new relationships in Mexico.
Aegon in Canada
In Canada, Aegon operates an insurance agency under the name World Financial Group Insurance Agency of Canada Inc. (WFGIA), in addition to an affiliated securities dealer under the name WFG Securities, Inc. (WFGS). WFGIA offers life insurance and segregated funds, and WFGS offers mutual funds.
Organizational structure
Aegon USA
Aegon USA was formed in 1989, when Aegon brought all of its operating companies in the United States together under a single financial services holding company: Aegon USA, LLC. On December 31, 2015, Aegon USA, LLC was merged into Transamerica Corporation, which is the holding company for the US operations. Business is conducted through its various subsidiaries. The use of the term Aegon USA throughout this business overview refers to the operating subsidiaries in the United States, collectively or individually, through which Aegon conducts business. Aegon USA has operating licenses in every US state, in addition to the District of Columbia, Puerto Rico, the Virgin Islands and Guam.
Aegon USAs primary insurance subsidiaries are:
◆ | Transamerica Life Insurance Company; |
◆ | Transamerica Financial Life Insurance Company; |
◆ | Transamerica Advisors Life Insurance Company; |
◆ | Transamerica Premier Life Insurance Company; and |
◆ | Transamerica Casualty Insurance Company. |
Aegon USA is a functionally organized firm that aims to meet customers needs and create a consistent, positive experience for customers, business partners and employees. Aegon USA is structured in such a way as to provide relevant customer solutions that are easy to understand, and that address the full range of customers financial protection and savings needs at every stage of life as they save, invest, protect and create retirement income. Moreover, Aegon USAs structure enables it to leverage Transamericas brand strength, expertise and capabilities in order to fulfill Aegons purpose of helping people achieve a lifetime of financial security.
The business lines operated through one or more of Aegon USAs life insurance companies include: life insurance, accident & health insurance, mutual funds, variable annuities, fixed annuities, retirement plans, stable value solutions, and Latin America. The business lines, described in greater detail below, represent groups of products and services that Aegon USA offers through a number of distribution methods and sales channels. Products are also offered and distributed through
Annual Report on Form 20-F 2017 |
40 | Business overview Results of operations Americas | |
one or more of Aegon USAs licensed insurance or brokerage subsidiary companies.
Overview of sales and distribution channels
Aegon USAs distribution channels are organized so as to meet customer needs and offer solutions to the third-party distributors that provide guidance to Aegon USA customers. Each channel is focused on a number of primary target market segments, which fall under four main categories: Brokerage, Partner, Institutional / Workplace, and Wholesale.
Brokerage
Aegon USA offers protection products (life insurance and accident & health insurance) through third-party distribution outlets known as Brokerage General Agents or Independent Wholesale Organizations. These are typically non-registered products sold through independent insurance agents. This channel offers life insurance (term life, universal life, variable universal life, index universal life and whole life insurance), long-term care and supplemental health products and services through approximately 65,000 independent brokerage distributors and financial institutions that target the affluent, emerging affluent and middle markets. These products are designed for family protection, business needs and legacy planning.
Partner
One of Aegon USAs partners, Transamerica Financial Network, provides advice and guidance to individuals to meet their protection and investment needs. With over 54,000 associates (World Financial Group), approximately 3,000 of which are registered broker-dealer and investment advisers (with Transamerica Financial Advisors Inc.), together with 1,700 agents (Transamerica Agency Network), Transamerica Financial Network offers insurance, annuities, mutual funds, retirement plans and managed accounts to individuals. This channel provides the same life and health products as the brokerage channel, with a focus on the middle and emerging affluent markets.
Institutional/Workplace
Aegon USA offers mutual funds, annuities, rollover individual retirement accounts (IRAs), life insurance (universal life, whole life and term life), supplemental health products (critical illness, cancer, hospital indemnity, supplemental medical expense, short-term disability, vision, and dental policies), accident products, and stable value solutions in this channel. The channel focuses on the sale of products to consumers through the employer segment, also known as the workplace. Aegon USA also offers individual products through institutions including large broker-dealer research and advisory platforms and large registered investment advisers.
Wholesale
Aegon USA offers annuities, mutual funds, retirement plans, life insurance and long-term care products through partnerships with independent broker-dealers that want a direct relationship with Aegon USA. The broker-dealer network is broken out into
three areas: banks, wirehouses, and independent financial planners. Aegon USAs wholesalers are dedicated to one business line, but work closely together to refer advisors across Aegon USAs multiple business lines with the intent of creating deeper partnerships with advisors and becoming even more relevant in the financial lives of customers.
Other
On December 8, 2016, Aegon announced that it would exit the Affinity and direct response channels of its accident and health lines, Transamerica wound-down its commitments and distribution operations throughout 2017 and will continue to do so in 2018.
Overview of business lines
Life
Aegon USA offers a comprehensive portfolio of protection solutions to customers in a broad range of market segments. Products offered include term life, universal life, variable universal life, index universal life and whole life insurance.
Term life insurance
Term life insurance provides protection for a stated period of time. Benefits are paid to policy beneficiaries in the event of the death of the insured during a specified period. Living benefit riders that provide accelerated benefits for critical illnesses or chronic conditions are available on term insurance.
Universal life insurance
Universal life insurance is flexible permanent life insurance that offers death benefit protection together with the potential for cash value accumulation. After the first few years, there is usually no set premium. The policyholder can adjust the frequency and amount of premium payments, as long as sufficient premiums are paid to cover charges in the month that follows, which are called monthly deductions. In determining the monthly deduction rate to apply to a specific policy plan, Aegon USA takes a wide number of factors into account that impact the cost of providing the insurance, including but not limited to: interest rates, mortality, persistency, premium funding levels, taxes, and other expenses associated with such plan. Any changes in the monthly deduction rate reflect Aegon USAs current expectations with respect to future policy performance. At any time, the policy owner is able to see the maximum monthly deduction rate that can be charged. Some versions of this product have secondary guarantees. These maintain life insurance coverage when cash value is insufficient, as long as the customer pays a specified minimum premium each year.
Variable universal life insurance
Variable universal life insurance is cash-value life insurance that offers both a death benefit and cash value accumulation potential. The premium amount for variable universal life insurance is flexible and within contract limits may be changed by the consumer. Coverage amount may change as well. The investment feature usually includes sub-accounts, which provide
Annual Report on Form 20-F 2017 |
41 | Business overview Results of operations Americas | |
exposure to stocks and bonds. This exposure increases cash value return potential but also risk of additional premium requirements or lower coverage amounts over a universal life or permanent insurance policy.
Index universal life insurance
Index Universal Life (IUL) insurance provides permanent death benefit protection and cash value accumulation with flexible premium payments. What distinguishes it from other types of permanent life insurance is the way in which interest earnings are credited. Net premiums may be allocated to either a fixed account or indexed accounts. Indexed accounts credit interest based in part on the performance of one or more market indices. The credited interest is based on the index, but with a floor and a cap. IUL offers both market-paced growth potential in the indexed accounts and downside protection. It is an appealing alternative to regular Universal Life - for which interest is credited at a fixed rate - and Variable Universal Life, in which the cash value is directly exposed to ups and downs of the market.
Long-term care riders that provide benefits if policyholders are unable to perform two or more specific activities of daily living or develop a severe cognitive impairment, and living benefit riders that provide accelerated benefits for critical illnesses or chronic conditions, are both available on IUL.
Whole life insurance
Whole life insurance provides permanent death benefit protection, provided that the required premiums are paid, while accumulating cash values based on statutory requirements. Premiums are generally fixed and usually payable over the life of the policy.
Accident & health
Aegon USA offers supplemental health insurance and long-term care insurance as well as casualty products.
Supplemental health insurance
Supplemental health insurance products include accidental death and dismemberment, accidental injury, cancer, critical illness, disability, hospital indemnity, Medicare Supplement, Medicare Part D prescription drug, retiree medical, and supplemental medical expense indemnity.
A number of these products provide policyholders with lump sum or specified payments if such policyholders are hospitalized, injured, or diagnosed with a critical illness. Others pay benefits for specific medical expenses and treatments, or cover deductibles, co-payments and co-insurance amounts not covered by other health insurance. Medical stop-loss insurance offered to employers to protect against catastrophic losses under self-funded health plans will be discontinued after a wind-down period.
Long-term care insurance
Long-term care (LTC) insurance products provide benefits to policyholders that require qualified LTC services as they are
unable to perform two or more specific activities of daily living or develop a severe cognitive impairment. LTC insurance helps protect a policyholders assets from the high cost of LTC services, and it may also help families better manage the financial, health and safety issues associated with LTC. The LTC product is offered as a standalone product or as a rider to certain life insurance products.
Casualty insurance
Casualty insurance products include travel, involuntary unemployment and bike insurance products that provide protection for covered trips, unemployment and damage/loss to bicycles, respectively. Following the announcement to exit the Affinity and direct response channels, these casualty products will be discontinued after a wind-down period.
Mutual funds
Mutual funds are professionally managed investment vehicles made up of a pool of money collected from many investors for the purpose of investing in different security types such as stocks, bonds, money market instruments and other securities. Transamerica offers mutual funds for many asset classes, including US equity, global/international equity, fixed income, and alternative investments, together with asset allocation and target date funds. Transamerica mutual funds utilize the portfolio management expertise of asset managers across the industry in a sub-advised platform using managers both affiliated and not affiliated with Aegon. These managers are subject to a rigorous selection process and are monitored through a continuous due-diligence process conducted by Transamerica Asset Management.
Exchange Traded Funds (ETFs) are a pooled investment vehicle with shares that investors can buy and sell throughout the day on an exchange. On August 2, 2017, Transamerica launched a suite of managed risk exchange-traded funds DeltaShares.
Variable annuities
Variable annuities allow the holder to accumulate assets for retirement on a tax-deferred basis and to participate in equity or bond market performance. Additional insurance guarantees, also referred to as riders, can be added to variable annuities, including guaranteed minimum death benefits (GMDBs) and guaranteed living benefits (GLBs). GMDBs provide a guaranteed benefit in the event of death. GLBs are intended to provide a measure of protection against market risk while the annuitant is alive. Different forms of GLBs are offered, such as guaranteeing an income stream for life and/or guaranteeing principal protection.
Fixed annuities
Fixed annuities allow investors to make a lump-sum payment or a series of payments and receive income in the form of periodic payments that can begin immediately or after a period of time. Aegon USA has de-emphasized traditional fixed deferred annuities, and is not actively marketing new sales. The traditional fixed deferred annuity book is, according to plan, continuing
Annual Report on Form 20-F 2017 |
42 | Business overview Results of operations Americas | |
to reduce over time. Aegon USA actively offers a fixed-index annuity that may credit interest based, in part, on the percentage change in the value of the selected index account option(s) at the start and end of the crediting period. A fixed account option is also available. Additional guarantees, also referred to as riders, can be added to fixed-index annuities, including GLBs. Aegon USAs fixed-index annuity is distributed through third-party or affiliated broker-dealers and/or insurance agencies.
Retirement plans and IRAs
Comprehensive and customized retirement plan services are offered to employers across the entire spectrum of defined benefit, defined contribution and non-qualified deferred compensation plans. Services are also offered to individuals rolling over funds from other qualified retirement funds or Individual Retirement Accounts (IRAs).
Retirement plan services, including administration, recordkeeping and related services are offered to employers of all sizes and to plans across all market segments. Aegon USA also partners with plan advisors and third-party administrators to serve their customers. Transamerica Retirement Solutions is a top ten defined contribution record-keeper in the United States based on plan participants and assets.
Plan sponsors have access to a wide array of investment options. Depending on the product chosen by the plan sponsor, unrestricted access to the entire universe of publicly-available investments can be offered. Certain smaller plans have access to an array of hundreds of investment choices from more than 40 investment advisory companies.
Tools are provided to help plan participants monitor their retirement accounts and engage in behavior to stay on track towards a funded retirement. Managed Advice ® is an option that plan sponsors can make available to participants that provides investment advice to participants using the plans line-up.
For individual plan participants in transition due to a job loss or change or planned retirement, services are offered through the Transamerica Advice Center, a team of experienced registered representatives and investment advisor representatives. Services and products include IRAs, advisory services, annuities and access to other financial products and resources.
Stable Value Solutions
Synthetic Guaranteed Investment Contracts (GICs) are offered primarily to tax-qualified institutional entities such as 401(k) plans and other retirement plans. A synthetic GIC wrapper is offered around fixed-income invested assets, which are owned by the plan and managed by the plan or a third-party money manager hired by the plan. A synthetic GIC is typically issued with an evergreen maturity and may be terminated under certain conditions. Such a contract helps to reduce fluctuations in the value of the wrapped assets and provides book value withdrawals
for plan participants, while ensuring that investment fund conditions are met.
Latin America
Aegons businesses in Latin America are comprised of a 50% interest in Mongeral Aegon Seguros e Previdência S.A., a Brazilian independent life insurer, and a 99.99% interest in Akaan-Aegon S.A.P.I. de C.V., a joint venture with Administradora Akaan S.A. de C.V., which operates as Akaan Transamerica in Mexico.
Mongeral Aegons insurance activities include pension product distribution, individual and group life insurance products, mutual fund management, and administrative services. To further capture growth prospects in Brazil, Mongeral Aegon and Bancoob (Banco Cooperativo do Brasil) established Sicoob Seguradora de Vida e Previdência, a new life insurance and pensions company dedicated to providing life insurance and pension products to the Sicoob system. The joint venture began operations on March
1, 2017, and distributes products through Sicoob, the largest cooperative financial system in the country, with over 3.2 million associates and 2,340 points of service. Bancoob is a private commercial bank owned by the credit cooperative entities affiliated with the Sicoob system. This agreement represents a key expansion of distribution for Mongeral Aegon, which already serves over 2 million customers nationwide through over 4,000 brokers
Akaan Transamerica offers a wide variety of Mexican and International mutual funds as well as diversified global investment solutions. In addition to the wide variety of investment products, Akaan Transamerica offers integrated investment solutions for individuals and companies based on their financial needs.
In 2017, the Mexican shareholders of Seguros Argos agreed to purchase Aegons shares for an undisclosed amount, ending the Seguros Argos joint venture. This was a mutual decision which allows both parties to pursue new opportunities and new relationships in Mexico.
Run-off businesses
On June 28, 2017, Aegon completed the divestment of its two largest US run-off businesses, the payout annuity business and the Bank Owned / Corporate Owned Life Insurance business (BOLI/COLI) to Wilton Re. The transaction was in line with the Companys stated strategic objective to reduce the amount of capital allocated to its run-off businesses.
Payout annuities are a form of immediate annuity purchased to provide periodic payments on an agreed schedule, in general to provide settlements of legal claims, product liability, pension payouts or other payment structured settlement. New sales of payout annuities were discontinued in 2003. BOLI/COLI products are purchased as an efficient way for banks and corporations to finance long-term employee benefit liabilities.
Annual Report on Form 20-F 2017 |
43 | Business overview Results of operations Americas | |
The bank or corporation insures key employees, and is the owner and beneficiary of the policies. New sales of BOLI/COLI were discontinued in 2010.
Institutional spread-based business
This business was put into run-off in 2009. The primary products included Guaranteed Investment Contracts (GICs), funding agreements and medium-term notes (MTNs). GICs were generally issued to tax qualified plans, while funding agreements and MTNs were typically issued to non-tax qualified institutional investors.
GICs and funding agreements are spread-based products issued on a fixed-rate or floating-rate basis. They provide customers with a guarantee of principal and a specified rate of return. A number of the outstanding fixed rate funding agreements were effectively converted to a floating-rate via swap agreements when the contracts were issued. Contracts issued in foreign currencies were converted at issuance to US dollars through swap agreements when the contracts were issued to eliminate currency risk.
Before 2009, Aegon USA utilized consolidated special purpose entities to issue MTNs that are backed by funding agreements. The proceeds of each note series were used to purchase a funding agreement from an Aegon USA insurance company, which was used to secure that particular series of notes. The payment terms of any particular series substantially matched the payment terms of the funding agreement that secured that series.
Life reinsurance
In August 2011, Aegon completed the effective divestment of its life reinsurance business with the exception of certain selected blocks of business. The retained businesses comprise primarily variable annuity guarantee business.
On December 28, 2017, Aegon divested a block of life reinsurance business that covers approximately half of the life reinsurance business Transamerica retained after it divested the vast majority of its life reinsurance business to SCOR in 2011. As part of the transaction, the Company will dissolve a related captive insurance company in place to finance redundant reserves, generally referred to as XXX term life insurance reserves, and will redeem operational leverage supporting that captive.
Competition
The US marketplace is highly competitive. Aegon USAs competitors include other large insurance carriers, in addition to certain banks, securities brokerage firms, investment advisors, and other financial intermediaries marketing insurance products, annuities and mutual funds. Aegon USA leverages long-term relationships with many institutions to offer them product lines such as life insurance, variable annuities, mutual funds, and defined contribution retirement plans.
In individual life insurance, leading competitors include AIG, Lincoln National, Nationwide, Prudential Financial, Pacific Life, Voya Financial, and John Hancock. LifeSecure and Mutual of Omaha are primary competitors for sales of individual long-term care insurance through the brokerage channel. Competitors for supplemental health include a wide range of companies and company types based on the nature of the coverage including Aflac, Allstate, MetLife, and Unum and Colonial Life.
Aegon USAs primary competitors in the variable annuity market are AIG, AXA Equitable, Jackson National, Lincoln National, Nationwide and Prudential Financial.
The largest competitors in the mutual fund market include American Funds, Fidelity, Vanguard, JP Morgan Funds and T. Rowe Price.
In the institutional segment of the defined contribution market, Aegon USAs main competitors are Fidelity, TIAA, Empower Retirement, Prudential Financial, MassMutual, Principal Financial, Charles Schwab, and Lincoln National. Aegon USAs main competitors in the defined benefit segment are MassMutual, New York Life, Principal Financial and Prudential Financial. In the emerging market segment and the multiple employer plan segment, Aegon USAs main competitors are Fidelity, Empower, Voya Financial, John Hancock, Principal Financial and MassMutual.
Regulation and supervision
Aegon USAs insurance companies and the business they conduct in the US are regulated primarily at the state level, as carried out by various state insurance regulators. Some activities, products and services are also subject to federal regulation.
State Insurance Regulation
Aegon USAs largest insurance companies are domiciled in the State of Iowa, and the Iowa Insurance Division exercises principal regulatory jurisdiction over those companies. This regulation includes implementation and enforcement of standards of solvency, adequacy of reserves and capital, and reinsurance.
The Aegon USA insurance companies are licensed as insurers and are regulated in each US state and jurisdiction in which they conduct insurance business. The extent of such regulation varies, but has a shared purpose in terms of the protection of policy and contract holders. The insurance regulators in each state carry out their mission by providing oversight in the broad areas of market conduct and financial solvency regulation.
In the areas of licensing and market conduct, states grant or revoke licenses to transact insurance business, regulate trade, advertising and marketing practices, approve policy forms and certain premium rates, review and approve products and certain rates prior to sale, address consumer complaints, and perform market conduct examinations on both a regular and targeted basis.
Annual Report on Form 20-F 2017 |
44 | Business overview Results of operations Americas | |
In the area of financial regulation, state regulators implement and supervise statutory reserve and capital requirements, including minimum risk-based capital solvency standards. Insurance companies are also subject to extensive reporting, investment limitations, and required approval of significant transactions. State regulators, by law, conduct extensive financial examinations every three to five years.
State regulators have the authority to impose a variety of punitive measures, including revoking licenses, for failure to comply with applicable regulations. All state insurance regulators are members of the National Association of Insurance Commissioners (NAIC), a non-regulatory association that works to achieve uniformity and efficiency of insurance regulation across the United States and US territories.
Recent regulatory enhancements include increased reporting of holding company activities, increased transparency and uniformity for certain captive reinsurance transactions, and requirements for companies to conduct an Own Risk and Solvency Assessment (ORSA). Aegon USA is subject to NAIC Actuarial Guidelines 48 and 49, which became fully effective in 2015 and 2016 respectively, and is also subject to Principle-based reserving requirements for life insurance, which became effective in 2017.
Emerging state issues that may impact Aegon USA include consideration of changes to accounting and actuarial requirements for variable annuities (VA), which may reduce insurers needs and abilities to deploy and cede specified risks to variable annuity captives. Aegon USA uses a captive for certain variable annuity business in order to facilitate effective hedging. Other current initiatives include a project to update capital charges for asset default risk, longevity risk and operational risk. A project to develop a group capital calculation is underway in the NAIC that could impact how captives are treated from a capital perspective. Long-term care is currently regulated by states as health insurance, although both state regulators and federal agencies are examining the current environment for the long-term care industry, which may lead to a more predictable regulatory regime for premium adjustments, and facilitate the development of new and innovative products In 2017, the NAIC approved amendments to the Life and Health Insurance Guaranty Association Model Act. Among other things, the amendments will bring health maintenance organizations (HMO) into the life and health guaranty association system and adjust guaranty fund assessments for future long-term care-related insolvencies so that 50% of such assessments will come from life/annuity accounts, with the other 50% from the combined health/HMO accounts. These amendments must be adopted into law in each state before becoming effective in each such state.
Federal Regulation of Financial Services and Health Insurance
Although the insurance business is primarily regulated at the state level, many federal laws and initiatives impact the
insurance sector in such areas as the regulation of financial services, derivatives, retirement plans, securities products, health care, taxes, data security and privacy. Regulation of financial services has increased as a result of the Dodd Frank Act, which also created the Federal Insurance Office (FIO) and the Office of Financial Research (OFR). The FIO is authorized to review the insurance market in the US and make recommendations to Congress, and the OFR conducts research in financial services, including insurance, in support of such oversight. In addition, the FIO is authorized to establish US insurance policy in international matters. The Federal Reserve Board also has authority to establish capital standards for systemically significant insurers, and insurers that own a federally insured bank or thrift, and to participate in the establishment of international insurance capital standards for Internationally Active Insurance Groups (IAIGs) and globally systemically significant insurers (G-SIIs). In the area of data security, there has been increased scrutiny at a state, federal and international level following a number of high-profile data breaches of financial services and other companies. As a result, numerous regulators and legislators at every level are proposing or have already passed additional legal requirements with regard to information security and data breach.
In addition to financial services products, many supplemental health insurance products offered by Aegon USA, such as Medicare Supplement products, are subject to both federal and state regulation as health insurance. The Patient Protection and Affordable Care Act (ACA), enacted in 2011, significantly changed the regulation of health insurance and the delivery of health care in the United States, including in certain respects, the regulation and delivery of supplemental health insurance products. The President and Congress have signaled their intent to repeal all or part of the ACA in order to, among other things, eliminate the employer mandate and remove barriers to provider and product offerings. While removal of barriers to provider and product offerings would be generally favorable to Aegon USAs supplemental health business, the likelihood that these efforts will be successful and actual impact of any such efforts on Aegon USA cannot be determined at this time.
Solvency II
The Solvency II requirements of the insurance and reinsurance activities of Aegon Americas have been consolidated into the Aegon Group Solvency II results through deduction and aggregation using available and required capital as per the local capital regimes. The US regulatory regimes have been granted provisional equivalence. The insurance regulatory regimes in the US, as well as Brazil and Mexico (which form part of the Aegon Americas operating segment) have been granted provisional equivalence under the Solvency II regime by the European Commission. The US insurance and reinsurance entities are included in Aegons group solvency calculation in accordance with local US (RBC) requirements. In 2017, Aegon obtained approval from the Dutch Central Bank (DNB) to amend the conversion methodology for its US business under Solvency II. This methodology is consistent with the European Insurance
Annual Report on Form 20-F 2017 |
45 | Business overview Results of operations Americas | |
and Occupational Pensions Authoritys (EIOPA) guidance on how to calculate group solvency in the context of equivalence. It includes lowering the conversion factor from 250% to 150% of the local RBC Company Action Level (CAL) as the Solvency Capital Requirement (SCR) equivalent, and reducing own funds by 100% RBC requirement to reflect transferability restrictions. This methodology is subject to annual review. The change in methodology leads to an increase in Aegons group solvency ratio by 13% points at the end of the second quarter of 2017, enhancing comparability with European peers and enhancing the quality of capital. The absolute and relative impact of this change in methodology may vary over time. The non-regulated US entities and the US holding companies are included in Aegons group Solvency II results through application of the Accounting Consolidation method under Solvency II, using Solvency II valuation and capital requirement calculations for these local balance sheets under the standard formula.
Securities Regulation
A number of Aegon USA subsidiaries are subject to regulation under the federal securities laws administered by the Securities and Exchange Commission (SEC) and aspects of states securities and other laws. Variable insurance policies, certain annuity contracts and registered management investment companies (mutual funds) offered by Aegon USA are subject to regulation under the federal securities laws administered by the SEC and aspects of states securities laws. Certain separate accounts of Aegon USA insurers that offer variable life insurance and certain annuities and interests under these annuity and insurance policies are registered and subject to SEC regulation. The distribution and sale of these and other securities by affiliate and non-affiliate broker-dealers are regulated by the SEC and the Financial Industry Regulatory Authority (FINRA). A number of Aegon USA companies are also registered as investment advisors and subject to SEC regulation.
Aegon USA also owns or manages other investment vehicles that are exempt from registration but may be subject to other requirements of those laws, such as anti-fraud provisions and the terms of applicable exemptions.
In accordance with Dodd-Frank Act requirements, in January 2011 the SEC studied and recommended a harmonized standard of care for broker-dealers, investment advisors and persons associated with firms that provide personalized investment advice. Broker-dealers are currently subject to requirements to make suitable recommendations, while investment advisors are regulated as fiduciaries, required to put customer interests above their own. On June 1, 2017, the SEC requested public comments from retail investors and other interested parties on standards of conduct for investment advisers and broker-dealers. The current SEC Chair has signaled a desire to regulate a harmonized standard of care, and to coordinate with the Department of Labor (DOL) in a harmonized standard of care for financial professional providers of both retirement and retail savings, and
for investment products and services. Legislation has also been introduced in Congress that, if enacted, will provide for a best interest standard of care for financial professionals that offer retirement and retail savings and investment products across jurisdictional lines. In addition, Nevada has enacted, and other states have proposed, an enhanced standard of care for insurance agents and securities brokers registered in their states. Finally, the NAIC is considering the addition of best interest standard of care for the sale of variable annuities in its model law. The likelihood of any such regulation or enactment of such legislation cannot be determined at this time.
The financial services industry continues to operate under heightened scrutiny and increased regulation in various jurisdictions. Such scrutiny and regulations have included matters relating to conflicts of interest, cash and non-cash compensation arrangements, suitability of sales (especially to seniors), misleading sales practices, unclaimed property reporting, revenue sharing, investment management and valuation issues involving mutual funds and life insurance separate accounts and their underlying funds, sales, investments and oversight processes related to retail investors saving for retirement, variable annuity buyout offers, and share classes in mutual funds and variable annuities. Aegon USA, like other businesses in the financial services industry, is routinely examined and receives requests for information from the SEC, FINRA, state regulators and others in connection with examinations and investigations of its own companies and third-party or unaffiliated insurers, broker-dealers, investment advisers, investment companies and service providers relating to certain historical and current practices with respect to these and other matters. Some of those inquiries have led to investigations, which remain open, or have resulted in fines, corrective actions or restitution. Aegon USA continues to cooperate with these regulatory agencies. In certain instances, Aegon USA modified business practices in response to those inquiries or findings. Certain Aegon USA companies have paid, or have been informed that the regulators may seek, restitution, disgorgement, fines or other monetary penalties or changes in the way that business is conducted. The impact of any such fines or other monetary penalties is not expected to have a material impact on Aegon USAs financial position.
Regulation of Retirement Plans and IRAs
Aegon USA administers and provides recordkeeping, investment and insurance services and products used to fund defined contribution plans, such as 401(k), 403(b) and 457 plans, in addition to defined benefit plans, IRAs, 529 plans and other savings vehicles. Aegon USA also administers benefits distributed on termination of defined benefit plans. These products and services are generally subject to the Employee Retirement Income Security Act (ERISA) (certain government and church plans are exempt from ERISA) and the federal Internal Revenue Code of 1986, as amended (the Code) for which the US Department of Labor (DOL) and the US Department of the Treasury (Treasury) have regulatory jurisdiction, respectively.
Annual Report on Form 20-F 2017 |
46 | Business overview Results of operations Americas | |
In June 2017, the DOL conflicts of interest rule (the DOL Rule) became applicable. The compliance deadline for many parts of the DOL Rule, including the best interest contract exemption (the BIC) and other prohibited transaction exemptions (PTEs), has however been extended until July 2019, during which time the DOL will consider further changes to the DOL Rule. The DOL Rule significantly expands the scope of persons providing services and products to workplace retirement plans and IRAs to an impartial standard of conduct and also impacts the delivery of certain products, such as variable annuities offered in the qualified space. Impartial conduct standards include: acting in the clients best interest; receiving no more than reasonable compensation; and making no misleading statements.
The reassessment of the DOL Rule, ordered by the President, could lead to major revisions in the DOL Rule. In addition, several lawsuits brought by industry coalitions remain pending in the appellate courts.
Legislation to enhance the retirement security of Americans, and in particular, through workplace retirement plans, is being considered in Congress. The legislation would facilitate the use of multiple employer plans (MEPs), of which Aegon USA is a leading provider, as well as expand the safe harbor for automatic enrollment in plans, and reduce the burden of offering annuities either as an in-plan investment option or as the form of distribution from a plan. In addition, both the Treasury and the DOL have published, in final and proposed forms respectively, guidance to facilitate the offering of guaranteed lifetime income products. Furthermore, many states have sought to open their plans to non-government workers who do not have access to an employer retirement savings plan.
Tax Treatment of Insurance Companies and their Products and Plans
Although the insurance business is regulated at state level, the US federal tax treatment of life insurers, life insurance, pension and annuity products is governed by the US federal tax code. The Tax Cuts and Jobs Act, signed into law on December 22, 2017, made significant changes to the federal tax code, generally effective as of January 1, 2018. Along with other changes, the new law lowered the corporate tax rate to 21 percent, eliminated the corporate alternative minimum tax, changed interest deductibility limitations (including by adding a new limitation on the deductibility of business interest expense) and moved the US to a partial territorial system of international business taxation. In addition, the new law introduces a base erosion anti-abuse tax, which may be imposed on companies that make significant deductible payments to their non-US affiliates. With respect to life insurance, pension and annuity contracts, among other changes, the Tax Cuts and Jobs Act reduced the tax deduction for life insurance reserves, limited the dividends received deduction for separate account products such as variable annuities, and increased the capitalization rates of acquisition costs for life insurance products and extended the amortization period for such deferred acquisition costs. It did not, however, make any significant changes to the tax incentives for life insurance, pensions or other retirement savings products. The impact of the tax law changes do not significantly favor one life insurance product or structure to the detriment of another. Aegon USA is in the process of assessing the overall impact of the Tax Cuts and Jobs Act on its business and financial condition. There can be no assurance that the Tax Cuts and Jobs Act will not have a material adverse impact on Aegons businesses, results of operations, and financial position.
Annual Report on Form 20-F 2017 |
47 | Business overview Results of operations Europe | |
The Results 2017 Europe cover the following operating segments: The Netherlands, United Kingdom (including VA Europe), Central & Eastern Europe, Spain & Portugal.
This segment reporting is based on the businesses as presented in internal reports that are regularly reviewed by the Executive Board which is regarded as Aegons chief operating decision
maker. For Europe, the underlying businesses are separate operating segments which under IFRS 8 cannot be aggregated, therefore further details will be provided for these operating segments in this section. Management is of the opinion that presenting the information for the entire European area is beneficial to the users of the financial information as it aligns to how Aegon management is looking at the information following convergence in Europe from a regulatory standpoint and financial markets perspective.
Income statement - Underlying earnings Amounts in EUR millions |
The Netherlands | United Kingdom |
Central & Eastern Europe |
Spain & Portugal |
Europe |
|||||||||||||||
2017 |
||||||||||||||||||||
Net underlying earnings |
399 | 96 | 58 | (2 | ) | 552 | ||||||||||||||
Tax on underlying earnings |
121 | 20 | 9 | 6 | 155 | |||||||||||||||
Underlying earnings before tax by product segment |
520 | 116 | 67 | 4 | 707 | |||||||||||||||
Fair value items |
30 | (82 | ) | - | - | (52 | ) | |||||||||||||
Gains / (losses) on investments |
184 | 62 | 1 | - | 248 | |||||||||||||||
Net impairments |
(17 | ) | - | (2 | ) | - | (19 | ) | ||||||||||||
Other income / (charges) |
296 | 40 | - | - | 336 | |||||||||||||||
Income / (loss) before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 1,013 | 137 | 66 | 4 | 1,220 | |||||||||||||||
Income tax |
(196 | ) | (56 | ) | (9 | ) | (6 | ) | (266 | ) | ||||||||||
Net income / (loss) |
818 | 81 | 57 | (2 | ) | 954 | ||||||||||||||
2017 |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Life insurance gross premiums |
1,857 | 9,603 | 411 | 208 | 12,079 | |||||||||||||||
Accident and health insurance premiums |
203 | 32 | 1 | 83 | 319 | |||||||||||||||
General insurance premiums |
148 | - | 216 | 103 | 467 | |||||||||||||||
Total gross premiums | 2,208 | 9,635 | 628 | 394 | 12,865 | |||||||||||||||
Investment income |
2,172 | 1,517 | 49 | 37 | 3,774 | |||||||||||||||
Fees and commission income |
326 | 235 | 43 | 17 | 621 | |||||||||||||||
Other revenues |
- | - | - | 3 | 3 | |||||||||||||||
Total revenues |
4,706 | 11,387 | 720 | 450 | 17,263 | |||||||||||||||
Commissions and expenses |
930 | 757 | 262 | 192 | 2,141 | |||||||||||||||
of which operating expenses |
818 | 546 | 152 | 94 | 1,610 |
Annual Report on Form 20-F 2017 |
48 | Business overview Results of operations Europe | |
Income statement - Underlying earnings Amounts in EUR millions |
The Netherlands | United Kingdom |
Central & Eastern Europe |
Spain & Portugal | Europe | |||||||||||||||
2016 |
||||||||||||||||||||
Net underlying earnings |
414 | 89 | 47 | (1 | ) | 548 | ||||||||||||||
Tax on underlying earnings |
119 | (30 | ) | 9 | 9 | 107 | ||||||||||||||
Underlying earnings before tax by product segment |
534 | 59 | 55 | 8 | 655 | |||||||||||||||
Fair value items |
(228 | ) | (7 | ) | - | (1 | ) | (236 | ) | |||||||||||
Gains / (losses) on investments |
189 | 153 | - | (1 | ) | 342 | ||||||||||||||
Net impairments |
(12 | ) | - | 1 | - | (10 | ) | |||||||||||||
Other income / (charges) |
44 | (678 | ) | (23 | ) | - | (658 | ) | ||||||||||||
Income / (loss) before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 526 | (474 | ) | 34 | 6 | 92 | ||||||||||||||
Income tax |
(109 | ) | 18 | (15 | ) | (8 | ) | (114 | ) | |||||||||||
Net income / (loss) |
418 | (456 | ) | 19 | (2 | ) | (22 | ) | ||||||||||||
2016 |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Life insurance gross premiums |
2,015 | 9,888 | 399 | 191 | 12,493 | |||||||||||||||
Accident and health insurance premiums |
210 | 36 | 1 | 73 | 320 | |||||||||||||||
General insurance premiums |
266 | - | 179 | 92 | 536 | |||||||||||||||
Total gross premiums | 2,491 | 9,924 | 578 | 355 | 13,348 | |||||||||||||||
Investment income |
2,135 | 1,661 | 45 | 45 | 3,886 | |||||||||||||||
Fees and commission income |
350 | 95 | 36 | 14 | 495 | |||||||||||||||
Other revenues |
- | - | - | 2 | 2 | |||||||||||||||
Total revenues |
4,976 | 11,680 | 659 | 416 | 17,732 | |||||||||||||||
Commissions and expenses |
975 | 667 | 244 | 172 | 2,058 | |||||||||||||||
of which operating expenses |
821 | 394 | 143 | 88 | 1,445 | |||||||||||||||
Income statement - Underlying earnings Amounts in EUR millions |
The Netherlands | United Kingdom |
Central & Eastern Europe |
Spain & Portugal | Europe | |||||||||||||||
2015 |
||||||||||||||||||||
Net underlying earnings |
419 | 31 | 26 | 6 | 482 | |||||||||||||||
Tax on underlying earnings |
118 | (58 | ) | 10 | 7 | 77 | ||||||||||||||
Underlying earnings before tax by product segment |
537 | (27 | ) | 37 | 12 | 559 | ||||||||||||||
Fair value items |
126 | (25 | ) | - | - | 101 | ||||||||||||||
Gains / (losses) on investments |
306 | 103 | 2 | - | 411 | |||||||||||||||
Net impairments |
(20 | ) | - | (2 | ) | - | (22 | ) | ||||||||||||
Other income / (charges) |
27 | (1,247 | ) | (2 | ) | 17 | (1,205 | ) | ||||||||||||
Income / (loss) before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 977 | (1,196 | ) | 35 | 29 | (156 | ) | |||||||||||||
Income tax |
(223 | ) | 268 | (11 | ) | (7 | ) | 27 | ||||||||||||
Net income / (loss) |
753 | (928 | ) | 24 | 22 | (129 | ) | |||||||||||||
2015 |
||||||||||||||||||||
Revenues |
||||||||||||||||||||
Life insurance gross premiums |
2,240 | 8,465 | 477 | 174 | 11,356 | |||||||||||||||
Accident and health insurance premiums |
234 | 47 | 1 | 64 | 345 | |||||||||||||||
General insurance premiums |
473 | - | 164 | 80 | 717 | |||||||||||||||
Total gross premiums | 2,947 | 8,512 | 642 | 317 | 12,419 | |||||||||||||||
Investment income |
2,277 | 2,331 | 45 | 41 | 4,693 | |||||||||||||||
Fees and commission income |
351 | 98 | 39 | 13 | 501 | |||||||||||||||
Other revenues |
- | - | - | 2 | 2 | |||||||||||||||
Total revenues |
5,575 | 10,941 | 726 | 373 | 17,615 | |||||||||||||||
Commissions and expenses |
1,053 | 907 | 264 | 144 | 2,368 | |||||||||||||||
of which operating expenses |
831 | 398 | 143 | 70 | 1,442 |
The results of operations Europe for 2017 and 2016 are based
on the figures of the separate operating segments that are
further disclosed on the following pages.
Annual Report on Form 20-F 2017 |
49 | Business overview Results of operations Europe | |
Results 2017 Europe
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Net underlying earnings |
552 | 548 | 1 | |||||||||
Tax on underlying earnings |
155 | 107 | 45 | |||||||||
Underlying earnings before tax by business / country |
||||||||||||
The Netherlands |
520 | 534 | (2) | |||||||||
United Kingdom |
116 | 59 | 98 | |||||||||
Central & Eastern Europe |
67 | 55 | 20 | |||||||||
Spain & Portugal |
4 | 8 | (47) | |||||||||
Underlying earnings before tax |
707 | 655 | 8 | |||||||||
Fair value items |
(52 | ) | (236 | ) | 78 | |||||||
Gains / (losses) on investments |
248 | 342 | (27) | |||||||||
Net impairments |
(19 | ) | (10 | ) | (83) | |||||||
Other income / (charges) |
336 | (658 | ) | n.m. | ||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 1,220 | 92 | n.m. | |||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
6 | 7 | (16) | |||||||||
Income tax |
(266 | ) | (114 | ) | (133) | |||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(6 | ) | (7 | ) | 16 | |||||||
Net income / (loss) |
954 | (22 | ) | n.m. | ||||||||
Life insurance gross premiums |
12,079 | 12,493 | (3) | |||||||||
Accident and health insurance premiums |
319 | 320 | - | |||||||||
General insurance premiums |
467 | 536 | (13) | |||||||||
Total gross premiums |
12,865 | 13,348 | (4) | |||||||||
Investment income |
3,774 | 3,886 | (3) | |||||||||
Fees and commission income |
621 | 495 | 25 | |||||||||
Other revenues |
3 | 2 | 38 | |||||||||
Total revenues |
17,263 | 17,732 | (3) | |||||||||
Commissions and expenses |
2,141 | 2,058 | 4 | |||||||||
of which operating expenses |
1,610 | 1,445 | 11 |
Annual Report on Form 20-F 2017 |
50 | Business overview Results of operations Europe | |
New life sales | ||||||||||||
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
The Netherlands |
99 | 111 | (11) | |||||||||
United Kingdom |
37 | 66 | (44) | |||||||||
Central & Eastern Europe |
88 | 83 | 6 | |||||||||
Spain & Portugal |
48 | 39 | 23 | |||||||||
Total recurring plus 1/10 single |
273 | 299 | (9) | |||||||||
Amounts in EUR million | 2017 | 2016 | % | |||||||||
New premium production accident and health insurance |
39 | 34 | 14 | |||||||||
New premium production general insurance |
109 | 94 | 16 | |||||||||
Gross deposits (on and off balance) | 2017 | 2016 | % | |||||||||
The Netherlands |
8,061 | 6,686 | 21 | |||||||||
United Kingdom |
35,896 | 5,791 | n.m. | |||||||||
Central & Eastern Europe |
323 | 265 | 22 | |||||||||
Spain & Portugal |
36 | 31 | 15 | |||||||||
Total gross deposits |
44,316 | 12,773 | n.m. | |||||||||
Net deposits (on and off balance) | 2017 | 2016 | % | |||||||||
The Netherlands |
1,067 | 1,909 | (44) | |||||||||
United Kingdom |
4,665 | (846 | ) | n.m. | ||||||||
Central & Eastern Europe |
176 | 176 | - | |||||||||
Spain & Portugal |
13 | 20 | (37) | |||||||||
Total net deposits / (outflows) |
5,921 | 1,260 | n.m. | |||||||||
Weighted average rate | ||||||||||||
Exchange rates |
||||||||||||
Per 1 EUR | 2017 | 2016 | ||||||||||
Pound sterling |
0.8758 | 0.8187 | ||||||||||
Czech koruna |
26.3165 | 27.0184 | ||||||||||
Hungarian forint |
308.7564 | 310.9128 | ||||||||||
Polish zloty |
4.2558 | 4.3616 | ||||||||||
Romanian leu |
4.5665 | 4.4889 | ||||||||||
Turkish Lira |
4.1197 | 3.3426 | ||||||||||
Ukrainian Hryvnia |
30.2092 | 28.3029 |
Annual Report on Form 20-F 2017 |
51 | Business overview Results of operations Europe | |
Results 2017 Europe
Net income improved to EUR 954 million in 2017 compared with 2016 driven by Other income and higher underlying earnings before tax. The gain on the sale of the insurance broker UMG in the Netherlands was the main driver behind Other income of EUR 336 million. Underlying earnings before tax in 2017 increased compared with 2016 to EUR 707 million. This was mainly the result of higher results in the United Kingdom, reflecting higher fee income.
Net income
Net income amounted to EUR 954 million in 2017 compared with a loss of EUR 22 million in 2016. Drivers of this improvement were Other income, improved results on fair value items and a higher underlying earnings before tax. Other income of EUR 336 million in 2017 included a gain on the sale of UMG in the Netherlands, while the sale of the majority of the UK annuity portfolio was the main driver behind Other charges of EUR 658 million in 2016.
Net income for the Netherlands
Net income from Aegons businesses in the Netherlands amounted to EUR 818 million in 2017, largely driven by underlying earnings before tax of EUR 520 million. Results on fair value items improved compared with 2016 to a gain of EUR 30 million in 2017, as positive real estate revaluations and the positive result from the mismatch on an IFRS basis between interest rate hedges, on the mortgage portfolio and the underlying mortgages, were partly offset by a fair value loss on the guarantee provision and hedging-related fair value losses. Realized gains of EUR 184 million in 2017 were the result of asset-liability management adjustments and normal trading activity in the investment portfolio. Impairments amounted to EUR 17 million in 2017 and were mostly driven by a loan loss provision related to growing consumer loan origination. Other income amounted to EUR 296 million in 2017. This reflects the EUR 208 million gain on the sale of UMG and EUR 101 million positive assumption changes and model updates mainly related to the guarantee provision in the Netherlands.
Net income for the United Kingdom
Net income from Aegons businesses in the United Kingdom amounted to EUR 81 million in 2017. The main driver was the underlying result before tax of EUR 116 million. Losses from fair value items of EUR 82 million were mainly caused by losses on equity hedging programs as a result of increased equity markets where hedges have been set up to protect against a decline in equity markets. Realized gains amounted to EUR 62 million in 2017 and reflect rebalancing of the investment portfolio, and the sale of bonds to fund remittances to the Group. Other income amounted to EUR 40 million, mainly driven by the net release of provisions following the
completion of the Part VII transfers of the annuity portfolios sold to Rothesay and Legal & General. This was partly offset by integration expenses for the acquired Cofunds and BlackRocks defined contribution business and the impairment of intangible assets related to the announced sales of Aegon Ireland.
Net income for Central & Eastern Europe
Net income from Aegons businesses in Central & Eastern Europe (CEE) amounted to EUR 57 million in 2017 and reflect underlying earnings before tax of EUR 67 million.
Net income for Spain & Portugal
Net income from Aegons businesses in Spain & Portugal amounted to a loss of EUR 2 million in 2017 as underlying earnings before tax of EUR 4 million were more than offset by income tax of EUR 6 million.
Underlying earnings before tax
Underlying earnings before tax in 2017 increased by 8% compared with 2016 to EUR 707 million. This was driven by higher fee income in the United Kingdom and growth in CEE.
Underlying earnings before tax for the Netherlands
Underlying earnings before tax for the Netherlands in 2017 decreased by 2% compared with 2016 to EUR 520 million.
◆ | Underlying earnings before tax from Life & Savings declined by 2% compared with 2016 to EUR 301 million, reflecting lower investment income in Life, partly offset by a higher interest margin in Savings. |
◆ | Underlying earnings before tax from Pensions decreased by 12% compared with 2016 to EUR 172 million, mainly due to lower investment income. |
◆ | The results from the Non-life business increased from EUR 1 million in 2016 to EUR 30 million in 2017. The main drivers were favorable claims experience, in part due to management actions, and one-time claims provision releases. |
◆ | Underlying earnings before tax from the Distribution business decreased compared with 2016 to EUR 17 million. The decrease was caused by the sale of UMG and pressure on fee income due to increased competition. |
Annual Report on Form 20-F 2017 |
52 | Business overview Results of operations Europe | |
Underlying earnings before tax for the United Kingdom
Underlying earnings before tax in the United Kingdom amounted to EUR 116 million in 2017.
◆ | Underlying earnings before tax from Life increased in 2017 compared with 2016 to EUR 65 million, reflecting higher results on inflation-linked bonds and growth in the protection business. |
◆ | Underlying earnings before tax from Pensions improved from EUR 9 million in 2016 to EUR 51 million in 2017. This was driven by higher fee income from favorable equity markets and net inflows, as well as the inclusion of Cofunds in 2017. |
Underlying earnings before tax for Central & Eastern Europe
Underlying earnings before tax from Central & Eastern Europe increased to EUR 67 million in 2017, up from EUR 55 million in 2016. This increase was primarily driven by business growth, better underwriting results and the acquisition of a non-life portfolio in Hungary.
Underlying earnings before tax for Spain & Portugal
Underlying earnings before tax from Spain & Portugal decreased compared with 2016 to EUR 4 million in 2017, mainly caused by higher operating expenses due to the write-down of an IT system, governance costs and project related expenses.
Commissions and expenses
Commissions and expenses increased by 4% compared with 2016 to EUR 2,141 million in 2017. Operating expenses increased by 11% compared with 2016 and amounted to EUR 1,610 million in 2017.
Commissions and expenses for the Netherlands
Commissions and expenses decreased compared with 2016 to EUR 930 million in 2017. Operating expenses were down compared with 2016 to EUR 818 million in 2017, reflecting the sale of UMG. Expense savings in the insurance businesses were more than offset by investments in growth.
Commissions and expenses for the United Kingdom
Commissions and expenses decreased by 14% in 2017 to EUR 757 million compared with 2017. Operating expenses increased by 39% in 2017 to EUR 546 million compared with 2016, mainly due to the inclusion of Cofunds and BlackRocks defined contribution business and integration of related activities.
Commissions and expenses for Central & Eastern Europe
Commissions and expenses increased compared with 2016 to EUR 262 million in 2017. Operating expenses increased compared with 2016 to EUR 152 million in 2017, reflecting the growth of the business and higher variable personnel expenses.
Commissions and expenses for Spain & Portugal
Commissions and expenses increased compared with 2016 to EUR 192 million in 2017. Operating expenses increased
compared with 2016 to EUR 94 million in 2017, mainly resulting from the growth of Aegons joint ventures with Santander and project-related expenses, severance costs and the write-down of an IT system.
Production
Gross deposits increased from EUR 12.8 billion in 2016 to EUR 44.3 billion in 2017. The increase compared with 2016 was primarily driven by the higher platform sales in the United Kingdom.
New life sales declined by 9% compared with 2016 to EUR 273 million in 2017. The decline compared with 2016 was mainly the result of the sale of the annuity business in the United Kingdom. New premium production for general and accident & health insurance increased compared with 2016 to EUR 148 million in 2017.
Production for the Netherlands
Gross deposits increased by 21% compared with 2016 to EUR 8.1 billion in 2017, mainly driven by the growth of Knab, Aegons online bank. New life sales declined compared with 2016 to EUR 99 million in 2017, caused by lower DB pension sales and individual life sales. Premium production for accident & health increased compared with 2016 to EUR 16 million in 2017, while general insurance production decreased compared with 2016 to EUR 15 million in 2017.
Production for the United Kingdom
Gross deposits increased from EUR 5.8 billion in 2016 to EUR 35.9 billion in 2017 as a result of higher platform sales, reflecting the inclusion of Cofunds. New life sales decreased compared with 2016 to EUR 37 million in 2017, mainly due to the sale of the majority of the annuity business in the second half of 2016.
Production for Central & Eastern Europe
In Central & Eastern Europe, new life sales in 2017 increased compared with 2016 to EUR 88 million, driven by sales growth in Turkey. For the general insurance business, there were higher sales compared with 2016 amounting to EUR 64 million in 2017, reflecting the acquisition of a portfolio in Hungary.
Production for Spain & Portugal
New life sales in Spain & Portugal in 2017 increased by 23% compared with 2016 and amounted to EUR 48 million, driven by increasing sales through the joint venture with Banco Santander. General insurance and accident & health insurance sales increased compared with 2016 to EUR 53 million in 2017, also as a result of higher sales from the joint ventures with Santander.
Annual Report on Form 20-F 2017 |
53 | Business overview Results of operations Europe | |
Results 2016 Europe
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Net underlying earnings |
548 | 482 | 14 | |||||||||
Tax on underlying earnings |
107 | 77 | 38 | |||||||||
Underlying earnings before tax by business / country |
||||||||||||
The Netherlands |
534 | 537 | (1) | |||||||||
United Kingdom |
59 | (27 | ) | n.m. | ||||||||
Central & Eastern Europe |
55 | 37 | 51 | |||||||||
Spain & Portugal |
8 | 12 | (38) | |||||||||
Underlying earnings before tax |
655 | 559 | 17 | |||||||||
Fair value items |
(236 | ) | 101 | n.m. | ||||||||
Gains / (losses) on investments |
342 | 411 | (17) | |||||||||
Net impairments |
(10 | ) | (22 | ) | 53 | |||||||
Other income / (charges) |
(658 | ) | (1,205 | ) | 45 | |||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 92 | (156 | ) | n.m. | ||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
7 | 6 | 19 | |||||||||
Income tax |
(114 | ) | 27 | n.m. | ||||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(7 | ) | (6 | ) | (19) | |||||||
Net income / (loss) |
(22 | ) | (129 | ) | 83 | |||||||
Life insurance gross premiums |
12,493 | 11,356 | 10 | |||||||||
Accident and health insurance premiums |
320 | 345 | (8) | |||||||||
General insurance premiums |
536 | 717 | (25) | |||||||||
Total gross premiums |
13,348 | 12,419 | 7 | |||||||||
Investment income |
3,886 | 4,693 | (17) | |||||||||
Fees and commission income |
495 | 501 | (1) | |||||||||
Other revenues |
2 | 2 | 47 | |||||||||
Total revenues |
17,732 | 17,615 | 1 | |||||||||
Commissions and expenses |
2,058 | 2,368 | (13) | |||||||||
of which operating expenses |
1,445 | 1,442 | - |
Annual Report on Form 20-F 2017 |
54 | Business overview Results of operations Europe | |
New life sales | ||||||||||||
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
The Netherlands |
111 | 130 | (15) | |||||||||
United Kingdom |
66 | 72 | (8) | |||||||||
Central & Eastern Europe |
83 | 91 | (9) | |||||||||
Spain & Portugal |
39 | 39 | 1 | |||||||||
Total recurring plus 1/10 single |
299 | 332 | (10) | |||||||||
Amounts in EUR million | 2016 | 2015 | % | |||||||||
New premium production accident and health insurance |
34 | 28 | 22 | |||||||||
New premium production general insurance |
94 | 84 | 12 | |||||||||
Gross deposits (on and off balance) | 2016 | 2015 | % | |||||||||
The Netherlands |
6,686 | 5,137 | 30 | |||||||||
United Kingdom |
5,791 | 6,096 | (5) | |||||||||
Central & Eastern Europe |
265 | 227 | 17 | |||||||||
Spain & Portugal |
31 | 29 | 8 | |||||||||
Total gross deposits |
12,773 | 11,489 | 11 | |||||||||
Net deposits (on and off balance) | 2016 | 2015 | % | |||||||||
The Netherlands |
1,909 | 1,885 | 1 | |||||||||
United Kingdom |
(846 | ) | (1,096 | ) | 23 | |||||||
Central & Eastern Europe |
176 | 63 | 180 | |||||||||
Spain & Portugal |
20 | 17 | 20 | |||||||||
Total net deposits / (outflows) |
1,260 | 869 | 45 | |||||||||
Weighted average rate | ||||||||||||
Exchange rates |
||||||||||||
Per 1 EUR | 2016 | 2015 | ||||||||||
Pound sterling |
0.8187 | 0.7256 | ||||||||||
Czech koruna |
27.0184 | 27.2662 | ||||||||||
Hungarian forint |
310.9128 | 309.3147 | ||||||||||
Polish zloty |
4.3616 | 4.1819 | ||||||||||
Romanian leu |
4.4889 | 4.4428 | ||||||||||
Turkish Lira |
3.3426 | 3.0206 | ||||||||||
Ukrainian Hryvnia |
28.3029 | 24.1414 |
Annual Report on Form 20-F 2017 |
55 | Business overview Results of operations Europe | |
Results 2016 Europe
The net result improved compared with 2015 to a loss of EUR 22 million in 2016 driven by higher underlying earnings before tax and lower losses from other charges, which more than offset a lower result from fair value items. The sale of the annuity portfolio of Aegon UK was the main driver behind Other charges of EUR 658 million in 2016. Underlying earnings before tax increased compared with 2015 to EUR 655 million in 2016. This was mainly the result of lower amortization of deferred policy acquisition costs in the United Kingdom related to upgrading customers to the new retirement platform.
Net income
The net loss amounted to EUR 22 million in 2016 compared with a loss of EUR 129 million in 2015. Drivers of the improvement were higher underlying earnings before tax and lower losses from other charges, which more than offset a lower result from fair value items. Other charges in 2015 included a write down of deferred policy acquisition costs in the United Kingdom. The sale of the UK annuity portfolio was the main driver behind Other charges of EUR 658 million in 2016.
Net income for the Netherlands
Net income from Aegons businesses in the Netherlands amounted to EUR 418 million in 2016, largely driven by underlying earnings before tax of EUR 534 million. Results on fair value items worsened compared with 2015 to a loss of EUR 228 million in 2016 as the impact of credit spreads movements, declining interest rates as a result of a mismatch on an IFRS basis between the valuation of interest rate hedges and liabilities, and declining interest rates as a result of the mismatch on an IFRS basis between certain interest rate hedges on the mortgage portfolio and the underlying mortgages more than offset positive real estate revaluations. Realized gains of EUR 189 million in 2016 were the result of asset-liability management adjustments and normal trading activity in the investment portfolio. Impairments amounted to EUR 12 million in 2016 and were mostly driven by the consumer loan portfolio. Other income amounted to EUR 44 million in 2016 and was driven by model updates.
Net income for the United Kingdom
Net income from Aegons businesses in the United Kingdom amounted to a loss of EUR 456 million in 2016. The sale of the annuity portfolio which resulted in a loss of EUR 678 million recorded in other charges, was the main driver behind this loss. Losses from fair value items of EUR 7 million were driven by losses on equity hedging programs which were only partly offset by fair value gains related to Aegons European variable annuities business. Positive components were realized gains which amounted to EUR 153 million in 2016 and were driven by rebalancing of the investment portfolio following the sale of the annuity portfolio, and underlying earnings before tax which amounted to EUR 59 million.
Net income for Central & Eastern Europe
Net income from Aegons businesses in Central & Eastern Europe (CEE) amounted to EUR 19 million in 2016. Underlying earnings before tax of EUR 55 million were partly offset by other charges which amounted to EUR 23 million in 2016 as a result of additions to a legal claims provision. Impairment reversals amounted to EUR 1 million in 2016.
Net income for Spain & Portugal
Net income from Aegons businesses in Spain & Portugal amounted to a loss of EUR 2 million in 2016 as underlying earnings before tax of EUR 8 million were more than offset by income tax of EUR 8 million, losses on fair value items of EUR 1 million and losses on investments of EUR 1 million.
Underlying earnings before tax
Underlying earnings before tax in 2016 increased 17% compared with 2015 to EUR 655 million. This was mainly driven by lower amortization of deferred policy acquisition costs in the United Kingdom related to upgrading customers to the retirement platform compared to 2015.
Underlying earnings before tax for the Netherlands
Underlying earnings before tax for the Netherlands in 2016 decreased by 1% compared with 2015 to EUR 534 million.
◆ | Underlying earnings before tax from Life & Savings declined by 5% compared with 2015 to EUR 309 million in 2016 as lower funding costs for the mortgage portfolio were offset by lower investment income and increased expenses, which were partly the result of new business initiatives. |
◆ | Underlying earnings before tax from Pensions decreased by 7% compared with 2015 to EUR 197 million in 2016, mainly due to lower investment income. |
◆ | The results from the Non-life business increased compared with 2015 to EUR 1 million in 2016. Lower investment income and weather related losses were more than offset by favorable claims experience driven by management actions implemented in 2015 and 2016 as well as the benefit from the divestment of the loss-making commercial line non-life business. |
◆ | Underlying earnings before tax from the Distribution business increased compared with 2015 to EUR 27 million in 2016. The increase was mainly driven by expense reductions. |
Annual Report on Form 20-F 2017 |
56 | Business overview Results of operations Europe | |
Underlying earnings before tax for the United Kingdom
Underlying earnings before tax in the United Kingdom amounted to EUR 59 million in 2016.
◆ | Underlying earnings before tax from Life decreased compared with 2015 to EUR 50 million. This was mostly due to the impact of the sale of the annuity business partly offset by expense savings, favorable claims experience and reserve releases. |
◆ | Underlying earnings before tax from Pensions improved compared with 2015 to EUR 9 million in 2016. This was mainly driven by lower amortization of deferred policy acquisition costs in the United Kingdom related to upgrading customers to the retirement platform compared to 2015. |
Underlying earnings before tax for Central & Eastern Europe
Underlying earnings before tax from Central & Eastern Europe increased to EUR 55 million in 2016, up from EUR 37 million in 2015. This increase was primarily driven by a normalization of surrender levels in Poland which led to a negative impact following product changes in 2015.
Underlying earnings before tax for Spain & Portugal
Underlying earnings before tax from Spain & Portugal decreased compared with 2015 to EUR 8 million in 2016. Higher results from the joint ventures with Banco Santander were offset by adverse claims experience and increased investments in the direct channel and new business initiatives.
Commissions and expenses
Commissions and expenses decreased by 13% compared with 2015 to EUR 2.1 billion in 2016. Operating expenses were stable compared with 2015 and amounted to EUR 1,445 million in 2016.
Commissions and expenses for the Netherlands
Commissions and expenses decreased compared with 2015 to EUR 975 million in 2016. Operating expenses were down compared with 2015 to EUR 821 million in 2016 as the non-recurrence of one-time charges in 2015 and expense savings were partly offset by investments in new business initiatives, Solvency II related expenses, and the cost of an IT project that will result in annual expense savings going forward.
Commissions and expenses for the United Kingdom
Commissions and expenses decreased by 27% in 2016 to EUR 667 million compared with 2015. Operating expenses decreased by 1% in 2016 to EUR 394 million compared with 2015, mainly due to favorable currency movements, partly offset by expenses related to the acquisitions of Cofunds and BlackRocks defined contribution business.
Commissions and expenses for Central & Eastern Europe
Commissions and expenses decreased compared with 2015 to EUR 244 million in 2016. Operating expenses remained stable compared with 2015 at EUR 143 million in 2016.
Commissions and expenses for Spain & Portugal
Commissions and expenses increased compared with 2015 to EUR 172 million in 2016. Operating expenses increased compared with 2015 to EUR 88 million in 2016, mainly resulting from growth of Aegons joint ventures with Santander in Spain & Portugal and project-related expenses.
Production
Gross deposits increased by 11% compared with 2015 to EUR 12.8 billion in 2016. The increase compared with 2015 was primarily driven by the growth of Knab, Aegons online bank in the Netherlands.
New life sales declined by 10% compared with 2015 to EUR 299 million in 2016. The decline compared with 2015 was mainly the result of the absence of large pension buyouts in the Netherlands. New premium production for general and accident & health insurance increased compared with 2015 to EUR 129 million in 2016.
Production for the Netherlands
Gross deposits increased by 30% compared with 2015 to EUR 6.7 billion in 2016, mainly driven by the growth of Knab, Aegons online bank. New life sales declined compared with 2015 to EUR 111 million in 2016, which was a result of the absence of large pension buyouts. Premium production for accident & health increased compared with 2015 to EUR 14 million in 2016, while general insurance production decreased compared with 2015 to EUR 21 million in 2016.
Production for the United Kingdom
Gross deposits of EUR 5.8 billion in 2016 were mainly driven by the addition of new customers as the platform continues to grow. New life sales decreased compared with 2015 to EUR 66 million in 2016.
Production for Central & Eastern Europe
In Central & Eastern Europe, new life sales in 2016 declined compared with 2015 to EUR 83 million. Sales growth in Turkey was more than offset by lower sales in Poland resulting from changes in the product offering. For general insurance business there were higher sales compared with 2015 amounting to EUR 43 million in 2016.
Production for Spain & Portugal
New life sales in Spain & Portugal in 2016 remained stable compared with 2015 and amounted to EUR 39 million as increasing sales through the joint venture with Banco Santander were offset by declines in other channels. General insurance and accident & health insurance sales increased compared with 2015 to EUR 50 million in 2016, also as a result of higher sales from the joint ventures with Santander.
Annual Report on Form 20-F 2017 |
57 | Business overview Results of operations the Netherlands | |
Overview of the Netherlands
Aegon has operated in the Netherlands for more than 170 years, and is a leading provider of life insurance and pensions, with approximately 3,100 employees. Aegon the Netherlands is headquartered in The Hague, and its other main offices are in Hoofddorp, Leeuwarden and Groningen.
Organizational structure
Aegon the Netherlands operates through a number of brands, including Knab, TKP Pension and Optas. Aegon is itself one of the most widely recognized brands in the Dutch financial services sector.
Aegon the Netherlands primary subsidiaries are:
◆ | Aegon Bank N.V.; |
◆ | Aegon Hypotheken B.V.; |
◆ | Aegon Levensverzekering N.V.; |
◆ | Aegon PPI B.V.; |
◆ | Aegon Schadeverzekering N.V.; |
◆ | Aegon Spaarkas N.V.; |
◆ | CAPPITAL Premiepensioeninstelling B.V.; |
◆ | Optas Pensioenen N.V.; and |
◆ | TKP Pensioen B.V. |
Aegon the Netherlands has four lines of business:
◆ | Life & Savings; |
◆ | Pensions; |
◆ | Non-life; and |
◆ | Distribution. |
Overview of sales and distribution channels
Aegon the Netherlands uses a variety of distribution channels to help customers assess which products and services are appropriate for their needs. In general, all business lines use the intermediary channel, which focuses on independent brokers in different market segments in the Netherlands.
In recent years, Aegon the Netherlands has invested heavily in its direct online channel, focussing primarily in 2017 on achieving a better digital self-service. Aegon usually distributes most of its products and services through intermediaries. The own advisory channel, Aegon Advisory, and the number of times that advice has been given to customers is growing rapidly. Distribution channels such as online and the contact centers generated leads for Aegon Advisory.
Aegon the Netherlands also uses specific distribution channels to help customers access its products and services. The Pensions business line includes sales and account management, which serves large corporations and financial institutions, such as company and industry pension funds.
Aegon Bank uses the direct channel primarily for savings, whereas Aegon Schadeverzekering uses an online channel and
independent brokers to sell its products. Knab, Aegons online bank, enables customers to make their own choices about their personal financial situation, thereby helping them to achieve their financial goals. Additional services were added throughout 2017, including mortgage advice and Knab Verzekeren. Knab helps its customers to make smart decisions by providing them with a clear overview of their finances, and advises them pro-actively on products that can help them achieve their financial goals.
On November 1, 2017, Aegon successfully completed the sale of Unirobe Meeùs Groep (UMG) to Aon Groep Nederland for EUR 295 million. The transaction is consistent with Aegons strategic objective to optimize its portfolio across its businessess.
Overview of products per business line
Pensions
Aegon the Netherlands provides full-service pension solutions, administration-only services and life or disability insurances to company and industry pension funds, large companies and owners of small and medium-sized companies and employees.
Separate account group contracts are large group contracts that have an individually-determined asset investment underlying the pension contract. For older generation products, a guarantee consists of profit sharing with a contractual interest rate of 3% or 4%. At present, the contracts offered to clients hold a guarantee of 3% or market interest rate, and Aegon the Netherlands always relates guarantee cost to the current market interest rate. If profit sharing turns into a loss, the minimum guarantee becomes effective, but the loss in any given year is carried forward to be offset against future surpluses. In general, the guarantee is dependent on the life of the insured in order that their pension benefit is guaranteed. Some large group contracts also receive part of the technical results for mortality risk and disability risk. The contract period for these types of contracts is typically five years and the tariffs, cost loadings and risk premiums are generally fixed over this period.
Aegon the Netherlands also offers products for small and medium-sized companies, both defined benefit and defined contribution products on a subscription basis. These products reduce complexity and enable Aegon to adapt the tariffs, cost loadings and risk premiums annually. Customers also have the opportunity on an annual basis to decide as to whether they wish to continue with their subscription. Larger group of customers are currently becoming more interested in these
Annual Report on Form 20-F 2017 |
58 | Business overview Results of operations the Netherlands | |
low cost and flexible solutions which results in a significant flow from separate account and other 5-year contracts to 1-year subscription products.
These subscription products include an all-in defined benefit product with guaranteed benefits. The expected profit for the customer and anticipated investment returns are taken into account in the pricing of the product. Customers may contribute funds for future pension increases to a separate account. Next to defined benefit subscriptions Aegon the Netherlands also offers defined contribution products on a subscription basis. Profit sharing is based on investment returns on specified funds. All positive and negative risks, such as investment risk and longevity risk, are attributed to the employees.
Defined benefit group contracts or defined benefit subscriptions both provide a guarantee on the benefits paid. The longevity risk therefore lies with Aegon the Netherlands.
A decrease in the number of company and industry pension funds in the Netherlands is continuing. By law, the assets and liabilities of a terminated pension fund must be transferred to another pension provider. Aegon the Netherlands offers a pension fund buy-out product for terminating pension funds. It takes on the guaranteed or non-guaranteed liabilities, with or without annual pension increases, and receives a lump-sum premium upfront. All risks related to the transferred benefits are carried by Aegon the Netherlands. Current market conditions lead to significantly fewer buy-outs in the Dutch market than in recent years.
Most of Aegon the Netherlands pensions are sold through sales and account management and Aegons intermediary channel. Customers include individuals, company and industry pension funds, and small, medium and large corporations. Aegon the Netherlands is one of the countrys leading pension providers.
For the majority of company and industry customers, Aegon the Netherlands provides a full range of pension products and services. In addition, TKP Pensioen specializes in pension administration for company and industry pension funds, and also provides defined contribution plans to corporate and institutional clients. Aegon offers defined contribution plans for small and medium-sized companies, and CAPPITAL offers the same plans for large companies.
On December 22, 2015, legislation was passed that enables companies to set up an Algemeen Pensioen Fonds (General Pension Fund). On June 20, 2016, Aegon received approval from the Dutch Central Bank (DNB) to launch the first such fund called Stap (a separate legal entity), together with TKP. Stap is a pension pooling vehicle that enables separate financial administration for multiple pension plans from multiple employers. This vehicle enables smaller pension schemes to benefit from economies of scale and to comply with complex pension regulations, meaning that a greater percentage of the
employees pension premium is invested, and that employers and participants receive the same high quality of service as a traditional pension plan. The fiduciary investments for Stap are carried out by TKP Investments, a subsidiary of Aegon Asset Management.
Non-life accident and income protection insurance
Aegon the Netherlands offers disability and sick leave products to employers that cover sick leave payments for employees not covered by social security, and for which the employer bears the risk.
Endowment insurance
Endowment insurance includes several products that accumulate a cash value. Premiums are paid at inception or over the term of the contract.
Accumulation products pay benefits on the policy maturity date, subject to survival of the insured. Most policies also pay death benefits should the insured die during the term of the contract. Death benefits may be stipulated in the policy or depend on the gross premiums paid to date. Premiums and amounts insured are established at inception of the contract. The amount insured can be increased as a result of profit sharing, if provided for under the terms and conditions of the product.
Minimum interest guarantees exist for all generations of accumulation products written, except for universal life products, for which premiums are invested solely in equity funds. Older generation products contained a 4% guarantee when sold. In 1999, the guarantee for new products decreased to 3%; and in 2013, the guarantee on new products was reduced to 0%.
Various profit-sharing mechanisms exist. Bonuses are either paid in cash (usually for a pension, as described below) or used to increase the sum insured. A common form of profit sharing is to set bonus levels by reference to external indexes based on pre-defined portfolios of Dutch government bonds. The bonds included in the portfolios have different remaining maturities and interest rates. Together they are considered an approximation of the long-term rate of return on high-quality Dutch financial investments.
Term and whole life insurance
Term life insurance pays out death benefits should the insured die during the term of the contract. Whole life insurance pays out death benefits in the event of death, regardless of when this occurs. Premiums and amounts insured are established at inception of the contract and are guaranteed. The amount insured may be adjusted at the request of the policyholder. Term life insurance policies do not include profit-sharing mechanisms. Part of the whole life insurance portfolio has profit-sharing features, which are based on external indexes or the return of related assets.
Annual Report on Form 20-F 2017 |
59 | Business overview Results of operations the Netherlands | |
Annuity insurance
Annuity insurance includes products in the accumulation phase and products in the deaccumulation phase. Payout commences at a date determined in the policy, and usually continues until the death of the insured or the beneficiary. Premiums are paid at inception of the policy or during the accumulation phase of the policy. The contracts contain minimum guarantees of 3% or 4%, and prior to 1999, of 4%. Interest rebates are given on both single and regular premium annuity insurance, and may be based on a portfolio of Dutch government bonds - although other calculation benchmarks may also be applied. There are also profit-sharing schemes set by reference to external indexes based on pre-defined portfolios of Dutch government bonds.
Variable unit-linked products
These products have a minimum benefit guarantee, except for those premiums invested in equity funds, and the initial guarantee period is ten years. A certain type of unit-linked products called tontine plans have a specific bonus structure. At the end of the year in which the insured dies, the policy balance is distributed to surviving policyholders that belong to the same tontine series, rather than to the policyholders estate. A death benefit is paid to the dependents in the event that the policyholder dies before the policy matures. Aegon the Netherlands manages tontine plans, but no longer sells them.
Mortgage loans
At present, Aegon the Netherlands mostly offers annuity mortgages. Before 2013, Aegon the Netherlands also offered interest-only, unit-linked and savings mortgage loans, and is continuing to do so for existing mortgage loans that are being renegotiated. Mortgage loans are partly funded externally. Besides residential mortgage-backed securities in Saecure - Aegons Dutch residential mortgage-backed securities program and private placements, the Aegon Mortgage fund is the main source of external funding. For this business, Aegon originates the mortgage loans fully for account of third parties and remains the service provider for these mortgage loans.
Investment contracts
Investment contracts are investment products that offer returns and generate fee income from the performance of the investments.
Non-life general insurance
Aegon the Netherlands commercial portfolio was sold to Allianz Benelux NV on January 18, 2016, and was subsequently transferred on July 1, 2016. Following this divestment, Aegon the Netherlands has focused exclusively on private lines in general insurance, with products offered providing cover for property, motor, travel, legal aid and casualty.
Aegon the Netherlands offers its non-life insurance products primarily through direct and intermediary channels. In addition,
sales and account management provides products for larger corporations in the Netherlands.
Savings and banking
Aegon Bank N.V. aims to achieve its vision and ambition through two business units: Aegon Bank and Knab.
Aegon Bank focuses on the income and housing market, together with seeking to reinforce the Aegon Netherlands-wide pensions offering. Customers are increasingly having to make provision for their current and future income and wealth since the government changed the rules for pension provisions.
The bank offers simple and high quality products. These include both savings products focused on security, and investment products focused on a suitable risk/return profile that fits the customers need and risk appetite. Processes are designed in such a way as to provide the maximum benefit to customers, and customer service is based on the principles of easy access, speed, first time right, convenience, insight and understanding.
Aegon Banks focus is on customers whose income and wealth is in the middle-market, in line with Aegon the Netherlandss target group. Products are distributed directly to Aegons customers. For more complex advice products, independent financial advisers continue to be a very important distribution channel for Aegon Bank. Aegon Banks activities mainly focus on Banksparen products. Banksparen is a tax-deferred savings product in which amounts are deposited in a locked bank account. The amount saved is available after a certain period of time for specific purposes such as for a supplementary pension or paying off a mortgage.
Knab aims to be the most customer-oriented bank in the Netherlands, by informing customers about their personal financial situation and enabling them to achieve their financial goals. It reflects the core of Aegons purpose, offering customers both insight and an overview of their finances through its financial planning tools and alerts. Furthermore, Knab offers a wide range of banking and investment products with a focus on wealth accumulation and payment services.
Distribution (owned)
The main distribution channel owned by Aegon the Netherlands was UMG, which Aegon sold in 2017. Aegons remaining owned distribution channel primarily consists of Nedasco, which offers financial advice to customers, including the sale of insurance, pensions, mortgage loans, financing, and savings and investment products.
Competition
Aegon the Netherlands has strong competition in all markets from insurers, banks, investment companies and pension funds. Its main competitors are Achmea, ASR, NN Group / Delta Lloyd and Vivat. In addition, these markets are subject to rapid changing
Annual Report on Form 20-F 2017 |
60 | Business overview Results of operations the Netherlands | |
dynamics, including the growing use of online distribution channels and the merger of NN Group with Delta Lloyd.
Aegon the Netherlands has been a key company in the total life market for many years, and was ranked second in 2017 based on gross premium income. The life insurance market in the Netherlands comprises pensions and life insurance. The top five companies in the Netherlands by gross premium income accounted for almost 85% (Ind. Life and Pension) of total premium income in 2017 in the insurance market. Following the merger of NN group and Delta Lloyd, Aegon the Netherlands is the second largest insurance company in the pensions market. Aegon the Netherlands is one of many insurers in the non-life market, where in 2017, ten companies accounted for 80% of the total premium income. In terms of premium income, Aegon the Netherlands non-life market share is around 3%, making it the nineth largest company in the market.
In the mortgage loans market, Aegon the Netherlands held a market share of approximately 9% based on new sales in 2017 (and 7% in 2016), making it the fourth largest mortgage loan provider in the market. Rabobank, ING Bank and ABN AMRO are the largest mortgage loan providers in the market, and competition is increasing from foreign competitors and capital from pension funds.
Aegon the Netherlands share is growing in the market for Dutch household savings. In 2017, its market share was approximately 3%, which is relatively small in comparison to banks such as Rabobank, ING and ABN AMRO.
Various legal and regulatory changes have had an impact on demand for insurance products in the Dutch market. This is especially true in the life insurance market, where the tax deductibility of certain products has been reduced, leading to a shift to bank-saving products. Moreover, volatility in economic and financial markets has meant that customers are more reluctant to commit themselves to long-term contracts. These changes have resulted in more competition, greater focus on competitive prices, improved customer service and retention, and product innovation.
In the pensions market, pension funds have faced pressure on their coverage ratios, in addition to increased regulatory and administrative requirements. In response, they have sought to reduce risks by insuring all or parts of their business. This is an opportunity for pension insurers, and Aegon is one of the leading providers of these solutions.
The defined contribution (PPI) market is set to grow significantly due to the shift from defined benefit plans to defined contribution plans and the demand for transparent and cost-effective pension products. As a result, significant economies of scale will be required to effectively serve this market and the number of providers is expected to shrink within a few years. Aegon the Netherlands has identified this market as an
opportunity for growth and intends to invest in maintaining its leadership position.
Regulation and supervision
General
Regulation of the financial sector in the Netherlands is included in the Financial Supervision Act (Wet op het financieel toezicht or Wft). The Wft embeds the cross-sectorial functional approach within the Dutch supervisory system. The supervision of financial institutions pursuant to the Wft rests with the DNB and the Dutch Authority for the Financial Markets (AFM).
The DNB is responsible for prudential supervision, while the AFM supervises the conduct of business of financial institutions, and the conduct of business on financial markets. The aim of the DNBs prudential supervision is to ensure the solidity of financial institutions and contribute to the stability of the financial sector. With regard to banks, the DNB undertakes its supervisory role, in particular with respect to prudential supervision, together with the European Central Bank (ECB).
The AFMs conduct of business supervision focuses on ensuring orderly and transparent financial market processes, integrity in relations between market parties and due care in the provision of services to customers.
The Dutch supervisory authorities have a number of formal tools to exercise their supervisory tasks. These tools include the authority to request information, if this is necessary for the purpose of prudential supervision; and the power to issue formal instructions to financial institutions, to impose fines, or to publish sanctions. The DNB, as prudential supervisory authority, can, under certain circumstances, require a recovery plan, a short-term financing plan, appoint a trustee, draw up a transfer plan or (ultimately) withdraw the license of a financial institution.
Financial supervision of insurance companies
Insurance supervision in EU member states is based on EU legislation, which, up until December 31, 2015, was set out in the Solvency I framework. Effective as of January 1, 2016, EU insurance regulation is embedded in the Solvency II framework. The Solvency I framework consisted primarily of EU directives, which were transposed into national law, in the Netherlands in the Dutch Financial Supervision Act and lower level national rules, such as in particular the Decree on Prudential Rules for Financial Undertakings (Besluit prudentiële regels Wft or Bpr Wft).
The Solvency II framework also consists of an EU Directive and has consequently been transposed into the Dutch Financial Supervision Act. A large part of the Level II Solvency II rules are, however, also set out in EU regulations, which apply directly in EU member states, and as a consequence have not been implemented into national legislation, such as in the Decree on Prudential Rules under the Wft (Besluit prudentiële regels Wft).
Annual Report on Form 20-F 2017 |
61 | Business overview Results of operations the Netherlands | |
The following insurance entities of Aegon the Netherlands are subject to prudential supervision of the DNB:
◆ | Aegon Levensverzekering N.V.; |
◆ | Aegon Schadeverzekering N.V.; |
◆ | Aegon Spaarkas N.V.; and |
◆ | Optas Pensioenen N.V. |
An insurance company is neither permitted to conduct both life insurance and non-life insurance business within a single legal entity (with the exception of reinsurance), nor to carry out both insurance and banking activities within the same legal entity. Within Aegon the Netherlands, Aegon Levensverzekering N.V., Aegon Spaarkas N.V. and Optas Pensioenen N.V. conduct life insurance activities. Aegon Schadeverzekering N.V. conducts non-life insurance activities. Prudential supervision is exercised by the home state supervisory authority (DNB in the Netherlands). Insurance companies in the Netherlands may conduct their activities on a cross-border basis or through a branch office based on the mutual recognition of (prudential) supervision in the EU (the so-called European passport). Aegon the Netherlands does not have material cross-border insurance business or business conducted through branch offices elsewhere in the EU.
Solvency II
Aegon the Netherlands uses a Partial Internal Model (PIM) to calculate the solvency position of its insurance activities under Solvency II. The calculation includes the use of the volatility adjustment, but does not include the use of any transitional measures. The internal model was approved on November 26, 2015, by the supervisor regulator the DNB as part of the Internal Model Application Process. Following the Internal Model Application Process, Aegon the Netherlands made several major changes to its internal model, which have been approved by the DNB on July 12, 2017. These model changes are therefore now reflected in the solvency position of Aegon the Netherlands. In the second half of 2017, Aegon the Netherlands received EUR 1 billion capital injection from Aegon N.V. to strengthen its capital position.
Financial supervision of credit institutions
As of November 4, 2014, Aegon Bank N.V. has been subject to indirect supervision by the ECB under the new European system of banking supervision, the Single Supervisory Mechanism (SSM), which comprises the European Central Bank and the relevant national authorities of participating EU Member States. The SSM is one of the elements of the Banking Union. The ECB may give instructions to the DNB in respect of Aegon Bank N.V. or even assume direct supervision over the prudential aspects of the Aegon Bank N.V.s business. Pursuant to the banking supervision by the DNB, Aegon Bank N.V. is (among others) required to file monthly regulatory reports and an audited Annual Report.
Credit institutions are subject to regulatory requirements. These include (among others) capital and liquidity requirements, the requirement to maintain a certain leverage ratio, governance
and reporting requirements in line with the requirements of EU Directive 2013/36/EU (CRD IV) and EU Regulation 575/2013 (CRR).
CRD IV and the CRR are the European Unions translation of the Basel III accord for prudential supervision of credit institutions and investment firms. The CRR is binding for all EU member states and became effective on January 1, 2014. CRD IV is an EU directive, and is required to be implemented into local legislation. CRD IV has been implemented in the Netherlands by means of amending the Financial Supervision Act (Wet op het financieel toezicht, the Wft) on August 1, 2014. The application in full of all measures under CRD IV (including any national implementation thereof in the Netherlands) has to be completed before January 1, 2019.
The CRR has been applied across all EU member states since January 1, 2014. The CRD IV and CRR frameworks include requirements with respect to capital adequacy, and introduce requirements with respect to increased capital against derivative positions, the introduction of two supplementary buffers (a capital conservation buffer and a counter-cyclical buffer), a new liquidity framework (liquidity coverage ratio and net stable funding ratio and a leverage ratio . The leverage ratio is defined as Tier-1 capital divided by a measure of non-risk weighted assets. If Basel III is followed under CRD IV, the leverage ratio may not fall below 3%, although uncertainty still remains as to the exact percentage and the scope of the leverage ratio under CRD IV. With respect to the percentage, the Dutch government has announced that it wishes to implement a leverage ratio of at least 4% for large Dutch banks, which does not apply to Aegon Bank N.V The ultimate aim of Basel III/CRD IV is to reduce leverage in order to bring institutions unweighted assets more in line with their Tier-1 capital. The capital requirements include qualitative in addition to quantitative requirements.
Capital of the highest quality, Common Equity Tier 1, forms a substantial part of the capital of a credit institution. Additional Tier 1 capital forms the rest of the Tier 1 capital. In addition, the capital of a credit institution may be composed of Tier 2 capital, which is of a lesser quality than Tier 1 capital.
EU Directive 2014/59/EU (the Banking Recovery and Resolution Directive, BRRD) and Regulation 806/2014 on the Single Resolution Mechanism (the SRM Regulation) form the European framework for recovery and resolution for (among others) ailing banks, certain investment firms and their holding companies. The BRRD was implemented in the Netherlands on November 26, 2015, by means of an amendment of the Wft (the BRRD Implementation Act). The SRM Regulation was adopted on July 15, 2014. Those parts of the SRM Regulation that deal with recovery and resolution entered into force on January 1, 2016.
The BBRD provides for early intervention measures that may be imposed by the national competent authority in respect of Aegon Bank N.V. in the event that its financial condition
Annual Report on Form 20-F 2017 |
62 | Business overview Results of operations the Netherlands | |
is deteriorating. These early intervention measures could pertain, among others, to a change of its legal or operational structure, the removal of (individuals within) senior management or the management body, or the appointment of a temporary administrator to work together with or replace such (individual within) senior management or management body. The national resolution authority may also under certain circumstances decide to write down or convert relevant capital instruments, including Common Equity Tier 1, Additional Tier 1 and Tier 2 instruments, in a specific order.
Were Aegon Bank N.V. to fail or be likely to fail and the other resolution conditions were also met, the national resolution authority would be able to place Aegon Bank N.V. under resolution. As part of the resolution scheme to be adopted
by the national resolution authority it may decide to apply certain resolution tools and exercise its powers pursuant to the implemented BRRD in order to give effect to such resolution tools. In addition, the SRM Regulation and the BRRD Implementation Act introduce the bail-in tool which gives the national resolution authority the power to write down or convert into equity certain debt and other liabilities of the institution.
Pursuant to the SRM Regulation and the BRRD Implementation Act, banks are required at all times to meet a minimum amount of own funds and eligible liabilities (MREL), expressed as a percentage of the total liabilities and own funds. The competent resolution authority will set a level of minimum MREL on a bank-by-bank basis based on assessment criteria due to be set out in technical regulatory standards.
Annual Report on Form 20-F 2017 |
63 | Business overview Results of operations United Kingdom | |
Overview of United Kingdom
Following the completed sale of its own annuity portfolio and announced sale of Aegon Ireland 8 , together with the acquisition of Cofunds and the BlackRocks Defined Contribution business, Aegon UK is primarily a long-term savings and protection business, supporting customers who are retired or saving for their retirement. Products are sold through its online platform, which enables advisors, employers and individuals to buy and manage investments online, and also have a single view of investments. Aegon Ireland is a specialist provider and reinsurer of variable annuity (guarantee) products in the United Kingdom and Germany. It also offers offshore investment bonds in the United Kingdom.
Organizational structure
Aegon UK PLC (Aegon UK) is Aegons holding company in the United Kingdom. It was registered as a public limited company at the beginning of December 1998. The leading operating subsidiaries, which all operate under the Aegon brand, are:
◆ | Scottish Equitable PLC; |
◆ | Cofunds Ltd; and |
◆ | Aegon Investment Solutions Ltd. |
Aegon UKs main offices are in Edinburgh, London and Witham. The main office of Aegon Ireland PLC (Aegon Ireland) is located in Dublin, Ireland, with a branch office in Frankfurt, Germany.
Acquisitions and disposals
Aegon UKs business strategy is focused on developing the business as the leading platform savings, investments and pensions provider in the market. For this reason, during 2016 it made a number of strategic changes in order to align its business model with its strategy.
On May 3, 2016, Aegon UK announced an agreement to acquire BlackRocks UK defined contribution (DC) platform and administration business, strengthening its position as a leading player in the UK workplace market, adding Master Trust and Investment Only capability, as well as assets under administration of around GBP 12 billion. This transaction will be finalized in 2018, once the legal ownership has been transferred through a so-called Part VII transfer.
On April 11, and May 23, 2016, respectively, Aegon announced the divestment of its own annuity portfolio to Rothesay Life on June 30, 2017, and Legal & General on September 22, 2017, following the Part VII transfers. These transactions were consistent with the Companys ambition to free up capital from non-core businesses, and the capital position of the Company improved as a result of the transactions. Aegon has approximately GBP 0.7 billion annuity liabilities remaining through an inward reinsurance transaction.
On January 1, 2017, Aegon UK completed the acquisition of Cofunds, funding for which came from the divestment of the annuity portfolio. The transaction demonstrates Aegons commitment to the retail platform market. Intermediaries that use Cofunds will be upgraded to an enhanced version of Aegons platform, with approximately 79,000 customer upgraded in December.
On August 9, 2017, Aegon announced the sale of Aegon Ireland plc to AGER Bermuda Holding Ltd., the holding company of the European operations of Athene Holding Ltd. Aegon Ireland provided both unit linked guarantees and offshore bond product in the UK. The transaction is expected to be completed in 2018.
The combination of the acquisitions and Aegons program to upgrade existing customers to the digital solutions platform have enabled Aegon to create the largest UK platform with approximately GBP 117 billion assets under administration, and provide broad expertise across the savings, investments and pensions markets.
Overview of sales and distribution channels
In the United Kingdom, Aegon has two main distribution channels: retail and workplace intermediaries. These are supported by Aegon UKs customer capability, which offers employees and advisor clients a market-leading portal to view and manage their money. Aegon UKs award-winning platform supports these channels in an integrated way, making it easier for customers to move between products and channels.
Retail channel
Aegon UK offers a comprehensive proposition to intermediaries and strategic partners underpinned by technology that drives efficiency and supports the profitability of advisors businesses.
Aegon Retirement Choices (ARC) helps advisors and their customers save for the long term and manage the transition from work to retirement. ARC uses leading-edge digital technology to deliver an intuitive method of saving for the long term, including retirement, taking income in retirement, such
Annual Report on Form 20-F 2017 |
64 | Business overview Results of operations United Kingdom | |
as the on-platform guaranteed drawdown product, and dealing with changing circumstances. It also provides valuable online reporting and lifestyle tools that enable advisors to demonstrate their professionalism and display their charges for advice in a transparent way. In addition to the Self Invested Pension Plan - which provides a range of pre-and post-retirement investment options for high-net-worth customers (including insured funds and a wide range of open-ended investment companies) - Individual Savings Accounts and General Investment Accounts are also offered.
Aegon UK offers two distinct versions of the proposition targeted at distinct market segments:
◆ | A fund supermarket service, which includes multiple wrapper choices, fully open architecture fund choice and digital advisor/ customer self-service access; and |
◆ | One Retirement, a standalone pension accumulation and drawdown product, designed to be a single-point solution for customers that do not have a broader set of needs. |
The acquisition of Cofunds made Aegon UK the UKs leading fund supermarket adding approximately GBP 80 billion of assets, predominantly in ISAs and GIAs, complementing Aegon UKs core pension expertise. The modernization of the Cofunds business by migrating it on to Aegons market-leading technology will see Aegon UK emerge with a market-leading position among intermediary platforms.
The process of migrating customers to Aegons technology platform began in December 2017, with the upgrading of 79,000 customers. The remaining 700,000 customers will be migrated during the course of 2018.
Workplace channel
Aegon is building and diversifying its workplace distribution capability to cover a range of intermediaries from Independent Financial Advisors (IFAs) to large Employee Benefit Consultants (EBCs) by utilizing successful partnerships, such as with Mercer. Services that Aegon UK offers include:
◆ | Workplace Aegon Retirement Choices, a comprehensive pension proposition that manages workplace pensions for employers in a seamless and streamlined way, enabling them to offer employees a choice of savings wrappers; |
◆ | Employers auto-enrolment obligations, which are supported through Aegons SmartEnrol capability; |
◆ | Support for the governance of the workplace pension scheme, which is offered through the sophisticated analytics of Aegons Smart Governance; and |
◆ | Employee access to Retiready, which enables employers to cater for all levels of employee investment knowledge and confidence, in addition to moving with their employees throughout their working life. |
The strength of Aegons proposition has historically been in the small- to medium-sized employer market. The acquisition of BlackRocks defined contribution pension business expanded
Aegon UKs market position in the large employer market. BlackRocks main focus in this market is on Master Trust products, defined benefit target, investment-only business, and unbundled defined contribution pension schemes.
Customer capability
Aegons Retiready digital retirement planning service is designed to help customers understand how on track they are for the retirement they want, and to support them in taking action. Answering a few simple questions gives customers a Retiready score out of 100, showing how ready they are for retirement.
Retiready is focused on existing Aegon UK customers that no longer have an advisor. The majority of customers receive the service having been upgraded from Aegon UKs existing business, thereby allowing long-standing customers to benefit from the advantages of a modern digital pension. Retiready customers have access to a number of tools to help them better engage with and manage their retirement savings. Since inception, approximately 370,000 customers, with assets of around GBP 6.6 billion, have been upgraded to Aegon UKs new proposition.
As part of the Cofunds migration, Aegon UK is redeveloping its digital customer portal. This aims to offer an industry-leading customer experience, with the service then being rolled out to all customers.
Aegon Ireland
Aegon Ireland reinsures Aegon UKs Secure Retirement Income product, a guaranteed SIPP/drawdown product on the ARC platform. It also manages an existing book of variable annuity (guaranteed) contracts through Aegon UKs retail advisor channel since 2006. In Germany, Aegon Ireland has its own branch office in Frankfurt and has a number of distributors and a customer service team.
Aegon Ireland offshore investment bonds are offered exclusively in the UK. They are not actively marketed, and are distributed through the ARC proposition, other third-party propositions, banks and financial advisors.
Overview of business Lines
Reporting for Aegon UK is organized along two business lines: Life and Pensions. Life comprises protection products sold to individuals and small- to medium-sized companies (SMEs). Pensions comprises a broad range of workplace and personal pensions in addition to investment products and variable annuities.
Aegon UK was reorganized in 2016 to Digital Solutions and Existing Business, which have separate leadership teams.
The Digital Solutions business is responsible for Aegon UKs new digital platform propositions sold through Retail Advisor and Workplace channels, together with the protection lines. The
Annual Report on Form 20-F 2017 |
65 | Business overview Results of operations United Kingdom | |
majority of new assets going forward will be accumulated in this business. In addition, where appropriate, Aegon UK is upgrading customers from its Existing Business to Digital Solutions to ensure an enhanced customer experience, a more engaged relationship, and lower cost to serve.
The Existing Business is responsible for older products that are no longer actively marketed to new customers. However, new assets are accumulated as customers pay into existing policies, or as new employees join older workplace schemes. These propositions include older style group pensions, individual pensions and with-profits policies.
Products
Aegon UKs main product focus is on savings, investments, pensions and protection products.
Savings, Investments & Pensions
Aegon UK provides a full range of personal and corporate pensions and saving-related products. These include:
◆ | Individual Saving Accounts; |
◆ | General Investment Account; |
◆ | Flexible personal pensions; |
◆ | Self-invested personal pensions; |
◆ | Group personal pensions; |
◆ | Group Self-invested personal pensions; |
◆ | Mastertrust; |
◆ | Investment Only capability for workplace pension schemes; and |
◆ | Institutional Trading Platform |
Protection products
Aegon UK offers a range of products for individual customers, including life cover, critical illness and income protection. The target market is wealthier customers over the age of 40, where Aegon UKs underwriting expertise helps it to provide a customer-centric proposition. This also provides a strong overlap with the target customers for Aegon Retirement Choices, giving opportunities to leverage sales and promotional activity. In addition, Aegon UK offers a range of protection products for small- to medium-sized companies that wish to insure key personnel. This is a key market for Aegon, and the Company currently protects 400,000 customers.
Traditional Pensions
Traditional Pensions include a variety of individual and corporate pensions, with-profits products and annuity products (via Legal
& General). These products are not actively marketed but have a large number of existing customers.
Competition
There are a diverse range of competitors in the markets in which Aegon UK operates, and market dynamics are continuing to evolve. While competition can be seen partly in terms of product features and benefits, it is also increasingly played out in terms of establishing Aegon UKs proposition as the
primary or secondary platform used by intermediaries to manage their clients assets, or as a preferred partner for EBCs advising corporate clients.
One of the key drivers for competition is the considerable regulatory and legislative change that is continuing to create new commercial opportunities. For example, automatic enrolment (which requires all employers to offer pensions to their employees) is driving greater numbers of customers to save in a pension. The next step will be for legislative minimum contributions to increase.
In addition, in April 2015, the government removed all restrictions on individuals being able to access their pension pots, thereby significantly increasing the flexibility with which individuals can use their pension savings. Individuals are now no longer restricted to buying an annuity or entering drawdown, and can choose to withdraw some of their money and take flexible income through drawdown, or secure income via an annuity or guaranteed product. This development has had a substantial impact on the at-retirement market, with a large reduction in annuity sales and an increase in the purchase of income drawdown products, in addition to supporting a shift from traditional products to platforms better able to support the delivery of flexible solutions to customers.
Aegons competitors include traditional insurance companies, investment platforms and asset managers, with a key competitive dimension being the degree to which companies are vertically integrating either to own distribution or to create in-house investment solutions.
Regulation and supervision
All relevant Aegon UK companies based in the United Kingdom are regulated by the Prudential Regulation Authority (PRA) and/ or the Financial Conduct AUthority (FCA).
The PRA is responsible for the prudential regulation of deposit takers, insurers and major investment firms. The FCA is responsible for regulating firms conduct in retail and wholesale markets. It is also responsible for the prudential regulation of those firms that do not come under the PRAs remit.
The UK vote to leave the European Union (EU) on June 23, 2016, has implications for the UK. Much financial regulation currently applicable in the UK derives from EU legislation. This regulation will remain in force until any changes are made, which will be a matter for the UK government and the UK Parliament. Aegon UK must therefore continue to comply with UK law, including those that derive from EU law and continue with implementation plans for legislation that is anticipated to come into effect. The FCA has acknowledged that the longer term impacts of the decision to leave the EU on the overall regulatory framework for the UK will depend, in part, on the relationship that the UK seeks with the EU in the future.
Annual Report on Form 20-F 2017 |
66 | Business overview Results of operations United Kingdom | |
Aegon Ireland is registered as a life insurance company in Ireland under the European Communities (Life Assurance) Framework Regulations 1994 (the 1994 Regulations), which implement the Consolidated Life Directive in Ireland. Aegon Ireland is regulated by the Central Bank of Ireland. As an Irish-authorized life insurance company, Aegon Ireland may undertake life insurance business in any member state of the European Economic Area on either a freedom of services (FOS) or freedom of establishment (FOE) basis, subject to the notification requirements set out in the 1994 Regulations.
Aegon Ireland operates on an FOE basis in Germany (with a branch office in Frankfurt) and on an FOS basis in the UK, selling life insurance products in Class III (contracts linked to investment funds) and Class I (life insurance and contracts to pay annuities), excluding contracts written in Class II (contracts of insurance to provide a sum on marriage or on the birth of a child). Aegon Ireland must comply with the general good provisions that apply to insurers selling such policies in each jurisdiction.
Financial supervision of insurance companies
The European Union Insurance Directives referred to collectively as Solvency II are incorporated into UK law. The Solvency II directives came into effect on January 1, 2016. The directives are based on the home country control principle, i.e. an insurance company with a license issued by the regulatory authorities in its home country is allowed to conduct business in any country of the European Union, either directly or through a branch. Separate licenses are required for each branch of the insurance company where it conducts business. The regulatory body that issued the license (the PRA in the UK) is responsible for monitoring the solvency of the insurer.
Under UK law, a company (other than existing conglomerates) is not permitted to conduct both life insurance and non-life insurance business within one legal entity, nor is a company allowed to carry out both insurance and banking business within the same legal entity.
Every life insurance company licensed by and/or falling under the supervision of the PRA must file audited regulatory reports on at least an annual basis. These reports, primarily designed to enable the PRA to monitor the solvency of the insurance company, include a (consolidated) balance sheet, a (consolidated) income statement, a breakdown of the Solvency Capital Requirements, extensive actuarial information, and detailed information regarding the investments of the insurance company. The PRAs regulatory reporting is based on a single entity focus, and is designed to highlight risk assessment and risk management.
The PRA may request additional information it considers necessary and may conduct an audit at any time. The PRA may also make recommendations for improvements, and may, ultimately, withdraw an insurance companys license.
Solvency II
Under Solvency II, life insurance companies are required to maintain certain levels of shareholders equity in accordance with EU directives, and have to hold the level of capital required to withstand a 1 in 200 shock on a 1-year value at risk basis.
Since the introduction of Solvency II on January 1, 2016, Aegon has been using a Partial Internal Model (PIM) to calculate the solvency position of its insurance activities in the United Kingdom. The internal model was approved on December 14, 2015, by the PRA as part of the Internal Model Application Process, with an additional Major Model Change approved in July 2017, which added Currency Risk and Operational Risk into the Internal Model.
In addition, Aegon uses the matching adjustment in the calculation of the technical provisions for its annuities, and uses the volatility adjustment in the calculation of the technical provisions for the With Profits business with investment guarantees. Following the reinsurance of the majority of its annuity business in 2016, Aegon no longer uses the transitional measures on technical provisions.
Aegon Ireland uses the Standard Formula to calculate the solvency position of its insurance activities.
Annual Report on Form 20-F 2017 |
67 | Business overview Results of operations Central & Eastern Europe | |
Overview of Central & Eastern Europe
Aegon has operations in the Central & Eastern European (CEE) countries of the Czech Republic, Hungary, Poland, Romania, Slovakia, and Turkey. It first entered the Central & Eastern European market in 1992 with the purchase of a majority stake in Hungarys former state-owned insurance company, Állami Biztosító. Aegon Hungary is Aegons leading business in Central & Eastern Europe.
Organizational structure
Aegons main subsidiaries in Central & Eastern Europe are:
◆ | Aegon Magyarország Általános Biztosító Zártkörűen Működő Részvénytársaság (Aegon Hungary Composite Insurance Co.); |
◆ | Aegon Towarzystwo Ubezpieczeń na Życie Spółka Akcyjna (Aegon Poland Life); |
◆ | Aegon Powszechne Towarzystwo Emerytalne Spółka Akcyjna (Aegon Poland Pension Fund Management Co.); |
◆ | Aegon Emeklilik ve Hayat A.Ş. (Aegon Turkey); |
◆ | Aegon Pensii Societate de Administrare a Fondurilor de Pensii Private S.A (Aegon Romania Pension Administrator Co.); |
◆ | Aegon Pojitovna, a.s (Aegon Czech Life); |
◆ | Aegon ivotná poistovňa, a.s. (Aegon Slovakia Life); and |
◆ | Aegon, d.s.s., a.s (Aegon Slovakia Pension Management Co.). |
Overview of sales and distribution channels
Aegon operates through a number of different sales channels in Central & Eastern Europe. In the Czech Republic and in Slovakia, Aegon distributes mostly unit-linked and term life insurance policies with the help of broker sales partners. In Poland and Romania, unit-linked and different types of traditional life insurance products are distributed by tied agents and bank partners respectively. In Turkey, the most important sales channels are insurance brokers and tied agents, in addition to bank partners, which distribute savings and term life insurance products. As Aegon Hungary Insurance is a composite insurance entity, owning several subsidiaries that also operate in the financial services sector, the Groups products are marketed via a broad range of channels. The most important of these are tied agents and insurance brokers, in addition to bank partners, call centers, key account managers and its online channel.
Overview of business lines
Life & Savings
Aegon companies in Central & Eastern Europe offer a range of life insurance and personal protection products. These include traditional life and unit-linked products. Unit-linked products cover all types of life insurance, including pension, endowment and savings.
Traditional general account life insurance mainly consists of index-life products that are not unit-linked but have guaranteed interest rates, in addition to group life and preferred term life products.
Preferred life is an individual term life insurance product that offers insurance protection. The product distinguishes between whether an individual is a smoker or non-smoker, and uses standard and preferred pricing dependent on the respective health of customers.
Group life contracts are renewable each year and carry optional accident and health cover.
In Poland, Aegon focuses on unit-linked as well as traditional life products. In line with the local regulatory and market developments, the products marketed have been modified in recent years.
In Hungary, Aegon offers a wide range of life insurance products: including term life, whole life, group life insurance, accidental life and traditional saving type products, in addition to unit-linked policies, which are frequently accompanied with riders. These riders provide customers - in addition to the main coverage - with additional financial support in the event of, for instance: having an accident, becoming disabled, or being hospitalized. Aegon is a significant market player in Hungary in the unit-linked segment 9 .
In both the Czech Republic and Slovakia, Aegon focuses on the unit-linked segment, in addition to offering term life products and offering a wide range of riders that cover, among others, accidental death, disability, critical illness risks, and providing a daily hospitalization allowance to insured clients.
In Turkey, Aegon provides only traditional life insurance products, the most important of which are pure term life with several riders, term life with premium refund on maturity, and saving-type endowment products. Aegons insurance portfolio is growing significantly in Turkey due to the countrys high growth rate.
In Romania, Aegon undertakes life insurance business via a branch of Aegon Poland Life Insurance Company. The Romanian branch sells unit-linked, term life and endowment insurance policies.
Also in Hungary, Aegon Hungary Home Savings and Loan Association provides a saving product combined with a preferential loan option, which is subsidized by the state during the saving period.
Annual Report on Form 20-F 2017 |
68 | Business overview Results of operations Central & Eastern Europe | |
Mortgage loans
Aegon Hungary first offered mortgage loans to retail customers in 2006 via Aegon Hungary Mortgage Finance Co., a subsidiary of Aegon Hungary Composite Insurance Company. After its launch, the mortgage loan business was affected by several legislative changes. On March 17, 2014, Aegon Hungary Mortgage Finance Company suspended the acceptance of new loan applications for an indefinite period of time.
Pensions
Aegons pension business in Central & Eastern Europe was impacted by reforms to the pension system in several countries in the region during recent years. Aegon is currently active in the (formerly mandatory) private pension market in Slovakia, Poland and Romania. In the voluntary pension market, Aegon is active in Hungary, Turkey and Romania.
As of December 31, 2017, Aegon managed the savings of 3.1 million pension fund members in Central & Eastern Europe. In terms of assets under management, Aegons private pension funds in Poland, Slovakia and Romania, and its voluntary pension fund in Hungary, are significant market players in the respective countries. In terms of numbers of members, Aegon has a significant market presence in Poland, Romania, and Hungary.
On September 1, 2017 Aegon took over the management of Nordeas Pillar 2 pension fund in Poland. The deal brought economies of scale and helped further improve the quality of services that Aegon provides to its customers. By end of May 2017, the pension fund under Aegon PTE S.A.s management had assets of PLN 6.93 billion (EUR 1.6 billion) and 890,000 members, whereas the fund managed by Nordea had assets of PLN 8.06 billion (EUR 1.9 billion) and 980,000 members. The merger of the two funds created the fourth largest Pillar 2 pension fund in the market 10 .
Non-life
Aegon Hungary offers non-life cover (mainly household and car insurance, in addition to some wealth and liability industrial risk and travel insurance). Aegon is the leading insurance company in the Hungarian household market 11 . In recent years, margins on non-life insurance in Hungary have been attractive. Moreover, household insurance provides considerable opportunities for the cross-selling of life insurance.
As part of Aegons regional expansion, Aegon Hungary has operated branch offices selling household insurance policies in Slovakia since 2010 and Poland since 2011.
Competition
In 2016, Aegon was the third largest life insurance provider in Hungary, based on annual standardized premium income, and the third largest provider in the non-life insurance market 12 . In Turkey, Aegon was ranked tenth in the life insurance market based on written premium at the end of Jul 2017 13 . Aegon is a
less significant market participant in Poland, Slovakia, the Czech Republic and Romania.
Aegon was ranked third in terms of both the number of participants and managed assets in 2016 in the voluntary pension fund market in Hungary 14 . In December 2017, Aegon was ranked fifth in terms of managed assets and fourth in terms of number of participants in the Slovakian private pension market 15 . Based on May 2017 data, Aegon combined with Nordea was ranked fourth in terms of both the number of participants and managed assets in Poland 16 . In November 2017, Aegon was the fourth largest provider in the Romanian mandatory private pension market, both in terms of net assets under management and number of participants 17 .
Regulation and supervision
In the European Union, a single insurance company may only be licensed for and conduct either a life insurance business or a non-life insurance business - not both. In Hungary, however, insurance companies established before 1995 are exempt from this rule. This exemption therefore applies to Aegon Hungary, which is a composite insurance company.
State supervision and oversight of the insurance industry is conducted by the following bodies and institutions:
◆ | The Central Bank of Hungary (MNB); |
◆ | National Bank of Slovakia (NBS); |
◆ | Czech National Bank (CNB); |
◆ | Polish Financial Supervisory Authority (KNF); |
◆ | Authority for Financial Supervision (ASF) (Romania); and |
◆ | Undersecretariat of Treasury (Turkey). |
The authorities mentioned above promote consumer protection and have the right to investigate prudential activities and conduct, financial position and solvency, and compliance with all relevant laws.
In addition to legal regulation, insurance companies are members of a number of self-regulatory groups in their respective countries. These self-regulatory groups are the main forums for discussion among insurance companies. Their specialized departments (for example, actuarial, financial, and legal) meet periodically.
Solvency II
The Solvency IIinsurance solvency regime, became effective in European Economic Area (EEA) countries on January 1, 2016. Aegons EU-domiciled entities in Central & Eastern Europe use the Standard Formula to calculate the solvency position of their insurance activities. The activities in Turkey have been included through Deduction & Aggregation on a Solvency II Standard Formula basis.
The foundation and operations of voluntary pension funds are regulated in Hungary by the countrys Voluntary Mutual Pension Funds Act (XCVI. 1993). Activity in this area is also
Annual Report on Form 20-F 2017 |
69 | Business overview Results of operations Central & Eastern Europe | |
supervised by the MNB. Slovakias pension market is regulated by the Pension Asset Management Companies and Respective Notices Act (43/2004). The private pension business is under the supervision of the National Bank of Slovakia (NBS). In Romania, the private and voluntary pension system is regulated and supervised by the Authority for Financial Supervision (ASF). The mandatory pension system is subject to the Privately Administered Pension Funds Act (411/2004) and the voluntary pension system is subject to the Voluntary Pension Law (204/2006), both complemented by individual regulations (as secondary legislation). In Poland, this activity is supervised by the KNF and governed by the Organization and Operation
of Pension Funds Act. In Turkey, the voluntary pension funds are under the supervision of the Undersecretariat of Treasury and the companies are subject to Individual Retirement Saving and Investment System Law No. 4632.
In Hungary, the Credit Institutions and Financial Enterprises Act (2013) stipulates the foundation, operation and reporting obligations of the countrys financial institutions (including Aegon Hungary Mortgage Finance Company). In addition, Aegon Hungary Mortgage Finance Company is under the supervision of the MNB, in exactly the same way as Aegon Hungary Home Savings and Loan Association.
Annual Report on Form 20-F 2017 |
70 | Business overview Results of operations Spain & Portugal | |
Overview of Spain & Portugal
Aegon entered in the Spanish insurance market in 1980. In recent years, Aegons activities in Spain have developed through distribution partnerships with Spanish banks.
Aegon Spain Holding BV (hereafter referred to as Aegon Spain) operates in Spain through Aegon España S.A.U. de Seguros y Reaseguros. In addition, Aegon Spain operates in Spain through long-term partnerships with Banco Santander S.A. (offering both life and general insurance products)and Liberbank, S.A. (offering life products).
Aegon Spain also operates in Portugal through a long-term partnership with Banco Santander, S.A., offering both life and general insurance products.
Aegon Administracion y Servicios A.I.E., a separate legal entity, provides administration and operations services to all Aegon companies in Spain and Portugal, including joint ventures with third parties.
Organizational structure
Aegons main subsidiaries and affiliates in Spain & Portugal are:
◆ | Aegon España S.A.U. de Seguros y Reaseguros; |
◆ | Aegon Administracion y Servicios A.I.E.; |
◆ | Aegon Activos A.V, S.A.; |
◆ | Aegon Mediación, S.L.U.; |
◆ | Santander Generales Seguros y Reaseguros S.A. (51%); |
◆ | Santander Vida Seguros y Reaseguros S.A. (51%); |
◆ | Aegon Santander Portugal Vida-Companhia de Seguros de Vida S.A. (51%); |
◆ | Aegon Santander Portugal Não Vida-Companhia de Seguros S.A. (51%); and |
◆ | Liberbank Vida y Pensiones, Seguros y Reaseguros, S.A. (50%). |
Overview of sales and distribution channels
Aegon Spains subsidiaries and affiliates distribute their insurance products nationwide through partner branches and its own sales network. The main distribution channel in the Spanish market is bancassurance, which accounts for 73% of life sales, whereas brokers and direct customers account for 22% and 5% of the total respectively. Overall, the bancassurance channel accounts for 42.5% of the Spanish household market.
In the Portuguese market, approximately 68% (2016: 67%) of pure life risk premiums and 43% (2016: 43%) of household insurance premiums are written through bancassurance channels, where credit-related policies mostly related to mortgages play a significant role.
Aegon Spain and Banco Santander
Since June 4, 2013, Aegon Spain and Banco Santander S.A. have partnered to distribute a number of insurance products in Spain.
Banco Santander S.A. is the largest financial institution in Spain, with over 2,800 branches nationwide.
Aegon Spains agreement with Banco Santander S.A. initially concerned pure life risk and general insurance products (accident, home and commercial multi-risk insurance, and critical illness). These products are developed through two insurance entities: Santander Vida for pure life risk products and health; and Santander Generales for general insurance products. Aegon Spain and Banco Santander are both shareholders of these entities: Aegon Spains share in each entity is 51%; and Banco Santander S.A. owns the remaining 49% of each entity. On December 28, 2016, Aegon Spain and Banco Santander further extended their partnership agreement to distribute health insurance products developed by Santander Vida, with sales commencing in 2017. Furthermore, Santander Generales began offering funeral insurance on July 7, 2017.
Since December 31, 2014, Aegon Spain and Banco Santander Totta, S.A., a Portuguese insurance company that is part of the Santander International group, have partnered to distribute a number of insurance products. The partnership concerns the distribution of pure life risk and general insurance products (accident, home and commercial multi-risk insurance, and health) through over 500 branches nationwide - the largest network of its kind in the country. These products are developed through two insurance entities: Aegon Santander Portugal Vida, for pure life risk products; and Aegon Santander Portugal Não Vida, for general insurance products. Aegon Spain and Banco Santander Totta, S.A. are both shareholders of these entities: Aegon Spain has a 51% share in each entity and Banco Santander Totta, S.A.s group owns the remaining 49% of each entity.
On December 21, 2015, Banco Santander Totta, S.A. announced that it had acquired Banco Internacional de Funchal (Banif). On December 5, 2016, Aegon Spain and Santander Totta reached an agreement in order to add Banifs retail and corporate network - consisting of 174 branches and 370,000 clients - to the current distribution network for Aegon Santander Portugal Vida and Aegon Santander Portugal Não Vida.
Aegon Spain and Liberbank
Liberbank, S.A. has a presence nationwide, with a special focus on retail markets in a number of Spanish regions (Asturias, Cantabria, Castilla La Mancha and Extremadura). Liberbank Vida y Pensiones, Seguros y Reaseguros, S.A. currently distributes its products through nearly 575 Liberbank, S.A. branches. Aegon Spain and Liberbank, S.A. are both shareholders of Liberbank Vida
Annual Report on Form 20-F 2017 |
71 | Business overview Results of operations Spain & Portugal | |
y Pensiones, Seguros y Reaseguros, S.A Aegons share in this entity is 50%, and Liberbank, S.A. owns the remaining 50%.
Aegon Spain own network
Aegon Spains own network offers life insurance, health insurance, pension products and mutual funds. It uses two main distribution channels: its own network of brokers and agents for the products of its full subsidiaries, which comprises 90% of the total; and a direct channel, which comprises 10% of the total.
Overview of business lines
Aegon Spain focuses primarily on retail customers. It offers individual life, pensions, general insurance, accident and health products through different distribution channels, including its own channels (agents, brokers and direct),together with bancassurance products through its joint venture partnerships with Liberbank, S.A. and Banco Santander Group, the latter of which in both Spain & Portugal.
Life insurance & Pensions
Aegon Spains life insurance business comprises both individual and group protection and savings products, with individual products forming the larger part of the business.
Protection business includes primarily life, accident and disability cover, and products can be complemented with critical illness, income protection and other riders. Customers saving needs are serviced by Aegon Spain through its targeted offering of universal life, unit-linked and pension funds. Both savings and protection products are distributed through the channels mentioned above. In addition, Aegon Spain distributes mutual funds from third parties.
General insurance
Aegon Spain has been offering general insurance products since 2013 through its joint venture with Banco Santander. The offering focuses mainly on household protection and funeral insurance products.
Health
Health insurance is offered by Aegon Spain in Spain through its own network of brokers and agents, direct channels, and Santanders network of branches. Medical expense coverage for doctor visits, diagnoses, hospitalization, dental and other health covers are offered through a broad network of medical partners across the country.
The gross premium written contribution in 2016 for each of Aegon Spains business lines was 54% for life insurance, 20% for accident and health insurance, and 26% for general insurance.
Competition
The Spanish insurance market is highly competitive. For Aegon Spains traditional life, unit-linked variable life and pension products, the major competitors are retail bank-owned insurance
companies. The life market is dominated by Grupo VidaCaixa, with a 33% market share, and Zurich, with a 10% market share, followed by Mapfre, with a 7% market share. Aegon Spains market share is less than 1%.
For Aegon Spains health and general insurance products, the main competitors are both foreign and local companies. Mapfre leads the non-life insurance market with a 14% market share, followed by Grupo Mutua Madrileña with a 14% market share, and Allianz with a 7% market share. The non-life market is more fragmented than the life one. Aegon Spains multi-risk business line is responsible for non-life and has a market share of less than 1%.
With respect to the life insurance Portuguese market, Fidelidade and Ocidental Vida are the main players with a combined market share in 2017 of 53.1% (based on issued premiums of insurance contracts and deposits of financial products).
In the non-life, Fidelidade is also the main player with a market share of 26%, followed by a new company named Seguradoras Unidas with 15%. Seguradoras Unidas is the result of a merger of several insurance companies, including Tranquilidade and Açoreana.
Regulation and supervision
Insurance companies in Spain are required to report on a quarterly basis to the Dirección General de Seguros y Fondos de Pensiones (DGSFP), the regulatory authority for the Spanish insurance industry. Spanish regulations incorporate all requirements from the relevant EU directives.
The regulatory authority for the Portuguese insurance industry is the Autoridade de Supervisão de Seguros e Fundos de Pensões (ASF). Insurance companies are required to report to the ASF on a monthly basis (issued premiums and claims costs per line of business) and more extensively on a quarterly basis. Portuguese regulations also incorporate all requirements from the relevant EU directives.
Catalonian political situation
In 2017, Spain experienced considerable political tension following the request for independence by the Regional Government of Catalonia, the application of article 155 of the Spanish Constitution by the Spanish Government, and the call for Regional Elections in December. Despite these events, markets were relatively calm. The spread of Spanish 10-year Government bonds compared with the German Bund was very stable. From a risk perspective, Aegons business in Spain has no exposure on its balance sheet to regional government debt or regional banks. From a business perspective, the total business of Aegon Spain in Catalonia is moderate, representing around 10 to 12% of Aegon Spains total business. At the time of publication of this annual report, impacts have not been significant, although it remains difficult to assess any long-term business impact.
Annual Report on Form 20-F 2017 |
72 | Business overview Results of operations Spain & Portugal | |
Solvency II
As of January 1, 2016, under Solvency II requirements, Aegon Spain has been using the Standard Formula to calculate the solvency position of its insurance activities. The calculation includes the use of the matching adjustment and volatility adjustment, depending on the underlying portfolio in addition to transitional measures on technical provisions.
Regularly risk scenarios are tested in order to check the solvency resilience and liquidity limitations of Aegon Spain, the results of which were satisfactory in all cases, and Aegon España and all Aegon entities in Spain are expected to remain adequately capitalized and to have sufficient liquidity.
Annual Report on Form 20-F 2017 |
73 | Business overview Results of operations Asia | |
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2017 | 2016 | % | 2017 | 2016 | % | |||||||||||||||||||
Net underlying earnings |
7 | (7 | ) | n.m. | 6 | (6 | ) | n.m. | ||||||||||||||||
Tax on underlying earnings |
48 | 30 | 59 | 43 | 27 | 56 | ||||||||||||||||||
Underlying earnings before tax by business / country | ||||||||||||||||||||||||
High net worth businesses |
67 | 61 | 9 | 59 | 55 | 6 | ||||||||||||||||||
Aegon Insights |
10 | 1 | n.m. | 9 | 1 | n.m. | ||||||||||||||||||
Strategic partnerships |
(21 | ) | (39 | ) | 45 | (19 | ) | (35 | ) | 46 | ||||||||||||||
Underlying earnings before tax |
55 | 23 | 136 | 49 | 21 | 131 | ||||||||||||||||||
Fair value items |
(1 | ) | (10 | ) | 95 | - | (9 | ) | 95 | |||||||||||||||
Gains / (losses) on investments |
5 | 9 | (47) | 4 | 8 | (48) | ||||||||||||||||||
Net impairments |
(1 | ) | (1 | ) | 48 | (1 | ) | (1 | ) | 49 | ||||||||||||||
Other income / (charges) |
(21 | ) | (6 | ) | n.m. | (19 | ) | (5 | ) | n.m. | ||||||||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 38 | 16 | 141 | 33 | 14 | 136 | ||||||||||||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
19 | 2 | n.m. | 16 | 2 | n.m. | ||||||||||||||||||
Income tax |
(32 | ) | (30 | ) | (6) | (28 | ) | (27 | ) | (4) | ||||||||||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(19 | ) | (2 | ) | n.m. | (16 | ) | (2 | ) | n.m. | ||||||||||||||
Net income / (loss) |
6 | (14 | ) | n.m. | 5 | (13 | ) | n.m. | ||||||||||||||||
Life insurance gross premiums |
1,110 | 1,240 | (11) | 983 | 1,121 | (12) | ||||||||||||||||||
Accident and health insurance premiums |
110 | 115 | (5) | 97 | 104 | (6) | ||||||||||||||||||
Total gross premiums |
1,220 | 1,355 | (10) | 1,080 | 1,225 | (12) | ||||||||||||||||||
Investment income |
277 | 257 | 8 | 246 | 232 | 6 | ||||||||||||||||||
Fees and commission income |
72 | 67 | 6 | 63 | 61 | 4 | ||||||||||||||||||
Total revenues |
1,569 | 1,680 | (7) | 1,390 | 1,517 | (8) | ||||||||||||||||||
Commissions and expenses |
257 | 257 | - | 228 | 232 | (2) | ||||||||||||||||||
of which operating expenses |
176 | 161 | 9 | 155 | 146 | 7 |
Annual Report on Form 20-F 2017 |
74 | Business overview Results of operations Asia | |
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
New life sales | 2017 | 2016 | % | 2017 | 2016 | % | ||||||||||||||||||
High net worth businesses |
84 | 88 | (4) | 75 | 79 | (6) | ||||||||||||||||||
Strategic partnerships |
86 | 54 | 60 | 76 | 49 | 56 | ||||||||||||||||||
Total recurring plus 1/10 single |
170 | 142 | 20 | 151 | 128 | 18 | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Gross deposits (on and off balance) | 2017 | 2016 | % | 2017 | 2016 | % | ||||||||||||||||||
Strategic partnerships - China |
3 | 7 | (57) | 3 | 6 | (58) | ||||||||||||||||||
Strategic partnerships - Japan |
247 | 330 | (25) | 219 | 298 | (27) | ||||||||||||||||||
Total gross deposits |
250 | 337 | (26) | 222 | 304 | (27) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Net deposits (on and off balance) | 2017 | 2016 | % | 2017 | 2016 | % | ||||||||||||||||||
Strategic partnerships - China |
- | 5 | n.m. | - | 4 | n.m. | ||||||||||||||||||
Strategic partnerships - Japan |
146 | 282 | (48) | 129 | 255 | (49) | ||||||||||||||||||
Total net deposits / (outflows) |
146 | 287 | (49) | 129 | 259 | (50) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2017 | 2016 | % | 2017 | 2016 | % | |||||||||||||||||||
New premium production accident and health insurance |
14 | 19 | (27) | 12 | 17 | (28) | ||||||||||||||||||
Weighted average rate | ||||||||||||||||||||||||
Exchange rates Per 1 EUR |
2017 | 2016 | ||||||||||||||||||||||
US dollar |
1.1291 | 1.1069 | ||||||||||||||||||||||
Chinese Yuan Renminbi |
7.6520 | 7.3364 |
Annual Report on Form 20-F 2017 |
75 | Business overview Results of operations Asia | |
Results 2017 Asia
Net income in 2017 amounted to USD 6 million, which was mainly driven by improved underlying earnings before tax and a one-time tax benefit from the write-down of deferred tax liabilities as a result of US tax reform. Underlying earnings before tax improved to USD 55 million in 2017 compared with 2016 mainly due to higher underlying earnings before tax from the High Net Worth businesses, Aegon Insights and China. Gross deposits decreased to USD 250 million in 2017 compared with USD 337 million in 2016, primarily due to sales of the recently launched foreign currency variable annuity being more than offset by lower Japanese Yen-denominated variable annuity sales. New life sales amounted to USD 170 million for 2017, mainly related to the critical illness product in China and the new direct sales strategy implemented in India.
Net income
Net income improved from a loss of USD 14 million in 2016 to USD 6 million in 2017, mainly due to increased underlying earnings before tax in the High Net Worth business, Aegon Insights and China. Fair value losses improved compared with 2016 to USD 1 million due to lower losses on hedging of the variable annuity business in Japan. Realized gains decreased to USD 5 million in 2017 due to lower gains from normal trading activity compared with 2016. Other charges increased compared with 2016 to USD 21 million as a result of the net impact of assumption changes and model updates in 2017. Income tax increased to USD 32 million in 2017 compared with USD 30 million in 2016 as higher taxes on higher underlying earnings before tax were partially offset by a one-time tax benefit of USD 10 million from the write-down of deferred tax liabilities in Aegon Insights as a result of US tax reform.
Underlying earnings before tax
In Asia, underlying earnings before tax improved by 136% compared with 2016 to USD 55 million in 2017.
◆ | Underlying earnings before tax from the high net worth businesses in Hong Kong and Singapore increased to USD 67 million in 2017, compared with USD 61 million in 2016. This increase was mainly the result of favorable mortality experience and favorable intangible adjustments related to anticipated investment yields compared with 2016. |
◆ | Underlying earnings before tax in Aegon Insights increased to USD 10 million in 2017 compared with USD 1 million in 2016 due to an accident & health reserve release, an expense release in Indonesia, and lower operating expenses as a result of discontinuing the outbound telemarketing business. |
◆ | Losses from Strategic Partnerships decreased to USD 21 million in 2017 compared with USD 39 million in 2016 mainly a result of favorable persistency and lower new business related expenses. Following the strong results in China throughout 2017, Aegon THTF is now profitable. |
Commissions and expenses
Commissions and expenses remained stable in 2017 compared with 2016 at USD 257 million. Operating expenses increased by 9% in 2017 compared with 2016 to USD 176 million. The increase in operating expenses was mainly driven by strong sales in China and India throughout the year and investments made to support future growth, partially offset by lower operating expenses in Aegon Insights as a result of discontinuing the outbound telemarketing business.
Production
New life sales increased by 20% in 2017 to USD 170 million compared with 2016.
◆ | In the high net worth businesses in Hong Kong and Singapore, new life sales were down 4% to USD 84 million in 2017, compared with USD 88 million in 2016. This decrease was mainly the result of lower sales of universal life products due to increased competitive environment. |
◆ | New life sales in Strategic Partnerships were up 60% to USD 86 million in 2017 compared with 2016 due to a strong increase from sales in China that was mainly driven by the critical illness product and the new direct sales strategy implemented in India during the first half of 2017. |
Gross deposits in Asia declined to USD 250 million in 2017 compared with USD 337 million in 2016. Increased inflows from foreign currency variable annuities were more than offset by lower Japanese Yen-denominated variable annuity sales. The latter was the result of a pricing change in order to maintain profitability by strictly adhering to Aegons pricing policy.
New premium production in Asias accident & health declined by 27% in 2017 compared with 2016 to USD 14 million as a result of running off the Aegon Insights outbound telemarketing business.
Annual Report on Form 20-F 2017 |
76 | Business overview Results of operations Asia | |
Results 2016 Asia
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2016 | 2015 | % | 2016 | 2015 | % | |||||||||||||||||||
Net underlying earnings |
(7 | ) | (4 | ) | (79) | (6 | ) | (3 | ) | (80) | ||||||||||||||
Tax on underlying earnings |
30 | 27 | 14 | 27 | 24 | 15 | ||||||||||||||||||
Underlying earnings before tax by business / country | ||||||||||||||||||||||||
High net worth businesses |
61 | 45 | 37 | 55 | 40 | 39 | ||||||||||||||||||
Aegon Insights |
1 | 5 | (86) | 1 | 5 | (88) | ||||||||||||||||||
Strategic partnerships |
(39 | ) | (27 | ) | (42) | (35 | ) | (25 | ) | (41) | ||||||||||||||
Underlying earnings before tax |
23 | 23 | 3 | 21 | 20 | 3 | ||||||||||||||||||
Fair value items |
(10 | ) | 7 | n.m. | (9 | ) | 7 | n.m. | ||||||||||||||||
Gains / (losses) on investments |
9 | 7 | 29 | 8 | 7 | 29 | ||||||||||||||||||
Net impairments |
(1 | ) | - | n.m. | (1 | ) | - | n.m. | ||||||||||||||||
Other income / (charges) |
(6 | ) | (68 | ) | 91 | (5 | ) | (61 | ) | 91 | ||||||||||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 16 | (31 | ) | n.m. | 14 | (27 | ) | n.m. | ||||||||||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
2 | 3 | (38) | 2 | 3 | (37) | ||||||||||||||||||
Income tax |
(30 | ) | (3 | ) | n.m. | (27 | ) | (3 | ) | n.m. | ||||||||||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(2 | ) | (3 | ) | 38 | (2 | ) | (3 | ) | 37 | ||||||||||||||
Net income / (loss) |
(14 | ) | (33 | ) | 58 | (13 | ) | (30 | ) | 58 | ||||||||||||||
Life insurance gross premiums |
1,240 | 1,902 | (35) | 1,121 | 1,713 | (35) | ||||||||||||||||||
Accident and health insurance premiums |
115 | 117 | (2) | 104 | 105 | (1) | ||||||||||||||||||
Total gross premiums |
1,355 | 2,019 | (33) | 1,225 | 1,819 | (33) | ||||||||||||||||||
Investment income |
257 | 216 | 19 | 232 | 194 | 19 | ||||||||||||||||||
Fees and commission income |
67 | 69 | (3) | 61 | 62 | (3) | ||||||||||||||||||
Total revenues |
1,680 | 2,304 | (27) | 1,517 | 2,076 | (27) | ||||||||||||||||||
Commissions and expenses |
257 | 268 | (4) | 232 | 242 | (4) | ||||||||||||||||||
of which operating expenses |
161 | 143 | 13 | 146 | 129 | 13 |
Annual Report on Form 20-F 2017 |
77 | Business overview Results of operations Asia | |
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
New life sales | 2016 | 2015 | % | 2016 | 2015 | % | ||||||||||||||||||
High net worth businesses |
88 | 151 | (42) | 79 | 136 | (42) | ||||||||||||||||||
Aegon Insights |
- | 1 | (64) | - | 1 | (64) | ||||||||||||||||||
Strategic partnerships |
54 | 41 | 31 | 49 | 37 | 32 | ||||||||||||||||||
Total recurring plus 1/10 single |
142 | 193 | (26) | 128 | 173 | (26) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Gross deposits (on and off balance) | 2016 | 2015 | % | 2016 | 2015 | % | ||||||||||||||||||
Strategic partnerships - China |
7 | 5 | 43 | 6 | 4 | 43 | ||||||||||||||||||
Strategic partnerships - Japan |
330 | 448 | (26) | 298 | 404 | (26) | ||||||||||||||||||
Total gross deposits |
337 | 453 | (26) | 304 | 408 | (25) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
Net deposits (on and off balance) | 2016 | 2015 | % | 2016 | 2015 | % | ||||||||||||||||||
Strategic partnerships - China |
5 | 3 | 48 | 4 | 3 | 49 | ||||||||||||||||||
Strategic partnerships - Japan |
282 | 388 | (27) | 255 | 350 | (27) | ||||||||||||||||||
Total net deposits / (outflows) |
287 | 392 | (27) | 259 | 353 | (27) | ||||||||||||||||||
Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2016 | 2015 | % | 2016 | 2015 | % | |||||||||||||||||||
New premium production accident and health insurance |
19 | 31 | (40) | 17 | 28 | (40) | ||||||||||||||||||
Weighted average rate | ||||||||||||||||||||||||
Exchange rates | ||||||||||||||||||||||||
Per 1 EUR |
2016 | 2015 | ||||||||||||||||||||||
US dollar |
1.1069 | 1.1100 | ||||||||||||||||||||||
Chinese Yuan Renminbi |
7.3364 | 6.9598 |
Annual Report on Form 20-F 2017 |
78 | Business overview Results of operations Asia | |
Results 2016 Asia
Net loss in 2016 amounted to USD 14 million, which was mainly driven by the increase in ownership from 26% to 49% in Aegons strategic partnership in India compared with 2015, hedging losses in the variable annuity business in Japan, and relatively high profits for tax purposes and limited tax benefits on losses. Underlying earnings before tax remained stable in 2016 compared with 2015 mainly as the result of higher underlying earnings before tax from the High Net Worth business offset by increased ownership in India. Gross deposits decreased to USD 337 million in 2016 compared with USD 453 million in 2015 primarily due to a pricing change on variable annuities in Japan to maintain profitability of new sales. New life sales for 2016 of USD 142 million mainly related to universal life products sold out of Hong Kong and Singapore.
Net income
Net loss in 2016 amounted to USD 14 million. Net losses improved from a loss of USD 33 million in 2015 mainly due to the non-recurrence of one-time charges in 2015 of USD 68 million primarily the result of a more detailed approach to modeled reinsurance premiums. Fair value losses increased compared with 2015 due to hedging as a result of the variable annuity business in Japan. The non-recurrence of charges and fair value losses were partially offset by higher income tax compared with 2015 due to the strong performance of Asias high net worth business out of Hong Kong and Singapore and limited tax benefits on losses in strategic partnerships.
Underlying earnings before tax
In Asia, underlying earnings before tax remained stable at USD 23 million in 2016 compared with 2015.
◆ | Underlying earnings before tax from the high net worth businesses in Hong Kong and Singapore increased to USD 61 million in 2016, compared with USD 45 million in 2015. This increase was mainly the result of favorable mortality experience compared with 2015. |
◆ | Underlying earnings before tax in Aegon Insights decreased to USD 1 million in 2016 compared with USD 5 million in 2015 due to lower production in Indonesia as a result of rationalizing sales campaigns and unfavorable currency movements. |
◆ | Losses from Strategic Partnerships increased to USD 39 million in 2016 compared with USD 27 million in 2015 mainly a result of the increase in ownership from 26% to 49% in India, which is currently loss-making. |
Commissions and expenses
Commissions and expenses decreased by 4% in 2016 compared with 2015 to USD 257 million driven by lower production levels. Operating expenses increased by 13% in 2016 compared with
2015 to USD 161 million. The increase in operating expenses was mainly driven by the investment made to support future growth, together with the increase in Aegons stake in its strategic partnership in India from 26% to 49%. On a comparable basis, operating expenses increased by 5% compared with 2015.
Production
New life sales decreased by 26% in 2016 to USD 142 million compared with 2015.
◆ | In the high net worth businesses in Hong Kong and Singapore, new life sales were down 42% to USD 88 million in 2016 compared with USD 151 million in 2015. This decrease was mainly the result of lower sales of universal life products as Aegon adhered to its strict pricing policy in the low interest rate environment. |
◆ | New life sales in Strategic Partnerships were up 31% to USD 54 million in 2016 compared with 2015 due to a strong increase from sales in China mainly driven by the continued success of the whole life critical illness product and successful launch of a universal life product in the bank channel. The increase in China in 2016 compared with 2015 was partly offset by the strategic decision to exit the agency distribution channel in India in order to move to a digital distribution model. |
Gross deposits in Asia declined to USD 337 million in 2016 compared with USD 453 million in 2015. This was the result of a pricing change on the Japanese Yen-denominated variable annuity in order to maintain profitability of new sales.
New premium production in Asias accident & health declined 40% in 2016 compared with 2015 to USD 19 million, driven by the rationalization of unprofitable sales campaigns in Aegon Insights, especially in Indonesia.
Annual Report on Form 20-F 2017 |
79 | Business overview Results of operations Asia | |
Overview of Asia
Aegon Asia operates through three major joint ventures in India, Japan and the Peoples Republic of China (hereafter referred to as China), in addition to several wholly-owned subsidiaries, including Aegons businesses in Hong Kong and Singapore that serve the high-net-worth segment.
Organizational structure
Aegons main operating companies in Asia (including Aegons ownership percentages) are:
◆ | Aegon THTF Life Insurance Co. Ltd. (50%); |
◆ | Aegon Life Insurance Co. Ltd. (49%); |
◆ | Aegon Sony Life Insurance Co. Ltd. (50%); |
◆ | SA Reinsurance Ltd. (50%); and |
◆ | Transamerica Life (Bermuda) Ltd. (TLB). |
Joint ventures
Aegon operates in China through a joint venture with Tsinghua Tongfang Co. Ltd (THTF). The name of the joint venture is Aegon THTF Life Insurance Co. Ltd. (Aegon THTF). Aegon THTF is licensed to sell both life insurance and accident and health products in China. The company has expanded its network of offices and business in China since 2003. Having obtained 12 provincial licenses, its geographic presence provides access to a potential market of over 650 million people, primarily in the coastal provinces of eastern China.
Aegon has been operating in India through its joint venture life insurance company, Aegon Life Insurance Co. Ltd (Aegon Life), since 2008, and its current joint venture partner is Bennett, Coleman & Co. Ltd. (BCCL). The joint venture follows a digitally focused direct-to-consumer strategy.
Since 2009, Aegon has been operating in Japan through a joint venture with Sony Life, one of Japans leading insurance companies, named Aegon Sony Life Insurance Co., Ltd. (Aegon Sony Life). The primary focus of Aegon Sony Life is annuity sales in Japan. Aegon and Sony Life also jointly established a reinsurance company, SA Reinsurance Ltd. (SARe), to provide Aegon Sony Life with greater flexibility in the pricing and design of its annuity products. Launched in 2010 and based in Bermuda, SARe manages the guaranteed benefit risks of Aegon Sony Lifes products.
Wholly-owned subsidiaries
Transamerica Life Bermuda and its predecessors have been serving customers in Asia for over 80 years. TLB today primarily serves the wealth preservation and wealth transfer needs of the high-net-worth market segment in Asia through its offices in Hong Kong and Singapore, and Europe through its office in Bermuda.
Aegon Insights is a marketing and distribution services business in the Asia-Pacific region. The Aegon Insights business first
established operations in Australia in 1998, and currently maintains operations in Australia, China, Hong Kong, Indonesia, Japan and Thailand. Given changes in consumer preferences in some countries, changes were also made during 2017 to close active partner distribution relationships, while continuing to serve existing customers.
Overview of sales and distribution
In China, Aegon THTF follows a multi-channel distribution strategy. Current distribution channels include agency, brokerage, banks, direct marketing, group and digital.
In India, Aegon Life now distributes its products predominantly via its e-sales channels utilizing its own website and e-commerce partners, as well as its own direct sales force.
Aegon Sony Life in Japan has two distribution channels: the Sony Life Planner channel (operated by Sony Life), with over 4,900 agents; and the bank distribution channel, which consists predominately of mega banks and regional banks.
TLB distributes its products to high-net-worth consumers exclusively through relationships with local and international brokers, in addition to private banks.
Overview of business lines
High-net-worth businesses
TLBs main products consist of USD denominated Universal Life and USD Term Life Insurance plans for the high-net-worth market segment. Universal Life is TLBs key product to meet the needs of high-net-worth individuals for wealth preservation and wealth transfer to successive generations. In addition to the Universal Life products, Term Life products are also marketed to high-net-worth consumers, with protection offered at a guaranteed level rate for up to 30 years.
Aegon Insights
Aegon Insights primarily worked with local insurers to develop marketing and distribution solutions tailored to the needs of specific markets and customers. With changes in consumer preferences, the focus is on exploring opportunities in the emerging digital distribution landscape. Revenue is primarily generated through reinsurance arrangements and fee income from marketing services and product distribution. During 2017, Aegon made the strategic decision to discontinue the outbound telemarketing businesses.
Annual Report on Form 20-F 2017 |
80 | Business overview Results of operations Asia | |
Strategic partnerships
In China and India, Aegon provides a broad range of life insurance products including unit-linked, universal life, and traditional life products. Aegon also offers variable annuities in Japan through Aegon Sony Life.
In China, Aegon THTFs agency, broker, and direct marketing channels primarily sell whole-life critical illness products, while the agency channel and direct marketing channel also offer participating endowment products and personal accident products respectively. Regular premium critical illness, participating annuity and single premium universal life are the key products offered in the bancassurance channel, while the digital channel is currently focused on offering protection products. Aegon THTF also offers non-life products (primarily consisting of short-term accident and short-term health products) through all channels. Non-life sales are, however, concentrated in the group channel, where the main products are group medical policies.
In India, Aegon Life offers term life plans, traditional individual participating products, traditional non-participating savings products, and unit-linked life insurance plans through the direct sales force and e-sales channels.
In Japan, Aegon Sony Life sells variable annuities in JPY, USD and AUD. These products typically provide a guaranteed minimum death benefit, together with a lifetime withdrawal benefit and an accumulation benefit with or without a minimum guarantee.
Since 2010, SARe has assumed the risk on all minimum guarantees offered on Aegon Sony Lifes variable annuity products.
Aegon also makes investments in digital distribution platforms in the Asia region to expand distribution capabilities.
Competition
China: Aegon THTF
As of November 30, 2017 there were 85 life insurance companies in the market, including 57 domestic life companies and 28 foreign life insurers. Based on total premium income, Aegon THTF ranked fifty-fifth among life insurance companies and fifteenth among foreign life companies in China. Aegon THTFs market share among foreign-invested companies was 1.4% in terms of total premium.
India: Aegon Life
There were 24 licensed life insurers in India at the end of November 2017. While the state-owned Life Insurance Corporation of India continues to maintain a dominant share of new business premiums (April 2017 to November 2017), private sector companies have shown double-digit growth to obtain more than 30% of the individual recurring new business premiums written. Aegon Life India ranked twenty-
third in the individual recurring premium market (April 2017 to November 2017).
Japan: Aegon Sony Life
There are seven active companies in Japans variable annuities market. In 2017, Aegon Sony Life ranked third in terms of market share behind Dai-ichi Frontier and Nippon.
Hong Kong and Singapore: TLB
TLBs main competitors in Hong Kong and Singapore have traditionally been the global providers for the high-net-worth market, such as HSBC Life, Manulife Bermuda, and Sun Life Bermuda. The local branches of both Sun Life and Manulife, in addition to domestic insurers such as AIA, Great Eastern Life and FWD, are however increasingly developing very competitive offerings for the same market segment.
Regulation and supervision
China: Aegon THTF
The insurance industry in China is regulated by the China Insurance Regulatory Commission (CIRC). During 2017, the CIRC made several regulatory changes to ensure that the industry focused on protection products rather than high guarantee savings products. The CIRC also strengthened the regulation with regards to mis-selling, corporate governance, related party transactions, the use of insurance fund, product design, customer service and innovative business risks.
India: Aegon Life
Indian life insurance companies are regulated by the Insurance Regulatory and Development Authority of India (IRDAI). The IRDAI regulates, promotes and encourages the orderly growth of insurance and reinsurance businesses in India. Established by the government of India, it safeguards the interests of the countrys insurance policyholders.
The IRDAI is active in introducing new regulations that focus on protecting policyholders interests and exploring avenues to support growth in the industry. Steps initiated by the IRDAI during 2017 included the issuing of regulations with regards to: the registration of Insurance Marketing Firms; the payment of commission, remuneration or rewards to insurance agents; insurance web aggregator; the outsourcing activities by the Indian Insurers; and the role, responsibilities and appointment of Appointed Actuaries. IRDAI has also issued circulars, rules that provide additional clarify and information about claims processing, point of sale, report on persistency rate and renewal rate, investment regulation, and the implementation of Indian accounting standards.
Japan: Aegon Sony Life
The Financial Services Agency (FSA) is the government agency that supervises all insurance companies in Japan. New products and major product amendments are filed with, and approved by, the FSA, in addition to general policy provisions, statements of business procedure, and pricing and valuation.
Annual Report on Form 20-F 2017 |
81 | Business overview Results of operations Asia | |
On March 30, 2017, the FSA published the Principles for Customer-Oriented Business Conduct to help financial accumulation of household financial assets, and appropriate rules regarding markets and financial instruments exchanges. Many insurers, including Sony Life, have published their own principles and the measures that they have taken in response to the FSA principles.
Hong Kong, Singapore and Bermuda: TLB
TLB is incorporated in Bermuda and regulated by the Bermuda Monetary Authority, the integrated regulator of the financial services sector in Bermuda. TLBs Asia branches are located in Hong Kong and Singapore. The insurance industry in Hong Kong was until June 26, 2017, regulated by the Office of the Commissioner of Insurance (OCI). Changes to the Insurance Companies Ordinance in 2015 provided for the establishment of a new independent insurance authority (IA, which came into operation in June 2017). The IA will take over the regulation of insurance companies and insurance intermediaries from the three Self-Regulatory Organizations (SROs) through a statutory licensing regime in the next two to three years.
The insurance industry in Singapore is regulated by the Monetary Authority of Singapore (MAS). The MAS is an integrated regulator that oversees all banks, insurers, capital market intermediaries and financial advisors in Singapore.
Asia: Aegon Insights
A broad range of regulations apply to Aegon Insights activities. Depending on the precise nature of the activities undertaken and the form of business entity used in the jurisdictions in which Aegon Insights operates, relevant regulations include: marketing/ consultancy business licensing rules, insurance laws, and personal data protection laws. In addition, various regulators also keep oversight of a number of activities undertaken by entities licensed by Aegon Insights. These regulators include the FSA in the Japan, the Office of Insurance Commission in Thailand, the Australian Securities & Investments Commission in Australia, and the Confederation of Insurance Brokers in Hong Kong. Aegon Insights keeps abreast of all changes or proposed changes to regulations in all of its markets. Where appropriate, it also implements industry standard compliance programs, such as Payment Card Industry Compliance in Australia and Privacy Mark in Japan.
Asia
Solvency II requirements became effective for Aegon Group as of January 1, 2016. Aegons Asian insurance activities are included in the Aegon Group Solvency II ratio through Deduction & Aggregation. For TLB and Japan, Deduction & Aggregation is applied using available and required capital as per the local capital regime. The regulatory regime of Bermuda and Japan were granted full provisional equivalence on December 7, 2015.
Annual Report on Form 20-F 2017 |
82 | Business overview Results of operations Aegon Asset Management | |
Results 2017 Aegon Asset Management
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Net underlying earnings | 94 | 99 | (5) | |||||||||
Tax on underlying earnings |
42 | 50 | (16) | |||||||||
Underlying earnings before tax by business / country |
||||||||||||
Americas |
59 | 55 | 6 | |||||||||
The Netherlands |
15 | 14 | 6 | |||||||||
United Kingdom |
16 | 30 | (46) | |||||||||
Rest of World |
(7 | ) | (4 | ) | (84) | |||||||
Strategic partnerships |
53 | 54 | (1) | |||||||||
Underlying earnings before tax | 136 | 149 | (9) | |||||||||
Fair value items |
- | - | n.m. | |||||||||
Gains / (losses) on investments |
3 | 3 | 6 | |||||||||
Net impairments |
- | (5 | ) | n.m. | ||||||||
Other income / (charges) |
(49 | ) | (2 | ) | n.m. | |||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 90 | 145 | (38) | |||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
17 | 19 | (7) | |||||||||
Income tax |
(42 | ) | (48 | ) | 11 | |||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(17 | ) | (19 | ) | 7 | |||||||
Net income / (loss) |
48 | 97 | (51) | |||||||||
Management fees |
473 | 503 | (6) | |||||||||
Performance fees |
36 | 34 | 4 | |||||||||
Other |
67 | 63 | 7 | |||||||||
Total revenues |
576 | 601 | (4) | |||||||||
Commissions and expenses |
481 | 486 | (1) | |||||||||
of which operating expenses |
444 | 451 | (2) | |||||||||
Cost / income ratio |
77.1% | 75.1% | ||||||||||
Amounts in EUR millions | 2017 | 2016 | % | |||||||||
Gross flows other third-party | ||||||||||||
Americas |
10,567 | 4,536 | 133 | |||||||||
The Netherlands |
5,936 | 4,656 | 27 | |||||||||
United Kingdom |
4,482 | 4,831 | (7) | |||||||||
Rest of World 1) |
127 | (317 | ) | n.m. | ||||||||
Strategic partnerships |
40,220 | 32,660 | 23 | |||||||||
Total gross flows other third-party |
61,332 | 46,366 | 32 | |||||||||
Net flows other third-party |
||||||||||||
Americas |
1,913 | 499 | n.m. | |||||||||
The Netherlands |
3,256 | 3,669 | (11) | |||||||||
United Kingdom |
(6,770 | ) | (865 | ) | n.m. | |||||||
Rest of World 1) |
167 | 62 | 170 | |||||||||
Strategic partnerships |
8,345 | (402 | ) | n.m. | ||||||||
Total net flows other third-party |
6,913 | 2,964 | 133 | |||||||||
1 Rest of world include intragroup eliminations from internal sub-advised agreements |
||||||||||||
Weighted average rate | ||||||||||||
Exchange rates | ||||||||||||
Per 1 EUR | 2017 | 2016 | ||||||||||
US dollar |
1.1291 | 1.1069 | ||||||||||
Pound sterling |
0.8758 | 0.8187 | ||||||||||
Hungarian forint |
308.7564 | 310.9128 | ||||||||||
Chinese Yuan Renminbi |
7.6520 | 7.3364 |
Annual Report on Form 20-F 2017 |
83 | Business overview Results of operations Aegon Asset Management | |
Results 2017 Aegon Asset Management
Net income in 2017 decreased compared with 2016 to EUR 48 million as a result of lower underlying earnings before tax compared with 2016 and a provision taken for a potential settlement with the SEC. Lower underlying earnings before tax in 2017 compared with 2016 was mainly the result of lower management fees in the United Kingdom. Gross flows in other third-party asset management increased by 32% to EUR 61 billion in 2017 compared with 2016, mainly driven by higher gross inflows in the US, the Netherlands and Strategic partnerships.
Net income
Net income in 2017 declined 51% compared with 2016 to EUR 48 million. This was partly driven by lower underlying earnings before tax in 2017 compared with 2016.
In addition, Aegon has taken a provision in anticipation of a possible settlement in connection with a previously disclosed investigation by the US Securities and Exchange Commission (SEC). The investigation relates to the operation or existence of errors in the quantitative models in question and disclosures regarding these matters. Aegon had discovered these errors in its asset management operations in the United States. The Company notified the SEC and cooperated fully with the investigation. Following the discovery of the errors, Aegon concluded a comprehensive and detailed review.
As a result of recent discussions, Aegon has taken a provision through Other charges in the fourth quarter of 2017 for a potential settlement. This amount is partly recorded in the Americas and partly in Asset Management (EUR 40 million). Aegon believes that the investigation will come to a conclusion in 2018.
Underlying earnings before tax
Underlying earnings before tax decreased by 9% in 2017 compared with 2016 to EUR 136 million. This decline was mainly driven by lower underlying earnings before tax in 2017 compared with 2016 from the United Kingdom due to lower management fees.
◆ | Americas underlying earnings before tax increased to EUR 59 million in 2017, compared with EUR 55 million in 2016, as lower expenses more than offset lower management fee income in 2017 compared with 2016. |
◆ | Underlying earnings before tax from the Netherlands in 2017 increased by EUR 1 million to EUR 15 million compared with 2016, mainly driven by higher management fee income, which was partly offset by higher expenses in 2017 compared with 2016. |
◆ | Underlying earnings before tax from the United Kingdom amounted to EUR 16 million in 2017, a decrease from the EUR 30 million level in 2016. Lower expenses in 2017 compared with 2016 were more than offset by lower management fee income. |
◆ | Rest of World underlying earnings before tax in 2017 decreased by EUR 3 million compared with 2016 to a loss of EUR 7 million. |
◆ | Underlying earnings before tax from Strategic partnerships decreased by EUR 1 million compared with 2016 to EUR 53 million in 2017. Aegons Chinese asset management joint venture AIFMC had lower performance fee income in 2017 compared with 2016. This was partly offset by higher underlying earnings before tax from French joint venture La Banque Postale Asset Management in 2017 compared with 2016. |
Commissions and expenses
Commissions and expenses declined in 2017 compared with 2016 to EUR 481 million. Operating expenses decreased by 2% in 2017 compared with 2016 to EUR 444 million. This decrease was mainly driven by lower expenses in the Americas and the United Kingdom as a result of continued strong expense control and favorable currency movements. These were partly offset by restructuring charges and higher one-time expenses in the Netherlands. The cost/income ratio in 2017 increased by 2 percentage points to 77% compared with 2016, as lower expenses were more than offset by lower revenues in 2017 compared with 2016. Annualized operating expenses as a percentage of average assets under management increased in 2017 compared with 2016 by 1 basis point to 14 basis points.
Annual Report on Form 20-F 2017 |
84 | Business overview Results of operations Aegon Asset Management | |
Production
Gross inflows in other third-party increased by 32% in 2017 to EUR 61.3 billion compared with 2016. This was mainly the result of higher gross flows in Strategic partnerships in 2017 compared with 2016, and higher gross flows in the US and the Netherlands.
Net other third-party inflows in 2017 increased compared with 2016 to EUR 6.9 billion, as higher net flows in Strategic partnerships and the Americas were partly offset by net outflows in the United Kingdom and lower net inflows in the Netherlands.
Assets under management
Assets under management decreased by EUR 14 billion in 2017 to EUR 318 billion compared with the start of 2017. Favorable market movements and net inflows in other third-party were more than offset by outflows in the general account, primarily resulting from the divestment of the majority of the run-off businesses in the US, outflows in affiliates, and unfavorable currency movements.
Annual Report on Form 20-F 2017 |
85 | Business overview Results of operations Aegon Asset Management | |
Results 2016 Aegon Asset Management
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Net underlying earnings | 99 | 120 | (17) | |||||||||
Tax on underlying earnings |
50 | 50 | (2) | |||||||||
Underlying earnings before tax by business / country |
||||||||||||
Americas |
55 | 66 | (16) | |||||||||
The Netherlands |
14 | 11 | 28 | |||||||||
United Kingdom |
30 | 32 | (7) | |||||||||
Rest of World |
(4 | ) | (4 | ) | (2) | |||||||
Strategic partnerships |
54 | 65 | (17) | |||||||||
Underlying earnings before tax |
149 | 170 | (12) | |||||||||
Fair value items |
- | - | - | |||||||||
Gains / (losses) on investments |
3 | 3 | 8 | |||||||||
Net impairments |
(5 | ) | - | n.m. | ||||||||
Other income / (charges) |
(2 | ) | (1 | ) | (16) | |||||||
Income before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) | 145 | 172 | (15) | |||||||||
Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
19 | 19 | (3) | |||||||||
Income tax |
(48 | ) | (50 | ) | 5 | |||||||
Of which Income tax from certain proportionately consolidated joint ventures and associates included in income before tax |
(19 | ) | (19 | ) | 3 | |||||||
Net income / (loss) |
97 | 121 | (20) | |||||||||
Management fees |
503 | 504 | - | |||||||||
Performance fees |
34 | 48 | (29) | |||||||||
Other |
63 | 61 | 3 | |||||||||
Total revenues |
601 | 614 | (2) | |||||||||
Commissions and expenses |
486 | 487 | - | |||||||||
of which operating expenses |
451 | 444 | 2 | |||||||||
Cost / income ratio |
75.1% | 72.3% | ||||||||||
Amounts in EUR millions | 2016 | 2015 | % | |||||||||
Gross flows other third-party |
||||||||||||
Americas |
4,536 | 2,329 | 95 | |||||||||
The Netherlands |
4,656 | 4,080 | 14 | |||||||||
United Kingdom |
4,831 | 7,538 | (36) | |||||||||
Rest of World 1) |
(317 | ) | (389 | ) | 19 | |||||||
Strategic partnerships |
32,660 | 20,165 | 62 | |||||||||
Total gross flows other third-party |
46,366 | 33,722 | 37 | |||||||||
Net flows other third-party |
||||||||||||
Americas |
499 | 307 | 63 | |||||||||
The Netherlands |
3,669 | 2,897 | 27 | |||||||||
United Kingdom |
(865 | ) | 3,490 | n.m. | ||||||||
Rest of World 1) |
62 | (27 | ) | n.m. | ||||||||
Strategic partnerships |
(402 | ) | 1,568 | n.m. | ||||||||
Total net flows other third-party |
2,964 | 8,235 | (64) | |||||||||
1 Rest of world include intragroup eliminations from internal sub-advised agreements |
||||||||||||
Weighted average rate | ||||||||||||
Exchange rates |
||||||||||||
Per 1 EUR |
2016 | 2015 | ||||||||||
US dollar |
1.1069 | 1.1100 | ||||||||||
Pound sterling |
0.8187 | 0.7256 | ||||||||||
Hungarian forint |
310.9128 | 309.3147 | ||||||||||
Chinese Yuan Renminbi |
7.3364 | 6.9598 |
Annual Report on Form 20-F 2017 |
86 | Business overview Results of operations Aegon Asset Management | |
Results 2016 Aegon Asset Management
Net income in 2016 decreased compared with 2015 to EUR 97 million as a result of lower underlying earnings before tax compared with 2015. Lower underlying earnings before tax in 2016 compared with 2015 was mainly the result of lower underlying earnings before tax in 2016 compared with 2015 from Aegons Chinese asset management joint venture AIFMC due to the normalization of performance fees. Gross flows in other third-party asset management increased by 37% to EUR 46 billion in 2016 compared with 2015, mainly driven by higher gross inflows in the US, the Netherlands and Strategic partnerships.
Net income
Net income in 2016 declined 20% compared with 2015 to EUR 97 million. This was mainly driven by lower underlying earnings before tax in 2016 compared with 2015.
Underlying earnings before tax
Underlying earnings before tax decreased by 12% in 2016 compared with 2015 to EUR 149 million. This decline was mainly driven by lower underlying earnings before tax in 2016 compared with 2015 from Aegons Chinese asset management joint venture AIFMC due to the normalization of performance fees.
◆ | Americas underlying earnings before tax decreased to EUR 55 million in 2016, compared with EUR 66 million in 2015, as higher transactional fee income was more than offset by lower management fee income in 2016 compared with 2015, and increased employee and project-related expenses. |
◆ | Underlying earnings before tax from the Netherlands in 2016 increased EUR 3 million to EUR 14 million compared with 2015, mainly driven by higher management fee income which were only partly offset by higher expenses in 2016 compared with 2015. |
◆ | Underlying earnings before tax from the United Kingdom amounted to EUR 30 million in 2016, a decrease from the EUR 32 million level in 2015. Lower expenses in 2016 compared with 2015 were more than offset by adverse currency movements and lower fee income mainly resulting from the sale of the majority of the UK annuity book. |
◆ | Rest of World underlying earnings before tax in 2016 remained stable compared with 2015 at a loss of EUR 4 million. |
◆ | Underlying earnings before tax from Strategic Partnerships decreased with EUR 11 million compared with 2015 to EUR 54 million in 2016. This was the result of lower performance fee income at AIFMC compared with 2015 and adverse currency movements, partly offset by higher underlying earnings before tax in 2016 compared with 2015 related to the inclusion of La Banque Postale Asset Management. |
Commissions and expenses
Operating expenses increased by 2% in 2016 compared with 2015 to EUR 451 million. This increase was mainly the result of higher employee related expenses in 2016 compared with 2015 due to increased headcount to support growth strategy and the inclusion of costs related to the partnership with La Banque Postale Asset Management, which was only partly offset by currency movements. As a result of higher expenses and lower net income in 2016 compared with 2015, the cost/income ratio in 2016 increased by 3 percentage points to 75% compared with 2015. Annualized operating expenses as a percentage of average assets under management remained in 2016 stable compared with 2015 at 13 basis points.
Production
Gross inflows in other third-party increased by 37% in 2016 to EUR 46.4 billion compared with 2015. This was mainly the result of higher gross flows in AIFMC in 2016 compared with 2015, which were mainly driven by higher recognized gross inflows, the acquisition of La Banque Postale Asset Management, and higher gross flows in the US and the Netherlands.
Net other third-party inflows in 2016 decreased compared with 2015 to EUR 3.0 billion, as higher net flows in 2016 compared with 2015 in mainly the Netherlands were more than offset by net outflows in the United Kingdom and AIFCM.
Assets under management
Assets under management decreased by EUR 14 billion in 2016 to EUR 332 billion compared with the start of 2016. Favorable market movements and net inflows in other third-party were more than offset by outflows in affiliates, due to a contract loss in the US, outflows in the general account, primarily resulting from the divestment of the majority of the annuity book in the United Kingdom, and unfavorable currency movements.
Annual Report on Form 20-F 2017 |
87 | Business overview Results of operations Aegon Asset Management | |
Overview of Aegon Asset Management
Aegon Asset Management is an active investment manager that uses its investment management expertise to help people achieve a lifetime of financial security.
Organizational structure
Aegon Asset Management is a provider of investment management expertise to institutional and private investors around the world. It has offices in the United States, the Netherlands, the United Kingdom, Hong Kong, Hungary and Spain. It operates under three main brands:
◆ | Aegon Asset Management specializes in providing clients with a range of high-quality investment solutions across asset classes, including fixed income, equities, real estate, absolute return, liability-driven, and multi-asset and balance sheet solutions. A long and successful history of partnership with Aegons insurance businesses has enabled Aegon Asset Management to establish experienced investment teams, a solid asset base and proven long-term records; |
◆ | Kames Capital is a UK-based asset management company that provides fixed income, equities, real estate and multi-asset solutions to both UK and international clients; and |
◆ | TKP Investments is a Netherlands-based fiduciary manager that is recognized for its manager selection and tailored advice on balance sheet solutions for the pension market. |
In addition, Aegon Asset Management operates two key strategic partnerships:
◆ | In China, Aegon Asset Management owns 49% of Aegon Industrial Fund Management Company (AIFMC), a Shanghai-based asset manager that offers mutual funds, segregated accounts and advisory services; and |
◆ | In France, Aegon Asset Management owns 25% of La Banque Postale Asset Management. La Banque Postale Asset Management offers a comprehensive range of investment strategies to French institutional clients, and to private investors through La Banque Postale groups retail banking network. |
Aegon Asset Managements main operating entities are Aegon USA Investment Management LLC, Aegon USA Realty Advisors LLC, Aegon Investment Management B.V. (the Netherlands), TKP Investments B.V. (the Netherlands), Kames Capital plc (United Kingdom) and Aegon Hungary Asset Management Company Zrt. Depending on regulatory requirements and the local business environment, boards of local operating entities may include oversight through independent non-executive directors.
Strategic direction and global oversight of business performance is executed by the Global Board of Aegon Asset Management, which has both global and local roles and responsibilities. This Board is supported by the Governance Risk & Compliance Committee and the Human Resources Committee, together with a Global Strategic Change Committee. Members of the Global
Board are appointed by Aegon N.V The Risk Advisory Committee and Remuneration Committee support Aegons oversight of Aegon Asset Management.
As of January 1, 2018, the activities of Aegon Investment Management B.V and Kames Capital plc have been governed by a joint European Executive Committee. The-day-to-day management of these two entities is delegated to the European Executive Committee. The statutory boards of Aegon Investment Management B.V. and Kames Capital plc remain ultimately responsible for the entities, and have the duty to oversee the delegated authorities. As part of this integration in Europe, Aegon Asset Management plans to merge the operating entities Aegon Investment Management B.V. and TKP Investments B.V To ensure the continued independence of the fiduciary services offered by TKP Investments, the respective teams have, since January 1, 2018, reported to the global CEO of Aegon Asset Management.
Overview of sales and distribution channels
Aegon Asset Management uses a variety of sales and distribution channels in the Americas, Europe and Asia. These include among others: affiliated companies, direct to institutional clients, independent investment advisors, investment consultants, joint ventures and third-party investment platforms.
Overview of business lines
Aegon Asset Management has three distinct business lines.
General account business consists of funds held on the balance sheet of Aegon insurance companies to meet policyholder liabilities - typically when the insurer has given the policyholder a guarantee. These assets are managed to match the insurers liabilities. As a rule, general account assets are managed in a closed architecture structure, and the main asset classes are fixed income and mortgage loans. Furthermore, Aegon Asset Management manages Aegons general account derivatives book of Aegon the Netherlands.
The majority of third-party business sourced through affiliates consists of funds sold by Aegon insurers through which the policyholders return is determined by the investment return of the fund. These funds have various legal structures, and are usually managed against a benchmark or peer group target. The main asset classes include fixed income, equities, real estate, mortgage loans and alternatives. In the United States and the United Kingdom, a significant element of Affiliate Sales is conducted on an open architecture basis, where Aegon Asset Management competes with external fund managers.
Annual Report on Form 20-F 2017 |
88 | Business overview Results of operations Aegon Asset Management | |
For third-party business sourced externally, Aegon Asset Management distributes its investment strategies directly to its clients. The wholesale businesses typically sell collective investment vehicles (mutual funds) to customers through wholesale distributors and independent intermediaries. The main asset classes are fixed income and equities, and the funds are usually managed against a benchmark or peer group target. The institutional businesses typically sell tailored services to large corporations or pension funds. Aegon Asset Management employs a full range of asset classes, and manages the funds against objectives, targets and risk profiles agreed with clients. Aegon Asset Management offers both absolute and relative return products.
Competition
Aegon Asset Management competes with other asset management companies to acquire business from open-architecture Aegon insurance units and third parties.
In the United States, Aegon Asset Management focuses on offering investors fixed income, balance sheet solutions and real estate-related strategies. It works directly with pension funds, endowments and foundations as well as investment consultants within the institutional market. In the wholesale market, Aegon Asset Management works as a sub-advisor with its insurance company affiliates and other partners in order to offer competitive and relevant strategies for its client base. It also works with consultants and other partners to offer products to third-party institutions. Primary competitors in the United States include AllianceBernstein, BlackRock, Invesco, JP Morgan, Legg Mason, Principal, PIMCO and Prudential.
In the Netherlands, Aegon Asset Management provides a wide range of investment strategies and solutions to institutional and wholesale clients, and through its affiliated insurance company to retail clients. In the third-party institutional market, it competes with domestic and global asset managers as well as with fiduciary and balance sheet managers. Competition continues to be strong in the institutional market due to both the ongoing consolidation of pension funds and the growing service requirements of pension fund clients. Primary competitors in the Netherlands include BlackRock, JP Morgan, Nationale Nederlanden Investment Partners and Robeco.
In the United Kingdom, Aegon Asset Management focuses on offering investors fixed income, equities, real estate, multi-asset, absolute return and ethical investments. It serves institutional clients and their advisors, and is active in the wholesale market. Primary competitors in the UK include Ashmore, BlackRock, Henderson Global Investors and Standard Life Aberdeen.
In mainland China, Aegon Industrial Fund Management Company focuses on Chinese equity, fixed income, and money market strategies. It competes against a wide range of locally-based asset managers including Alibabas Yuebao fund China Universal Asset Management, E Fund Management, Fullgoal Fund Management, and Yinhua Fund Management.
In France, La Banque Postale Asset Management competes for private investors through La Banque Postales retail banking network, with a focus on new multi-asset strategies. In the institutional market, it also offers strategies from Aegon Asset Management businesses in order to compete with large local asset managers and specialized international competitors. In France, primary competitors include Amundi Asset Management, AXA Investment Management, BNP Paribas Investment Partners and Natixis Global Asset Management.
Regulation and supervision
Regulation of asset management companies in general differs to that of insurers. Aegon Asset Managements global holding company, Aegon Asset Management Holding B.V., is regulated by the Dutch Central Bank (DNB) as a financial holding company according to the Dutch Financial Supervision Act (Wft). Local operating entities are regulated by their local regulators, most notably the Dutch Authority for the Financial Markets (AFM) (conduct of business supervision) and the DNB (prudential supervision) for Dutch-based entities, the Financial Conduct Authority (FCA) for Kames Capital, and the Securities & Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) for the US-based entities. Kames Capital is also regulated by the SEC for its activities in the US market. From a regulatory perspective, the asset management activities of the US-based entities of Aegon Asset Management in the United States do not fall under the responsibility of Aegon Asset Management Holding B.V., as these entities are subsidiaries of Transamerica Corporation.
Solvency II
Solvency II requirements became effective for Aegon Group as of January 1, 2016. The EU-domiciled asset management activities are accounted for in the Group Solvency II calculation using the requirements set by the Capital Requirements Directives IV (CRD IV). Non EU-domiciled activities are accounted for using local capital requirements.
MiFID II
MIFID II requirements became effective for Aegon Asset Management as of January 3, 2018, and the Company adheres to the regulation. In line with most of its peers, the European Aegon Asset Management entities (Aegon Investment Management B.V., Kames Capital plc and TKP Investments B.V.) have decided in principle to pay external research costs by their own means.
Annual Report on Form 20-F 2017 |
89 | Business overview Asset-Liability Management | |
Aegon specializes in writing long-term life insurance business with key markets in the US, Europe and Asia. Its product suite includes savings and annuity products that feature a guaranteed level of benefit. Aegon also writes mortgages in The Netherlands that are initiated using long-term insurance funds. Products are priced using a market-consistent framework, and comprehensive asset-liability management (ALM) programs are implemented to ensure that the assets backing policyholder benefits are invested prudently over the long term.
A range of ALM techniques are used across the Group. These range in terms of sophistication and complexity from cash-flow matching (for traditional fixed annuities) to duration matching (for the universal life family) to derivative-based semi-static and dynamic hedges (to match variable annuities).
The Enterprise Risk Management (ERM) framework includes a number of risk policies that govern ALM strategies, such as the Investment and Counterparty Risk Policy (ICRP), the Interest Rate Risk Policy (IRRP) and the Currency Risk Policy (CRP). The ICRP governs the management of investment risks associated with credit, equity, property and alternative asset classes, in addition to option markets and implied volatility risk. The other policies govern interest rate and currency risk, including the risk associated with interest rate options and swaptions.
As well as product-level ALM programs, subsidiary businesses are required by the ICRP to maintain overarching ALM strategies that set the direction and limits for the various individual product-level programs. Significant or complex ALM strategies are approved at group level, and all programs are subject to group risk oversight.
Together with the ICRP, IRRP and CRP, which guide ALM strategy, a number of other ERM policies govern concentration risk, liquidity risk, use of derivatives and securities lending and repos. As Aegon uses derivatives extensively, collateral calls can be significant depending on market circumstances. Liquidity is managed at legal entity level in the first instance, and the large US and Dutch units may use external market solutions to match projected liquidity requirements with funding.
The introduction of Dodd-Frank and the European Market Infrastructure Regulation (EMIR) derivative regulations has led in recent years to Aegon transitioning a significant proportion of formerly over-the-counter positions to clearing houses. Collateral and margin requirements have also increased, introducing the potential for liquidity strain, which has to be carefully managed. Market volatility can cause collateral requirements to increase rapidly, which means that it is important to have sufficient high quality collateral available at all times. Regular liquidity stress testing is used to monitor required liquidity and ensure that sufficient funding is available.
Americas
The investment choices of Aegon USAs companies are subject to regulation dependent upon the laws of the applicable state in which each such company is domiciled. Each state prescribes the nature, quality and percentage of various types of investments that may be made by the companies. Such laws generally permit investments in government bonds, corporate debt, preferred and common stock, real estate and mortgage loans, while limiting investment in other classes of investments.
A range of ALM strategies are used at the product-group level. For traditional general account insurance, the ALM strategy is to select high-quality investment assets that are matched to the corresponding liability. This strategy takes currency, yield and maturity characteristics into consideration. Asset quality and diversification are also taken into account, together with policyholders reasonable expectations with regard to the sharing of excess interest.
Transamerica also writes a significant volume of variable annuity business, which is managed using sophisticated dynamic hedging techniques. Clearly-defined hedge strategies cover first order delta and rho, together with higher order programs covering gamma and vega sensitivities. The Distributed Earning Macro Program is a largely option-based semi-static hedge that provides protection for distributable earnings against a sharp fall in equity markets.
Aegon USA also uses various liquidity management techniques, including a contingent liquidity management facility, to ensure sufficient access to funding for collateral calls in the event of rapidly rising interest rates. Regular stress testing is used to monitor and manage liquidity risk.
Europe
The Netherlands
Aegon the Netherlands uses fixed income instruments to match its long-term liabilities. These include high-quality sovereign and corporate bonds, together with a sizeable portfolio of Dutch residential mortgages. Cash flow matching is used to manage the asset portfolio, and a derivative-based dynamic hedge program in addition to the cash flow matching. The hedge program is rebalanced on a daily basis in order to both offset embedded guarantee sensitivities, and protect against volatility in best estimate economic cost of these guarantees.
Derivatives are central to Aegons hedging strategy, and the derivatives market has been subject to a large number of changes in recent years. These include the introduction of the EMIR in Europe. Furthermore, counterparty risks associated with derivative contracts are mitigated by collateral, and the introduction of central clearing has increased collateral requirements and reduced counterparty risk over recent years.
Annual Report on Form 20-F 2017 |
90 | Business overview Asset-Liability Management | |
United Kingdom
Having disposed of the majority of its annuity portfolio, the primary role of ALM at Aegon UK is to protect Solvency II own funds. This is achieved by using options and equity and interest rate swaps to guard against fluctuations in best estimate liabilities. Programs are also in place to match assets with the liabilities of the remaining annuity book and the staff pension scheme.
The UK with-profits business is written in the policyholder-owned fund (otherwise called the with-profits fund). The funds with the highest guaranteed rates have been closed to premiums since 1999, and all funds have been closed to new business with investment guarantees since October 2002 (except for a small increase in regular payments). The fund contains free assets that have not yet been fully distributed to individual policyholders. Free assets help meet the cost of guarantees and provide a buffer to protect the fund from the impact of adverse events. The free assets are partly invested in equity put options and interest rate swaps and swaptions. Aegon UK has an exposure only once these assets have been exhausted. The risk of exposure has been assessed by Aegon UK as remote, based on applying
the risk-based capital approach required for Solvency II reporting in the UK. As the fund is closed for new business, the free assets are gradually being distributed to the with-profit policyholders through the applicable bonus system.
Central & Eastern Europe
Aegon has a range of ALM programs in place across life and non-life businesses in the Central & Eastern Europe region. Across the CEE units, ALM focuses on asset-liability matching in terms of duration and liquidity.
Spain & Portugal
Aegon has a range of ALM programs in place in Spain & Portugal across life and non-life businesses. In Spain & Portugal, insurance liabilities are predominately long-term life benefits, and the focus of ALM is to minimize interest rate risk by duration matching.
Asia
SARe uses a sophisticated dynamic hedge program to manage guarantee risk included in variable annuity products associated with equity markets and interest rates.
Annual Report on Form 20-F 2017 |
91 | Business overview Reinsurance ceded | |
Aegon uses reinsurance to manage and diversify risk, limit volatility, improve capital positions, limit maximum losses, and sometimes to enter into strategic partnerships and gain access to reinsurer technology. While the objectives and use can vary by region due to local market considerations and product offerings, the use is coordinated and monitored globally.
In order to minimize its exposure to reinsurer defaults, Aegon regularly monitors the creditworthiness of its reinsurers, and where appropriate, arranges additional protection through letters of credit, trust agreements and overcollateralization. For certain agreements, funds are withheld for investment rather than relying on the reinsurer to meet investment expectations. Default exposure is further reduced by the use of multiple reinsurers within certain reinsurance agreements. Aegon has experienced no material reinsurance recoverability problems in recent years.
External reinsurance counterparties are in general major global reinsurers (approximately 60% of reinsurance premium) with more local reinsurers ensuring a balance between regional and global considerations. The key way in which reinsurance is used and the role that it plays by region is as follows:
Corporate Center and Blue Square Re
Global coordination takes place through Aegon Corporate Center working closely with local business units. Regular calls are conducted with reinsurance partners to manage relationships. The Global Reinsurance Use Committee (GRUC) is a global body that shares and discusses updates and matters of interest among local and global reinsurance managers. The GRUC also oversees Aegons Reinsurance Use Policy and facilitates approval of transactions if counterparties are not pre-approved. Reports are shared with the Global Risk and Capital Committee and Group Management Board as appropriate.
Blue Square Re is a global reinsurer 100% owned by Aegon N.V. that specializes in internal reinsurance and related consideration, and offers product and underwriting expertise to Aegon units and partners. In accepting risks from Aegon units, Blue Square Re may at times retrocede risk to external reinsurers, thereby realizing economies of scale and diversification.
Americas
Aegon Americas manages its life insurance exposure through various types of agreements with reinsurers. It relies heavily on quota-share and excess-of-loss reinsurance arrangements. The primary purpose of these agreements is to diversify Aegon Americas overall risk and limit the maximum loss on risks that exceed policy retention levels. Maximum retention levels vary by product, method of underwriting, and the nature of the risk being reinsured.
Europe
The Netherlands
Aegon the Netherlands reinsures part of its insurance exposure with third-party reinsurers under traditional indemnity and excess of loss contracts. Reinsurance helps Aegon manage, mitigate and diversify its insurance risks, and thereby limit the maximum loss it may incur. Since January 1, 2014, Aegon the Netherlands has reinsured its term life assurance through a quota-sharing contract. For non-life, Aegon the Netherlands only reinsures its property, general and motor third-party liability business. For property insurance, motor third-party liability insurance, and general third-party liability, excess of loss contracts are in place.
United Kingdom
Aegon UK uses reinsurance to both manage risk and maximize financial value through returns achieved and efficient capital management. The degree to which reinsurance is used across the product lines varies, depending largely on the appropriateness and value of reinsurance available in the market. The protection business is significantly reinsured. A reinsurance panel is in place to provide reinsurance, predominantly on a quota share basis, across the range of benefits. A facultative reinsurance panel is also used to assist the placement of very large cases.
Central & Eastern Europe
Aegon CEE uses reinsurance for its life and non-life businesses in order to mitigate insurance risk. The majority of treaties in force for Aegons operations in Central & Eastern Europe are non-proportional excess of loss programs except for the life reinsurance treaties which are made on a surplus and quota-share basis (including various riders). The most significant reinsurance programs currently in force are property catastrophe excess of loss treaty and excess of loss treaties for other risks.
Spain & Portugal
Aegon Spain has a one Aegon reinsurance management policy. This means that both its joint ventures in Spain & Portugal and own business are treated as a whole, with similar economic conditions and a similar panel of reinsurers, while individual profit shares without losses are carried forward by each entity belonging to Aegon Spain. The main contract for mortality and morbidity provides proportional reinsurance protection for both its individual risk and group risk policies. Aegon Spain thereby seeks to optimize the cost of reinsurance coverage, including through profit sharing, while achieving prudential diversification of its insurance risk by limiting the maximum possible losses on risks that exceed retention levels. Household insurance contracts for the Aegon Santander joint ventures follow the same principles, with maximum retention levels varying both by product and by the nature of the risk being reinsured. Natural catastrophe reinsurance programs are also in place to provide cover for high impact low frequency events.
Annual Report on Form 20-F 2017 |
92 | Business overview Reinsurance ceded | |
Asia
China: Aegon THTF
Aegon THTF shares its morbidity and mortality risk with international and national reinsurers. The mortality risk of individual products is shared through a surplus reinsurance structure. Aegon THTF reviews the reinsurance structure regularly, adjusting it based on claims experience and its risk acceptance capability.
India: Aegon Life
Reinsurance arrangements are regulated by the Insurance Regulatory and Development Authority of India. Aegon Life reinsures the mortality and morbidity risks of the policies it sells.
Japan: Aegon Sony Life and SARe
Aegon Sony Life reinsures 100% of its guarantees on variable annuities with SARe. In addition, Aegon Sony Life maintains a Surplus Relief reinsurance contract on a local statutory basis only. Surplus Relief provides relief from acquisition cost recovery risk.
Hong Kong and Singapore: Transamerica Life Bermuda (TLB)
TLB uses third-party mortality reinsurance for its universal life and traditional policies. Mortality reinsurance takes the form of yearly-renewable term, excess-of-retention or quota-share arrangements. This is typically arranged through a pool of reinsurers. In October 2016, TLB entered into a reinsurance treaty to provide further protection for the local solvency position in Singapore.
Asia: Aegon Insights
Aegon Insights traditional business model primarily creates value by reinsurance of the third-party carrier partner through an Aegon risk carrier, whereby risk-based premium is acquired for the Group. Aegon Insights acts as an independent marketing services provider. This enables it to form partnerships with local insurers, particularly in locations in which Aegon does not have a local presence.
Annual Report on Form 20-F 2017 |
93 | Business overview Risk management | |
General
As an insurance group, Aegon manages risk for the benefit of its customers and other stakeholders. As a result, the Company is exposed to a range of underwriting, operational and financial risks. Aegons risk management and internal control systems are designed to ensure that these risks are managed effectively and efficiently in a way that is aligned with the Companys strategy.
For Aegon, risk management involves:
◆ | Understanding risks that the Company faces; |
◆ | Maintaining a company-wide framework through which the risk-return trade-off associated with these risks can be assessed; |
◆ | Maintaining risk tolerances and supporting policies to limit exposure to a particular risk or combination of risks; and |
◆ | Monitoring risk exposures and actively maintaining oversight of the Companys overall risk and solvency positions. |
By setting certain predefined tolerances and adhering to policies that limit the overall risk to which the Company is exposed, Aegon is able to accept risk with the knowledge of potential returns and losses.
Enterprise Risk Management (ERM) framework
Aegons ERM framework is designed and applied to identify and manage potential risks that may affect Aegon. This means identifying and managing individual and aggregate risks within Aegons risk tolerance in order to provide reasonable assurance regarding the achievement of Aegons objectives. The ERM framework is designed in line with the Committee of Sponsoring Organizations of the Treadway Commission (COSO) model. The ERM framework applies to all of Aegons businesses for which it has operational control. Aegons businesses are required to either adopt the Group level ERM framework directly, or tailor it to local needs while meeting the requirements of the Group level ERM framework.
Risk strategy and risk tolerance
The formulation of the risk strategy starts with the principle that taking a risk should be based on serving a customers need. In terms of Aegons purpose statement, risk taking should be instrumental to helping people achieve a lifetime of financial security. The competence with which Aegon is able to manage the risk is assessed and Aegons risk preferences are formulated, taking into account Aegons risk capacity. The risk preferences eventually lead to a targeted risk profile that reflects the risks Aegon wants to keep on the balance sheet, and the risks Aegon would like to avoid. Aegons tolerance for risk is established in order to assist management in carrying out Aegons strategy using the resources available to Aegon Group. Aegon has defined four areas where risk tolerance plays an important role:
◆ | Financial strength: ensure Aegon meets long-term obligations to policyholders, thereby enabling Aegon to compete in key markets as a financially strong global insurer; |
◆ | Continuity: ensure that Aegon remains solvent and liquid even under adverse scenarios; |
◆ | Culture: encourage strong risk awareness by stressing the Companys low tolerance for operational risk. This helps to improve operational excellence and ensures that the Company is fair in its treatment of customers and other stakeholders; and |
◆ | Risk balance: manage the concentration of risk and encourage risk diversification within Aegon. |
Risk identification and risk assessment
Aegon has identified a risk universe that captures all known material risks to which the Company is exposed. An Emerging Risk process is in place to ensure on-going appropriateness of both the risk universe and the risk management framework. In order to assess all risks, a consistent methodology for measuring risks is required. Aegons methodology for this is documented in a manual and maintained up-to-date. The risk metrics are embedded in Aegons key reports and are used for decision making.
Risk response
Aegon distinguishes the following risk responses:
◆ | When the risk exposure is within the set risk tolerance, management can accept the risk; and |
◆ | When an exposure exceeds the risk tolerance of management or if cost-benefit analysis supports further actions, management can decide to control, transfer or avoid the risk. |
Risk monitoring and reporting
Risks are monitored regularly and reported on at least a quarterly basis. The impact of key financial, underwriting and operational risk drivers on earnings and capital is shown in the quarterly risk dashboard for the various risk types both separately as well as on an aggregate basis.
Risk exposures are compared with the limits as defined by Aegons risk tolerance statements. Reporting also includes risk policy compliance and incident and compliance reporting. Finally, the main risks derived from Aegons strategy and the day-to-day business are discussed, as well as forward looking points for attention. If necessary, mitigating actions are taken and documented.
Risk control
A system of effective controls is required to mitigate the risks identified. In Aegons ERM framework risk control includes risk governance, risk policies, internal control framework, model validation, risk embedding, risk culture and compliance.
Risk universe and risk appetite
The risk factors described in this Annual Report (see risk factors in the additional information section) generally have an impact on financial markets (e.g. interest rates and share prices),
Annual Report on Form 20-F 2017 |
94 | Business overview Risk management | |
underwriting assumptions (e.g. longevity and policyholder behavior) or result in operational risk events (e.g. fraud and business disruption). Aegons risk universe is structured to reflect the type of risk events to which the Company is exposed. The identified risk categories are financial risk, underwriting risk and operational risk. Specific risk types are identified within these risk
categories. The risk universe captures all known material risks to which Aegon is exposed. These risks, internal or external, may affect the Companys operations, earnings, share price, value of its investments, or the sale of certain products and services. In the context of Aegons risk strategy, a risk appetite is set for the three identified risk categories (see table below).
Risk category |
Description | Appetite | ||
Underwriting |
The risk of incurring losses when actual experience deviates from Aegons best estimate assumptions on mortality, longevity, morbidity, policyholder behavior, P&C claims and expenses used to price products and establish technical provisions. | Medium to high Underwriting risk is Aegons core business and meets customer needs. | ||
Financial |
The risk of incurring financial losses due to movements in financial markets and the market value of balance sheet items. Elements of financial risk are credit risk, investment risk, interest rate risk and currency risk. | Low to medium Accepted where it meets customer needs and the risk return profile is acceptable. | ||
Operational |
Operational risk results from operational failures or external events, such as processing errors, legal and compliance issues, natural or man-made disasters, and cybercrime. | Low Accepted to serve customer needs, but mitigated as much as possible. |
Most significant risks
The most significant risks Aegon faces are changes in:
◆ | Financial markets (particularly related to income credit, equity and interest rates), and |
◆ | Underwriting risk (particularly related to longevity and policyholder behavior). |
Description of risk types
Credit risk
Credit risk is the risk of economic loss due to the deterioration in the financial condition of counterparties, either through fair value losses on traded securities or through defaults on traded securities, loans and mortgages. Having a well-diversified investment portfolio means that Aegon can accept credit spread risk to earn a liquidity premium on assets that match liabilities. The focus is on high quality securities with low expected defaults because Aegon has a low appetite for default risk.
Equity market risk and other investment risks
Aegon runs the risk that the market value of its investments changes. Investment risk affects Aegons direct investments in the general account, indirect investments on the account of policyholders and agreements where Aegon relies on counterparties, such as reinsurance and derivative counterparties. Aegon has a low preference for investments in equity securities via the general account. Equity investments generate an equity risk premium over the long run, but in combination with a high capital charge result in a relatively low return on capital. Aegon has experience and expertise in managing complex investment guarantees, and leverages this capability by providing customers access to a range of investment strategies and guaranteed benefits.
Interest rate risk
Aegon is exposed to interest rates as both its assets and liabilities are sensitive to movements in long- and short-term
interest rates, as well as to changes in the volatility of interest rates. Aegon accepts interest rate risk in order to meet customer needs. However, as no spread is earned on this interest rate risk, Aegon prefers to mitigate the risk to the extent possible.
Currency exchange rate risk
As an international company, Aegon is exposed to different currencies, and therefore to movements in currency exchange rates. Foreign currency exposure exists primarily when policies are denominated in currencies other than the issuers functional currency. Currency risk in the investment portfolios backing insurance and investment liabilities is managed using asset liability matching principles. Assets allocated to equity are held in local currencies to the extent shareholders equity is required to satisfy regulatory and self-imposed capital requirements. Currency exchange rate fluctuations therefore affect the level of shareholders equity as a result of converting local currencies into euro, the Groups reporting currency. The Company holds its capital base in various currencies in amounts that correspond to the book value of individual business units.
Liquidity risk
Aegon needs to maintain sufficient liquidity to meet short term cash demands not only under normal conditions, but also in the event of a crisis. To that end, Aegon has put a strong liquidity management strategy in place. The Company considers extreme liquidity stress scenarios, including the possibility of prolonged frozen capital markets, an immediate and permanent rise in interest rates, and policyholders withdrawing liabilities at the earliest conceivable date. In addition, the Company has liquidity stress planning in place.
Underwriting risk
Underwriting risk relates to the products sold by Aegons insurance entities, and represents the risk of incurring losses when actual experience deviates from Aegons best
Annual Report on Form 20-F 2017 |
95 | Business overview Risk management | |
estimate assumptions on mortality, morbidity, policyholder behavior, P&C claims and expenses. Aegon has a preference to selectively grow underwriting risk, but this must work hand-in-hand with a strong underwriting process. Aegons earnings depend, to a significant degree, on the extent to which claims experience is consistent with assumptions used to price products and establish technical liabilities. Changes in, among other things, morbidity, mortality, longevity trends and policyholder behavior may have a considerable impact on the Companys income. Assumptions used to price products and establish technical liabilities are reviewed on a regular basis. Please refer to note 3 Critical accounting estimates and judgment in applying accounting policies to the consolidated financial statement for further information.
Operational risk
Like other companies, Aegon faces operational risk resulting from operational failures or external events, such as processing errors, inaccuracies in used models, acts from personnel, non-compliance to laws and regulations, and natural or man-made disasters. In addition, major programs or organizational transformations may also increase potential for operational risks. Aegons systems and processes are designed to support complex products and transactions, and to avoid such issues as system failures, business disruption, financial crime and breaches of information security. Aegon monitors and analyses these risks on a regular basis, and where necessary revises contingency plans to deal with them.
Cyber risk
Cyber security has been recognized by Aegon as an important operational risk. Aegons digital security controls and cyber threat management program, as defined within the Companys global information security program, therefore play an important role in reducing risk by establishing security controls that safeguard data, technology and operations, as well as activities outsourced to third parties. Aegon prioritizes its commitment of significant resources to protect and continually strengthen its existing security control environment and preventative tooling to minimize impact and exposure as new cyber threats and exposures emerge. Comprehensive evaluations and scenario testing of security controls - including detection and response capabilities - are frequently performed by both internal and external experts, and resulting vulnerabilities require risk-based action plans that are reported, tracked and monitored by management. This program is overseen by Aegons Global Chief Information Security Officer, who has a direct reporting line to the Global Chief Technology Officer, who is a member of the Management Board. Moreover, regular updates are provided to Aegons Supervisory Board. Aegon takes cybercrime very seriously, and wherever applicable applies available safeguards to assure investors and customers that data, technology and operations are adequately protected.
Conduct Risk
Both industry-wide and within Aegon, cultural and behavioral elements of risks increasingly play a role within overall risk
frameworks. Relevant in this context are, among others, the European Insurance Distribution Directive (IDD) and the General Data Protection Regulation (GDPR). Conduct risk refers to the risks inherent in behaviors, business and staff integrity and business culture, including, but not limited to, meeting the standards of Aegons Market Conduct Principles. In 2017, Aegon created and updated several policies with a specific focus on conduct risks (e.g. update of the Pricing and Product Development Policy), and continued to strengthen the Group-wide oversight of conduct risks, including the piloting of a broader set of conduct risk tests to support the Aegon Market Conduct Principles.
Risk governance framework
Aegons risk management is based on clear, well-defined risk governance. The goals of risk governance are to:
◆ | Define roles and responsibilities, and risk reporting procedures for decision makers; |
◆ | Institute a proper system of checks and balances; |
◆ | Provide a consistent framework for managing risk in line with the targeted risk profile; and |
◆ | Facilitate risk diversification. |
Governance structure
Aegons risk management framework is represented across all levels of the organization. This ensures a coherent and integrated approach to risk management throughout the Company. Similarly, Aegon has a comprehensive range of company-wide risk policies that detail specific operating guidelines and limits. These policies include legal, regulatory and internally set requirements, and are designed to keep overall risk-specific exposures to a manageable level. Any breach of policy limits or warning levels triggers immediate remedial action or heightened monitoring. Further risk policies may be developed at a local level to cover situations specific to particular regions or business units.
Aegons risk management governance structure has four basic layers:
◆ | The Supervisory Board and the Supervisory Board Risk Committee (SBRC); |
◆ | The Executive Board and the Management Board; |
◆ | The Group Risk & Capital Committee (GRCC) and its sub-committees; and |
◆ | The Regional Risk & Capital Committees. |
The SBRC reports to the Supervisory Board on topics related to the ERM framework and the internal control system. The formal responsibility regarding the effectiveness and design, operation and appropriateness of the ERM and internal control system rests, however, with the Audit Committee of the Supervisory Board. The Audit Committee works closely together with the SBRC with regard to the oversight of and reports on the effectiveness of the ERM framework and the risk control systems of the Company. The Audit Committee relies on the findings of the SBRC. The SBRC is responsible for overseeing Aegons ERM framework, including risk governance and measures taken
Annual Report on Form 20-F 2017 |
96 | Business overview Risk management | |
to ensure risk management is properly integrated into the Companys broader strategy. The main roles and responsibilities of the SBRC are to assist and advice the Supervisory Board and the Audit Committee of the Supervisory Board in fulfilling their oversight responsibilities regarding the effective operation and appropriateness of the ERM framework and internal controls system of Aegon N.V., and its subsidiaries and affiliates that comprise the Aegon Group. These include:
◆ | Risk strategy, risk tolerance and risk governance; |
◆ | Product development and pricing; |
◆ | Risk assessment; |
◆ | Risk responses and internal control effectiveness; |
◆ | Risk monitoring; |
◆ | Risk reporting; |
◆ | Operational Risk; and |
◆ | Transformation Risks. |
Furthermore, the SBRC regularly reviews risk exposures relating to capital, earnings and compliance with Group Risk policies. It is the responsibility of the Executive Board and the Groups Chief Risk Officer (CRO) to inform the Supervisory Board of any risk that directly threatens the solvency, liquidity or operations of the Company.
Aegons Executive Board has overall responsibility for risk management. The Executive Board adopts the risk strategy, risk governance, risk tolerance and material changes in risk methodology and risk policies. The Groups CRO has a standing invitation to attend Executive Board meetings and a direct reporting line to the Supervisory Board to discuss ERM and related matters, and is a member of the Management Board.
The Management Board oversees a broad range of strategic and operational issues. While the Executive Board remains Aegons statutory executive body, the Management Board provides vital support and expertise in safeguarding Aegons strategic goals. The Management Board discusses and sponsors ERM, in particular the risk strategy, risk governance, risk tolerance and the introduction of new risk policies.
The Executive Board and Management Board are supported by the GRCC. The GRCC is Aegons most senior risk committee. It is responsible for managing Aegons balance sheet at the global level, and is in charge of risk oversight, risk monitoring and risk management related decisions on behalf of the Executive Board in line with its charter. The GRCC ensures risk-taking is within Aegons risk tolerances; that the capital position is adequate to support financial strength, credit rating objectives and regulatory requirements, and that capital is properly allocated. The GRCC informs the Executive Board about any identified (near) breaches of overall tolerance levels, as well as any potential threats to the Companys solvency, liquidity or operations.
The GRCC has three sub-committees: the ERM framework, Accounting and Actuarial Committee (ERMAAC), the Non-
Financial Risk Committee (NFRC) and the Model Validation Committee (MVC).
The purpose of the ERMAAC is to assist the GRCC, Executive Board and Management Board with framework setting and maintenance across all group-level balance sheet bases, including policies, standards, guidelines, methodologies and assumptions.
The ERMAAC can seek advice on significant framework development from temporary working groups comprised of subject-matter experts from across the Companys businesses. These working groups are established by the ERMAAC, including their membership, scope of work and deliverables.
The NFRC exchanges information on non-financial risk matters and prepares decision making for the GRCC or relevant Board, in line with applicable governance requirements. The NFRC receives and reviews the regular reports from the regions on non-financial risk exposure, including issues related to regulatory compliance and conduct.
The MVC is responsible for approving all model validation reports across Aegon. This is an independent committee that reports into the GRCC and Executive Board to provide information on model integrity and recommendations for further strengthening of models.
Each of Aegons regions has a Risk & Capital Committee (RCC). The responsibilities and prerogatives of the RCCs are aligned with the GRCC and further set out in their respective charters, which are tailored to local circumstances.
In addition to the four basic layers described above, Aegon has an established group-wide risk function. It is the mission of the Risk Management function to ensure the continuity of the Company through safeguarding the value of existing business, protecting Aegons balance sheet and reputation, and through supporting the creation of sustainable value for all stakeholders.
In general, the objective of the Risk Management function is to support the Executive Board, Management Board, Supervisory Board, and regional and business unit boards in ensuring that the Company reviews, assesses, understands and manages its risk profile. Through oversight, the Risk Management function ensures the group-wide risk profile is managed in line with Aegons risk tolerances, and stakeholder expectations are managed under both normal business conditions and adverse conditions caused by unforeseen negative events.
The following roles are important in order to realize the objective of the Risk Management function:
◆ | Advising on risk-related matters including risk tolerance, risk governance, risk methodology and risk policies; |
◆ | Supporting and facilitating the development, incorporation, maintenance and embedding of the ERM framework and sound practices; and |
Annual Report on Form 20-F 2017 |
97 | Business overview Risk management | |
◆ | Monitoring and challenging the implementation and effectiveness of ERM practices. |
In the context of these roles, the following responsibilities can be distinguished:
Advising on risk-related matters
◆ | Bringing businesses together to facilitate information exchange, sharing best practices and working together on relevant case studies and external standards in order to develop, adopt and maintain relevant standards of practice throughout Aegon; and |
◆ | Optimizing the use of capital and growth within risk/return and consumer conduct criteria. |
Supporting and facilitating
◆ | Developing and maintaining the global ERM framework for identifying, measuring and managing all material risks the Company is exposed to as defined in Aegons risk universe and protecting Aegons reputation; |
◆ | Developing and maintaining Aegons risk methodology as described in the Aegon Market Consistent Reporting Manual (AMCRM); |
◆ | Supporting the businesses with implementing the ERM framework, risk methodology and standards of practice where needed; |
◆ | Supporting the Management Board in ensuring the effective operation of the ERM framework and related processes, providing subject matter expertise to businesses as appropriate and facilitating information exchange on good risk practices; |
◆ | Identifying and analyzing emerging risks, being input for ongoing risk strategy development and to ensure that Aegons risk universe remains up to date; |
◆ | Designing the Solvency II PIM, including the validation thereof. Model validation ensures independent review of methodology, assumptions, data, testing, production, reporting and use of the Solvency II PIM; |
◆ | Analyzing Solvency II PIM outputs and performance and reporting results to the Boards and relevant (Supervisory) Committees; |
◆ | Providing subject matter expertise from the Centers of Excellence of the global Risk Management function to business areas through review of key initiatives, transactions, programs, projects, assumptions, methodologies and results across all important paradigms; |
◆ | Providing assurance on the integrity of models and cash flows through model validations and maintenance of model validation policies and standards; and |
◆ | Promoting a strong risk management culture across Aegon, including review of performance targets and remuneration in line with the Aegon Group Global Remuneration Framework. |
Challenging and monitoring
◆ | Monitoring the ERM framework and overseeing compliance with group-wide risk governance requirements, risk strategy and risk tolerances, risk policies and risk methodology, which are applicable to all businesses for which Aegon has operational control; |
◆ | Ensuring appropriate risk management information is prepared for use by the GRCC, the Management Board, the Executive Board and Supervisory Board; |
◆ | Overseeing material risk, balance sheet and business decisions taken throughout Aegon in line with established risk governance arrangements; |
◆ | Monitoring and reporting on risk exposures and advising the Boards and (Supervisory) Committees on risk management related matters, including in relation to strategic affairs such as corporate strategy, mergers and acquisitions and major projects and investments; |
◆ | Monitoring that the internal model is and remains appropriate to the Companys risk profile and informing the Management Board and the Supervisory Board about the on-going performance, suggesting improvements; |
◆ | Monitoring risk exposures and risk policy compliance, including review of the Own Risk and Solvency Assessment (ORSA) and Recovery Plan defined triggers and early warning indicators; |
◆ | Acting as independent business partner with focus on talent development, control excellence, customer conduct, capital allocation and by providing management focused risk tools or fostering debates and proactively challenging on key business developments that may create significant exposure for example through hedging and investment remits; |
◆ | Providing subject matter expertise and overseeing critical business initiatives to strengthen risk management activities, to improve the risk profile and to resolve risk events and control issues noted; |
◆ | Embedding robust oversight and risk management culture and processes; and |
◆ | Protecting group capital for all stakeholders. |
Aegons Group and business units risk management staff structure is fully integrated. Business unit CROs have either a direct reporting line to the Group CRO or one of the regional CROs that reports directly to the Group CRO.
Internal control system
Aegon has developed an internal control system that serves to facilitate its compliance with applicable laws, regulations and administrative processes, and the effectiveness and efficiency of operations with regard to its objectives, in addition to the availability and reliability of financial and non-financial information. The overall internal control system ensures appropriate control activities for key processes and the documentation and reporting of administrative and accounting information. The internal control system is embedded through policies and frameworks such as the ERM framework, the Model Validation Framework and the Operational and Conduct Risk Management (OCRM) Framework, and is considered wider than
Annual Report on Form 20-F 2017 |
98 | Business overview Risk management | |
the Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO, 2013), on which criteria for the internal control system is based.
The internal control system was developed in accordance with regulations that Aegon must comply with (i.e. Sarbanes-Oxley Act and Solvency II). Aegons control activities should assure an adequate level of internal control over Aegons objectives and in particular compliance, operational and financial reporting objectives including the production of Solvency II and IFRS numbers. The objective is to provide assurance regarding the reliability, accuracy, completeness, timeliness and quality of internal and external (regulatory) reporting, the safeguarding of assets, and compliance with internal and external requirements. A key element of Aegons internal control system is to facilitate action planning and embed continuous improvement regarding the internal control environment throughout the organization.
In 2017, risk management and internal control topics were discussed by the relevant management committees and bodies, including the Management Board, the Executive Board, the Risk Committee and the Audit Committee of the Supervisory Board, and the Supervisory Board, according to their roles and responsibilities as outlined in the respective frameworks and charters. No material weaknesses was observed, and no significant changes or major improvements were made or planned to the risk management and internal control systems following from material weaknesses.
Lines of defense
Aegons risk management structure is organized along three lines of defense to ensure conscious risk-return decisions, and to limit the magnitude of potential losses within defined levels of certainty. The objective of this structure is to avoid surprises due to the materialization of unidentified risks, or from losses that exceed predefined risk tolerance levels and related limit structures.
The Companys three lines of defense are its business and support functions, the risk management department, and the audit function. The Companys first line of defense, the business and support functions, has direct responsibility for managing and taking risk in accordance with defined risk strategy, risk tolerances and risk policies. The second line of defense - which includes the risk management department, including the operational and conduct risk management function - facilitates and oversees the effectiveness and integrity of ERM across the Company. The third line of defense - the audit function - provides independent assurance opinions on the effectiveness of the internal control, risk management and governance systems.
Risk management in 2017
Solvency II is used to both measure and aggregate risk, and to calculate Aegons Solvency Capital Requirement. Solvency II metrics are embedded in Aegons key reports and used for risk management purposes. In 2017, Aegon published its first Solvency and Financial Condition Reports (SFCRs). These were prepared in accordance with the requirements of the Solvency II Directive and Delegated Regulation and relevant European Insurance and Occupational Pensions Authority (EIOPA) Guidelines. These reports cover the year ended December 31, 2016, and inform Aegons stakeholders about Aegons business and performance, system of governance, risk profile, valuation for solvency purposes, and capital management. SFCRs were published within the Aegon Group by Aegon N.V. and by various life, non-life and reinsurance companies established within the EU.
In 2017, a number of management actions were taken, particularly with regard to strengthening the solvency position of the Dutch insurance entities. These actions included Group support through a capital injection, portfolio optimization and risk profile improvements. The latter included de-risking the General Account and hedging. Furthermore, the Capital Management Policy was updated, with an enhanced focus on protecting capital generation. The target capitalization zone was lifted and widened in order to further strengthen the Companys ability to absorb market volatility.
Annual Report on Form 20-F 2017 |
99 | Business overview Capital and liquidity management | |
Capital and liquidity management
Guiding principles
The management of capital and liquidity is of vital importance for the Aegon Group, for its customers, investors in Aegon securities and for Aegons other stakeholders. In line with its risk tolerance, the goal of Aegons capital and liquidity management is to promote strong and stable capital adequacy levels for its businesses, in addition to maintaining adequate liquidity to ensure that the Company is able to meet its obligations.
Aegon follows a number of guiding principles in terms of capital and liquidity management:
◆ | Promoting strong capital adequacy in Aegons businesses and operating units; |
◆ | Managing and allocating capital efficiently in support of the strategy and in line with its risk tolerance; |
◆ | Maintaining an efficient capital structure, with an emphasis on optimizing Aegons cost of capital; |
◆ | Maintaining adequate liquidity in the operating units and at the holding to ensure that the Company is able to meet its obligations by enforcing stringent liquidity risk policies; and |
◆ | Maintaining continued access to international capital markets on competitive terms. |
Aegon believes that the combination of these guiding principles strengthen the Companys ability to withstand adverse market conditions, enhances its financial flexibility, and serves both the short-term and the long-term interests of the Company, its customers and other stakeholders.
The management and monitoring of capital and liquidity is firmly embedded in Aegons ERM framework, and is in line with Aegons risk tolerance. Aegons risk tolerance focuses on financial strength, continuity, steering the risk balance and the desired risk culture. Its core aim is to assist management in carrying out Aegons strategy within the Groups capital and liquidity resources.
Management of capital
The Companys overall capital management strategy is based on adequate solvency capital, capital quality and the use of leverage.
Capital adequacy
Aegons goal for both its operating units and for the Aegon Group as a whole is to maintain a strong financial position and to be able to sustain losses resulting from adverse business and market conditions. The capitalization of Aegon and its operating units is managed in accordance with the most stringent of local regulatory requirements, rating agency requirements and self-imposed criteria.
Regulatory capital requirements
For EU-domiciled insurance and reinsurance entities, the Solvency II regulatory framework determines the regulatory capital requirements. In Aegons Non-EEA (European Economic Arena) regions, (re)insurance entities domiciled in third-countries deemed (provisionally) equivalent (US Life insurance entities, Bermuda, Japan, Mexico and Brazil), the capital requirement is based on local capital requirements.
Please note that numbers and ratios related to Solvency II as disclosed in this section represent Aegons estimates and are subject to supervisory review. After discussions with the DNB, Aegon resolved a number of outstanding methodological matters with respect to its partial internal model in 2017. Following agreement on the interpretation of the DNBs guidance on the loss absorbing capacity of deferred taxes (LAC-DT), Aegon has applied a LAC-DT factor in the Netherlands of 75% as of December 31, 2017. The LAC-DT factor will be recalibrated on a quarterly basis using the agreed methodology. The Solvency II capital ratios of the Group and Aegon the Netherlands do not include any contingent liability potentially arising from unit-linked products sold, issued or advised on by Aegon in the Netherlands in the past, as the potential liability cannot be reliably quantified at this point.
Adequate capitalization
To calculate its Group Solvency Ratio, Aegon applies a combination of the Group consolidation methods available under Solvency II which are the Accounting Consolidation (AC) and Deduction & Aggregation (D&A) based methods. Solvency II capital requirements are mainly used for the EEA-based insurance and reinsurance entities, applying the Accounting Consolidation method. Local requirements are used for insurance and reinsurance entities in (provisionally) equivalent third-country jurisdictions. On August 8, 2017, Aegon received a confirmation from the Dutch Central Bank (DNB) to apply a revised method in calculating the Solvency II contribution of the Aegon US Insurance entities under Deduction & Aggregation (D&A), affecting Aegons tiering of capital, retrospectively as of the second quarter of 2017. It includes lowering the conversion factor from 250% to 150% Risk-Based Capital Company Action Level and reducing own funds by a 100% RBC Company Action Level requirement to reflect transferability restrictions. The methodology is subject to annual review. Under the new methodology, a 100% RBC CAL haircut is applied to own funds by decreasing Americas regulated entities deferred tax assets and subsequently reducing Tier 1 unrestricted capital. The allocation of restricted Tier 1 and Tier 2 capital instruments is based on the share of AC and D&A entities in the total available own funds (OF), instead of the total Solvency Capital Requirement (SCR) under the previous methodology. This methodology is consistent with EIOPAs guidance on group solvency calculation in the context of equivalence, and in line with methods applied by other
Annual Report on Form 20-F 2017 |
100 | Business overview Capital and liquidity management | |
European peer companies. As a consequence, this adjustment improves the comparability to capital positions of European insurance groups with substantial insurance activities in the US. The impact on Available Own Funds in 2016 is included in the table in the Capital quality section below. Aegon will manage its available capital on the new basis. Aegon Bank is excluded
from the Group Solvency ratio, as required by the Group Solvency II supervisor, the DNB.
As at December 31, 2017, Aegons estimated capital position was:
December 31, 2017 1), 3), 4), 5), 6) | December 31, 2016 2), 4), 5) | December 31, 2016 4), 5), 7) | ||||||
Group own funds |
15,628 | 15,957 | 18,119 | |||||
Group SCR |
7,774 | 9,401 | 11,563 | |||||
Group Solvency II ratio |
201% | 170% | 157% |
1 | The Group Own Funds information is based on the revised method which was confirmed by the DNB on August 8, 2017. Based on the old method, the December 31, 2017 Group Solvency II ratio is equal to 182% |
2 | The numbers are based on the revised method which was confirmed by the DNB on August 8, 2017. Presented for comparative purposes. |
3 | The Solvency II ratios are estimates and subject to supervisory review. |
4 | The Solvency II ratios are based on Aegons partial internal model |
5 | Aegon Bank is not included in the Group Solvency II ratio. |
6 | Group Solvency II ratio at December 31, 2017 does not reflect impact of NAIC tax factor changes following the US tax reform. At this point it is unclear when the NAIC will update the tax factors used in the RBC calculation. |
7 | The 2016 comparative numbers are the final numbers as disclosed in Aegons 2016 Solvency and Financial Condition Report. |
Aegon Group OF amounted to EUR 15,628 million on December 31, 2017 (2016: EUR 18,119 million). The decrease of EUR 2,491 million in OF since December 31, 2016, is mostly driven by the change in the treatment of the US insurance entities within Solvency II. This methodology change reduced the Group OF by EUR 2,162 million. Aside from this methodology change, during 2017, normalized capital generation by Aegons operating units was more than offset by the impact of the weakening of the US dollar against the euro, final dividend for 2016 and interim dividend for 2017 to shareholders and offsetting impacts from market movements, the divestment of the US run-off business, the acquisition of Cofunds and the impact of the US tax reform.
Aegon Group Partial Internal Model (PIM) SCR amounted to EUR 7,774 million on December 31, 2017 (2016: EUR 11,563 million). The SCR decreased by EUR 2,162 million as a result of a change in the treatment of US insurance entities within Solvency II. Aside from this, the SCR was reduced by EUR 1,627 million driven by a weakening of the US dollar against the euro, the implementation of approved major model
changes to Aegons PIM, positive market movements and management actions, including the divestment of the majority of the US run-off business, the divestment of the vast majority of UK annuity book and the divestment of UMG and separate account derisking in Aegon the Netherlands.
The Group Solvency II ratio improved by 44% to 201% in 2017. The transition to the new conversion methodology for the US under Solvency II had an impact of 13%. The solvency ratio increased by another 31% as a result of normalized capital generation, the implementation of approved major model changes to Aegons PIM and management actions including the divestment of the majority of the US run-off businesses, the divestment of the UK annuity book, and the divestment of UMG and separate account derisking in Aegon the Netherlands. The increase in solvency ratio was partly offset by the impact of the external dividend and the US tax reform.
The capitalization levels of the most relevant country units are as follows:
Capitalization December 31, 2017 1), 2) | Capitalization December 31, 2016 2), 3) | |||
Aegon USA (Life entities) (RBC CAL) |
472% | 440% | ||
Aegon the Netherlands (Solvency II ratio) |
199% | 134% | ||
Aegon United Kingdom (Solvency II ratio) |
176% | 156% |
1 | The Solvency II ratios are estimates, are not final until filed with the regulator and are subject to supervisory review. |
2 | Refer to section Internal capital management framework for Aegons capitalization target ranges. |
3 | The 2016 comparative numbers are the final numbers as disclosed in Aegons 2016 Solvency and Financial Condition Report. |
Aegon Americas
In the United States, regulation of the insurance business is principally undertaken at the state level. State insurance regulators and the National Association of Insurance Commissioners have adopted RBC requirements for insurance companies. RBC calculations measure the ratio of a companys statutory capital, which is measured on a prudent regulatory accounting basis, to a minimum capital amount determined by the risk-based capital formula. The RBC formula measures exposures to investment risk, insurance risk, market
risk, and general business risk. The formula, as used for calculating the solvency ratio, applies a covariance diversification offset to determine the appropriate Risk-Based Capital. Life reinsurance is treated as life insurance. The most pertinent RBC measure is the CAL risk-based capital requirement. This is the regulatory intervention level at which a company has to submit a plan to its state regulators. The domiciliary state regulator has the authority to require additional capital depending on the type, volume and nature of the business being conducted.
Annual Report on Form 20-F 2017 |
101 | Business overview Capital and liquidity management | |
The domiciliary state regulator also has the ability to require corrective actions if a company is deemed by the commissioner to pose a Hazardous Financial Condition. The CAL is set at 200% of the Authorized Control Level (ACL), the level at which regulators are permitted to seize control of the Company. At the end of 2017, the combined risk-based capital ratio of Aegons life insurance subsidiaries in the United States was estimated to be 472% of the CAL risk-based capital requirement. As of January
1, 2016, under the Solvency II requirements, the activities of Aegon Americas life insurance and reinsurance companies have been consolidated into the Aegon Group Solvency II figures through Deduction & Aggregation using available and required capital as per the local capital regimes. US insurance and reinsurance entities are included in Aegons group solvency calculation in accordance with local US (RBC) requirements of the top regulated entity. Aegon uses 150% of the local RBC Company Action Level as the SCR equivalent for including the US life insurance and reinsurance entities into the Group solvency calculation. The non-regulated US entities and the US holding companies are included in the Aegon Group Solvency II results through application of the Accounting Consolidation method under Solvency II, using Solvency II valuation and capital requirement calculations for these entities. The contribution of the Aegon Americas entities to the Group Solvency II position on December 31, 2017, is estimated to be 199% (2016: 163%). This ratio includes the US Life insurance and reinsurance entities as well as non-regulated US entities and US holding companies. The Americas ratio does not include a diversification benefit between the US life companies and there is no diversification benefit between US and other group entities.
Aegon the Netherlands
Aegon the Netherlands uses a PIM to calculate the solvency position of its insurance activities under Solvency II. The calculation includes the use of the volatility adjustment, but does not include the use of any transitional measures. The initial internal model of Aegon the Netherlands was approved on November 26, 2015, by the supervisor, the DNB, as part of the Internal Model Application Process. The combined Solvency
II position of the activities of Aegon the Netherlands, including Aegon Bank 18 , on December 31, 2017, is estimated to be 199% (2016: 134%). This increase mainly reflects a capital injection from Aegon Group of EUR 1 billion, the sale of UMG, positive market impacts, and model adjustments approved by the DNB, which mainly related to adjusting the calculation of spread risk. These benefits were partly offset by higher capital requirements from an ongoing program of increasing the share of illiquid investments on the balance sheet of Aegon the Netherlands. The solvency position of the banking activities are calculated using the CRR/CRD IV framework. As at December 31, 2017, the factor of LAC DT is set at 75%, unchanged from 2016. The Solvency II capital ratio of the Group and Aegon the Netherlands does not include any contingent liability potentially arising from unit-linked products sold, issued or advised on by Aegon in the Netherlands in the past, as the potential liability cannot be reliably quantified at this point.
Aegon UK
Aegon UK uses a PIM to calculate the solvency position of its insurance activities under Solvency II. The calculation includes the use of both the matching adjustment and volatility adjustment (for the with-profits fund). The initial internal model of Aegon UK was approved on December 14, 2015, by the PRA as part of the Internal Model Application Process. The combined Solvency II position of the activities of Aegon in the UK on December 31, 2017, is estimated to be 176% (2016: 156%). This increase mainly reflects positive market impacts, the divestment of the vast majority of the annuity book, and model adjustments approved by the PRA, which related to operational and currency risk being included in the internal model,
Sensitivities
Aegon calculates sensitivities of its Solvency II ratios as part of its risk management framework. The following table provides an overview of the shocks to parameters used to assess the sensitivities, and their estimated impact on the Solvency II ratio as at December 31, 2017:
Scenario | Group | US | NL | UK | ||||||||||||||||||||||||||||||||
December
31, 2017 |
December 31, 2016 |
December
31, 2017 |
December
31, 2016 |
December
31, 2017 |
December
31, 2016 |
December
31, 2017 |
December
31, 2016 |
|||||||||||||||||||||||||||||
Equity markets |
+20% | +10% | (1% | ) | +17% | (2% | ) | +5% | +2% | (10% | ) | 0% | ||||||||||||||||||||||||
Equity markets |
(20% | ) | (5% | ) | (6% | ) | (10% | ) | (7% | ) | (5% | ) | (4% | ) | +12% | 0% | ||||||||||||||||||||
Interest rates |
+100 bps | +12% | +2% | +12% | (6% | ) | +8% | +11% | +12% | +16% | ||||||||||||||||||||||||||
Interest rates |
-100 bps | (16% | ) | (18% | ) | (21% | ) | (12% | ) | (11% | ) | (15% | ) | (16% | ) | (20% | ) | |||||||||||||||||||
Credit spreads 1) |
+100 bps | (2% | ) | +2% | 0% | 0% | (2% | ) | +6% | +13% | +17% | |||||||||||||||||||||||||
US credit defaults 2) |
~+200 bps | (23% | ) | (17% | ) | (53% | ) | (22% | ) | - | - | - | - | |||||||||||||||||||||||
Ultimate Forward Rate |
-50 bps | (4% | ) | (4% | ) | - | - | (12% | ) | (13% | ) | - | - | |||||||||||||||||||||||
Longevity shock |
+5% | (10% | ) | (7% | ) | (9% | ) | (2% | ) | (12% | ) | (13% | ) | (3% | ) | (4% | ) | |||||||||||||||||||
NL loss absorbency of taxes factor |
-25%pts | (6% | ) | (3% | ) | - | - | (11% | ) | (8% | ) | - | - |
1 | Non-government bonds credit spreads. |
2 | Additional defaults for 1 year including rating migration of structured products. |
Annual Report on Form 20-F 2017 |
102 | Business overview Capital and liquidity management | |
Aegon is mainly exposed to movements in equity, interest rates, credit spreads and defaults/migrations, and longevity. The Group is exposed to losses in the downward equity scenario, which is driven by Aegon Americas and Aegon the Netherlands. This is partially offset by hedging gains in Aegon UK. In the US, the sensitivity to equities rising changed due an updated hedging strategy. The Group and its main operating units entities are exposed to a decrease in interest rates. The sensitivity towards lower interest rates is mainly caused by higher SCRs in NL and UK, and lower OF in the US due to additional reserves. Aegon the Netherlands and Aegon UK move in opposite directions with the widening of credit spreads. Aegon the Netherlands sees an
increase in SCR that drives the decrease in solvency ratio for the Group. This is partially offset by Aegon UK, where
liabilities reduce driven by the IAS 19 discount rate. In the US, the credit defaults reduce OF, decreasing the solvency position. Lower mortality rates (longevity) increase the longevity exposed liabilities. The higher liability values decrease OF in US and NL, as longevity is only partially hedged, and increase the SCR.
Rating agency ratings
Aegons objective is to maintain a very strong financial strength rating in its main operating units, and this plays an important role in determining the Companys overall capital management strategy. Aegon maintains strong financial strength ratings from leading international rating agencies for its main operating units, and a strong credit rating for Aegon N.V..
Agency | ||||||||||||||||
December 31, 2017 | Aegon N.V. | Aegon USA |
Aegon the
Netherlands |
Aegon UK | ||||||||||||
S&P Global |
||||||||||||||||
Financial strength |
- | AA- | AA- | A+ | ||||||||||||
Long-term issuer |
A- | - | - | - | ||||||||||||
Senior debt |
A- | - | - | - | ||||||||||||
Subordinated debt |
BBB | - | - | - | ||||||||||||
Commercial paper |
A-2 | - | - | - | ||||||||||||
Moodys Investors Service |
||||||||||||||||
Financial strength |
- | A1 | - | - | ||||||||||||
Long-term issuer |
A3 | - | - | - | ||||||||||||
Senior debt |
A3 | - | - | - | ||||||||||||
Subordinated debt |
Baa1 | - | - | - | ||||||||||||
Commercial paper |
P-2 | - | - | - | ||||||||||||
Fitch Ratings |
||||||||||||||||
Financial strength |
- | A+ | - | A+ | ||||||||||||
Long-term issuer |
A- | - | - | - | ||||||||||||
Senior debt |
BBB+ | - | - | - | ||||||||||||
Subordinated debt |
BBB- | - | - | - | ||||||||||||
Commercial paper |
F2 | - | - | - | ||||||||||||
A.M. Best |
||||||||||||||||
Financial strength |
- | A+ | - | - |
Internal capital management framework
In managing the capital adequacy of the Group and its operating units, Aegons capital management framework is built on, among other things, managing capitalizations towards target
capital management zones. Under Aegons capital management framework, the most relevant target capitalization zones are as follows:
Capitalization target range 1 | ||
Aegon Group |
150% - 200% Solvency II Capital Ratio | |
Aegon USA (Life entities) |
350% - 450% RBC Company Action Level | |
Aegon the Netherlands |
150% - 190% Solvency II Capital Ratio | |
Aegon United Kingdom |
145% - 185% Solvency II Capital Ratio |
1 | Capitalization target ranges follow the revised capital management policy as of 2Q 2017 |
The frequent monitoring of actual and forecast capitalization levels of both the Aegon Group and of its underlying businesses is an important element in Aegons capital framework in order to actively steer and manage towards maintaining adequate capitalization levels. Aegons capital framework is based
on several capital management zones in which escalating management actions are called for in a timely manner to ensure that there is always adequate capitalization of both the Aegon Group and its operating units.
Annual Report on Form 20-F 2017 |
103 | Business overview Capital and liquidity management | |
The capital management zones and the management interventions connected to these zones are set consistently throughout the Group, as illustrated in the table below. In 2017, Aegon upwardly adjusted the capital management zones of the Netherlands and the UK, and also as a result those of Aegon
Group. The higher capital buffers resulting from this upward adjustment enables these units to better absorb market volatility, thereby improving the robustness of capital generation and dividend payments.
Aegon Group |
Capitalization
management zones 1 |
US Life entities | The Netherlands | United Kingdom |
Capitalization management actions |
|||||
>200% SCR |
Opportunity | >450% RBC | >190% SCR | >185% SCR | Accelerate capital redeployment and/or additional dividends. | |||||
150% - 200% SCR |
Target | 350% - 450% RBC | 150% - 190% SCR | 145% - 185% SCR | Execute capital deployment and remittances according to capital plan. | |||||
120% - 150% SCR |
Retention | 300% - 350% RBC | 130% - 150% SCR | 130% - 145% SCR | Re-assess capital plan and risk positions. | |||||
100% - 120% SCR |
Recovery | 100% - 300% RBC | 100% - 130% SCR | 100% - 130% SCR | Re-assess capital plan and risk positions. Reduce or suspend remittances. | |||||
<100% SCR |
Regulatory plan | <100% RBC | <100% SCR | <100% SCR | Suspension of dividends. Regulatory plan required. |
1 | Capitalization management zones follow the revised capital management policy as of the second quarter of 2017. |
Minimum solvency requirements
Insurance laws and regulations in local regulatory jurisdictions often contain minimum regulatory capital requirements. For insurance companies in the European Union, Solvency II formally defines a lower capital requirement: the Minimum Capital Requirement (MCR). An irreparable breach of the MCR would lead to a withdrawal of the insurance license. Similarly, for the US insurance entities, the withdrawal of the insurance license is triggered by a breach of the 100% Authorized Control Level (ACL), which is set at 50% of the CAL.
With the introduction of Solvency II for EEA countries, Aegon views these minimum regulatory capital requirements as the level at which regulators will formally require management to provide regulatory recovery plans. For the US insurance entities this is set at 100% CAL, and for insurance companies in the European Union this is set at 100% SCR.
The minimum regulatory capital requirements, as viewed by Aegon, for its main operating units and the capitalization levels as at December 31, 2017, are included in the following table:
Capital requirements | Minimum capital requirement | Actual capitalization |
Excess over minimum capital requirement |
|||
Aegon USA (Life entities) 1), 3) |
100% Company Action Level (NAIC RBC CAL) | 472% of combined CAL | ~EUR 7.8 bln | |||
Aegon the Netherlands 2), 3) |
100% Solvency II SCR | 199% Solvency II SCR | ~EUR 3.2 bln | |||
Aegon United Kingdom 3) |
100% Solvency II SCR | 176% Solvency II SCR | ~EUR 1.1 bln |
1 | Capitalization for the United States represents the internally defined combined Risk-Based Capital (RBC) ratio of Aegons life insurance subsidiaries in the United States. The combined RBC ratio utilizes the NAIC RBC ratio excluding affiliated notes and taking into account excess or deficient amounts related to offshore life affiliates. |
2 | Including Aegon Bank. |
3 | Please note, this reflects Aegons estimated Capitalization levels. |
The capitalization level and shareholders equity of the operating units can be impacted by various factors (e.g. general economic conditions, capital markets risks, underwriting risk factors, changes in government regulations, legal and arbitrational proceedings). To mitigate the impact of such factors on the ability of operating units to transfer funds, the operating units hold additional capital in excess of the levels of the minimum regulatory solvency requirements.
In practice and for upstreaming purposes Aegon manages the capitalization of its operating units towards the capitalization
target ranges as identified in Aegons capital framework. These ranges are both in excess of the minimum regulatory requirements contained in the applicable regulations, and in excess of the minimum requirements stated in the table above.
Improving risk-return profile
Aegon continues to take measures to improve its risk-return profile. These measures include de-emphasizing the selling of various spread based products and the strategic growth in fee-based businesses. In 2016, Aegon divested its annuity business in the UK, and reinvested part of the proceeds for
Annual Report on Form 20-F 2017 |
104 | Business overview Capital and liquidity management | |
the acquisition of Cofunds and BlackRocks DC business in the UK. In 2017, Aegon continued its commitment to optimize its portfolio by divesting UMG in the Netherlands and completing the sale of the majority of its US run-off businesses. Aegon also announced the divestment of its business in Ireland, which is expected to be completed in the first half of 2018.
Extensive asset-liability management and hedging programs are also in place. Examples of these programs include hedging the interest rate and equity risk stemming from guarantees in the Netherlands, hedging of interest rate risk and equity risk in Aegon UK, and hedging the capital position in the Americas against adverse equity and interest rate movements. In addition, Aegon is actively involved in hedging longevity risk in the Netherlands and has an active global reinsurance program in order to optimize the risk-return profile of other insurance risks. Aegon strictly monitors the risk-return profile of new business written, withdrawing products that do not meet the required hurdle rates for all stakeholders including the policyholders and shareholders.
G-SII designation and International Capital Standards
For more information about Aegons G-SII designation, its consequences and the status of development of the International Capital Standards, see page 110.
Capital quality
Capital quality is a reflection of Aegons stability and ability to absorb future financial losses.
Solvency II distinguishes between basic own funds and ancillary own funds. Aegons total own funds are comprised of Tier 1, Tier 2 and Tier 3 basic own funds. Aegon does not currently have ancillary own funds. Tier 1 basic own funds are divided into unrestricted Tier 1 items and restricted Tier 1 items. The latter category contains own fund items subject to the restrictions of article 82 (3) of the Solvency II Delegated Regulation, which includes grandfathered Tier 1 own fund items. Based on agreements with its supervisory authorities, Aegon applies a fungibilty and transferability restriction with respect to charitable trusts within Aegon Americas, and a restriction equal to the own funds of Aegon Bank. These restrictions, applied to Aegons basic own funds, result in Aegons available own funds.
Aegon updated the method to calculate the Solvency II contribution of the Aegon US insurance and reinsurance entities under D&A, to the Group. This methodology is consistent with the European Insurance and Occupational Pensions Authoritys (EIOPA) guidance on group solvency calculation with regards to equivalence and in line wth methods applied by other European peer compnaies. Furthermore, Aegon applied a revised method to allocate centrally issued subordinated debt between the AC and D&A parts of the Group. The allocation of Aegon Groups 2016 subordinate debt was based on the Solvency II PIM SCR, but has been changed to an available own funds basis. In addition to increasing Aegon Groups Solvency II ratio, the new methodology also had a positive effect on capital quality, mainly by reducing the share of Tier 3 own funds, and increasing the share of unrestricted Tier 1 own funds.
Tier 1
|
Tier 2
|
Tier 3
|
||
Unrestricted Tier 1 |
∎ Dated or perpetual |
∎ Dated or perpetual |
||
∎ Equity (Share capital and share premium). ∎ Reconciliation Reserve.
Restricted Tier 1 ∎ Perpetual subordinated capital instruments with loss absorption. |
∎ Subordinated capital instruments. ∎ With an original maturity of at least 10 years. ∎ Limited loss absorption. ∎ With suspension of payments and deferral of interest. |
∎ Subordinated capital instruments. ∎ With an original maturity of at least 5 years. ∎ Limited loss absorption. ∎ With suspension of payments and deferral of interest. ∎ Net deferred tax assets. |
||
Available own funds
Unrestricted Tier 1 capital consists of Aegons share capital, share premium and the reconciliation reserve. The reconciliation reserve includes deductions to account for foreseeable dividends that have been approved by the Board but that have yet to be distributed to Aegons shareholders, and restrictions related to Aegons with-profits fund in the UK for which the excess of own funds over its capital requirement is ringfenced for the policyholder, and therefore unavailable to Aegons shareholders.
Restricted Tier 1 capital consists of Aegons junior perpetual capital securities and perpetual cumulative subordinated bonds,
both of which are grandfathered. Tier 1 restricted capital is subject to tiering restrictions.
Aegons Tier 2 capital consists of its grandfathered dated subordinated notes, and deferred tax asset balances related to the inclusion of (provisional) equivalent regimes in Aegons Solvency II calculation. Both restricted Tier 1 and Tier 2 capital are subject to tiering restrictions.
The grandfathered restricted Tier 1 and Tier 2 capital instruments are grandfathered to count as capital under Solvency II for up to 10 years as of January 1, 2016. All call dates are listed in note 33
Annual Report on Form 20-F 2017 |
105 | Business overview Capital and liquidity management | |
Other equity instruments and note 34 Subordinated borrowings to Aegons consolidated financial statements.
Aegons Tier 3 capital under the Solvency II framework consists of Aegons deferred tax asset position under Solvency II.
Eligible own funds
Under Solvency II regulation, restrictions apply to the eligibility of Tier 2 and Tier 3 capital, as well as the eligibility of restricted Tier 1 capital. The total of Tier 2 and Tier 3 capital may not exceed 50% of the SCR while the eligibility of Tier 3 capital is limited to 15% of SCR. Restricted Tier 1 capital may not exceed 20% of Tier 1 Own Funds. As a result, it is possible that part of the own funds overflows to another tier or that is not considered eligible in determining the Group Solvency ratio.
When applying the eligibility restrictions, Aegon determines its tiering limits based on:
◆ | EEA entities - representing the part of the Group covered by the Accounting Consolidation based method, for which tiering limits are based on the SCR of the consolidated part of the Group, i.e. the consolidated group SCR; and |
◆ | Non-EEA entities - representing the part of the Group covered by the Deduction & Aggregation method. If a prudential regime of an equivalent or provisionally equivalent third-country applies, such as the regulatory regimes in the United States, Aegon does not initially categorize these own funds into tiers or define tiers that are significantly different from those established under the Solvency II Directive. The own funds brought in by the Deduction & Aggregation method are then allocated to tiers according to the principles laid out in Articles 87 to 99 of the Solvency II Directive for each individual third-country insurance undertaking. |
The table below shows the composition of Aegons available and eligible own funds, taking into consideration tiering restrictions.
December 31, 2017 1) | December 31, 2016 1) | December 31, 2016 | ||||||||||||||||||||||
Available own funds |
Eligible own funds |
Available own funds |
Eligible own funds |
Available own funds |
Eligible own
funds |
|||||||||||||||||||
Unrestricted Tier 1 |
10,428 | 10,428 | 10,081 | 10,081 | 10,656 | 10,656 | ||||||||||||||||||
Restricted Tier 1 |
3,540 | 2,451 | 3,817 | 2,373 | 3,817 | 2,517 | ||||||||||||||||||
Tier 2 |
1,213 | 2,302 | 1,291 | 2,735 | 2,008 | 3,309 | ||||||||||||||||||
Tier 3 |
448 | 448 | 768 | 768 | 1,638 | 1,638 | ||||||||||||||||||
Total Tiers |
15,628 | 15,628 | 15,957 | 15,957 | 18,119 | 18,119 |
1 | The tiering information is based on the revised method which was confirmed by the DNB on August 8, 2017. |
As a result of applying the restrictions to the available own funds, there was an overflow from Tier 1 restricted own funds to Tier 2 in the eligible own funds as of December 31, 2017.
Aegons use of leverage
Aegon uses leverage in order to lower the cost of capital that supports businesses in the Aegon Group, thereby contributing to a more effective use of capital and realizing capital efficiencies. In managing the use of financial and non-financial leverage throughout the Group, Aegon has implemented a Leverage Use Framework that is part of Aegons broader Enterprise Risk Management framework.
Leverage metrics
In line with the guiding principles of its capital and liquidity management, Aegon N.V. monitors and manages several leverage metrics:
◆ | Gross financial leverage ratio; |
◆ | Fixed charge coverage; and |
◆ | Various rating agency leverage metrics. |
Aegons gross financial leverage ratio is calculated by dividing total financial leverage by total capitalization. Aegon defines total financial leverage as debt or debt-like funding issued for general corporate purposes and for capitalizing Aegons business
units. Total financial leverage includes hybrid instruments, subordinated and senior debt. Aegons total capitalization consists of the following components:
◆ | Shareholders equity, excluding revaluation reserves, cash flow hedge reserves, and the remeasurement of defined benefit plans, based on IFRS as adopted by the EU; |
◆ | Non-controlling interests and share options not yet exercised; and |
◆ | Total financial leverage. |
Aegons fixed charge coverage is a measure of the Companys ability to service its financial leverage. It is calculated as the sum of underlying earnings before tax and interest expenses on financial leverage divided by interest payments on financial leverage. The fixed charge coverage includes the impact of interest rate hedging.
For further information, please refer to note 46 Capital Management and Solvency to the consolidated financial statements.
Operational leverage
Although operational leverage is not considered part of Aegons total capitalization, it is an important source of liquidity and funding. Operational leverage relates primarily
Annual Report on Form 20-F 2017 |
106 | Business overview Capital and liquidity management | |
to financing Aegons mortgage portfolios through securitizations, warehouse facilities, covered bonds, and the funding of US Regulation XXX and Guideline AXXX redundant reserves.
Aegon enters into reinsurance agreements for risk and capital management purposes with several affiliated captive insurance companies (captives). All captives are fully consolidated for IFRS reporting and for Solvency II based on local valuations under equivalence.
The captives are utilized for a number of purposes that may include:
◆ | Financing term life insurance (subject to Regulation XXX reserves) and universal life insurance with secondary guarantees (subject to Regulation AXXX reserves) to support lower-risk statutory reserves at a lower cost for policyholders and shareholders; |
◆ | Managing variable annuity hedging programs; |
◆ | Managing and segregating risks; and |
◆ | Monetizing embedded value. |
All external financing provided to captives to support statutory reserves is disclosed in note 39 Borrowings to the consolidated financial statements to the extent to which it has been funded. Letters of Credit (LOCs) issued by third parties provided to captives to provide collateral to affiliated insurers are disclosed in note 48 Commitments and contingencies to the consolidated financial statements. These LOCs have been provided by third parties for the benefit of the affiliated company whose liabilities are reinsured.
Funding and back-up facilities
The majority of Aegons financial leverage is issued by Aegon N.V., the parent company. A limited number of other Aegon companies have also issued debt securities, but for the most part these securities are guaranteed by Aegon N.V.
Aegon N.V. has regular access to international capital markets under a USD 6 billion debt issuance program. Access to the capital market in the United States is made possible by a separate shelf registration.
Aegon also has access to domestic and international money markets through its EUR 2.5 billion commercial paper programs. As at December 31, 2017, Aegon had EUR 72 million outstanding under these programs (2016: EUR 128 million).
To support its commercial paper programs and need for LOCs, and to enhance its liquidity position, Aegon maintains backup credit and LOC facilities with international lenders. The Companys principal arrangements comprise a EUR 2 billion syndicated revolving credit facility and a LOC facility of USD 2.6 billion. On February 28, 2018, the company refinanced its syndicated revolving credit facility. The new facility matures in 2023. The LOC facility matures in 2021. In addition,
Aegon also maintains various shorter-dated bilateral backup liquidity facilities, and committed and uncommitted LOC facilities.
Liquidity management
Liquidity management is a fundamental building block of Aegons overall financial planning and capital allocation processes. The Companys liquidity risk policy sets guidelines for its operating companies and the holding in order to achieve a prudent liquidity profile and to meet cash demands under extreme conditions.
Liquidity is coordinated centrally and managed both at Aegon N.V. and at the operating unit level. Aegon maintains a liquidity policy that requires all business units to project and assess their sources and uses of liquidity over a two-year period under normal and severe business and market scenarios. This policy ensures that liquidity is measured and managed consistently across the Company, and that liquidity stress management plans are in place.
Sources and uses of liquidity
Liquidity in Aegons subsidiaries
Aegons operating units are primarily engaged in the life insurance and pensions business, which is a long-term activity with relatively illiquid liabilities and generally matching assets. Liquidity consists of liquid assets held in investment portfolios, in addition to inflows generated by premium payments and customer deposits. These are used primarily to purchase investments, as well as to fund benefit payments to policyholders, policy surrenders, operating expenses, and, if the subsidiarys capital position allows, to pay dividends to the holding.
After investments have been made in new business to generate organic growth, capital generated by Aegons operating units is available for distribution to the holding company, while maintaining a capital and liquidity position in the operating units in line with Aegons capital management and liquidity risk policies. In addition, the ability of Aegons insurance subsidiaries to transfer funds to the holding company is also constrained by the requirement for these subsidiaries to remain adequately capitalized at the levels set by local insurance regulations, and as administered by local insurance regulatory authorities.
Aegon N.V.
At the holding company Aegon N.V., liquidity is sourced from internal dividends from operating units and through the capital markets. The main sources and uses of liquidity at the holding company Aegon N.V. are dividends from operating units, movements in debt, net expenses (including interest), funding operations, capital returns to shareholders, and the balance of acquisitions and divestitures. In addition, contingent internal and external liquidity programs are maintained to provide additional safeguards against extreme unexpected liquidity stresses.
Annual Report on Form 20-F 2017 |
107 | Business overview Capital and liquidity management | |
Aegon uses cash flows from its operating units to pay for holding expenses, including funding costs. The remaining cash flow is available to execute the Companys strategy and to fund dividends on its shares. Aegon aims to pay out a sustainable dividend to enable equity investors to share in its performance.
When determining whether to declare or propose a dividend, Aegons Executive Board balances prudence with offering an attractive return to shareholders. This is particularly important during adverse economic and/or financial market conditions. Furthermore, Aegons operating subsidiaries are subject to local insurance regulations that could restrict dividends to be paid to the holding company. There is no requirement or assurance that Aegon will declare and pay any dividends.
Aegons holding excess cash
The ability of the holding company to meet its cash obligations depends on the amount of liquid assets on its balance sheet and on the ability of the operating units to pay dividends to the holding company. In order to ensure the holding companys ability to fulfil its cash obligations and maintain sufficient management flexibility to allocate capital and liquidity support for Aegons operating units and external dividend stability, it is the Companys policy that the holding excess cash position, including Aegons centrally managed (unregulated) holding companies, is managed to a target range of EUR 1.0 to 1.5 billion.
As at December 31, 2017, Aegon held a balance of EUR 1.4 billion in excess cash in the holding, compared with EUR 1.5 billion on December 31, 2016. The decrease of EUR 0.1 billion reflects the net impact of dividends from subsidiaries and capital injections in subsidiaries, divestments, acquisitions, the issuance of senior unsecured notes, holding expenses and capital returns to shareholders. During 2017, an injection of EUR 1 billion was made into Aegon the Netherlands to strengthen its capital position. This cash outflow was partly offset by dividends from Aegon Americas and Aegon UK. The EUR 1,359 million includes dividends from Aegon Americas regular capital upstream and capital releases as a result of the divestment of the pay-out annuity and BOLI/ COLI businesses. The EUR 167 million from Aegon UK was funded from the capital release related to the divestment of the annuity portfolio. The EUR 176 million from Asia was funded through capital efficiencies programs. The proceeds of the issuance of EUR 500 million senior unsecured notes at -16 basis points yield on August 30, 2017, offset the redemption of EUR 500 million 3% senior unsecured notes on July 18, 2017.
Aegons liquidity is invested in accordance with the Companys internal risk management policies. Aegon believes that its working capital, backed by its external funding programs and facilities, is ample for the Companys present requirements.
Annual Report on Form 20-F 2017 |
108 | Business overview Regulation and Supervision | |
Individual regulated Aegon companies are each subject to prudential supervision in their respective home countries. Insurance and banking companies, together with a number of the investment undertakings in the Group, are required to maintain a minimum solvency margin based on local requirements. In addition, some parts of the Group are subject to prudential requirements on a consolidated basis, including capital and reporting requirements. Such additional requirements lead, in certain circumstances, to duplicative requirements, such as the simultaneous application of consolidated banking requirements and Solvency II group solvency requirements. Eligible capital to cover solvency requirements includes shareholders equity, perpetual capital securities, and dated subordinated debt.
Solvency II
Introduction
The Solvency II framework imposes prudential requirements at group level as well as on the individual EU insurance and reinsurance companies in the Aegon Group. Insurance supervision is exercised by local supervisors on the individual insurance and reinsurance companies in the Aegon Group, and by the group supervisor at group level. The Dutch Central Bank (DNB) is Aegons Solvency II group supervisor. Solvency II, which came into effect in EU member states on January 1, 2016, introduced economic, risk-based capital requirements for insurance and reinsurance companies in all EU member states, as well as for groups with insurance and/or reinsurance activities in the EU. The Solvency II approach to prudential supervision can be described as a total balance sheet-approach, and takes material risks to which insurance companies are exposed into account in addition to the correlation between these risks.
The Solvency II framework is structured along three pillars. Pillar 1 comprises quantitative requirements (including technical provisions, valuation of assets and liabilities, solvency requirements and own fund requirements). Pillar 2 requirements include governance and risk management requirements, and requirements for effective supervision (the supervisory review process). Pillar 3 consists of disclosure and supervisory reporting requirements. These three pillars should not only be considered in isolation, but also in terms of how they interact with one another. More complex risks, for instance, require a stronger risk management and governance structure, and a more complex governance structure could lead to higher capital requirements.
In addition to these requirements, which apply to individual EU insurers and reinsurers, the Solvency II framework is complemented by requirements that apply at group level (group supervision). This means that a number of requirements from the Solvency II framework that apply to the individual EU insurance and reinsurance undertakings apply, with necessary modifications, at group level. The core focus of EU insurance supervision is, however, on the supervision of individual EU insurance and reinsurance undertakings.
Pillar 1
Solvency II requires EU insurance and reinsurance companies to determine technical provisions at a value that corresponds with the present exit value of their insurance and reinsurance obligations towards policyholders and other beneficiaries of insurance and reinsurance contracts. The calculation of the technical provisions should be based on market consistent information to the extent to which that information is available. The value of the technical provisions is equal to the sum of a best estimate and a risk margin. The discount rate at which technical provisions are calculated is an important element in order to determine the technical provisions. This and other parameters to determine the technical provisions may have an important effect on the amount and volatility of the own funds that insurance and reinsurance undertakings are required to maintain. The Solvency II framework contains several measures (in particular the volatility adjustment and matching adjustment) that should reduce volatility of the technical provisions and own funds, in particular for insurance and reinsurance products with long-term guarantees.
Insurers and reinsurers are required to hold eligible own funds in addition to the assets held to cover the technical provisions in order to ensure that they are able to meet their obligations over the next 12 months with a probability of at least 99.5% (insurance or reinsurance companys balance sheet ability to withstand a 1-in-200-year event). The buffer that insurance and reinsurance companies are required to hold is the Solvency Capital Requirement (SCR). Insurance and reinsurance companies are allowed to: (a) use a standard formula to calculate their SCR (the rules for which are set out in detail in the Solvency II rules and guidelines); (b) use an internal model (for which the approval of the supervisory authorities is required); or (c) use a partial internal model (PIM) (which is a combination of the standard formula and an internal model, and requires approval of the supervisory authorities). An internal model is developed by the insurance or reinsurance company in question, and should better reflect the actual risk profile of the insurance or reinsurance company than the standard formula. Aegon (as a group) uses a PIM.
In addition to the SCR, insurance and reinsurance companies should also calculate a Minimum Capital Requirement (MCR). This represents a lower level of financial security than the SCR, below which the level of eligible own funds held by the insurance or reinsurance company is not allowed to drop. An irreparable breach of the MCR would lead to the withdrawal of an insurance or reinsurance companys license.
Insurance and reinsurance companies are required to hold eligible own funds against the SCR and MCR. Own funds capital is divided into three tiers in accordance with the quality of the own funds. The lower tiers of own funds (tiers 2 and 3) represent a limited part of the eligible own funds, as excess lower tier capital
Annual Report on Form 20-F 2017 |
109 | Business overview Regulation and Supervision | |
is disregarded for purposes of calculating SCR. Furthermore, the SCR may consist of limited amounts of off-balance sheet own funds (ancillary own funds such as letters of credits or guarantees). The MCR must be covered entirely by on-balance sheet items (basic own funds).
Pillar 2
Under Pillar 2, insurance and reinsurance companies are required to set up and maintain an adequate and effective system of governance, which includes an appropriate internal organization (such as policies and procedures), a risk governance system and an effective assessment of the risk and solvency position of the Company (including a prospective assessment of risks), through the Own Risk and Solvency Assessment (ORSA) process. In general, Solvency II requires insurance and reinsurance companies to maintain an effective system of governance that is proportionate to the nature, scale and complexity of the insurance or reinsurance company. A number of risks that insurance or reinsurance companies face can only be addressed through proper governance structures, rather than quantitative requirements. Management of the insurance or reinsurance company is ultimately responsible for the maintenance of an effective governance system.
Insurance and reinsurance companies are required to have an adequate and transparent organizational structure, with a clear allocation and appropriate segregation of responsibilities. The system of governance should be subject to regular internal review. Solvency II requires insurance and reinsurance companies to have written policies in a number of areas (such as risk management, internal control, internal audit and outsourcing (where appropriate)). A number of key functions are required to be part of the system of governance (compliance, risk management, the actuarial function and internal audit). The persons responsible for these functions are required to be fit and proper.
The Pillar 2 requirements include specific requirements relating to the risk management system. This should cover at least the following areas: underwriting and reserving, asset-liability matching, investments (in particular derivatives and similar commitments), liquidity and concentration risk management, operational risk management, reinsurance and other risk mitigating techniques. Risk management relating to Solvency II is discussed in further detail in the section Risk management on page 93. As part of the risk management system, insurance and reinsurance undertakings are required to undertake an ORSA, which includes the overall solvency needs of the undertaking, taking into account the risk profile, risk tolerance limits and business strategy, the ongoing compliance with Solvency II capital requirements and rules regarding technical provisions, and the extent to which the risk profile of the undertaking deviates from the assumptions underlying the calculation of the SCR. Solvency II Pillar 2 requirements also include detailed requirements with respect to outsourcing, including intra group outsourcing.
The Supervisory Review Process (SRP), which is part of Pillar 2, allows supervisory authorities to supervise the ongoing compliance of insurance and reinsurance undertakings with Solvency II requirements. Possible enforcement measures include: the imposition of capital add-ons (for instance in the event that the risk profile of the undertaking deviates from the SCR calculation or if there are weaknesses in the system of governance); the requirement to submit and execute a recovery plan (in the event of a (potential) breach of the SCR or a short-term financing plan (in the event of a (threatening) breach of the MCR); and ultimately, the revocation of an insurance or reinsurance license (a measure that relates to EU-licensed insurance or reinsurance undertakings, and not to the Group as a whole, which does not have a license).
Pillar 3
Solvency II has introduced new and more detailed reporting and disclosure requirements than formerly prescribed under the Solvency I framework. These requirements include non-public supervisory reporting on a regular (usually tri-annual) basis through regular supervisory reports (RSR), complemented by detailed quantitative reporting templates (QRTs) reported on a quarterly basis, which contain detailed financial data. In addition, it is a requirement to publish a Solvency and Financial Condition Report (SFCR) on an annual basis.
Group supervision
Solvency II not only imposes regulatory requirements on individual EU insurance and reinsurance undertakings; many of the requirements that apply to the individual insurance and reinsurance undertakings apply, with the necessary modifications, at group level. These requirements include group solvency requirements, group reporting and disclosure requirements, and requirements regarding the system of governance, risk management and internal control framework at group level. The group requirements do not include an MCR. Solvency II does however require groups to maintain eligible own funds, at least equal to a floor, as further defined in the Solvency II rules (the absolute floor of the group solvency), which can be considered to be an MCR at group level. Although entities that are not subject to solo supervision under Solvency II (such as entities in other financial sectors, non-financial entities, and regulated and non-regulated entities in third countries) are not directly subject to Solvency II requirements, these entities may be affected indirectly by the Solvency II group requirements. Entities in other financial sectors are, in most cases, taken into account in the group solvency calculation, applying the capital requirements of that specific financial sector (such as Basel III requirements for banks and certain investment firms) and using the Deduction and Aggregation method for inclusion of these entities in the group calculation (as opposed to the Accounting Consolidation method, which is the default method under Solvency II). However, subject to certain conditions, entities in other financial sectors may be included in accordance with the accounting consolidation method. In particular, this may
Annual Report on Form 20-F 2017 |
110 | Business overview Regulation and Supervision | |
be the case when the group supervisor is satisfied as to the level of integrated management and internal control regarding these entities. Furthermore, the DNB may require groups to deduct any participation from the own funds eligible for the Group Solvency ratio. As required by the DNB, Aegon deducts its participation in Aegon Bank N.V. from Aegons group solvency.
However, Aegon Bank N.V. is subject to Basel III requirements (as implemented in Europe in the EU Capital Requirements Directive (CRD IV) and EU Capital Requirements Regulation (CRR) on a solo-basis and on consolidated basis, whereby consolidation takes place at the level of Aegon Bank N.V The prudential requirements (including CRD IV and CRR) are described in more detailed on page 61.
As referred to in the Capital and liquidity management section, Aegon uses a combination of the two aggregation methods defined within the Solvency II framework to calculate the Group Solvency ratio, the Accounting Consolidation method and the Deduction and Aggregation method. Aegon applies the Accounting Consolidation method as the default method. However, for insurance entities domiciled outside the EEA for which provisional or full equivalence applies, such as the United States, Aegon uses the Deduction and Aggregation method, with local regulatory requirements to translate these into the Group Solvency position. US insurance and reinsurance entities are included in Aegons group solvency calculation in accordance with local US (RBC) requirements. US insurance and reinsurance entities are included in Aegons group solvency calculation in accordance with local U.S. Risk-Based Capital (RBC) requirements. Until June 30, 2017, Aegon used 250% of the local Company Action Level (CAL) RBC as the SCR equivalent. Aegon received approval from the DNB to apply a revised methodology, as of July 1, 2017, that includes lowering the conversion factor from 250% to 150% RBC, and reducing the contribution to own funds by 100% of the local Company Action Level RBC requirement to reflect transferability restrictions. This methodology is subject to annual review, and the change enhances comparability with European peers. The RBC and CAL, as well as the allocation of restricted Tier 1 and Tier 2 capital instruments between the accounting consolidation and deduction and aggregation part of the Group are described in more detail in the Capital and Liquidity section of this Annual Report.
Solvency II group supervision is exercised by a combination of the supervisory authorities of the local insurance and reinsurance entities and the group supervisor. An important role in the cooperation between the supervisory authorities in the context of group supervision is played by the college of supervisors, in which the local and group supervisors are represented. This college is chaired by the group supervisor.
Financial conglomerate supervision
Since October 2009, Aegon has been subject to supplemental group supervision by the DNB in accordance with the requirements of the EUs Financial Conglomerate Directive.
Supplemental group supervision pursuant to the Financial Conglomerate Directive includes supplementary capital adequacy requirements for financial conglomerates and supplementary supervision on risk concentrations and intra-group transactions in the financial conglomerate. Due to the introduction of the Solvency II group supervisory requirements which include similar, and to a large extent overlapping, requirements to those covered by Financial Conglomerates Directive the relevance of supplemental group supervision pursuant to the Financial Conglomerates Directive has become significantly less.
Globally systemically important insurer (G-SII)
On November 3, 2015, Aegon was first designated by the Financial Stability Board (FSB) as a Global Systemically Important Insurer (G-SII), based on an assessment methodology developed by the International Association of Insurance Supervisors (IAIS). The FSB reviews the G-SII designation annually. However, the FSB, in consultation with the IAIS and national authorities, has decided not to publish a new list of G-SIIs for 2017 and that the measures will continue to apply to the G-SIIs that were on the 2016 list. Consequently, Aegon continues to be designated at the time of publication of this annual report.
As a result of the G-SII designation, Aegon is subject to an additional layer of direct supervision at group level. Aegon has put a specific G-SII governance structure in place to ensure the G-SII requirements are met. Within 12 months of a G-SII designation, G-SIIs were required to develop a liquidity risk management plan, a systemic risk management plan, and an ex ante recovery plan. In accordance with these requirements, Aegon submitted plans to DNB, and to the G-SII crisis management group (CMG) that was established for Aegon and is updating these plans on an annual basis. The CMG is required to: enter into a cross-border cooperation agreement; develop a resolution plan based on a resolution strategy (within 18 months); and undertake a resolvability assessment (within 24 months).
International Capital Standards (ICS)
In 2017, for financial year 2016, G-SIIs have calculated and reported a Basic Capital Requirement (BCR) and Higher Loss Absorbing Capacity (HLAC) on a confidential basis pursuant to IAIS guidelines. On November 2, 2017, the IAIS has announced its members have reached an agreement on a unified path to convergence on the development of International Capital Standards (ICS) for Internationally Active Insurance Groups (IAIGs). Aegon will qualify as such. After an extended field testing period of ICS version 1.0, that ended in 2017, the IAIS will proceed with the development of ICS version 2.0 informed by field tests in 2018 and 2019. The implementation of ICS version 2.0 will be conducted in two phases a five-year monitoring phase, where all IAIGs will submit mandatory reference ICS, followed by an implementation phase where the ICS is envisaged to become a required capital standard. Following the announcement by IAIS members from the United States of development of an aggregation-based group capital calculation, the IAIS has further agreed to collect data during the
Annual Report on Form 20-F 2017 |
111 | Business overview Regulation and Supervision | |
monitoring period to assess whether the aggregation approach can be considered as outcome-equivalent for implementation of ICS in the US.
US - EU Covered Agreement
On January 13, 2017, the European Commission and the US Department of the Treasury announced the signing of the US-EU Covered Agreement on insurance and reinsurance measures. The Covered Agreement covers three areas of prudential insurance oversight: reinsurance, group supervision
and exchange of information between supervisors. The impact of this agreement (or any changes made to the regulatory frameworks in the US or the EU as a result of this agreement) on Aegon is expected to be limited. Currently, insurance group supervision is only exercised at the level of Aegon N.V., pursuant to Solvency II, and the Covered Agreement increases the likelihood that this will continue to be the case. Also the impact of the agreed measures in the other areas covered in the agreement is expected to be limited.
Annual Report on Form 20-F 2017 |
112 | Governance Rep ort of the Supervisory Board | |
Report of the Supervisory Board
The Supervisory Board is entrusted with supervising and advising the Executive Board on management of the Company, and overseeing Aegons strategy and the general course of its businesses.
Oversight and advice
The Supervisory Board is a separate independent corporate body, consisting of nine members on December 31, 2017. The Supervisory Board is charged with the supervision of the Executive Board, of the general course of affairs and strategy of the Company, and of its businesses. In performing their duties, members of the Supervisory Board are guided by the interests of Aegon and the Companys stakeholders.
The duties of the Supervisory Board with regard to the activities of members of the Executive Board are published in the Supervisory Board Charter, which is published on Aegons corporate website, aegon.com. The Supervisory Board makes recommendations to the General Meeting of Shareholders concerning all appointments and reappointments to, and dismissals from, both the Executive Board and the Supervisory Board.
In addition, the Supervisory Board determines the remuneration of individual members of the Executive Board in line with the Remuneration Policy adopted at the Companys General Meeting of Shareholders. Overall accountability for Aegons remuneration governance also resides with the Supervisory Board, which is advised by its Remuneration Committee. This includes the responsibility for designing, approving and maintaining the Aegon Group Global Remuneration Framework, including the remuneration policies for the Executive Board, Identified Staff, and for staff in Control Functions.
Corporate governance
Details of Aegons corporate governance structure and a summary of how the Company complies with the Dutch Corporate Governance Code can be found on pages 131-135 of this Annual Report and in the Corporate Governance Statement published on aegon.com.
Composition of the Supervisory Board and
Executive Board
Supervisory Board
The composition of the Board is discussed regularly in Board meetings and in particular by the Nomination and Governance Committee. An overview of the composition of the Supervisory Board in 2017 can be found on pages 120-122. All members of the Supervisory Board are considered independent under the terms of best practice provisions 2.1.7, 2.1.8 and 2.1.9 of the Dutch Corporate Governance Code.
There were a number of changes to the Supervisory Board in 2017. Shemaya Levy stepped down as a member of the Board on May 19, 2017, after he reached the end of his third and final term. The Board benefitted greatly from Mr. Levys knowledge and contributions. On May 19, 2017, shareholders approved the reappointment of Dona Young to the Board for another term of four years. She has also taken over the role of Shemaya Levy as Chairman of the Risk Committee. In addition, the proposed Board members William Connelly and Mark Ellman were appointed as new members of the Supervisory Board at the Annual General Meeting of Shareholders on May 19, 2017.
On December 14, 2017, Aegon announced that Rob Routs, Chairman of the Supervisory Board, decided to step down, after 10 years of service, at the Annual General Meeting of Shareholders on May 18, 2018. The Supervisory Board elected William Connelly as its next Chairman following the Annual General Meeting.
On February 15, 2018, Aegon announced that Dirk Verbeek, member of the Supervisory Board, decided to step down after 10 years of service, at the General Meeting of Shareholders on May 18, 2018. The Supervisory Board is in the process of selecting new candidates for appointment and will propose any such candidate in due course for approval to the Companys shareholders.
In compliance with the Dutch Corporate Governance Code, members of the Supervisory Board are appointed by shareholders for a term of four years. From 2018 on, the option will exist to reappoint members for one additional four-year term. A Supervisory Board member can then subsequently be reappointed again for a period of two years, which reappointment may be extended by at most two years. For a reappointment after an eight-year period, reasons will be provided in the report of the Supervisory Board. The retirement schedule and other information about members of the Supervisory Board are available on aegon.com.
Executive Board
The Executive Board consists of Alexander R. Wynaendts, Chief Executive Officer (CEO) and Chairman of the Executive Board, and Matthew J. Rider, Chief Financial Officer (CFO). Matthew J. Rider joined Aegon in January 2017 and was formally appointed as member of the Executive Board during the Annual General Meeting of Shareholders on May 19, 2017.
Annual Report on Form 20-F 2017 |
113 | Governance Report of the Supervisory Board | |
Members of the Executive Board are appointed by shareholders for a term of four years, with the option of reappointment for additional four-year terms. The appointment schedule and other information about members of the Executive Board are available on aegon.com.
Board meetings
Attendance
In 2017, the Supervisory Board had seven regular (face-to-face) meetings: four related to the quarterly results; one to the annual report; and two to strategy (including the budget and Medium Term Plan). In addition, four conference calls took place, three
of which were updates in between the face-to-face meetings. Supervisory Board Committee meetings were usually held the day before the meetings of the full Supervisory Board. All regular board meetings were attended by all Board members, except for one Supervisory Board strategy meeting that Ben van der Veer was unable to attend. All committee meetings were attended by all committee members, except for one Risk Committee meeting that Dona Young and Bob Dineen were unable to attend, and the Audit Committee deep dive meeting in October which Bob Dineen was unable to attend. An overview of Supervisory Board members attendance by meeting is provided in the table below.
Name |
Regular SB
meeting |
SB conference
call |
Audit
Committee |
Risk
Committee |
Remunera-
tion Committee |
Nomination &
Governance Committee |
Combined Audit & Risk Committee |
|||||||||||||||||||||
Rob Routs |
7/7 | 4/4 | - | - | 6/6 | 6/6 | - | |||||||||||||||||||||
Bill Connelly 1) |
4/4 | 2/2 | 3/3 | - | 3/3 | - | 1/1 | |||||||||||||||||||||
Bob Dineen |
7/7 | 4/4 | 5/6 | 3/4 | - | - | 1/1 | |||||||||||||||||||||
Mark Ellman 1) |
4/4 | 2/2 | 3/3 | 2/2 | - | - | 1/1 | |||||||||||||||||||||
Shemaya Levy 1) |
3/3 | 2/2 | - | 2/2 | - | 3/3 | - | |||||||||||||||||||||
Ben Noteboom 1) |
7/7 | 4/4 | 3/3 | 2/2 | 6/6 | - | 1/1 | |||||||||||||||||||||
Ben van der Veer |
6/7 | 4/4 | 6/6 | - | - | 6/6 | 1/1 | |||||||||||||||||||||
Dirk Verbeek 1) |
7/7 | 4/4 | 3/3 | 4/4 | - | 6/6 | 1/1 | |||||||||||||||||||||
Corien Wortmann 1) |
7/7 | 4/4 | 3/3 | 2/2 | 3/3 | 3/3 | 1/1 | |||||||||||||||||||||
Dona Young |
7/7 | 4/4 | 6/6 | 3/4 | - | - | 1/1 |
1 | Where a Supervisory Board member retired from the Supervisory Board, stepped down from a Committee or was appointed throughout the year, only meetings during his / her tenure are taken into account. |
Members of the Executive Board and Management Board attended the Supervisory Board meetings held in 2017 when relevant with regard to the meeting agenda. At the request of the Supervisory Board, other Company executives also attended the meetings to provide reports and updates on specific topics. Representatives from Aegons external auditor PwC attended the March 2017 Supervisory Board meeting on Aegons Annual Report. PwC also attended all 2017 Audit Committee meetings except for the October deep dive meeting in the Netherlands focused on Aegon the Netherlands. Regular Board meetings were preceded or followed by meetings attended only by the members of the Supervisory Board and the CEO. Furthermore, the Supervisory Board held meetings without the presence of Executive Board or Management Board members.
Highlights and activities
Key topics discussed during the 2017 Supervisory Board meetings were Aegons quarterly results and (annual) reporting, Aegons strategy, the main business risks, IT, acquisitions and divestments and human resources items.
Quarterly results were discussed on the basis of feedback from the Audit Committee. The full-year results reported in the Annual Report were discussed in the March 2018 meeting in the presence of the external auditor PwC. At the Supervisory Board meeting in December 2017, the budget for 2018 was approved and the Medium Term Plan was discussed.
After approving the corporate strategy in December 2015, the Supervisory Board regularly discussed the long-term value creation strategy with the Executive Board and the Management Board, and closely monitored its execution, the risks involved in its execution, and any opportunities to further enhance the strategy where necessary. Plans and projects were discussed during executive sessions and in regular meetings, together with the strategic focus for all operating segments. Furthermore, digitization and the cultural transformation of the business were additional important strategic priorities that were discussed during the Supervisory Board meetings.
Acquisitions and divestments were discussed in the context of the execution of the strategy. The Supervisory Board supported the active management of the business portfolio with add-on acquisitions, the sale of underperforming businesses and the disposals of entities no longer consistent with Aegons strategy. While acquisitions and divestments of EUR 50 million or more require Supervisory Board approval, smaller add-ons and divestments were also discussed. During the year, the Board discussed various M&A transactions, including but not limited to the divestment of Aegon Ireland, the sale of the Unirobe Meeùs Groep in the Netherlands and the divestment of the two largest US run-off businesses, the payout annuity business, and the Bank Owned / Corporate Owned Life Insurance business.
Annual Report on Form 20-F 2017 |
114 | Governance Report of the Supervisory Board | |
In recognition of the importance of succession planning and talent management, the Board received updates from Aegons Global Head Human Resources on progress made towards achieving the objectives of Aegons talent agenda: continuing to attract new staff with a wide range of different skills and experience; identifying sufficiently qualified succession candidates; and strengthening the talent pipeline for future succession. The Board also received and discussed the results of the annual global employee survey.
In 2017, Supervisory Board discussions included the following topics:
◆ | Strategy, including Aegons long-term value creation, its responsible business strategy and business reviews; |
◆ | Acquisitions, divestments and the strategic direction of Aegons businesses, including the organizational transformation throughout the business, such as the strategic partnership to outsource administration of the majority of Transamericas insurance and annuity business. |
◆ | Executive Board and senior management succession planning; |
◆ | Executive remuneration, including the risks of the remuneration framework; |
◆ | Corporate Governance, including the Dutch Corporate Governance Code 2016 and how the Code is implemented within the Company; |
◆ | Composition of the Supervisory Board, including the Boards effectiveness; |
◆ | Human resources, including talent development, results of the global employee survey, cultural change and the risks of cultural behavior within the Company; |
◆ | Annual and quarterly results, dividends and the Companys Medium Term Plan, including the 2018 budget, capital and funding plan; |
◆ | Capital generation and Solvency II capital position, including regulatory capital reports and the capital position of Aegon the Netherlands; |
◆ | Enterprise risk management, cybersecurity and information security risks, and the risks related to the execution of the strategy within the Company; |
◆ | Investor relations, including shareholder listing, market analysis and roadshow feedback; |
◆ | Legal, regulatory and compliance issues, including Aegons engagement with regulators and the governance of global functions within Aegon; |
◆ | Hghlighted topics by Supervisory Board Committees; |
◆ | Tax policy and tax developments; and |
◆ | Technology, including the technology strategy and technological developments, and how they can be used to enhance customer centricity. |
Results and budget
In February 2017, the Supervisory Board convened to discuss the fourth quarter 2016 results. In March 2017, the Supervisory Board reviewed and adopted Aegons 2016 Annual Report, the Consolidated Financial Statements of Aegon N.V., the Financial Statements of Aegon N.V., and the Annual Review of 2016.
In May, August and November, the Supervisory Board reviewed Aegons first, second and third quarter 2017 results respectively.
In December 2017, the Supervisory Board and Management Board reviewed the Companys Medium Term Plan, including the budget and capital plan for 2018. The Boards took note of the uncertainties and challenges in the coming years as described in the Plan. These included, among others: increased regulatory requirements, low interest rates, market volatility, digital developments, and the changing distribution landscape. The Board discussed Aegons free cash flow and capital projections, together with the continued focus on cost efficiency. The Plan provides for a continuation of investments in digital capabilities to increase customer connectivity. The Supervisory Board supported the Plan and approved the budget for 2018. The Board also approved the 2018 funding plan and authorized the Executive Board to execute on the funding plan in 2018.
Legal, compliance and regulatory affairs
In 2017, the Supervisory Board and the Audit Committee discussed a number of compliance, regulatory and legal topics relating to the Americas, Europe, Asia, and Asset Management with management, the General Counsel, the Global Head of Regulatory Compliance, and the Global Head of Operational and Conduct Risk Management. In particular, the Board discussed the consequences and actions resulting from being designated as a Global Systematically Important Insurer (G-SII) and the possible settlement in connection with a previously disclosed investigation by the US Securities and Exchange Commission (SEC). An overview of the topics discussed in the field of Risk Management can be found in the Audit Committee and Risk Committee sections below. The new members of the Supervisory Board and Executive Board took the Dutch financial sector oath.
The Supervisory Board also discussed the new Dutch Corporate Governance Code 2016 and the analysis on how the Company was impacted by the new Code and what was needed to comply with the new Code. The Supervisory Board approved an amended Executive Board Charter, Supervisory Board Charter and Supervisory Board Committee Charters to reflect the clauses of the new Dutch Corporate Code 2016.
The Chairmen of the Supervisory Board, Audit Committee and Risk Committee visited the group supervisor (Dutch Central Bank, DNB) in the first half of 2017 for their annual meeting to discuss issues with regards to strategy, risk management and compliance.
Educational sessions
The Board and its Committees received updates and presentations on topics ranging from developments in acquisitions and divestments, corporate governance, and remuneration regulations for the insurance sector, to sustainability and technology. In addition to these updates and presentations from the Company, the members of the Supervisory Board gathered general information on industry developments by participating in networks, reading independent
Annual Report on Form 20-F 2017 |
115 | Governance Report of the Supervisory Board | |
reports and sharing knowledge with other Board members within and outside Aegon. The Board visited local offices and employees in the UK and the US and was furthermore in particular informed on the strategic direction of Aegons activities in Europe, Asia and Asset Management. In addition, the Board was updated on the developments around IFRS 17 and followed an educational program dedicated to digital developments and digital customer solutions. The Audit Committee furthermore held a meeting dedicated to a detailed discussion program on Aegon the Netherlands.
Board review
The Supervisory Board undertakes a Board review on an annual basis, and an external assessment takes place at least once every three years. In 2015, an external assessment of the Supervisory Board was conducted in which each member of the Board was interviewed on the basis of a completed questionnaire. In 2016 and 2017 a self-assessment was undertaken by the Board. This Board review assessed the collective performance and effectiveness of the Board and its Committees, and the performance of the Chairman. In doing so, it addressed the composition, competencies, expertise and profile of the Board, the meeting processes and procedures, the mutual interaction, dynamics and communication in the Board, and the Boards key areas of supervision. The 2017 questionnaire further addressed events from which lessons could be learned and reviewed the mutual interaction between the Supervisory Board and the Executive Board and Management Board. With regard to this mutual interaction, the 2017 Supervisory Board review also included input from the Management Board. The Supervisory Board discussed the outcome of the self-assessment in detail in the absence of the Executive Board and Management Board in February 2018, and agreed that it and its Committees functioned well and fulfilled its duties and responsibilities in a satisfactory way. During the same meeting, the Supervisory Board listed the priorities and follow-up for the Board to address in 2018.
The performance of the members of the Executive Board was discussed regularly during 2017. The Supervisory Board reviewed the performance of individual members of the Executive and Management Board over the preceding calendar year in January 2017. In addition, the Supervisory Board discussed the cooperation and communication between the Supervisory Board and Management Board in 2017.
Supervisory Board Committees
The Supervisory Board has four Committees that discuss specific issues in depth and prepare items about which the full Board makes decisions. The Committees report verbally about their discussions, and they are discussed in full at Supervisory Board meetings. Supervisory Board members receive all minutes of the Committee meetings. These meetings are open to all members of the Board, regardless of membership of the
Committees. All Committee reports were prepared by the respective Committees and approved by the Supervisory Board. These provide an overview of the responsibilities and activities of the Committees.
The four Committees are the:
◆ | Audit Committee; |
◆ | Risk Committee; |
◆ | Nomination and Governance Committee; and |
◆ | Remuneration Committee. |
The Risk Committee is responsible for supervising the activities of, and advising the Supervisory Boards Audit Committee with respect to, the Companys enterprise risk management framework and internal control systems. The Audit Committee primarily relies on the Risk Committee for these topics, as stated in the Dutch Corporate Governance Code.
The Audit Committee
Composition
On December 31, 2017, the composition of the Audit Committee was as follows:
◆ | Ben van der Veer (chair); |
◆ | William L. Connelly; |
◆ | Mark A. Ellman; |
◆ | Robert W. Dineen; |
◆ | Corien M. Wortmann-Kool; and |
◆ | Dona D. Young. |
The members of the Audit Committee meet all relevant independence and experience requirements of financial administration and accounting for listed companies.
The Committee confirmed that all of its members qualified as independent according to Rule 10A-3 of the SEC, and it also confirmed that the Chairman of the Audit Committee, Ben van der Veer, qualified as a financial expert according to the Sarbanes Oxley Act in the United States and his competence in accounting and auditing according to the Audit Committee Decree 2016 (Besluit instelling auditcommissie), section 2(3).
Role and responsibilities
As Aegon has both an Audit Committee and a Risk Committee, the risk management responsibilities stated in the Dutch Corporate Governance Code are assigned to the Risk Committee. With regard to the oversight of the operation of the risk management framework and risk control systems, including supervising the enforcement of relevant legislation and regulations, the Audit Committee operates in close coordination with the Risk Committee as established by the Board. Certain Board members participate in both committees and a combined meeting of the Audit and Risk Committees is scheduled on an annual basis.
Annual Report on Form 20-F 2017 |
116 | Governance Report of the Supervisory Board | |
The main role and responsibilities of the Audit Committee are to assist and advise the Supervisory Board in fulfilling its oversight responsibilities regarding:
◆ | The integrity of the consolidated interim and full-year financial statements and financial reporting processes; |
◆ | Internal control systems and the effectiveness of the internal audit process; and |
◆ | The performance of the external auditors and the effectiveness of the external audit process, including monitoring the independence and objectivity of PwC. |
The Audit Committee reports to the Supervisory Board on its activities, identifying any matters about which it considers action or improvements are needed, and making recommendations as to the steps to be taken. For more information about the functioning of the Audit Committee, please see the Audit Committee Charter on aegon.com.
Committee meetings
In 2017, the Audit Committee held seven meetings, one of which was a combined meeting with the Risk Committee of the Supervisory Board in December 2017. As part of regular deep-dive sessions, a separate meeting took place in October in the Netherlands dedicated to Aegons business in the Netherlands. Topics for discussion included the Dutch market developments, the capital generation, operational management and digital solutions within Aegon the Netherlands. Audit Committee meetings were attended by the members of the Audit Committee, Aegons Chief Financial Officer, the Head of Corporate Financial Center, the Chief Risk Officer, the internal auditor, and partners of PwC, Aegons external auditor.
Members of Aegons Group Risk, Group Legal, Investor Relations, Tax, Actuarial and Business departments regularly attended Audit Committee meetings. Aside from the Audit Committee meetings, additional sessions were held with internal and external auditors without members of the Executive Board or senior management present.
Financial Reporting
In discharging their responsibilities with regards to the 2017 interim and full year financial statements, the Audit Committee:
◆ | Reviewed and discussed the management letter and follow up actions with PwC, Internal Audit, the Executive and the Management Board; |
◆ | Discussed PwCs quarterly reports (included in local filings) leading to a review opinion on the interim financial statements; |
◆ | Received presentations on various topics by local business unit managers and chief financial officers; and |
◆ | Reviewed and discussed areas of significant judgments in the preparation of the financial statements, including, in particular: Solvency II, investment valuation and impairments, economic and actuarial assumption setting, and model validations. |
The Audit Committee was satisfied with the explanations provided by PwC, Internal Audit and Executive and Management Board, and conclusions reached. Recurring items on the Audit Committee agenda in 2017 were Solvency II developments, controls, capital and liquidity, legal and compliance updates, and preparations for IFRS 17.
Risk management and internal controls
With respect to their oversight of accounting risk management and internal controls (provided they did not pertain to the work and responsibilities of the Risk Committee) the Audit Committee:
◆ | Reviewed and approved the internal and external audit plans for 2017 and monitored execution, including progress in respect of recommendations made; |
◆ | Discussed quarterly updates on the activities of the internal audit function, together with details of progress on internal audits with the internal auditor. Areas of focus in 2017 included the internal audit organization, asset management, Solvency II reporting and controls, information technology, remuneration, model management, vendor management and outsourcing, capital management and liquidity, and the remediation of outstanding issues; |
◆ | Reviewed the internal control framework, among others with respect to the Sarbanes Oxley Act; and |
◆ | Discussed the internal control statement with the Executive Board. |
In addition, the Committee reviewed quarterly legal and compliance updates.
External audit effectiveness
The Audit Committee discussed and approved the external auditors engagement letter and the audit plan for 2017. Aegon has well-established policies on audit effectiveness and independence of auditors that set out, among other things:
◆ | The review and evaluation of the external auditor and the lead partner of the external audit team on at least an annual basis; |
◆ | Non-audit services performed by the external auditor; |
◆ | Rotations of the external auditor and lead partner; and |
◆ | Discussions about planning and staffing of the external audit activities. |
For more information about the policies relating to the effectiveness and independence of the external auditor, please see Annex A, B and C of the Audit Committee Charter on aegon.com.
The Audit Committee Charter was furthermore discussed and revised as a result of the new Dutch Corporate Governance Code in November 2017.
Annual Report on Form 20-F 2017 |
117 | Governance Report of the Supervisory Board | |
The Risk Committee
Composition
On December 31, 2017, the composition of the Risk Committee was as follows:
◆ | Dona D. Young (chair); |
◆ | Robert W. Dineen; |
◆ | Mark A. Ellman; |
◆ | Ben J. Noteboom; and |
◆ | Dirk P.M. Verbeek. |
Role and responsibilities
The main role and responsibilities of the Risk Committee are to assist and advise the Supervisory Board in fulfilling its oversight responsibilities regarding the effectiveness of the design, operation and appropriateness of both the Enterprise Risk Management (ERM) framework and the internal control systems of the Company and the subsidiaries and affiliates that comprise the Aegon Group. This includes:
◆ | Risk strategy, risk tolerance and risk governance; |
◆ | Product development and pricing; |
◆ | Risk assessment; |
◆ | Risk responses and internal control effectiveness; |
◆ | Risk monitoring; |
◆ | Risk reporting; |
◆ | Operational Risk; and |
◆ | Transformation Risks. |
Furthermore, the Risk Committee regularly reviews risk exposures as they relate to capital, earnings and compliance with risk policies. The Companys risk management is an important topic for the Supervisory Board.
For more information about the functioning of the Risk Committee, please see the Risk Committee Charter on aegon.com.
Committee meetings
The Risk Committee works closely together with the Audit Committee and has an annual combined meeting, which in 2017 was held in December. This combined meeting focused on internal reporting changes, the Group risk appetite, the resilience of the Group, the evaluation of internal controls and information technology security.
The Risk Committee convened five times in 2017, including the combined meeting with the Audit Committee. The Companys Chief Executive Officer and Chief Risk Officer attend all the Committee meetings. The Chief Financial Officer had a standing invitation to attend the Committee meetings and attended all the meetings in 2017 as well. Other Management Board members and senior managers attended the meetings when relevant for the discussion.
Risk management and Internal controls
Recurring items on the Risk Committee agenda in 2017 were risk exposure information and risk policy compliance monitoring. The Risk Committee assessed the effectiveness of the design and
operation of the ERM framework and internal control systems in 2017 by:
◆ | Discussing the quarterly risk dashboard, including all material group level risks, with the Executive Board members and relevant senior managers . The material group level risks consisted of financial, actuarial and operational risks, including cybersecurity and information security risks and controls; |
◆ | Assessing a quarterly transformation dashboard that outlined risks with regards to the execution of the strategy in each region, and how those risks were monitored and mitigated; |
◆ | Discussing in-depth the control excellence programs within the regions with the relevant CROs. The CROs provided updates on the progress of the programs and the implementation of the programs in the day-to-day business; |
◆ | Reviewing the Group Risk appetite, which consists of the risk strategy and risk limits and tolerances; and |
◆ | Reviewing the risk governance structure and risk competencies, including the skills necessary for the risk function. |
The Risk Committee also discussed several regulatory topics on a regular basis, including the DNB Focus report, the Group ORSA report and the consequences and actions following the designation of Aegon as a G-SII in November 2015. In addition, the Risk Committee dedicated time to wider developments in the geopolitical environment and financial markets in 2017. Furthermore, the Risk Committee discussed the implications of the new Dutch Corporate Governance Code on its work, and approved an updated Risk Committee Charter that reflects the requirements of the new Dutch Corporate Governance Code.
The Nomination and Governance Committee
Composition
On December 31, 2017, the composition of the Nomination and Governance Committee was as follows:
◆ | Robert J. Routs (chair); |
◆ | Ben van der Veer; |
◆ | Dirk P.M. Verbeek; and |
◆ | Corien M. Wortmann-Kool. |
Role and responsibilities
The main role and responsibilities of the Nomination and Governance Committee are to assist and advise the Supervisory Board in fulfilling its responsibilities in the areas of Human Resources Management and Corporate Governance. This includes:
◆ | Board member and senior management succession planning; |
◆ | Drawing up selection criteria and procedures for Board members, together with supervising the selection criteria and procedures for senior management; |
◆ | Advising on and proposing nominations, appointments and reappointments; |
◆ | Reviewing and updating the Supervisory Board profile and charters for the Supervisory Board and its committees; |
◆ | Periodically assessing the functioning of individual members of the Supervisory Board and the Executive Board; |
Annual Report on Form 20-F 2017 |
118 | Governance Report of the Supervisory Board | |
◆ | Discussing the annual global employee survey; |
◆ | Overseeing the corporate governance structure of the Company, compliance with the Dutch Corporate Governance Code and any other applicable corporate governance legislation and regulations; and |
◆ | Assessing and advising on the responsible business strategy as part of the corporate strategy, and overseeing the execution of the responsible business strategy. |
Committee meetings
Aegons Nomination and Governance Committee held six meetings in 2017. In addition to the committee members, these meetings were attended in whole or in part by the CEO, the Global Head Human Resources and the General Counsel.
Further to the activities mentioned below, the Nomination and Governance Committee discussed the Companys responsible business strategy. In addition, the Nomination and Governance Committee discussed the new Dutch Corporate Governance Code and the implications for the Charters of the Executive Board, the Supervisory Board and the Supervisory Board Committees. The Nomination and Governance Committee furthermore advised the Supervisory Board to approve the updated Charters of the Executive Board, the Supervisory Board and the Supervisory Board Committees, including the Charter of the Nomination and Governance Committee.
The Nomination and Governance Committee also reviewed the important outside board positions of the members of the Management and Supervisory Board, and discussed specific appointments to important outside board positions where applicable.
Supervisory Board related activities
The Nomination and Governance Committee discussed the composition of the Supervisory Board and its Committees and governance topics. The profile of Supervisory Board members, as well as their capabilities in terms of working collectively with other members of the Supervisory Board, were debated by the Committee. Furthermore, the existing and impending vacancies in the Supervisory Board were discussed and a search process for fulfilling those vacancies was commenced.
Executive Board related activities
During 2017, the Nomination and Governance Committee reviewed the composition of the Executive Board and Management Board, together with the functioning and effectiveness of the Board members, both individually and as a team. Acknowledging the importance of good succession planning, the Committee discussed with the CEO and Aegons Global Head Human Resources the extent to which sufficient internal candidates are available to fill positions at Executive Board, Management Board and senior management level both in the event of emergency and when positions open up in the future. The CEO also discussed changes in the global senior management team with the Nomination and Governance
Committee during the year. The Committee was kept appraised of developments in employee engagement, talent management and international mobility. As in previous years, the Supervisory Board noted that Aegon continued to make progress in order to ensure proper succession planning is in place. The Supervisory Board was also informed about the annual Global Employee Survey, which was conducted at the end of 2017. The Supervisory Board discussed the outcome of this survey in detail in the February 2018 Supervisory Board meeting.
Diversity
Enhancing diversity in the Executive, Management and
Supervisory Board is an important issue for Aegon. Selection and appointment is based on expertise, skills and relevant experience, and the Supervisory Board takes diversity into account with a view to achieving its aim of having a balanced Supervisory, Executive and Management Board composition. In 2017, the Supervisory Board adopted a diversity policy for the Executive, Management and Supervisory Board.
The Supervisory Board is aware that the current composition of the Executive and Supervisory Board does not meet the balanced composition requirement under Dutch law with regard to gender diversity (at least 30% of the positions should be filled by women and at least 30% by men). Following the appointment of Corien Wortmann-Kool to the Supervisory Board in 2014, the gap in terms of the balanced composition was reduced, and the Supervisory Board currently has two female Board members. When identifying candidates for open positions in the Executive, Management and Supervisory Board, the Board actively searches for female candidates. It also instructs external search firms to present female candidates. While this has had a positive effect, the requirement has not yet been fully met. More information on diversity within the Board is available in the Supervisory Board Composition and Competency Overview as published on aegon.com.
The Remuneration Committee
Composition
On December 31, 2017, the composition of the Remuneration Committee was as follows:
◆ | Ben J. Noteboom (chair); |
◆ | William L. Connelly; and |
◆ | Robert J. Routs. |
Role and responsibilities
The main role and responsibilities of the Remuneration Committee are to advise the Supervisory Board and prepare decisions to be taken by the Board. The Committee is designated to safeguard sound remuneration policies and practices within the Company by overseeing the development and execution of these policies and practices. In order to ensure that the remuneration policies and practices take all types of risks properly into account, in addition to liquidity and capital levels, the Remuneration Committee assesses in particular the remuneration governance processes, procedures and
Annual Report on Form 20-F 2017 |
119 | Governance Report of the Supervisory Board | |
methodologies adopted. Furthermore, the Committee ensures that the overall remuneration policy is consistent with the longer-term strategy of the Company and the longer-term interest of its shareholders, investors and other stakeholders. This includes:
◆ | Reviewing the Aegon Group Global Remuneration Framework and making recommendations on the outcomes; |
◆ | Preparing recommendations regarding variable compensation both at the beginning and after the end of the performance year; |
◆ | Overseeing the remuneration of the Executive Board, Identified Staff and Heads of Group Control functions; and |
◆ | Preparing the information provided to shareholders on remuneration policies and practices, including the Remuneration Report. |
Committee meetings
The Remuneration Committee had six meetings in 2017. In addition to the committee members, these meetings were attended in whole or in part by the CEO, the Global Head Human Resources and the General Counsel.
In 2017, the Remuneration Committee oversaw the further application, implementation and approval of Aegons Group Global Remuneration Framework and the various policies and procedures related to it, including the Remuneration Policy for Identified Staff. This included:
◆ | Setting the 2017 performance indicators and targets for remuneration purposes; |
◆ | Preparing the 2018 performance indicators for remuneration purposes; |
◆ | Allocating variable compensation for 2016; |
◆ | Overseeing the scenario analysis of payout levels under the Executive Board Remuneration Policy; and |
◆ | Reviewing and/or approving the ex-ante assessments and ex-post assessments, any exemption requests under the remuneration policies, and changes to the list of Identified Staff. |
Furthermore, the Committee discussed the results of the audit by the Internal Audit Department on the application of the Remuneration Framework.
In addition, the Remuneration Committee discussed possible developments with regards to regulations pertaining to remuneration and discussed the new Dutch Corporate Governance Code and the implications for the work of the Remuneration Committee. The Remuneration Committee approved an updated Remuneration Committee Charter that reflects the requirements of the new Dutch Corporate Governance Code.
Annual Accounts
This Annual Report includes the Annual Accounts for 2017, which were prepared by the Executive Board and discussed by both the Audit Committee and the Supervisory Board. The Annual Accounts are signed by the members of the Executive Board and the Supervisory Board, and will be placed on the agenda of the 2018 Annual General Meeting of Shareholders for adoption. The Supervisory Board recommends that shareholders adopt the annual accounts.
Acknowledgement
The members of the Supervisory Board are very grateful for the work undertaken by Executive and Management Boards in pursuit of Aegons purpose of helping people achieve a lifetime of financial security.
We would like to thank Aegons employees for all they do to serve Aegons millions of customers, and furthermore we would like to express our thanks to Aegons business partners and loyal customers for their continued confidence in the Company.
Finally, the Board wishes to thank all those who invest in Aegon for their continued trust and confidence.
The Hague, the Netherlands, March 22, 2018.
Robert J. Routs
Chairman of the Supervisory Board of Aegon N.V.
Annual Report on Form 20-F 2017 |
120 | Governance Members of the Supervisory Board | |
Members of the Supervisory Board
Robert J. Routs (1946, Dutch)
Chairman of the Supervisory Board
Chairman of the Nomination and Governance Committee Member of the Remuneration Committee
Robert J. Routs is a former Executive Director for Downstream at the energy company Royal Dutch Shell. He was appointed to Aegons Supervisory Board in April 2008 and became Chairman in April 2010. Mr. Routs was re-appointed as a member of the Supervisory Board during the 2016 Annual General Meeting
of Shareholders 19 . Mr. Routs is Chairman of the Supervisory Board Nomination and Governance Committee and a member of the Supervisory Board Remuneration Committee.
Mr. Routs is also Chairman of the Supervisory Board of Royal DSM N.V. and sits on the Board of Directors of ATCO Ltd., A.P. Møller-Mærsk A/S and AECOM Technology Corporation. He is a former non-executive director at UPM and former Vice Chairman of the Supervisory Board of Royal KPN N.V.
William L. Connelly (1958, French)
Member of the Audit Committee
Member of the Remuneration Committee.
William L. Connelly is a former member of the Management Board of ING Bank, where he was responsible for INGs corporate, financial institutions and financial markets activities.
He started his career at Chase Manhattan Bank, fulfilling senior roles in commercial and investment banking in France,
the Netherlands, Spain, the United Kingdom and the United States. He was appointed to Aegons Supervisory Board in 2017, and his current term ends in 2021. He is a member of the Supervisory Board Audit Committee and the Supervisory Board Remuneration Committee.
Mr. Connelly is also an independent director at the Board of Directors of Société Générale.
Robert W. Dineen (1949, American)
Member of the Audit Committee
Member of the Risk Committee
Robert W. Dineen was Vice Chairman of Lincoln Financial Network (LFN) and a member of the Senior Management Committee of Lincoln Financial Group (LFG), before retiring in 2013. Before joining Lincoln Financial Group, Mr. Dineen was Senior Vice President and head of Merrill Lynchs Managed Asset Group.
He was appointed to Aegons Supervisory Board in May 2014, and his current term ends in 2018. He is a member of the Supervisory Board Audit Committee and the Supervisory Board Risk Committee.
Mr. Dineen is also the non-executive Chairman of the Board of Aretec Inc (not listed, US-based) and was a member of Lincoln New York Life Company Board.
Mark A. Ellman (1957, American)
Member of the Audit Committee
Member of the Risk Committee
Mark A. Ellman is a former Vice Chairman Global Origination of Bank of America/Merrill Lynch. Before joining Bank of Amercia/ Merrill Lynch, he held various roles in the US insurance industry. These mostly entailed working in corporate finance at large US financial institutions, where he was engaged in M&A advice and transactions, together with equity and debt raisings for
insurance companies. He was a founding partner of Barrett Ellman Stoddard Capital Partners. Mr. Ellman was appointed to Aegons Supervisory Board in 2017, and his current term ends in 2021. He is a member of the Supervisory Board Audit Committee and the Supervisory Board Risk Committee.
Mr. Ellman was a non-executive director of Aegon USA from 2012 to 2017.
Annual Report on Form 20-F 2017 |
121 | Governance Members of the Supervisory Board | |
Shemaya Levy (1947, French)
Vice Chairman of the Supervisory Board
Chairman of the Risk Committee
Member of the Nomination and Governance Committee
Shemaya Levy is retired Executive Vice President and Chief Financial Officer of the Renault Group. He was appointed
to Aegons Supervisory Board in 2005, and his final term ended in May 2017. He was Chairman of the Supervisory Board Risk Committee and a member of the Supervisory Board Nomination and Governance Committee.
Ben J. Noteboom (1958, Dutch)
Chairman of the Remuneration Committee
Member of the Risk Committee
Ben J. Noteboom worked for Randstad Holding N.V. from 1993 until 2014, where he was appointed member of the Executive Committee in 2001 and became CEO in 2003. Before joining Randstad, Mr. Noteboom worked for Dow Chemical in several international management functions between 1984 and 1993. He started his career in 1982 at Zurel as management assistant. He was appointed to Aegons Supervisory Board in May 2015,
and his current term ends in 2019. He is Chairman of the Supervisory Board Remuneration Committee and a member of the Supervisory Board Risk Committee.
Mr. Noteboom is also a member of the Supervisory Board of Royal Ahold Delhaize N.V., Wolters Kluwer N.V. and Chairman of the Supervisory Board of Royal Vopak N.V. In addition, Mr. Noteboom is a member of the Board of Directors of VUmc Cancer Center Amsterdam.
Ben van der Veer (1951, Dutch)
Chairman of the Audit Committee
Member of the Nomination and Governance Committee
Ben van der Veer is former Chairman of the Board of Management of KPMG N.V. Mr. Van der Veer retired from KPMG on September 30, 2008, and was appointed to Aegons Supervisory Board in October 2008. Mr. Van der Veer was re-appointed as a member of the Supervisory Board during the 2016 Annual General Meeting of Shareholders, and his third and final term ends in 2020. He is Chairman of the Supervisory Board Audit
Committee and a member of the Supervisory Board Nomination and Governance Committee.
Mr. Van der Veer is a non-executive member of the Board of Directors of RELX N.V., RELX PLC and RELX Group PLC. He is also a member of the Supervisory Board of Royal FrieslandCampina N.V. (not listed), and a former member of the Supervisory Board of Royal Imtech N.V., TomTom N.V., and Siemens Nederland N.V. (not listed).
Dirk P.M. Verbeek (1950, Dutch)
Member of the Risk Committee
Member of the Nomination and Governance Committee
Dirk P.M. Verbeek is a former Executive Board member and former vice president Emeritus of Aon Group. Mr. Verbeek was appointed to Aegons Supervisory Board in 2008 20 . He is a member of the Supervisory Board Risk Committee and the Supervisory Board Nomination and Governance Committee.
Mr. Verbeek is a member of the Advisory Council of CVC Benelux (not listed) and OVG Real Estate (not listed), and member of the INSEAD Dutch Council. Mr. Verbeek was a member of the Supervisory Board of Aon Groep Nederland B.V. (not listed) until July 2017, and Chairman of the Supervisory Board of Robeco Groep N.V. (not listed) until December 2015.
Annual Report on Form 20-F 2017 |
122 | Governance Members of the Supervisory Board | |
Corien M. Wortmann-Kool (1959, Dutch)
Vice Chairman of the Supervisory Board
Member of the Audit Committee
Member of the Nomination and Governance Committee
Corien M. Wortmann-Kool is Chairman of the Board of Stichting Pensioenfonds ABP, the Dutch public sector collective pension fund. Ms. Wortmann-Kool is a former Member of the European Parliament and Vice President on Financial, Economic and Environmental affairs for the EPP Group (European Peoples Party). She was appointed to Aegons Supervisory Board in May 2014, and her current term ends in 2018. She
is Vice Chairman of the Supervisory Board, and a member of the Supervisory Board Audit Committee and the Supervisory Board Nomination and Governance Committee.
Ms. Wortmann-Kool is also a member of the Supervisory Board of Het Kadaster (not listed), member of the Advisory Council of the Centraal Bureau voor de Statistiek, Chairman of the Board of Trustees of Save the Children Netherlands and vice president of the European Peoples Party. She was a member of the Supervisory Board of Mercedes-Benz Netherlands (not listed) until 2014.
Dona D. Young (1954, American)
Member of the Audit Committee
Chairman of the Risk Committee
Dona D. Young is an executive/board consultant and retired Chairman, President and Chief Executive Officer of The Phoenix Companies, which was an insurance and asset management company at the time of her tenure. She was appointed to Aegons Supervisory Board in 2013, and her current term will end in 2021. She is a member of the Supervisory Board
Audit Committee and Chairman of the Supervisory Board Risk Committee.
Ms. Young is member and Lead Director of the Board of Directors of Foot Locker, Inc Furthermore, Ms. Young is Chair of the Audit Committee of the Board of Trustees of Save the Children US (not listed), and member of the Board of Save the Children International and Save the Children Association.
Annual Report on Form 20-F 2017 |
123 | Governance Remuneration Report | |
Global Remuneration Principles
The Aegon Group Global Remuneration Principles provide the foundation for remuneration policies and practices throughout Aegon. They are applied regionally and/or locally.
The key pillars of the Aegon Group Remuneration Principles are as follows:
◆ | Aegon remuneration is employee-oriented by: fostering a sense of value and appreciation in each individual employee; promoting the short- and long-term interests and well-being of all Aegon staff via fair compensation, pension and/or other benefits; supporting employees career development; and supporting the (international) mobility of its staff; |
◆ | Aegon remuneration is performance-related by: establishing a clear link between pay and performance by aligning objectives and target setting with performance evaluation and remuneration; reflecting individual as well as collective performance in line with Aegons long-term interests; enhancing the transparency and simplicity of Aegon Group remuneration, consistent with the principle of pay for performance; and avoiding any pay for non-performance; |
◆ | Aegon remuneration is fairness-driven by: promoting fairness and consistency in Aegons remuneration policies and practices, with remuneration packages that are well-balanced across the different echelons within Aegon and its business units; avoiding any discrimination in Aegons remuneration structures, including, among others, discrimination based on nationality, race, gender, religion, sexual orientation, and/ or cultural beliefs; creating global alignment in the total compensation of all Identified Staff; and aiming at controlled market competitive remuneration, by providing total compensation packages in line with an appropriately established peer group at a regional unit, country and/ or functional level; and |
◆ | Aegon remuneration is risk-prudent by: aligning business objectives with risk management requirements in the target setting practices throughout the Aegon Group; giving an incentive to appropriate risk-taking behavior while discouraging the taking of excessive risks; and protecting the risk alignment effects embedded in the remuneration arrangements of individual staff against any personal strategies or insurance to counter them. |
The key pillars outlined above are set out in Aegons Global Remuneration Framework (GRF). The GRF covers all Aegon staff. It contains the guiding principles for remuneration and therefore supports the consistent setting of sound and effective remuneration policies throughout the Aegon Group. The GRF is designed in accordance with relevant rules, guidelines and interpretations, for instance the Decree on Sound Remuneration Policy (Regeling beheerst beloningsbeleid (Rbb) Wft 2014) from the DNB, and the 2015 Act on the Remuneration Policy
of Financial Undertakings (Wet beloningsbeleid financiële ondernemingen, Wbfo 2015 stb 2015, 45). Aegons remuneration policies are derived from the GRF, among which is the Remuneration Policy for the Executive Board. These policies define specific terms and conditions for the employment of various groups of staff. All steps in the remuneration process are governed by the GRF and its underlying policies. Staff from Human Resources, Risk Management, Compliance and Audit are involved in all steps of the process.
2017 was a year with relatively few changes to the remuneration regulations impacting Aegon. For this reason, the Companys remuneration practices and processes did not change materially compared with the previous performance period.
The Dutch Code introduced, among other things, caps on variable compensation that go beyond the maximums suggested by European legislation, and require at least 50% of the performance indicators used for determining variable compensation to be of a non-financial nature. In addition, the regulations limit the use of financial retention and severance arrangements.
The Wbfo 2015 has a provision that makes it possible to apply a variable compensation maximum that is aligned with the European CRD IV compensation ratio (100% of fixed compensation at maximum level). This has been specifically created for all people working for the corporate office of companies with a strong international nature. In 2017, Aegon met the applicable criteria. Although the regular maximum levels of variable compensation apply in the Netherlands, Aegon has offered selected senior staff at its corporate office a maximum variable compensation opportunity in line with CRD IV remuneration ratios.
For compensation of staff outside Europe, the Company obtained shareholder approval at the Annual General Meeting of Shareholders of May 20, 2016, to pay a maximum of 200% of base salary as variable compensation for performance delivered by selected senior staff in positions that, based on local market practice, could exceed the 100% of base salary variable compensation set out in the legislation. The Companys capital is not adversely impacted by the maximum variable compensation that could be paid out.
In line with the Wbfo, Aegon wishes to disclose the total amount of variable compensation paid in performance year 2017.
Annual Report on Form 20-F 2017 |
124 | Governance Remuneration Report | |
The total amount of variable compensation paid out in 2017 was EUR 197 million. In 2017, the total annual compensation paid out to 17 people was equal to or higher than EUR 1 million. These people worked for Aegons Global Corporate Office, Aegon Americas, Aegon UK and Aegon Asset Management.
Role of risk management and compliance
Variable compensation may have an impact on risk-taking behaviors and, as such, may undermine effective risk management. The opportunity to receive high variable compensation can lead to excessive risk taking, which can have a material impact on the Companys financial soundness. To avoid such undesired effects, both the Risk Management and Compliance functions are involved in the design and execution of remuneration policies and practices.
The GRF includes separate remuneration policies for three specific groups of employees. This is in recognition of the fact that these employees roles and responsibilities require specific risk mitigating measures and governance processes. These remuneration policies are for: (i) the Executive Board; (ii) material risk takers (Identified Staff); and (iii) Control Staff. Given the rationale for having a separate policy for material risk takers and the risk mitigating measures that are applied to the remuneration of these individuals, Risk Management is involved in deciding which positions are deemed Identified Staff. Furthermore, where exceptions to the policies are requested to reflect local practices or regulations, Risk Management and Compliance are involved in order to ensure such exceptions do not undermine effective risk management and that sufficient mitigating measures are undertaken.
In addition, the Risk Management and Compliance functions, together with the Human Resources and Finance functions, are responsible for the execution of the various measures that ensure the GRF and associated practices are aligned with the defined risk tolerances and behaviors. The risk mitigating measures are taken prior to the payout of compensation to individual employees (regardless of whether the compensation is deferred) as well as after payouts, or allocated but deferred payments (before vesting of these payments) to ensure sustainability of performance, are considered ex-post measures.
Aegon endeavors to seek an appropriate balance of ex-ante and ex-post assessments to ensure effectiveness in both the short- and long-term risk taking behavior of employees.
General compensation practices
Aegon has a pay philosophy based on total compensation. This means that the aim is for total remuneration for experienced and competent employees to be consistent with those in the markets in which Aegon operates and competes for employees. Total compensation typically consists of base salaries and -
where in line with local market practices - variable compensation. Market survey information from reputable sources is used to provide information on competitive compensation levels and practices.
Variable compensation, if any, is capped at an appropriate level as a percentage of base pay. Variable compensation for senior management is usually paid out in cash and shares over multiple years, and is subject to further conditions being fulfilled. Additional holding periods may apply to shares after they have vested, restricting their sale for a further one to three years. Variable compensation already paid out may also be retrieved under certain circumstances (Claw-back).
In the following sections more detailed information is provided on the compensation practice for the Supervisory Board and the Executive Board.
Supervisory Board Remuneration Policy 2017
Aegons Remuneration Policy for members of its Supervisory Board is aimed at ensuring fair compensation, and protecting the independence of the Boards members. Terms and conditions for members of the Supervisory Board are part of Aegons broader Remuneration Policy, and are the responsibility of the Companys Remuneration Committee.
Fees and entitlements
Members of the Supervisory Board are entitled to the following:
◆ | A base fee for membership of the Supervisory Board. No separate attendance fees are paid to members for attendance at the regular Supervisory Board meetings; |
◆ | An attendance fee for each extra Board meeting attended, be it in person or by video and/or telephone conference; |
◆ | A committee fee for members on each of the Supervisory Boards Committees; |
◆ | An attendance fee for each Committee meeting attended, be it in person or through video and/or telephone conference; and |
◆ | An additional fee for attending meetings that require intercontinental travel between the Supervisory Board members home location and the meeting location. |
Each of these fees is a fixed amount. Members of Aegons Supervisory Board do not receive any performance or equity-related compensation, and do not accrue pension rights with the Company. These measures are designed to ensure the independence of Supervisory Board members and to strengthen the overall effectiveness of Aegons corporate governance.
Under the current policy, as approved by shareholders at the Annual General Meeting on May 15, 2013, members of the Supervisory Board are entitled to the following payments:
Annual Report on Form 20-F 2017 |
125 | Governance Remuneration Report | |
Base fee for membership of the Supervisory Board | EUR / year | |||
Chairman |
80,000 | |||
Vice-Chairman |
50,000 | |||
Member |
40,000 | |||
Fee for membership of a Supervisory Board committee | EUR / year | |||
Chairman of the Audit Committee |
13,000 | |||
Member of the Audit Committee |
8,000 | |||
Chairman of other committees |
10,000 | |||
Member of other committees |
5,000 | |||
Attendance fees | EUR | |||
Extra Supervisory Board meeting |
3,000 | |||
Audit Committee |
3,000 | |||
Other committees |
2,000 |
Information on members of the Supervisory Board and the composition of Aegons four committees - Audit, Nomination and Governance, Remuneration and Risk - can be found on pages 115 - 119.
Details on the remuneration of the Supervisory Board over the course of 2017 can be found in the Supervisory Board Remuneration Report 2017 on page 304.
Executive Board Remuneration in 2017
The following section describes how the Company applies the principles of good governance relating to Directors remuneration. It was prepared by the Remuneration Committee of Aegon N.V. (the Committee) in accordance with the Dutch Code (the Dutch Code), and was approved by Aegon N.V.s Supervisory Board.
Executive Board remuneration
Aegons Executive Board is remunerated on the basis of the principles described in Aegons GRF. Aegons remuneration policy for members of the Executive Board is derived from this framework and sets out terms and conditions for members of the Companys Executive Board.
The Executive Board Remuneration Policy was adopted at the General Meeting of Shareholders on May 12, 2011. The Policy will remain in force until such time as the Supervisory Board proposes changes or amendments. Any material changes in the Executive Board Remuneration Policy will be referred to the General Meeting of Shareholders for adoption. The implementation of the current policy during 2017 is described in the Executive Board Remuneration Report on pages 129 - 130.
In determining the expected level of pay for each Executive Board member, scenarios have been considered in which the minimum, maximum and at target pay was assessed. In these scenarios the share component in the variable pay element has been assessed at the plan years grant price.
In addition to the pay-out scenario, the committee has considered the ratio of the average employee pay expense (excluding CEO expense) versus the expense of the CEO pay elements based on costs recognized under IFRS. For 2017 this ratio is 41.7 (2016: 41.9; 2015: 44.0). The committee is conscious of the significant difference in the geographical footprint of the Companys employee population, which may impact the outcome of the ratio. The composition of the Company and the way this is affected by restructuring and other organisational changes (e.g. major acquisitions or divestments) will also have an impact.
Through the implementation of the Executive Board Remuneration policy, the Company is able to reward the members of the Executive Board in line with the Aegon Group Remuneration Principles, as described earlier. In particular, the variable compensation element in the remuneration ensures a clear link between individual pay and (both short- and long-term) company performance. The objectives set for each Executive Board member are derived from the Companys strategy (including the long-term value creation objective embedded therein) and focussed on the role of the Executive. The targets support the achievement of the operational- and financial-goals to which the Company has committed itself. Performance is assessed following the year. Pay-out of variable compensation is based on the assessed performance.
The amount of variable compensation actually allocated in relation to the performance delivered during 2017 is based on the achievement against the objectives and targets that were set at the start of the year. The objectives are an elaborate set of financial IFRS (non-Risk adjusted), financial market Consistent (risk-adjusted), and non-financial, personal-, and strategic, sustainability measures linked to the Company strategy. These include Underlying Earnings, ROE, MCVNB, Capital Generation, ROERC (pre-tax), Cultural transformation, responsible business and control environment.
Annual Report on Form 20-F 2017 |
126 | Governance Remuneration Report | |
The actual target levels are regarded commercially sensitive and are therefore not disclosed on an objective by objective basis. Instead, the performance on the 2017 mix of financial- and non-financial targets is disclosed. For Mr Wynaendts this was 28.7% (of 32.5% possible) for the financial objectives and 61.7% (of 67.5% possible) for the non-financial objectives. For Mr Rider this was 28.7% (of 32.5% possible) for the financial objectives and 60.4% (of 67.5% possible) for the non-financial objectives.
Role of the Remuneration Committee
The Supervisory Board has overall responsibility for the Companys Remuneration Policies, including the Executive Board Remuneration Policy. Members of the Committee are drawn from the Supervisory Board.
Each year, Aegons Remuneration Committee reviews Aegons remuneration policies to ensure they remain in line with prevailing international standards. This review is based partly on information provided by Aegons external advisor, Towers Watson. The advisor does not, however, advise individual members of the Executive and Supervisory Boards.
The Remuneration Committee may recommend changes to the policies to the Supervisory Board.
Review of the Remuneration Policy
Aegons Executive Board Remuneration Policy is reviewed every year by the Remuneration Committee. The policy applies to all members of Aegons Executive Board.
Ensuring pay remains competitive
The Company regularly compares its levels of executive remuneration with those of other comparable companies. Companies included in the peer group are chosen according to the following criteria:
◆ | Industry (preferably life insurance); |
◆ | Size (companies with similar number of employees, assets, revenue and market capitalization); |
◆ | Geographic scope (preferably the majority of revenues generated outside of the country of origin); and |
◆ | Location (companies based in Europe). |
The peer group was updated in 2015. It comprises the following fourteen companies: Allianz, Aviva, Axa, CNP Assurances, Generali, Legal & General, Mapfre, Münchener Rückversicherung, NN Group, Old Mutual, Prudential plc., Standard Life, Swiss Re and Zurich Financial Services.
In addition, a reference group is used in order to monitor alignment with the general industry in the Netherlands. This is comprised of the 12 leading companies listed on Euronext Amsterdam, excluding financial services providers. The Supervisory Board regularly reviews the composition of the two groups in order to ensure that they continue to provide a reliable and suitable basis for comparison.
Total compensation
For each member of the Executive Board, Aegons Supervisory Board determines a maximum total compensation, reflecting the specific roles and responsibilities of the individual. Each year, the Supervisory Board reviews total compensation levels to ensure they remain competitive and to provide proper, risk-based incentives to members of Aegons Executive Board. To ensure Executive Board members are compensated in accordance with the desired market positioning, alignment to the desired market position needs to be addressed over time, in accordance with applicable rules, regulations and codes.
Consistent with the Executive Board Remuneration Policy, the total direct compensation for Executive Board members consists of fixed compensation and variable compensation.
The Supervisory Board conducts regular scenario analyses to determine the long-term effect on the level and structure of compensation granted to members of the Executive Board. The Supervisory Board (Remuneration Committee) discussed and endorsed the 2017 total compensation for the Executive Board.
Fixed compensation
It is the responsibility of the Supervisory Board to determine fixed compensation for members of the Executive Board based on their qualifications, experience and expertise.
Variable compensation
Aegon believes that variable compensation strengthens the commitment of Executive Board members to the
Companys objectives, business strategy, risk tolerance and long-term performance. Variable compensation is based on a number of individual and company performance indicators that are linked to these items. The indicators are regularly evaluated by experts in the Companys Finance, Risk Management, Business Control, Audit, Human Resources and Compliance departments to ensure alignment with the Companys objectives, business strategy, risk tolerance and long-term performance remains strong.
Performance is determined by using a mix of financial and non-financial indicators. For the CEO and CFO the mix of individual and company performance measures is 37.5% to 62.5% and 27.5% to 72.5% respectively. The type of performance indicators are selected in accordance with the long-term goals of the Company. The level of the indicators should be challenging but achievable. The targets and levels are agreed by the Supervisory Board.
Performance is assessed by Aegons Remuneration Committee and validated by the full Supervisory Board. Each year, a one-year target is set for each performance indicator. By paying half of the variable compensation in cash and the other half in shares, together with adding deferral and additional holding periods to the variable compensation that is allocated, Aegon believes that the long-term interests of Executive Board members are aligned with the interests of Aegon and its stakeholders.
Annual Report on Form 20-F 2017 |
127 | Governance Remuneration Report | |
All variable compensation is conditionally granted at the beginning of each performance period. The number of conditionally granted shares is calculated using the value of one Aegon share at the beginning of this period. This value is equal to the volume weighted average price on the Euronext Amsterdam stock exchange for the period December 15 to January 15. After the performance year, the Company assesses the realized performance against the performance indicators and compares the minimum, target and maximum levels of the performance indicators with the realized performance. The amount of conditional variable compensation that can be allocated is then established. Variable compensation is allocated once the accounts for the financial year in question have been adopted by the Companys general meeting of shareholders and after an ex-ante assessment.
The allocated variable compensation consists of equal parts of cash and shares, of which 40% is paid out (or vests) in the year following the performance year, and 60% is deferred to later years. This deferred portion remains conditional until it vests.
The deferred parts vest in equal tranches over a three-year period. After an ex-post assessment, which may lower the vesting parts, these individual parts are paid 50% in cash and 50% in shares. The shares are restricted for a further period of three years (with the exception of shares withheld to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares).
The variable compensation payout can be illustrated by the following example and the table below. For every 1,000 variable compensation that is allocated following the performance period, 400 is paid out/vested in the year following that performance year (N in the following table). This part will be paid 50% in cash (=200) and 50% in shares vesting immediately (=200 / 5.246 = 38 shares). The remaining 600 is deferred and vests according to a pre-defined schedule.
Information on the expenses recognized for variable compensation and the status of awards are provided in note 53 of this report.
Variable compensation over 2017
At an aggregated level, payments are made as follows 21 .
◆ | 50% of base salary if the threshold target is reached. This results in the allocation of EUR 317,370 and 60,497 shares for Mr. Wynaendts and EUR 225,002 and 42,889 shares for Mr. Rider; |
◆ | 80% of base salary if the pre-determined performance targets are met. This results in the allocation of EUR 507,791 and 96,795 shares for Mr. Wynaendts and EUR 360,000 and 68,623 shares for Mr. Rider; |
◆ | Up to 100% of base salary if the targets are exceeded. This results in the allocation of EUR 634,739 and 120,994 shares for Mr. Wynaendts and EUR 450,000 and 85,779 shares for Mr. Rider; |
◆ | If at an aggregated level the threshold target is not reached, no variable compensation related to the performance period will be made available. |
Annual Report on Form 20-F 2017 |
128 | Governance Remuneration Report | |
Objectives | Performance indicator |
Maximum % of variable compensation |
||||||
Mr. Wynaendts | Mr. Rider | |||||||
Group financial IFRS based |
Group underlying earnings after tax, return on equity | 15.0% | 15.0% | |||||
Group financial risk adjusted based |
Group market consistent value of new business | 17.5% | 17.5% | |||||
Normalized operational free cash flow | ||||||||
Group pre-tax return on economic required capital | ||||||||
Group non financial business indicators |
Objectives measuring corporate responsibility, strategy implementation and sustainability | 30.0% | 40.0% | |||||
Objectives measuring Aegons control environment | ||||||||
Personal objectives |
Individual basket of strategic and personal objectives related to Aegons strategy | 37.5% | 27.5% |
Risk adjustment methodology (ex-ante)
At the end of the performance period, but prior to allocation of variable compensation, the Supervisory Board assesses whether (downward) modifications are needed. For this purpose, quantitative and qualitative measures at group, regional unit and individual level are taken into account, such as:
◆ | Breaches of laws and regulations; |
◆ | Breaches of internal risk policies (including compliance); |
◆ | Significant deficiencies or material weaknesses relating to the Sarbanes-Oxley Act; and |
◆ | Reputation damage due to risk events. |
Ex-post assessment and discretionary adjustments
The Supervisory Board uses its judgment in the assessment of the outcome of strategic/personal targets to ensure that, taken together, they represent a fair reflection of the overall performance of the Board member over the performance period.
In addition, the Supervisory Board applies an ex-post risk assessment to deferred payouts of variable compensation to determine whether allocated (that is, unvested) variable compensation should become unconditional (meaning it vests) or should be adjusted. This ex-post assessment is based on informed judgment by the Supervisory Board, taking into account significant and exceptional circumstances that are not (sufficiently) reflected in the initially applied performance indicators.
Implementation of this authority is on the basis of criteria such as:
◆ | The outcome of a re-assessment of the performance against the original financial performance indicators; |
◆ | A significant downturn in the Companys financial performance; |
◆ | Evidence of misbehavior or serious error by the participant; |
◆ | A significant failure in risk management; and |
◆ | Significant changes in the Companys economic or regulatory capital base. |
The Supervisory Board asks the Remuneration Committee to review these criteria in detail prior to each vesting and to document its findings. Based on this analysis, the Committee may then put forward a proposal to the Supervisory Board
to adjust unvested variable compensation. Deferred variable compensation may only be adjusted downwards. Ex-post, risk-based assessments concern deferred variable compensation, not fixed compensation.
Circuit breaker
For each performance indicator, variable compensation is only paid if the threshold level set for that performance indicator is reached.
Claw-back provision
Aegons Supervisory Board is obliged to claim back variable compensation that has already been paid out or vested where required based on the regulations that apply from time to time, if variable compensation is based on incorrect data (including non-achievement of performance indicators in hindsight), or in the event of material financial restatements or individual gross misconduct.
Pension arrangements
Members of Aegons Executive Board are offered pension arrangements and retirement benefits. Benefits offered are consistent with Executive Board members agreements. Details on the pension contributions to the Executive Board over the course of 2017 can be found in the Remuneration of members of the Executive Board on page 303.
The arrangements with Mr. Wynaendts include retirement provisions that allow benefits to be taken at the end of the term. This retirement arrangement stem from pre Executive Board membership. The arrangement with Mr. Rider is similar to the arrangements for other staff in the Netherlands and consists of a so-called career average defined benefits plan up to EUR 103,317 (2017 threshold) base salary and a defined contribution plan for the amount above EUR 103,317. Details are not disclosed due to the individual nature of such arrangement.
Loans
Aegon does not grant Executive Board members personal loans, guarantees or other such arrangements, unless in the normal course of business and on terms applicable to all employees, and only with the approval of the Companys Supervisory Board.
Annual Report on Form 20-F 2017 |
129 | Governance Remuneration Report | |
Terms of Engagement Agreement
Members of the Executive Board are appointed for four years, and may then be re-appointed for successive mandates also for a period of four years.
Both Executive Board members have an Engagement Agreement with Aegon N.V., rather than a contract of employment.
Members of the Executive Board may terminate their engagement agreement with a notice period of three months. The Company may terminate the board agreement by giving six months notice if it wishes to terminate the agreement of Mr. Wynaendts, and three months notice if it wishes to terminate the agreement of Mr. Rider.
The arrangements with current members of the Executive Board contain provisions for severance payments in the event that their agreement is terminated as a result of a merger or takeover. The Supervisory Board has taken appropriate steps to ensure the arrangements of members of the Executive Board are in line with the Executive Board Remuneration Policy.
Currently, it is expected that the terms of the engagement agreements will remain largely unchanged during 2018.
Executive Board Remuneration Report
At the end of December 2017, Aegons Executive Board had two members:
◆ | Alex Wynaendts, Chief Executive Officer and Chairman of the Executive Board. Mr. Wynaendts was appointed as a member of the Executive Board in 2003 for four years, and re-appointed in 2007, 2011 and most recently in 2015. Mr. Wynaendts current term ends at the General Meeting of Shareholders 2019. |
◆ | Matthew J. Rider, Chief Financial Officer and member of the Executive Board, was appointed as a member of the Executive Board for four years at the Annual General Meeting of Shareholders on May 19, 2017. Mr. Riders current term ends at the General Meeting of Shareholders 2021. |
Fixed compensation
Mr. Wynaendts fixed compensation remained unchanged in 2017 at EUR 1,269,478. The annual fixed compensation of Aegons CFO was agreed at EUR 900,000, and remained unchanged in 2017.
Conditional variable compensation awards 2017
Subject to the adoption of the annual accounts at the General Meeting of Shareholders on May 18, 2018, variable compensation for Executive Board members is set in cash and shares, based on both their individual and the Companys performance. Targets for the performance indicators have been set in line
with the agreed variable compensation targets and 2017 company budgets.
Performance as reported on the financial and non-financial Group performance indicators and targets resulted in a performance score of 56.6% (maximum 62.50%) for Mr. Wynaendts and 64.4% (maximum 72.5%) for Mr. Rider. The performance on individual (strategic) objectives resulted in a pay-out of 33.8% and 24.8% for Mr. Wynaendts and Mr. Rider respectively (maximum 37.50% and 27.50% respectively). The amounts and number of shares below are reflective of period for which Mr. Rider has been part of the Executive Board.
Over the performance year 2017, Mr. Wynaendts was awarded EUR 1,147,100 in total conditional variable compensation. Mr. Rider was awarded EUR 498,783.
Forty percent of variable compensation related to performance year 2017 is payable in 2018. This is split 50/50 in a cash payment and in an allocation of shares.
In 2018, Mr. Wynaendts and Mr. Rider are eligible to receive a cash payment of EUR 229,420 and EUR 99,758 respectively.
The number of shares to be made available in 2018 is 43,732 for Mr. Wynaendts and 19,017 for Mr. Rider. With regard to vested shares (with the exception of shares withheld to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares), a retention (holding) period of a further three years is applicable before they are at the disposal of the Executive Board members.
The remaining part of variable compensation for the performance year 2017 (60% of the total, which for Mr. Wynaendts equates to EUR 344,130 and 65,598 shares, and for Mr. Rider equates to EUR 149,633 and 28,522 shares) is to be paid out in future years, subject to ex-post assessments, which may result in downward adjustments and be subject to meeting additional conditions. In each of the years 2019, 2020 and 2021, 20% of the total variable compensation may be made available. Any payout is split 50/50 in a cash payment and an allocation of shares (vesting). After vesting (with the exception of shares withheld to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares), a retention (holding) period is applicable for a further three years, before shares are at the disposal of the Executive Board members.
Annual Report on Form 20-F 2017 |
130 | Governance Remuneration Report | |
Impact of ex-ante and ex-post assessment on attribution of variable compensation
No variable compensation from previous performance years payable in 2017 has been adjusted downwards in 2017.
No circumstances have been identified to lower payout of the deferred payment from prior performance years that vest in 2017 (the so called ex-post assessment) or to lower the payout of the up-front payment of the 2016 performance year variable compensation that vests in 2017 (the so called ex-ante assessment).
Future changes
No material changes to the executive board remuneration policy are foreseen for 2018. Compensation for individuals in the financial sector, in particular for those that materially influence the risk profile of the organization, does however continue to be a focus of regulatory attention. Aegon will ensure compliance if and when new regulations are approved. Any such regulations may require further deferral and the extension of holding periods, which Aegon will apply to new allocations of variable compensation going forward.
Annual Report on Form 20-F 2017 |
131 | Governance Corporate governance | |
Aegon is incorporated and based in the Netherlands. As a company established and listed in the Netherlands, Aegon must comply with Dutch law and is subject to the Dutch Corporate Governance Code.
Aegon is governed by three corporate bodies:
◆ | General Meeting of Shareholders |
◆ | Supervisory Board |
◆ | Executive Board |
Aegon also has a Management Board. This works in unison with the Executive Board, and helps to oversee operational issues and the implementation of Aegons strategy. Aegons corporate governance structure is the responsibility of both the Supervisory Board and the Executive Board. Any substantive change to this structure is submitted to the General Meeting of Shareholders for discussion.
The shareholders
Listing and shareholder base
Aegons common shares are listed on Euronext Amsterdam and the New York Stock Exchange. Aegon has institutional and retail shareholders around the world. More than three-quarters of shareholders are located in Aegons three main markets, the Netherlands, United States and the United Kingdom. Aegons largest shareholder is Vereniging Aegon, a Dutch association with a special purpose to protect the broader interests of the Company and its stakeholders.
General Meeting of Shareholders
A General Meeting of Shareholders is held at least once a year and, if deemed necessary, the Supervisory or Executive Board of the Company is able to convene an Extraordinary General Meeting of Shareholders. The main function of the General Meeting of Shareholders is to decide on matters such as the adoption of annual accounts, the approval of dividend payments and (re)appointments to the Supervisory Board and Executive Board of Aegon.
Convocation
General Meetings of Shareholders are convened by public notice at least 42 days before the meeting. The convocation states the time and location of the meeting, the record date, the agenda items, and the procedures for admittance to the meeting and representation at the meeting by means of a written proxy. Those shareholders who alone or jointly represent at least 1% of Aegons issued capital or a block of shares worth at least EUR 100 million may request items be added to the agenda of a General Meeting of Shareholders. In accordance with Aegons Articles of Association, such a request will be granted if it is received in writing at least 60 days before the meeting, and if there are no important interests of the Company that dictate otherwise.
Record date
The record date is used to determine shareholders entitlements with regard to their participation and voting rights. In accordance with Dutch law, the record date is 28 days before the day of the General Meeting of Shareholders.
Attendance
Every shareholder is entitled to attend the General Meeting to speak and vote, either in person or by proxy granted in writing. This includes proxies submitted electronically. All shareholders wishing to take part must provide proof of their identity and shareholding, and must notify the Company ahead of time of their intention to attend the meeting. Aegon also solicits proxies from New York registry shareholders in line with common practice in the United States.
Voting at the General Meeting
At the General Meeting, each common share carries one vote. In the absence of a Special Cause, Vereniging Aegon casts one vote for every 40 common shares B it holds.
Supervisory Board
Aegons Supervisory Board oversees the management of the Executive Board, in addition to the Companys business and corporate strategy. The Supervisory Board must take into account the interests of all Aegon stakeholders. The Supervisory Board operates according to the principles of collective responsibility and accountability.
Composition of the Supervisory Board
Members of the Supervisory Board are appointed by the General Meeting of Shareholders, following nomination by the Supervisory Board itself. Aegon aims to ensure that the composition of the Companys Supervisory Board is in line with Aegons diversity policy for the Supervisory Board, Executive Board and Management Board and is as such well-balanced in terms of professional background, geography, gender and other relevant aspects of the diversity policy. A profile, which is published on aegon.com, has been established that outlines the required qualifications of its members. Supervisory Board members are appointed for a four-year term, and may then be reappointed for another four-year period. Subsequently, the Supervisory Board member can be reappointed again for a period of two years, and then extended by two years at the most. Supervisory Board members are no longer eligible for (re)appointment after reaching the age of 70, unless the Supervisory Board decides to make an exception. Remuneration of the Supervisory Board members is determined by the General
Annual Report on Form 20-F 2017 |
132 | Governance Corporate governance | |
Meeting of Shareholders. In 2017, no transactions were concluded between the Company and any of the Supervisory Board members. Furthermore, the Company did not provide loans or issue guarantees to any members of the Supervisory Board. At present, Aegons Supervisory Board consists of nine members, all of whom qualify as independent in accordance with the Dutch Corporate Governance Code.
Committees
The Supervisory Board also oversees the activities of its committees. These committees are composed exclusively of Supervisory Board members and deal with specific issues related to Aegons financial accounts, risk management, executive remuneration and appointments. These committees are the:
◆ | Audit Committee; |
◆ | Risk Committee; |
◆ | Remuneration Committee; and |
◆ | Nomination and Governance Committee. |
Executive Board
Aegons Executive Board is charged with the overall management of the Company and is therefore responsible for achieving Aegons aims and developing the strategy and its associated risk profile, in addition to overseeing any relevant sustainability issues and the development of the Companys earnings. Each member has duties related to his or her specific area of expertise.
Aegons Articles of Association determine that for certain decisions the Executive Board must seek prior approval from the Supervisory Board and/or the approval of the General Meeting of Shareholders. In addition, the Supervisory Board may also subject other Executive Board decisions to its prior approval.
Composition of the Executive Board
Aegons Executive Board consists of Alexander R. Wynaendts, who is Chief Executive Officer (CEO) and Chairman of the Executive Board, and Matthew J. Rider, who is Chief Financial Officer (CFO), and member of the Executive Board, having been appointed to the Executive Board at the Annual General Meeting of the Company on May 19, 2017.
The number of Executive Board members and their terms of employment are determined by the Companys Supervisory Board. Executive Board members are appointed by the General Meeting of Shareholders for a four-year term, following nomination by the Supervisory Board.
The members of the Executive Board have an engagement agreement with the Company rather than an employment contract. The Companys Remuneration Policy for the Executive Board limits exit arrangements to a maximum of one year of the fixed component of the salary.
In 2017, no transactions were concluded between the Company and either member of the Executive Board. Furthermore, the
Company did not provide any loans to or issue guarantees in the favor of either of the members of the Executive Board.
Management Board
Aegons Executive Board is assisted in its work by the
Companys Management Board, which has ten members, including the members of the Executive Board. Aegons Management Board is composed of Alex Wynaendts, Matthew J. Rider, Mark Bloom, Adrian Grace, Allegra van Hövell-Patrizi, Marco Keim, Onno van Klinken, Carla Mahieu, Mark Mullin and Sarah Russell.
Aegons Management Board works in unison with the
Executive Board, and helps oversee operational issues and the implementation of Aegons strategy. Members are drawn from Aegons business units and from Aegons global functions. The members have both regional and global responsibilities. This ensures that Aegon is managed as an integrated international business. While the Executive Board is Aegons sole statutory executive body, the Management Board provides vital support and expertise in pursuit of the Companys strategic objectives.
In the relation between the Management Board and the Supervisory Board, the CEO shall be the first contact for the Supervisory Board and its Chairman. In addition thereto, and in connection with how the contacts between the Supervisory Board and the Management Board committee have been given shape, the members of the Management Board will act in accordance with the provisions provided therefore in the Management Board Charter, the Executive Board Charter and the Supervisory Board Charter.
Capital, significant shareholders and exercise of control
As a publicly-listed company, Aegon is required to provide the following detailed information regarding any structures or measures that may hinder or prevent a third party from acquiring the Company or exercising effective control over it.
The capital of the Company
Aegon has an authorized capital of EUR 1,080 million, divided into 6 billion common shares and 3 billion common shares B, each with a nominal value of EUR 0.12. As of December, 31 2017, a total of 2,095,648,244 common shares and 585,022,160 common shares B had been issued.
Depository receipts for Aegon shares are not issued with the Companys cooperation.
Each common share carries one vote. There are no restrictions on the exercise of voting rights by holders of common shares.
All common shares B are held by Vereniging Aegon, the Companys largest shareholder. The nominal value of the common shares B is equal to the nominal value of a common share. This means that common shares B also carry one vote per share. However, the voting rights attached to common
Annual Report on Form 20-F 2017 |
133 | Governance Corporate governance | |
shares B are subject to restrictions as laid down in the Voting Rights Agreement, under which Vereniging Aegon may cast one vote for every 40 common shares B it holds in the absence of a Special Cause.
The financial rights attached to a common share B are one-fortieth (1/40th) of the financial rights attached to a common share. The rights attached to the shares of both classes are otherwise identical. For the purpose of the issuance of shares, reduction of issued capital, the sale and transfer of common shares B or otherwise, the value or the price of a common share B is determined as one-fortieth (1/40th ) of the value of a common share. For such purposes, no account is taken of the difference between common shares and common shares B in terms of the proportion between financial rights and voting rights.
Significant shareholdings
On December 31, 2017, Vereniging Aegon, Aegons largest shareholder, held a total of 279,236,609 common shares and 569,676,480 common shares B.
Under the terms of the 1983 Merger Agreement as amended in May 2013, Vereniging Aegon has the option to acquire additional common shares B. Vereniging Aegon may exercise its call option to keep or restore its total stake to 32.6% of the voting rights, irrespective of the circumstances that caused the total shareholding to be or become lower than 32.6%.
During 2017, three transactions were concluded between Aegon N.V. and Vereniging Aegon under or in connection with the 1983 Merger Agreement. All requirements determined by Best Practice 2.7.5 of the Dutch Corporate Governance Code were complied with in the execution of these transactions.
On May 19, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 1,979,260 common shares B at fair value (1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on May 19, 2017, in connection with the Long Term Incentive Plans for senior management.
On June 23, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 13,042,612 common shares B at fair value (1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on June 23, 2017, in connection with the distribution of dividend in stock.
From October 2, 2017, to December 15, 2017, Aegon N.V. repurchased 51,864,626 common shares to neutralize the dilutive effect of the 2016 final and 2017 interim dividends in stock. Following the completion of this Share Buy Back Program, Aegon N.V. repurchased 13,042,612 Common Shares B from Vereniging Aegon for the amount of EUR 1.7 million,
(1/40th of the Value Weight Average Price of the Common Shares of the 5 trading days preceding this transaction) on December 15, 2017. The repurchase of common shares B was executed to align the aggregate shareholding of Vereniging Aegon in Aegon N.V. with its special cause voting rights of 32.6%.
To Aegons knowledge based on the filings made with the Dutch Autoriteit Financiële Markten, the US based investment management firm Dodge & Cox International Stock Fund holds a capital and voting interest in Aegon of over 5%.
Based on its last filing with the Dutch Autoriteit Financiële Markten as at September 22, 2016, Dodge & Cox International Stock Fund stated to hold 134,654,439 common shares, which represent 5.2% of the issued and outstanding capital and of the votes as at December 31, 2017.
On February 20, 2018, Dodge & Coxs filing with the
US Securities and Exchange Commission (SEC) shows that Dodge & Cox holds 256,029,115 common shares, representing 9.8% of the issued and outstanding capital as at December 31, 2017, and has voting rights for 250,384,686 shares, representing 9.6% of the votes as at December 31, 2017.
Based on its filing with the Dutch Autoriteit Financiële Markten as at May 26 2017, BlackRock, Inc. stated to hold 59,827,512 shares, representing 2.3% of the issued and outstanding capital as at December 31, 2017 and 79,077,402 voting rights, representing 3.0% of the votes as at December 31, 2017.
On February 20, 2018, BlackRock, Inc.s filing with the US Securities and Exchange Commission (SEC) shows that BlackRock holds 119,424,291 common shares, representing 4.6% of the issued and outstanding capital as at December 31, 2017, and has voting rights for 107,367,731 shares, representing 4.1% of the votes as at December 31, 2017.
Based on its filing with the Dutch Autoriteit Financiële Markten as at June 10, 2015, Franklin Resources, Inc (FRI). stated to hold 81,510,408 shares, representing 3.1% of the issued and outstanding capital and of the votes as of December 31, 2017.
On February 20, 2018, the filing of Franklin Resources, Inc. (FRI), a US based investment management firm, with the SEC shows that FRI holds 156,591,360 common shares and voting rights, representing 6.0% of the issued and outstanding capital, as at December 31, 2017.
Special control rights
As a matter of Dutch corporate law, the common shares and the common shares B offer equal full voting rights, as they have equal nominal value (EUR 0.12). The Voting Rights Agreement entered into between Vereniging Aegon and Aegon provides that under normal circumstances, i.e. except in the event of a Special Cause, Vereniging Aegon is not allowed to exercise more votes than is proportionate to the financial rights represented
Annual Report on Form 20-F 2017 |
134 | Governance Corporate governance | |
by its shares. This means that in the absence of a Special Cause, Vereniging Aegon may cast one vote for every common share it holds and one vote only for every 40 common shares B it holds. In the event of a Special Cause, Vereniging Aegon may cast one vote for every common share and one vote for every common share B.
A Special Cause may include:
◆ | The acquisition by a third party of an interest in Aegon N.V. amounting to 15% or more; |
◆ | A tender offer for Aegon N.V. shares; or |
◆ | A proposed business combination by any person or group of persons, whether acting individually or as a group, other than in a transaction approved by the Companys Executive and Supervisory Boards. |
If Vereniging Aegon, acting at its sole discretion, determines that a Special Cause has arisen, it must notify the General Meeting of Shareholders. In this event, Vereniging Aegon retains full voting rights on its common shares B for a period limited to six months. Vereniging Aegon would, for that limited period, command 32.6% of the votes at a General Meeting of Shareholders.
Issue and repurchase of shares
New shares may be issued up to the maximum of the Companys authorized capital, following a resolution adopted by the General Meeting of Shareholders. Shares may also be issued following a resolution of the Executive Board, subject to approval by the Supervisory Board, providing, and to the extent that, the Board has been authorized to do so by the General Meeting of Shareholders. A resolution authorizing the Executive Board to issue new shares is usually presented at Aegons Annual General Meeting of Shareholders.
Aegon is entitled to acquire its own fully paid-up shares, providing it acts within existing statutory restrictions. Shareholders usually authorize the Executive Board to purchase the Companys shares under terms and conditions determined by the General Meeting.
Transfer of shares
There are no restrictions on the transfer of common shares. Common shares B can only be transferred with the prior approval of Aegons Supervisory Board.
Aegon has no knowledge of any agreement between shareholders that might restrict the transfer of shares or the voting rights pertaining to them.
Significant agreements and potential change of control
Aegon is not party to any significant agreements that would take effect, alter or terminate as a result of a change of control following a public offer for the outstanding shares of the Company, other than those customary in financial markets
(for example, financial arrangements, loans and joint venture agreements).
Share plan
Senior executives at Aegon companies and some other employees are entitled to variable compensation of which part is granted in the form of shares. For further details, please see the remuneration-report on page 123 and note 53 of the notes to Aegons consolidated financial statements of this Annual Report. Under the terms of existing share plans the vesting of granted rights is predefined. The shares shall vest as soon as possible in accordance with payroll requirements of the relevant subsidiary after the adoption of the Companys Annual Report at the Annual General Meetings of Shareholders in the year of vesting of these shares.
Appointing, suspending or dismissing Board members
The General Meeting of Shareholders appoints members of both the Supervisory and Executive Boards, following nominations by the Supervisory Board. These nominations are binding providing at least two candidates are nominated. The General Meeting of Shareholders may cancel the binding nature of these nominations with a majority of two-thirds of votes cast, representing at least one half of Aegons issued capital. The General Meeting may, in addition, bring forward a resolution to appoint someone not nominated by the Supervisory Board. Such a resolution also requires a two-thirds majority of votes cast, representing at least one half of Aegons issued capital.
Members of Aegons Supervisory and Executive Boards may be suspended or dismissed by the General Meeting of Shareholders with a two-thirds majority of votes cast, representing at least one half of Aegons issued capital, unless the suspension or dismissal has first been proposed by the Companys Supervisory Board. A member of the Executive Board may also be suspended by the Supervisory Board, although the General Meeting of Shareholders has the power to annul this suspension.
Amending the Articles of Association
The General Meeting of Shareholders may, with an absolute majority of votes cast, pass a resolution to amend Aegons Articles of Association or to dissolve the Company, in accordance with a proposal made by the Executive Board and approved by the Supervisory Board.
Dutch Corporate Governance Code
As a company based in the Netherlands, Aegon adheres to the Dutch Corporate Governance Code. The version of the code applicable to the financial year 2017 is the version that came into force on January 1, 2017. Aegon endorses the Code and strongly supports its principles for sound and responsible corporate governance and long-term value creation. Aegon regards the Code as an effective means to help ensure that the interests of all stakeholders are duly represented and taken into account. It is the responsibility of both the Supervisory Board
Annual Report on Form 20-F 2017 |
135 | Governance Corporate governance | |
and the Executive Board to oversee Aegons overall corporate governance structure.
In general, Aegon applies the best practice provisions set out in the Code. There is one best practice provision with which Aegon does not fully apply. In this case, Aegon adheres, as much as is possible, to the spirit of the Code.
Best Practice 4.3.3
The Dutch Corporate Governance Code recommends that the General Meeting of Shareholders may cancel the binding nature of nominations for appointments of members of the Executive Board and Supervisory Board with an absolute majority of votes and a limited quorum.
Aegons position on Best Practice 4.3.3
Aegons Articles of Association provide for a larger majority and a higher quorum than those advocated by the Code. Given that the Company has no specific anti-takeover measures, the current system is deemed appropriate within the context of the 1983 Merger Agreement under which Aegon was formed. However, to mitigate any possible negative effects stemming from this, the Supervisory Board has decided that, in the absence of any hostile action, it will only make nominations for the appointment of members to the Executive and Supervisory Boards that are non-binding in nature.
Corporate Governance Statement
For an extensive review of Aegons compliance with the Dutch Corporate Governance Code, please refer to the Corporate Governance Statement on Aegons corporate website.
Annual Report on Form 20-F 2017 |
136 | Governance Differences between Dutch and US company laws | |
Differences between Dutch and US company laws
Dutch company law is different from US law in the following respects: Aegon, like most large Dutch public companies, has a two-tier governance system comprising an Executive Board and a Supervisory Board. The Executive Board is the executive body. Its members are not Aegon employees and have an engagement agreement with the Company. Members of the Executive Board are appointed and dismissed by the General Meeting of Shareholders, as inside directors are in the United States. The Remuneration Policy as regards the members of the Executive Board is adopted by the General Meeting of Shareholders. The number of the Executive Board members and the terms of their engagement are determined by the Supervisory Board within the scope of the adopted Remuneration Policy.
The Supervisory Board performs supervisory and advisory functions only, and its members are outsiders that are not employed by the Company. The Supervisory Board has the duty to supervise the performance of the Executive Board, the Companys general course of affairs and the business connected with it. The Supervisory Board also assists the Executive Board by giving advice. Other powers of the Supervisory Board include the prior approval of certain important resolutions of the Executive Board. Members of the Supervisory Board are appointed for a four-year term and may be dismissed by the General Meeting of Shareholders. The remuneration of Supervisory Board members is fixed by the General Meeting of Shareholders. Resolutions entailing a significant change in the identity or character of the Company or its business require the approval of the General Meeting of Shareholders.
Annual Report on Form 20-F 2017 |
137 | Governance Code of ethics | |
Aegons Code of Conduct is a code of ethics that outlines the Companys ethical principles in relation to various subjects. This code applies to all directors, officers (regardless of the contractual basis of their employment) and employees of all Aegon companies. This includes members of the Executive Board, the Management Board and the Supervisory Board of Aegon N.V., as well as other executive and non-executive or supervisory directors of Aegon companies.
Aegons Code of Conduct is available on aegon.com. The Code outlines Aegons clear commitment to a customer centric approach, and reflects Aegons core values: Working Together; Bringing Clarity and Exceeding Expectations. The Code of Conduct was updated in 2017. All Aegon employees sign the Code
of Conduct to declare their compliance with the Code. Moreover, the rolling out of a new Code of Conduct e-learning for all Aegon companies began in 2017 and will continue in 2018.
In order to support the Code, Aegon has engaged a vendor to supply a tool that enables employees and third parties to report actual or potential violations of the Code on an anonymous and confidential basis. Employees are encouraged to raise concerns. All reports are investigated and results are reported to the Audit Committee of the Supervisory Board. Suspected or actual frauds that exceed certain thresholds must also be reported to Group Regulatory Compliance. All fraud matters are investigated and corrective actions are taken as appropriate.
Annual Report on Form 20-F 2017 |
138 | Governance Controls and procedures | |
Disclosure controls and procedures
At the end of the period covered by this Annual Report, Aegons management carried out an evaluation, under the supervision and with the participation of its Chief Executive Officer (CEO) and Chief Financial Officer (CFO), of the effectiveness of the design and operation of Aegons disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based on this evaluation, Aegons CEO and CFO concluded that, as of December 31, 2017, the disclosure controls and procedures were effective. There have been no material changes in the Companys internal controls or in other factors that could significantly affect internal controls over financial reporting subsequent to the end of the period covered by this Annual Report.
Due to the listing of Aegon shares on the New York Stock Exchange, Aegon is required to comply with the US Securities and Exchange Commission regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act, or SOX 404. These regulations require that Aegons CEO (the Chairman of the Executive Board) and CFO report on and certify the effectiveness of Aegons internal controls over financial reporting on an annual basis. Furthermore, external auditors are required to provide an opinion on the effectiveness of Aegons internal controls over financial reporting. The SOX 404 statement by the Executive Board is stated below, followed by the report of the external auditor.
Managements Annual Report on internal control over financial reporting
The directors and management of Aegon are responsible for establishing and maintaining adequate internal control over financial reporting. Aegons internal control over financial reporting is a process designed under the supervision of Aegons principal executive and financial officers to provide reasonable assurance regarding the reliability of financial reporting and the preparation of its published financial statements. Internal control over financial reporting includes policies and procedures that:
◆ | Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; |
◆ | Provide reasonable assurance that transactions are recorded as necessary to permit the preparation of financial statements in accordance with generally accepted accounting principles; |
◆ | Provide reasonable assurance that receipts and expenditures are made only in accordance with the authorizations of management and directors of the Company; and |
◆ | Provide reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on Aegons financial statements would be prevented or detected in a timely manner. |
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.
Management assessed the effectiveness of Aegons internal control over financial reporting as of December 31, 2017.
In making its assessment management used the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO, 2013 framework).
Based on the assessment, management concluded that, in all material aspects, the internal control over financial reporting was effective as of December 31, 2017. They have reviewed the results of its work with the Audit Committee of the Supervisory Board.
The effectiveness of internal control over financial reporting as of December 31, 2017, was audited by PricewaterhouseCoopers Accountants N.V., an independent registered public accounting firm, as stated in their report included on page 332.
Managements assessment of going concern
The directors and management of Aegon have adopted a going concern basis, in preparing the consolidated financial statements, on the reasonable assumption that the Company is, and will be, able to continue its normal course of business in the foreseeable future.
Relevant facts and circumstances relating to the consolidated financial position on December 31, 2017, were assessed in order to reach the going concern assumption. The main areas assessed are financial performance, capital adequacy, financial flexibility, liquidity and access to capital markets, together with the factors likely to affect Aegons future development, performance and financial position. Commentary on these is set out in the Business Overview sections Results of operations, Risk management and Capital and liquidity management in this Annual Report. Taking into account the financial performance of the Company, its continued ability to access capital markets, the fact that its solvency and leverage ratios are well within target range, and the level of excess cash in the holding, management concluded that the going concern assumption is appropriate.
The Hague, March 22, 2018
The Executive Board of Aegon N.V.
Annual Report on Form 20-F 2017 |
139 | Governance Controls and procedures | |
Report of Independent Registered
Public Accounting Firm
To: The Annual General Meeting of Shareholders and Supervisory Board of Aegon N.V.
In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Companys management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Managements Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Companys internal control over financial reporting based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Companys assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
PricewaterhouseCoopers Accountants N.V.
Amsterdam, The Netherlands,
March 22, 2018
Annual Report on Form 20-F 2017 |
141 | Consolidated financial statements of Aegon N.V. | |
143 | ||||||
144 | ||||||
Consolidated statement of comprehensive income of Aegon N.V. |
145 | |||||
146 | ||||||
147 | ||||||
150 | ||||||
Notes to the consolidated financial statements | ||||||
1 |
General information | 151 | ||||
2 |
Summary of significant accounting policies | 151 | ||||
3 |
Critical accounting estimates and judgment in applying accounting policies | 173 | ||||
4 |
Financial risks | 175 | ||||
5 |
Segment information | 202 | ||||
6 |
Premium income and premiums paid to reinsurers | 213 | ||||
7 |
Investment income | 213 | ||||
8 |
Fee and commission income | 214 | ||||
9 |
Income from reinsurance ceded | 214 | ||||
10 |
Results from financial transactions | 214 | ||||
11 |
Other income | 216 | ||||
12 |
Policyholder claims and benefits | 216 | ||||
13 |
Profit sharing and rebates | 216 | ||||
14 |
Commissions and expenses | 216 | ||||
15 |
Impairment charges / (reversals) | 218 | ||||
16 |
Interest charges and related fees | 219 | ||||
17 |
Other charges | 219 | ||||
18 |
Income tax | 220 | ||||
19 |
Earnings per share | 221 | ||||
20 |
Dividend per common share | 222 | ||||
21 |
Cash and cash equivalents | 223 |
Annual Report on Form 20-F 2017 |
142 | Consolidated financial statements of Aegon N.V. | |
|
|
|||||
307 | ||||||
308 | ||||||
Notes to the financial statements | ||||||
1 |
General information | 309 | ||||
2 |
Summary of significant accounting policies | 309 | ||||
3 |
Investment income | 309 | ||||
4 |
Results from financial transactions | 310 | ||||
5 |
Commissions and expenses | 310 | ||||
6 |
Interest charges and related fees | 310 | ||||
7 |
Income tax | 310 | ||||
8 |
Shares in group companies | 310 | ||||
9 |
Loans to group companies | 311 | ||||
10 |
Receivables | 311 | ||||
11 |
Other assets | 311 | ||||
12 |
Share capital | 311 | ||||
13 |
Shareholders equity | 313 | ||||
14 |
Other equity instruments | 316 | ||||
15 |
Subordinated borrowings | 317 | ||||
16 |
Long-term borrowings | 318 | ||||
17 |
Other liabilities | 318 | ||||
18 |
Commitments and contingencies | 318 | ||||
19 |
Number of employees | 318 | ||||
20 |
Accountants remuneration | 318 | ||||
21 |
Events after the reporting period | 319 | ||||
22 |
Proposal for profit appropriation | 319 | ||||
Other information | ||||||
320 | ||||||
321 |
|
||
324 | ||
325 | ||
328 | ||
330 | ||
331 | ||
Auditors report on the Annual Report on Form 20-F | 332 | |
Additional information | ||
335 | ||
336 | ||
356 | ||
356 | ||
357 | ||
358 | ||
359 | ||
360 | ||
360 | ||
361 | ||
368 | ||
Purchases of equity securities by the issuer and affiliated purchasers |
369 | |
370 | ||
376 | ||
377 | ||
378 | ||
380 | ||
381 | ||
382 |
Annual Report on Form 20-F 2017 |
143 | Consolidated financial statements of Aegon N.V. | |
Exchange rates at December 31,
2017 | 2016 | |||||||||||||||||||||||||||
EUR | USD | GBP | EUR | USD | GBP | |||||||||||||||||||||||
1 | EUR | - | 1.2008 | 0.8877 | - | 1.0548 | 0.8536 | |||||||||||||||||||||
1 | USD | 0.8328 | - | 0.7393 | 0.9480 | - | 0.8093 | |||||||||||||||||||||
1 |
GBP | 1.1265 | 1.3527 | - | 1.1715 | 1.2357 | - |
Weighted average exchange rates
2017 | 2016 | 2015 | ||||||||||||||||||||||||||||||||||||
EUR | USD | GBP | EUR | USD | GBP | EUR | USD | GBP | ||||||||||||||||||||||||||||||
1 | EUR | - | 1.1291 | 0.8758 | - | 1.1069 | 0.8187 | - | 1.1100 | 0.7256 | ||||||||||||||||||||||||||||
1 | USD | 0.8857 | - | 0.7757 | 0.9034 | - | 0.7396 | 0.9009 | - | 0.6537 | ||||||||||||||||||||||||||||
1 |
GBP | 1.1418 | 1.2892 | - | 1.2214 | 1.3520 | - | 1.3782 | 1.5298 | - |
Annual Report on Form 20-F 2017 |
144 | Consolidated financial statements of Aegon N.V. | |
Consolidated inco me statement of Aegon N.V.
For the year ended December 31
Amounts in EUR million (except per share data) |
Note | 2017 | 2016 | 2015 | ||||||||||||
Premium income |
6 | 22,826 | 23,453 | 22,925 | ||||||||||||
Investment income |
7 | 7,338 | 7,788 | 8,525 | ||||||||||||
Fee and commission income |
8 | 2,802 | 2,408 | 2,438 | ||||||||||||
Other revenues |
7 | 7 | 14 | |||||||||||||
Total revenues |
32,973 | 33,655 | 33,902 | |||||||||||||
Income from reinsurance ceded |
9 | 4,288 | 3,687 | 3,321 | ||||||||||||
Results from financial transactions |
10 | 20,250 | 15,753 | 521 | ||||||||||||
Other income |
11 | 540 | 66 | 83 | ||||||||||||
Total income |
58,052 | 53,162 | 37,827 | |||||||||||||
Premiums paid to reinsurers |
6 | 3,431 | 3,176 | 2,979 | ||||||||||||
Policyholder claims and benefits |
12 | 45,599 | 41,974 | 26,443 | ||||||||||||
Profit sharing and rebates |
13 | 23 | 49 | 31 | ||||||||||||
Commissions and expenses |
14 | 5,925 | 6,351 | 6,598 | ||||||||||||
Impairment charges / (reversals) |
15 | 42 | 95 | 1,251 | ||||||||||||
Interest charges and related fees |
16 | 435 | 347 | 412 | ||||||||||||
Other charges |
17 | 235 | 700 | 774 | ||||||||||||
Total charges
|
|
55,689
|
|
|
52,693
|
|
|
38,489
|
|
|||||||
Income before share in profit / (loss) of joint ventures, associates and tax |
2,363 | 470 | (661 | ) | ||||||||||||
Share in profit / (loss) of joint ventures |
161 | 137 | 142 | |||||||||||||
Share in profit / (loss) of associates |
11 | 3 | 5 | |||||||||||||
Income / (loss) before tax |
2,534 | 610 | (514 | ) | ||||||||||||
Income tax (expense) / benefit |
18 | (65 | ) | (172 | ) | 83 | ||||||||||
Net income / (loss) |
2,469 | 438 | (431 | ) | ||||||||||||
Net income / (loss) attributable to: |
||||||||||||||||
Owners of Aegon N.V. |
2,469 | 437 | (432 | ) | ||||||||||||
Non-controlling interests |
- | - | 1 | |||||||||||||
Earnings per share (EUR per share) |
19 | |||||||||||||||
Basic earnings per common share |
1.14 | 0.15 | (0.27 | ) | ||||||||||||
Basic earnings per common share B |
0.03 | - | (0.01 | ) | ||||||||||||
Diluted earnings per common share |
1.14 | 0.15 | (0.27 | ) | ||||||||||||
Diluted earnings per common share B |
0.03 | - | (0.01 | ) |
Annual Report on Form 20-F 2017 |
145 | Consolidated financial statements of Aegon N.V. | |
Consolidated statement of comprehensive income of Aegon N.V.
For the year ended December 31
Amounts in EUR million |
2017 | 2016 | 2015 | |||||||||
Net income / (loss) |
2,469 | 438 | (431 | ) | ||||||||
Items that will not be reclassified to profit or loss : |
||||||||||||
Changes in revaluation reserve real estate held for own use |
8 | 8 | 13 | |||||||||
Remeasurements of defined benefit plans |
224 | (392 | ) | 240 | ||||||||
Income tax relating to items that will not be reclassified |
(166 | ) | 86 | (77 | ) | |||||||
Items that may be reclassified subsequently to profit or loss: |
||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
1,283 | 854 | (2,175 | ) | ||||||||
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
(1,330 | ) | (2,122 | ) | (485 | ) | ||||||
Changes in cash flow hedging reserve |
(853 | ) | (54 | ) | 446 | |||||||
Movement in foreign currency translation and net foreign investment hedging reserves |
(2,149 | ) | 69 | 1,419 | ||||||||
Equity movements of joint ventures |
(15 | ) | 9 | (8 | ) | |||||||
Equity movements of associates |
(5 | ) | 3 | (1 | ) | |||||||
Disposal of group assets |
7 | - | (544 | ) | ||||||||
Income tax relating to items that may be reclassified |
951 | 225 | 783 | |||||||||
Other |
9 | 12 | 9 | |||||||||
Total other comprehensive income / (loss) |
(2,038 | ) | (1,301 | ) | (380 | ) | ||||||
Total comprehensive income / (loss) |
431 | (863 | ) | (811 | ) | |||||||
Total comprehensive income/ (loss) attributable to: |
||||||||||||
Owners of Aegon N.V. |
435 | (878 | ) | (811 | ) | |||||||
Non-controlling interests |
(3 | ) | 15 | - |
Annual Report on Form 20-F 2017 |
146 | Consolidated financial statements of Aegon N.V. | |
Consolidated statement of financial position of Aegon N.V.
As at December 31
Amounts in EUR million |
Note | 2017 | 2016 | |||||||||
Assets |
||||||||||||
Cash and cash equivalents |
21 | 10,768 | 11,347 | |||||||||
Assets held for sale |
22 | 5,249 | 8,705 | |||||||||
Investments |
23 | 136,804 | 156,303 | |||||||||
Investments for account of policyholders |
24 | 194,063 | 203,610 | |||||||||
Derivatives |
25 | 5,912 | 8,318 | |||||||||
Investments in joint ventures |
26 | 1,712 | 1,614 | |||||||||
Investments in associates |
27 | 308 | 270 | |||||||||
Reinsurance assets |
28 | 19,202 | 11,208 | |||||||||
Defined benefit assets |
41 | 55 | 51 | |||||||||
Deferred tax assets |
43 | 79 | 87 | |||||||||
Deferred expenses |
29 | 10,135 | 11,423 | |||||||||
Other assets and receivables |
30 | 10,002 | 10,667 | |||||||||
Intangible assets |
31 | 1,633 | 1,820 | |||||||||
Total assets |
395,923 | 425,425 | ||||||||||
Equity and liabilities |
||||||||||||
Shareholders equity |
32 | 20,288 | 20,520 | |||||||||
Other equity instruments |
33 | 3,794 | 3,797 | |||||||||
Issued capital and reserves attributable to owners of Aegon N.V. |
24,082 | 24,318 | ||||||||||
Non-controlling interests |
20 | 23 | ||||||||||
Group equity |
24,102 | 24,341 | ||||||||||
Subordinated borrowings |
34 | 764 | 767 | |||||||||
Trust pass-through securities |
35 | 133 | 156 | |||||||||
Insurance contracts |
36 | 110,818 | 119,569 | |||||||||
Insurance contracts for account of policyholders |
36 | 122,168 | 120,929 | |||||||||
Investment contracts |
37 | 16,943 | 19,572 | |||||||||
Investment contracts for account of policyholders |
37 | 74,434 | 84,774 | |||||||||
Derivatives |
25 | 7,130 | 8,878 | |||||||||
Borrowings |
39 | 13,635 | 13,153 | |||||||||
Provisions |
40 | 210 | 173 | |||||||||
Defined benefit liabilities |
41 | 4,005 | 4,817 | |||||||||
Deferred gains |
42 | 13 | 64 | |||||||||
Deferred tax liabilities |
43 | 1,029 | 2,201 | |||||||||
Liabilities held for sale |
22 | 5,003 | 8,816 | |||||||||
Other liabilities |
44 | 15,208 | 16,978 | |||||||||
Accruals |
45 | 329 | 237 | |||||||||
Total liabilities
|
|
371,821
|
|
|
401,084
|
|
||||||
Total equity and liabilities |
395,923 | 425,425 |
Annual Report on Form 20-F 2017 |
147 | Consolidated financial statements of Aegon N.V. | |
Consolidated statement of chang es i n equity of Aegon N.V.
For the year ended December 31, 2017
Amounts in EUR million |
Note |
|
Share
capital |
|
|
Retained
earnings |
|
|
Revaluation
reserves |
|
|
Remea-
surement of defined benefit plans |
|
|
Other
reserves |
|
|
Other
equity instru- ments |
|
|
Issued
capital and reserves 1) |
|
|
Non-
controlling interests |
|
Total | ||||||||||||||
At January 1, 2017 |
8,193 | 7,419 | 5,381 | (1,820 | ) | 1,347 | 3,797 | 24,318 | 23 | 24,341 | ||||||||||||||||||||||||||||||
Net income / (loss) recognized in the income statement |
- | 2,469 | - | - | - | - | 2,469 | - | 2,469 | |||||||||||||||||||||||||||||||
Other comprehensive income: Items that will not be reclassified to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
Changes in revaluation reserve real estate held for own use |
- | - | 8 | - | - | - | 8 | - | 8 | |||||||||||||||||||||||||||||||
Remeasurements of defined benefit plans |
- | - | - | 224 | - | - | 224 | - | 224 | |||||||||||||||||||||||||||||||
Income tax relating to items that will not be reclassified |
- | - | 9 | (175 | ) | - | - | (166 | ) | - | (166 | ) | ||||||||||||||||||||||||||||
Items that may be reclassified subsequently to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
- | - | 1,283 | - | - | - | 1,283 | - | 1,283 | |||||||||||||||||||||||||||||||
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
- | - | (1,330 | ) | - | - | - | (1,330 | ) | - | (1,330 | ) | ||||||||||||||||||||||||||||
Changes in cash flow hedging reserve |
- | - | (853 | ) | - | - | - | (853 | ) | - | (853 | ) | ||||||||||||||||||||||||||||
Movements in foreign currency translation and net foreign investment hedging reserves |
- | - | (452 | ) | 102 | (1,800 | ) | - | (2,149 | ) | - | (2,149 | ) | |||||||||||||||||||||||||||
Equity movements of joint ventures |
- | - | - | - | (15 | ) | - | (15 | ) | - | (15 | ) | ||||||||||||||||||||||||||||
Equity movements of associates |
- | - | - | - | (5 | ) | - | (5 | ) | - | (5 | ) | ||||||||||||||||||||||||||||
Disposal of group assets |
- | - | - | - | 7 | - | 7 | - | 7 | |||||||||||||||||||||||||||||||
Income tax relating to items that may be reclassified |
- | - | 874 | - | 76 | - | 951 | - | 951 | |||||||||||||||||||||||||||||||
Other |
- | 13 | - | - | - | - | 13 | (3 | ) | 9 | ||||||||||||||||||||||||||||||
Total other comprehensive income / (loss)
|
|
-
|
|
|
13
|
|
|
(461
|
)
|
|
151
|
|
|
(1,737
|
)
|
|
-
|
|
|
(2,034
|
)
|
|
(3
|
)
|
|
(2,038
|
)
|
|||||||||||||
Total comprehensive income / (loss) for 2017 | - | 2,482 | (461 | ) | 151 | (1,737 | ) | - | 435 | (3 | ) | 431 | ||||||||||||||||||||||||||||
Shares issued |
3 | - | - | - | - | - | 3 | - | 3 | |||||||||||||||||||||||||||||||
Issuance and purchase of treasury shares |
- | (105 | ) | - | - | - | - | (105 | ) | - | (105 | ) | ||||||||||||||||||||||||||||
Dividends paid on common shares |
(142 | ) | (296 | ) | - | - | - | - | (439 | ) | - | (439 | ) | |||||||||||||||||||||||||||
Dividend withholding tax reduction |
- | 2 | - | - | - | - | 2 | - | 2 | |||||||||||||||||||||||||||||||
Coupons on perpetual securities |
- | (103 | ) | - | - | - | - | (103 | ) | - | (103 | ) | ||||||||||||||||||||||||||||
Coupons on non-cumulative subordinated notes |
- | (28 | ) | - | - | - | - | (28 | ) | - | (28 | ) | ||||||||||||||||||||||||||||
Incentive plans |
- | 4 | - | - | - | (4 | ) | (1 | ) | - | (1 | ) | ||||||||||||||||||||||||||||
At December 31, 2017 |
32, 33 | 8,053 | 9,374 | 4,920 | (1,669 | ) | (390 | ) | 3,794 | 24,082 | 20 | 24,102 |
1 | Issued capital and reserves attributable to owners of Aegon N.V. |
Annual Report on Form 20-F 2017 |
148 | Consolidated financial statements of Aegon N.V. | |
Consolidated statement of changes in equity of Aegon N.V.
For the year ended December 31, 2016
Amounts in EUR million | Note |
Share
capital |
Retained
earnings |
Revaluation
reserves |
Remea-
surement of defined benefit plans |
Other
reserves |
Other
equity instru- ments |
Issued
capital and reserves 1) |
Non-con-
trolling interests |
Total | ||||||||||||||||||||||||||||||
At January 1, 2016 |
8,387 | 7,832 | 6,471 | (1,532 | ) | 1,283 | 3,800 | 26,241 | 9 | 26,250 | ||||||||||||||||||||||||||||||
Net income / (loss) recognized in the income statement |
- | 437 | - | - | - | - | 437 | - | 438 | |||||||||||||||||||||||||||||||
Other comprehensive income: |
||||||||||||||||||||||||||||||||||||||||
Items that will not be reclassified to profit or loss: | ||||||||||||||||||||||||||||||||||||||||
Changes in revaluation reserve real estate held for own use |
- | - | 8 | - | - | - | 8 | - | 8 | |||||||||||||||||||||||||||||||
Remeasurements of defined benefit plans |
- | - | - | (392 | ) | - | - | (392 | ) | - | (392 | ) | ||||||||||||||||||||||||||||
Income tax relating to items that will not be reclassified |
- | - | (3 | ) | 89 | - | - | 86 | - | 86 | ||||||||||||||||||||||||||||||
Items that may be reclassified subsequently to profit or loss: | ||||||||||||||||||||||||||||||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
- | - | 854 | - | - | - | 854 | - | 854 | |||||||||||||||||||||||||||||||
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
- | - | (2,122 | ) | - | - | - | (2,122 | ) | - | (2,122 | ) | ||||||||||||||||||||||||||||
Changes in cash flow hedging reserve |
- | - | (54 | ) | - | - | - | (54 | ) | - | (54 | ) | ||||||||||||||||||||||||||||
Movements in foreign currency translation and net foreign investment hedging reserves |
- | - | (38 | ) | 16 | 91 | - | 69 | - | 69 | ||||||||||||||||||||||||||||||
Equity movements of joint ventures |
- | - | - | - | 9 | - | 9 | - | 9 | |||||||||||||||||||||||||||||||
Equity movements of associates |
- | - | - | - | 3 | - | 3 | - | 3 | |||||||||||||||||||||||||||||||
Income tax relating to items that may be reclassified |
- | - | 264 | - | (39 | ) | - | 225 | - | 225 | ||||||||||||||||||||||||||||||
Other |
- | (2 | ) | - | - | - | - | (2 | ) | 14 | 12 | |||||||||||||||||||||||||||||
Total other comprehensive income / (loss)
|
|
-
|
|
|
(2
|
)
|
|
(1,090
|
)
|
|
(288
|
)
|
|
64
|
|
|
-
|
|
|
(1,315
|
)
|
|
14
|
|
|
(1,301
|
)
|
|||||||||||||
Total comprehensive income / (loss) for 2016 | - | 435 | (1,090 | ) | (288 | ) | 64 | - | (878 | ) | 15 | (863 | ) | |||||||||||||||||||||||||||
Shares issued |
1 | - | - | - | - | - | 1 | - | 1 | |||||||||||||||||||||||||||||||
Shares withdrawn |
(10 | ) | (372 | ) | - | - | - | - | (382 | ) | - | (382 | ) | |||||||||||||||||||||||||||
Issuance and purchase of treasury shares |
- | (27 | ) | - | - | - | - | (27 | ) | - | (27 | ) | ||||||||||||||||||||||||||||
Dividends paid on common shares |
(186 | ) | (304 | ) | - | - | - | - | (490 | ) | - | (490 | ) | |||||||||||||||||||||||||||
Dividend withholding tax reduction |
- | (2 | ) | - | - | - | - | (2 | ) | - | (2 | ) | ||||||||||||||||||||||||||||
Coupons on perpetual securities |
- | (105 | ) | - | - | - | - | (105 | ) | - | (105 | ) | ||||||||||||||||||||||||||||
Coupons on non-cumulative subordinated notes |
- | (28 | ) | - | - | - | - | (28 | ) | - | (28 | ) | ||||||||||||||||||||||||||||
Incentive plans |
- | (9 | ) | - | - | - | (3 | ) | (12 | ) | - | (12 | ) | |||||||||||||||||||||||||||
At December 31, 2016 |
32, 33 | 8,193 | 7,419 | 5,381 | (1,820 | ) | 1,347 | 3,797 | 24,318 | 23 | 24,341 |
1 | Issued capital and reserves attributable to owners of Aegon N.V. |
Annual Report on Form 20-F 2017 |
149 | Consolidated financial statements of Aegon N.V. | |
Consolidated statement of changes in equity of Aegon N.V.
For the year ended December 31, 2015
Amounts in EUR million | Note |
Share
capital |
Retained
earnings |
Revaluation
reserves |
Remea-
surement of defined benefit plans |
Other
reserves |
Other
equity instru- ments |
Issued
capital and reserves 1) |
Non-con-
trolling interests |
Total | ||||||||||||||||||||||||||||||
At January 1, 2015 |
8,597 | 8,639 | 8,308 | (1,611 | ) | (86 | ) | 3,827 | 27,674 | 9 | 27,683 | |||||||||||||||||||||||||||||
Net income / (loss) recognized in the income statement |
- | (432 | ) | - | - | - | - | (432 | ) | 1 | (431 | ) | ||||||||||||||||||||||||||||
Other comprehensive income: | ||||||||||||||||||||||||||||||||||||||||
Items that will not be reclassified to profit or loss: | ||||||||||||||||||||||||||||||||||||||||
Changes in revaluation reserve real estate held for own use |
- | - | 13 | - | - | - | 13 | - | 13 | |||||||||||||||||||||||||||||||
Remeasurements of defined benefit plans |
- | - | - | 240 | - | - | 240 | - | 240 | |||||||||||||||||||||||||||||||
Income tax relating to items that will not be reclassified |
- | - | (2 | ) | (75 | ) | - | - | (77 | ) | - | (77 | ) | |||||||||||||||||||||||||||
Items that may be reclassified subsequently to profit or loss: | ||||||||||||||||||||||||||||||||||||||||
Gains / (losses) on revaluation of available-for-sale investments |
- | - | (2,175 | ) | - | - | - | (2,175 | ) | - | (2,175 | ) | ||||||||||||||||||||||||||||
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
- | - | (485 | ) | - | - | - | (485 | ) | - | (485 | ) | ||||||||||||||||||||||||||||
Changes in cash flow hedging reserve |
- | - | 446 | - | - | - | 446 | - | 446 | |||||||||||||||||||||||||||||||
Movements in foreign currency translation and net foreign investment hedging reserves |
- | - | - | (86 | ) | 1,505 | - | 1,419 | - | 1,419 | ||||||||||||||||||||||||||||||
Equity movements of joint ventures |
- | - | - | - | (8 | ) | - | (8 | ) | - | (8 | ) | ||||||||||||||||||||||||||||
Equity movements of associates |
- | - | - | - | (1 | ) | - | (1 | ) | - | (1 | ) | ||||||||||||||||||||||||||||
Disposal of group assets 2) |
- | - | (468 | ) | - | (76 | ) | - | (544 | ) | - | (544 | ) | |||||||||||||||||||||||||||
Income tax relating to items that may be reclassified |
- | - | 836 | - | (52 | ) | - | 783 | - | 783 | ||||||||||||||||||||||||||||||
Other |
- | 10 | - | - | - | - | 10 | (1 | ) | 9 | ||||||||||||||||||||||||||||||
Total other comprehensive income / (loss)
|
|
-
|
|
|
10
|
|
|
(1,837
|
)
|
|
79
|
|
|
1,369
|
|
|
-
|
|
|
(379
|
)
|
|
(1
|
)
|
|
(380
|
)
|
|||||||||||||
Total comprehensive income / (loss) for 2015 | - | (422 | ) | (1,837 | ) | 79 | 1,369 | - | (811 | ) | - | (811 | ) | |||||||||||||||||||||||||||
Shares issued and withdrawn |
1 | - | - | - | - | - | 1 | - | 1 | |||||||||||||||||||||||||||||||
Issuance and purchase of treasury shares |
- | 52 | - | - | - | - | 52 | - | 52 | |||||||||||||||||||||||||||||||
Dividends paid on common shares |
(211 | ) | (292 | ) | - | - | - | - | (503 | ) | - | (503 | ) | |||||||||||||||||||||||||||
Dividend withholding tax reduction |
- | 1 | - | - | - | - | 1 | - | 1 | |||||||||||||||||||||||||||||||
Coupons on perpetual securities |
- | (111 | ) | - | - | - | - | (111 | ) | - | (111 | ) | ||||||||||||||||||||||||||||
Coupons on non-cumulative subordinated notes |
- | (28 | ) | - | - | - | - | (28 | ) | - | (28 | ) | ||||||||||||||||||||||||||||
Share options and incentive plans |
- | (7 | ) | - | - | - | (27 | ) | (33 | ) | - | (33 | ) | |||||||||||||||||||||||||||
At December 31, 2015 |
32, 33 | 8,387 | 7,832 | 6,471 | (1,532 | ) | 1,283 | 3,800 | 26,241 | 9 | 26,250 |
1 | Issued capital and reserves attributable to owners of Aegon N.V. |
2 | Refer to note 51 for details on the disposals. |
Annual Report on Form 20-F 2017 |
150 | Consolidated financial statements of Aegon N.V. | |
Consolidated cash flow statement of Aegon N.V.
For the year ended December 31
Amounts in EUR million | Note | 2017 | 2016 | 2015 | ||||||||||||
Income / (loss) before tax |
2,534 | 610 | (514 | ) | ||||||||||||
Results from financial transactions |
(23.445 | ) | (16,294 | ) | (896 | ) | ||||||||||
Amortization and depreciation |
781 | 1,208 | 1,519 | |||||||||||||
Impairment losses |
84 | 88 | 1,261 | |||||||||||||
Income from joint ventures |
(161 | ) | (137 | ) | (142 | ) | ||||||||||
Income from associates |
(11 | ) | (3 | ) | (5 | ) | ||||||||||
Release of cash flow hedging reserve |
(739 | ) | (59 | ) | (39 | ) | ||||||||||
Other |
(620 | ) | 577 | 476 | ||||||||||||
Adjustments of non-cash items |
(24.112 | ) | (14,621 | ) | 2,174 | |||||||||||
Insurance and investment liabilities |
(613 | ) | 2,640 | 3,381 | ||||||||||||
Insurance and investment liabilities for account of policyholders |
12,988 | 10,716 | (3,343 | ) | ||||||||||||
Accrued expenses and other liabilities |
309 | 2,610 | (1,843 | ) | ||||||||||||
Accrued income and prepayments |
(1,797 | ) | (2,812 | ) | (1,387 | ) | ||||||||||
Changes in accruals |
10,887 | 13,153 | (3,192 | ) | ||||||||||||
Purchase of investments (other than money market investments) |
(32,057 | ) | (34,873 | ) | (38,290 | ) | ||||||||||
Purchase of derivatives |
752 | (831 | ) | (1,003 | ) | |||||||||||
Disposal of investments (other than money market investments) |
35.512 | 33,246 | 36,619 | |||||||||||||
Disposal of derivatives |
(878 | ) | 2,373 | 3,099 | ||||||||||||
Net purchase of investments for account of policyholders |
8,869 | 5,160 | 4,371 | |||||||||||||
Net change in cash collateral |
(455 | ) | (1,347 | ) | (2,569 | ) | ||||||||||
Net purchase of money market investments |
(659 | ) | 532 | 648 | ||||||||||||
Cash flow movements on operating items not reflected in income |
11.082 | 4,260 | 2,875 | |||||||||||||
Tax paid |
173 | (116 | ) | (405 | ) | |||||||||||
Other |
(12 | ) | 34 | (23 | ) | |||||||||||
Net cash flows from operating activities |
21 | 553 | 3,319 | 914 | ||||||||||||
Purchase of individual intangible assets (other than VOBA and future servicing rights) |
(34 | ) | (22 | ) | (52 | ) | ||||||||||
Purchase of equipment and real estate for own use |
(72 | ) | (69 | ) | (90 | ) | ||||||||||
Acquisition of subsidiaries, net of cash |
(52 | ) | (2 | ) | (66 | ) | ||||||||||
Acquisition joint ventures and associates |
(121 | ) | (112 | ) | (173 | ) | ||||||||||
Disposal of intangible asset |
1 | - | - | |||||||||||||
Disposal of equipment |
5 | 3 | 8 | |||||||||||||
Disposal of subsidiaries and businesses, net of cash |
(1,054 | ) | (1,082 | ) | 542 | |||||||||||
Disposal joint ventures and associates |
2 | 3 | 371 | |||||||||||||
Dividend received from joint ventures and associates |
129 | 203 | 76 | |||||||||||||
Net cash flows from investing activities |
21 | (1,196 | ) | (1,078 | ) | 615 | ||||||||||
Issuance of share capital |
- | - | 1 | |||||||||||||
Issuance of treasury shares |
2 | - | - | |||||||||||||
Purchase of treasury shares |
(266 | ) | (623 | ) | (213 | ) | ||||||||||
Proceeds from TRUPS 1) , Subordinated borrowings and borrowings |
9,170 | 3,711 | 1,821 | |||||||||||||
Repayment of TRUPS 1) , Subordinated borrowings and borrowings |
(7,918 | ) | (3,070 | ) | (3,916 | ) | ||||||||||
Dividends paid |
(294 | ) | (306 | ) | (292 | ) | ||||||||||
Coupons on perpetual securities |
(138 | ) | (140 | ) | (148 | ) | ||||||||||
Coupons on non-cumulative subordinated notes |
(37 | ) | (38 | ) | (38 | ) | ||||||||||
Net cash flows from financing activities |
21 | 519 | (465 | ) | (2,785 | ) | ||||||||||
Net increase / (decrease) in cash and cash equivalents 2) |
(125 | ) | 1,776 | (1,257 | ) | |||||||||||
Net cash and cash equivalents at the beginning of the year |
11,347 | 9,593 | 10,649 | |||||||||||||
Effects of changes in exchange rate |
(196 | ) | (23 | ) | 200 | |||||||||||
Net cash and cash equivalents at the end of the year |
21 | 11,026 | 11,346 | 9,593 |
1 | Trust pass-through securities. |
2 | Included in net increase / (decrease) in cash and cash equivalents are interest received (2017: EUR 6,215 million, 2016: EUR 6,691 million and 2015: EUR 7,118 million) dividends received (2017: EUR 1,292 million, 2016: EUR 1,387 million and 2015: EUR 1,384 million) and interest paid (2017: EUR 311 million, 2016: EUR 300 million and 2015: EUR 350 million). All included in operating activities except for dividend received from joint ventures and associates (2017: EUR 129 million, 2016: EUR 203 million and 2015: EUR 76 million). |
The cash flow statement is prepared according to the indirect method.
Annual Report on Form 20-F 2017 |
151 | Notes to the consolidated financial statements Note 1 | |
Notes to the consolidated financial statements
Aegon N.V., incorporated and domiciled in the Netherlands, is a public limited liability company organized under Dutch law and recorded in the Commercial Register of The Hague registered under number 27076669 and with its registered address at Aegonplein 50, 2591 TV, The Hague, the Netherlands. Aegon N.V. serves as the holding company for The Aegon Group and has listings of its common shares in Amsterdam and New York.
Aegon N.V. (or the Company) and its subsidiaries (Aegon or the Group) have life insurance and pensions operations in more than 20 countries in the Americas, Europe and Asia and are also active in savings and asset management operations, accident and health insurance, general insurance and to a limited extent banking operations. Headquarters are located in The Hague, the Netherlands. The Group employs over 28,000 people worldwide (2016: over 29,000).
2 Sum mary of significant accounting policies
2.1 Basis of presentation
The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS) and with Part 9 of Book 2 of the Netherlands Civil Code for purpose of reporting with the U.S. Securities and Exchange Commission (SEC), including financial information contained in this Annual Report on Form 20-F.
The consolidated financial statements have been prepared in accordance with the historical cost convention as modified by the revaluation of investment properties and those financial instruments (including derivatives) and financial liabilities that have been measured at fair value. Information on the standards and interpretations that were adopted in 2017 is provided below in note 2.1.1 Adoption of new IFRS accounting standards. The consolidated financial statements are presented in euro and all values are rounded to the nearest million unless otherwise stated. The consequence is that the rounded amounts may not add up to the rounded total in all cases. All ratios and variances are calculated using the underlying amount rather than the rounded amount. Certain amounts in prior years may have been reclassified to conform to the current year presentation. These reclassifications had no effect on net income, shareholders equity or earnings per share.
The preparation of financial statements in conformity with IFRS requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. Included among the material (or potentially material) reported amounts and disclosures that require extensive use of estimates are: fair value of certain invested assets and derivatives, deferred policy acquisition costs, value of business acquired and other purchased intangible assets, goodwill, policyholder claims and benefits, insurance guarantees, pension plans, income taxes and the potential effects of resolving litigation matters.
The consolidated financial statements of Aegon N.V. were approved by the Executive Board and by the Supervisory Board on March 22, 2018. The financial statements will be put for adoption to the Annual General Meeting of Shareholders on May 18, 2018. The shareholders meeting can decide not to adopt the financial statements but cannot amend them.
Other then for SEC reporting, Aegon prepares its Annual Accounts under International Financial Reporting Standards as adopted by the European Union, including the decisions Aegon made with regard to the options available under International Financial Reporting Standards as adopted by the EU (IFRS-EU). IFRS-EU differs from IFRS in respect of certain paragraphs in IAS 39 Financial Instruments: Recognition and Measurement regarding hedge accounting for portfolio hedges of interest rate risk (faitr value macro hedges) in accordance with the EU carve outversion of IAS 39. Under IFRS, hedge accounting for fair value macro hedges cannot be applied to mortage loans and ineffectiveness arises whenever the revised estimate of the amount of cash flows in scheduled time buckets is either more or less than the original designated amount of that bucket.
Annual Report on Form 20-F 2017 |
152 | Notes to the consolidated financial statements Note 2 | |
A reconciliation between IFRS and IFRS-EU is included in the table below.
Shareholders equity |
Net income |
|||||||||||||||||||||||
2017 | 2016 | 2015 | 2017 | 2016 | 2015 | |||||||||||||||||||
In accordance with IFRS |
20,288 | 20,520 | 22,441 | 2,469 | 438 | (431 | ) | |||||||||||||||||
Adjustment of EU IAS 39 carve-out |
368 | 510 | 315 | (142 | ) | 195 | (120 | ) | ||||||||||||||||
Tax effect of the adjustment |
(83 | ) | (117 | ) | (71 | ) | 34 | (47 | ) | 27 | ||||||||||||||
Effect of the adjustment after tax |
285 | 393 | 244 | (108 | ) | 149 | (92 | ) | ||||||||||||||||
In accordance with IFRS-EU |
20,573 | 20,913 | 22,684 | 2,361 | 586 | ` (523 | ) |
2.1.1 Adoption of new IFRS accounting standards
New standards and amendments to standards become effective at the date specified by IFRS, but may allow companies to opt for an earlier adoption date. In 2017, the following amendments to existing standards issued by the IASB became mandatory, but are not currently relevant or do not significantly impact the financial position or financial statements:
Accounting standard/ amendment/ interpretation | IASB effective date | Impact for Aegon | ||||||
IAS 7 Amendment Disclosure initiative |
January 1, 2017 | Low | ||||||
IAS 12 Recognition of Deferred Tax Assets for Unrealised Losses |
January 1, 2017 | Low | ||||||
Annual improvements 2014-2016 IFRS 12 Disclosure of interests in other entities |
January 1, 2017 | Low |
2.1.2 Future adoption of new IFRS accounting standards
The following standards and amendments to existing standards, published prior to January 1, 2018, were not early adopted by the Group, but will be applied in future years:
Accounting standard/ amendment/ interpretation | IASB effective date | Early adopted by Aegon | Impact for Aegon | |||||||||
IFRS 2 Clarifications of Classification an measurement of Share Based Payments Transactions |
January 1, 2018 | No | Low | |||||||||
IFRS 9 Financial instruments, including the separate amendment applying IFRS 9 Financial instruments with IFRS 4 Insurance contracts |
|
January 1, 2018
(Aegon intends to make
|
|
No | See below for comments | |||||||
Amendment to IFRS 9 Financial instruments on prepayment features with negative compensation |
January 1, 2019 | No | See below for comments | |||||||||
IFRS 15 Revenue from Contracts with Customers, including Clarifications to IFRS 15 as issued in 2016 |
January 1, 2018 | No | See below for comments | |||||||||
IFRS 16 leases |
January 1, 2019 | No | See below for comments | |||||||||
IFRS 17 Insurance contract |
January 1, 2021 | No | See below for comments | |||||||||
IAS 40 Investment property, amendments regarding the transfer of property |
January 1, 2018 | No | Low | |||||||||
IFRIC 22 Foreign currency transactions and advance consideration |
January 1, 2018 | No | Low | |||||||||
IFRIC 23 Uncertainty over Tax Treatments |
January 1, 2019 | No | Low | |||||||||
Annual improvements 2014-2016 IFRS 1, First time adoption of IFRS, regarding IFRS 7, IAS 19 and IFRS 10, IAS 28 Investments in associates and joint ventures |
January 1, 2018 | No | Low |
IFRS 9 Financial Instruments
The IASB issued the complete version of IFRS 9 Financial Instruments in July 2014. IFRS 9 combines classification and measurement, the expected credit loss impairment model and hedge accounting. The standard will replace IAS 39 and all previous versions of IFRS 9. Under IFRS 9 Classification and Measurement, financial assets are measured at amortized cost, fair value through profit or loss or fair value through other comprehensive income, based on both the entitys business model for managing the financial assets and the financial assets contractual cash flow characteristics. The classification and measurement of financial liabilities is unchanged from existing requirements apart from own credit risk. For financial liabilities that are designated at fair value through profit or loss, the changes which are attributable to the change in an entitys own credit risk are presented in other comprehensive income, unless doing so would enlarge or create an accounting mismatch. For the impairment component, the IASB included requirements for a credit loss allowance or provision which should be based on expected losses rather than incurred losses.
Annual Report on Form 20-F 2017 |
153 | Notes to the consolidated financial statements Note 2 | |
Application of IFRS 9 is required for annual periods beginning on or after January 1, 2018. However, on May 18, 2017, the IASB published the final version of the IFRS 17 Insurance Contracts standard. Prior to its finalization, the IASB issued an amendment to IFRS 4 Insurance Contracts (the predecessor standard to IFRS 17) that provides for a qualifying insurer a temporary exemption that permits, but does not require, the insurer to apply IAS 39 Financial Instruments: Recognition and Measurement rather than IFRS 9 for annual periods beginning before January 1, 2021 (i.e., a temporary exemption of IFRS 9). The objective of the amendment is to address the temporary accounting consequences of the different effective dates of IFRS 9 and IFRS 17.
In order for an entity to be eligible for the temporary exemption it must have liabilities connected with insurance activities whose carrying value comprises either greater than 90% of the total carrying value of all liabilities or less than or equal to 90% but greater than 80%, and the insurer does not have significant activities unrelated to insurance. Aegon performed this analysis, and concluded that it meets the requirements for the temporary exception. As a result, Aegon will not implement IFRS 9 until January 1, 2021.
As Aegon defers the application of IFRS 9 until 2021, the full impact of the standard is not yet clear, however an initial impact assessment resulted in the expectation that it will have a significant impact on shareholders equity, income and/or other comprehensive income and disclosures. An implementation project has started in 2017 and will be combined with the implementation of IFRS17 Insurance Contracts.
IFRS 15 Revenue from Contracts with Customers
In May 2014, the IASB issued IFRS 15 Revenue from Contracts with Customers. IFRS 15 will replace IAS 18 Revenue, as well as other interpretations issued by the IFRIC (International Financial Reporting Interpretations Committee) and SIC (Standing Interpretations Committee) regarding revenue unless the contracts are within the scope of other standards (for example, financial instruments, insurance contracts or lease contracts). The standard outlines the principles an entity shall apply to measure and recognize revenue and the related cash flows. The core principle is that an entity will recognize revenue at an amount that reflects the consideration to which the entity expects to be entitled in exchange for transferring goods or services to a customer. In April 2016, the IASB issued amendments to IFRS 15 to address several implementation issues discussed by the Transition Resource Group (TRG). The amendments are intended to clarify the requirements in IFRS 15, not to change the standard. IFRS 15 and the amendments is effective for the Group from January 1, 2018, using either of two methods: a full retrospective approach with certain practical expedients or a modified retrospective approach with the cumulative effect of initially applying this standard recognized at the date of initial application with certain additional disclosures. Aegon has evaluated the impact that adoption of this standard is expected to have on the Groups financial statements and came to the conclusion that this impact will be very limited because insurance revenue is not in scope of IFRS 15 and because the other types of revenue are already materially compliant with this standard. Since IFRS 15 will have very limited impact on the Groups financial statements, Aegon chose to apply the modified retrospective approach as transition method.
IFRS 16 Leases
IFRS 16 Leases which replaces IAS 17 has been issued by the IASB In January 2016. It will be mandatorily effective for annual reporting periods beginning on or after January 1, 2019. IFRS 16 introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than 12 months, unless the underlying asset is of low value. A lessee is required to recognize a right-of-use asset representing its right to use the underlying leased asset and a lease liability representing its obligation to make lease payments. IFRS 16 substantially carries forward the lessor accounting requirements in IAS 17. Accordingly, a lessor continues to classify its leases as operating leases or finance leases, and to account for those two types of leases differently. Aegon is evaluating the impact that adoption of this Standard is expected to have on the Groups financial statements.
IFRS 17 Insurance Contracts
The IASB issued IFRS 17 Insurance Contracts in May 2017. The Standard will replace IFRS 4, which was intended as an interim solution and allowed insurers to continue to use accounting principles that they had applied prior to the initial adoption of IFRS. IFRS 17 establishes principles for the recognition, measurement, presentation and disclosure of insurance contracts issued, reinsurance contracts held and investment contracts with discretionary participating features issued. The objective of the Standard is to ensure that entities provide relevant information in a way that faithfully represents those contracts. This information should provide users of financial statements with a basis to assess the effects that the contracts have on the financial position, financial performance and cash flows of the insurer. The Standard also specifies presentation and disclosure requirements to enhance comparability between insurance companies.
IFRS 17 is effective for annual periods beginning on or after January 1, 2021. The Standard represents a fundamental change to current financial reporting and the implementation effort is expected to be significant. Early adoption of the standard is therefore not expected. An implementation project was started soon after the publication of the new Standard. Currently no choices have
Annual Report on Form 20-F 2017 |
154 | Notes to the consolidated financial statements Note 2 | |
been made as to the accounting policy options provided in IFRS 17, however, it is expected that the impact of the initial application on Aegons financial statements is significant.
2.2 Basis of consolidation
Subsidiaries
The consolidated financial statements include the financial statements of Aegon N.V. and its subsidiaries. Subsidiaries (including consolidated structured entities) are entities over which Aegon has control. Aegon controls an entity when Aegon is exposed, or has rights, to variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. The assessment of control is based on the substance of the relationship between the Group and the entity and, among other things, considers existing and potential voting rights that are substantive. For a right to be substantive, the holder must have the practical ability to exercise that right.
The subsidiarys assets, liabilities and contingent liabilities are measured at fair value on the acquisition date and are subsequently accounted for in accordance with the Groups accounting policies, which is consistent with IFRS. Intra-group transactions, including Aegon N.V. shares held by subsidiaries, which are recognized as treasury shares in equity, are eliminated. Intra-group losses may indicate an impairment that requires recognition in the consolidated financial statements. Non-controlling interests are initially stated at their share in the fair value of the net assets on the acquisition date and subsequently adjusted for the non-controlling share in changes in the subsidiarys equity.
The excess of the consideration paid to acquire the interest and the fair value of any interest already owned, over the Groups share in the net fair value of assets, liabilities and contingent liabilities acquired is recognized as goodwill. Negative goodwill is recognized directly in the income statement. If the fair value of the assets, liabilities and contingent liabilities acquired in the business combination has been determined provisionally, adjustments to these values resulting from the emergence of new evidence within 12 months after the acquisition date are made against goodwill. Aegon recognized contingent considerations either as provision or as financial liability depending on the characteristics. Contingent considerations recognized as provisions are discounted and the unwinding is recognized in the income statement as an interest expense. Any changes in the estimated value of contingent consideration given in a business combination are recognized in the income statement. Contingent considerations recognized as financial liabilities are measured at fair value through profit or loss.
The identifiable assets, liabilities and contingent liabilities are stated at fair value when control is obtained.
Subsidiaries are deconsolidated when control ceases to exist. Any difference between the net proceeds plus the fair value of any retained interest and the carrying amount of the subsidiary including non-controlling interests is recognized in the income statement.
Transactions with non-controlling interests
Transactions with non-controlling interests are accounted for as transactions with owners. Therefore disposals to non-controlling interests and acquisitions from non-controlling interests, not resulting in losing or gaining control of the subsidiary are recorded in equity. Any difference between consideration paid or received and the proportionate share in net assets is accounted for in equity attributable to shareholders of Aegon N.V.
Investment funds
Investment funds managed by the Group in which the Group holds an interest are consolidated in the financial statements if the Group has power over that investment fund and it is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. In assessing control, all interests held by the Group in the fund are considered, regardless of whether the financial risk related to the investment is borne by the Group or by the policyholders (unless a direct link between the policyholder and the fund can be assumed).
In determining whether Aegon has power over an investment fund all facts and circumstances are considered, including the following:
◆ | Control structure of the asset manager (i.e. whether an Aegon subsidiary); |
◆ | The investment constraints posed by investment mandate; |
◆ | Legal rights held by the policyholder to the separate assets in the investment vehicle (e.g. policyholders could have the voting rights related to these investments); |
◆ | The governance structure, such as an independent board of directors, representing the policyholders, which has substantive rights (e.g. to elect or remove the asset manager); and |
◆ | Rights held by other parties (e.g. voting rights of policyholders that are substantive or not). |
Annual Report on Form 20-F 2017 |
155 | Notes to the consolidated financial statements Note 2 | |
Exposure or rights to variability of returns can be the result of, for example:
◆ | General account investment of Aegon; |
◆ | Aegons investments held for policyholder; |
◆ | Guarantees provided by Aegon on return of policyholders in specific investment vehicles; |
◆ | Fees dependent on fund value (including, but not limited to, asset management fees); and |
◆ | Fees dependent on performance of the fund (including, but not limited to, performance fees). |
Investment funds where Aegon acts as an agent are not consolidated due to lack of control of the funds. In particular, for some separate accounts, the independent board of directors has substantive rights and therefore Aegon does not have power over these separate accounts but acts as an agent.
For limited partnerships, the assessment takes into account Aegons legal position (i.e. limited partner or general partner) and any substantive removal rights held by other parties. Professional judgment is applied concerning the substantiveness of the removal rights and the magnitude of the exposure to variable returns, leading to the conclusion that Aegon controls some, but not all, of the limited partnerships in which it participates.
Upon consolidation of an investment fund, a liability is recognized to the extent that the Group is legally obliged to buy back participations held by third parties. The liability is presented in the consolidated financial statements as investment contracts for account of policyholders. Where no repurchase obligation exists, the participations held by third parties are presented as non-controlling interests in equity. The assets allocated to participations held by third parties or by the Group on behalf of policyholders are presented in the consolidated financial statements as investments for account of policyholders.
Equity instruments issued by the Group that are held by investment funds are eliminated on consolidation. However, the elimination is reflected in equity and not in the measurement of the related financial liabilities towards policyholders or other third parties.
Structured entities
A structured entity is defined in IFRS 12 as An entity that has been designed so that voting rights are not the dominant factor in deciding who controls the entity, such as when any voting rights relate to administrative tasks only and the relevant activities are directed by means of contractual arrangements. In these instances the tests and indicators to assess control provided by IFRS 10 have more focus on the purpose and design of the investee (with relation to the relevant activities that most significantly affect the structured entity) and the exposure to variable returns, which for structured entities lies in interests through e.g. derivatives, and will not be focused on entities that are controlled by voting rights.
Structured entities that are consolidated include certain mortgage backed securitization deals, where Aegon was involved in the design of the structured entities and also has the ability to use its power to affect the amount of the investees returns. Other factors that contribute to the conclusion that consolidation of these entities is required includes consideration of whether Aegon fully services the investees and can therefore influence the defaults of the mortgage portfolios and the fact that in these cases the majority of risks are maintained by Aegon.
Structured entities that are not consolidated include general account investments in non-affiliated structured entities that are used for investment purposes.
Non-current assets held for sale and disposal groups
Disposal groups are classified as held for sale if they are available for immediate sale in their present condition, subject only to the customary sales terms of such assets and disposal groups and their sale is considered highly probable. Management must be committed to the sale, which is expected to occur within one year from the date of classification as held for sale.
Upon classification as held for sale, the carrying amount of the disposal group (or group of assets) is compared to their fair value less cost to sell. If the fair value less cost to sell is lower than the carrying value, this expected loss is recognized through a reduction of the carrying value of any goodwill related to the disposal group or the carrying value of certain other non-current, non-financial assets to the extent that the carrying value of those assets exceeds their fair value. Any excess of the expected loss over the reduction of the carrying amount of these relevant assets is not recognized upon classification as held for sale, but is recognized as part of the result on disposal if and when a divestment transaction occurs.
Classification into or out of held for sale does not result in restating comparative amounts in the statement of financial position.
Annual Report on Form 20-F 2017 |
156 | Notes to the consolidated financial statements Note 2 | |
2.3 Foreign exchange translation
a. Translation of foreign currency transactions
The Groups consolidated financial statements are presented in euros. Items included in the financial statements of individual group companies are recorded in their respective functional currency which is the currency of the primary economic environment in which each entity operates. Transactions in foreign currencies are initially recorded at the exchange rate prevailing at the date of the transaction.
At the reporting date, monetary assets and monetary liabilities in foreign currencies are translated to the functional currency at the closing rate of exchange prevailing on that date, except for own equity instruments in foreign currencies which are translated using historical exchange rates. Non-monetary items carried at cost are translated using the exchange rate at the date of the transaction, while assets carried at fair value are translated at the exchange rate when the fair value was determined.
Exchange differences on monetary items are recognized in the income statement when they arise, except when they are deferred in other comprehensive income as a result of a qualifying cash flow or net investment hedge. Exchange differences on non-monetary items carried at fair value are recognized in other comprehensive income or the income statement, consistently with other gains and losses on these items.
b. Translation of foreign currency operations
On consolidation, the financial statements of group entities with a foreign functional currency are translated to euro, the currency in which the consolidated financial statements are presented. Assets and liabilities are translated at the closing rates on the reporting date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. Goodwill and fair value adjustments arising on the acquisition of a foreign entity are translated at the closing rates on the reporting date.
The resulting exchange differences are recognized in the foreign currency translation reserve, which is part of shareholders equity. On disposal of a foreign entity the related cumulative exchange differences included in the reserve are recognized in the income statement.
2.4 Segment reporting
Reporting segments and segment measures are explained and disclosed in note 5 Segment information.
2.5 Offsetting of assets and liabilities
Financial assets and liabilities are offset in the statement of financial position when the Group has a legally enforceable right to offset and has the intention to settle the asset and liability on a net basis or simultaneously. The legally enforceable right must not be contingent on future events and must be enforceable in the normal course of business and in the event of default, insolvency or bankruptcy of the Company or the counterpart.
2.6 Intangible assets
a. Goodwill
Goodwill is recognized as an intangible asset for interests in subsidiaries and is measured as the positive difference between the acquisition cost and the Groups interest in the net fair value of the entitys identifiable assets, liabilities and contingent liabilities. Subsequently, goodwill is carried at cost less accumulated impairment charges. It is derecognized when the interest in the subsidiary is disposed.
b. Value of business acquired
When a portfolio of insurance contracts is acquired, whether directly from another insurance company or as part of a business combination, the difference between the fair value and the carrying amount of the insurance liabilities is recognized as value of business acquired (VOBA). The Group also recognizes VOBA when it acquires a portfolio of investment contracts with discretionary participation features.
VOBA is amortized over the useful life of the acquired contracts, based on either the expected future premiums, revenues or the expected gross profit margins. The amortization period and pattern are reviewed at each reporting date; any change in estimates is recorded in the income statement. For all products, VOBA, in conjunction with deferred policy acquisition costs (DPAC) where appropriate, is assessed for recoverability using aggregation levels on a geographical jurisdiction basis or at the level of portfolio of contracts that are subject to broadly similar risks and managed together as a single portfolio. The portion determined not to be recoverable is charged to the income statement. VOBA is considered in the liability adequacy test for each reporting period, for more details refer to 2.19.f Liability adequacy testing.
Annual Report on Form 20-F 2017 |
157 | Notes to the consolidated financial statements Note 2 | |
When unrealized gains or losses arise on available-for-sale assets backing the insurance liabilities, VOBA is adjusted to equal the effect that the realization of the gains or losses (through a sale or impairment) would have had on VOBA. The adjustment is recognized directly in shareholders equity. VOBA is derecognized when the related contracts are settled or disposed.
c. Future servicing rights
On the acquisition of a portfolio of investment contracts without discretionary participation features under which Aegon will render investment management services, the present value of future servicing rights is recognized as an intangible asset. Future servicing rights can also be recognized on the sale of a loan portfolio or the acquisition of insurance agency activities.
The present value of the future servicing rights is amortized over the servicing period and is subject to impairment testing. It is derecognized when the related contracts are settled or disposed.
Where applicable, Aegon recognizes other intangibles on the acquisition of a business combination such as those related to customer relationships. This can include customer contracts, distribution agreements and client portfolios. For these intangibles the present value of future cash flows are recognized and amortized in the period when future economic benefits arise from these intangibles. These intangible assets are also presented under future servicing rights.
d. Software and other intangible assets
Software and other intangible assets are recognized to the extent that the assets can be identified, are controlled by the Group, are expected to provide future economic benefits and can be measured reliably. The Group does not recognize internally generated intangible assets arising from research or internally generated goodwill, brands, customer lists and similar items.
Software and other intangible assets are carried at cost less accumulated depreciation and impairment losses. Depreciation of the asset is over its useful life as the future economic benefits emerge and is recognized in the income statement as an expense. The depreciation period and pattern are reviewed at each reporting date, with any changes recognized in the income statement.
An intangible asset is derecognized when it is disposed of or when no future economic benefits are expected from its use or disposal.
2.7 Investments
General account investments comprise financial assets, excluding derivatives, as well as investments in real estate.
a. Financial assets, excluding derivatives
Financial assets are recognized on the trade date when the Group becomes a party to the contractual provisions of the instrument and are classified for accounting purposes depending on the characteristics of the instruments and the purpose for which they were purchased.
Classification
The following financial assets are measured at fair value through profit or loss: financial assets held for trading, financial assets managed on a fair value basis in accordance with the Groups investment strategy and financial assets containing an embedded derivative that is not closely related and that cannot be reliably bifurcated. In addition, in certain instances the Group designates financial assets to this category when by doing so a potential accounting mismatch in the financial statements is eliminated or significantly reduced.
Financial assets with fixed or determinable payments, that are not quoted in an active market and that the Group does not intend to sell in the near future are classified as loans. Those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, are accounted for as available-for-sale.
All remaining non-derivative financial assets are classified as available-for-sale.
Measurement
Financial assets are initially recognized at fair value excluding interest accrued to date plus, in the case of a financial asset not at fair value through profit or loss, any directly attributable incremental transaction costs.
Loans and financial assets held-to-maturity are subsequently carried at amortized cost using the effective interest rate method. Financial assets at fair value through profit or loss are measured at fair value with all changes in fair value recognized in the income statement as incurred. Available-for-sale assets are recorded at fair value with unrealized changes in fair value recognized in other
Annual Report on Form 20-F 2017 |
158 | Notes to the consolidated financial statements Note 2 | |
comprehensive income. Financial assets that are designated as hedged items are measured in accordance with the requirements for hedge accounting.
Amortized cost
The amortized cost of a debt instrument is the amount at which it is measured at initial recognition minus principal repayments, plus or minus the cumulative amortization of any difference between the initial amount and the maturity amount, and minus any reduction for impairment. The effective interest rate method is a method of calculating the amortized cost and of allocating the interest income or expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the debt instrument or, when appropriate, a shorter period to the net carrying amount of the instrument. When calculating the effective interest rate, all contractual terms are considered. Possible future credit losses are not taken into account. Charges and interest paid or received between parties to the contract that are an integral part of the effective interest rate, transaction costs and all other premiums or discounts are included in the calculation.
Fair value
The consolidated financial statements provide information on the fair value of all financial assets, including those carried at amortized cost where the values are provided in the notes to the financial statements.
Fair value is defined as the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions (i.e. an exit price at the measurement date from the perspective of a market participant that holds the asset or owes the liability). For quoted financial assets for which there is an active market, the fair value is the bid price at the reporting date. In the absence of an active market, fair value is estimated by using present value based or other valuation techniques. Where discounting techniques are applied, the discount rate is based on current market rates applicable to financial instruments with similar characteristics. The valuation techniques that include unobservable inputs can result in a different outcome than the actual transaction price at which the asset was acquired. Such differences are not recognized in the income statement immediately but are deferred. They are released over time to the income statement in line with the change in factors (including time) that market participants would consider in setting a price for the asset. Interest accrued to date is not included in the fair value of the financial asset.
Derecognition
A financial asset is derecognized when the contractual rights to the assets cash flows expire and when the Group retains the right to receive cash flows from the asset or has an obligation to pay received cash flows in full without delay to a third party and either: has transferred the asset and substantially all the risks and rewards of ownership, or has neither transferred nor retained all the risks and rewards but has transferred control of the asset. Financial assets of which the Group has neither transferred nor retained significantly all the risk and rewards are recognized to the extent of the Groups continuing involvement. If significantly all risks are retained, the assets are not derecognized.
On derecognition, the difference between the disposal proceeds and the carrying amount is recognized in the income statement as a realized gain or loss. Any cumulative unrealized gain or loss previously recognized in the revaluation reserve in shareholders equity is also recognized in the income statement.
Security lending and repurchase agreements
Financial assets that are lent to a third party or that are transferred subject to a repurchase agreement at a fixed price are not derecognized as the Group retains substantially all the risks and rewards of the asset. A liability is recognized for cash (collateral) received, on which interest is accrued.
A security that has been received under a borrowing or reverse repurchase agreement is not recognized as an asset. A receivable is recognized for any related cash (collateral) paid by Aegon. The difference between sale and repurchase price is treated as investment income. If the Group subsequently sells that security, a liability to repurchase the asset is recognized and initially measured at fair value.
Collateral
With the exception of cash collateral, assets received as collateral are not separately recognized as an asset until the financial asset they secure defaults. When cash collateral is recognized, a liability is recorded for the same amount.
Annual Report on Form 20-F 2017 |
159 | Notes to the consolidated financial statements Note 2 | |
b. Real estate
Investments in real estate include property held to earn rentals or for capital appreciation, or both. Investments in real estate are presented as Investments. Property that is occupied by the Group and that is not intended to be sold in the near future is classified as real estate held for own use and is presented in Other assets and receivables.
All property is initially recognized at cost. Such cost includes the cost of replacing part of the real estate and borrowing cost for long-term construction projects if recognition criteria are met. Subsequently, investments in real estate are measured at fair value with the changes in fair value recognized in the income statement. Real estate held for own use is carried at its revalued amount, which is the fair value at the date of revaluation less subsequent accumulated depreciation and impairment losses. Depreciation is calculated on a straight line basis over the useful life of a building. Land is not depreciated. On revaluation the accumulated depreciation is eliminated against the gross carrying amount of the asset and the net amount is restated to the revalued amount.
On disposal of an asset, the difference between the net proceeds received and the carrying amount is recognized in the income statement. Any remaining surplus attributable to real estate in own use in the revaluation reserve is transferred to retained earnings.
Maintenance costs and other subsequent expenditure
Expenditure incurred after initial recognition of the asset is capitalized to the extent that the level of future economic benefits of the asset is increased. Costs that restore or maintain the level of future economic benefits are recognized in the income statement as incurred.
2.8 Investments for account of policyholders
Investments held for account of policyholders consist of investments in financial assets as well as investments in real estate.
Investment return on these assets is passed on to the policyholder. Also included are the assets held by consolidated investment funds that are backing liabilities towards third parties. Investments for account of policyholders are valued at fair value through profit or loss.
2.9 Derivatives
a. Definition
Derivatives are financial instruments of which the value changes in response to an underlying variable, that require little or no net initial investment and are settled at a future date.
Assets and liabilities may include derivative-like terms and conditions. With the exception of features embedded in contracts held at fair value through profit or loss, embedded derivatives that are not considered closely related to the host contract are bifurcated, carried at fair value and presented as derivatives. In assessing whether a derivative-like feature is closely related to the contract in which it is embedded, the Group considers the similarity of the characteristics of the embedded derivative and the host contract. Embedded derivatives that transfer significant insurance risk are accounted for as insurance contracts.
Derivatives with positive values are reported as assets and derivatives with negative values are reported as liabilities. Derivatives for which the contractual obligation can only be settled by exchanging a fixed amount of cash for a fixed amount of Aegon N.V. equity instruments are accounted for in shareholders equity .
b. Measurement
All derivatives recognized on the statement of financial position are carried at fair value.
The fair value is calculated net of the interest accrued to date and is based on market prices, when available. When market prices are not available, other valuation techniques, such as option pricing or stochastic modeling, are applied. The valuation techniques incorporate all factors that market participants would consider and are based on observable market data, to the extent possible.
c. Hedge accounting
As part of its asset liability management, the Group enters into economic hedges to limit its risk exposure. These transactions are assessed to determine whether hedge accounting can and should be applied.
To qualify for hedge accounting, the hedge relationship is designated and formally documented at inception, detailing the particular risk management objective and strategy for the hedge (which includes the item and risk that is being hedged), the derivative that is being used and how hedge effectiveness is being assessed. A derivative has to be highly effective in accomplishing the objective of offsetting either changes in fair value or cash flows for the risk being hedged. The effectiveness of the hedging relationship is evaluated on a prospective and retrospective basis using qualitative and quantitative measures of correlation. Qualitative methods may include
Annual Report on Form 20-F 2017 |
160 | Notes to the consolidated financial statements Note 2 | |
comparison of critical terms of the derivative to the hedged item. Quantitative methods include a comparison of the changes in the fair value or discounted cash flow of the hedging instrument to the hedged item. A hedging relationship is considered highly effective if the results of the hedging instrument are within a ratio of 80% to 125% of the results of the hedged item.
For hedge accounting purposes, a distinction is made between fair value hedges, cash flow hedges and hedges of a net investment in a foreign operation.
Fair value hedges
Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognized in the profit and loss account, together with fair value adjustments to the hedged item attributable to the hedged risk. If the hedge relationship no longer meets the criteria for hedge accounting, the cumulative adjustment of the hedged item is, in the case of interest bearing instruments, amortized through the profit and loss account over the remaining term of the original hedge or recognized directly when the hedged item is derecognized.
Cash flow hedges
Cash flow hedges are hedges of the exposure to variability in cash flows that is attributable to a particular risk of a forecasted transaction or a recognized asset or liability and could affect profit or loss. To the extent that the hedge is effective, the change in the fair value of the derivative is recognized in the related revaluation reserve in shareholders equity. Any ineffectiveness is recognized directly in the income statement. The amount recorded in shareholders equity is released to the income statement to coincide with the hedged transaction, except when the hedged transaction is an acquisition of a non-financial asset or liability. In this case, the amount in shareholders equity is included in the initial cost of the asset or liability.
Net investment hedges
Net investment hedges are hedges of currency exposures on a net investment in a foreign operation. To the extent that the hedge is effective, the change in the fair value of the hedging instrument is recognized in the net foreign investment hedging reserve in shareholders equity. Any ineffectiveness is recognized in the income statement. The amount in shareholders equity is released to the income statement when the foreign operation is disposed of.
Hedge accounting is discontinued prospectively for hedges that are no longer considered effective. When hedge accounting is discontinued for a fair value hedge, the derivative continues to be carried on the statement of financial position with changes in its fair value recognized in the income statement. When hedge accounting is discontinued for a cash flow hedge because the cash flow is no longer expected to occur, the accumulated gain or loss in shareholders equity is recognized immediately in the income statement. In other situations where hedge accounting is discontinued for a cash flow hedge, including those where the derivative is sold, terminated or exercised, accumulated gains or losses in shareholders equity are amortized into the income statement when the income statement is impacted by the variability of the cash flow from the hedged item.
2.10 Investments in joint arrangements
In general, joint arrangements are contractual agreements whereby the Group undertakes, with other parties, an economic activity that is subject to joint control. Joint control exists when it is contractually agreed to share control over an economic activity. Joint control exists only when decisions about the relevant activities require the unanimous consent of the parties sharing control.
Investments in joint arrangements are classified as either joint operations or joint ventures depending on the contractual rights and obligations each investor has rather than the legal structure of the joint arrangement. Aegon has assessed the nature of its joint arrangements and determined them to be joint ventures. Joint ventures are accounted for using the equity method.
Under the equity method of accounting, interests in joint ventures are initially recognized at cost, which includes positive goodwill arising on acquisition. Negative goodwill is recognized in the income statement on the acquisition date. If joint ventures are obtained in successive share purchases, each significant transaction is accounted for separately.
The carrying amount is subsequently adjusted to reflect the change in the Groups share in the net assets of the joint venture and is subject to impairment testing. The net assets are determined based on the Groups accounting policies. Any gains and losses recorded in other comprehensive income by the joint venture are reflected in other reserves in shareholders equity, while the share in the joint ventures net income is recognized as a separate line item in the consolidated income statement. The Groups share in losses is recognized until the investment in the joint ventures equity and any other long-term interest that are part of the net investment are reduced to nil, unless guarantees exist.
Annual Report on Form 20-F 2017 |
161 | Notes to the consolidated financial statements Note 2 | |
Gains and losses on transactions between the Group and the joint ventures are eliminated to the extent of the Groups interest in the entity, with the exception of losses that are evidence of impairment which are recognized immediately. Own equity instruments of Aegon N.V. that are held by the joint venture are not eliminated.
On disposal of an interest in a joint venture, the difference between the net proceeds and the carrying amount is recognized in the income statement and gains and losses previously recorded directly in the revaluation reserve are reversed and recorded through the income statement.
2.11 Investments in associates
Entities over which the Group has significant influence through power to participate in financial and operating policy decisions, but which do not meet the definition of a subsidiary, are accounted for using the equity method. Interests held by venture capital entities, mutual funds and investment funds that qualify as an associate are accounted for as an investment held at fair value through profit or loss. Interests held by the Group in venture capital entities, mutual funds and investment funds that are managed on a fair value basis, are also accounted for as investments held at fair value through profit or loss.
Interests in associates are initially recognized at cost, which includes positive goodwill arising on acquisition. Negative goodwill is recognized in the income statement on the acquisition date. If associates are obtained in successive share purchases, each significant transaction is accounted for separately.
The carrying amount is subsequently adjusted to reflect the change in the Groups share in the net assets of the associate and is subject to impairment testing. The net assets are determined based on the Groups accounting policies. Any gains and losses recorded in other comprehensive income by the associate are reflected in other reserves in shareholders equity, while the share in the associates net income is recognized as a separate line item in the consolidated income statement. The Groups share in losses is recognized until the investment in the associates equity and any other long-term interest that are part of the net investment are reduced to nil, unless guarantees exist.
Gains and losses on transactions between the Group and the associate are eliminated to the extent of the Groups interest in the entity, with the exception of losses that are evidence of impairment which are recognized immediately. Own equity instruments of Aegon N.V. that are held by the associate are not eliminated.
On disposal of an interest in an associate, the difference between the net proceeds and the carrying amount is recognized in the income statement and gains and losses previously recorded directly in the revaluation reserve are reversed and recorded through the income statement.
2.12 Reinsurance assets
Reinsurance contracts are contracts entered into by the Group in order to receive compensation for claims/benefits incurred on contracts written by the Group (outgoing reinsurance). Reinsurance assets are also held as part of exiting the business. For contracts transferring sufficient insurance risk, a reinsurance asset is recognized for the expected future benefits, less expected future reinsurance premiums. Reinsurance contracts with insufficient insurance risk transfer are accounted for as investment or service contracts, depending on the nature of the agreement.
Reinsurance assets are measured consistently with the assumptions associated with the underlying insurance contracts and in accordance with the terms of each reinsurance contract. They are subject to impairment testing and are derecognized when the contractual rights are extinguished or expire or when the contract is transferred to another party.
Aegon is not relieved of its legal liabilities when entering into reinsurance transactions, therefore the reserves relating to the underlying insurance contracts will continue to be reported on the consolidated statement of financial position during the contractual term of the underlying contracts.
Reinsurance premiums, commissions and claim settlements are accounted for in the same way as the original contracts for which the reinsurance was concluded. The insurance premiums for the original contracts are presented gross of reinsurance premiums paid.
2.13 Deferred expenses
a. Deferred policy acquisition costs (DPAC)
DPAC relates to all insurance contracts as well as investment contracts with discretionary participation features and represents directly attributable costs that are related to the selling, underwriting and initiating of these insurance contracts.
Annual Report on Form 20-F 2017 |
162 | Notes to the consolidated financial statements Note 2 | |
DPAC are deferred to the extent that they are recoverable and are subsequently amortized based on factors such as expected gross profit margins. For products sold in the United States with amortization based on expected gross profit margins or revenues, the amortization period and pattern are reviewed at each reporting date and any change in estimates is recognized in the income statement. Estimates include, but are not limited to: an economic perspective in terms of future returns on bond and equity instruments, mortality, morbidity and lapse assumptions, maintenance expenses and expected inflation rates.
For all products, DPAC, in conjunction with VOBA where appropriate, is assessed for recoverability at least annually on a country-by-country basis as part of the liability adequacy test for each reporting period. If appropriate, the assumptions included in the determination of estimated gross profits or revenues are adjusted. The portion of DPAC that is determined not to be recoverable is charged to the income statement.
For products sold in the United States, when unrealized gains or losses arise on available-for-sale assets backing the insurance liabilities, DPAC is adjusted to equal the effect that the realization of the gains or losses (through sale or impairment) would have had on its measurement. This is recognized directly in the related revaluation reserve in shareholders equity.
DPAC is derecognized when the related contracts are settled or disposed.
b. Deferred cost of reinsurance
A deferred cost of reinsurance is established when Aegon enters into a reinsurance transaction, except for reinsurance transactions that are entered into as part of a plan to exit a business. When Aegon enters into a reinsurance contract as part of a plan to exit a business, an immediate loss is recognized in the income statement. Upon reinsurance, Aegon is not relieved of its legal liabilities, so the reserves relating to the underlying reinsured contracts will continue to be reported in the consolidated statement of financial position during the contractual term of the underlying contracts.
The difference, if any, between amounts paid in a reinsurance transaction and the amount of the liabilities relating to the underlying reinsured contracts is part of the deferred cost of reinsurance.
When losses on buying reinsurance are deferred, the amortization is based on the assumptions of the underlying insurance contracts. The amortization is recognized in the income statement.
c. Deferred transaction costs
Deferred transaction costs relate to investment contracts without discretionary participation features under which Aegon will render investment management services. Incremental costs that are directly attributable to securing these investment management contracts are recognized as an asset if they can be identified separately and measured reliably and if it is probable that they will be recovered.
For contracts involving both the origination of a financial liability and the provision of investment management services, only the transaction costs allocated to the servicing component are deferred. The other transaction costs are included in the carrying amount of the financial liability.
The deferred transaction costs are amortized in line with fee income, unless there is evidence that another method better represents the provision of services under the contract. The amortization is recognized in the income statement. Deferred transaction costs are subject to impairment testing at least annually.
Deferred transaction costs are derecognized when the related contracts are settled or disposed.
2.14 Other assets and receivables
Other assets include trade and other receivables, prepaid expenses, equipment and real estate held for own use. Trade and other receivables are initially recognized at fair value and are subsequently measured at amortized cost. Equipment is initially carried at cost, depreciated on a straight line basis over its useful life to its residual value and is subject to impairment testing. The accounting for real estate held for own use is described in note 2.7 Investments.
2.15 Cash and cash equivalents
Cash comprises cash at banks and in-hand. Cash equivalents are short-term, highly liquid investments generally with original maturities of three months or less that are readily convertible to known cash amounts, are subject to insignificant risks of changes in value and are held for the purpose of meeting short-term cash requirements. Money market investments that are held for investment purposes
Annual Report on Form 20-F 2017 |
163 | Notes to the consolidated financial statements Note 2 | |
(backing insurance liabilities, investment liabilities or equity based on asset liability management considerations) are not included in cash and cash equivalents but are presented as investments or investments for account of policyholders.
2.16 Impairment of assets
An asset is impaired if the carrying amount exceeds the amount that would be recovered through its use or sale. For tangible and intangible assets, financial assets and reinsurance assets, if not held at fair value through profit or loss, the recoverable amount of the asset is estimated when there are indications that the asset may be impaired. Irrespective of the indications, goodwill and other intangible assets with an indefinite useful life that are not amortized, are tested at least annually.
There are a number of significant risks and uncertainties inherent in the process of monitoring investments and determining if impairment exists. These risks and uncertainties include the risk that the Groups assessment of an issuers ability to meet all of its contractual obligations will change based on changes in the credit characteristics of that issuer and the risk that the economic outlook will be worse than expected or have more of an impact on the issuer than anticipated. Any of these situations could result in a charge against the income statement to the extent of the impairment charge recorded.
a. Impairment of non-financial assets
Assets are tested individually for impairment when there are indications that the asset may be impaired. For goodwill and intangible assets with an undefined life, an impairment test is performed at least once a year or more frequently as a result of an event or change in circumstances that would indicate an impairment charge may be necessary. The impairment loss is calculated as the difference between the carrying and the recoverable amount of the asset, which is the higher of an assets value in use and its fair value less cost of disposal. The value in use represents the discounted future net cash flows from the continuing use and ultimate disposal of the asset and reflects its known inherent risks and uncertainties. The valuation utilizes the best available information, including assumptions and projections considered reasonable and supportable by management. The assumptions used in the valuation involve significant judgments and estimates. Refer to note 31 Intangible assets for more details.
Impairment losses are charged to shareholders equity to the extent that they offset a previously recorded revaluation reserve relating to the same item. Any further losses are recognized directly in the income statement. Impairment of deferred policy acquisition costs is included in note 15 Impairment charges/(reversals).
With the exception of goodwill, impairment losses are reversed when there is evidence that there has been a change in the estimates used to determine the assets recoverable amount since the recognition of the last impairment loss. The reversal is recognized in the income statement to the extent that it reverses impairment losses previously recognized in the income statement. The carrying amount after reversal cannot exceed the amount that would have been recognized had no impairment taken place.
Non-financial assets that only generate cash flows in combination with other assets and liabilities are tested for impairment at the level of the cash-generating unit. The goodwill acquired in a business combination, for the purpose of impairment testing, is allocated to cash-generating units, or groups of cash-generating units, that are expected to benefit from the synergies of the combination. The allocation is based on the level at which goodwill is monitored internally and cannot be larger than an operating segment. When impairing a cash-generating unit, any goodwill allocated to the unit is first written-off and recognized in the income statement. The remaining impairment loss is allocated on a pro rata basis among the other assets, on condition that the resulting carrying amounts do not fall below the individual assets recoverable amounts.
b. Impairment of debt instruments
Debt instruments are impaired if there is objective evidence that a credit event has occurred after the initial recognition of the asset that has a negative impact on the estimated future cash flows. Individually significant loans and other receivables are first assessed separately. All non-impaired assets measured at amortized cost are then grouped by credit risk characteristics and collectively tested for impairment.
For debt instruments carried at amortized cost, the carrying amount of impaired financial assets is reduced through an allowance account. The impairment loss is calculated as the difference between the carrying and recoverable amount of the investment. The recoverable amount is determined by discounting the estimated probable future cash flows at the original effective interest rate of the asset. For variable interest debt instruments, the current effective interest rate under the contract is applied.
For debt instruments classified as available-for-sale, the asset is impaired to its fair value. Any unrealized loss previously recognized in other comprehensive income is taken to the income statement in the impairment loss. After impairment the interest accretion
Annual Report on Form 20-F 2017 |
164 | Notes to the consolidated financial statements Note 2 | |
on debt instruments that are classified as available-for-sale is recognized using the rate of interest used to discount the future cash flows for the purpose of measuring the impairment loss.
Impairment losses recognized for debt instruments can be reversed if in subsequent periods the amount of the impairment loss decreases and that decrease can be objectively related to a credit event occurring after the impairment was recognized. For debt instruments carried at amortized cost, the carrying amount after reversal cannot exceed what the amortized cost would have been at the reversal date, had the impairment not been recognized.
c. Impairment of equity instruments
For equity instruments, objective evidence of impairment of an investment in an equity instrument classified as available-for-sale includes information about significant changes with an adverse effect that have taken place in the technological, market, economic or legal environment in which the issuer operates, and indicates that the cost of the investment in the equity instrument may not be recovered. A significant or prolonged decline in fair value below initial cost is also considered objective evidence of impairment and always results in a loss being recognized in the income statement. Significant or prolonged decline is defined as an unrealized loss position for generally more than six months or a fair value of less than 80% of the cost price of the investment. Equity investments are impaired to the assets fair value and any unrealized gain or loss previously recognized in shareholders equity is taken to the income statement as an impairment loss. The amount exceeding the balance of previously recognized unrealized gains or losses is recognized in the income statement. If an available-for-sale equity security is impaired based upon Aegons qualitative or quantitative impairment criteria, any further declines in the fair value at subsequent reporting dates are recognized as impairments. Therefore, at each reporting period, for an equity security that is determined to be impaired based upon Aegons impairment criteria, an impairment is recognized for the difference between the fair value and the original cost basis, less any previously recognized impairments.
Impairment losses on equity instruments cannot be reversed.
d. Impairment of reinsurance assets
Reinsurance assets are impaired if there is objective evidence, as a result of an event that occurred after initial recognition of the reinsurance asset, that not all amounts due under the terms of the contract may be received. In such a case, the value of the reinsurance asset recoverable is determined based on the best estimate of future cash flows, taking into consideration the reinsurers current and expected future financial conditions plus any collateral held in trust for Aegons benefit. The carrying value is reduced to this calculated recoverable value, and the impairment loss recognized in the income statement.
2.17 Equity
Financial instruments that are issued by the Group are classified as equity if they represent a residual interest in the assets of the Group after deducting all of its liabilities and the Group has an unconditional right to avoid delivering cash or another financial asset to settle its contractual obligation. In addition to common shares, the Group has issued perpetual securities. Perpetual securities have no final maturity date, repayment is at the discretion of Aegon and for junior perpetual capital securities, Aegon has the option to defer coupon payments at its discretion. The perpetual capital securities are classified as equity rather than debt, are measured at par and those that are denominated in US dollars are translated into euro using historical exchange rates.
Non-cumulative subordinated notes are identified as a compound instrument due to the nature of this financial instrument. For these non-cumulative subordinated notes, Aegon has an unconditional right to avoid delivering cash or another financial asset to settle the coupon payments. The redemption of the principal is however not at the discretion of Aegon and therefore Aegon has a contractual obligation to settle the redemption in cash or another financial asset or through the exchange of financial assets and liabilities at potentially unfavorable conditions for Aegon. Compound instruments are separated into liability components and equity components. The liability component for the non-cumulative subordinated notes is equal to the present value of the redemption amount and carried at amortized cost using the effective interest rate method. The unwinding of the discount of this component is recognized in the income statement. The liability component is derecognized when the Groups obligation under the contract expires, is discharged or is cancelled. At initial recognition the equity component is assigned the residual amount after deducting the liability component from the fair value of the instrument as a whole. The equity component in US dollars is translated into euro using historical exchange rates.
Incremental external costs that are directly attributable to the issuing or buying back of own equity instruments are recognized in equity, net of tax. For compound instruments incremental external costs that are directly attributable to the issuing or buying back of the compound instruments are recognized proportionate to the equity component and liability component, net of tax.
Annual Report on Form 20-F 2017 |
165 | Notes to the consolidated financial statements Note 2 | |
Dividends and other distributions to holders of equity instruments are recognized directly in equity, net of tax. A liability for non-cumulative dividends payable is not recognized until the dividends have been declared and approved.
Treasury shares are shares issued by Aegon N.V. that are held by Aegon, one of its subsidiaries or by another entity controlled by Aegon. Treasury shares are deducted from Group equity, regardless of the objective of the transaction. No gain or loss is recognized in the income statement on the purchase, sale, issue or cancellation of the instruments. If sold, the difference between the carrying amount and the proceeds is reflected in retained earnings. The consideration paid or received is recognized directly in shareholders equity. All treasury shares are eliminated in the calculation of earnings per share and dividend per common share.
2.18 Trust pass-through securities and (subordinated) borrowings
A financial instrument issued by the Group is classified as a liability if the contractual obligation must be settled in cash or another financial asset or through the exchange of financial assets and liabilities at potentially unfavorable conditions for the Group.
Trust pass-through securities and (subordinated) borrowings are initially recognized at their fair value including directly attributable transaction costs and are subsequently carried at amortized cost using the effective interest rate method, with the exception of specific borrowings that are designated as at fair value through profit or loss to eliminate, or significantly reduce, an accounting mismatch, or specific borrowings which are carried as at fair value through profit or loss as they are managed and evaluated on a fair value basis. The liability is derecognized when the Groups obligation under the contract expires, is discharged or is cancelled.
Subordinated borrowings include the liability component of non-cumulative subordinated notes. These notes are identified as a compound instrument due to the nature of this financial instrument. Compound instruments are separated into equity components and liability components. The liability component for the non-cumulative subordinated notes is related to the redemption amount. For further information on the accounting policy of the non-cumulative subordinated notes refer to note 2.17 Equity.
2.19 Insurance contracts
Insurance contracts are accounted for under IFRS 4 Insurance Contracts. In accordance with this standard, Aegon continues to apply the existing accounting policies that were applied prior to the adoption of IFRS with certain modifications allowed by IFRS 4 for standards effective subsequent to adoption. Aegon applies, in general, non-uniform accounting policies for insurance liabilities and insurance related intangible assets to the extent that it was allowed under Dutch Accounting Principles. As a result, specific methodologies applied may differ between Aegons operations as they may reflect local regulatory requirements and local practices for specific product features in these local markets. At the time of IFRS adoption, Aegon was applying US GAAP for its United States operations whereas in the Netherlands and the United Kingdom, Aegon was applying Dutch Accounting Principles. Since adoption of IFRS, Aegon has considered new and amended standards in those GAAPs which have become effective subsequent to the date of transition to IFRS. If any changes are made to current accounting policies for insurance contracts, these will be in accordance with IFRS 4.
Insurance contracts are contracts under which the Group accepts a significant risk other than a financial risk from a policyholder by agreeing to compensate the beneficiary on the occurrence of an uncertain future event by which he or she will be adversely affected. Contracts that do not meet this definition are accounted for as investment contracts. The Group reviews homogeneous books of contracts to assess whether the underlying contracts transfer significant insurance risk on an individual basis. This is considered the case when at least one scenario with commercial substance can be identified in which the Group has to pay significant additional benefits to the policyholder. Contracts that have been classified as insurance are not reclassified subsequently.
Insurance liabilities are recognized when the contract is entered into and the premiums are charged. The liability is derecognized when the contract expires, is discharged, disposed or cancelled. Within the United States, the Netherlands and the United Kingdom, substantially modified contracts are accounted for as an extinguishment of the original liability and the recognition of a new liability.
Insurance assets and liabilities are valued in accordance with the accounting principles that were applied by the Group prior to the transition to IFRS and with consideration of standards effective subsequent to the date of transition to IFRS, as further described in the following paragraphs. In order to reflect the specific nature of the products written, subsidiaries are allowed to apply local accounting principles to the measurement of insurance contracts. All valuation methods used by the subsidiaries are based on the general principle that the carrying amount of the net liability must be sufficient to meet any reasonably foreseeable obligation resulting from the insurance contracts.
a. Life insurance contracts
Life insurance contracts are insurance contracts with life-contingent benefits. The measurement of the liability for life insurance contracts varies depending on the nature of the product.
Annual Report on Form 20-F 2017 |
166 | Notes to the consolidated financial statements Note 2 | |
Liabilities arising from traditional life insurance products that are offered by Aegon, particularly those with fixed and guaranteed account terms, are typically measured using the net premium method. Under this method the liability is determined as the sum of the discounted value of the expected benefits and future administration expenses directly related to the contract, less the discounted value of the expected theoretical premiums that would be required to meet the future cash outflows based on the valuation assumptions used. The liability is either based on current assumptions or calculated using the assumptions established at the time the contract was issued, in which case a margin for risk and adverse deviation is generally included. Furthermore, the liability for life insurance comprises reserves for unearned premiums and accrued annuity benefits payable.
Depending on local accounting principles, the liability may include amounts for future services on contracts where the policy administration charges are higher in the initial years than in subsequent years.
Terms and conditions, including participation features, are considered when establishing the insurance liabilities. Where the Group has discretion over the amount or timing of the bonuses distributed resulting from participation features, a liability is recognized equal to the amount that is available at the reporting date for future distribution to policyholders.
In establishing the liability, guaranteed minimum benefits issued to the policyholder are measured as described in note 2.19.c Embedded derivatives or, if bifurcated from the host contract, as described in note 2.9 Derivatives.
b. Life insurance contracts for account of policyholders
Life insurance contracts under which the policyholder bears the risks associated with the underlying investments are classified as insurance contracts for account of policyholders.
The liability for the insurance contracts for account of policyholders is measured at the policyholder account balance. Contracts with unit-denominated payments are measured at current unit values, which reflect the fair values of the assets of the fund. If applicable, the liability representing the nominal value of the policyholder unit account is amortized over the term of the contract so that interest on actuarial funding is at an expected rate of return.
c. Embedded derivatives
Life insurance contracts may include derivative-like terms and conditions. With the exception of policyholder options to surrender the contract at a fixed amount, contractual features that are not closely related to the insurance contract and that do not themselves meet the definition of insurance contracts are accounted for as derivatives.
Guaranteed minimum benefits
Certain life insurance contracts, issued by the Group, contain guaranteed minimum benefits. Bifurcated guaranteed minimum benefits are classified as derivatives.
In the United States, the additional liability for guaranteed minimum benefits that are not bifurcated is determined each period by estimating the expected value of benefits in excess of the projected account balance and recognizing the excess over the accumulation period based on total expected assessments. The estimates are reviewed regularly and any resulting adjustment to the additional liability is recognized in the income statement. The benefits used in calculating the liabilities are commonly based on the average benefits payable over a range of stochastic scenarios. Where applicable, the calculation of the liability incorporates a percentage of the potential annuitizations that may be elected by the contract holder.
In the Netherlands, an additional liability is established for guaranteed minimum investment returns on group pension plans with profit sharing and on traditional insurance contracts, with profit sharing based on an external interest index, that are not bifurcated. These guarantees are measured at fair value.
d. Shadow accounting
Shadow accounting allows that all gains and losses on investments affect the measurement of the insurance assets and liabilities in the same way, regardless of whether they are realized or unrealized and regardless of whether the unrealized gains and losses are recognized in the income statement or directly in shareholders equity in the revaluation reserve. In some instances, realized gains or losses on investments have a direct effect on the measurement of the insurance assets and liabilities. For example, some insurance contracts include benefits that are contractually based on the investment returns realized by the insurer. In addition, realization of gains or losses on available-for-sale investments can lead to unlocking of VOBA or DPAC and can also affect the outcome of the liability adequacy test to the extent that it considers actual future investment returns. For similar changes in unrealized gains and losses, shadow accounting is applied. If an unrealized gain or loss triggers a shadow accounting adjustment to VOBA, DPAC or the insurance
Annual Report on Form 20-F 2017 |
167 | Notes to the consolidated financial statements Note 2 | |
liabilities, the corresponding adjustment is recognized through other comprehensive income in the revaluation reserve, together with the unrealized gain or loss.
Some profit sharing schemes issued by the Group entitle the policyholder to a bonus which is based on the actual total return on specific assets held. To the extent that the bonus relates to gains or losses on available-for-sale investments for which the unrealized gains or losses are recognized in the revaluation reserve in shareholders equity, shadow accounting is applied. This means that the increase in the liability is also charged to shareholders equity to offset the unrealized gains rather than to the income statement.
e. Non-life insurance contracts
Non-life insurance contracts are insurance contracts where the insured event is not life-contingent. For non-life products the insurance liability generally includes reserves for unearned premiums, unexpired risk, inadequate premium levels and outstanding claims and benefits. No catastrophe or equalization reserves are included in the measurement of the liability.
The reserve for unearned premiums includes premiums received for risks that have not yet expired. Generally, the reserve is released over the coverage period of the premium and is recognized as premium income.
The liability for outstanding claims and benefits is established for claims that have not been settled and any related cash flows, such as claims handling costs. It includes claims that have been incurred but have not been reported to the Group. The liability is calculated at the reporting date using statistical methods based on empirical data and current assumptions that may include a margin for adverse deviation. Liabilities for claims subject to periodic payment are calculated using actuarial methods consistent with those applied to life insurance contracts. Discounting is applied if allowed by the local accounting principles used to measure the insurance liabilities. Discounting of liabilities is generally applied when there is a high level of certainty concerning the amount and settlement term of the cash outflows.
f. Liability adequacy testing
At each reporting date, the adequacy of the life insurance liabilities (including life insurance contracts for account of policyholders), net of VOBA and DPAC, is assessed using a liability adequacy test.
All tests performed within the Group are based on current estimates of all contractual future cash flows, including related cash flows from policyholder options and guarantees. A number of valuation methods are applied, including discounted cash flow methods, option pricing models and stochastic modeling. Aggregation levels are set either on geographical jurisdiction or at the level of portfolio of contracts that are subject to broadly similar risks and managed together as a single portfolio. Specifically, in the Netherlands the liability adequacy test is performed on a consolidated basis for all life and non-life business, whereas in the Americas and the UK it is performed at the level of the portfolio of contracts. To the extent that the tests involve discounting of future cash flows, the interest rate applied is based on market rates or is based on managements expectation of the future return on investments. These future returns on investments take into account managements best estimate related to the actual investments and, where applicable, reinvestments of these investments at maturity. Aegon the Netherlands, as required locally, adjusts the outcome of the liability adequacy test for the difference between the fair value and the book value of the assets that are measured at amortized cost in the statement of financial position.
To the extent that the account balances are insufficient to meet future benefits and expenses, any resulting deficiency is recognized in the income statement, initially by impairing the DPAC and VOBA and subsequently by establishing an insurance liability for the remaining loss, unless shadow loss recognition has taken place. In the Netherlands, in situations where market interest rates for the valuation of debt securities leads to a change in the revaluation reserve, and where the result of using the same assumptions for the liabilities could lead to a deficiency in the liability adequacy test that should be recognized in the income statement, shadow loss recognition is applied. Shadow loss recognition is applied to the extent that the deficiency of the insurance liabilities relates to the revaluation of debt securities as a result of movements in interest rates, the addition to the insurance liabilities is then offset against the revaluation reserve. If in subsequent periods such a deficiency of the insurance liability is no longer applicable, shadow loss recognition is reversed via the revaluation reserve.
The adequacy of the non-life insurance liability is tested at each reporting date. Changes in expected claims that have occurred, but that have not been settled, are reflected by adjusting the liability for claims and future benefits. The reserve for unexpired risk is increased to the extent that the future claims and expenses in respect of current insurance contracts exceed the future premiums plus the current unearned premium reserve.
Annual Report on Form 20-F 2017 |
168 | Notes to the consolidated financial statements Note 2 | |
2.20 Investment contracts
Aegon conducts its operations through the following reporting segments:
Contracts issued by the Group that do not transfer significant insurance risk, but do transfer financial risk from the policyholder to the Group are accounted for as investment contracts. Depending on whether the Group or the policyholder runs the risks associated with the investments allocated to the contract, the liabilities are classified as investment contracts or as investment contracts for account of policyholders. Investment contract liabilities are recognized when the contract is entered into and are derecognized when the contract expires, is discharged, cancelled or substantially modified.
a. Investment contracts with discretionary participation features
Some investment contracts have participation features whereby the policyholder has the right to receive potentially significant additional benefits which are based on the performance of a specified pool of investment contracts, specific investments held by the Group or on the issuers net income. If the Group has discretion over the amount or timing of the distribution of the returns to policyholders, the investment contract liability is measured based on the accounting principles that apply to insurance contracts with similar features.
Some unitized investment contracts provide policyholders with the option to switch between funds with and without discretionary participation features. The entire contract is accounted for as an investment contract with discretionary participation features if there is evidence of actual switching resulting in discretionary participation benefits that are a significant part of the total contractual benefits.
b. Investment contracts without discretionary participation features
At inception, investment contracts without discretionary features are carried at amortized cost.
Investment contracts without discretionary participation features are carried at amortized cost based on the expected cash flows and using the effective interest rate method. The expected future cash flows are re-estimated at each reporting date and the carrying amount of the financial liability is recalculated as the present value of estimated future cash flows using the financial liabilitys original effective interest rate. Any adjustment is immediately recognized in the income statement. For these investment contracts deposit accounting is applied, meaning that deposits are not reflected as premium income, but are recognized as part of the financial liability.
The consolidated financial statements provide information on the fair value of all financial liabilities, including those carried at amortized cost. As these contracts are not quoted in active markets, their value is determined by using valuation techniques, such as discounted cash flow methods and stochastic modeling. For investment contracts without discretionary participation features that can be cancelled by the policyholder, the fair value cannot be less than the surrender value.
c. Investment contracts for account of policyholders
Investment contracts for account of policyholders are investment contracts for which the actual return on investments allocated to the contract is passed on to the policyholder. Also included are participations held by third parties in consolidated investment funds that meet the definition of a financial liability.
Investment contracts for account of policyholders are designated at fair value through profit or loss. Contracts with unit-denominated payments are measured at current unit values, which reflect the fair values of the assets of the fund.
These segments are based on the business as presented in internal reports that are regularly reviewed by the Executive Board which is regarded as the chief operating decision maker.
For unit-linked contracts without discretionary participation features and subject to actuarial funding, the Group recognizes a liability at the funded amount of the units. The difference between the gross value of the units and the funded value is treated as an initial fee paid by the policyholder for future asset management services and recognized as a deferred revenue liability, refer to note 2.23 Deferred gains.
2.21 Provisions
A provision is recognized for present legal or constructive obligations arising from past events, when it is probable that it will result in an outflow of economic benefits and the amount can be reliably estimated. Management exercises judgment in evaluating the probability that a loss will be incurred.
Annual Report on Form 20-F 2017 |
169 | Notes to the consolidated financial statements Note 2 | |
The amount recognized as a provision is the best estimate of the expenditure required to settle the present obligation at the reporting date, considering all its inherent risks and uncertainties, as well as the time value of money. The estimate of the amount of a loss requires management judgment in the selection of a proper calculation model and the specific assumptions related to the particular exposure. The unwinding of the effect of discounting is recorded in the income statement as an interest expense.
Onerous contracts
With the exception of insurance contracts and investment contracts with discretionary participation features for which potential future losses are already considered in establishing the liability, a provision is recognized for onerous contracts in which the unavoidable costs of meeting the resulting obligations exceed the expected future economic benefits. The unavoidable costs under a contract reflect the least net cost of exiting from the contract, which is the lower of the cost of fulfilling it and any compensation or penalties arising from failure to fulfill it.
2.22 Assets and liabilities relating to employee benefits
a. Short-term employee benefits
A liability is recognized for the undiscounted amount of short-term employee benefits expected to be settled within one year after the end of the period in which the service was rendered. Accumulating short-term absences are recognized over the period in which the service is provided. Benefits that are not service-related are recognized when the event that gives rise to the obligation occurs.
b. Post-employment benefits
The Group has issued defined contribution plans and defined benefit plans. A plan is classified as a defined contribution plan when the Group has no further obligation than the payment of a fixed contribution. All other plans are classified as defined benefit plans.
Defined contribution plans
The contribution payable to a defined contribution plan for services provided is recognized as an expense in the income statement. An asset is recognized to the extent that the contribution paid exceeds the amount due for services provided.
Defined benefit plans
Measurement
The defined benefit obligation is based on the terms and conditions of the plan applicable on the reporting date. In measuring the defined benefit obligation the Group uses the projected unit credit method and actuarial assumptions that represent the best estimate of future variables. The benefits are discounted using an interest rate based on the market yield for high-quality corporate bonds that are denominated in the currency in which the benefits will be paid and that have terms to maturity that approximate the terms of the related pension liability. Actuarial assumptions used in the measurement of the liability include the discount rate, estimated future salary increases, mortality rates and price inflation. To the extent that actual experience deviates from these assumptions, the valuation of defined benefit plans and the level of pension expenses recognized in the future may be affected. Plan improvements (either vested or unvested) are recognized in the income statement at the date when the plan improvement occurs.
Plan assets are qualifying insurance policies and assets held by long-term employee benefit funds that can only be used to pay the employee benefits under the plan and are not available to the Groups creditors. They are measured at fair value and are deducted from the defined benefit obligation in determining the amount recognized on the statement of financial position.
Profit or loss recognition
The cost of the defined benefit plans are determined at the beginning of the year and comprise the following components:
◆ | Current year service cost which is recognized in profit or loss; and |
◆ | Net interest on the net defined benefit liability (asset) which is recognized in profit or loss. |
Remeasurements of the net defined benefit liability (asset) which is recognized in other comprehensive income are revisited quarterly and shall not be reclassified to profit or loss in a subsequent period.
Deducted from current year service cost are discretionary employee contributions and employee contributions that are linked to service (those which are independent of the number of years of service). Net interest on the net defined benefit liability (asset) shall be determined by multiplying the net defined benefit liability (asset) by the applicable discount rate. Net interest on the net defined benefit liability (asset) comprises interest income on plan assets and interest cost on the defined benefit obligation. Whereby interest income on plan assets is a component of the return on plan assets and is determined by multiplying the fair value of the plan assets by the applicable discount rate. The difference between the interest income on plan assets and the actual return on plan assets is included in the remeasurement of the net defined benefit liability (asset).
Annual Report on Form 20-F 2017 |
170 | Notes to the consolidated financial statements Note 2 | |
Remeasurements of the net defined benefit liability (asset) comprise of:
◆ | Actuarial gains and losses; |
◆ | The return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and |
◆ | Any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). |
Past service cost and gains or losses on settlements
Past service cost is the change in the present value of the defined benefit obligation for employee service, resulting from a plan amendment or curtailment.
Gains or losses on curtailments or settlements of a defined benefit plan comprise of the difference between:
◆ | The present value of the defined benefit obligation being settled, as determined on the date of settlement; and |
◆ | The settlement price, including any plan assets transferred and any payments made directly by Aegon in connection with the settlement. |
Aegon recognizes (in the income statement) gains or losses on the curtailment or settlement of a defined benefit plan when the curtailment or settlement occurs.
c. Share-based payments
The Group has issued share-based plans that entitle employees to receive equity instruments issued by the Group or cash payments based on the price of Aegon N.V. common shares. Some plans provide employees of the Group with the choice of settlement.
For long-term share-based plans where employees are granted the conditional right to receive Aegon shares if certain performance indicators are met and depending on continued employment of the individual employee, expenses recognized are based on the fair value on the grant date of the shares. The fair value is measured at the market price of the entities shares, adjusted to take into account the terms and conditions upon which the shares were granted. For example, where the employee is not entitled to receive dividends during the vesting period, this factor is taken into account when estimating the fair value of the shares granted. For the determination of factors such as expected dividends, market observable data has been considered.
The cost for long term incentive plans are recognized in the income statement, together with a corresponding increase in shareholders equity, as the services are rendered. During this period the cumulative expense recognized at the reporting date reflects managements best estimate of the number of shares expected to vest ultimately. For cash settled components (such as net settled component of long-term share-based plans) a liability will be recognized using the fair value of the equity settled award based on the elapsed portion of the vesting period. For modifications of the terms and conditions of equity-settled plans that result in those plans to be classified as cash-settled plans, the liability is recognized using the fair value measured at the modification date. The liability is remeasured at each reporting date and at the date of settlement, with any changes in fair value recognized in the income statement.
2.23 Deferred gains
Initial fees and front-end loadings paid by policyholders and other clients for future investment management services related to investment contracts without discretionary participation features are deferred and recognized as revenue when the related services are rendered.
2.24 Tax assets and liabilities
a. Current tax receivables and payables
Tax receivables and payables for current and prior periods are measured at the amount that is expected to be received from or paid to the taxation authorities and that reflects uncertainty to income taxes, if any. Measurement is done using the tax rates that have been enacted or substantively enacted by the reporting date.
b. Deferred tax assets and liabilities
Deferred tax assets and liabilities are recognized for the estimated future tax effects of temporary differences between the carrying value of an item and its tax value, with the exception of differences arising from the initial recognition of goodwill and of assets and liabilities that do not impact taxable or accounting profits. A tax asset is recognized for tax loss carryforwards to the extent that it is probable at the reporting date that future taxable profits will be available against which the unused tax losses and unused tax credits can be utilized.
Annual Report on Form 20-F 2017 |
171 | Notes to the consolidated financial statements Note 2 | |
Deferred tax liabilities relating to investments in subsidiaries, associates and joint ventures are not recognized if the Group is able to control the timing of the reversal of the temporary difference and it is probable that the difference will not be reversed in the foreseeable future.
Deferred tax assets and liabilities are reviewed at each reporting period and are measured at tax rates that are expected to apply when the asset is realized or the liability is settled. Since there is no absolute assurance that these assets will ultimately be realized, management reviews Aegons deferred tax positions at each reporting period to determine if it is probable that the assets will be realized. These reviews include, among other things, the nature and amount of the taxable income and deductible expenses, the expected timing when certain assets will be used or liabilities will be required to be reported and the reliability of historical profitability of businesses expected to provide future earnings. Furthermore, management considers tax-planning opportunities it can utilize to increase the likelihood that the tax assets will be realized. The carrying amount is not discounted and reflects the Groups expectations concerning the manner of recovery or settlement.
Deferred tax assets and liabilities are recognized in relation to the underlying transaction either in profit and loss, other comprehensive income or directly in equity.
2.25 Contingent assets and liabilities
Contingent assets are disclosed in the notes if the inflow of economic benefits is probable, but not virtually certain. When the inflow of economic benefits becomes virtually certain, the asset is no longer contingent and its recognition is appropriate.
A provision is recognized for present legal or constructive obligations arising from past events, when it is probable that it will result in an outflow of economic benefits and the amount can be reliably estimated. If the outflow of economic benefits is not probable, a contingent liability is disclosed, unless the possibility of an outflow of economic benefits is remote.
2.26 Premium income
Gross premiums, including recurring and single premiums, from life and non-life insurance and investment contracts with discretionary participation features are recognized as revenue when they become receivable. For products where deposit accounting is required, the deposits are not reflected as premium income, but are recognized as part of the financial liability. For these products the surrender charges and charges assessed have been included in gross premiums.
Premium loadings for installment payments and additional payments by the policyholder towards costs borne by the insurer are included in the gross premiums. Rebates that form part of the premium rate, such as no-claim rebates, are deducted from the gross premium, others are recognized as an expense. Depending on the applicable local accounting principles, bonuses that are used to increase the insured benefits may be recognized as gross premiums. The insurance premiums for the original contracts are presented gross of reinsurance premiums paid.
2.27 Investment income
For interest-bearing assets, interest is recognized as it accrues and is calculated using the effective interest rate method. Fees and commissions that are an integral part of the effective yield of the financial assets or liabilities are recognized as an adjustment to the effective interest rate of the instrument. Investment income includes the interest income and dividend income on financial assets carried at fair value through profit or loss.
Investment income also includes rental income due.
2.28 Fee and commission income
Fees and commissions from investment management services and mutual funds, services where Aegon acts as service provider (including mortgage loan fee business) and from sales activities are recognized as revenue over the period in which the services are performed or for sales activities where services have been rendered.
2.29 Policyholder claims and benefits
Policyholder claims and benefits consist of claims and benefits paid to policyholders, including benefits in excess of account value for products for which deposit accounting is applied and the change in the valuation of liabilities for insurance and investment contracts. It includes internal and external claims handling costs that are directly related to the processing and settlement of claims. Amounts receivable in respect of salvage and subrogation are also considered.
Annual Report on Form 20-F 2017 |
172 | Notes to the consolidated financial statements Note 2 | |
2.30 Results from financial transactions
Results from financial transactions include:
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives include fair value changes of financial assets carried at fair value through profit or loss. The net gains and losses do not include interest or dividend income.
Realized gains and losses on financial investments
Gains and losses on financial investments include realized gains and losses on general account financial assets, other than those classified as at fair value through profit or loss.
Net fair value change of derivatives
All changes in fair value are recognized in the income statement, unless the derivative has been designated as a hedging instrument in a cash flow hedge or a hedge of a net investment in a foreign operation. Fair value movements of fair value hedge instruments are offset by the fair value movements of the hedged item, and the resulting hedge ineffectiveness, if any, is included in this line. In addition, the fair value movements of bifurcated embedded derivatives are included in this line.
Net fair value change on for account of policyholder financial assets at fair value through profit or loss
Net fair value change on for account of policyholder financial assets at fair value through profit or loss includes fair value movements of investments held for account of policyholders (refer to note 2.8 Investments for account of policyholders). The net fair value change does not include interest or dividend income.
Other
In addition, results from financial transactions include gains/losses on real estate (general account and account of policyholders), net foreign currency gains/(losses) and net fair value change on borrowings and other financial liabilities and realized gains on repurchased debt.
2.31 Impairment charges/(reversals)
Impairment charges and reversals include impairments and reversals on investments in financial assets, impairments and reversals on the valuation of insurance assets and other non-financial assets and receivables. Impairment of deferred policy acquisition costs is included in note 15 Impairment charges/ (reversals). Refer to note 15 Impairment charges/(reversals).
2.32 Interest charges and related fees
Interest charges and related fees includes interest expense on trust pass-through securities and other borrowings. Interest expense on trust pass-through securities and other borrowings carried at amortized cost is recognized in profit or loss using the effective interest method.
2.33 Leases
Arrangements that do not take the form of a lease but convey a right to use an asset in return for a payment are assessed at inception to determine whether they are, or contain, a lease. This involves an assessment of whether fulfillment of the arrangement is dependent on the use of a specific asset and whether the purchaser (lessee) has the right to control the use of the underlying asset.
Leases that do not transfer substantially all the risks and rewards of ownership are classified as operating leases.
Payments made under operating leases, where the Group is the lessee, are charged to the income statement on a straight line basis over the period of the lease.
Where the Group is the lessor under an operating lease, the assets subject to the operating lease arrangement are presented in the statement of financial position according to the nature of the asset. Income from these leases are recognized in the income statement on a straight line basis over the lease term, unless another systematic basis is more representative of the time pattern in which use benefit derived from the leased asset is diminished.
2.34 Events after the reporting period
The financial statements are adjusted to reflect events that occurred between the reporting date and the date when the financial statements are authorized for issue, provided they give evidence of conditions that existed at the reporting date.
Annual Report on Form 20-F 2017 |
173 | Notes to the consolidated financial statements Note 3 | |
Events that are indicative of conditions that arose after the reporting date are disclosed, but do not result in an adjustment of the financial statements themselves.
3 Critical accounting estimates and judgment in applying accounting policies
Application of the accounting policies in the preparation of the financial statements requires management to apply judgment involving assumptions and estimates concerning future results or other developments, including the likelihood, timing or amount of future transactions or events. Those estimates are inherently subject to change and actual results could differ from those estimates. Included among the material (or potentially material) reported amounts and disclosures that require extensive use of estimates are: fair value of certain invested assets and derivatives, deferred policy acquisition costs (please refer to paragraph 2.13), value of business acquired and other purchased intangible assets (please refer to paragraph 2.6), goodwill (please refer to paragraph 2.6), policyholder claims and benefits (please refer to paragraph 2.29), insurance guarantees (please refer to paragraph 2.19), pension plans (please refer to paragraph 2.22), income taxes (please refer to paragraph 2.24) and the potential effects of resolving litigation matters (please refer to paragraph 2.25). Accounting policies that are critical to the financial statement presentation and that require complex estimates or significant judgment are described in the following sections.
Valuation of assets and liabilities arising from life insurance contracts
The liability for life insurance contracts with guaranteed or fixed account terms is either based on current assumptions, on the assumptions established at inception of the contract, reflecting the best estimates at the time increased with a margin for adverse deviation or on the valuation assumptions (historical cost), without risk margin. All contracts are subject to liability adequacy testing which reflects managements current estimates of future cash flows (including investment returns). To the extent that the liability is based on current assumptions, a change in assumptions will have an immediate impact on the income statement. Also, if a change in assumption results in not passing the liability adequacy test, the entire deficiency is recognized in the income statement. To the extent that the deficiency relates to unrealized gains and losses on available-for-sale investments, the additional liability is recognized in the revaluation reserve in shareholders equity.
Some insurance contracts without a guaranteed or fixed contractual term contain guaranteed minimum benefits. Depending on the nature of the guarantee, it may either be bifurcated and presented as a derivative or be reflected in the value of the insurance liability in accordance with local accounting principles. Given the dynamic and complex nature of these guarantees, stochastic techniques under a variety of market return scenarios are often used for measurement purposes. Such models require management to make numerous estimates based on historical experience and market expectations. Changes in these estimates will immediately affect the income statement.
In addition, certain acquisition costs related to the sale of new policies and the purchase of policies already in force are recorded as DPAC and VOBA assets respectively, and are amortized to the income statement over time. If the assumptions relating to the future profitability of these policies are not realized, the amortization of these costs could be accelerated and may require write-offs due to unrecoverability.
Actuarial and economic assumptions
The main assumptions used in measuring DPAC, VOBA and the liabilities for life insurance contracts with fixed or guaranteed terms relate to mortality, morbidity, investment return and future expenses. Depending on local accounting principles, surrender, lapse, and utilization rates may be considered.
Mortality tables applied are generally developed based on a blend of company experience and industry wide studies, taking into consideration product characteristics, own risk selection criteria, target market and past experience. Mortality experience is monitored through regular studies, the results of which are fed into the pricing cycle for new products and reflected in the liability calculation when appropriate. For contracts insuring survivorship or mortality, allowance may be made for further longevity or mortality improvements. Morbidity assumptions are based on own claims severity and frequency experience, adjusted where appropriate for industry information.
Investment assumptions are prescribed by the local regulator, market observable or based on managements future expectations. In the latter case, the anticipated future investment returns are set by management on a countrywide basis, considering available market information and economic indicators. A significant assumption related to estimated gross profits on variable annuities and variable life insurance products in the United States and some of the smaller countries, is the annual long-term growth rate of the underlying assets. The reconsideration of this assumption may affect the original DPAC or VOBA amortization schedule, referred to as DPAC or VOBA unlocking. The difference between the original DPAC or VOBA amortization schedule and the revised schedule, which
Annual Report on Form 20-F 2017 |
174 | Notes to the consolidated financial statements Note 3 | |
is based on actual and estimates of future gross profits, is recognized in the income statement as an expense or a benefit in the period of determination.
Assumptions on future expenses are based on the current level of expenses, adjusted for expected expense inflation if appropriate. In Aegon the Netherlands, the expense basis makes an allowance for planned future cost savings, which are included in the liability adequacy test.
Surrender and lapse rates depend on product features, policy duration and external circumstances such as the interest rate environment and competitor behavior. For policies with account value guarantees based on equity market movements, a dynamic lapse assumption is utilized to reflect policyholder behavior based on whether the guarantee is in the money. Own experience, as well as industry published data, are used in establishing assumptions. Lapse experience is correlated to mortality and morbidity levels, as higher or lower levels of surrenders may indicate future claims will be higher or lower than anticipated. Such correlations are accounted for in the mortality and morbidity assumptions based on the emerging analysis of experience.
Actuarial assumption and model updates
Assumptions are reviewed periodically, typically in the third quarter, based on historical experience, observable market data, including market transactions such as acquisitions and reinsurance transactions, anticipated trends and legislative changes. Similarly, the models and systems used for determining our liabilities are reviewed periodically and, if deemed necessary, updated based on emerging best practices and available technology.
During 2017, Aegon implemented actuarial assumption and model updates resulting in a net EUR 276 million charge to income before tax (2016: EUR 118 million charge). Refer to note 5 Segment information for further details.
For the years 2015 through 2017, Aegon kept its long-term equity market return assumption for the estimated gross profits on variable life and variable annuity products in the Americas at 8%. During the three year period, the long-term assumption for 10-year US Treasury yields was 4.25% and the uniform grading period was 10 years. The long term credit spread assumption on our most common corporate bonds is 114bps. The 90-day Treasury yield was 1.39%, 0.51% and 0.16% at December 31, 2017, 2016 and 2015, respectively. During 2016 and 2017 the 90-day Treasury yield was assumed to have a uniform grading over 10 years to 2.5%. In 2015, the 90-day Treasury yield was assumed to remain level for six months followed by a 9.5 year grade to 2.5%. On a quarterly basis, the estimated gross profits are updated for the difference between the estimated market return and the actual market return.
Sensitivity on variable annuities and variable life insurance products in the United States
A 1% decrease in the expected long-term equity growth rate with regard to Aegons variable annuities and variable life insurance products in the United States would result in a decrease in DPAC and VOBA balances and reserve strengthening of approximately EUR 130 million (2016: EUR 158 million). The DPAC and VOBA balances for these products in the United States amounted to EUR 2.7 billion at December 31, 2017 (2016: EUR 3.0 billion).
A relative increase of 10% to the mortality assumption was used, dependent on product and characteristics of the block of business, would reduce net income by approximately EUR 265 million (2016: EUR 223 million). A relative 20% increase in the lapse rate assumption would increase net income by approximately EUR 78 million (2016: EUR 60 million).
Any reasonably possible changes in the other assumptions Aegon uses to determine EGP margins (i.e. maintenance expenses, inflation and disability) would reduce net income by less than EUR 15 million (per assumption change) (2016: EUR 12 million).
Determination of fair value and fair value hierarchy
The following is a description of Aegons methods of determining fair value, and a quantification of its exposure to assets and liabilities measured at fair value.
Fair value is defined as the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions (i.e. an exit price at the measurement date from the perspective of a market participant that holds the asset or owes the liability). A fair value measurement assumes that the transaction to sell the asset or transfer the liability takes place either:
◆ | In the principal market for the asset or liability; or |
◆ | In the absence of a principal market, in the most advantageous market for the asset or liability. |
Annual Report on Form 20-F 2017 |
175 | Notes to the consolidated financial statements Note 4 | |
Aegon uses the following hierarchy for measuring and disclosing of the fair value of assets and liabilities:
◆ | Level I: quoted prices (unadjusted) in active markets for identical assets or liabilities that Aegon can access at the measurement date; |
◆ | Level II: inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices of identical or similar assets and liabilities) using valuation techniques for which all significant inputs are based on observable market data; and |
◆ | Level III: inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) using valuation techniques for which any significant input is not based on observable market data. |
The best evidence of fair value is a quoted price in an actively traded market. In the event that the market for a financial instrument is not active or quoted market prices are not available, a valuation technique is used.
The degree of judgment used in measuring the fair value of assets and liabilities generally inversely correlates with the level of observable valuation inputs. Aegon maximizes the use of observable inputs and minimizes the use of unobservable valuation inputs when measuring fair value. Financial instruments, for example, with quoted prices in active markets generally have more pricing observability and therefore less judgment is used in measuring fair value. Conversely, financial instruments for which no quoted prices are available have less observability and are measured at fair value using valuation models or other pricing techniques that require more judgment.
The assets and liabilities categorization within the fair value hierarchy is based on the lowest input that is significant to the fair value measurement.
An active market is one in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The judgment as to whether a market is active may include, although not necessarily determinative, lower transaction volumes, reduced transaction sizes and, in some cases, no observable trading activity for short periods. In inactive markets, assurance is obtained that the transaction price provides evidence of fair value or it is determined that adjustments to transaction prices are necessary to measure the fair value of the instrument.
The majority of valuation techniques employ only observable market data, and so the reliability of the fair value measurement is high. However, certain assets and liabilities are valued on the basis of valuation techniques that feature one or more significant market inputs that are unobservable and, for such assets and liabilities, the derivation of fair value is more judgmental. An instrument is classified in its entirety as valued using significant unobservable inputs (Level III) if, in the opinion of management, a significant proportion of the instruments carrying amount is driven by unobservable inputs. Unobservable in this context means that there is little or no current market data available from which to determine the price at which an at arms length transaction would be likely to occur. It generally does not mean that there is no market data available at all upon which to base a determination of fair value. Additional information is provided in the table headed Effect of changes in significant unobservable assumptions to reasonably possible alternatives in note 47 Fair Value. While Aegon believes its valuation techniques are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain instruments (both financial and non-financial) could result in a different estimate of fair value at the reporting date.
To operationalize Aegons fair value hierarchy, individual instruments (both financial and non-financial) are assigned a fair value level based primarily on the type of instrument and the source of the prices (e.g. index, third-party pricing service, broker, internally modeled). Periodically, this logic for assigning fair value levels is reviewed to determine if any modifications are necessary in the context of the current market environment.
General
As an insurance group, Aegon is exposed to a variety of risks. Aegons largest exposures are to changes in financial markets (e.g. foreign currency, interest rate, credit and equity market risks) that affect the value of the investments, liabilities from products that Aegon sells, deferred expenses and value of business acquired. Other risks include insurance related risks, such as changes in mortality and morbidity, which are discussed in note 36 Insurance contracts. Aegon manages risk at local level where business is transacted, based on principles and policies established at the Group level. Aegons integrated approach to risk management involves similar measurement of risk and scope of risk coverage to allow for aggregation of the Groups risk position.
To manage its risk exposure, Aegon has risk policies in place. Many of these policies are group-wide while others are specific to the unique situation of local businesses. The Group level policies limit the Groups exposure to major risks such as equity, interest
Annual Report on Form 20-F 2017 |
176 | Notes to the consolidated financial statements Note 4 | |
rates, credit, and currency. The limits in these policies in aggregate remain within the Groups overall tolerance for risk and the
Groups financial resources. Operating within this policy framework, Aegon employs risk management programs including asset liability management (ALM) processes and models and hedging programs (which are largely conducted via the use of financial derivative instruments). These risk management programs are in place in each country unit and are not only used to manage risk in each unit, but are also part of the Groups overall risk strategy.
Aegon operates a Derivative Use Policy to govern its usage of derivatives. This policy establishes the control, authorization, execution and monitoring requirements of the usage of such instruments. In addition, the policy stipulates necessary mitigation of credit risk created through derivatives management tools. For derivatives, counterparty credit risk is normally mitigated by requirements to post collateral via credit support annex agreements or through a central clearinghouse.
As part of its risk management programs, Aegon takes inventory of its current risk position across risk categories. Aegon also measures the sensitivity of net income and shareholders equity under both deterministic and stochastic scenarios. Management uses the insight gained through these what if? scenarios to manage the Groups risk exposure and capital position. The models, scenarios and assumptions used are reviewed regularly and updated as necessary.
Results of Aegons sensitivity analyses are presented throughout this section to show the estimated sensitivity of net income and shareholders equity to various scenarios. For each type of market risk, the analysis shows how net income and shareholders equity would have been affected by changes in the relevant risk variable that were reasonably possible at the reporting date. For each sensitivity test the impact of a reasonably possible change in a single factor is shown. Management action is taken into account to the extent that it is part of Aegons regular policies and procedures, such as established hedging programs. However, incidental management actions that would require a change in policies and procedures are not considered.
Each sensitivity analysis reflects the extent to which the shock tested would affect managements critical accounting estimates and judgment in applying Aegons accounting policies. Market-consistent assumptions underlying the measurement of non-listed assets and liabilities are adjusted to reflect the shock tested. The shock may also affect the measurement of assets and liabilities based on assumptions that are not observable in the market. For example, a shock in interest rates may lead to changes in the amortization schedule of DPAC or to increased impairment losses on equity investments. Although managements short-term assumptions may change if there is a reasonably possible change in a risk factor, long-term assumptions will generally not be revised unless there is evidence that the movement is permanent. This fact is reflected in the sensitivity analyses.
The accounting mismatch inherent in IFRS is also apparent in the reported sensitivities. A change in interest rates has an immediate impact on the carrying amount of assets measured at fair value. However, the shock will not have a similar effect on the carrying amount of the related insurance liabilities that are measured based on locked-in assumptions or on managements long-term expectations. Consequently, the different measurement bases for assets and liabilities lead to increased volatility in IFRS net income and shareholders equity. Aegon has classified a significant part of its investment portfolio as available-for-sale, which is one of the main reasons why the economic shocks tested have a different impact on net income than on shareholders equity. Unrealized gains and losses on these assets are not recognized in the income statement but are booked directly to the revaluation reserves in shareholders equity, unless impaired. As a result, economic sensitivities predominantly impact shareholders equity but leave net income unaffected. The effect of movements of the revaluation reserve on capitalization ratios and capital adequacy are minimal. Aegons target ratio for the composition of its capital base is based on shareholders equity excluding the revaluation reserve.
The sensitivities do not reflect what the net income for the period would have been if risk variables had been different because the analysis is based on the exposures in existence at the reporting date rather than on those that actually occurred during the year. Nor are the results of the sensitivities intended to be an accurate prediction of Aegons future shareholders equity or earnings. The analysis does not take into account the impact of future new business, which is an important component of Aegons future earnings. It also does not consider all methods available to management to respond to changes in the financial environment, such as changing investment portfolio allocations or adjusting premiums and crediting rates. Furthermore, the results of the analyses cannot be extrapolated for wider variations since effects do not tend to be linear.
Concentration risk for financial risks are measured and managed at the following levels:
◆ | Concentration per risk type: Risk exposures are measured per risk type as part of Aegons internal economic framework. A risk tolerance framework is in place which sets risk limits per risk type to target desired risk balance and promote diversification across risk types; |
◆ | Concentration per counterparty: Risk exposure is measured and risk limits are in place per counterparty as part of the Counterparty Name Limit Policy; and |
Annual Report on Form 20-F 2017 |
177 | Notes to the consolidated financial statements Note 4 | |
◆ | Concentration per sector, geography and asset class: Aegons investment strategy is translated in investment mandates for its internal and external asset managers. Through these investment mandates limits on sector, geography and asset class are set. Compliance monitoring of the investment mandates is done by the insurance operating companies. |
Moreover, concentration of financial risks are measured in Aegon business planning cycle. As part of business planning, the resilience of Aegons business strategy is tested in several extreme event scenarios. In the Adverse Financial scenario, financial markets are stressed without assuming diversification across different market factors. Within the projection certain management actions may be implemented when management deems this necessary.
Currency exchange rate risk
As an international group, Aegon is subject to foreign currency translation risk. Foreign currency exposure exists mainly when policies are denominated in currencies other than the issuers functional currency. Currency risk in the investment portfolios backing insurance and investment liabilities is managed using asset liability matching principles. Assets allocated to equity are kept in local currencies to the extent shareholders equity is required to satisfy regulatory and self-imposed capital requirements. Therefore, currency exchange rate fluctuations will affect the level of shareholders equity as a result of translation of subsidiaries into euro, the Groups presentation currency. Aegon holds the remainder of its capital base (perpetual capital securities, subordinated and senior debt) in various currencies in amounts that are targeted to correspond to the book value of the country units. This balancing mitigates currency translation impacts on shareholders equity and leverage ratios. Aegon does not hedge the income streams from the main non-euro units and, as a result, earnings may fluctuate due to currency translation. As Aegon has significant business segments in the Americas and in the United Kingdom, the principal sources of exposure from currency fluctuations are from the differences between the US dollar and the euro and between the UK pound and the euro. Aegon may experience significant changes in net income and shareholders equity because of these fluctuations.
Aegon operates a Currency Risk Policy which applies currency risk exposure limits both at Group and regional levels, and under which direct currency speculation or program trading by country units is not allowed unless explicit approval has been granted by the Group Risk and Capital Committee and the Management Board. Assets should be held in the functional currency of the business written or hedged back to that currency. Where this is not possible or practical, remaining currency exposure should be sufficiently documented and limits are placed on the total exposure at both group level and for individual country units.
Information on Aegons three year historical net income/(loss) and shareholders equity in functional currency are shown in the table below:
2017 | 2016 | 2015 | ||||||||||
Net income |
||||||||||||
Americas (in USD) |
1,762 | 618 | (261 | ) | ||||||||
The Netherlands (in EUR) |
818 | 418 | 753 | |||||||||
United Kingdom (in GBP) |
71 | (346 | ) | (674 | ) | |||||||
Central & Eastern Europe (in EUR) |
57 | 19 | 24 | |||||||||
Spain & Portugal (in EUR) |
(2 | ) | (2 | ) | 22 | |||||||
Asia (in USD) |
6 | (14 | ) | (33 | ) | |||||||
Asset Management (in EUR) |
48 | 97 | 121 | |||||||||
Equity in functional currency |
||||||||||||
Americas (in USD) |
17,712 | 17,103 | 17,609 | |||||||||
The Netherlands (in EUR) |
6,558 | 5,101 | 5,263 | |||||||||
United Kingdom (in GBP) |
1,905 | 1,845 | 2,981 | |||||||||
Central & Eastern Europe (in EUR) |
402 | 378 | 396 | |||||||||
Spain & Portugal (in EUR) |
433 | 451 | 464 | |||||||||
Asia (in USD) |
1,169 | 1,281 | 674 | |||||||||
Asset Management (in EUR) |
397 | 422 | 444 |
The exchange rates for US dollar and UK pound per euro for each of the last five year ends are set forth in the table below:
Closing rates | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||
USD |
1.20 | 1.05 | 1.09 | 1.21 | 1.38 | |||||||||||||||
GBP |
0.89 | 0.85 | 0.74 | 0.78 | 0.83 |
Annual Report on Form 20-F 2017 |
178 | Notes to the consolidated financial statements Note 4 | |
Aegon Group companies foreign currency exposure from monetary assets and liabilities denominated in foreign currencies is not material.
The sensitivity analysis in the following table shows an estimate of the effect of movements in the exchange rates of Aegons non-euro currencies relative to the euro on net income and shareholders equity.
Sensitivity analysis of net income and shareholders equity to translation risk
Movement of currency exchange rates 1) |
Estimated approximate effects on
net income 2) |
Estimated approximate effects on
shareholders equity |
||||||
2017 |
||||||||
Increase by 15% of USD currencies relative to the euro |
260 | 2,159 | ||||||
Increase by 15% of GBP currencies relative to the euro |
21 | 321 | ||||||
Increase by 15% of non-euro currencies relative to the euro |
265 | 2,598 | ||||||
Decrease by 15% of USD currencies relative to the euro |
(189 | ) | (1,566 | ) | ||||
Decrease by 15% of GBP currencies relative to the euro |
(16 | ) | (216 | ) | ||||
Decrease by 15% of non-euro currencies relative to the euro |
(184 | ) | (1,868 | ) | ||||
2016 |
||||||||
Increase by 15% of USD currencies relative to the euro |
87 | 2,179 | ||||||
Increase by 15% of GBP currencies relative to the euro |
(3 | ) | 259 | |||||
Increase by 15% of non-euro currencies relative to the euro |
79 | 2,537 | ||||||
Decrease by 15% of USD currencies relative to the euro |
(61 | ) | (1,558 | ) | ||||
Decrease by 15% of GBP currencies relative to the euro |
(55 | ) | (170 | ) | ||||
Decrease by 15% of non-euro currencies relative to the euro |
(110 | ) | (1,794 | ) |
1 | The effect of currency exchange movements is reflected as a one-time shift up or down in the value of the non-euro currencies relative to the euro on December 31. |
2 | For the sensitivity analysis the book loss of the UK annuity portfolio in 2016 has been excluded. |
Interest rate risk
Aegon bears interest rate risk with many of its products. In cases where cash flows are highly predictable, investing in assets that closely match the cash flow profile of the liabilities can offset this risk. For some Aegon country units, local capital markets are not well developed, which prevents the complete matching of assets and liabilities for those businesses. For some products, cash flows are less predictable as a result of policyholder actions that can be affected by the level of interest rates.
In periods of rapidly increasing interest rates, policy loans, surrenders and withdrawals may increase. Premiums in flexible premium policies may decrease as policyholders seek investments with higher perceived returns. This activity may result in cash payments by Aegon requiring the sale of invested assets at a time when the prices of those assets are adversely affected by the increase in market interest rates; this may result in realized investment losses. These cash payments to policyholders result in a decrease in total invested assets and a decrease in net income. Among other things, early withdrawals may also require accelerated amortization of DPAC, which in turn reduces net income.
During periods of sustained low interest rates, Aegon may not be able to preserve margins as a result of minimum interest rate guarantees and minimum guaranteed crediting rates provided on policies. Also, investment earnings may be lower because the interest earnings on new fixed-income investments are likely to have declined with the market interest rates. Mortgage loans and redeemable bonds in the investment portfolio are more likely to be repaid as borrowers seek to borrow at lower interest rates and Aegon may be required to reinvest the proceeds in securities bearing lower interest rates. Accordingly, net income declines as a result of a decrease in the spread between returns on the investment portfolio and the interest rates either credited to policyholders or assumed in reserves.
Aegon manages interest rate risk closely, taking into account all of the complexity regarding policyholder behavior and management action. Aegon employs sophisticated interest rate measurement techniques and actively uses derivatives and other risk mitigation tools to closely manage its interest rate risk exposure. Aegon operates an Interest Rate Risk policy that limits the amount of interest rate risk to which the Group is exposed. All derivative use is governed by Aegons Derivative Use Policy. A detailed description on the use of derivatives within Aegon is included in note 25 Derivatives.
Annual Report on Form 20-F 2017 |
179 | Notes to the consolidated financial statements Note 4 | |
The following table shows interest rates at the end of each of the last five years.
2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||||
3-month US LIBOR |
1.69% | 1.00% | 0.61% | 0.26% | 0.25% | |||||||||||||||
3-month EURIBOR |
(0.33% | ) | (0.32% | ) | (0.13% | ) | 0.08% | 0.29% | ||||||||||||
10-year US Treasury |
2.41% | 2.43% | 2.27% | 2.17% | 3.03% | |||||||||||||||
10-year Dutch government |
0.53% | 0.35% | 0.79% | 0.68% | 2.23% |
The sensitivity analysis in the table below shows an estimate of the effect of a parallel shift in the yield curves on net income and shareholders equity arising from the impact on general account investments and offset due to liabilities from insurance and investment contracts. In general, increases in interest rates are beneficial to Aegon. However, timing and valuation differences between assets and liabilities may cause short-term reductions in net income as rates rise. The rising interest rates would also cause the fair value of the available-for-sale bond portfolio to decline and the level of unrealized gains could become too low to support recoverability of the full deferred tax asset triggering an allowance charge to income. The offsetting economic gain on the insurance and investment contracts is however not fully reflected in the sensitivities because many of these liabilities are not measured at fair value. The short to medium term reduction in net income due to rising interest rates would be offset by higher net income in later years, all else being equal. Therefore, higher interest rates are not considered a long-term risk to the Group. However, a long sustained period of low interest rates will erode net income due to lower returns earned on reinvestments and due to lower long term returns from decreased overall portfolio yields.
Parallel movement of yield curve |
Estimated approximate effects on
net income |
Estimated approximate effects on
shareholders equity |
||||||
2017 |
||||||||
Shift up 100 basis points |
(282 | ) | (2,620 | ) | ||||
Shift down 100 basis points |
200 | 2,160 | ||||||
2016 |
||||||||
Shift up 100 basis points |
364 | (2,257 | ) | |||||
Shift down 100 basis points |
(300 | ) | 2,020 |
The estimated effect on net income due to movements of the yield curve has increased compared to 2016 due to changes in the hedging strategy on guarantee provisions by Aegon the Netherlands. The hedge strategy targets minimal mismatch according to the Aegon economic framework which aligns with Solvency II Own Funds and stabilize Solvency II ratio volatility. The IFRS impact of the changed hedge strategy has led to increased sensitivity of net income.
Credit risk
As premiums and deposits are received, these funds are invested to pay for future policyholder obligations. For general account products, Aegon typically bears the risk for investment performance which is equal to the return of principal and interest. Aegon is exposed to credit risk on its general account fixed-income portfolio (debt securities, mortgages and private placements), over-the-counter derivatives and reinsurance contracts. Some issuers have defaulted on their financial obligations for various reasons, including bankruptcy, lack of liquidity, downturns in the economy, downturns in real estate values, operational failure and fraud. During financial downturns, Aegon can incur defaults or other reductions in the value of these securities and loans, which could have a materially adverse effect on Aegons business, results of operations and financial condition. Investments for account of policyholders are excluded as the policyholder bears the credit risk associated with the investments.
The table that follows shows the Groups maximum exposure to credit risk from investments in general account financial assets, as well as general account derivatives and reinsurance assets, collateral held and net exposure. Please refer to note 49 Transfer of financial assets for further information on collateral given, which may expose the Group to credit risk.
Annual Report on Form 20-F 2017 |
180 | Notes to the consolidated financial statements Note 4 | |
2017 |
Maximum
exposure to credit risk |
Cash |
Secu-
rities |
Letters of
credit / guarantees |
Real
estate property |
Master
netting agree- ments |
Other |
Total
collateral |
Surplus
collateral (or over- collateral- ization) |
Net
exposure |
||||||||||||||||||||||||||||||
Debt securities - carried at fair value |
84,344 | - | - | 242 | - | - | - | 242 | - | 84,102 | ||||||||||||||||||||||||||||||
Debt securities - carried at amortized cost |
- | - | - | 14 | - | - | - | 14 | - | (14 | ) | |||||||||||||||||||||||||||||
Money market and other short-term investments - carried at fair value |
6,809 | - | 719 | - | - | - | - | 719 | 25 | 6,115 | ||||||||||||||||||||||||||||||
Mortgage loans - carried at amortized cost |
33,562 | 2,437 | - | 379 | 49,756 | - | - | 52,573 | 19,271 | 260 | ||||||||||||||||||||||||||||||
Private loans - carried at amortized cost |
3,642 | 79 | - | - | - | - | - | 79 | - | 3,563 | ||||||||||||||||||||||||||||||
Other loans - carried at amortized cost |
2,164 | - | - | - | - | - | 1,886 | 1,886 | 1,195 | 1,473 | ||||||||||||||||||||||||||||||
Other financial assets - carried at fair value |
2,586 | - | - | - | - | - | - | - | - | 2,586 | ||||||||||||||||||||||||||||||
Derivatives |
5,563 | 647 | 56 | 29 | - | 4,867 | - | 5,599 | 85 | 48 | ||||||||||||||||||||||||||||||
Reinsurance assets |
19,200 | - | 4,395 | 137 | - | - | - | 4,532 | - | 14,667 | ||||||||||||||||||||||||||||||
At December 31 |
157,869 | 3,163 | 5,171 | 801 | 49,756 | 4,867 | 1,886 | 65,644 | 20,576 | 112,800 | ||||||||||||||||||||||||||||||
2016 |
Maximum
exposure to credit risk |
Cash |
Securi-
ties |
Letters of
credit / guarantees |
Real
estate property |
Master
netting agree- ments |
Other |
Total
collateral |
Surplus
collateral (or over- collateral- ization) |
Net
exposure |
||||||||||||||||||||||||||||||
Debt securities - carried at fair value |
103,169 | - | - | 392 | - | - | - | 392 | - | 102,777 | ||||||||||||||||||||||||||||||
Money market and other short-term investments - carried at fair value |
7,093 | - | 815 | - | - | - | - | 815 | 27 | 6,306 | ||||||||||||||||||||||||||||||
Mortgage loans - carried at amortized cost |
33,696 | 2,319 | - | 760 | 49,448 | - | - | 52,527 | 19,198 | 366 | ||||||||||||||||||||||||||||||
Private loans - carried at amortized cost |
3,166 | 67 | - | - | - | - | - | 67 | - | 3,099 | ||||||||||||||||||||||||||||||
Other loans - carried at amortized cost |
2,441 | - | - | - | - | - | 2,197 | 2,197 | 1,326 | 1,570 | ||||||||||||||||||||||||||||||
Other financial assets - carried at fair value |
3,425 | - | - | - | - | - | - | - | - | 3,425 | ||||||||||||||||||||||||||||||
Derivatives |
7,916 | 1,606 | 407 | - | - | 5,841 | - | 7,855 | 47 | 109 | ||||||||||||||||||||||||||||||
Reinsurance assets |
11,206 | - | 5,064 | 171 | - | - | - | 5,235 | - | 5,971 | ||||||||||||||||||||||||||||||
At December 31 |
172,113 | 3,992 | 6,287 | 1,322 | 49,448 | 5,841 | 2,197 | 69,087 | 20,598 | 123,623 |
Debt securities
Several bonds in Aegons USAs portfolio are guaranteed by monoline insurers. This is shown in the table above in the column Letters of credit / guarantees. Further information on the monoline insurers is provided below under Monoline insurers.
Money market and short-term investments
The collateral reported for the money market and short-term investments are related to tri-party repurchase agreements (repos). Within tri-party repos Aegon invests under short-term reverse repurchase agreements and the counterparty posts collateral to a third party custodian. The collateral posted is typically high-quality, short-term securities and is only accessible for or available to Aegon in the event the counterparty defaults.
Annual Report on Form 20-F 2017 |
181 | Notes to the consolidated financial statements Note 4 | |
Mortgage loans
The real estate collateral for mortgages includes both residential and commercial properties. The collateral for commercial mortgage loans in Aegon Americas is measured at fair value. At a minimum on an annual basis, a fair value is estimated for each individual real estate property that has been pledged as collateral. When a loan is originally provided, an external appraisal is obtained to estimate the value of the property. In subsequent years, the value is typically estimated internally using various professionally accepted valuation methodologies. Internal appraisals are performed by qualified, professionally accredited personnel. International valuation standards are used and the most significant assumptions made during the valuation of real estate are the current cost of reproducing or replacing the property, the value that the propertys net earning power will support, and the value indicated by recent sales of comparable properties. Valuations are primarily supported by market evidence. For Aegon the Netherlands, collateral for the residential mortgages is measured as the foreclosure value which is indexed periodically.
Cash collateral for mortgage loans includes the savings that have been received to redeem the underlying mortgage loans at redemption date. These savings are part of the credit side of the statement of financial position, but reduce the credit risk for the mortgage loan as a whole.
A substantial part of Aegons Dutch residential mortgage loan portfolio benefits from guarantees by a Dutch government-backed trust (Stichting Waarborgfonds Eigen Woning) through the Dutch Mortgage loan Guarantee program (NHG). With exception of NHG-backed mortgage loans originated after January 1, 2014, for which a 10% lender-incurred haircut applies on realized losses on each defaulted loan, these guarantees cover all principal losses, missed interest payments and foreclosure costs incurred upon termination and settlement of defaulted mortgage loans when lender-specific terms and conditions of the guarantee are met. When not fully met, the trust may pay claims in part or in full, depending on the severity of the breach of terms and conditions. For each specific loan, the guarantee amortizes in line with an equivalent annuity mortgage loan. When the remaining loan balance at default does not exceed the amortized guarantee, it covers the full loss under its terms and conditions. Any loan balance in excess of this decreasing guarantee profile serves as a first loss position for the lender.
Derivatives
The master netting agreements column in the table relates to derivative liability positions which are used in Aegons credit risk management. The offset in the master netting agreements column includes balances where there is a legally enforceable right of offset, but no intention to settle these balances on a net basis under normal circumstances. As a result, there is a net exposure for credit risk management purposes. However, as there is no intention to settle these balances on a net basis, they do not qualify for net presentation for accounting purposes.
Reinsurance assets
The collateral related to the reinsurance assets include assets in trust that are held by the reinsurer for the benefit of Aegon. The assets in trust can be accessed to pay policyholder benefits in the event the reinsurers fail to perform under the terms of their contract. Further information on the related reinsurance transactions is included in note 28 Reinsurance assets.
Other loans
The collateral included in the other column represents the policyholders account value for policy loans. The excess of the account value over the loan value is included in the surplus collateral column. For further information on the policy loans refer to note 23.1 Financial assets, excluding derivatives.
The total collateral includes both under- and over-collateralized positions. To present a net exposure of credit risk, the over-collateralization, which is shown in the surplus collateral column, is extracted from the total collateral.
Credit risk management
Aegon manages credit risk exposure by individual counterparty, sector and asset class, including cash positions. Normally, Aegon mitigates credit risk in derivative contracts by entering into credit support agreement, where practical, and in ISDA master netting agreements for most of Aegons legal entities to facilitate Aegons right to offset credit risk exposure. Main counterparties to these transactions are investment banks which are typically rated A or higher. The credit support agreement will normally dictate the threshold over which collateral needs to be pledged by Aegon or its counterparty. Transactions requiring Aegon or its counterparty to post collateral are typically the result of derivative trades, comprised mostly of interest rate swaps, equity swaps, currency swaps and credit swaps. Collateral received is mainly cash (USD and EUR). The credit support agreements that outline the acceptable collateral require high quality instruments to be posted. Over the last three years, there was no default with any derivatives counterparty. The credit risk associated with financial assets subject to a master netting agreement is eliminated only to the extent
Annual Report on Form 20-F 2017 |
182 | Notes to the consolidated financial statements Note 4 | |
that financial liabilities due to the same counterparty will be settled after the assets are realized. Eligible derivative transactions are traded via Central Clearing Houses as required by EMIR and the Dodd-Frank act. Credit risk in these transactions is mitigated through posting of initial and variation margins.
Aegon may also mitigate credit risk in reinsurance contracts by including downgrade clauses that allow the recapture of business, retaining ownership of assets required to support liabilities ceded or by requiring the reinsurer to hold assets in trust. For the resulting net credit risk exposure, Aegon employs deterministic and stochastic credit risk modeling in order to assess the Groups credit risk profile, associated earnings and capital implications due to various credit loss scenarios.
Aegon operates a Credit Name Limit Policy (CNLP) under which limits are placed on the aggregate exposure that it has to any one counterparty. Limits are placed on the exposure at both group level and individual country units. The limits also vary by a rating system, which is a composite of the main rating agencies (S&P, Moodys and Fitch) and Aegons internal rating of the counterparty. If an exposure exceeds the stated limit, then the exposure must be reduced to the limit for the country unit and rating category as soon as possible. Exceptions to these limits can only be made after explicit approval from Aegons Group Risk and Capital Committee (GRCC). The policy is reviewed regularly.
At December 31, 2017 there was no violations of the Credit Name Limit Policy at Group level. At December 31, 2016 there were two violations of the Credit Name Limit Policy at Group level. These violations have been resolved in 2017 by reducing the exposure of one and by approving an exemption for the other.
At December 31, 2017 Aegons largest corporate credit exposures are to Wilton Re Holdings Ltd, American United Mutual Insurance, Barclays and Citigroup. Aegon had large government exposures, the largest being in the USA, the Netherlands and Germany. Highly rated government bonds and government exposure domestically issued and owned in local currency are excluded from the Credit Name Limit Policy.
Aegon group level long-term counterparty exposure limits are as follows:
Group limits per credit rating | ||||||||
Amounts in EUR million | 2017 | 2016 | ||||||
AAA |
900 | 900 | ||||||
AA |
900 | 900 | ||||||
A |
675 | 675 | ||||||
BBB |
450 | 450 | ||||||
BB |
250 | 250 | ||||||
B |
125 | 125 | ||||||
CCC or lower |
50 | 50 |
Credit rating
The ratings distribution of general account portfolios of Aegons major reporting units, excluding reinsurance assets, are presented in the table that follows, organized by rating category and split by assets that are valued at fair value and assets that are valued at amortized cost. Aegon uses a composite rating based on a combination of the external ratings of S&P, Moodys, Fitch and National Association of Insurance Commissioners (NAIC which is for US only) and internal ratings. The rating used is the lower of the external rating and the internal rating.
Annual Report on Form 20-F 2017 |
183 | Notes to the consolidated financial statements Note 4 | |
Americas | The Netherlands | United Kingdom |
Central & Eastern Europe |
Spain & Portugal | ||||||||||||||||||||||||||||||||||||
Credit rating general account investments, excluding reinsurance assets 2017 |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value | ||||||||||||||||||||||||||||||
AAA |
958 | 18,935 | 1,658 | 12,727 | - | 137 | - | 1 | - | 9 | ||||||||||||||||||||||||||||||
AA |
2,693 | 3,353 | 85 | 5,449 | - | 1,139 | - | 5 | - | 48 | ||||||||||||||||||||||||||||||
A |
2,905 | 18,684 | 56 | 3,186 | - | 449 | 8 | 126 | 55 | 167 | ||||||||||||||||||||||||||||||
BBB |
330 | 16,822 | 941 | 1,267 | - | 78 | 3 | 495 | (3 | ) | 401 | |||||||||||||||||||||||||||||
BB |
18 | 1,567 | 18 | 22 | - | 9 | 72 | 92 | - | 20 | ||||||||||||||||||||||||||||||
B |
- | 1,162 | - | - | - | - | 2 | 1 | - | - | ||||||||||||||||||||||||||||||
CCC or lower |
- | 793 | - | 3 | - | - | - | - | - | - | ||||||||||||||||||||||||||||||
Assets not rated |
1,892 | 2,797 | 27,133 | 3,770 | - | 219 | 107 | 55 | 2 | 6 | ||||||||||||||||||||||||||||||
Total | 8,796 | 64,114 | 29,890 | 26,425 | - | 2,031 | 193 | 775 | 54 | 651 | ||||||||||||||||||||||||||||||
Past due and / or impaired assets |
35 | 1,145 | 299 | 41 | - | - | 82 | 1 | - | - | ||||||||||||||||||||||||||||||
At December 31 |
8,831 | 65,259 | 30,189 | 26,467 | - | 2,031 | 275 | 777 | 54 | 651 |
Asia | Asset Management | Total 2017 1) | ||||||||||||||||||||||||||
Credit rating general account investments, excluding reinsurance assets 2017 |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Total
carrying value |
|||||||||||||||||||||
AAA |
- | 985 | - | 144 | 2,616 | 32,960 | 35,575 | |||||||||||||||||||||
AA |
- | 340 | - | - | 2,778 | 10,334 | 13,111 | |||||||||||||||||||||
A |
- | 1,775 | - | - | 3,024 | 24,399 | 27,423 | |||||||||||||||||||||
BBB |
- | 1,920 | - | - | 1,271 | 20,983 | 22,254 | |||||||||||||||||||||
BB |
- | 140 | - | 1 | 107 | 1,852 | 1,959 | |||||||||||||||||||||
B |
- | 117 | - | 4 | 2 | 1,284 | 1,287 | |||||||||||||||||||||
CCC or lower |
- | 23 | - | 4 | - | 823 | 823 | |||||||||||||||||||||
Assets not rated |
6 | 1 | - | 4 | 29,154 | 7,011 | 36,165 | |||||||||||||||||||||
Total | 6 | 5,300 | - | 157 | 38,951 | 99,645 | 138,597 | |||||||||||||||||||||
Past due and / or impaired assets |
- | 20 | - | - | 416 | 1,207 | 1,624 | |||||||||||||||||||||
At December 31 |
6 | 5,320 | - | 157 | 39,368 | 100,853 | 140,221 |
1 | Includes investments of Holding and other activities. |
Americas | The Netherlands | United Kingdom |
Central & Eastern Europe |
Spain & Portugal | ||||||||||||||||||||||||||||||||||||
Credit rating general account investments, excluding reinsurance assets 2016 |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value | ||||||||||||||||||||||||||||||
AAA |
1,560 | 21,580 | 1,628 | 13,020 | - | 171 | - | 2 | - | 12 | ||||||||||||||||||||||||||||||
AA |
3,214 | 6,102 | 86 | 6,011 | - | 1,158 | - | 1 | - | 58 | ||||||||||||||||||||||||||||||
A |
3,281 | 25,147 | 12 | 3,397 | - | 549 | 8 | 116 | 48 | 157 | ||||||||||||||||||||||||||||||
BBB |
481 | 21,461 | 850 | 2,402 | - | 85 | 20 | 433 | (6 | ) | 436 | |||||||||||||||||||||||||||||
BB |
70 | 1,964 | 18 | 107 | - | 90 | 56 | 80 | - | 18 | ||||||||||||||||||||||||||||||
B |
- | 1,207 | - | 10 | - | 2 | 4 | 1 | - | 3 | ||||||||||||||||||||||||||||||
CCC or lower |
- | 1,049 | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||
Assets not rated |
2,196 | 3,847 | 25,133 | 4,792 | - | 215 | 111 | 44 | 3 | 3 | ||||||||||||||||||||||||||||||
Total | 10,802 | 82,357 | 27,727 | 29,740 | - | 2,269 | 201 | 676 | 45 | 687 | ||||||||||||||||||||||||||||||
Past due and / or impaired assets |
17 | 1,397 | 390 | 77 | - | - | 102 | 2 | - | - | ||||||||||||||||||||||||||||||
At December 31 |
10,820 | 83,755 | 28,117 | 29,817 | - | 2,269 | 303 | 678 | 45 | 687 |
Annual Report on Form 20-F 2017 |
184 | Notes to the consolidated financial statements Note 4 | |
Asia | Asset Management | Total 2016 1) | ||||||||||||||||||||||||||
Credit rating general account investments, excluding
reinsurance assets 2016 |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Amortized
cost |
Fair value |
Total carrying
value |
|||||||||||||||||||||
AAA |
- | 950 | - | - | 3,189 | 35,758 | 38,946 | |||||||||||||||||||||
AA |
- | 402 | - | - | 3,300 | 13,731 | 17,032 | |||||||||||||||||||||
A |
- | 1,823 | - | - | 3,349 | 31,204 | 34,553 | |||||||||||||||||||||
BBB |
- | 1,904 | - | - | 1,346 | 26,721 | 28,067 | |||||||||||||||||||||
BB |
- | 132 | - | - | 145 | 2,391 | 2,536 | |||||||||||||||||||||
B |
- | 57 | - | - | 5 | 1,279 | 1,284 | |||||||||||||||||||||
CCC or lower |
- | 28 | - | - | - | 1,078 | 1,078 | |||||||||||||||||||||
Assets not rated |
18 | - | - | 90 | 27,460 | 9,267 | 36,727 | |||||||||||||||||||||
Total | 18 | 5,297 | - | 90 | 38,793 | 121,429 | 160,222 | |||||||||||||||||||||
Past due and / or impaired assets |
- | 13 | - | - | 510 | 1,489 | 1,999 | |||||||||||||||||||||
At December 31 |
18 | 5,310 | - | 90 | 39,303 | 122,918 | 162,221 |
1 | Includes investments of Holding and other activities. |
The following table shows the credit quality of the gross positions in the statement of financial position for general account reinsurance assets specifically:
Carrying value 2017 | Carrying value 2016 | |||||||||
AAA |
- | 7 | ||||||||
AA |
13,379 | 7,724 | ||||||||
A |
5,242 | 3,120 | ||||||||
Below A |
24 | 18 | ||||||||
Not rated |
555 | 338 | ||||||||
At December 31 |
19,200 | 11,206 |
Credit risk concentration
The tables that follow present specific credit risk concentration information for general account financial assets.
Credit risk concentrations debt securities and money market investments 2017 |
Americas |
The
Netherlands |
United
Kingdom |
Central &
Eastern Europe |
Spain &
Portugal |
Asia |
Asset
Manage- ment |
Total 2017 1) |
Of which
past due and / or impaired assets |
|||||||||||||||||||||||||||
Residential mortgage-backed securities |
||||||||||||||||||||||||||||||||||||
(RMBSs) |
3,025 | 556 | 17 | - | - | 57 | - | 3,655 | 1,022 | |||||||||||||||||||||||||||
Commercial mortgage-backed securities |
||||||||||||||||||||||||||||||||||||
(CMBSs) |
3,375 | 28 | 146 | - | - | 537 | - | 4,086 | 10 | |||||||||||||||||||||||||||
Asset-backed securities (ABSs) - CDOs backed by ABS, Corp. bonds, Bank loans |
751 | 1,529 | - | - | - | 47 | - | 2,327 | 3 | |||||||||||||||||||||||||||
ABSs Other |
1,688 | 270 | 88 | - | 1 | 331 | - | 2,378 | 35 | |||||||||||||||||||||||||||
Financial - Banking |
6,525 | 1,440 | 124 | 102 | 104 | 730 | - | 9,026 | 3 | |||||||||||||||||||||||||||
Financial - Other |
9,028 | 212 | 58 | 3 | 114 | 498 | 137 | 10,069 | 4 | |||||||||||||||||||||||||||
Industrial |
21,975 | 1,726 | 255 | 7 | 129 | 2,344 | - | 26,435 | 62 | |||||||||||||||||||||||||||
Utility |
3,386 | 119 | 65 | 3 | 45 | 309 | - | 3,927 | - | |||||||||||||||||||||||||||
Government bonds |
11,319 | 15,531 | 1,060 | 603 | 253 | 466 | 17 | 29,249 | 14 | |||||||||||||||||||||||||||
At December 31 |
61,073 | 21,411 | 1,812 | 718 | 646 | 5,319 | 153 | 91,153 | 1,154 |
1 | Includes investments of Holding and other activities. |
Annual Report on Form 20-F 2017 |
185 | Notes to the consolidated financial statements Note 4 | |
Credit risk concentrations Government bonds per country of risk 2017 |
Americas |
The
Netherlands |
United
Kingdom |
Central &
Eastern Europe |
Spain &
Portugal |
Asia |
Asset
Management |
Total 2017 1 ) | ||||||||||||||||||||||||
United States |
10,501 | 32 | - | - | - | 372 | - | 10,906 | ||||||||||||||||||||||||
Netherlands |
- | 5,777 | - | - | 4 | - | - | 5,781 | ||||||||||||||||||||||||
United Kingdom |
- | - | 946 | 1 | - | - | 17 | 964 | ||||||||||||||||||||||||
Austria |
- | 1,154 | - | - | 4 | - | - | 1,158 | ||||||||||||||||||||||||
Belgium |
- | 1,065 | 23 | - | 6 | - | - | 1,094 | ||||||||||||||||||||||||
Finland |
- | 938 | - | - | - | - | - | 938 | ||||||||||||||||||||||||
France |
- | 1,216 | 34 | - | 5 | - | - | 1,255 | ||||||||||||||||||||||||
Germany |
- | 4,233 | 28 | - | - | - | - | 4,261 | ||||||||||||||||||||||||
Hungary |
3 | - | - | 402 | - | - | - | 405 | ||||||||||||||||||||||||
Luxembourg |
- | 785 | - | - | 1 | - | - | 786 | ||||||||||||||||||||||||
Spain |
- | 89 | - | 2 | 203 | - | - | 294 | ||||||||||||||||||||||||
Rest of Europe |
133 | 205 | - | 198 | 16 | 17 | - | 568 | ||||||||||||||||||||||||
Rest of world |
652 | 36 | 29 | - | 14 | 77 | - | 809 | ||||||||||||||||||||||||
Supranational |
30 | - | - | - | - | - | - | 30 | ||||||||||||||||||||||||
At December 31 |
11,319 | 15,531 | 1,060 | 603 | 253 | 466 | 17 | 29,249 |
1 | Includes investments of Holding and other activities. |
Credit risk concentrations Credit rating 2017 2) |
Government
bonds |
Corporate bonds |
RMBSs CMBSs
ABSs |
Other | Total 2017 1) | |||||||||||||||
AAA |
21,855 | 792 | 7,102 | 3,157 | 32,906 | |||||||||||||||
AA |
5,462 | 2,879 | 1,700 | - | 10,040 | |||||||||||||||
A |
311 | 20,765 | 1,443 | - | 22,520 | |||||||||||||||
BBB |
1,198 | 19,045 | 396 | 6 | 20,646 | |||||||||||||||
BB |
269 | 1,395 | 178 | - | 1,842 | |||||||||||||||
B |
152 | 1,011 | 111 | - | 1,273 | |||||||||||||||
CCC or lower |
2 | 309 | 1,516 | - | 1,828 | |||||||||||||||
Assets not rated |
- | 3 | - | 95 | 98 | |||||||||||||||
At December 31 |
29,249 | 46,199 | 12,446 | 3,258 | 91,153 |
1 | Includes investments of Holding and other activities. |
2 | CNLP Ratings are used and are the lower of the Barclays Rating and the Internal Rating with the Barclays rating being a blended rating of S&P, Fitch, and Moodys. |
Credit risk concentrations debt securities and money market investments 2016 |
Americas |
The
Netherlands |
United
Kingdom |
Central &
Eastern Europe |
Spain &
Portugal |
Asia |
Asset
Manage- ment |
Total 2016 1) |
Of which
past due and / or impaired assets |
|||||||||||||||||||||||||||
Residential mortgage-backed securities |
||||||||||||||||||||||||||||||||||||
(RMBSs) |
3,583 | 649 | 19 | - | - | 80 | - | 4,331 | 1,267 | |||||||||||||||||||||||||||
Commercial mortgage-backed securities |
||||||||||||||||||||||||||||||||||||
(CMBSs) |
5,340 | 44 | 195 | - | - | 576 | - | 6,155 | 8 | |||||||||||||||||||||||||||
Asset-backed securities (ABSs) - CDOs backed by ABS, Corp. bonds, Bank loans |
1,066 | 2,437 | - | - | - | 29 | - | 3,532 | 7 | |||||||||||||||||||||||||||
ABSs Other |
2,324 | 276 | 97 | - | 1 | 373 | - | 3,072 | 36 | |||||||||||||||||||||||||||
Financial - Banking |
8,457 | 1,194 | 157 | 67 | 110 | 800 | - | 10,785 | 4 | |||||||||||||||||||||||||||
Financial - Other |
10,487 | 282 | 118 | 6 | 120 | 465 | 87 | 11,588 | - | |||||||||||||||||||||||||||
Industrial |
29,364 | 2,824 | 332 | 7 | 126 | 2,367 | - | 35,020 | 65 | |||||||||||||||||||||||||||
Utility |
4,704 | 392 | 67 | 3 | 43 | 280 | - | 5,490 | 7 | |||||||||||||||||||||||||||
Government bonds |
12,406 | 15,642 | 1,068 | 553 | 282 | 339 | - | 30,289 | 4 | |||||||||||||||||||||||||||
At December 31 |
77,730 | 23,741 | 2,054 | 636 | 683 | 5,310 | 87 | 110,262 | 1,399 |
1 | Includes investments of Holding and other activities. |
Annual Report on Form 20-F 2017 |
186 | Notes to the consolidated financial statements Note 4 | |
Credit risk concentrations Government bonds per country of risk 2016 | Americas |
The Netherlands |
United Kingdom |
Central & Eastern Europe |
Spain & Portugal |
Asia |
Asset Manage- ment |
Total 2016 1) |
||||||||
United States | 11,738 | 22 | - | - | - | 300 | - | 12,060 | ||||||||
Netherlands | - | 5,374 | - | - | 4 | - | - | 5,378 | ||||||||
United Kingdom | - | - | 948 | 2 | - | - | - | 949 | ||||||||
Austria | - | 1,171 | - | - | 4 | - | - | 1,175 | ||||||||
Belgium | - | 1,119 | 25 | - | 7 | - | - | 1,151 | ||||||||
Finland | - | 935 | - | - | - | - | - | 935 | ||||||||
France | - | 1,356 | 36 | - | 5 | - | - | 1,397 | ||||||||
Germany | - | 4,138 | 29 | - | - | - | - | 4,167 | ||||||||
Hungary | 4 | - | - | 360 | - | - | - | 364 | ||||||||
Luxembourg | - | 872 | - | - | 4 | - | - | 876 | ||||||||
Spain | - | 112 | - | 2 | 221 | - | - | 335 | ||||||||
Rest of Europe | 118 | 484 | - | 189 | 18 | - | - | 808 | ||||||||
Rest of world | 506 | 59 | 30 | - | 20 | 39 | - | 654 | ||||||||
Supranational | 40 | - | - | - | - | - | - | 40 | ||||||||
At December 31 |
12,406 | 15,642 | 1,068 | 553 | 282 | 339 | - | 30,289 |
1 | Includes investments of Holding and other activities. |
Credit risk concentrations Credit rating 2016 2) | Government bonds | Corporate bonds | RMBSs CMBSs ABSs | Other | Total 2016 1) | |||||||||||||||
AAA | 22,620 | 912 | 9,809 | 2,362 | 35,704 | |||||||||||||||
AA | 5,682 | 4,835 | 2,645 | - | 13,161 | |||||||||||||||
A | 569 | 26,291 | 1,740 | - | 28,599 | |||||||||||||||
BBB | 1,166 | 24,662 | 540 | 3 | 26,370 | |||||||||||||||
BB | 158 | 1,943 | 274 | - | 2,376 | |||||||||||||||
B | 91 | 1,023 | 145 | - | 1,260 | |||||||||||||||
CCC or lower | 4 | 386 | 1,937 | - | 2,326 | |||||||||||||||
Assets not rated | - | 4 | - | 462 | 466 | |||||||||||||||
At December 31 |
30,289 | 60,055 | 17,090 | 2,827 | 110,262 |
1 | Includes investments of Holding and other activities. |
2 | CNLP Ratings are used and are the lower of the Barclays Rating and the Internal Rating with the Barclays rating being a blended rating of S&P, Fitch, and Moodys. |
Credit risk concentrations mortgage loans 2017 |
Americas |
The
Netherlands |
United
Kingdom |
Central &
Eastern Europe |
Spain &
Portugal |
Asia |
Asset
Manage- ment |
Total 2017 1) |
Of which
past due and / or impaired assets |
|||||||||||||||||||||||||||
Agricultural | 77 | - | - | - | - | - | - | 77 | 8 | |||||||||||||||||||||||||||
Apartment | 3,371 | - | - | - | - | - | - | 3,371 | - | |||||||||||||||||||||||||||
Industrial | 631 | - | - | - | - | - | - | 631 | 7 | |||||||||||||||||||||||||||
Office | 1,226 | - | - | - | - | - | - | 1,226 | - | |||||||||||||||||||||||||||
Retail | 1,375 | 11 | - | - | - | - | - | 1,385 | 19 | |||||||||||||||||||||||||||
Other commercial | 256 | 38 | - | - | - | - | - | 294 | 2 | |||||||||||||||||||||||||||
Residential | 16 | 26,384 | - | 176 | 1 | - | - | 26,578 | 343 | |||||||||||||||||||||||||||
At December 31 |
6,951 | 26,434 | - | 176 | 1 | - | - | 33,562 | 379 |
1 | Includes investments of Holding and other activities. |
Annual Report on Form 20-F 2017 |
187 | Notes to the consolidated financial statements Note 4 | |
Credit risk concentrations mortgage loans 2016 |
Americas |
|
The
Netherlands |
|
|
United
Kingdom |
|
|
Central &
Eastern Europe |
|
|
Spain &
Portugal |
|
Asia |
|
Asset
Manage- ment |
|
|
Total 2016
1) |
|
|
Of which
past due and / or impaired assets |
|
|||||||||||||
Agricultural | 101 | - | - | - | - | - | - | 101 | 11 | |||||||||||||||||||||||||||
Apartment | 3,525 | - | - | - | - | - | - | 3,525 | - | |||||||||||||||||||||||||||
Industrial | 838 | - | - | - | - | - | - | 838 | - | |||||||||||||||||||||||||||
Office | 1,869 | 1 | - | - | - | - | - | 1,869 | 1 | |||||||||||||||||||||||||||
Retail | 1,889 | 12 | - | - | - | - | - | 1,901 | 5 | |||||||||||||||||||||||||||
Other commercial | 397 | 41 | - | - | - | - | - | 438 | - | |||||||||||||||||||||||||||
Residential | 23 | 24,793 | - | 207 | 1 | - | - | 25,023 | 448 | |||||||||||||||||||||||||||
At December 31 |
8,641 | 24,847 | - | 207 | 1 | - | - | 33,696 | 464 |
1 | Includes investments of Holding and other activities. |
The fair value of Aegon Americas commercial and agricultural mortgage loan portfolio as per December 31, 2017, amounted to EUR 7,132 million (2016: EUR 8,789 million). The loan to value (LTV) amounted to approximately 55% (2016: 54%). Of the portfolio 0.06% (2016: nil) is in delinquency (defined as 60 days in arrears). In 2017, Aegon Americas recognized EUR 19 million impairments (net of recoveries) (2016: nil) on this portfolio. In 2017, Aegon Americas foreclosed upon, or recovered no amount of real estate (2016: EUR 15 million). The 2017 additional impairments associated with these loans at the time of foreclosure amounted to EUR 0.2 million (2016: EUR 2 million).
The fair value of Aegon the Netherlands mortgage loan portfolio as per December 31, 2017, amounted to EUR 30,926 million (2016: EUR 29,479 million). The LTV amounted to approximately 76% (2016: 83%). A significant part of the portfolio 51% (2016: 57%) is government guaranteed. Of the portfolio, 0.2% (2016: 0.4%) is in delinquency (defined as 60 days in arrears). Impairments in 2017 amounted to EUR 8 million (2016: EUR 5 million release). During the last ten years defaults of the portfolio have been 5 basis points on average.
Unconsolidated structured entities
Aegons investments in unconsolidated structured entities such as RMBSs, CMBSs and ABSs and investment funds are presented in the line item Investments of the statement of financial position. Aegons interests in these unconsolidated structured entities can be characterized as basic interests, Aegon does not have loans, derivatives, guarantees or other interests related to these investments. Any existing commitments such as future purchases of interests in investment funds are disclosed in note 48 Commitments and contingencies.
For debt instruments, specifically for RMBSs, CMBSs and ABSs, the maximum exposure to loss is equal to the carrying amount which is reflected in the credit risk concentration table regarding debt securities and money market investments. To manage credit risk Aegon invests primarily in senior notes of RMBSs, CMBSs and ABSs. Additional information on credit ratings for Aegons investments in RMBSs, CMBSs and ABSs are disclosed in the sections that describe per category of debt securities the composition and impairment assessments. The composition of the RMBSs, CMBSs and ABSs portfolios of Aegon are widely dispersed looking at the individual amount per entity, therefore Aegon only has non-controlling interests in individual unconsolidated structured entities. Furthermore these investments are not originated by Aegon.
Except for commitments as noted in note 48 Commitments and contingencies, Aegon did not provide, nor is required to provide financial or other support to unconsolidated structured entities. Nor does Aegon have intentions to provide financial or other support to unconsolidated structured entities in which Aegon has an interest or previously had an interest.
For RMBSs, CMBSs and ABSs in which Aegon has an interest at reporting date, the following table presents total income received from those interests. The Investments column reflects the carrying values recognized in the statement of financial position of Aegons interests in RMBSs, CMBSs and ABSs.
Annual Report on Form 20-F 2017 |
188 | Notes to the consolidated financial statements Note 4 | |
Total income 2017 | December 31, 2017 | |||||||||||||||
2017 | Interest income |
Total gains and
losses on sale of assets |
Total | Investments | ||||||||||||
Residential mortgage-backed securities | 174 | 95 | 269 | 3,655 | ||||||||||||
Commercial mortgage-backed securities | 159 | 53 | 212 | 4,086 | ||||||||||||
Asset-backed securities | 56 | 26 | 82 | 2,327 | ||||||||||||
ABSs - Other | 87 | 71 | 158 | 2,378 | ||||||||||||
Total |
476 | 245 | 721 | 12,446 | ||||||||||||
Total income 2016 | December 31, 2016 | |||||||||||||||
2016 | Interest income |
Total gains and
losses on sale of assets |
Total | Investments | ||||||||||||
Residential mortgage-backed securities | 215 | 61 | 276 | 4,331 | ||||||||||||
Commercial mortgage-backed securities | 191 | 28 | 219 | 6,155 | ||||||||||||
Asset-backed securities | 64 | 12 | 75 | 3,532 | ||||||||||||
ABSs - Other | 85 | 7 | 92 | 3,072 | ||||||||||||
Total |
555 | 107 | 662 | 17,090 |
Monoline insurers
EUR 264 million (2016: EUR 413 million) of the bonds in Aegon USAs and Asias portfolios are insured by Monoline insurers.
An insolvency by one of the Monolines could create significant market price volatility for the affected holdings. Of the EUR 264 million indirect exposure on the Monoline insurers, 31% relates to Municipal Bond Insurance Association, Inc. (MBIA), 13% to Ambac Financial Group, inc. (AMBAC), and 43% to Assured Guaranty Corporation (AGC) (2016: 37% related to MBIA, 14% to AMBAC, and 39% to AGC).
Additional information on credit risk, unrealized losses and impairments
Debt instruments
The amortized cost and fair value of debt securities, money market investments and other, included in Aegons available-for-sale (AFS) portfolios, are as follows as of December 31, 2017, and December 31, 2016
2017 |
Amortized
cost |
Unrealized
gains |
Unrealized
losses |
Total fair
value |
Fair value of
instruments with unrealized gains |
Fair value of
instruments with unrealized losses |
||||||||||||||||||
Debt securities, money market instruments and other | ||||||||||||||||||||||||
United States government | 8,011 | 936 | (101) | 8,846 | 6,805 | 2,041 | ||||||||||||||||||
Dutch government | 4,799 | 992 | (11) | 5,781 | 4,885 | 896 | ||||||||||||||||||
Other government | 11,746 | 838 | (17) | 12,568 | 11,501 | 1,067 | ||||||||||||||||||
Mortgage-backed securities | 7,326 | 424 | (56) | 7,694 | 5,569 | 2,126 | ||||||||||||||||||
Asset-backed securities | 4,624 | 92 | (17) | 4,698 | 3,878 | 820 | ||||||||||||||||||
Corporate | 37,168 | 3,663 | (218) | 40,613 | 34,945 | 5,668 | ||||||||||||||||||
Money market investments | 6,690 | - | - | 6,690 | 5,642 | 1,048 | ||||||||||||||||||
Other | 765 | 98 | (73) | 791 | 597 | 193 | ||||||||||||||||||
Total | 81,130 | 7,043 | (493) | 87,681 | 73,822 | 13,858 | ||||||||||||||||||
Of which held by Aegon Americas, NL and UK |
74,672 | 6,665 | (464 | ) | 80,873 | 68,385 | 12,488 |
Annual Report on Form 20-F 2017 |
189 | Notes to the consolidated financial statements Note 4 | |
2016 |
|
Amortized
cost |
|
|
Unrealized
gains |
|
|
Unrealized
losses |
|
|
Total fair
value |
|
|
Fair value of
instruments with unrealized gains |
|
|
Fair value of
instruments with unrealized losses |
|
||||||
Debt securities, money market instruments and
other |
||||||||||||||||||||||||
United States government | 11,452 | 882 | (343) | 11,990 | 7,012 | 4,979 | ||||||||||||||||||
Dutch government | 4,164 | 1,215 | (5) | 5,374 | 5,286 | 87 | ||||||||||||||||||
Other government | 11,788 | 1,096 | (20) | 12,865 | 12,278 | 586 | ||||||||||||||||||
Mortgage-backed securities | 10,099 | 453 | (156) | 10,396 | 6,543 | 3,853 | ||||||||||||||||||
Asset-backed securities | 6,568 | 88 | (64) | 6,592 | 4,192 | 2,399 | ||||||||||||||||||
Corporate | 50,431 | 4,073 | (668) | 53,837 | 42,361 | 11,476 | ||||||||||||||||||
Money market investments | 6,776 | - | - | 6,776 | 6,758 | 18 | ||||||||||||||||||
Other | 1,019 | 228 | (41) | 1,206 | 1,168 | 38 | ||||||||||||||||||
Total | 102,298 | 8,035 | (1,297) | 109,036 | 85,599 | 23,436 | ||||||||||||||||||
Of which held by Aegon Americas, NL and UK |
95,806 | 7,739 | (1,217 | ) | 102,329 | 81,335 | 20,993 |
Unrealized bond losses by sector
The composition by industry category of Aegons available-for-sale (AFS) debt securities, money market investments and other in an unrealized loss position at December 31, 2017, and December 31, 2016, is presented in the following table:
December 31, 2017 | December 31, 2016 | |||||||||||||||
Unrealized losses - debt securities, money market investments and other |
Carrying value of
instruments with unrealized losses |
Unrealized
losses |
Carrying value of
instruments with unrealized losses |
Unrealized
losses |
||||||||||||
Residential mortgage-backed securities (RMBSs) | 732 | (30 | ) | 1,588 | (83 | ) | ||||||||||
Commercial mortgage-backed securities (CMBSs) | 1,140 | (22 | ) | 2,027 | (67 | ) | ||||||||||
Asset-backed securities (ABSs) - CDOs backed by ABS, Corp.bonds, Bank loans |
87 | (2 | ) | 958 | (11 | ) | ||||||||||
ABSs - Other | 603 | (13 | ) | 1,130 | (43 | ) | ||||||||||
Financial Industry - Banking | 663 | (39 | ) | 1,679 | (135 | ) | ||||||||||
Financial Industry - Insurance | 231 | (7 | ) | 554 | (34 | ) | ||||||||||
Financial Industry - Other | 1,411 | (10 | ) | 618 | (28 | ) | ||||||||||
Industrial | 3,330 | (132 | ) | 6,216 | (369 | ) | ||||||||||
Utility | 375 | (14 | ) | 836 | (45 | ) | ||||||||||
Government | 3,722 | (123 | ) | 5,349 | (361 | ) | ||||||||||
Other | 193 | (73 | ) | 38 | (41 | ) | ||||||||||
Total held by Aegon Americas, NL and UK |
12,488 | (464 | ) | 20,993 | (1,217 | ) | ||||||||||
Held by other segments | 1,371 | (29 | ) | 2,443 | (80 | ) | ||||||||||
Total |
13,858 | (493 | ) | 23,436 | (1,297 | ) |
As of December 31, 2017, there are EUR 6,665 million (December 31, 2016: EUR 7,739 million) of gross unrealized gains and EUR 464 million (December 31, 2016: EUR 1,217 million) of gross unrealized losses in the AFS debt securities, money markets and other portfolio of Aegon Americas, Aegon the Netherlands and Aegon UK. Two issuers each represent more than 4% of the total unrealized loss position. The unrealized loss relates to securities issued by the government of the United States of America and Belfius Bank.
Financial and credit market conditions were stronger during 2017. Developed-world growth showed continued signs of acceleration, allowing policy makers to slow or even reverse accommodative credit market conditions. Emerging Market economies have stabilized and improved somewhat with more stable commodities prices. Global equity markets produced very strong returns. The US dollar weakened after strengthening significantly in 2016. The US Federal Reserve tightened the Fed Funds rate by 50 basis points in the first half of 2017, and by another 25 basis points in December, reflecting strong labor market conditions. Long-term US Treasury rates, after rising sharply late in 2016, fell very modestly. Corporate default rates remained low due to readily available access to funding and to healthy corporate balance sheet fundamentals. Credit spreads tightened. Oil prices rose slightly, after having weakened in the first half of 2017. Tighter credit spreads and lower US treasury rates increased the market values of fixed income holdings.
Annual Report on Form 20-F 2017 |
190 | Notes to the consolidated financial statements Note 4 | |
The Eurozone has experienced a period of strong growth. Consumption was supported by the rapid decline in unemployment, while investments grew strongly due to a supportive global economic backdrop. Spain and Germany were the fastest growing large economies. Inflation pressures were again absent. Wage growth did pick up slightly, but not enough to push inflation above the target of the European Central Bank. The central bank therefore maintained its accommodative stance, but did decide to taper its purchase program further from EUR 60 billion to EUR 30 billion per month. Growth in the UK slowed down, due to uncertainty surrounding Brexit. The French elections resulted in a victory for Mr. Macron, who is likely to pursue a pro-European course. Catalonian politicians tried to gain independence from Spain via a referendum. However, so far their efforts did not result in more autonomy. Italy reformed its electoral law and announced to hold elections in March 2018. The UK triggered Article 50 in March which set the Brexit negotiation process in motion. Prime minister May called early elections soon afterward, in which she wasnt able to achieve her desired majority. At the end of the year, the EU and the UK managed to agree on a deal covering citizens rights, the Irish border and the financial settlement. This allowed the negotiations to proceed to the next stage, which will mainly cover a transition period and a trade agreement.
Impairment of financial assets
Aegon regularly monitors industry sectors and individual debt securities for indicators of impairment. These indicators may include one or more of the following: 1) deteriorating market to book ratio, 2) increasing industry risk factors, 3) deteriorating financial condition of the issuer, 4) covenant violations by the issuer, 5) high probability of bankruptcy of the issuer, or 6) downgrades by internationally recognized credit rating agency. Additionally, for asset-backed securities, cash flow trends and underlying levels of collateral are monitored. A security is impaired if there is objective evidence that a loss event has occurred after the initial recognition of the asset that has a negative impact on the estimated future cash flows.
In the sections below a description is provided on the composition of the categories of debt securities and money market investments. Individual issuers rated below investment grade in any sector which have unrealized loss positions greater than EUR 25 million are disclosed separately. Furthermore, quality ratings of investment portfolios are based on a composite of the main rating agencies (S&P, Moodys and Fitch) and Aegons internal rating of the counterparty.
Residential mortgage-backed securities
Aegon Americas, Aegon the Netherlands and Aegon UK hold EUR 3,557 million (December 31, 2016: EUR 4,162 million) of residential mortgage-backed securities available-for-sale (RMBS), of which EUR 2,985 million (December 31, 2016: EUR 3,494 million) is held by Aegon Americas, EUR 556 million (December 31, 2016: EUR 649 million) by Aegon the Netherlands, and EUR 17 million (December 31, 2016: EUR 19 million) by Aegon UK. Residential mortgage-backed securities are securitizations of underlying pools of non-commercial mortgages on real estate. The underlying residential mortgages have varying credit characteristics and are pooled together and sold in tranches. The following table shows the breakdown of Aegon USAs RMBS available-for-sale (AFS) portfolio.
Annual Report on Form 20-F 2017 |
191 | Notes to the consolidated financial statements Note 4 | |
A significant part of Aegon USAs RMBS holdings are rated < BBB, as the issuances took place before the United States housing downturn that started in 2007.
Additionally, Aegon USA has investments in RMBS of EUR 40 million (December 31, 2016: EUR 89 million), which are classified as fair value through profit or loss.
RMBS of Aegon USA are monitored and reviewed on a monthly basis. Detailed cash flow models using the current collateral pool and capital structure on the portfolio are updated and reviewed quarterly. Model output is generated under base and stress-case scenarios. Aegons RMBS asset specialists utilize widely recognized industry modeling software to perform a loan-by-loan, bottom-up approach to modeling. Key assumptions used in the models are projected defaults, loss severities, and prepayments. Each of these key assumptions varies greatly based on the significantly diverse characteristics of the current collateral pool for each security. Loan-to- value, loan size, and borrower credit history are some of the key characteristics used to determine the level of assumption that is utilized. Defaults were estimated by identifying the loans that are in various delinquency buckets and defaulting a certain percentage of them over the near-term and long-term. Assumed defaults on delinquent loans are dependent on the specific securitys collateral attributes and historical performance.
Loss severity assumptions were determined by obtaining historical rates from broader market data and by adjusting those rates for vintage, specific pool performance, collateral type, mortgage insurance and estimated loan modifications. Prepayments were estimated by examining historical averages of prepayment activity on the underlying collateral. Quantitative ranges of significant assumptions within Aegons modeling process for Prime Jumbo, Alt-A, Negative Amortization and subprime RMBS are as follows: prepayment assumptions range from approximately 0% to 29% with a weighted average of approximately 5.5% (December 31, 2016: 4.6%), assumed defaults on delinquent loans range from 51% to 88% with a weighted average of approximately 77.6% (December 31, 2016: 79.4%), assumed defaults on current loans are dependent on the specific securitys collateral attributes and historical performance, while loss severity assumptions range from approximately 24% to 75%, with a weighted average of approximately 58.3% (December 31, 2016: 57.6%).
Once the entire pool is modeled, the results are closely analyzed by Aegons asset specialists to determine whether or not Aegons particular tranche or holding is at risk for not collecting all contractual cash flows taking into account the seniority and other terms of the tranches held.
Aegon the Netherlands uses its own proprietary cash flow tools to analyse and stress test RMBS transactions. The key input parameters are default rates and loss given default assumptions, which are established based historical pool characteristics and current loan level data. Cash flows for each bond are modelled in 225 scenarios of varying severity, ranging from our base case to extreme stress to even unrealistic scenarios to establish breaking points of the tranche. The model takes all deal characteristics, such as waterfall or reserve funds, into account and gives us detailed insight in the risk of principal loss or deferral of contractual cash flows.
The total gross unrealized loss on available-for-sale RMBS of Aegon Americas, Aegon the Netherlands and Aegon UK amounted to EUR 30 million (December 31, 2016: 83 million), of which EUR 29 million (December 31, 2016: EUR 78 million) relates to positions of Aegon USA, and the total net unrealized gain on available-for-sale RMBS was EUR 284 million (December 31, 2016: EUR 210 million), including a EUR 268 million (December 31, 2016: EUR 199 million) net unrealized gain relating to positions of Aegon USA. The housing market in the United States continues to be robust, evidenced by rising home prices and strong sales volume although the pace of improvement is slowing compared to initial post-financial crisis years. The housing market is still benefiting from improving employment, historically low inventory, rising household formation rates, income growth, and modest credit easing. This is manifesting itself in lower borrower delinquencies, increased recoveries upon liquidation, and shorter timelines to sell properties. These factors have contributed to continued credit spread tightening across the asset class.
The housing market showed further improvement in Europe in 2017. Housing prices rose and affordability remained high. Economic growth continues to pick up and supports the positive trend in the labour market. This is clearly beneficial for consumer risk in general and retail mortgages in particular. A general theme in Europe is that mostly legacy collateral gets securitised, while a large part of the funding for new origination is obtained outside the structured credit market. As a result the underlying collateral in most of our holdings is deleveraging, loan-to-values decline and prepayment speeds are increasing. The improving fundamentals, the deleveraging of the collateral, the negative net supply (together with increasing demand) and the shortening of our ABS holdings resulted in tightening of credit spreads.
Annual Report on Form 20-F 2017 |
192 | Notes to the consolidated financial statements Note 4 | |
There are no individual issuers rated below investment grade in this RMBS sector which have unrealized loss position greater than EUR 25 million.
The fair values of Aegon USAs available-for-sale (AFS) RMBS instruments were determined as follows:
Level II | Level III | Total 2017 | Level II | Level III | Total 2016 | |||||||||||||||||||
RMBS |
2,931 | 54 | 2,985 | 3,419 | 75 | 3,494 |
Commercial mortgage-backed securities
As of December, 31, 2017, Aegon Americas, Aegon the Netherlands and Aegon UK hold EUR 3,549 million (December 31, 2016: EUR 5,579 million) of AFS commercial mortgage-backed securities (CMBS), of which EUR 3,375 million (December 31, 2016: EUR 5,340 million) is held by Aegon USA, EUR 146 million (December 31, 2016: EUR 195 million) by Aegon UK and EUR 28 million (December 31, 2016: EUR 44 million) by Aegon the Netherlands. CMBS are securitizations of underlying pools of mortgages on commercial real estate. The underlying mortgages have varying risk characteristics and are pooled together and sold in different rated tranches. The companys CMBS include conduit, large loan, single borrower, commercial real estate collateralized debt obligations (CRE CDOs), collateralized debt obligations (CDOs), government agency, and franchise loan receivable trusts.
The total gross unrealized loss on available-for-sale CMBS of Aegon Americas amounted to EUR 22 million as of December 31, 2017 (December 31, 2016: EUR 67 million). The total net unrealized gain on the available-for-sale CMBS as of December 31, 2017, is EUR 81 million (December 31, 2016: EUR 87 million), of which EUR 36 million (December 31, 2016: EUR 34 million) relates to positions of Aegon USA, followed by Aegon UK at EUR 44 million. CMBS fundamentals remain supportive with commercial property prices above their prior peak. Commercial real estate valuation increases have slowed. The delinquency rate has started to fall as loan resolutions outpace new defaults and positive net supply increases the total outstanding balance. Liquidity remains reasonable for the CMBS market; however, credit spreads on legacy subordinate CMBS tranches remain at wide levels.
The tables below summarize the credit quality of Aegon USAs available-for-sale (AFS) CMBS portfolio. Additionally, Aegon USA has no investments in CMBS (December 31, 2016: EUR nil), which are classified as fair value through profit or loss.
CMBS of Aegon USA are monitored and reviewed on a monthly basis. Detailed cash flow models using the current collateral pool and capital structure on the portfolio are updated and reviewed quarterly. Model output is generated under base and several stress-case scenarios by Aegons internal CMBS asset specialists. For conduit securities, a widely recognized industry modeling software is used to perform a loan-by-loan, bottom-up approach. For non-conduit securities, a CMBS asset specialist works closely with Aegons real estate valuation group to determine underlying asset valuation and risk. Both methodologies incorporate external estimates on the property market, capital markets, property cash flows, and loan structure. Results are then closely analyzed by the asset specialist to determine whether or not a principal or interest loss is expected to occur.
As the remaining unrealized losses in the CMBS portfolio relate to holdings where Aegon expects to receive full principal and interest, Aegon does not consider the underlying investments to be impaired as of December 31, 2017.
There are no individual issuers rated below investment grade in the CMBS sector which have unrealized loss position greater than EUR 25 million.
Annual Report on Form 20-F 2017 |
193 | Notes to the consolidated financial statements Note 4 | |
The fair values of Aegon USAs available-for-sale (AFS) CMBS instruments were determined as follows:
Level II | Level III | Total 2017 | Level II | Level III | Total 2016 | |||||||||||||||||||
CMBS |
3,372 | 3 | 3,375 | 5,337 | 3 | 5,340 |
Asset-backed securities
Aegon Americas, Aegon the Netherlands and Aegon UK hold EUR 4,314 million (December 31, 2016: EUR 6,188 million) of AFS ABS instruments of which EUR 2,429 million (December 31, 2016: EUR 3,377 million) is held by Aegon USA, EUR 1,799 million (December 31, 2016: EUR 2,714 million) by Aegon the Netherlands and EUR 88 million (December 31, 2016 EUR 97 million) by Aegon UK. Additionally, Aegon Americas has investments in ABS of EUR 10 million (December 31, 2016: EUR 13 million), which are classified as fair value through profit or loss. ABS are securitizations of underlying pools of credit card receivables, auto financing loans, small business loans, bank loans, and other receivables. The underlying assets of the asset backed securities have been pooled together and sold in tranches with varying credit ratings.
The total gross unrealized loss on available-for-sale ABS of Aegon Americas, Aegon the Netherlands and Aegon UK amounted to EUR 15 million as of December 31, 2017 (December 31, 2016: EUR 54 million). Aegon USA has EUR 12 million (December 31, 2016: EUR 44 million) of this gross unrealized loss and Aegon the Netherlands EUR 2 million (December 31, 2016: EUR 10 million). In the United States, increasing investor demand has been met with new issuance in the asset-backed sector. The combination of these factors has led to varied performance by sector with most sectors exhibiting tighter credit spreads over the course of the year. During 2017, the European ABS spreads tightened considerably on the backdrop of a benign macro environment. The majority of European ABS sectors is now trading at their tightest levels since the financial crisis. The more basic sectors are slowly approaching their all-time lows helped by very low issuance volumes and the support of the European Central Bank asset backed securities purchase program. Due to the ample liquidity provided through the different programs of the Central Banks issuance levels for European ABS will remain subdued and in combination with further improving fundamentals this leads to continued downward pressure on spreads going forward.
The breakdown by quality of the available-for-sale (AFS) ABS portfolio of Aegon USA, Aegon the Netherlands and Aegon UK is as follows:
There were no individual issuers rated below investment grade in this ABS sector which has unrealized loss position greater than EUR 25 million.
The fair values of Aegon USA, Aegon the Netherlands and Aegon UK available-for-sale (AFS) ABS instruments were determined as follows:
Annual Report on Form 20-F 2017 |
194 | Notes to the consolidated financial statements Note 4 | |
Corporate - Financial sector
The Corporate - Financial sector is further subdivided into banking, brokerage, insurance, REITs and Financial - Other sub-sectors. A majority of the gross unrealized loss in Aegons available-for-sale portfolio is from the banking sub-sector.
Level II | Level III | Total 2017 | Level II | Level III | Total 2016 | |||||||||||||||||||
ABSs |
3,411 | 903 | 4,314 | 4,880 | 1,309 | 6,188 |
Corporate - Financial sector - Banking sub-sector
The Banking sub-sector in Aegons portfolio is relatively large, diverse, and of high quality. Aegon Americas, Aegon the Netherlands and Aegon UK hold EUR 6,793 million (December 31, 2016: EUR 8,527 million) of AFS bonds issued by banks. In aggregate, the gross unrealized loss on these bonds amounted to EUR 39 million (December 31, 2016: EUR 135 million) and the net unrealized gain on these bonds amounted to EUR 323 million (December 31, 2016: EUR 188 million).
Bank regulators continue to implement a wide array of reforms designed to strengthen capital levels, reduce balance sheet risk and improve liquidity in an ongoing effort to reduce systemic risk and harmonize global bank regulation. Both regulators and central governments are adopting new bank guidelines designed to improve resolvability in an attempt to ensure that banks can fail in an orderly manner without the use of taxpayer money. While most banks already meet new capital and liquidity requirements, well ahead of regulatory deadlines, they are now in the process of issuing loss absorbing securities and altering their legal, financial and operating structures. Bank balance sheet repair and risk reduction is expected to continue. Globally, risk concentrations on bank balance sheets continue to exist but confidence in the sector has increased materially since the financial crisis.
Within the Banking sub-sector, Aegon holds EUR 629 million (December 31, 2016: EUR 750 million) of deeply subordinated securities with deferrable coupons that have an associated unrealized loss of EUR 10 million (December 31, 2016: EUR 93 million).
There are no individual issuers rated below investment grade in the Banking sub-sector which have unrealized losses greater than EUR 25 million.
Government bonds
Aegon Americas, Aegon the Netherlands and Aegon UKs government issued available-for-sale debt securities include emerging market government bonds, US Treasury bonds, agency and state bonds. Aegon evaluated the near-term prospects of the issuers and it is believed that the contractual terms of these investments will be met and these investments are not impaired as of December 31, 2017.
There are no individual issuers rated below investment grade in the government sector which have unrealized loss positions greater than EUR 25 million.
Annual Report on Form 20-F 2017 |
195 | Notes to the consolidated financial statements Note 4 | |
Unrealized loss by maturity
The table below shows the composition by maturity of all available-for-sale debt securities in an unrealized loss position held by Aegon Americas, Aegon the Netherlands and Aegon UK.
The unrealized loss improved during 2017 due to tightening credit spreads and declining long term interest rates, which was offset slightly by rising short term interest rates.
Annual Report on Form 20-F 2017 |
196 | Notes to the consolidated financial statements Note 4 | |
Aging and severity unrealized losses
The table below provides the length of time a below investment grade security has been in an unrealized loss and the percentage of carrying value (CV) to amortized cost in Aegon Americas, Aegon the Netherlands and Aegon UK.
2017 | 2016 | |||||||||||||||
Aging and severity unrealized losses debt securities |
Carrying value |
Unrealized losses |
Carrying value |
Unrealized losses |
||||||||||||
CV 70-100% of amortized cost |
482 | (13 | ) | 585 | (27 | ) | ||||||||||
CV 40-70% of amortized cost |
3 | (2 | ) | 2 | (2 | ) | ||||||||||
CV < 40% of amortized cost |
- | - | 1 | (2 | ) | |||||||||||
0-6 months |
485 | (15 | ) | 587 | (30 | ) | ||||||||||
CV 70-100% of amortized cost |
62 | (5 | ) | 196 | (18 | ) | ||||||||||
CV 40-70% of amortized cost |
- | - | 3 | (2 | ) | |||||||||||
CV < 40% of amortized cost |
- | - | - | - | ||||||||||||
6-12 months |
62 | (5 | ) | 198 | (20 | ) | ||||||||||
CV 70-100% of amortized cost |
67 | (10 | ) | 475 | (55 | ) | ||||||||||
CV 40-70% of amortized cost |
8 | (4 | ) | 3 | (2 | ) | ||||||||||
CV < 40% of amortized cost |
- | - | - | (3 | ) | |||||||||||
12-24 months |
75 | (13 | ) | 478 | (60 | ) | ||||||||||
CV 70-100% of amortized cost |
511 | (63 | ) | 582 | (71 | ) | ||||||||||
CV 40-70% of amortized cost |
30 | (16 | ) | 119 | (67 | ) | ||||||||||
CV < 40% of amortized cost |
8 | (12 | ) | 7 | (15 | ) | ||||||||||
> 24 months
|
|
549
|
|
|
(92
|
)
|
|
708
|
|
|
(153
|
)
|
||||
Total |
1,171 | (125 | ) | 1,971 | (263 | ) |
There are no individual issuers rated below investment grade which has an unrealized loss greater than EUR 25 million.
Realized gains and losses on debt securities of Aegon Americas, Aegon the Netherlands and Aegon UK
The following table provides the realized gains and losses on the debt securities of Aegon Americas, Aegon the Netherlands and Aegon UK for the twelve months ended December 31, 2017, and December 31, 2016. Gross realised gains in 2017 decreased compared to 2016 due to the sale of the UK annuity portfolio in 2016.
Gross realized gains and (losses) | Gross realized gains | Gross realized losses | ||||||
December 31, 2017 | ||||||||
Debt securities |
1,876 | (173 | ) | |||||
December 31, 2016 |
||||||||
Debt securities |
2,257 | (323 | ) |
The table below provides the length of time the security was below cost prior to the sale and the respective realized loss for assets not considered impaired.
Gross realized losses | ||||||||||||
0 -12 months | >12 months | Total | ||||||||||
December 31, 2017 |
||||||||||||
Debt securities |
(137 | ) | (36 | ) | (173 | ) | ||||||
December 31, 2016 |
||||||||||||
Debt securities |
(221 | ) | (103 | ) | (323 | ) |
Annual Report on Form 20-F 2017 |
197 | Notes to the consolidated financial statements Note 4 | |
Impairment losses and recoveries
The composition of Aegon Americas, Aegon the Netherlands and Aegon UKs bond impairment losses and recoveries by issuer for the periods ended December 31, 2017, and December 31, 2016, is presented in the table below. Those issuers with impairments or recoveries above EUR 25 million are specifically noted.
2017 | 2016 | |||||||
(Impairment) / recovery | (Impairment) / recovery | |||||||
Impairments: |
||||||||
Other (none individually greater than EUR 25 million) |
(16 | ) | (52 | ) | ||||
Subtotal |
(16 | ) | (52 | ) | ||||
Recoveries: |
||||||||
Total recoveries |
16 | 42 | ||||||
Sub-total
|
|
16
|
|
|
42
|
|
||
Net (impairments) and recoveries |
- | (11 | ) |
Net (impairments) and recoveries
Net impairments for the twelve months ended December 31, 2017, totalled EUR 0 million (twelve months ended December 31, 2016: EUR 11 million net recoveries).
For the twelve months ended December 31, 2017, Aegon recognized EUR 16 million (twelve months ended December 31, 2016: EUR 42 million) in recoveries on previously impaired securities. In each case where a recovery was taken on structured securities, improvements in underlying cash flows for the security were documented and modeling results improved significantly. Recoveries on non-structured securities were supported by documented credit events combined with significant market value improvements.
Past due and impaired assets
The tables that follow provide information on past due and individually impaired financial assets for the whole Aegon Group. An asset is past due when a counterparty has failed to make a payment when contractually due. Assets are impaired when an impairment loss has been charged to the income statement relating to this asset. After the impairment loss is reversed in subsequent periods, the asset is no longer considered to be impaired. When the terms and conditions of financial assets have been renegotiated, the terms and conditions of the new agreement apply in determining whether the financial assets are past due.
Aegons policy is to pursue realization of the collateral in an orderly manner as and when liquidity permits. Aegon generally does not use the non-cash collateral for its own operations.
2017 | 2016 | |||||||||||||||||||||||||||||||
Past due but not impaired assets |
0-6 months |
6-12 months |
> 1 year | Total |
0-6 months |
6-12 months |
> 1 year | Total | ||||||||||||||||||||||||
Debt securities - carried at fair value |
49 | 14 | 28 | 91 | 58 | 9 | 7 | 73 | ||||||||||||||||||||||||
Mortgage loans |
111 | 2 | 4 | 117 | 80 | 4 | 3 | 87 | ||||||||||||||||||||||||
Other loans |
31 | 1 | 3 | 35 | 29 | 4 | 2 | 36 | ||||||||||||||||||||||||
Accrued interest |
- | 1 | 1 | 1 | - | - | 1 | 1 | ||||||||||||||||||||||||
At December 31 |
191 | 18 | 35 | 244 | 167 | 17 | 13 | 197 |
Impaired financial assets |
Carrying amount 2017 |
Carrying amount
2016 |
||||||
Shares |
48 | 81 | ||||||
Debt securities - carried at fair value |
1,063 | 1,326 | ||||||
Mortgage loans |
262 | 377 | ||||||
Private Loans |
- | 6 | ||||||
Other loans |
3 | 3 | ||||||
Other financial assets - carried at fair value |
6 | 9 | ||||||
At December 31 |
1,381 | 1,803 |
Annual Report on Form 20-F 2017 |
198 | Notes to the consolidated financial statements Note 4 | |
Equity instruments classified as available-for-sale
Objective evidence of impairment of an investment in an equity instrument classified as available-for-sale includes information about significant changes with an adverse effect that have taken place in the technological, market, economic or legal environment in which the issuer operates, and indicates that the cost of the investment in the equity instrument may not be recovered. A significant or prolonged decline in the fair value of an investment in an equity instrument below its cost is also objective evidence of impairment. Significant or prolonged decline is generally defined within Aegon as an unrealized loss position for more than six months or a fair value of less than 80% of the cost price of the investment. Additionally, as part of an ongoing process, internal equity analysts actively monitor earnings releases, company fundamentals, new developments and industry trends for any signs of possible impairment.
These factors typically require significant management judgment. The impairment review process has resulted in EUR 2 million of impairment charges for the twelve months ended December 31, 2017 (twelve months ended December 31, 2016: EUR 1 million) for Aegon Americas, Aegon the Netherlands and Aegon UK.
As of December 31, 2017, there are EUR 62 million of gross unrealized gains and EUR 13 million of gross unrealized losses in the equity portfolio of Aegon (December 31, 2016: EUR 202 million of gross unrealized gains and EUR 13 million of gross unrealized losses). There is one security held by Aegon, issued by Cobank, which had an unrealized loss above EUR 5 million. The table below represents the unrealized gains and losses on share positions held by Aegon Americas, Aegon the Netherlands and Aegon UK.
Cost basis | Carrying value |
Net unrealized gains / (losses) |
Carrying value of securities with gross unrealized gains |
Gross unrealized gains |
Carrying value of securities with gross unrealized losses |
Gross unrealized losses |
||||||||||||||||||||||
December 31, 2017 |
||||||||||||||||||||||||||||
Shares |
386 | 434 | 49 | 401 | 62 | 34 | (13 | ) | ||||||||||||||||||||
December 31, 2016 |
||||||||||||||||||||||||||||
Shares |
596 | 786 | 190 | 722 | 202 | 64 | (13 | ) |
The composition of shares by industry sector in an unrealized loss position held by Aegon Americas, Aegon the Netherlands and Aegon UK at December 31, 2017, and December 31, 2016 is presented in the following table.
2017 | 2016 | |||||||||||||||
Unrealized losses on shares |
Carrying value of instruments with unrealized losses |
Unrealized losses |
Carrying value of instruments with unrealized losses |
Unrealized losses |
||||||||||||
Financials |
19 | (12 | ) | 54 | (12 | ) | ||||||||||
Other |
14 | (2 | ) | 10 | - | |||||||||||
Total |
34 | (13 | ) | 64 | (13 | ) |
Impairment losses on shares
The table below provides the length of time the shares held by Aegon Americas, Aegon the Netherlands and Aegon UK were below cost prior to their impairment in 2017 and 2016.
In million EUR | 0-6 months | |||
2017 |
||||
Shares |
- | |||
2016 |
||||
Shares |
(1 | ) |
Equity market risk and other investments risk
Fluctuations in the equity, real estate and capital markets have affected Aegons profitability, capital position and sales of equity related products in the past and may continue to do so. Exposure to equity, real estate and capital markets exists in both assets and liabilities. Asset exposure exists through direct equity investment, where Aegon bears all or most of the volatility in returns and investment performance risk. Equity market exposure is also present in insurance and investment contracts for policyholders where funds are invested in equities, backing variable annuities, unit-linked products and mutual funds. Although most of the risk remains with the policyholder, lower investment returns can reduce the asset management fee earned by Aegon on the asset balance in these products. In addition, some of this business has minimum return or accumulation guarantees.
Annual Report on Form 20-F 2017 |
199 | Notes to the consolidated financial statements Note 4 | |
The general account equity, real estate and other non-fixed-income portfolio of Aegon is as follows:
Annual Report on Form 20-F 2017 |
200 | Notes to the consolidated financial statements Note 4 | |
The table that follows sets forth the closing levels of certain major indices at the end of the last five years.
2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||||
S&P 500 |
2,674 | 2,239 | 2,044 | 2,059 | 1,848 | |||||||||||||||
Nasdaq |
6,903 | 5,383 | 5,007 | 4,736 | 4,177 | |||||||||||||||
FTSE 100 |
7,688 | 7,143 | 6,242 | 6,566 | 6,749 | |||||||||||||||
AEX |
545 | 483 | 442 | 424 | 402 |
The sensitivity analysis of net income and shareholders equity to changes in equity prices is presented in the table below. The sensitivity of shareholders equity and net income to changes in equity markets reflects changes in the market value of Aegons portfolio, changes in DPAC amortization, contributions to pension plans for Aegons employees and the strengthening of the guaranteed minimum benefits, when applicable. Aegon generally has positive income benefits from equity market increases and negative impacts from equity market declines as it earns fees on policyholder account balances and provides minimum guarantees for account values. Aegon uses options and other equity derivatives to provide protection against the negative impact of equity market declines. The increase in Aegons sensitivity compared with the prior year is due to a different payoff profile resulting from a change in the hedging strategy.
Sensitivity analysis of net income and shareholders equity to equity markets Immediate change of |
Estimated approximate effects on net income |
Estimated approximate effects on shareholders equity |
||||||
2017 |
||||||||
Equity increase 10% |
317 | 405 | ||||||
Equity decrease 10% |
(316 | ) | (405 | ) | ||||
Equity increase 20% |
647 | 820 | ||||||
Equity decrease 20% |
(660 | ) | (839 | ) | ||||
2016 |
||||||||
Equity increase 10% |
158 | 291 | ||||||
Equity decrease 10% |
(227 | ) | (360 | ) | ||||
Equity increase 20% |
324 | 587 | ||||||
Equity decrease 20% |
(338 | ) | (604 | ) |
Liquidity risk
Liquidity risk is inherent in much of Aegons business. Each asset purchased and liability incurred has its own liquidity characteristics. Some liabilities are surrenderable while some assets, such as privately placed loans, mortgage loans, real estate and limited partnership interests, have low liquidity. If Aegon requires significant amounts of cash on short notice in excess of normal cash requirements and existing credit facilities, it may have difficulty selling these investments at attractive prices or in a timely manner. Liquidity risk is also affected by our use of collateralized financial derivatives to mitigate risk.
Aegon operates a Liquidity Risk Policy under which country units are obliged to maintain sufficient levels of highly liquid assets to meet cash demands by policyholders and account holders over the next two years. Potential cash demands are assessed under a stress scenario including spikes in disintermediation risk due to rising interest rates and concerns over Aegons financial strength due to multiple downgrades of the Groups credit rating. At the same time, the liquidity of assets other than cash and government issues is assumed to be severely impaired for an extended period of time. All legal entities and Aegon Group must maintain enough liquidity in order to meet all cash needs under this extreme scenario.
Aegon held EUR 34,393 million of general account investments in cash, money market products and government bonds that are readily saleable or redeemable on demand (2016: EUR 35,841 million). The Group expects to meet its obligations, even in a stressed liquidity event, from operating cash flows and the proceeds of maturing assets as well as these highly liquid assets. Further, the Group has access to back-up credit facilities, as disclosed in note 39 Borrowings, amounting to EUR 3,367 million which were unused at the end of the reporting period (2016: EUR 3,885 million).
The maturity analysis below shows the remaining contractual maturities of each category of financial liabilities (including coupon interest). When the counterparty has a choice of when an amount is paid, the liability is included on the basis of the earliest date on which it can be required to be paid. Financial liabilities that can be required to be paid on demand without any delay are reported in the category On demand. If there is a notice period, it has been assumed that notice is given immediately and the repayment has been presented at the earliest date after the end of the notice period. When the amount payable is not fixed, the amount reported
Annual Report on Form 20-F 2017 |
201 | Notes to the consolidated financial statements Note 4 | |
is determined by reference to the conditions existing at the reporting date. For example, when the amount payable varies with changes in an index, the amount disclosed may be based on the level of the index at the reporting date.
To manage the liquidity risk arising from financial liabilities, Aegon holds liquid assets comprising cash and cash equivalents and investment grade investment securities for which there is an active and liquid market. These assets can be readily sold to meet liquidity requirements. For this reason, Aegon believes that it is not necessary to disclose a maturity analysis in respect of these assets to enable users to evaluate the nature and extent of liquidity risk.
1 | The liability amount in the consolidated financial statements reflects the discounting for interest as well as adjustments for the timing of other factors as described above. As a result, the sum of the cash benefit payments shown for all years in the table exceeds the corresponding liability amounts included in notes 36 Insurance contracts and 37 Investments contracts. |
The following table details the Groups liquidity analysis for its derivative financial instruments, based on the undiscounted contractual net cash inflows and outflows on derivative instruments that settle on a net basis, and the undiscounted gross inflows and outflows on those derivatives that require gross settlement.
Annual Report on Form 20-F 2017 |
202 | Notes to the consolidated financial statements Note 5 | |
1 | Derivatives includes all financial derivatives regardless whether they have a positive or a negative value. It does not include bifurcated embedded derivatives. These are presented together with the host contract. For interest rate derivatives only, cash flows related to the pay leg are taken into account for determining the gross undiscounted cash flows. |
Aegons operating segments are based on the businesses as presented in internal reports that are regularly reviewed by the Executive Board which is regarded as the chief operating decision maker. All reportable segments are involved in insurance or reinsurance business, asset management or services related to these activities. The reportable segments are:
◆ | Americas: one operating segment which covers business units in the United States, Brazil and Mexico, including any of the units activities located outside these countries; |
◆ | the Netherlands; |
◆ | United Kingdom (including Variable Annuities Europe); |
◆ | Central & Eastern Europe; |
◆ | Spain & Portugal; |
◆ | Asia: one operating segment which covers businesses operating in Hong Kong, Singapore, China, Japan, India and Indonesia including any of the units activities located outside these countries; |
◆ | Asset Management: one operating segment which covers business activities from Aegon Asset Management; |
◆ | Holding and other activities: one operating segment which includes financing, reinsurance activities, employee and other administrative expenses of holding companies. |
Aegons segment information is prepared by consolidating on a proportionate basis Aegons joint ventures and associated companies.
Performance Measure
A non-IFRS performance measure of reporting segments utilized by the Company is underlying earnings before tax. Underlying earnings before tax reflects Aegons profit from underlying business operations and excludes components that relate to accounting mismatches that are dependent on market volatility, updates to best estimate actuarial and economic assumptions and model updates or events that are considered outside the normal course of business.
Aegon believes that its performance measure underlying earnings before tax provides meaningful information about the underlying results of Aegons business, including insight into the financial measures that Aegons senior management uses in managing the business. Among other things, Aegons senior management is compensated based in part on Aegons results against targets using underlying earnings before tax. While many other insurers in Aegons peer group present substantially similar performance measures, the performance measures presented in this document may nevertheless differ from the performance measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards.
Annual Report on Form 20-F 2017 |
203 | Notes to the consolidated financial statements Note 5 | |
The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the tables in this note.
The items that are excluded from underlying earnings before tax as described further below are: fair value items, realized gains or losses on investments, impairment charges/reversals, other income or charges, run-off businesses and share in earnings of joint ventures and associates.
Impact from assumption and model updates
In 2017 a charge of EUR 276 million (2016: EUR 118 million charge) has been recorded in other income/ (charges) in respect of assumption changes and model updates. The impact is mainly attributable to Aegons business in the Americas and the Netherlands. Assumption changes and model updates in the Americas led to a net negative impact of EUR 402 million and were mainly driven by a charge of EUR 303 million (USD 343 million) from the conversion of the largest block of universal life business to a new model. The model allows for modeling policyholder behavior and other assumptions on a policy by policy basis, whereas in the previous model this was done at a cohort level. A model change in fixed annuities discount rate, resulted in a charge of EUR 44 million (USD 50 million) and other assumption changes and model updates led to a charge of EUR 54 million (USD 61 million). In the Netherlands, assumption changes and model updates led to a gain of EUR 101 million, which mainly relates to the guarantee provision.
During 2016 Aegon implemented actuarial assumption and model updates resulting in a net EUR 118 million charge (2015: EUR 131 million charge) to income before tax.
Fair value items
Fair value items include the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings before tax.
In addition, hedge ineffectiveness on hedge transactions, fair value changes on economic hedges without natural offset in earnings and for which no hedge accounting is applied and fair value movements on real estate are included under fair value items.
Certain assets held by Aegon are carried at fair value and managed on a total return basis, with no offsetting changes in the valuation of related liabilities. These include assets such as investments in hedge funds, private equities, real estate (limited partnerships), convertible bonds and structured products. Underlying earnings before tax exclude any over- or underperformance compared to managements long-term expected return on assets. Based on current holdings and asset returns, the long-term expected return on an annual basis is 8-10%, depending on asset class, including cash income and market value changes. The expected earnings from these asset classes are net of deferred policy acquisition costs (DPAC) where applicable.
In addition, certain products offered by Aegon Americas contain guarantees and are reported on a fair value basis and the total return annuities and guarantees on variable annuities. The earnings on these products are impacted by movements in equity markets and risk-free interest rates. Short-term developments in the financial markets may therefore cause volatility in earnings. Included in underlying earnings before tax is a long-term expected return on these products and excluded is any over- or underperformance compared to managements expected return.
The fair value movements of certain guarantees and the fair value change of derivatives that hedge certain risks on these guarantees of Aegons businesses in the Netherlands, VA Europe (included in United Kingdom) and Japan are excluded from underlying earnings before tax, and the long-term expected return for these guarantees is set at zero. In addition, fair value items include market related results on our loyalty bonus reserves in the United Kingdom. The value of these reserves are directly related to policyholder investments which value is directly impacted by movements in equity and bond markets.
Holding and other activities include certain issued bonds that are held at fair value through profit or loss (FVTPL). The interest rate risk on these bonds is hedged using swaps. The fair value movement resulting from changes in Aegons credit spread used in the valuation of these bonds are excluded from underlying earnings before tax and reported under fair value items.
Realized gains or losses on investments
Includes realized gains and losses on available-for-sale investments, mortgage loans and other loan portfolios.
Annual Report on Form 20-F 2017 |
204 | Notes to the consolidated financial statements Note 5 | |
Impairment charges/reversals
Impairment charges include impairments on available-for-sale debt securities, shares including the effect of deferred policyholder acquisition costs, mortgage loans and other loan portfolios at amortized cost, joint ventures and associates. Impairment reversals include reversals on available-for-sale debt securities.
Other income or charges
Other income or charges includes the following:
◆ | items which cannot be directly allocated to a specific line of business; |
◆ | the impact of assumption and model updates used to support calculations of our liabilities for insurance and investment contracts sold to policyholders and related assets; and |
◆ | items that are outside the normal course of business, including restructuring charges. |
In the Consolidated income statement, these restructuring charges are included in operating expenses. Actuarial assumption and model updates are recorded in Policyholder claims and benefits in the Consolidated income statement.
Run-off businesses
Includes underlying results of business units where management has decided to exit the market and to run -off the existing block of business. This line includes results related to the run-off of the institutional spread-based business, structured settlements blocks of business, the life reinsurance business and the bank-owned and corporate-owned life insurance (BOLI/COLI) business in the United States. Aegon has other blocks of business for which sales have been discontinued and of which the earnings are included in underlying earnings before tax.
Annual Report on Form 20-F 2017 |
205 | Notes to the consolidated financial statements Note 5 | |
Share in earnings of joint ventures and associates
Earnings from Aegons joint ventures in the Netherlands, Mexico, Spain, Portugal, China and Japan and Aegons associates in India, Brazil, the Netherlands, United Kingdom, Mexico and France are reported on an underlying earnings before tax basis.
The following table presents Aegons segment results.
Income statement - Underlying earnings |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||||||||||
Underlying earnings before tax |
1,381 | 520 | 116 | 67 | 4 | 49 | 136 | (170 | ) | - | 2,103 | 61 | 2,163 | |||||||||||||||||||||||||||||||||||
Fair value items |
170 | 30 | (82 | ) | - | - | - | - | 24 | - | 142 | (97 | ) | 45 | ||||||||||||||||||||||||||||||||||
Realized gains / (losses) on investments |
157 | 184 | 62 | 1 | - | 4 | 3 | - | - | 413 | (5 | ) | 408 | |||||||||||||||||||||||||||||||||||
Impairment charges |
(38 | ) | (27 | ) | - | (2 | ) | - | (1 | ) | - | (3 | ) | - | (71 | ) | - | (71 | ) | |||||||||||||||||||||||||||||
Impairment reversals |
22 | 10 | - | - | - | - | - | - | - | 32 | - | 32 | ||||||||||||||||||||||||||||||||||||
Other income / (charges) |
(353 | ) | 296 | 40 | - | - | (19 | ) | (49 | ) | 16 | - | (68 | ) | (4 | ) | (72 | ) | ||||||||||||||||||||||||||||||
Run-off businesses |
30 | - | - | - | - | - | - | - | - | 30 | - | 30 | ||||||||||||||||||||||||||||||||||||
Income / (loss) before tax |
1,369 | 1,013 | 137 | 66 | 4 | 33 | 90 | (134 | ) | - | 2,579 | (44 | ) | 2,534 | ||||||||||||||||||||||||||||||||||
Income tax (expense) / benefit |
198 | (196 | ) | (56 | ) | (9 | ) | (6 | ) | (28 | ) | (42 | ) | 29 | - | (110 | ) | 44 | (65 | ) | ||||||||||||||||||||||||||||
Net income / (loss) |
1,567 | 818 | 81 | 57 | (2 | ) | 5 | 48 | (105 | ) | - | 2,469 | - | 2,469 | ||||||||||||||||||||||||||||||||||
Inter-segment underlying earnings |
(78 | ) | (111 | ) | (87 | ) | (11 | ) | (1 | ) | (1 | ) | 214 | 73 | ||||||||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
7,437 | 1,857 | 9,603 | 411 | 208 | 983 | - | 7 | (9 | ) | 20,498 | (546 | ) | 19,952 | ||||||||||||||||||||||||||||||||||
Accident and health insurance |
2,115 | 203 | 32 | 1 | 83 | 97 | - | - | - | 2,531 | (20 | ) | 2,511 | |||||||||||||||||||||||||||||||||||
General insurance |
- | 148 | - | 216 | 103 | - | - | 1 | (1 | ) | 466 | (103 | ) | 363 | ||||||||||||||||||||||||||||||||||
Total gross premiums |
9,553 | 2,208 | 9,635 | 628 | 394 | 1,080 | - | 8 | (10 | ) | 23,496 | (670 | ) | 22,826 | ||||||||||||||||||||||||||||||||||
Investment income |
3,368 | 2,172 | 1,517 | 49 | 37 | 246 | 4 | 295 | (291 | ) | 7,396 | (58 | ) | 7,338 | ||||||||||||||||||||||||||||||||||
Fee and commission income |
1,919 | 326 | 235 | 43 | 17 | 63 | 609 | - | (221 | ) | 2,991 | (189 | ) | 2,802 | ||||||||||||||||||||||||||||||||||
Other revenues |
5 | - | - | - | 3 | 1 | - | 4 | - | 13 | (5 | ) | 7 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,844 | 4,706 | 11,387 | 720 | 450 | 1,390 | 613 | 308 | (522 | ) | 33,895 | (922 | ) | 32,973 | ||||||||||||||||||||||||||||||||||
Inter-segment revenues |
- | (1 | ) | - | - | - | 3 | 222 | 298 |
Annual Report on Form 20-F 2017 |
206 | Notes to the consolidated financial statements Note 5 | |
Income statement - Underlying earnings |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||||||||||
Underlying earnings before tax |
1,249 | 534 | 59 | 55 | 8 | 21 | 149 | (162 | ) | - | 1,913 | 48 | 1,960 | |||||||||||||||||||||||||||||||||||
Fair value items |
(521 | ) | (228 | ) | (7 | ) | - | (1 | ) | (9 | ) | - | (74 | ) | - | (840 | ) | (72 | ) | (912 | ) | |||||||||||||||||||||||||||
Realized gains / (losses) on investments |
(13 | ) | 189 | 153 | - | (1 | ) | 8 | 3 | - | - | 340 | (6 | ) | 334 | |||||||||||||||||||||||||||||||||
Impairment charges |
(72 | ) | (29 | ) | - | 1 | - | (1 | ) | (5 | ) | (7 | ) | 1 | (113 | ) | - | (112 | ) | |||||||||||||||||||||||||||||
Impairment reversals |
42 | 17 | - | - | - | - | - | - | (1 | ) | 58 | - | 58 | |||||||||||||||||||||||||||||||||||
Other income / (charges) |
(100 | ) | 44 | (678 | ) | (23 | ) | - | (5 | ) | (2 | ) | (6 | ) | - | (771 | ) | - | (771 | ) | ||||||||||||||||||||||||||||
Run-off businesses |
54 | - | - | - | - | - | - | - | - | 54 | - | 54 | ||||||||||||||||||||||||||||||||||||
Income / (loss) before tax |
638 | 526 | (474 | ) | 34 | 6 | 14 | 145 | (249 | ) | - | 641 | (31 | ) | 610 | |||||||||||||||||||||||||||||||||
Income tax (expense) / benefit |
(80 | ) | (109 | ) | 18 | (15 | ) | (8 | ) | (27 | ) | (48 | ) | 65 | - | (203 | ) | 31 | (172 | ) | ||||||||||||||||||||||||||||
Net income / (loss) |
559 | 418 | (456 | ) | 19 | (2 | ) | (13 | ) | 97 | (183 | ) | - | 438 | - | 438 | ||||||||||||||||||||||||||||||||
Inter-segment underlying earnings |
(194 | ) | (95 | ) | (87 | ) | (14 | ) | (1 | ) | 74 | 234 | 84 | |||||||||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
7,363 | 2,015 | 9,888 | 399 | 191 | 1,121 | - | 6 | (84 | ) | 20,898 | (498 | ) | 20,400 | ||||||||||||||||||||||||||||||||||
Accident and health insurance |
2,204 | 210 | 36 | 1 | 73 | 104 | - | (4 | ) | - | 2,624 | (15 | ) | 2,609 | ||||||||||||||||||||||||||||||||||
General insurance |
- | 266 | - | 179 | 92 | - | - | 5 | (5 | ) | 536 | (92 | ) | 444 | ||||||||||||||||||||||||||||||||||
Total gross premiums |
9,567 | 2,491 | 9,924 | 578 | 355 | 1,225 | - | 7 | (89 | ) | 24,058 | (606 | ) | 23,453 | ||||||||||||||||||||||||||||||||||
Investment income |
3,717 | 2,135 | 1,661 | 45 | 45 | 232 | 3 | 406 | (403 | ) | 7,841 | (54 | ) | 7,788 | ||||||||||||||||||||||||||||||||||
Fee and commission income |
1,651 | 350 | 95 | 36 | 14 | 61 | 632 | - | (242 | ) | 2,596 | (188 | ) | 2,408 | ||||||||||||||||||||||||||||||||||
Other revenues |
4 | - | - | - | 2 | - | 1 | 3 | - | 11 | (4 | ) | 7 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,940 | 4,976 | 11,680 | 659 | 416 | 1,517 | 636 | 416 | (734 | ) | 34,507 | (852 | ) | 33,655 | ||||||||||||||||||||||||||||||||||
Inter-segment revenues |
- | 3 | - | - | - | 79 | 243 | 409 |
Annual Report on Form 20-F 2017 |
207 | Notes to the consolidated financial statements Note 5 | |
Income statement - Underlying earnings |
||||||||||||||||||||||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||||||||||
Underlying earnings before tax |
1,278 | 537 | (27 | ) | 37 | 12 | 20 | 170 | (163 | ) | 2 | 1,867 | 34 | 1,901 | ||||||||||||||||||||||||||||||||||
Fair value items |
(691 | ) | 126 | (25 | ) | - | - | 7 | - | (68 | ) | - | (651 | ) | (59 | ) | (710 | ) | ||||||||||||||||||||||||||||||
Realized gains / (losses) on investments |
(74 | ) | 306 | 103 | 2 | - | 7 | 3 | - | - | 346 | (8 | ) | 338 | ||||||||||||||||||||||||||||||||||
Impairment charges |
(43 | ) | (25 | ) | - | (2 | ) | - | - | - | - | - | (70 | ) | (21 | ) | (91 | ) | ||||||||||||||||||||||||||||||
Impairment reversals |
114 | 5 | - | - | - | - | - | - | - | 119 | - | 119 | ||||||||||||||||||||||||||||||||||||
Other income / (charges) |
(913 | ) | 27 | (1,247 | ) | (2 | ) | 17 | (61 | ) | (1 | ) | - | - | (2,180 | ) | 21 | (2,159 | ) | |||||||||||||||||||||||||||||
Run-off businesses |
88 | - | - | - | - | - | - | - | - | 88 | - | 88 | ||||||||||||||||||||||||||||||||||||
Income / (loss) before tax |
(241 | ) | 977 | (1,196 | ) | 35 | 29 | (27 | ) | 172 | (230 | ) | 2 | (482 | ) | (33 | ) | (514 | ) | |||||||||||||||||||||||||||||
Income tax (expense) / benefit |
6 | (223 | ) | 268 | (11 | ) | (7 | ) | (3 | ) | (50 | ) | 71 | - | 51 | 33 | 83 | |||||||||||||||||||||||||||||||
Net income / (loss) |
(235 | ) | 753 | (928 | ) | 24 | 22 | (30 | ) | 121 | (159 | ) | 2 | (431 | ) | - | (431 | ) | ||||||||||||||||||||||||||||||
Inter-segment underlying earnings |
(220 | ) | (55 | ) | (63 | ) | (14 | ) | - | 77 | 264 | 10 | ||||||||||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
7,046 | 2,240 | 8,465 | 477 | 174 | 1,713 | - | 4 | (106 | ) | 20,013 | (431 | ) | 19,583 | ||||||||||||||||||||||||||||||||||
Accident and health insurance |
2,266 | 234 | 47 | 1 | 64 | 105 | - | 6 | (6 | ) | 2,717 | (14 | ) | 2,703 | ||||||||||||||||||||||||||||||||||
General insurance |
- | 473 | - | 164 | 80 | - | - | 2 | - | 720 | (80 | ) | 640 | |||||||||||||||||||||||||||||||||||
Total gross premiums |
9,312 | 2,947 | 8,512 | 642 | 317 | 1,819 | - | 13 | (112 | ) | 23,450 | (524 | ) | 22,925 | ||||||||||||||||||||||||||||||||||
Investment income |
3,680 | 2,277 | 2,331 | 45 | 41 | 194 | 7 | 392 | (391 | ) | 8,576 | (51 | ) | 8,525 | ||||||||||||||||||||||||||||||||||
Fee and commission income |
1,704 | 351 | 98 | 39 | 13 | 62 | 650 | - | (284 | ) | 2,633 | (195 | ) | 2,438 | ||||||||||||||||||||||||||||||||||
Other revenues |
9 | - | - | - | 2 | - | - | 7 | - | 19 | (5 | ) | 14 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,705 | 5,575 | 10,941 | 726 | 373 | 2,076 | 657 | 412 | (787 | ) | 34,677 | (775 | ) | 33,902 | ||||||||||||||||||||||||||||||||||
Inter-segment revenues |
24 | 2 | - | - | - | 101 | 261 | 399 |
The Group uses underlying earnings before tax in its segment reporting as an important indicator of its financial performance. The reconciliation of this measure to the income before tax is shown below. Aegon believes that underlying earnings before tax, together with the other information included in this report, provides a meaningful measure for the investing public to evaluate Aegons business relative to the businesses of its peers.
Annual Report on Form 20-F 2017 |
208 | Notes to the consolidated financial statements Note 5 | |
The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the table below. For those items that cannot be directly reconciled to the respective notes, the explanation is provided below the table.
Note | 2017 | 2016 | 2015 | |||||||||||||
Underlying earnings before tax |
2,103 | 1,913 | 1,867 | |||||||||||||
Elimination of share in earnings of joint ventures and associates |
61 | 48 | 34 | |||||||||||||
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives |
10 | (437 | ) | (783 | ) | (571 | ) | |||||||||
Realized gains and losses on financial investments |
10 | 431 | 327 | 349 | ||||||||||||
Gains and (losses) on investments in real estate |
10 | 193 | 70 | 145 | ||||||||||||
Net fair value change of derivatives |
10 | (134 | ) | (277 | ) | (29 | ) | |||||||||
Net foreign currency gains and (losses) |
10 | 5 | 30 | (5 | ) | |||||||||||
Realized gains and (losses) on repurchased debt |
10 | 1 | 1 | 2 | ||||||||||||
Other income |
11 | 540 | 66 | 83 | ||||||||||||
Change in valuation of liabilities for insurance contracts |
12 | (254 | ) | (144 | ) | (602 | ) | |||||||||
Change in valuation of liabilities for investment contracts |
12 | (19 | ) | (18 | ) | - | ||||||||||
Policyholder claims and benefits - Other |
12 | 34 | 45 | 17 | ||||||||||||
Commissions and expenses |
14 | 256 | 75 | 130 | ||||||||||||
Impairment (charges) reversals |
15 | (40 | ) | (97 | ) | (1,250 | ) | |||||||||
Other charges |
17 | (235 | ) | (700 | ) | (774 | ) | |||||||||
Run-off businesses |
5 | 30 | 54 | 88 | ||||||||||||
Income / (loss) before tax |
2,534 | 610 | (514 | ) |
◆ | Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives is reported as part of the respective line in Note 10 and reflects the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings before tax. |
◆ | Net fair value change of derivatives is reported as part of the respective line in Note 10 and includes: 1) the over- or underperformance of derivatives of EUR 9 million gain (2016: EUR 8 million gain, 2015: EUR 4 million gain) for which the expected long-term return is included in underlying earnings before tax; 2) Net fair value change on economic hedges where no hedge accounting is applied of EUR 145 million loss (2016: EUR 297 million loss, 2015: EUR 41 million loss); 3) Ineffective portion of hedge transactions to which hedge accounting is applied of EUR 2 million gain (2016: EUR 12 million gain, 2015: EUR 8 million gain). |
◆ | Net foreign currency gains and (losses) are reported as part of the respective line in Note 10. |
◆ | Change in valuation of liabilities for insurance contracts is reported as part of the respective line in Note 12. |
◆ | Change in valuation of liabilities for investment contracts is reported as part of the respective line in Note 12. |
◆ | Policyholder claims and benefits - Other are reported as part of the Other line in note 12 and is related to policyholder tax. |
◆ | Commissions and expenses include: 1) Restructuring charges of EUR 116 million (2016: EUR 54 million charge, 2015: EUR 59 million charge) which are reported as part of Employee and Administration expenses lines in Note 14; 2) Amortization of deferred expenses of EUR 285 million gain (2016: gain of EUR 137 million, 2015: gain of EUR 126 million) which is reported as part of the respective line in Note 14. This is offset against realized gains and losses and impairments on financial investments; 3) Amortization of VOBA and future servicing rights of EUR 94 million gain (2016: charge of EUR 8 million; 2015: gain of EUR 63 million) which is reported as part of the respective line in Note 14. Commissions and expenses include a DPAC/VOBA fair value adjustment of EUR 135 million (2016: EUR 105 million; 2015: EUR 41 million). |
◆ | Impairment (charges) reversals include: 1) Impairment charges and reversals on financial assets, excluding receivables of EUR 42 million charge (2016: EUR 59 million charge, 2015: EUR 24 million gain) as shown in Note 15; 2) Impairment charges and reversals on non-financial assets and receivables of EUR 1 million gain (2016: EUR 38 million charge; 2015: EUR 1,274 million charge) reported as part of the respective line in Note 15. |
◆ | There are no interest charges and related fees that are classified for segment reporting purposes as non-underlying earnings. |
Annual Report on Form 20-F 2017 |
209 | Notes to the consolidated financial statements Note 5 | |
Other selected income statement items |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Amortization of deferred expenses, VOBA and future servicing rights |
336 | 27 | 134 | 55 | - | 33 | - | - | - | 586 | ||||||||||||||||||||||||||||||
Depreciation |
44 | 16 | 28 | 8 | 3 | 1 | 3 | 2 | - | 105 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on financial assets, excluding receivables |
19 | 17 | - | 2 | - | - | - | 3 | - | 42 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
(2 | ) | 3 | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Amortization of deferred expenses, VOBA and future servicing rights |
761 | 32 | 177 | 59 | - | 32 | - | - | 2 | 1,065 | ||||||||||||||||||||||||||||||
Depreciation |
38 | 17 | 21 | 9 | 3 | 1 | - | 2 | - | 89 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on financial assets, excluding receivables |
35 | 12 | - | (1 | ) | - | 1 | 5 | 7 | - | 59 | |||||||||||||||||||||||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
7 | (2 | ) | 31 | (1 | ) | - | - | - | - | - | 36 | ||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||
Amortization of deferred expenses, VOBA and future servicing rights |
731 | 39 | 377 | 80 | - | 34 | - | - | - | 1,261 | ||||||||||||||||||||||||||||||
Depreciation |
31 | 17 | 23 | 9 | 2 | 1 | - | - | - | 84 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on financial assets, excluding receivables |
(68 | ) | 20 | - | 2 | 21 | - | - | - | - | (24 | ) | ||||||||||||||||||||||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
- | 2 | 1,274 | - | - | - | - | - | - | 1,275 | ||||||||||||||||||||||||||||||
Number of employees | ||||||||||||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Number of employees - headcount |
10,951 | 3,089 | 3,435 | 2,337 | 610 | 6,025 | 1,500 | 371 | 28,318 | |||||||||||||||||||||||||||||||
Of which Aegons share of employees in joint ventures and associates |
549 | - | - | - | 83 | 5,702 | 163 | - | 6,497 | |||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Number of employees - headcount |
11,943 | 4,464 | 2,673 | 2,317 | 600 | 5,579 | 1,474 | 330 | 29,380 | |||||||||||||||||||||||||||||||
Of which Aegons share of employees in joint ventures and associates |
561 | - | - | - | 41 | 5,186 | 156 | - | 5,944 | |||||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||
Number of employees - headcount |
12,701 | 4,503 | 2,478 | 2,470 | 534 | 7,163 | 1,382 | 299 | 31,530 | |||||||||||||||||||||||||||||||
Of which Aegons share of employees in joint ventures and associates |
545 | - | - | - | 33 | 6,780 | 141 | - | 7,499 |
Annual Report on Form 20-F 2017 |
210 | Notes to the consolidated financial statements Note 5 | |
Summarized assets and liabilities per segment |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||||||
Cash and Cash equivalents |
548 | 8,382 | 317 | 67 | 116 | 71 | 141 | 1,125 | - | 10,768 | ||||||||||||||||||||||||||||||
Assets held for sale |
- | - | 5,249 | - | - | - | - | - | - | 5,249 | ||||||||||||||||||||||||||||||
Investments |
73,469 | 53,975 | 2,011 | 1,055 | 720 | 5,326 | 157 | 91 | - | 136,804 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
102,964 | 26,697 | 62,961 | 1,343 | 105 | - | - | - | (6 | ) | 194,063 | |||||||||||||||||||||||||||||
Investments in joint ventures |
6 | 1,008 | - | - | 480 | 118 | 99 | 1 | - | 1,712 | ||||||||||||||||||||||||||||||
Investments in associates |
77 | 74 | 7 | 6 | - | 14 | 122 | 8 | - | 308 | ||||||||||||||||||||||||||||||
Deferred expenses |
8,552 | 76 | 945 | 70 | 1 | 490 | - | - | - | 10,135 | ||||||||||||||||||||||||||||||
Other assets |
26,628 | 6,763 | 1,840 | 245 | 72 | 1,786 | 101 | 28,427 | (28,979 | ) | 36,883 | |||||||||||||||||||||||||||||
Total assets |
212,245 | 96,975 | 73,331 | 2,787 | 1,494 | 7,805 | 620 | 29,651 | (28,985 | ) | 395,923 | |||||||||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||||||||||||||||||
Insurance contracts |
68,556 | 34,379 | 1,451 | 624 | 703 | 6,696 | - | 24 | (1,615 | ) | 110,818 | |||||||||||||||||||||||||||||
Insurance contracts for account of policyholders |
72,501 | 25,587 | 22,862 | 1,109 | 108 | - | - | - | - | 122,168 | ||||||||||||||||||||||||||||||
Investment contracts |
6,824 | 9,787 | 278 | 52 | - | 2 | - | - | - | 16,943 | ||||||||||||||||||||||||||||||
Investment contracts for account of policyholders |
30,463 | 3,255 | 40,482 | 234 | - | - | - | - | - | 74,434 | ||||||||||||||||||||||||||||||
Liabilities held for sale |
- | - | 5,003 | - | - | - | - | - | - | 5,003 | ||||||||||||||||||||||||||||||
Other liabilities |
19,145 | 17,400 | 1,103 | 365 | 250 | 133 | 218 | 5,526 | (1,684 | ) | 42,456 | |||||||||||||||||||||||||||||
Total liabilities |
197,490 | 90,408 | 71,178 | 2,385 | 1,061 | 6,830 | 218 | 5,550 | (3,299 | ) | 371,821 |
Summarized assets and liabilities per segment |
||||||||||||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||||||
Cash and Cash equivalents |
928 | 7,410 | 1,010 | 47 | 92 | 271 | 183 | 1,407 | - | 11,347 | ||||||||||||||||||||||||||||||
Assets held for sale |
- | - | 8,705 | - | - | - | - | - | - | 8,705 | ||||||||||||||||||||||||||||||
Investments |
93,046 | 53,788 | 2,236 | 983 | 747 | 5,328 | 90 | 85 | - | 156,303 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
107,341 | 27,985 | 66,786 | 1,418 | 88 | - | - | - | (7 | ) | 203,610 | |||||||||||||||||||||||||||||
Investments in joint ventures |
7 | 877 | - | - | 495 | 134 | 99 | - | - | 1,614 | ||||||||||||||||||||||||||||||
Investments in associates |
95 | 21 | 8 | 2 | - | 21 | 125 | (1 | ) | - | 270 | |||||||||||||||||||||||||||||
Deferred expenses |
9,351 | 84 | 1,084 | 71 | 1 | 832 | - | - | - | 11,423 | ||||||||||||||||||||||||||||||
Other assets |
20,725 | 7,766 | 1,920 | 174 | 77 | 2,018 | 109 | 29,308 | (29,946 | ) | 32,152 | |||||||||||||||||||||||||||||
Total assets |
231,493 | 97,931 | 81,747 | 2,696 | 1,500 | 8,604 | 607 | 30,800 | (29,952 | ) | 425,425 | |||||||||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||||||||||||||||||
Insurance contracts |
75,942 | 34,900 | 1,747 | 558 | 722 | 7,466 | - | 20 | (1,785 | ) | 119,569 | |||||||||||||||||||||||||||||
Insurance contracts for account of policyholders |
75,328 | 26,275 | 18,112 | 1,126 | 89 | - | - | - | - | 120,929 | ||||||||||||||||||||||||||||||
Investment contracts |
10,148 | 9,043 | 355 | 24 | - | 2 | - | - | - | 19,572 | ||||||||||||||||||||||||||||||
Investment contracts for account of policyholders |
32,013 | 3,160 | 49,309 | 292 | - | - | - | - | - | 84,774 | ||||||||||||||||||||||||||||||
Liabilities held for sale |
- | - | 8,816 | - | - | - | - | - | - | 8,816 | ||||||||||||||||||||||||||||||
Other liabilities |
21,837 | 19,445 | 1,249 | 318 | 238 | (78 | ) | 180 | 6,438 | (2,203 | ) | 47,424 | ||||||||||||||||||||||||||||
Total liabilities |
215,268 | 92,822 | 79,586 | 2,318 | 1,049 | 7,390 | 180 | 6,458 | (3,988 | ) | 401,084 |
Annual Report on Form 20-F 2017 |
211 | Notes to the consolidated financial statements Note 5 | |
Investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Shares |
567 | 859 | 5 | 54 | 5 | 1 | 2 | 57 | - | 1,551 | ||||||||||||||||||||||||||||||
Debt securities |
54,535 | 21,411 | 1,779 | 712 | 646 | 5,252 | 9 | - | - | 84,344 | ||||||||||||||||||||||||||||||
Loans |
8,831 | 30,189 | - | 275 | 54 | 6 | - | 13 | - | 39,368 | ||||||||||||||||||||||||||||||
Other financial assets |
8,904 | 21 | 228 | 10 | - | 67 | 146 | 20 | - | 9,395 | ||||||||||||||||||||||||||||||
Investments in real estate |
633 | 1,495 | - | 4 | 15 | - | - | - | - | 2,147 | ||||||||||||||||||||||||||||||
Investments general account |
73,469 | 53,975 | 2,011 | 1,055 | 720 | 5,326 | 157 | 91 | - | 136,804 | ||||||||||||||||||||||||||||||
Shares |
- | 9,262 | 15,856 | 244 | 14 | - | - | - | (6 | ) | 25,370 | |||||||||||||||||||||||||||||
Debt securities |
3,116 | 13,370 | 8,125 | 216 | 9 | - | - | - | - | 24,836 | ||||||||||||||||||||||||||||||
Unconsolidated investment funds |
99,426 | 276 | 33,476 | 873 | 81 | - | - | - | - | 134,132 | ||||||||||||||||||||||||||||||
Other financial assets |
422 | 3,788 | 4,850 | 11 | 1 | - | - | - | - | 9,072 | ||||||||||||||||||||||||||||||
Investments in real estate |
- | - | 655 | - | - | - | - | - | - | 655 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
102,964 | 26,697 | 62,961 | 1,343 | 105 | - | - | - | (6 | ) | 194,063 | |||||||||||||||||||||||||||||
Investments on balance sheet |
176,434 | 80,672 | 64,972 | 2,398 | 825 | 5,326 | 157 | 91 | (6 | ) | 330,868 | |||||||||||||||||||||||||||||
Off-balance sheet investments third parties |
212,736 | 1,759 | 114,906 | 5,709 | 528 | 2,718 | 143,923 | - | (981 | ) | 481,297 | |||||||||||||||||||||||||||||
Total revenue-generating investments |
389,170 | 82,431 | 179,878 | 8,107 | 1,353 | 8,043 | 144,079 | 91 | (987 | ) | 812,165 | |||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||||||||||||||
Available-for-sale |
59,459 | 19,841 | 2,007 | 756 | 651 | 5,299 | 137 | 20 | - | 88,170 | ||||||||||||||||||||||||||||||
Loans |
8,831 | 30,189 | - | 275 | 54 | 6 | - | 13 | - | 39,368 | ||||||||||||||||||||||||||||||
Financial assets at fair value through profit or loss |
107,511 | 29,147 | 62,310 | 1,363 | 105 | 21 | 20 | 57 | (6 | ) | 200,528 | |||||||||||||||||||||||||||||
Investments in real estate |
633 | 1,495 | 655 | 4 | 15 | - | - | - | - | 2,801 | ||||||||||||||||||||||||||||||
Total investments on balance sheet |
176,434 | 80,672 | 64,972 | 2,398 | 825 | 5,326 | 157 | 91 | (6 | ) | 330,868 | |||||||||||||||||||||||||||||
Investments in joint ventures |
6 | 1,008 | - | - | 480 | 118 | 99 | 1 | - | 1,712 | ||||||||||||||||||||||||||||||
Investments in associates |
77 | 74 | 7 | 6 | - | 14 | 122 | 8 | - | 308 | ||||||||||||||||||||||||||||||
Other assets |
35,728 | 15,221 | 8,352 | 383 | 189 | 2,347 | 242 | 29,552 | (28,979 | ) | 63,034 | |||||||||||||||||||||||||||||
Consolidated total assets |
212,245 | 96,975 | 73,331 | 2,787 | 1,494 | 7,805 | 620 | 29,651 | (28,985 | ) | 395,923 |
Annual Report on Form 20-F 2017 |
212 | Notes to the consolidated financial statements Note 5 | |
Investments |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Shares |
793 | 334 | 84 | 35 | 4 | - | 2 | 62 | - | 1,314 | ||||||||||||||||||||||||||||||
Debt securities |
70,766 | 23,741 | 2,036 | 633 | 683 | 5,310 | - | - | - | 103,169 | ||||||||||||||||||||||||||||||
Loans |
10,820 | 28,117 | - | 303 | 45 | 18 | - | - | - | 39,303 | ||||||||||||||||||||||||||||||
Other financial assets |
9,924 | 358 | 115 | 10 | - | - | 88 | 23 | - | 10,519 | ||||||||||||||||||||||||||||||
Investments in real estate |
743 | 1,238 | - | 3 | 15 | - | - | - | - | 1,999 | ||||||||||||||||||||||||||||||
Investments general account |
93,046 | 53,788 | 2,236 | 983 | 747 | 5,328 | 90 | 85 | - | 156,303 | ||||||||||||||||||||||||||||||
Shares |
- | 9,689 | 15,503 | 295 | 13 | - | - | - | (7 | ) | 25,492 | |||||||||||||||||||||||||||||
Debt securities |
4,779 | 15,434 | 9,847 | 235 | 10 | - | - | - | - | 30,305 | ||||||||||||||||||||||||||||||
Unconsolidated investment funds |
102,534 | - | 36,600 | 879 | 64 | - | - | - | - | 140,077 | ||||||||||||||||||||||||||||||
Other financial assets |
27 | 2,862 | 4,150 | 9 | 1 | - | - | - | - | 7,049 | ||||||||||||||||||||||||||||||
Investments in real estate |
- | - | 686 | - | - | - | - | - | - | 686 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
107,341 | 27,985 | 66,786 | 1,418 | 88 | - | - | - | (7 | ) | 203,610 | |||||||||||||||||||||||||||||
Investments on balance sheet |
200,387 | 81,774 | 69,021 | 2,401 | 834 | 5,328 | 90 | 85 | (7 | ) | 359,914 | |||||||||||||||||||||||||||||
Off-balance sheet investments third parties |
240,072 | 952 | 5,333 | 3,154 | 507 | 2,734 | 130,889 | - | (864 | ) | 382,776 | |||||||||||||||||||||||||||||
Total revenue-generating investments |
440,458 | 82,725 | 74,354 | 5,556 | 1,342 | 8,061 | 130,979 | 85 | (871 | ) | 742,690 | |||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||||||||||||||
Available-for-sale |
77,918 | 23,044 | 2,152 | 660 | 687 | 5,289 | 87 | 23 | - | 109,860 | ||||||||||||||||||||||||||||||
Loans |
10,820 | 28,117 | - | 303 | 45 | 18 | - | - | - | 39,303 | ||||||||||||||||||||||||||||||
Financial assets at fair value through profit or loss |
110,906 | 29,374 | 66,183 | 1,436 | 88 | 21 | 4 | 62 | (7 | ) | 208,066 | |||||||||||||||||||||||||||||
Investments in real estate |
743 | 1,238 | 686 | 3 | 15 | - | - | - | - | 2,685 | ||||||||||||||||||||||||||||||
Total investments on balance sheet |
200,387 | 81,774 | 69,021 | 2,401 | 834 | 5,328 | 90 | 85 | (7 | ) | 359,914 | |||||||||||||||||||||||||||||
Investments in joint ventures |
7 | 877 | - | - | 495 | 134 | 99 | - | - | 1,614 | ||||||||||||||||||||||||||||||
Investments in associates |
95 | 21 | 8 | 2 | - | 21 | 125 | (1 | ) | - | 270 | |||||||||||||||||||||||||||||
Other assets |
31,003 | 15,260 | 12,718 | 293 | 170 | 3,122 | 293 | 30,715 | (29,946 | ) | 63,627 | |||||||||||||||||||||||||||||
Consolidated total assets |
231,493 | 97,931 | 81,747 | 2,696 | 1,500 | 8,604 | 607 | 30,800 | (29,952 | ) | 425,425 |
Annual Report on Form 20-F 2017 |
213 | Notes to the consolidated financial statements Note 6 | |
6 Premium income and premiums paid to reinsurers
2017 | 2016 | 2015 | ||||||||||
Life insurance |
19,952 | 20,400 | 19,583 | |||||||||
Non-life insurance |
2,874 | 3,053 | 3,342 | |||||||||
Total premium income |
22,826 | 23,453 | 22,925 | |||||||||
- Accident and health insurance |
2,511 | 2,609 | 2,703 | |||||||||
- General insurance |
363 | 444 | 640 | |||||||||
Non-life insurance premium income |
2,874 | 3,053 | 3,342 | |||||||||
2017 | 2016 | 2015 | ||||||||||
Life insurance |
3,214 | 2,932 | 2,694 | |||||||||
Non-life insurance |
217 | 244 | 286 | |||||||||
Total premiums paid to reinsurers |
3,431 | 3,176 | 2,979 | |||||||||
- Accident and health insurance |
205 | 238 | 268 | |||||||||
- General insurance |
13 | 7 | 18 | |||||||||
Non-life insurance paid to reinsurers |
217 | 244 | 286 |
Premium income Life insurance includes EUR 5,139 million (2016: EUR 5,255 million) of premiums related to insurance policies upgraded to the retirement platform in the UK.
Annual Report on Form 20-F 2017 |
214 | Notes to the consolidated financial statements Note 8 | |
Investment income from financial assets held for general account: |
2017 | 2016 | 2015 | |||||||||
Available-for-sale |
3,467 | 4,007 | 4,235 | |||||||||
Loans |
1,686 | 1,752 | 1,760 | |||||||||
Financial assets designated at fair value through profit or loss |
148 | 80 | 115 | |||||||||
Real estate |
71 | 69 | 61 | |||||||||
Derivatives |
31 | (139 | ) | (96 | ) | |||||||
Other |
(10 | ) | (32 | ) | 25 | |||||||
Total |
5,394 | 5,737 | 6,099 |
2017 | 2016 | 2015 | ||||||||||
Fee income from asset management |
2,126 | 1,702 | 1,648 | |||||||||
Commission income |
535 | 562 | 614 | |||||||||
Other |
140 | 144 | 176 | |||||||||
Total fee and commission income |
2,802 | 2,408 | 2,438 |
Included in fee and commission income is EUR 190 million of fees on trust and fiduciary activities (2016: EUR 55 million; 2015: EUR 56 million). The increase of EUR 134 million in 2017 compared to 2016 was mainly driven by the acquisition of Cofunds in UK in January 2017.
9 Income from reinsurance ceded
2017 | 2016 | 2015 | ||||||||||
Recovered claims and benefits |
3,669 | 3,477 | 2,784 | |||||||||
Change in technical provisions |
497 | (26 | ) | 309 | ||||||||
Commissions |
122 | 236 | 227 | |||||||||
Total |
4,288 | 3,687 | 3,321 |
Income from reinsurance ceded is generated from reinsurance activities directly related to premiums paid to reinsurers in note 6, therefore both should be viewed concurrently.
10 Results from financial transactions
Results from financial transactions comprise: |
2017 | 2016 | 2015 | |||||||||
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives |
232 | (42 | ) | (35 | ) | |||||||
Realized gains and (losses) on financial investments |
431 | 327 | 349 | |||||||||
Gains and (losses) on investments in real estate |
193 | 70 | 145 | |||||||||
Net fair value change of derivatives |
(1,159 | ) | 239 | 123 | ||||||||
Net fair value change on for account of policyholder financial assets at fair value through profit or loss |
20,524 | 15,121 | (110 | ) | ||||||||
Net fair value change on investments in real estate for account of policyholders |
38 | (26 | ) | 67 | ||||||||
Net foreign currency gains and (losses) |
(20 | ) | 41 | (29 | ) | |||||||
Net fair value change on borrowings and other financial liabilities |
10 | 21 | 9 | |||||||||
Realized gains and (losses) on repurchased debt |
1 | 1 | 2 | |||||||||
Total |
20,250 | 15,753 | 521 |
Annual Report on Form 20-F 2017 |
215 | Notes to the consolidated financial statements Note 10 | |
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives comprise: |
2017 | 2016 | 2015 | |||||||||
Shares |
25 | 4 | - | |||||||||
Debt securities and money market investments |
127 | 8 | (24 | ) | ||||||||
Other |
80 | (54 | ) | (12 | ) | |||||||
Total |
232 | (42 | ) | (35 | ) | |||||||
Other mainly includes net fair value changes of alternative investments. |
||||||||||||
Realized gains and losses on financial investments comprise: | 2017 | 2016 | 2015 | |||||||||
Shares |
165 | 46 | 44 | |||||||||
Debt securities and money market investments |
242 | 211 | 346 | |||||||||
Loans |
20 | 16 | 20 | |||||||||
Other |
3 | 54 | (60 | ) | ||||||||
Total |
431 | 327 | 349 | |||||||||
Realized gains and losses on financial investments comprise: | 2017 | 2016 | 2015 | |||||||||
Available-for-sale investments |
411 | 311 | 330 | |||||||||
Loans |
20 | 16 | 20 | |||||||||
Total |
431 | 327 | 349 | |||||||||
Net fair value change of derivatives comprise: | 2017 | 2016 | 2015 | |||||||||
Net fair value change on economic hedges where no hedge accounting is applied |
70 | 793 | (500 | ) | ||||||||
Net fair value change on bifurcated embedded derivatives |
(1,231 | ) | (565 | ) | 614 | |||||||
Ineffective portion of hedge transactions to which hedge accounting is applied |
2 | 12 | 8 | |||||||||
Total |
(1,159 | ) | 239 | 123 | ||||||||
The ineffective portion of hedge transactions to which hedge accounting is applied comprises: |
2017 | 2016 | 2015 | |||||||||
Fair value change on hedging instruments in a fair value hedge |
(12 | ) | (29 | ) | (49 | ) | ||||||
Fair value change on hedged items in a fair value hedge |
15 | 35 | 54 | |||||||||
Ineffectiveness fair value hedge |
3 | 7 | 5 | |||||||||
Ineffectiveness cash flow hedges |
- | 5 | 4 | |||||||||
Total |
2 | 12 | 8 | |||||||||
Net fair value change on for account of policyholder financial assets at fair value through profit or loss comprise: |
2017 | 2016 | 2015 | |||||||||
Shares |
2,372 | 2,462 | 706 | |||||||||
Debt securities and money market investments |
166 | 1,682 | (529 | ) | ||||||||
Unconsolidated investment funds |
17,720 | 10,496 | (356 | ) | ||||||||
Derivatives |
94 | 252 | 69 | |||||||||
Other |
171 | 230 | - | |||||||||
Total |
20,524 | 15,121 | (110 | ) |
Net fair value change on for account of policyholder financial assets at fair value through profit or loss increased in 2017 compared to 2016, mainly from favorable equity markets results, which were partly offset by losses from interest rates movements. Net fair value changes on for account of policyholder financial assets at fair value through profit or loss are offset by changes in technical provisions reported as part of the lines Change in valuation of liabilities for insurance contracts and Change in valuation of liabilities for investment contracts in note 12 Policyholder claims and benefits.
Annual Report on Form 20-F 2017 |
216 | Notes to the consolidated financial statements Note 11 | |
2017 | 2016 | 2015 | ||||||||||
Other income |
540 | 66 | 83 |
Other income in 2017 of EUR 540 million mainly related to a book gain of EUR 231 million (USD 250 million) from the divestment of the payout annuity and the BOLI/COLI businesses in the Americas and a book gain of EUR 208 million on the sale of the Unirobe Meeùs Groep. Furthermore, a release of an expense reserve of EUR 82 million (GBP 71 million) was recorded that was embedded in the liabilities for insurance contracts following the completion of the Part VII transfer to Rothesay Life. Also EUR 17 million (GBP 14 million) related to the completion of the Part VII transfer of annuities reinsured to Legal & General in 2016 was included. For more details refer to note 51 Business combinations.
Other income of EUR 66 million for 2016 includes the result on the sale of Transamerica Financial Advisors. This transaction has resulted in a gain of USD 58 million (EUR 52 million). Refer to note 51 Business combinations for more details.
Other income in 2015 included a release of EUR 38 million of the earn out provision regarding Liberbank in Spain. In addition, other income included the results from the sale of Clark Consulting and the 25.1% share in Seven Investment Management (7IM). The 7IM transaction led to a net gain of EUR 10 million (GBP 7 million) and was recorded as an associate in the books of Aegon. The sale of Clark Consulting led to a book gain of EUR 7 million (USD 8 million). Please see also note 51 Business combinations for more details.
12 Policyholder claims and benefits
2017 | 2016 | 2015 | ||||||||||
Benefits and claims paid life |
23,634 | 23,877 | 23,130 | |||||||||
Benefits and claims paid non-life |
1,903 | 2,052 | 2,128 | |||||||||
Change in valuation of liabilities for insurance contracts |
22,741 | 16,193 | 7,880 | |||||||||
Change in valuation of liabilities for investment contracts |
(2,644 | ) | (104 | ) | (6,678 | ) | ||||||
Other |
(34 | ) | (45 | ) | (17 | ) | ||||||
Total |
45,599 | 41,974 | 26,443 |
Policyholder claims and benefits includes claims and benefits in excess of account value for products for which deposit accounting is applied and the change in valuation of liabilities for insurance and investment contracts. The lines Change in valuation of liabilities for insurance contracts and Change in valuation of liabilities for investment contracts reflect changes in technical provisions resulting from net fair value changes on for account of policyholder financial assets included in note 10 Results from financial transactions of EUR 20,524 million (2016: EUR 15,121 million, 2015: EUR (110) million). In addition, the line Change in valuation of liabilities for insurance contracts includes an increase of technical provisions for life insurance contracts of EUR 601 million (2016: increase of EUR 2,349 million, 2015: increase of EUR 3,410 million).
2017 | 2016 | 2015 | ||||||||||
Surplus interest bonuses |
2 | 4 | 2 | |||||||||
Profit appropriated to policyholders |
21 | 45 | 29 | |||||||||
Total |
23 | 49 | 31 |
2017 | 2016 | 2015 | ||||||||||
Commissions |
2,661 | 2,929 | 3,313 | |||||||||
Employee expenses |
2,234 | 2,287 | 2,280 | |||||||||
Administration expenses |
1,424 | 1,273 | 1,278 | |||||||||
Deferred expenses |
(980 | ) | (1,203 | ) | (1,533 | ) | ||||||
Amortization of deferred expenses |
543 | 880 | 1,143 | |||||||||
Amortization of VOBA and future servicing rights |
43 | 184 | 117 | |||||||||
Total |
5,925 | 6,351 | 6,598 |
Annual Report on Form 20-F 2017 |
217 | Notes to the consolidated financial statements Note 14 | |
Included in administration expenses is an amount of EUR 105 million of depreciation that relates to equipment, software and real estate held for own use (2016: EUR 89 million; 2015: EUR 84 million). Minimum lease payments recognized as expense amounted to EUR 18 million (2016: EUR 17 million; 2015: EUR 19 million).
Employee expenses | 2017 | 2016 | 2015 | |||||||||
Salaries |
1,470 | 1,471 | 1,462 | |||||||||
Post-employment benefit costs |
318 | 338 | 335 | |||||||||
Social security charges |
151 | 155 | 145 | |||||||||
Other personnel costs |
267 | 294 | 320 | |||||||||
Shares, share appreciation rights, share options |
28 | 28 | 17 | |||||||||
Total |
2,234 | 2,287 | 2,280 |
An amount of EUR 46 million is included in employee expenses relating to defined contributions (2016: EUR 46 million; 2015: EUR 51 million).
Long-term incentive plans
Senior managers within Aegon, not classified as Identified Staff, have been granted the conditional right to receive Aegon shares if certain performance indicators are met and depending on continued employment of the individual employee to whom the rights have been granted. The shares were conditionally granted at the beginning of the year at the volume weighted average price (VWAP) on the Euronext stock exchange in Amsterdam during the period between December 15 preceding a plan year and January 15 of a plan year. The performance indicators apply over a performance period of one year and consist of financial and non-financial targets set by the Supervisory Board or the local remuneration committees. Following the performance year, shares are allocated based on actual performance. A vesting period of two years applies after which the shares are transferred to the individual employees. In specific circumstances Aegons Supervisory Board will reclaim variable compensation that has already been paid out or vested.
Variable compensation Identified Staff
Members of the Executive Board and the Management Board as well as other selected jobholders have been defined as Identified Staff in accordance with the rules applicable to them and their interpretation by relevant supervisory authorities. Of these, the Dutch 2015 Act on compensation in the financial sector (Wet beloningsbeleid financiële ondernemingen Wft) and the Dutch 2014 Decree on sound remuneration policy (Regeling beheerst beloningsbeleid 2014) are prominent examples. The rules have been adopted in Aegons Global Remuneration Framework. After the performance period, and based on the framework, variable compensation, if any, is partially made available and partly deferred. Variable compensation is paid in both cash and in Aegon N.V. shares. The shares were conditionally granted at the beginning of the year at the volume weighted average price (VWAP) on the Euronext stock exchange in Amsterdam during the period between December 15 preceding a plan year and January 15 of the plan year. The performance indicators apply over a performance period of one year and consist of Group and/or reporting unit targets (both financial and non-financial) set by the Supervisory Board or the local remuneration committees and personal/strategic targets. The conditional grant of variable compensation is also dependent on continued employment of the individual employee to whom the rights have been granted. An ex-post assessment is applicable to determine whether allocated (unvested) variable compensation should become unconditional or should be adjusted. In addition, in specific circumstances Aegons Supervisory Board will reclaim variable compensation that has already been paid out or vested. For members of the Executive Board and the Management Board all variable compensation has vested after three years following the performance period. At vesting, the variable compensation is transferred to the individual employees. Additional holding periods of up to three years may apply for vested shares. Members of the Executive Board and the members of the Management Board who are based in the Netherlands are not entitled to execute any transactions regarding the shares for a period of three years following vesting (with the exception of shares withheld or sold to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares).
In compliance with regulations under Dutch law, no transactions regarding the shares may be exercised in closed periods.
Annual Report on Form 20-F 2017 |
218 | Notes to the consolidated financial statements Note 15 | |
Below an overview is provided of shares provided in active plans for Long-term incentive and Variable compensation Identified Staff.
2007 | 2011 1) | 2012 1) | 2013 1) | 2014 1) | 2015 1) | 2016 1) | 2017 1) | Total | ||||||||||||||||||||||||||||
Number of shares conditionally granted 2) |
18,506 | 4,075,460 | 9,195,284 | 5,735,046 | 5,306,037 | 5,178,633 | 6,809,814 | 6,722,418 | 43,041,198 | |||||||||||||||||||||||||||
Number of shares allocated |
18,506 | 6,452,535 | 13,392,200 | 8,536,076 | 4,714,569 | 4,942,275 | 7,155,420 | - | 45,211,581 | |||||||||||||||||||||||||||
Unvested at January 1, 2016 |
9,253 | - | 6,584,783 | 7,458,390 | 4,372,405 | 5,178,633 | - | - | 23,603,464 | |||||||||||||||||||||||||||
Number of shares conditionally granted 2) |
- | - | - | - | - | - | 6,809,814 | - | 6,809,814 | |||||||||||||||||||||||||||
Number of shares allocated |
280 | - | - | (45,557 | ) | 16,937 | (330,501 | ) | - | - | (358,841 | ) | ||||||||||||||||||||||||
Number of shares forfeited |
- | - | 76,435 | 141,013 | 95,977 | 15,985 | - | - | 329,410 | |||||||||||||||||||||||||||
Number of shares vested |
9,533 | - | 6,508,348 | 3,167,260 | 111,521 | 278,510 | - | - | 10,075,172 | |||||||||||||||||||||||||||
Unvested at December 31, 2016 | - | - | - | 4,104,560 | 4,181,844 | 4,553,637 | 6,809,814 | - | 19,649,855 | |||||||||||||||||||||||||||
Number of shares conditionally granted 2) |
- | - | - | - | - | - | - | 6,722,418 | 6,722,418 | |||||||||||||||||||||||||||
Number of shares allocated |
- | - | - | - | 49,780 | - | 345,606 | - | 395,386 | |||||||||||||||||||||||||||
Number of shares forfeited |
- | - | - | - | 42,580 | 116,505 | 136,506 | - | 295,591 | |||||||||||||||||||||||||||
Number of shares vested |
- | - | - | 4,104,560 | 1,887,728 | 122,638 | 427,485 | - | 6,542,411 | |||||||||||||||||||||||||||
Unvested at December 31, 2017 | - | - | - | - | 2,301,316 | 4,314,494 | 6,591,429 | 6,722,418 | 19,929,657 | |||||||||||||||||||||||||||
Average share price used for grant in EUR 3) |
4.727 | 3.126 | 4.917 | 6.739 | 6.106 | 5.128 | 5.246 | |||||||||||||||||||||||||||||
Fair value of shares at grant date in EUR |
|
3.915 to
4.581 |
|
|
2.260 to
2.886 |
|
|
3.900 to
4.684 |
|
|
5.840 to
6.658 |
|
|
5.159 to
6.018 |
|
3.990 to 4.898 | 4.040 to 4.933 |
1 | Performance year for both Long-term incentive plans and Variable compensation Identified Staff |
2 | Number of shares conditionally granted based on the at target number of grants made that could increase or decrease subject to the actual performance attained |
3 | This value is the volume weighted average price (VWAP) of Aegon on the Euronext Amsterdam stock exchange for the period December 15 to January 15 |
For the vested tranches from 2016 onwards Aegon introduced a net settlement option for participants to meet income tax obligations. This means that Aegon will not sell shares on the market, but hold these shares within Aegon and settle directly with the tax authorities in cash rather than selling shares first. The net settlement option does not change the share based payment right of the participants, therefore there is no incremental fair value, nor a related recognition of incremental fair value.
Refer to note 53 Related party transactions for detailed information on conditional shares granted to the Executive Board.
15 Impairment charges / (reversals)
Impairment charges / (reversals) comprise: | 2017 | 2016 | 2015 | |||||||||
Impairment charges on financial assets, excluding receivables |
74 | 117 | 95 | |||||||||
Impairment reversals on financial assets, excluding receivables |
(32 | ) | (58 | ) | (119 | ) | ||||||
Impairment charges and reversals on non-financial assets and receivables |
- | 36 | 1,275 | |||||||||
Total |
42 | 95 | 1,251 |
In 2015, impairment charges and reversals on non-financial assets and receivables include a charge of EUR 1,274 million mainly related to deferred acquisition costs in the UK. Recoverability of capitalized deferred policy acquisition costs was affected by the restructuring of the organization.
Annual Report on Form 20-F 2017 |
219 | Notes to the consolidated financial statements Note 16 | |
The interest charges accrued on financial assets and liabilities that are not carried at fair value through profit or loss amounted to EUR 162 million (2016: EUR 176 million; 2015: EUR 269 million).
2017 | 2016 | 2015 | ||||||||||
Other charges |
235 | 700 | 774 |
Other charges in 2017 of EUR 235 million mainly relate to the book loss of EUR 105 million (USD 119 million) regarding the divestment of a block of life reinsurance business in the Americas and a charge of EUR 85 million (USD 100 million), regarding a provision in anticipation of a possible settlement in connection with an investigation by the SEC, refer to Note 48 Commitments and contingencies. In addition, an impairment of deferred transaction costs of EUR 36 million (GBP 32 million) was recorded as a result of the sale of Aegon Ireland plc, which is subject to customary regulatory approvals. For more details on the divestment of a block of US reinsurance run off business and Aegon Ireland plc. refer to note 51 Business combinations.
Other charges in 2016 of EUR 700 million mainly relate to the book loss on the sale of the UK annuity portfolio (EUR 682 million) and charges related to claims and litigations regarding fees payable upon purchase or surrender of unit-linked policies in the Polish Life insurance portfolio (EUR 19 million). For more details on the sale of the UK annuity portfolio refer to note 22 Assets and Liabilities held for sale and note 51 Business combinations. In note 40 Provisions more details are provided on the Polish claims and litigations.
Other charges of EUR 774 million in 2015 mainly relate to the book loss on the sale of Aegons Canadian life insurance business. For the sale of Canada refer to note 51 Business combinations.
Annual Report on Form 20-F 2017 |
220 | Notes to the consolidated financial statements Note 18 | |
Note | 2017 | 2016 | 2015 | |||||||||||||
Current tax |
||||||||||||||||
Current year |
220 | 33 | 111 | |||||||||||||
Adjustments to prior years |
47 | (46 | ) | (70 | ) | |||||||||||
267 | (13 | ) | 42 | |||||||||||||
Deferred tax |
43 | |||||||||||||||
Origination / (reversal) of temporary differences |
397 | 102 | (169 | ) | ||||||||||||
Changes in tax rates / bases |
(550 | ) | 93 | (22 | ) | |||||||||||
Changes in deferred tax assets as a result of recognition / write off of previously not recognized / recognized tax losses, tax credits and deductible temporary differences |
(45 | ) | (54 | ) | (8 | ) | ||||||||||
Non-recognition of deferred tax assets |
41 | 33 | 22 | |||||||||||||
Adjustments to prior years |
(45 | ) | 12 | 53 | ||||||||||||
(201 | ) | 185 | (125 | ) | ||||||||||||
Income tax for the period (income) / charge |
65 | 172 | (83 | ) | ||||||||||||
Adjustments to prior years include shifts between current and deferred tax. |
||||||||||||||||
Reconciliation between standard and effective income tax: | 2017 | 2016 | 2015 | |||||||||||||
Income before tax |
2,534 | 610 | (514 | ) | ||||||||||||
Income tax calculated using weighted average applicable statutory rates |
745 | 239 | (57 | ) | ||||||||||||
Difference due to the effects of: |
||||||||||||||||
Non-taxable income |
(157 | ) | (126 | ) | 43 | |||||||||||
Non-tax deductible expenses |
28 | 21 | 49 | |||||||||||||
Changes in tax rate/base |
(550 | ) | 93 | (22 | ) | |||||||||||
Different tax rates on overseas earnings |
(1 | ) | 8 | 6 | ||||||||||||
Tax credits |
(67 | ) | (41 | ) | (100 | ) | ||||||||||
Other taxes |
67 | 38 | 14 | |||||||||||||
Adjustments to prior years |
2 | (34 | ) | (17 | ) | |||||||||||
Origination and change in contingencies |
9 | 8 | 3 | |||||||||||||
Changes in deferred tax assets as a result of recognition / write off of previously not recognized / recognized tax losses, tax credits and deductible temporary differences |
(45 | ) | (54 | ) | (8 | ) | ||||||||||
Non-recognition of deferred tax assets |
41 | 33 | 22 | |||||||||||||
Tax effect of (profit) / losses from joint ventures and associates |
(7 | ) | (7 | ) | (8 | ) | ||||||||||
Other |
(1 | ) | (6 | ) | (8 | ) | ||||||||||
(680 | ) | (67 | ) | (27 | ) | |||||||||||
Income tax for the period (income) / charge |
65 | 172 | (83 | ) |
The weighted average applicable statutory tax rate for 2017 is 29.4% (2016: 39.2%; 2015: 11.0%). The decrease in the weighted average applicable statutory tax rate compared to 2016 is caused by relatively more income before tax in the Netherlands and the UK versus income before tax in the US. The weighted average applicable statutory tax rate in 2015 was impacted by a disproportional loss in the UK.
Non-taxable income in 2017 includes the tax exempt sale proceeds of the Dutch Unirobe Meeùs Group. Non-taxable income in 2015 was negatively impacted by the non-deductible loss on the sale of Aegons Canadian life insurance business.
Changes in tax rate/base in 2017 highly benefited by the decrease of the US corporate income tax rate from 35% to 21% as from January 1, 2018.
Changes in tax rate/base in 2016 was heavily impacted by the release of profits from other comprehensive income (OCI) to income statement in the UK. These profits were taxed in the past against high historic tax rates and were released from OCI to the income statement against a lower statutory tax rate in 2016. The difference caused a negative impact in changes in tax rate/base.
Annual Report on Form 20-F 2017 |
221 | Notes to the consolidated financial statements Note 19 | |
In the UK, the corporate income tax rate decreased to 19% as per April 1, 2017. The beneficial impact of this change was reflected in the 2015 change in tax rate/base. The tax rate will continue to decrease from 19% to 17% with effect from April 1, 2020. The minor impact of this tax rate change was included in the 2016 change in tax rate/base. In Hungary, the corporate income tax rate decreased from 19% to 9% as from January 1, 2017. The minor impact of this tax rate change was included in the 2016 change in tax rate/base.
Tax credits in 2017 increased by US foreign tax credits. Tax credits in 2015 includes tax benefits related to solar investments in the US.
Adjustments to prior years in 2016 included a one-time tax benefit in the US caused by the revised tax deduction for dividends received on prior filed tax returns.
The following tables present income tax related to components of other comprehensive income and retained earnings.
2017 | 2016 | 2015 | ||||||||||||||
Items that will not be reclassified to profit and loss: |
||||||||||||||||
Changes in revaluation reserve real estate held for own use |
9 | (3 | ) | (2 | ) | |||||||||||
Remeasurements of defined benefit plans |
(175 | ) | 89 | (75 | ) | |||||||||||
(166 | ) | 86 | (77 | ) | ||||||||||||
Items that may be reclassified subsequently to profit and loss: |
||||||||||||||||
Gains / losses on revaluation of available-for-sale investments |
(134 | ) | (187 | ) | 810 | |||||||||||
Gains / losses transferred to the income statement on disposal and impairment of available-for-sale investments |
441 | 427 | 124 | |||||||||||||
Changes in cash flow hedging reserve |
567 | 24 | (98 | ) | ||||||||||||
Movement in foreign currency translation and net foreign investment hedging reserve |
76 | (39 | ) | (52 | ) | |||||||||||
951 | 225 | 783 | ||||||||||||||
Total income tax related to components of other comprehensive income |
785 | 311 | 706 | |||||||||||||
2017 | 2016 | 2015 | ||||||||||||||
Income tax related to equity instruments and other | ||||||||||||||||
Income tax related to equity instruments |
33 | 44 | 44 | 46 | ||||||||||||
Other |
14 | (3 | ) | - | ||||||||||||
Total income tax recognised directly in retained earnings |
58 | 41 | 46 |
The income tax related to components of OCI includes a deferred tax benefit of EUR 479 million caused by the decrease of the US corporate income tax rate from 35% to 21% as from January 1, 2018.
Basic earnings per share
Basic earnings per share is calculated by dividing the net income attributable to owners, after deduction of coupons on perpetual securities and non-cumulative subordinated notes by the weighted average number of common shares, excluding common shares purchased by the Company and held as treasury shares (refer to note 32.1 Share capital par value and 32.3 Treasury shares respectively).
2017 | 2016 | 2015 | ||||||||||
Net income / (loss) attributable to owners |
2,469 | 437 | (432 | ) | ||||||||
Coupons on perpetual securities |
(103 | ) | (105 | ) | (111 | ) | ||||||
Coupons on non-cumulative subordinated notes |
(28 | ) | (28 | ) | (28 | ) | ||||||
Net income / (loss) attributable to owners for basic earnings per share calculation |
2,338 | 304 | (571 | ) | ||||||||
Net income / (loss) attributable to common shareholders |
2,321 | 302 | (567 | ) | ||||||||
Net income / (loss) attributable to common shareholders B |
16 | 2 | (4 | ) | ||||||||
Weighted average number of common shares outstanding (in million) |
2,042 | 2,048 | 2,101 | |||||||||
Weighted average number of common shares B outstanding (in million) |
575 | 575 | 584 | |||||||||
Basic earnings per common share (EUR per share) |
1.14 | 0.15 | (0.27 | ) | ||||||||
Basic earnings per common share B (EUR per share) |
0.03 | - | (0.01 | ) |
Annual Report on Form 20-F 2017 |
222 | Notes to the consolidated financial statements Note 20 | |
Diluted earnings per share
The diluted earnings per share equaled the basic earnings per share for all years disclosed since there were no outstanding share options which were considered dilutive.
Final dividend 2017
It will be proposed to the Annual General Meeting of Shareholders on May 18, 2018, absent unforeseen circumstances, to pay a final dividend for the year 2017 of EUR 0.14 per common share. After taking into account the interim dividend 2017 of EUR 0.13 per common share, this will result in a total 2017 dividend of EUR 0.27 per common share. With respect to the common shares B, each of which has financial rights attached to it of 1/40th of a common share, the proposed final dividend will be EUR 0.0035. After taking the interim dividend 2017 of EUR 0.00325 per common share B into account, this will result in a total 2017 dividend of EUR 0.00675 per common share B.
Interim dividend 2017
The interim dividend 2017 was paid in cash or stock at the election of the shareholder. Approximately 57% of holders of common shares elected to receive the cash dividend. The remaining 43% have opted for stock dividend. The cash dividend amounted to EUR 0.13 per common share, the stock dividend amounted to one new Aegon common share for every 36 common shares held. The stock dividend and cash dividend are approximately equal in value. The interim dividend was payable as of September 15, 2017. The interim dividend 2017 for common shares B amounted to 1/40th of the dividend paid on common shares.
To neutralize the dilutive effect of the 2016 final and 2017 interim dividend paid in shares, Aegon executed a program to repurchase 51,864,626 common shares. Between October 2, 2017, and December 15, 2017, these common shares were repurchased at an average price of EUR 5.0950 per share. These shares will be held as treasury shares and will be used to cover future stock dividends.
Final dividend 2016
The Annual General Meeting of Shareholders on May 19, 2017, approved a final dividend over 2016 of EUR 0.13 per common share payable in either cash or stock, related to the second half of 2016. Approximately 54% of holders of common shares elected to receive the cash dividend. The remaining 46% have opted for stock dividend. The final dividend was payable as of June 23, 2017. The stock dividend amounted to one new Aegon common share for every 35 common shares held. The stock dividend and cash dividend are approximately equal in value. Dividend paid on common shares B amounted to 1/40th of the dividend paid on common shares.
Interim dividend 2016
The interim dividend 2016 was paid in cash or stock at the election of the shareholder. Approximately 58% of holders of common shares elected to receive the cash dividend. The remaining 42% have opted for stock dividend. The cash dividend amounted to EUR 0.13 per common share, the stock dividend amounted to one new Aegon common share for every 28 common shares held. The stock dividend and cash dividend are approximately equal in value. The interim dividend was payable as of September 16, 2016. The interim dividend 2016 for common shares B amounted to 1/40th of the dividend paid on common shares.
To neutralize the dilutive effect of the 2016 interim dividend paid in shares, Aegon executed a program to repurchase 30,765,224 common shares. Between October 3, 2016, and November 11, 2016, these common shares were repurchased at an average price of EUR 3.8406 per share. These shares will be held as treasury shares and will be used to cover future stock dividends.
Final dividend 2015
The Annual General Meeting of Shareholders on May 20, 2016, approved a final dividend over 2015 of EUR 0.13 per common share payable in either cash or stock, related to the second half of 2015. Approximately 57% of holders of common shares elected to receive the cash dividend. The remaining 43% have opted for stock dividend. The final dividend was payable as of June 24, 2016. The stock dividend amounted to one new Aegon common share for every 30 common shares held. The stock dividend and cash dividend are approximately equal in value. Dividend paid on common shares B amounted to 1/40th of the dividend paid on common shares.
To neutralize the dilutive effect of the 2015 final dividend paid in shares, Aegon executed a program to repurchase 29,258,662 common shares. Between July 4, 2016, and August 12, 2016, these common shares were repurchased at an average price of EUR 3.5054 per share. These shares will be held as treasury shares and will be used to cover future stock dividends.
Interim dividend 2015
The interim dividend 2015 was paid in cash or stock at the election of the shareholder. Approximately 57% of holders of common shares elected to receive the cash dividend. The remaining 43% have opted for stock dividend. The cash dividend amounted
Annual Report on Form 20-F 2017 |
223 | Notes to the consolidated financial statements Note 21 | |
to EUR 0.12 per common share, the stock dividend amounted to one new Aegon common share for every 45 common shares held. The stock dividend and cash dividend are approximately equal in value. The interim dividend was payable as of September 18, 2015. The interim dividend 2015 for common shares B amounted to 1/40th of the dividend paid on common shares.
Aegon repurchased common shares to neutralize the dilutive effect of the 2015 interim dividend paid in shares. Aegon executed a program to repurchase 20,136,673 common shares. Between September 16, 2015, and October 13, 2015, these common shares were repurchased at an average price of EUR 5.2777 per share. These shares are held as treasury shares and will be used to cover future stock dividends.
2017 | 2016 | 2015 | ||||||||||
Cash at bank and in hand |
3,720 | 3,727 | 2,199 | |||||||||
Short-term deposits |
2,544 | 3,666 | 3,614 | |||||||||
Money market investments |
4,496 | 3,939 | 3,318 | |||||||||
Short-term collateral |
7 | 16 | 463 | |||||||||
At December 31 |
10,768 | 11,347 | 9,594 |
The carrying amounts disclosed reasonably approximate the fair values as at the year-end.
EUR 7 billion (2016: EUR 8 billion) of cash collateral is received related to securities lending, repurchase agreements and margins on derivatives transactions. A corresponding liability to repay the cash is recognized in other liabilities (note 44 Other liabilities). Refer to note 49 Transfer of financial assets for details on collateral received and paid. Investment of cash collateral received is restricted through limitations on credit worthiness, duration, approved investment categories and borrower limits. EUR 7 million (2016: EUR 16 million) of the cash collateral received is included in cash and cash equivalents and the remainder is included in other asset classes as that collateral is typically reinvested. Aegon earns a share of the spread between the collateral earnings and the rebate paid to the borrower of the securities. Due to the sale of the UK annuity portfolio in 2016 the short term collateral has decreased significantly since then. Income from securities lending programs was approximately EUR 11 million (2016: EUR 13 million; 2015: EUR 8 million).
The weighted effective interest rate on short-term deposits was 0.32% negative (2016: 0.17% negative) and these deposits have an average maturity of 31 days (2016: 23 days).
For the purposes of the cash flow statement, cash and cash equivalents comprise the following:
Note | 2017 | 2016 | 2015 | |||||||||||||
Cash and cash equivalents |
10,768 | 11,347 | 9,594 | |||||||||||||
Cash classified as Assets held for sale |
22 | 260 | - | - | ||||||||||||
Bank overdrafts |
44 | (2 | ) | (1 | ) | - | ||||||||||
Bank overdrafts classified as Liabilities held for sale |
(1 | ) | - | - | ||||||||||||
Net cash and cash equivalents |
11,026 | 11,346 | 9,593 |
Cash and cash equivalents include cash and demand balances held at the Dutch Central Bank. The Dutch Central Bank requires Aegon Bank N.V. to place 1% of their deposits with agreed maturity or the savings accounts (without restrictions to withdraw their money) in an account with the Dutch Central Bank. This deposit is renewed every 42-49 days, based on an updated valuation of total assets. The interest received on this deposit is equal to the ECB deposit rate (which was -40bp throughout 2017). The year-end minimum required balance on deposit by the Dutch Central Bank was EUR 67 million (2016: EUR 63 million). These deposits are therefore not freely available.
Summary cash flow statement | 2017 | 2016 | 2015 | |||||||||
Net cash flows from operating activities |
553 | 3,319 | 914 | |||||||||
Net cash flows from investing activities |
(1,196 | ) | (1,078 | ) | 615 | |||||||
Net cash flows from financing activities |
519 | (465 | ) | (2,785 | ) | |||||||
Net increase in cash and cash equivalents |
(125 | ) | 1,776 | (1,257 | ) |
Annual Report on Form 20-F 2017 |
224 | Notes to the consolidated financial statements Note 21 | |
Net cash and cash equivalents at December 31, 2017, are negatively impacted by effects of changes in exchange rates of EUR 196 million (2016: EUR 23 million negative; 2015: EUR 200 million positive).
Analysis of cash flows
2017 compared to 2016
Net cash flows from operating activities
Total net cash flows from operating activities decreased by EUR 2,766 million to a EUR 553 million inflow (2016: 3,319 EUR million inflow). The decrease is mainly driven by an outflow from results from financial transactions, changes in accruals and money market investments. These cash outflows are partly offset by the net purchase of investments for account of policyholders and by net changes in cash collateral.
Net cash flows from investing activities
Net cash flows from investing activities decreased by EUR 118 million to a EUR 1,196 million outflow (2016: EUR 1,078 million outflow). The total consideration paid for acquisitions, including cash in acquired entities, was EUR 52 million. The total consideration received for disposals, excluding transferred assets and reinsurance assets from reinsurance transactions, was EUR 299 million. Total consideration received in cash and cash equivalents amounted to EUR 306 million, as an earn-out of EUR 7 million was part of the total consideration. Transferred cash and cash equivalents amounts to an outflow of EUR 1,361 million as a result of reinsurance transactions and disposals of entities over which control is lost. The decrease is mainly driven by the aquisition of Cofunds Ltd., the divestment of the payout annuity business and Bank Owned Life Insurance / Corporate Owned Life Insurance business (BOLI/COLI) and the sale of Unirobe Meeùs Groep (UMG) (refer to note 51 Business combinations).
Net cash flows from financing activities
Net cash flows from financing activities increased by EUR 984 million to a EUR 519 million inflow (2016: EUR 465 million outflow). The increase is mainly a result of proceeds and repayments of borrowings (refer to the table below and note 39 Borrowings).
2016 compared to 2015
Net cash flows from operating activities
Total net cash flows from operating activities increased by EUR 2,405 million to a EUR 3,319 million inflow (2015: EUR 914 million inflow). The increase is mainly driven by higher inflows from insurance and investment liabilities for account of policyholders and an increase in changes in other liabilities. These cash inflows are partly offset by a decrease in results from financial transactions.
Net cash flows from investing activities
Net cash flows from investing activities decreased by EUR 1,693 million to a EUR 1,078 million outflow (2015: EUR 615 million inflow). The total consideration received for disposals, excluding transferred assets and reinsurance assets from reinsurance transactions, was EUR 69 million. Total consideration received in cash and cash equivalents amounted to EUR 56 million as an earn-out of EUR 13 million was part of the total consideration. Transferred cash and cash equivalents amounts to an outflow of EUR 1,130 million as a result of reinsurance transactions and disposal of entities over which control is lost. The decrease is mainly driven by net cash outflows related to the sale of Aegons UK annuity portfolio and the commercial non-life insurance business in Aegon Nederland (refer to note 51 Business combinations).
Net cash flows from financing activities
Net cash flows from financing activities increased by EUR 2,320 million to a EUR 465 million outflow (2015: EUR 2,785 million outflow). The increase is a result of proceeds and repayments of borrowings (refer to note 39 Borrowings). This was partly offset by the share buyback program, executed in 2016, to neutralize the dilutive effect of the cancellation of the preferred shares in 2013.
Annual Report on Form 20-F 2017 |
225 | Notes to the consolidated financial statements Note 22 | |
Reconciliation of liabilities arising from financing activities
The table below shows the reconciliation between the net cash flows from financing activities and the liabilities as included in the consolidated statement of financial position.
Cash flows | Non-cash changes | |||||||||||||||||||||||||||||||||||
Reconciliation of debt from financing activities |
|
At
January 1, 2017 |
|
Addition | Repayment |
|
Realized
gains / losses in income statement |
|
|
Movements
related to fair value hedges |
|
|
Amorti-
zation |
|
Other |
|
Net
exchange difference |
|
|
At
December 31, 2017 |
|
|||||||||||||||
Subordinated borrowings |
767 | - | - | - | - | 6 | - | (9 | ) | 764 | ||||||||||||||||||||||||||
Trust pass-through securities |
156 | - | - | - | (4 | ) | - | - | (19 | ) | 133 | |||||||||||||||||||||||||
Borrowings |
13,153 | 9,170 | (7,918 | ) | (10 | ) | - | (1 | ) | 1 | (760 | ) | 13,635 | |||||||||||||||||||||||
Assets held to hedge Trust pass-through securities |
22 | - | - | (4 | ) | - | - | - | (2 | ) | 15 |
22 Assets and liabilities held for sale
Assets and liabilities held for sale include disposal groups whose carrying amount will be recovered principally through a sale transaction expected within the next year rather than through continuing operations. This relates to businesses for which a sale is agreed upon or a sale is highly probable at the reporting date, but for which the transaction has not yet fully closed. As of December 31, 2017, this relates to the assets and liabilities of Aegon Ireland plc.
In 2017, following court approval on the Part VII transfer (22) , the sale of the UK annuity portfolio to Rothesay Life and Legal & General has been completed. As a consequence the related assets and liabilities are no longer classified as assets and liabilities held for sale at year-end 2017. Also refer to note 51 Business combinations.
Aegon Ireland plc., also referred to as VA Europe, is included in the UK segment (note 5 Segment information). For more information related to the sale transaction, refer to note 51 Business combinations.
The table below presents the major types of assets and liabilities of Aegon Ireland plc. included in assets and liabilities classified as held for sale on the consolidated statement of financial position.
Amounts in EUR million | 2017 | |||
Assets |
||||
Cash and cash equivalents |
260 | |||
Investments |
139 | |||
Investments for account of policyholders |
4,775 | |||
Derivatives |
57 | |||
Deferred tax assets |
5 | |||
Deferred expenses |
6 | |||
Other assets and receivables |
7 | |||
Total assets |
5,249 | |||
Liabilities |
||||
Insurance contracts for account of policyholders |
1,346 | |||
Investment contracts for account of policyholders |
3,518 | |||
Derivatives |
74 | |||
Deferred gains |
43 | |||
Other liabilities |
18 | |||
Accruals |
3 | |||
Total liabilities |
5,003 |
As of December 31, 2017, there are no unrealized gains relating to non-current assets and disposal groups classified as held for sale included in other comprehensive income.
Annual Report on Form 20-F 2017 |
226 | Notes to the consolidated financial statements Note 23 | |
Fair value measurement
The fair value hierarchy of financial assets and liabilities (measured at fair value), which are presented as held for sale is included below. The fair value hierarchy consists of three levels. Reference is made to note 3 Critical accounting estimates and judgment in applying accounting policies for more details on the fair value hierarchy.
Level I | Level II | Level III | Total 2017 | |||||||||||||
Assets carried at fair value |
||||||||||||||||
Fair value through profit or loss |
||||||||||||||||
Shares |
139 | - | - | 139 | ||||||||||||
Investments for account of policyholders |
1,699 | 3,076 | - | 4,775 | ||||||||||||
Derivatives |
- | 57 | - | 57 | ||||||||||||
Total assets at fair value |
1,837 | 3,133 | - | 4,971 | ||||||||||||
Liabilities carried at fair value |
||||||||||||||||
Investment contracts for account of policyholders |
- | 3,518 | - | 3,518 | ||||||||||||
Derivatives |
- | 41 | 33 | 74 | ||||||||||||
Total liabilities at fair value |
- | 3,559 | 33 | 3,592 |
Investments for general account comprise financial assets, excluding derivatives, as well as investments in real estate.
Note | 2017 | 2016 | ||||||||||
Available-for-sale (AFS) |
88,170 | 109,860 | ||||||||||
Loans |
39,368 | 39,303 | ||||||||||
Financial assets at fair value through profit or loss (FVTPL) |
7,119 | 5,142 | ||||||||||
Total financial assets, excluding derivatives |
23.1 | 134,658 | 154,304 | |||||||||
Investments in real estate |
23.2 | 2,147 | 1,999 | |||||||||
Total investments for general account |
136,804 | 156,303 |
The decrease of EUR 19.6 billion in financial assets, for general account, excluding derivatives compared to December 31, 2016 is mainly driven by the disposal of debt securities related to the divestments of the pay-out annuity and BOLI/COLI businesses and the block of life reinsurance in the Americas. In addition, the balance is affected by foreign exchange rates translation adjustments. Refer to note 51 Business combinations for the disposals of BOLI/COLI businesses and the block of life reinsurance in the Americas.
Refer to note 47 Fair value for information on fair value measurement. Loans are held at amortized cost, but the estimated fair value is also disclosed in note 47.
Annual Report on Form 20-F 2017 |
227 | Notes to the consolidated financial statements Note 23 | |
23.1 Financial assets, excluding derivatives
AFS | FVTPL | Loans | Total | Fair value | ||||||||||||||||
2017 |
||||||||||||||||||||
Shares |
490 | 1,062 | - | 1,551 | 1,551 | |||||||||||||||
Debt securities |
80,200 | 4,144 | - | 84,344 | 84,344 | |||||||||||||||
Money market and other short-term investments |
6,690 | 119 | - | 6,809 | 6,809 | |||||||||||||||
Mortgage loans |
- | - | 33,562 | 33,562 | 38,076 | |||||||||||||||
Private loans |
- | - | 3,642 | 3,642 | 4,181 | |||||||||||||||
Deposits with financial institutions |
- | - | 139 | 139 | 139 | |||||||||||||||
Policy loans |
- | - | 1,897 | 1,897 | 1,897 | |||||||||||||||
Other |
791 | 1,795 | 127 | 2,713 | 2,713 | |||||||||||||||
At December 31, 2017 |
88,170 | 7,119 | 39,368 | 134,658 | 139,711 | |||||||||||||||
2016 |
||||||||||||||||||||
Shares |
824 | 490 | - | 1,314 | 1,314 | |||||||||||||||
Debt securities |
101,054 | 2,115 | - | 103,169 | 103,169 | |||||||||||||||
Money market and other short-term investments |
6,776 | 317 | - | 7,093 | 7,093 | |||||||||||||||
Mortgage loans |
- | - | 33,696 | 33,696 | 38,499 | |||||||||||||||
Private loans |
- | - | 3,166 | 3,166 | 3,569 | |||||||||||||||
Deposits with financial institutions |
- | - | 129 | 129 | 129 | |||||||||||||||
Policy loans |
- | - | 2,207 | 2,207 | 2,207 | |||||||||||||||
Other |
1,206 | 2,219 | 104 | 3,529 | 3,529 | |||||||||||||||
At December 31, 2016 |
109,860 | 5,142 | 39,303 | 154,304 | 159,510 |
Of the debt securities, money market and other short-term investments, mortgage loans and private loans EUR 13,749 million is current (2016: EUR 15,729 million).
Refer to note 47 Fair value for information on fair value measurement.
Loan allowance
Movement on the loan allowance account during the year were as follows:
2017 | 2016 | |||||||
At January 1 |
(137 | ) | (142 | ) | ||||
Addition charged to income statement |
(50 | ) | (23 | ) | ||||
Reversal to income statement |
13 | 14 | ||||||
Amounts written off |
10 | 17 | ||||||
Net exchange differences |
3 | - | ||||||
Other |
(4 | ) | (3 | ) | ||||
At December 31 |
(165 | ) | (137 | ) |
Refer to note 49 Transfers of financial assets for a discussion of collateral received and paid.
Annual Report on Form 20-F 2017 |
228 | Notes to the consolidated financial statements Note 23 | |
23.2 Investments in real estate
2017 | 2016 | |||||||
At January 1 |
1,999 | 1,990 | ||||||
Additions |
239 | 89 | ||||||
Subsequent expenditure capitalized |
10 | 12 | ||||||
Transfers from other headings |
1 | 34 | ||||||
Disposals |
(202 | ) | (215 | ) | ||||
Fair value gains / (losses) |
193 | 70 | ||||||
Net exchange differences |
(89 | ) | 19 | |||||
Other |
(4 | ) | (1 | ) | ||||
At December 31 |
2,147 | 1,999 |
95% of the value of Aegons properties, both for general account and for account of policyholders, were appraised (2016: 78%), of which 99% was performed by independent external appraisers (2016: 98%).
Of the investments in real estate EUR 633 million (2016: EUR 743 million) is held by Aegon Americas and EUR 1,494 million (2016: EUR 1,238 million) is held by Aegon the Netherlands.
Aegon USA has entered into a commercial property portfolio, consisting of office, retail and industrial buildings. These non-cancellable leases have remaining lease terms up to 20 years. Most leases include a clause to enable upward revision of the rental charge on an annual basis according to either a fixed schedule or prevailing market conditions.
Aegon the Netherlands has entered into long-term residential property leases that can be terminated subject to a short-term notice. Under Dutch law, the maximum annual rent increase on residential property rented in the affordable housing segment is specified by the Dutch national government and equals the annual inflation rate plus a small margin.
Refer to note 48 Commitments and contingencies for a description of non-cancellable lease rights.
Rental income of EUR 71 million (2016: EUR 69 million; 2015: EUR 61 million) is reported as part of investment income in the income statement. Direct operating expenses (including repairs and maintenance) arising from investment property that generated rental income during the period amounted to EUR 21 million (2016: EUR 79 million; 2015: EUR 97 million). In 2017, EUR 1 million of direct operating expenses is related to investment properties that did not generate rental income during the period (2016: EUR 1 million; 2015: 1 million).
Transfers from other headings mainly reflect the properties that were foreclosed during the year. The associated mortgage loans were previously reported as part of investments.
There are no restrictions on the realizability of investment property or the remittance of income and proceeds of disposal.
Refer to note 48 Commitments and contingencies for a summary of contractual obligations to purchase investment property or for repairs, maintenance or enhancements.
Annual Report on Form 20-F 2017 |
229 | Notes to the consolidated financial statements Note 24 | |
24 Investments for account of policyholders
Investments for account of policyholders comprise financial assets at fair value through profit or loss, excluding derivatives, and investments in real estate.
Note | 2017 | 2016 | ||||||||||
Shares |
25,370 | 25,492 | ||||||||||
Debt securities |
24,836 | 30,305 | ||||||||||
Money market and other short-term investments |
2,340 | 1,231 | ||||||||||
Deposits with financial institutions |
2,946 | 2,951 | ||||||||||
Unconsolidated investment funds |
134,132 | 140,077 | ||||||||||
Other |
3,786 | 2,868 | ||||||||||
Total investments for account of policyholders at fair value through profit or loss, excluding derivatives | 193,409 | 202,924 | ||||||||||
Investments in real estate |
24.1 | 655 | 686 | |||||||||
Total investments for account of policyholders |
194,063 | 203,610 |
The decrease in investments for account of policyholders compared to December 31, 2016 is mainly caused by the reclassification to held for sale of Aegon Ireland plc. and negative foreign exchange rates translation adjustments. Refer to note 51 Business combinations for the sale of Aegon Ireland plc.
Refer to note 47 Fair value for a summary of all financial assets and financial liabilities at fair value through profit or loss.
24.1 Investments in real estate for account of policyholders
2017 | 2016 | |||||||
At January 1 |
686 | 1,022 | ||||||
Additions |
7 | 74 | ||||||
Subsequent expenditure capitalized |
3 | 7 | ||||||
Disposals |
(53 | ) | (260 | ) | ||||
Fair value gains / (losses) |
38 | (26 | ) | |||||
Net exchange differences |
(26 | ) | (131 | ) | ||||
At December 31 |
655 | 686 |
The investment property is leased out under operating leases.
Rental income of EUR 50 million (2016: EUR 60 million; 2015: EUR 72 million) is reported as part of investment income in the income statement. Direct operating expenses relating to investments in real estate for account of policyholder amounted to EUR 4 million in 2017 (2016: EUR 5 million, 2015: EUR 7 million). There are no restrictions on the realizability of investment property or the remittance of income and proceeds of disposal.
Refer to note 48 Commitments and contingencies for a summary of contractual obligations to purchase investment property or for repairs, maintenance or enhancements.
Annual Report on Form 20-F 2017 |
230 | Notes to the consolidated financial statements Note 25 | |
Derivative asset |
Derivative liability | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Derivatives for general account |
||||||||||||||||
Derivatives not designated in a hedge |
5,081 | 6,533 | 6,716 | 8,280 | ||||||||||||
Derivatives designated as fair value hedges |
32 | 45 | 48 | 119 | ||||||||||||
Derivatives designated as cash flow hedges |
393 | 1,234 | 233 | 250 | ||||||||||||
Derivatives designated as Net foreign investment hedges |
57 | 104 | 57 | 123 | ||||||||||||
5,563 | 7,916 | 7,053 | 8,771 | |||||||||||||
Derivatives for account of policyholders |
||||||||||||||||
Derivatives not designated in a hedge |
349 | 402 | 76 | 107 | ||||||||||||
349 | 402 | 76 | 107 | |||||||||||||
Total derivatives 1) |
5,912 | 8,318 | 7,130 | 8,878 |
1 | Refer to note 47 Fair value for a summary of all financial assets and financial liabilities at fair value through profit or loss. |
The fair value of derivatives on both the asset and liability side of the consolidated statement of financial position decreased during 2017 mainly due to changes in interest rates and other market movements during the year, as well as purchases, disposals and maturities. The divestment of the payout annuity business and Bank Owned Life Insurance / Corporate Owned Life Insurance (BOLI/ COLI) business in the Americas contributed to the decrease of derivative assets with EUR 259 million compared to December 31, 2016. See note 47 Fair value for details on fair value measurement of derivatives.
Of the derivatives EUR 495 million (2016: EUR 1,030 million) and EUR 949 million (2016: EUR 2,537 million) are current derivative assets and liabilities respectively.
Aegon the Netherlands partially hedges the risk of future longevity increases in the Netherlands related to a part of its insurance liabilities. These longevity derivatives are constructed to pay out if the mortality rates in future years have decreased more than a pre-determined percentage compared with the base scenario at the moment of signing the contract.
The above mentioned transactions are used to enhance Aegons risk-return profile and to improve capital efficiency.
The derivatives are measured at fair value through profit or loss in accordance with IAS 39. The value of the longevity derivatives are calculated using an internal model as there is no active market for this type of derivatives. For more details refer to the paragraph on underwriting risk included in note 36 Insurance contracts and the paragraph on derivatives included in note 47 Fair value.
Use of derivatives
Derivatives not designated in a hedge - general account
Derivative asset |
Derivative liability | |||||||||||||||
Derivatives not designated in a hedge general account | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Derivatives held as an economic hedge |
4,933 | 6,398 | 4,774 | 6,122 | ||||||||||||
Bifurcated embedded derivatives |
13 | 12 | 1,937 | 2,192 | ||||||||||||
Other |
134 | 124 | 5 | (35 | ) | |||||||||||
Total |
5,081 | 6,533 | 6,716 | 8,280 |
Aegon utilizes derivative instruments as a part of its asset liability risk management practices. The derivatives held for risk management purposes are classified as economic hedges to the extent that they do not qualify for hedge accounting, or that Aegon has elected not to apply hedge accounting. The economic hedges of certain exposures relate to an existing asset, liability or future reinvestment risk. In all cases, these are in accordance with internal risk guidelines and are closely monitored for continuing compliance.
Bifurcated embedded derivatives that are not closely related to the host contracts have been bifurcated and recorded at fair value in the consolidated statement of financial position. These bifurcated embedded derivatives are embedded in various institutional products, modified coinsurance and unit-linked insurance contracts in the form of guarantees for minimum benefits. Please refer to note 38 Guarantees in insurance contracts for more disclosures about these guarantees.
Annual Report on Form 20-F 2017 |
231 | Notes to the consolidated financial statements Note 25 | |
CDSs
Aegon has entered into free-standing credit derivative transactions. The positions outstanding at the end of the year were:
2017 | 2016 | |||||||||||||||
Notional | Fair value | Notional | Fair value | |||||||||||||
CDSs |
3,606 | 92 | 4,466 | 51 | ||||||||||||
2017 | 2016 | |||||||||||||||
Credit derivative disclosure by quality | Notional | Fair value | Notional | Fair value | ||||||||||||
AAA |
4 | - | 1 | - | ||||||||||||
AA |
83 | 2 | 483 | 2 | ||||||||||||
A |
750 | 15 | 763 | 7 | ||||||||||||
BBB |
2,392 | 68 | 2,849 | 41 | ||||||||||||
BB |
357 | 8 | 243 | - | ||||||||||||
B or lower |
21 | - | 128 | 3 | ||||||||||||
Total |
3,606 | 92 | 4,466 | 51 |
Certain derivatives are used to add risk by selling protection in the form of single name and index based credit default swaps. Another strategy used is to synthetically replicate corporate and government credit exposures with credit derivatives. This involves the purchase of high quality, low risk assets and the sale of credit derivatives. The table above provides a breakdown to credit quality of these credit derivatives.
Derivatives designated as fair value hedges
Aegons fair value hedges consist mainly of interest rate swaps, swaptions, equity and fixed income total return swaps, equity options, equity futures, bond futures and variance swaps that are used to protect against changes in the fair value of interest rate and equity sensitive instruments or liabilities. Gains and losses on derivatives designated under fair value hedge accounting are recognized in the income statement. The effective portion of the fair value change on the hedged item is also recognized in the income statement. As a result, only the net accounting ineffectiveness has an impact on the net result.
Aegon has entered into interest rate swap agreements that effectively convert certain fixed-rate assets and liabilities to a floating-rate basis (generally to six months or less LIBOR). These hedges are used for portfolio management to better match assets to liabilities or to protect the value of the hedged item from interest rate movements. These agreements involve the payment or receipt of fixed-rate interest amounts in exchange for floating-rate interest amounts over the life of the agreement without the exchange of the underlying principal amounts. Some of the arrangements use forward starting swaps to better match the duration of assets and liabilities.
Aegon has entered into cross-currency interest rate swap agreements that effectively convert certain foreign currency fixed-rate and floating-rate assets and liabilities to US dollar floating-rate assets and liabilities. These agreements involve the exchange of the underlying principal amounts.
For the years ended December 31, 2017, 2016, and 2015, Aegon recognized gains and (losses) related to the ineffectiveness portion of designated fair value hedges of EUR (6) million, EUR 26 million and EUR (17) million respectively. No portion of derivatives was excluded when assessing hedge effectiveness.
Annual Report on Form 20-F 2017 |
232 | Notes to the consolidated financial statements Note 25 | |
Derivatives designated as cash flow hedges
Aegon has entered primarily into interest rate swap agreements that effectively convert certain variable-rate assets and liabilities to a fixed-rate basis in order to match the cash flows of the assets and liabilities within Aegons portfolio more closely. These agreements involve the payment or receipt of variable-rate interest amounts in exchange for fixed-rate interest amounts over the life of the agreement without the exchange of the underlying principal amounts. Aegon hedges its exposure to the variability of future cash flows from the interest rate movements for terms up to 28 years for hedges converting existing floating-rate assets and liabilities to fixed-rate assets.
Aegon uses forward starting interest rate swap agreements to hedge the variability in future cash flows associated with the forecasted purchase of fixed-income assets. These agreements reduce the impact of future interest rate changes on the forecasted transaction. Fair value adjustments for these interest rate swaps are deferred and recorded in equity until the occurrence of the forecasted transaction at which time the interest rate swaps will be terminated. The accumulated gain or loss in equity will be amortized into investment income as the acquired asset affects income. Aegon hedges its exposure to the variability of future cash flows from interest rate movements for terms up to 26 years. The cash flows from these hedging instruments are expected to affect the profit and loss for approximately the next 35 years. For the year ended December 31, 2017, the contracts for which cash flow hedge accounting was terminated resulted in deferred gains of EUR 598 million (2016: EUR 407 million) that are recognized directly in equity to be reclassified into net income during the period when the cash flows occur of the underlying hedged items. During the year ended December 31, 2017, EUR 248 million of Aegons cash flow hedges were discontinued, due to the divestment of the payout annuity and BOLI/COLI businesses. Refer to note 51 Business combinations for more details regarding this divestment. Outside of this transaction no other of Aegons cash flow hedges were discontinued as it was highly probable that the original forecasted transactions would occur by the end of the originally specified time period documented at the inception of the hedging relationship. Aegon projects investment needs many years into the future in order to support the insurance liabilities and pay all contractual obligations arising from the policies in force today.
In addition, Aegon also makes use of cross currency swaps to convert variable or fixed foreign currency cash flows into fixed cash flows in local currencies. The cash flows from these hedging instruments are expected to occur over the next 19 years. These agreements involve the exchange of the underlying principal amounts.
For the year ended December 31, 2017, Aegon recognized EUR 0 million of hedge ineffectiveness on cash flow hedges (2016: EUR 5 million gain; 2015: EUR 4 million gain). In 2017, EUR 113 million loss was reclassified from equity into investment income (2016: EUR 37 million loss, 2015: EUR 13 million loss). The amount of deferred gains or losses to be reclassified from equity into net income during the next 12 months is expected to be EUR 63 million gain.
The periods when the cash flows are expected to occur are as follows:
< 1 year | 1 5 years | 5 10 years | > 10 years | 2017 Total | ||||||||||||||||
Cash inflows |
78 | 315 | 312 | 5,648 | 6,352 | |||||||||||||||
Cash outflows |
- | 1 | 4 | - | 5 | |||||||||||||||
Net cash flows |
78 | 314 | 309 | 5,648 | 6,348 | |||||||||||||||
< 1 year | 1 5 years | 5 10 years | > 10 years | 2016 Total | ||||||||||||||||
Cash inflows |
319 | 1,326 | 888 | 8,338 | 10,870 | |||||||||||||||
Cash outflows |
- | 1 | 4 | - | 5 | |||||||||||||||
Net cash flows |
318 | 1,325 | 883 | 8,338 | 10,864 |
Net foreign investment hedges
Aegon funds its investments in insurance subsidiaries with a mixture of debt and equity. Aegon aims to denominate debt funding in the same currency as the functional currency of the investment. Investments outside the eurozone, the United States and the United Kingdom are funded in euros. When the debt funding of investments is not in the functional currency of the investment, Aegon uses derivatives to swap the currency exposure of the debt instrument to the appropriate functional currency. This policy will ensure that total capital will reflect currency movements without distorting debt to shareholders equity ratios. Aegon utilizes various financial instruments as designated hedging instruments of its foreign investments. These instruments include long-term and short-term borrowings, short-term debts to credit institutions, cross currency swap contracts and forward foreign exchange contracts.
Annual Report on Form 20-F 2017 |
233 | Notes to the consolidated financial statements Note 26 | |
26 Investments in joint ventures
2017 | 2016 | |||||||
At January 1 |
1,614 | 1,561 | ||||||
Additions |
81 | 92 | ||||||
Share in net income |
161 | 137 | ||||||
Share in changes in joint ventures equity (note 32.6) |
(15 | ) | 9 | |||||
Dividend |
(118 | ) | (196 | ) | ||||
Net exchange difference |
(17 | ) | (4 | ) | ||||
Other |
7 | 15 | ||||||
At December 31 |
1,712 | 1,614 |
All joint ventures are unlisted and are accounted for using the equity method and are considered to be non-current. The investments in joint ventures include interest in insurance companies that are required to maintain a minimum solvency margin based on local directives. Such restrictions can affect the ability of these joint ventures to transfer funds in the form of cash dividends, or repayment of loans or advances, and therefore, there can be no assurance that these restrictions will not become a limitation in the future. Refer to note 48 Commitments and contingencies for any commitments and contingencies related to investments in joint ventures. There are no unrecognized shares of losses in joint ventures. The financial statements of the principal joint ventures have the same reporting date as the Group. Refer to note 52 Group companies for a listing of the investments in joint ventures and the Groups percentage holding.
Summarized financial information of joint ventures
The summarized financial information presented in the following table presents the joint ventures on a 100% basis. Aegon considers its investment in AMVEST Vastgoed B.V. (AMVEST) a material joint venture and is therefore presented separately.
AMVEST |
Other Joint ventures | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Summarized statement of financial position |
||||||||||||||||
Cash and cash equivalents |
109 | 135 | 342 | 373 | ||||||||||||
Other current assets |
166 | 237 | 721 | 737 | ||||||||||||
Total current assets |
276 | 372 | 1,063 | 1,110 | ||||||||||||
Non-current assets
|
|
3,173
|
|
|
2,519
|
|
|
6,521
|
|
|
6,375
|
|
||||
Total assets |
3,449 | 2,891 | 7,584 | 7,485 | ||||||||||||
Current financial liabilities excluding trade payables and other provisions |
- | - | 30 | 60 | ||||||||||||
Other current liabilities |
133 | 149 | 503 | 403 | ||||||||||||
Total current liabilities |
133 | 149 | 533 | 464 | ||||||||||||
Non-current financial liabilities excluding trade payables and other provisions |
643 | 476 | 220 | 292 | ||||||||||||
Other non-current liabilities |
- | - | 5,871 | 5,721 | ||||||||||||
Total non-current financial liabilities |
643 | 476 | 6,091 | 6,013 | ||||||||||||
Total liabilities |
776 | 625 | 6,624 | 6,477 | ||||||||||||
Net assets |
2,673 | 2,266 | 960 | 1,009 | ||||||||||||
Summarized statement of comprehensive income |
||||||||||||||||
Revenue |
91 | 86 | 1,420 | 1,248 | ||||||||||||
Results from financial transactions |
275 | 205 | (1 | ) | 1 | |||||||||||
Depreciation and amortization |
- | - | (20 | ) | (12 | ) | ||||||||||
Interest income |
- | - | 186 | 48 | ||||||||||||
Interest expense |
(5 | ) | (7 | ) | (3 | ) | (3 | ) | ||||||||
Profit or loss |
357 | 275 | 160 | 122 | ||||||||||||
Income tax (expense) or income |
(1 | ) | (10 | ) | (74 | ) | (47 | ) | ||||||||
Post-tax profit or (loss) |
357 | 266 | 86 | 75 | ||||||||||||
Other comprehensive income |
- | 7 | (32 | ) | 13 | |||||||||||
Total comprehensive income |
357 | 273 | 54 | 89 | ||||||||||||
Dividends received |
49 | 95 | 69 | 101 |
Annual Report on Form 20-F 2017 |
234 | Notes to the consolidated financial statements Note 27 | |
An overview of the summarized financial information of the carrying amount of the joint ventures is as follows:
AMVEST |
Other Joint ventures | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net assets of joint venture as presented above |
2,673 | 2,266 | 960 | 1,009 | ||||||||||||
Net assets of joint venture excluding goodwill |
2,673 | 2,266 | 587 | 626 | ||||||||||||
Group share of net assets of joint venture, excluding goodwill |
1,008 | 877 | 312 | 338 | ||||||||||||
Goodwill on acquisition |
- | - | 373 | 383 | ||||||||||||
Carrying amount |
1,008 | 877 | 685 | 721 |
The difference in the carrying value of investments in joint ventures of EUR 1,712 million (2016: EUR 1,614 million) and the total of the carrying value of joint ventures presented above of EUR 1,693 million (2016: EUR 1,598 million) relates to joint ventures with a negative carrying value of EUR 18 million (2016: EUR 16 million) which have been reclassified to Provisions.
Aegons group share of net assets of joint ventures, as presented in the table above, is less than Aegons share of the net assets as presented in the summarized financial information on a 100% basis, due to the inclusion of third parties in the joint ventures.
The following table includes the summarized financial information of the joint ventures based on the Groups relative holding.
AMVEST |
Other Joint ventures | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Post-tax profit or loss |
126 | 106 | 35 | 28 | ||||||||||||
Other comprehensive income |
- | 2 | (14 | ) | 7 | |||||||||||
Total comprehensive income |
126 | 108 | 20 | 34 |
2017 | 2016 | |||||||
At January 1 |
270 | 242 | ||||||
Additions |
73 | 20 | ||||||
Disposals |
(15 | ) | (4 | ) | ||||
Share in net income |
11 | 3 | ||||||
Share in changes in associates equity (note 32.6) |
(5 | ) | 3 | |||||
Impairment losses |
(1 | ) | - | |||||
Dividend |
(11 | ) | (7 | ) | ||||
Net exchange difference |
(13 | ) | 13 | |||||
At December 31 |
308 | 270 |
All associates are unlisted and are accounted for using the equity method and are considered to be non-current. The investments in associates include interest in insurance companies that are required to maintain a minimum solvency margin based on local directives. Such restrictions can affect the ability of these associates to transfer funds in the form of cash dividends, or repayment of loans or advances, and therefore, there can be no assurance that these restrictions will not become a limitation in the future. There are no unrecognized shares of losses in associates. The financial statements of the principal associates have the same reporting date as the Group. Refer to note 52 Group companies for a listing of the investments in associates and the Groups percentage holding.
Summarized financial information of associates
2017 | 2016 | |||||||
Post-tax profit or loss |
9 | 3 | ||||||
Other comprehensive income |
(5 | ) | 3 | |||||
Total comprehensive income |
3 | 7 | ||||||
Carrying amount |
308 | 270 |
The summarized financial information of associates presented above is based on the Groups relative holding.
Annual Report on Form 20-F 2017 |
235 | Notes to the consolidated financial statements Note 28 | |
Assets arising from reinsurance contracts related to: | 2017 | 2016 | ||||||
Life insurance general account |
17,419 | 9,714 | ||||||
Life insurance for account of policyholders |
2 | 2 | ||||||
Non-life insurance |
1,327 | 1,481 | ||||||
Investment contracts |
453 | 11 | ||||||
At December 31 |
19,202 | 11,208 |
Amounts due from reinsurers in respect of claims already paid by the Group are included in note 30 Other assets and receivables.
Of the reinsurance assets EUR 13 million is current (2016: EUR 15 million).
Movements during the year in reinsurance assets relating to
life insurance: |
Life insurance
general account |
Life insurance for
account of policyholders |
Total life insurance | |||||||||
At January 1, 2017 |
9,714 | 2 | 9,716 | |||||||||
Gross premium and deposits existing and new business |
11,326 | 6 | 11,332 | |||||||||
Unwind of discount / interest credited |
533 | - | 533 | |||||||||
Insurance liabilities released |
(2,877 | ) | (3 | ) | (2,880 | ) | ||||||
Fund charges released |
(49 | ) | - | (49 | ) | |||||||
Changes to valuation of expected future benefits |
823 | - | 823 | |||||||||
Policy transfers |
(38 | ) | - | (38 | ) | |||||||
Net exchange differences |
(1,698 | ) | - | (1,697 | ) | |||||||
Transfers to disposal groups |
(239 | ) | (3 | ) | (242 | ) | ||||||
Transfer to/from insurance contract |
23 | - | 23 | |||||||||
Other movements |
(97 | ) | - | (97 | ) | |||||||
At December 31, 2017 |
17,419 | 2 | 17,421 | |||||||||
At January 1, 2016 |
9,677 | 64 | 9,741 | |||||||||
Gross premium and deposits existing and new business |
13,108 | 897 | 14,005 | |||||||||
Unwind of discount / interest credited |
783 | 23 | 806 | |||||||||
Insurance liabilities released |
(5,965 | ) | 15 | (5,950 | ) | |||||||
Fund charges released |
(11 | ) | - | (11 | ) | |||||||
Changes to valuation of expected future benefits |
38 | - | 38 | |||||||||
Policy transfers |
(14 | ) | - | (14 | ) | |||||||
Net exchange differences |
183 | (6 | ) | 177 | ||||||||
Transfers to disposal groups |
(8,085 | ) | (991 | ) | (9,076 | ) | ||||||
At December 31, 2016 |
9,714 | 2 | 9,716 |
Annual Report on Form 20-F 2017 |
236 | Notes to the consolidated financial statements Note 29 | |
Movements during the year in reinsurance assets relating to non-life insurance: | 2017 | 2016 | ||||||
At January 1 |
1,481 | 1,503 | ||||||
Gross premium and deposits existing and new business |
99 | 111 | ||||||
Unwind of discount / interest credited |
89 | 89 | ||||||
Insurance liabilities released |
(129 | ) | (148 | ) | ||||
Changes to valuation of expected future benefits |
28 | (57 | ) | |||||
Changes in unearned premiums |
(42 | ) | (37 | ) | ||||
Incurred related to current year |
85 | 66 | ||||||
Incurred related to prior years |
37 | 30 | ||||||
Release for claims settled current year |
(19 | ) | (12 | ) | ||||
Release for claims settled prior years |
(119 | ) | (117 | ) | ||||
Change in IBNR |
(8 | ) | (2 | ) | ||||
Shadow accounting adjustment |
6 | 19 | ||||||
Net exchange differences |
(180 | ) | 41 | |||||
Portfolio transfers and acquisitions |
2 | - | ||||||
Other movements |
(4 | ) | (5 | ) | ||||
At December 31 |
1,327 | 1,481 | ||||||
Assets arising from reinsurance contracts related to: | 2017 | 2016 | ||||||
Normal course of business |
6,648 | 7,609 | ||||||
Exit of a business |
12,553 | 3,599 | ||||||
At December 31 |
19,202 | 11,208 |
Reinsurance assets increased by EUR 8.0 billion compared to December 31, 2016 mainly due to the divestment of the payout annuity, BOLI/COLI businesses and a block of life reinsurance business in the US. For more details on the divestment of these businesses refer to note 51 Business combinations.
The assets arising from reinsurance contracts related to the exit of a business per December 31, 2017 and 2016 relate, next to the above mentioned divestments, also to the sale of Aegons life reinsurance business from Transamerica Reinsurance (TARe) to SCOR, completed on August 9, 2011. The divestment of TARe consists of a series of reinsurance agreements between various statutory insurance entities and SCOR for the US domestic business.
2017 | 2016 | |||||||
DPAC for insurance contracts and investment contracts with discretionary participation features |
9,688 | 10,882 | ||||||
Deferred cost of reinsurance |
41 | 60 | ||||||
Deferred transaction costs for investment management services |
406 | 481 | ||||||
At December 31 |
10,135 | 11,423 | ||||||
Current |
838 | 1,080 | ||||||
Non-current |
9,297 | 10,343 |
The divestment of the payout annuity and BOLI/COLI business in the Americas resulted in a write off of deferred policy acquisition costs of EUR 205 million. In addition, deferred policy acquisition costs are predominantly impacted by unfavorable currency translation adjustments.
Annual Report on Form 20-F 2017 |
237 | Notes to the consolidated financial statements Note 30 | |
DPAC |
Deferred costs of
reinsurance |
Deferred
transaction costs |
||||||||||
At January 1, 2017 |
10,882 | 60 | 481 | |||||||||
Costs deferred during the year |
938 | - | 41 | |||||||||
Amortization through income statement |
(770 | ) | (13 | ) | (29 | ) | ||||||
Shadow accounting adjustments |
(216 | ) | - | - | ||||||||
Impairments |
- | - | (36 | ) | ||||||||
Net exchange differences |
(1,227 | ) | (7 | ) | (52 | ) | ||||||
Transfers to disposal groups |
(6 | ) | - | - | ||||||||
Other |
88 | - | - | |||||||||
At December 31, 2017 |
9,688 | 41 | 406 | |||||||||
DPAC |
Deferred costs of
reinsurance |
Deferred
transaction costs |
||||||||||
At January 1, 2016 |
10,457 | 72 | 467 | |||||||||
Costs deferred during the year |
1,157 | - | 46 | |||||||||
Disposal of group assets |
(9 | ) | - | - | ||||||||
Amortization through income statement |
(837 | ) | (14 | ) | (28 | ) | ||||||
Shadow accounting adjustments |
38 | - | - | |||||||||
Impairments |
(31 | ) | - | - | ||||||||
Net exchange differences |
119 | 1 | (3 | ) | ||||||||
Other |
(12 | ) | - | - | ||||||||
At December 31, 2016 |
10,882 | 60 | 481 |
In the following table a breakdown is provided of DPAC balances by line of business and reporting segment:
Annual Report on Form 20-F 2017 |
238 | Notes to the consolidated financial statements Note 30 | |
30.1 Real estate held for own use and equipment
Net book value |
General account real
estate held for own use |
Equipment | Total | |||||||||
At January 1, 2016 |
338 | 237 | 575 | |||||||||
At December 31, 2016 |
332 | 241 | 572 | |||||||||
At December 31, 2017 |
307 | 223 | 530 | |||||||||
Cost |
||||||||||||
At January 1, 2017 |
453 | 593 | 1,046 | |||||||||
Additions |
3 | 68 | 71 | |||||||||
Acquired through business combinations |
- | 11 | 11 | |||||||||
Capitalized subsequent expenditure |
1 | - | 1 | |||||||||
Disposals |
(34 | ) | (144 | ) | (179 | ) | ||||||
Unrealized gains/(losses) through equity |
8 | - | 8 | |||||||||
Transfer to investments in real estate |
- | - | - | |||||||||
Transfers to disposal groups |
- | (5 | ) | (5 | ) | |||||||
Net exchange differences |
(34 | ) | (40 | ) | (74 | ) | ||||||
Other |
- | 7 | 7 | |||||||||
At December 31, 2017 |
396 | 488 | 885 | |||||||||
Accumulated depreciation and impairment losses |
||||||||||||
At January 1, 2017 |
121 | 352 | 474 | |||||||||
Depreciation through income statement |
8 | 63 | 71 | |||||||||
Disposals |
(28 | ) | (131 | ) | (159 | ) | ||||||
Impairment losses |
- | - | - | |||||||||
Impairment losses reversed |
(1 | ) | - | (1 | ) | |||||||
Transfers to disposal groups |
- | (5 | ) | (5 | ) | |||||||
Net exchange differences |
(10 | ) | (20 | ) | (30 | ) | ||||||
Other |
- | 6 | 6 | |||||||||
At December 31, 2017 |
90 | 265 | 355 | |||||||||
Cost |
||||||||||||
At January 1, 2016 |
442 | 544 | 986 | |||||||||
Additions |
8 | 58 | 67 | |||||||||
Acquired through business combinations |
- | - | - | |||||||||
Capitalized subsequent expenditure |
2 | - | 2 | |||||||||
Disposals |
(1 | ) | (11 | ) | (12 | ) | ||||||
Unrealized gains/(losses) through equity |
8 | - | 8 | |||||||||
Transfer to investments in real estate |
(15 | ) | - | (15 | ) | |||||||
Transfers to disposal groups |
- | - | - | |||||||||
Net exchange differences |
8 | 2 | 10 | |||||||||
Other |
- | - | - | |||||||||
At December 31, 2016 |
453 | 593 | 1,046 | |||||||||
Accumulated depreciation and impairment losses |
||||||||||||
At January 1, 2016 |
104 | 307 | 411 | |||||||||
Depreciation through income statement |
9 | 54 | 63 | |||||||||
Disposals |
- | (9 | ) | (9 | ) | |||||||
Impairment losses |
7 | - | 7 | |||||||||
Impairment losses reversed |
- | - | - | |||||||||
Transfers to disposal groups |
- | - | - | |||||||||
Net exchange differences |
2 | - | 2 | |||||||||
Other |
- | - | - | |||||||||
At December 31, 2016 |
121 | 352 | 474 |
General account real estate held for own use are mainly held by Aegon USA and Aegon the Netherlands, with relatively smaller holdings at Aegon Hungary and Aegon Spain. The carrying value under a historical cost model amounted to EUR 319 million (2016: EUR 350 million).
Annual Report on Form 20-F 2017 |
239 | Notes to the consolidated financial statements Note 30 | |
30% of the value of the general account real estate held for own use was last revalued in 2017 (2016: 35%), based on market value appraisals by qualified internal and external appraisers. 95% of the appraisals in 2017 were performed by independent external appraisers (2016: 97%).
General account real estate held for own use has not been pledged as security for liabilities, nor are there any restrictions on title. Depreciation expenses are recorded in Commissions and expenses in the income statement. The useful lives of buildings range between 40 and 50 years.
None of the equipment is held for lease (2016: none). Equipment has not been pledged as security for liabilities, nor are there any restrictions on title. Depreciation expenses have been recorded in Commissions and expenses in the income statement. Equipment is generally depreciated over a period of three to five years.
30.2 Receivables
2017 | 2016 1) | |||||||
Loans to associates |
12 | 2 | ||||||
Loans to joint ventures |
13 | 7 | ||||||
Receivables from policyholders |
999 | 1,187 | ||||||
Receivables from brokers and agents |
400 | 459 | ||||||
Receivables from reinsurers |
2,708 | 1,979 | ||||||
Cash outstanding from assets sold |
46 | 67 | ||||||
Trade receivables |
910 | 1,434 | ||||||
Cash collateral |
1,545 | 1,457 | ||||||
Reverse repurchase agreements |
230 | 77 | ||||||
Income tax receivable |
85 | 477 | ||||||
Other |
1,190 | 1,463 | ||||||
Provision for doubtful debts |
(48 | ) | (79 | ) | ||||
At December 31 |
8,091 | 8,530 | ||||||
Current |
8,061 | 8,487 | ||||||
Non-current |
30 | 44 |
1 | Certain amounts within Receivables in 2016 have been reclassified to conform to the current year presentation as certain accounts were previously not mapped correctly to the line items disclosed in this note. These reclassifications are not considered material as these reclassifications had no effect on net income, shareholders equity and earnings per share, nor on the total of receivables of EUR 8,530 reported in 2016. The reclassifications have been made to the line items Receivables from policyholders, Receivables from brokers and agents, Receivables from reinsurers, Cash outstanding from assets sold, Trade receivables, Cash collateral and Other. |
The movements in the provision for doubtful debts during the year were as follows:
2017 | 2016 | |||||||
At January 1 |
(79 | ) | (107 | ) | ||||
Additions charged to earnings |
(6 | ) | (5 | ) | ||||
Unused amounts reversed through the income statement |
4 | 7 | ||||||
Used during the year |
31 | 26 | ||||||
Net exchange differences |
2 | - | ||||||
At December 31 |
(48 | ) | (79 | ) | ||||
30.3 Accrued income | ||||||||
2017 | 2016 | |||||||
Accrued interest |
1,357 | 1,543 | ||||||
Other |
25 | 22 | ||||||
At December 31 |
1,382 | 1,565 |
Of accrued income EUR 1,364 million is current (2016: EUR 1,547 million).
Annual Report on Form 20-F 2017 |
240 | Notes to the consolidated financial statements Note 31 | |
Net book value | Goodwill | VOBA |
Future
servicing rights |
Software | Other | Total | ||||||||||||||||||
At January 1, 2016 |
299 | 1,472 | 57 | 61 | 12 | 1,901 | ||||||||||||||||||
At December 31, 2016
|
|
294
|
|
|
1,399
|
|
|
64
|
|
|
50
|
|
|
12
|
|
|
1,820
|
|
||||||
At December 31, 2017 |
293 | 1,153 | 99 | 51 | 36 | 1,633 | ||||||||||||||||||
Cost |
||||||||||||||||||||||||
At January 1, 2017 |
503 | 7,576 | 327 | 362 | 109 | 8,876 | ||||||||||||||||||
Additions |
- | 6 | - | 29 | 2 | 37 | ||||||||||||||||||
Acquisitions through business combinations |
56 | - | 47 | 9 | 29 | 140 | ||||||||||||||||||
Capitalized subsequent expenditure |
- | - | - | 3 | - | 3 | ||||||||||||||||||
Disposals |
(55 | ) | (175 | ) | - | (98 | ) | - | (328 | ) | ||||||||||||||
Net exchange differences |
(42 | ) | (841 | ) | (15 | ) | (9 | ) | (11 | ) | (919 | ) | ||||||||||||
Transfers to disposal groups |
- | - | - | (2 | ) | - | (2 | ) | ||||||||||||||||
At December 31, 2017 |
462 | 6,565 | 359 | 294 | 128 | 7,808 | ||||||||||||||||||
Accumulated amortization, depreciation and impairment losses | ||||||||||||||||||||||||
At January 1, 2017 |
209 | 6,177 | 263 | 311 | 97 | 7,056 | ||||||||||||||||||
Amortization through income statement |
- | 63 | 7 | 28 | 6 | 104 | ||||||||||||||||||
Shadow accounting adjustments |
- | 26 | - | - | - | 26 | ||||||||||||||||||
Disposals |
(28 | ) | (165 | ) | - | (95 | ) | - | (288 | ) | ||||||||||||||
Impairment losses |
- | - | - | 8 | - | 8 | ||||||||||||||||||
Net exchange differences |
(11 | ) | (689 | ) | (9 | ) | (8 | ) | (11 | ) | (728 | ) | ||||||||||||
Transfers to disposal groups |
- | - | - | (2 | ) | - | (2 | ) | ||||||||||||||||
At December 31, 2017 |
169 | 5,412 | 260 | 243 | 92 | 6,176 | ||||||||||||||||||
Cost |
||||||||||||||||||||||||
At January 1, 2016 |
507 | 7,462 | 314 | 381 | 105 | 8,769 | ||||||||||||||||||
Additions |
- | 2 | - | 16 | 3 | 21 | ||||||||||||||||||
Acquisitions through business combinations |
(8 | ) | - | 12 | - | - | 4 | |||||||||||||||||
Capitalized subsequent expenditure |
- | - | - | 3 | - | 3 | ||||||||||||||||||
Disposals |
- | - | - | (3 | ) | - | (3 | ) | ||||||||||||||||
Net exchange differences |
4 | 112 | 1 | (35 | ) | 1 | 83 | |||||||||||||||||
At December 31, 2016 |
503 | 7,576 | 327 | 362 | 109 | 8,876 | ||||||||||||||||||
Accumulated amortization, depreciation and impairment losses | ||||||||||||||||||||||||
At January 1, 2016 |
208 | 5,990 | 257 | 320 | 93 | 6,868 | ||||||||||||||||||
Amortization through income statement |
- | 178 | 6 | 25 | 2 | 211 | ||||||||||||||||||
Shadow accounting adjustments |
- | (89 | ) | - | - | - | (89 | ) | ||||||||||||||||
Disposals |
- | - | - | (3 | ) | - | (3 | ) | ||||||||||||||||
Net exchange differences |
- | 98 | (1 | ) | (30 | ) | 2 | 69 | ||||||||||||||||
At December 31, 2016 |
209 | 6,177 | 263 | 311 | 97 | 7,056 |
Amortization and depreciation through income statement is included in Commissions and expenses. None of the intangible assets have titles that are restricted or have been pledged as security for liabilities.
With the exception of goodwill, all intangible assets have a finite useful life and are amortized accordingly. VOBA and future servicing rights are amortized over the term of the related insurance contracts, which can vary significantly depending on the maturity of the acquired portfolio. VOBA currently recognized is amortized over an average period of 24 years, with an average remaining amortization period of 7 years (2016: 8 years). Future servicing rights are amortized over an average period up to 30 years, of which 14 years remain at December 31, 2017 (2016: 9 years). Software is generally depreciated over an average period of 5 years. At December 31, 2017, the remaining average amortization period was 4 years (2016: 3 years).
Annual Report on Form 20-F 2017 |
241 | Notes to the consolidated financial statements Note 31 | |
Goodwill increased by EUR 56 million and customer intangibles by EUR 29 million (included in the line Other) following the acquisition of Cofunds Ltd. in January 2017.
Future servicing rights increased by EUR 36 million following the acquisition of the Nordea second-pillar pension fund in August 2017.
The line disposals reflects the divestment of the payout annuity and BOLI/COLI business in the Americas and Unirobe Meeùs Groep in the Netherlands impacting goodwill by EUR 27 million, VOBA by EUR 11 million and software by EUR 3 million.
Refer to note 51 Business combinations on the acquisitions of Cofunds Ltd and Nordea second-pillar pension fund. As well as the divestments of the payout annuity and BOLI/COLI business, and Unirobe Meeùs Groep.
Goodwill
The goodwill balance has been allocated across the cash-generating units which are expected to benefit from the synergies inherent in the goodwill. Goodwill is tested for impairment both annually and when there are specific indicators of a potential impairment. The recoverable amount is the higher of the value in use and fair value less costs of disposal for a cash-generating unit. The operating assumptions used in all the calculations are best estimate assumptions and based on historical data where available.
The economic assumptions used in all the calculations are based on observable market data and projections of future trends. All the cash-generating units tested showed that the recoverable amounts were higher than their carrying values, including goodwill. A reasonably possible change in any key assumption is not expected to cause the carrying value of the cash-generating units to exceed its recoverable amount.
A geographical summary of the cash-generating units to which the goodwill is allocated is as follows:
Goodwill | 2017 | 2016 | ||||||
Americas |
174 | 198 | ||||||
Central & Eastern Europe |
34 | 36 | ||||||
Asset Management |
31 | 36 | ||||||
United Kingdom |
54 | - | ||||||
The Netherlands |
- | 25 | ||||||
At December 31 |
293 | 294 |
Goodwill in Aegon USA is allocated to groups of cash-generating units including variable annuities, fixed annuities and the retirement plans cash-generating unit. Value in use calculations of Aegon USA have been actuarially determined based on business plans covering a period of typically three years and pre-tax risk adjusted discount rates. The value in use tests in the USA for the group of annuities cash-generating units remain unchanged from prior year except for the impact of currency translation adjustments (2017: EUR 121 million: 2016: EUR 131 million) and the retirement plans cash-generating unit (2017: EUR 52 million: 2016: EUR 57 million). The tests assume business plans covering a period of three years further extrapolated to ten years, where the new business levels for years 4-10 assumed a 0% growth rate (2016: 0%). The pre-tax adjusted discount rate was 17% for annuities and 18% for retirement plans as determined at date of acquisition.
To determine the recoverable amounts of the cash generating units of Aegon Central & Eastern Europe (CEE), value in use was calculated, and compared to the carrying amounts. Value in use has been determined based on a business plan covering a period of typically 3 years, that, in certain instances was further extrapolated to 20 years where the new business levels for years 4-20 assumed a growth rate based on the business plan of the third year, prudentially decreased by 20% (2016: 20%). Other key assumptions used for the calculation were pre-tax risk adjusted discount rate of 8.3%-14.6% (2016: 7.4%-15.9%), new business contribution, renewals, asset fees, investment return, persistency and expenses. Operating assumptions are best estimate assumptions and based on historical data where available. Economic assumptions are based on observable market data and projections of future trends.
For Aegon UK, goodwill was allocated to one cash-generating unit Cofunds Ltd., whose value in use EUR 263 million exceeded its carrying value. This was determined using a management approved business plan spanning 3 years and terminal growth rate prudentially assumed at 3%. Other key assumptions were post-tax discount rate of 10.8% and pre-tax discount rate of 11.8% used to adjust cash flows forecast.
Annual Report on Form 20-F 2017 |
242 | Notes to the consolidated financial statements Note 32 | |
VOBA
The movement in VOBA over 2017 can be summarized and compared to 2016 as follows:
2017 | 2016 | |||||||
At January 1 |
1,399 | 1,472 | ||||||
Additions |
6 | 2 | ||||||
Disposals |
(11 | ) | - | |||||
Amortization / depreciation through income statement |
(63 | ) | (178 | ) | ||||
Shadow accounting adjustments |
(26 | ) | 89 | |||||
Net exchange differences |
(153 | ) | 14 | |||||
At December 31 |
1,153 | 1,399 |
A geographical summary of the lines of business to which the VOBA is allocated is as follows:
VOBA | Americas | The Netherlands | United Kingdom | Asia | Total | |||||||||||||||
2017 |
||||||||||||||||||||
Life |
883 | - | - | 1 | 884 | |||||||||||||||
Individual savings and retirement products |
144 | - | - | - | 144 | |||||||||||||||
Pensions |
7 | 17 | 98 | - | 122 | |||||||||||||||
Run-off businesses |
4 | - | - | - | 4 | |||||||||||||||
Total VOBA |
1,038 | 17 | 98 | 1 | 1,153 | |||||||||||||||
2016 |
||||||||||||||||||||
Life |
1,028 | - | - | 10 | 1,038 | |||||||||||||||
Individual savings and retirement products |
181 | - | - | - | 181 | |||||||||||||||
Pensions |
10 | 22 | 118 | - | 149 | |||||||||||||||
Distribution |
- | 8 | - | - | 8 | |||||||||||||||
Run-off businesses |
23 | - | - | - | 23 | |||||||||||||||
Total VOBA |
1,242 | 30 | 118 | 10 | 1,399 |
Issued share capital and reserves attributable to shareholders of Aegon N.V.
Note | 2017 | 2016 | 2015 | |||||||||||||
Share capital par value |
32.1 | 322 | 319 | 328 | ||||||||||||
Share premium |
32.2 | 7,731 | 7,873 | 8,059 | ||||||||||||
Total share capital |
8,053 | 8,193 | 8,387 | |||||||||||||
Retained earnings |
9,699 | 7,609 | 8,100 | |||||||||||||
Treasury shares |
32.3 | (325 | ) | (190 | ) | (269 | ) | |||||||||
Total retained earnings |
9,374 | 7,419 | 7,832 | |||||||||||||
Revaluation reserves |
32.4 | 4,920 | 5,381 | 6,471 | ||||||||||||
Remeasurement of defined benefit plans |
32.5 | (1,669 | ) | (1,820 | ) | (1,532 | ) | |||||||||
Other reserves |
32.6 | (390 | ) | 1,347 | 1,283 | |||||||||||
Total shareholders equity |
20,288 | 20,520 | 22,441 |
In May 2017, Aegon issued a total of 1,979,260 common shares B with a par value of EUR 0.12 to compensate for the dilution of Vereniging Aegons shareholding caused by the allocation of shares with senior management on May 19, 2017, in connection with the Long Term Incentive Plans for senior management.
In June 2017, Aegon distributed to its shareholders who elected stock dividend a total number of 26,916,371 common shares in respect to the final dividend for 2016. This stock dividend distribution was paid from treasury shares (note 32.3 Treasury shares).
In June 2017, Aegon issued to Vereniging Aegon 13,042,612 common shares B with a par value of EUR 0.12 to compensate for the dilution of Vereniging Aegons shareholding caused by the distribution of the final dividend 2016 in shares.
Annual Report on Form 20-F 2017 |
243 | Notes to the consolidated financial statements Note 32 | |
In September 2017, Aegon distributed to its shareholders 24,948,255 common shares as interim dividend 2017 in the form of stock. This stock dividend distribution was paid from treasury shares (note 32.3 Treasury shares) and with the issuance of 21,099,402 common shares with a par value of EUR 0.12
In December 2017, Aegon completed a share buyback program to neutralize the dilutive effect of the 2016 final dividend and 2017 interim dividend paid in shares, and repurchased a total of 51,864,626 common shares.
Furthermore, in December 2017, Aegon repurchased 13,042,592 common shares B from Vereniging Aegon to keep the voting rights of Vereniging Aegon on the agreed level.
In June 2016, Aegon distributed to its shareholders who elected stock dividend a total number of 29,258,662 common shares in respect to the final dividend for 2015. This stock dividend distribution was paid from treasury shares (note 32.3 Treasury shares) and with the issuance of 9,121,989 common shares with a par value of EUR 0.12.
In September 2016, Aegon distributed to its shareholders 30,765,224 common shares as interim dividend 2016 in the form of stock. This stock dividend distribution was paid from treasury shares (note 32.3 Treasury shares) and with the issuance of 1,506,562 common shares with a par value of EUR 0.12.
In 2016, following each distribution of stock dividend, Aegon completed a share buyback program to neutralize the dilutive effect of the 2015 final dividend and 2016 interim dividend paid in shares, and repurchased a total of 60,023,886 common shares.
Aegon also executed a EUR 400 million share buyback program in which 83,116,535 common shares were repurchased. These common shares have been repurchased as part of a program to neutralize the dilutive effect of the cancellation of the preferred shares in 2013. All 83,116,535 common shares repurchased under this program were cancelled in September 2016.
Furthermore, in June 2016, Aegon repurchased 17,324,960 common shares B from Vereniging Aegon to keep the voting rights of Vereniging Aegon on the agreed level.
In June 2015, Aegon distributed to its shareholders who elected stock dividend a total number of 16,279,933 common shares in respect to the final dividend for 2014. This stock dividend distribution was fully paid from treasury shares (note 32.3 Treasury shares).
In September 2015, Aegon distributed to its shareholders 20,136,673 common shares as interim dividend 2015 in the form of stock. This stock dividend distribution was paid from 19,047,358 treasury shares (note 32.3 Treasury shares) and with the issuance of 1,089,315 common shares with a par value of EUR 0.12.
In 2015, following each distribution of stock dividend, Aegon completed a share buyback program to neutralize the dilutive effect of the 2014 final dividend and 2015 interim dividend paid in shares, and repurchased a total of 36,416,606 common shares.
Furthermore, in 2015, Aegon issued a total of 3,696,440 common shares B with a par value of EUR 0.12 to compensate for the dilution of Vereniging Aegons shareholding caused by the issuance of shares on January 1, 2015 and May 21, 2015, in connection with the Long Term Incentive Plans for senior management.
32.1 Share capital par value
2017 | 2016 | 2015 | ||||||||||
Common shares |
251 | 249 | 258 | |||||||||
Common shares B |
70 | 70 | 70 | |||||||||
At December 31 |
322 | 319 | 328 | |||||||||
Common shares | 2017 | 2016 | 2015 | |||||||||
Authorized share capital |
720 | 720 | 720 | |||||||||
Number of authorized shares (in million) |
6,000 | 6,000 | 6,000 | |||||||||
Par value in cents per share |
12 | 12 | 12 |
Annual Report on Form 20-F 2017 |
244 | Notes to the consolidated financial statements Note 32 | |
Common shares B | 2017 | 2016 | 2015 | |||||||||
Authorized share capital |
360 | 360 | 360 | |||||||||
Number of authorized shares (in million) |
3,000 | 3,000 | 3,000 | |||||||||
Par value in cents per share |
12 | 12 | 12 |
Common shares | Common shares B | |||||||||||||||
Number of shares | Number of shares | |||||||||||||||
(thousands) | Total amount | (thousands) | Total amount | |||||||||||||
At January 1, 2015 |
2,145,948 | 258 | 581,326 | 70 | ||||||||||||
Shares issued |
- | - | 3,696 | - | ||||||||||||
Dividend |
1,089 | - | - | - | ||||||||||||
At December 31, 2015 |
2,147,037 | 258 | 585,022 | 70 | ||||||||||||
Dividend |
10,629 | 1 | - | - | ||||||||||||
Shares withdrawn |
(83,117 | ) | (10 | ) | - | - | ||||||||||
At December 31, 2016 |
2,074,549 | 249 | 585,022 | 70 | ||||||||||||
Dividend |
21,099 | 3 | - | - | ||||||||||||
At December 31, 2017 |
2,095,648 | 251 | 585,022 | 70 |
Weighted average number of
common shares (thousands) |
Weighted average number of
common shares B (thou- sands) |
|||||||
2015 |
2,146,261 | 583,608 | ||||||
2016 |
2,129,074 | 585,022 | ||||||
2017 |
2,080,792 | 585,022 |
All issued common shares and common shares B each have a nominal value of EUR 0.12 and are fully paid up. Repayment of capital can only be initiated by the Executive Board, is subject to approval of the Supervisory Board and must be resolved by the General Meeting of Shareholders. Moreover, repayment on common shares B needs approval of the related shareholders. Refer to Other information for further information on dividend rights.
Vereniging Aegon, based in The Hague, the Netherlands, holds all of the issued and outstanding common shares B.
Under the terms of the 1983 Amended Merger Agreement, dated May 2013, Vereniging Aegon has a call option relating to common shares B. Vereniging Aegon may exercise its call option to keep or restore its total stake at 32.6%, irrespective of the circumstances which cause the total shareholding to be or become lower than 32.6%.
32.2 Share premium
2017 | 2016 | 2015 | ||||||||||
At January 1 |
7,873 | 8,059 | 8,270 | |||||||||
Share dividend |
(142 | ) | (186 | ) | (211 | ) | ||||||
At December 31 |
7,731 | 7,873 | 8,059 | |||||||||
Share premium relating to: |
||||||||||||
- Common shares |
6,078 | 6,220 | 6,406 | |||||||||
- Common shares B |
1,653 | 1,653 | 1,653 | |||||||||
Total share premium |
7,731 | 7,873 | 8,059 |
The share premium account reflects the balance of paid-in amounts above par value at issuance of new shares less the amounts charged for share dividends.
Annual Report on Form 20-F 2017 |
245 | Notes to the consolidated financial statements Note 32 | |
32.3 Treasury shares
On the reporting date, Aegon N.V. and its subsidiaries held 65,650,650 (2016: 48,780,045) of its own common shares and 15,345,680 (2016: 17,324,960) own common shares B with a par value of EUR 0.12 each.
Movements in the number of treasury common shares of Aegon N.V. were as follows:
2017 | 2016 | 2015 | ||||||||||||||||||||||
Number of shares
(thousands) |
Amount |
Number of shares
(thousands) |
Amount |
Number of shares
(thousands) |
Amount | |||||||||||||||||||
At January 1 |
47,473 | 178 | 42,998 | 257 | 49,537 | 306 | ||||||||||||||||||
Transactions in 2017: |
||||||||||||||||||||||||
Sale: transactions, average price EUR 3.44 |
(4,085 | ) | (14 | ) | ||||||||||||||||||||
Sale: 1 transaction, average price EUR 3.68 |
(26,916 | ) | (99 | ) | ||||||||||||||||||||
Sale: 1 transaction, average price EUR 3.77 |
(3,849 | ) | (14 | ) | ||||||||||||||||||||
Purchase: 1 transaction, average price EUR 5.09 |
51,865 | 263 | ||||||||||||||||||||||
Transactions in 2016: |
||||||||||||||||||||||||
Purchase: transactions, average price EUR 4.81 |
83,117 | 400 | ||||||||||||||||||||||
Sale: transactions, price average EUR 6.49 |
(6,153 | ) | (40 | ) | ||||||||||||||||||||
Sale: 1 transaction, price EUR 6.38 |
(20,137 | ) | (129 | ) | ||||||||||||||||||||
Purchase: transactions, average price EUR 3.51 |
29,259 | 103 | ||||||||||||||||||||||
Sale: 1 transaction, price EUR 5.11 |
(29,259 | ) | (150 | ) | ||||||||||||||||||||
Shares withdrawn: 1 transaction, price EUR 4.60 |
(83,117 | ) | (382 | ) | ||||||||||||||||||||
Purchase: transactions, average price EUR 3.84 |
30,765 | 118 | ||||||||||||||||||||||
Transactions in 2015: |
||||||||||||||||||||||||
Sale: 1 transaction, price EUR 7.24 |
(7,628 | ) | (47 | ) | ||||||||||||||||||||
Sale: 1 transaction, price EUR 6.62 |
(16,280 | ) | (93 | ) | ||||||||||||||||||||
Purchase: transactions, average price EUR 6.63 |
16,280 | 108 | ||||||||||||||||||||||
Sale: 1 transaction, price EUR 5.40 |
(19,047 | ) | (123 | ) | ||||||||||||||||||||
Purchase: transactions, average price EUR 5.28 |
20,137 | 106 | ||||||||||||||||||||||
At December 31 |
64,488 | 314 | 47,473 | 178 | 42,998 | 257 |
Movements in the number of treasury common shares B of Aegon N.V. were as follows:
2017 | 2016 | 2015 | ||||||||||||||||||||||
Number of shares
(thousands) |
Amount |
Number of shares
(thousands) |
Amount |
Number of shares (thousands) |
Amount | |||||||||||||||||||
At January 1 |
17,325 | 2 | - | - | - | - | ||||||||||||||||||
Transactions in 2017: |
||||||||||||||||||||||||
Sale: 1 transaction, average price EUR 0.11 |
(1,979 | ) | - | |||||||||||||||||||||
Sale: 1 transaction, average price EUR 0.11 |
(13,043 | ) | (1 | ) | ||||||||||||||||||||
Purchase: 1 transaction, average price EUR 0.13 |
13,043 | 2 | ||||||||||||||||||||||
Transactions in 2016: |
||||||||||||||||||||||||
Purchase: transactions, average price EUR 0.11 |
17,325 | 2 | ||||||||||||||||||||||
Transactions in 2015: |
||||||||||||||||||||||||
- |
- | - | - | - | - | - | ||||||||||||||||||
At December 31 |
15,346 | 2 | 17,325 | 2 | - | - |
As part of their insurance and investment operations, subsidiaries within the Group also hold Aegon N.V. common shares, both for their own account and for account of policyholders. These shares have been treated as treasury shares and are (de)recognized at the consideration paid or received.
Annual Report on Form 20-F 2017 |
246 | Notes to the consolidated financial statements Note 32 | |
2017 | 2016 | 2015 | ||||||||||||||||||||||
Number of shares
(thousands) |
Total
amount |
Number of shares
(thousands) |
Total
amount |
Number of shares
(thousands) |
Total
amount |
|||||||||||||||||||
Common shares |
||||||||||||||||||||||||
Held by Aegon N.V. |
64,488 | 314 | 47,473 | 178 | 42,998 | 257 | ||||||||||||||||||
Held by subsidiaries |
1,162 | 9 | 1,307 | 10 | 1,534 | 12 | ||||||||||||||||||
Common shares B |
||||||||||||||||||||||||
Held by Aegon N.V. |
15,346 | 2 | 17,325 | 2 | - | - | ||||||||||||||||||
At December 31 |
80,996 | 325 | 66,105 | 190 | 44,532 | 269 |
Weighted average number of treasury shares, including
treasury shares held by subsidiaries (thousands) |
Weighted average number of treasury
shares B (thousands) |
|||||||
2015 |
45,097 | - | ||||||
2016 |
81,570 | 9,893 | ||||||
2017 |
38,490 | 9,841 |
32.4 Revaluation reserves
Available-for-sale
investments |
Real estate held for
own use |
Cash flow hedging
reserve |
Total | |||||||||||||
At January 1, 2017 |
3,418 | 59 | 1,904 | 5,381 | ||||||||||||
Gross revaluation |
1,310 | 8 | (115 | ) | 1,203 | |||||||||||
Net (gains) / losses transferred to income statement |
(1,330 | ) | - | (738 | ) | (2,069 | ) | |||||||||
Foreign currency translation differences |
(228 | ) | (8 | ) | (216 | ) | (452 | ) | ||||||||
Tax effect |
308 | 9 | 567 | 883 | ||||||||||||
Other |
(28 | ) | - | 1 | (27 | ) | ||||||||||
At December 31, 2017 |
3,450 | 68 | 1,402 | 4,920 | ||||||||||||
At January 1, 2016 |
4,546 | 52 | 1,873 | 6,471 | ||||||||||||
Gross revaluation |
857 | 8 | (131 | ) | 733 | |||||||||||
Net (gains) / losses transferred to income statement |
(2,122 | ) | - | 78 | (2,044 | ) | ||||||||||
Foreign currency translation differences |
(101 | ) | 2 | 61 | (38 | ) | ||||||||||
Tax effect |
240 | (3 | ) | 24 | 262 | |||||||||||
Other |
(2 | ) | - | - | (2 | ) | ||||||||||
At December 31, 2016 |
3,418 | 59 | 1,904 | 5,381 | ||||||||||||
At January 1, 2015 |
6,741 | 42 | 1,525 | 8,308 | ||||||||||||
Gross revaluation |
(2,479 | ) | 8 | 278 | (2,193 | ) | ||||||||||
Net (gains) / losses transferred to income statement |
(485 | ) | - | (13 | ) | (498 | ) | |||||||||
Disposal of a business |
(468 | ) | - | - | (468 | ) | ||||||||||
Foreign currency translation differences |
307 | 5 | 181 | 492 | ||||||||||||
Tax effect |
934 | (2 | ) | (98 | ) | 833 | ||||||||||
Other |
(3 | ) | - | - | (3 | ) | ||||||||||
At December 31, 2015 |
4,546 | 52 | 1,873 | 6,471 |
The revaluation accounts for both available-for-sale investments and for real estate held for own use include unrealized gains and losses on these investments, net of tax. Upon sale, the amounts realized are recognized in the income statement (for available-for-sale investments) or transferred to retained earnings (for real estate held for own use). Upon impairment, unrealized losses are recognized in the income statement.
Annual Report on Form 20-F 2017 |
247 | Notes to the consolidated financial statements Note 32 | |
The closing balances of the revaluation reserve for available-for-sale investments relate to the following instruments:
2017 | 2016 | 2015 | ||||||||||
Shares |
40 | 130 | 139 | |||||||||
Debt securities |
3,423 | 3,245 | 4,354 | |||||||||
Other |
(14 | ) | 43 | 53 | ||||||||
Revaluation reserve for available-for-sale investments |
3,450 | 3,418 | 4,546 |
The cash flow hedging reserve includes (un)realized gains and losses on the effective portions of hedging instruments, net of tax. The amounts are recognized in the income statement at the moment of realization of the hedged position to offset the gain or loss from the hedged cash flow. No amounts have been released from equity to be included in the initial measurement of non-financial assets or liabilities.
32.5 Remeasurement of defined benefit plans
2017 | 2016 | 2015 | ||||||||||
At January 1 |
(1,820 | ) | (1,532 | ) | (1,611 | ) | ||||||
Remeasurements of defined benefit plans |
224 | (392 | ) | 234 | ||||||||
Tax effect |
(175 | ) | 89 | (75 | ) | |||||||
Net exchange differences |
102 | 16 | (86 | ) | ||||||||
Disposal of a business |
- | - | 6 | |||||||||
Total remeasurement of defined benefit plans |
(1,669 | ) | (1,820 | ) | (1,532 | ) |
32.6 Other reserves
Foreign
currency translation reserve |
Net foreign
investment hedging reserve |
Equity
movements of joint ventures and associates |
Total | |||||||||||||
At January 1, 2017 |
1,734 | (418 | ) | 31 | 1,347 | |||||||||||
Movement in foreign currency translation and net foreign investment hedging reserves |
(1,929 | ) | 129 | - | (1,800 | ) | ||||||||||
Disposal of a business |
7 | - | - | 7 | ||||||||||||
Tax effect |
108 | (32 | ) | - | 76 | |||||||||||
Equity movements of joint ventures |
- | - | (15 | ) | (15 | ) | ||||||||||
Equity movements of associates |
- | - | (5 | ) | (5 | ) | ||||||||||
At December 31, 2017 |
(80 | ) | (321 | ) | 11 | (390 | ) | |||||||||
At January 1, 2016 |
1,731 | (467 | ) | 19 | 1,283 | |||||||||||
Movement in foreign currency translation and net foreign investment hedging reserves |
25 | 65 | - | 91 | ||||||||||||
Tax effect |
(22 | ) | (17 | ) | - | (39 | ) | |||||||||
Equity movements of joint ventures |
- | - | 9 | 9 | ||||||||||||
Equity movements of associates |
- | - | 3 | 3 | ||||||||||||
At December 31, 2016 |
1,734 | (418 | ) | 31 | 1,347 | |||||||||||
At January 1, 2015 |
268 | (382 | ) | 27 | (86 | ) | ||||||||||
Movement in foreign currency translation and net foreign investment hedging reserves |
1,687 | (181 | ) | - | 1,505 | |||||||||||
Disposal of a business |
(127 | ) | 51 | - | (76 | ) | ||||||||||
Tax effect |
(98 | ) | 45 | - | (52 | ) | ||||||||||
Equity movements of joint ventures |
- | - | (8 | ) | (8 | ) | ||||||||||
Equity movements of associates |
- | - | (1 | ) | (1 | ) | ||||||||||
At December 31, 2015 |
1,731 | (467 | ) | 19 | 1,283 |
The foreign currency translation reserve includes the currency results from investments in non-euro denominated subsidiaries. The amounts are released to the income statement upon the sale of the subsidiary.
Annual Report on Form 20-F 2017 |
248 | Notes to the consolidated financial statements Note 33 | |
The net foreign investment hedging reserve is made up of gains and losses on the effective portions of hedging instruments, net of tax. The amounts are recognized in the income statement at the moment of realization of the hedged position to offset the gain or loss from the net foreign investment.
The equity movements of joint ventures and associates reflect Aegons share of changes recognized directly in the joint ventures and associates equity.
Junior
perpetual capital securities |
Perpetual
cumulative subordinated bonds |
Share options
and incentive plans 1) |
Non-cumulative
subordinated notes |
Total | ||||||||||||||||
At January 1, 2017 |
3,008 | 454 | 65 | 271 | 3,797 | |||||||||||||||
Shares granted |
- | - | 26 | - | 26 | |||||||||||||||
Shares vested |
- | - | (30 | ) | - | (30 | ) | |||||||||||||
At December 31, 2017 |
3,008 | 454 | 61 | 271 | 3,794 | |||||||||||||||
At January 1, 2016 |
3,008 | 454 | 68 | 271 | 3,800 | |||||||||||||||
Shares granted |
- | - | 13 | - | 13 | |||||||||||||||
Shares vested |
- | - | (16 | ) | - | (16 | ) | |||||||||||||
At December 31, 2016 |
3,008 | 454 | 65 | 271 | 3,797 | |||||||||||||||
At January 1, 2015 |
3,008 | 454 | 94 | 271 | 3,827 | |||||||||||||||
Shares granted / Share options cost incurred |
- | - | 26 | - | 26 | |||||||||||||||
Shares vested / Share options forfeited |
- | - | (53 | ) | - | (53 | ) | |||||||||||||
At December 31, 2015 |
3,008 | 454 | 68 | 271 | 3,800 |
1 | Share options and incentive plans include the shares and options granted to personnel which are not yet vested. |
Junior perpetual capital securities |
Coupon rate | Coupon date, as of |
Year of
next call |
2017 | 2016 | 2015 | ||||||||||||||
USD 500 million |
6.50% | Quarterly, December 15 | 2018 | 424 | 424 | 424 | ||||||||||||||
USD 250 million |
floating LIBOR rate 1) | Quarterly, December 15 | 2018 | 212 | 212 | 212 | ||||||||||||||
USD 500 million |
floating CMS rate 2) | Quarterly, July 15 | 2018 | 402 | 402 | 402 | ||||||||||||||
USD 1 billion |
6.375% | Quarterly, June 15 | 2018 | 821 | 821 | 821 | ||||||||||||||
EUR 950 million |
floating DSL rate 3) | Quarterly, July 15 | 2018 | 950 | 950 | 950 | ||||||||||||||
EUR 200 million |
6.0% | Annually, July 21 | 2018 | 200 | 200 | 200 | ||||||||||||||
At December 31 |
3,008 | 3,008 | 3,008 |
1 | The coupon of the USD 250 million junior perpetual capital securities is reset each quarter based on the then prevailing three-month LIBOR yield plus a spread of 87.5 basis points, with a minimum of 4%. |
2 | The coupon of the USD 500 million junior perpetual capital securities is reset each quarter based on the then prevailing ten-year US dollar interest rate swap yield plus a spread of ten basis points, with a maximum of 8.5%. |
3 | The coupon of the EUR 950 million junior perpetual capital securities is reset each quarter based on the then prevailing ten-year Dutch government bond yield plus a spread of ten basis points, with a maximum of 8%. |
The interest rate exposure on some of these securities has been swapped to a three-month LIBOR and/or EURIBOR based yield.
The securities have been issued at par. The securities have subordination provisions, rank junior to all other liabilities and senior to shareholders equity only. The conditions of the securities contain certain provisions for optional and required coupon payment deferral and mandatory coupon payment events. Although the securities have no stated maturity, Aegon has the right to call the securities for redemption at par for the first time on the coupon date in the years as specified, or on any coupon payment date thereafter.
Annual Report on Form 20-F 2017 |
249 | Notes to the consolidated financial statements Note 34 | |
Perpetual cumulative subordinated
bonds |
Coupon rate | Coupon date |
Year of next
call |
2017 | 2016 | 2015 | ||||||||||||||
EUR 136 million |
5.185% 1), 4) | Annual, October 14 | 2018 | 136 | 136 | 136 | ||||||||||||||
EUR 203 million |
4.260% 2), 4) | Annual, March 4 | 2021 | 203 | 203 | 203 | ||||||||||||||
EUR 114 million |
1.506% 3), 4) | Annual, June 8 | 2025 | 114 | 114 | 114 | ||||||||||||||
At December 31 |
454 | 454 | 454 |
1 | The coupon of the EUR 136 million bonds was originally set at 7.25% until October 14, 2008. Subsequently, the coupon has been reset at 5.185% until October 14, 2018. |
2 | The coupon of the EUR 203 million bonds was originally set at 7.125% until March 4, 2011. Subsequently, the coupon has been reset at 4.26% until March 4, 2021. |
3 | The coupon of the EUR 114 million bonds was originally set at 8% until June 8, 2005. Subsequently, the coupon has been reset at 4.156% until 2015 and 1.506% until 2025. |
4 | If the bonds are not called on the respective call dates and after consecutive period of ten years, the coupons will be reset at the then prevailing effective yield of ten-year Dutch government securities plus a spread of 85 basis points. |
The bonds have the same subordination provisions as dated subordinated debt. In addition, the conditions of the bonds contain provisions for interest deferral.
Although the bonds have no stated maturity, Aegon has the right to call the bonds for redemption at par for the first time on the coupon date in the year of next call.
Non-cumulative subordinated notes | Coupon rate | Coupon date |
Year of next
call |
2017 | 2016 | 2015 | ||||||||||||||||
USD 525 million |
8% | Quarterly, February 15 | 2018 | 271 | 271 | 271 | ||||||||||||||||
At December 31 |
271 | 271 | 271 |
On February 7, 2012, Aegon issued USD 525 million in aggregate principal amount of 8.00% non-cumulative subordinated notes, due 2042, in an underwritten public offering in the United States registered with the US Securities and Exchange Commission. The subordinated notes bear interest at a fixed rate of 8.00% and have been priced at 100% of their principal amount. Any cancelled interest payments will not be cumulative.
The securities are subordinated and rank senior to the junior perpetual capital securities, equally with the perpetual cumulative subordinated bonds and fixed floating subordinated notes, and junior to all other liabilities. The conditions of the securities contain certain provisions for optional and required cancellation of interest payments. The securities have a stated maturity of 30 years, however, Aegon has the right to call the securities for redemption at par on any coupon payment date. In 2017 Aegon had this right for the first time, but it was not exercised.
These notes are recognized as a compound instrument due to the nature of this financial instrument. Compound instruments are separated into an equity component and a liability component. At December 31, 2017, the equity component amounted to EUR 271 million (2016: EUR 271 million), subordinated borrowings amounted to EUR 69 million (2016: EUR 72 million) and a deferred tax liability amounting to EUR 92 million (2016: EUR 106 million).
Refer to note 34 Subordinated borrowings for details of the component classified as subordinated borrowings.
Coupon rate | Coupon date | Year of next call | 2017 | 2016 | ||||||||||||
Fixed floating subordinated notes |
||||||||||||||||
EUR 700 million |
4% | Annually, April 25 | 2024 | 695 | 695 | |||||||||||
Non-cumulative subordinated notes |
||||||||||||||||
USD 525 million |
8% | Quarterly, February 15 | 2018 | 69 | 72 | |||||||||||
At December 31 |
764 | 767 |
On April 25, 2014, Aegon issued EUR 700 million of subordinated notes, first callable on April 25, 2024, and maturing on April 25, 2044. The coupon is fixed at 4% until the first call date and floating thereafter.
Subordinated borrowings include a liability of EUR 69 million (2016: EUR 72 million) relating to the USD 525 million non-cumulative subordinated notes issued on February 7, 2012. The liability component of the non-cumulative subordinated notes is related to the
Annual Report on Form 20-F 2017 |
250 | Notes to the consolidated financial statements Note 35 | |
redemption amount. For further information on the non-cumulative subordinated notes and their subordination refer to note 33 Other equity instruments.
These securities are subordinated and rank senior to the junior perpetual capital securities, equally with the perpetual cumulative subordinated bonds and junior to all other liabilities. The conditions of the securities contain certain provisions for optional and required deferral of interest payments. There have been no defaults or breaches of conditions during the period.
The fair value of these loans amounted to EUR 953 million (2016: EUR 844 million).
35 Trust pass-through securities
Coupon rate | Coupon date | Year of issue | Year of maturity | Year of next call | 2017 | 2016 | ||||||||||||||||||||
USD 225 million 1) |
7.65% | Semi-annually, December 1 | 1996 | 2026 | n.a. | 91 | 109 | |||||||||||||||||||
USD 190 million 1) |
7.625% | Semi-annually, November 15 | 1997 | 2037 | n.a. | 41 | 47 | |||||||||||||||||||
At December 31 |
133 | 156 |
1 | Issued by a subsidiary of, and guaranteed by Aegon N.V. |
Trust pass-through securities are securities through which the holder participates in a trust. The assets of these trusts consist of junior subordinated deferrable interest debentures issued by Transamerica Corporation. The trust pass-through securities carry provisions with regard to deferral of distributions for extension periods up to a maximum of 10 consecutive semi-annual periods. The trust pass-through securities are subordinated to all other unsubordinated borrowings and liabilities of Transamerica Corporation.
There were no defaults or breaches of conditions during the period.
The fair value of these loans amounted to EUR 137 million (2016: EUR 141 million).
36.1 Underwriting risk
Aegons earnings depend significantly upon the extent to which actual claims experience differs from the assumptions used in setting the prices for products and establishing the technical liabilities and liabilities for claims. To the extent that actual claims experience is less favorable than the underlying assumptions used in establishing such liabilities, income would be reduced. Furthermore, if these higher claims were part of a permanent trend, Aegon may be required to change best estimate assumptions for future claims which could increase liabilities, which could reduce income. In addition, certain acquisition costs related to the sale of new policies and the purchase of policies already in force have been recorded as assets on the statement of financial position and are being amortized into income over time. If the assumptions relating to the future profitability of these policies (such as future claims, investment income and expenses) are not realized, the amortization of these costs could be accelerated and may even require write offs should there be an expectation of unrecoverability. This could have a materially adverse effect on Aegons business, results of operations and financial condition.
Sources of underwriting risk include policyholder behavior (such as lapses, surrender of policies or partial withdrawals), policy claims (such as mortality, longevity or morbidity) and expenses. For some product lines, Aegon is at risk if policy lapses increase as sometimes Aegon is unable to fully recover upfront expenses in selling a product despite the presence of commission recoveries or surrender charges and fees. There are also products where Aegon is at risk if lapses decrease, for example where this would result in a higher utilization rate of product guarantees. For mortality and morbidity risk, Aegon sells certain types of policies that are at risk if mortality or morbidity increases, such as term life insurance and accident insurance, and sells certain types of policies that are at risk if mortality decreases (longevity risk) such as annuity products. Aegon is also at risk if expenses are higher than assumed by management.
Aegon monitors and manages its underwriting risk by underwriting risk type. Attribution analysis is performed on earnings and reserve movements in order to understand the source of any material variation in actual results from what was expected. Aegons units also perform experience studies for underwriting risk assumptions, comparing Aegons experience to industry experience as well as combining Aegons experience and industry experience based on the depth of the history of each source to Aegons underwriting assumptions. Where policy charges are flexible in products, Aegon uses these analyses as the basis for modifying these charges, with a view to maintain a balance between policyholder and shareholder interests. Aegon also has the ability to reduce expense levels over time, thus mitigating unfavorable expense variation.
Sensitivity analysis of net income and shareholders equity to various underwriting risks is shown in the table that follows. Aegons best estimate assumptions already include expected future developments and the sensitivities represent an increase or decrease of lapse
Annual Report on Form 20-F 2017 |
251 | Notes to the consolidated financial statements Note 36 | |
rates, mortality rates and morbidity rates, compared to Aegons best estimate assumptions. Increases in mortality rates lead to an increase in the level of benefits and claims. These underwriting sensitivities were run using a permanent shock applied to all of Aegons products, both products exposed to an increase and products exposed to a decrease in the rates. From the table below we can see that the mortality sensitivity has the largest impact and in aggregate, Aegon is exposed to a decrease in mortality rates.
2017 | 2016 | |||||||||||||||
Sensitivity analysis of net income and shareholders equity to changes in various underwriting risks Estimated approximate effect |
On shareholders
equity |
On net income |
On shareholders
equity |
On net income | ||||||||||||
20% increase in lapse rates |
69 | 94 | 47 | 36 | ||||||||||||
20% decrease in lapse rates |
(124 | ) | (155 | ) | (104 | ) | (91 | ) | ||||||||
10% increase in mortality rates |
514 | 91 | 548 | 153 | ||||||||||||
10% decrease in mortality rates |
(1,011 | ) | (577 | ) | (1,039 | ) | (582 | ) | ||||||||
10% increase in morbidity rates |
(492 | ) | (463 | ) | (521 | ) | (445 | ) | ||||||||
10% decrease in morbidity rates |
189 | 142 | 184 | 127 |
Aegon the Netherlands partially hedges the risk of future longevity increases in the Netherlands related to a part of its insurance liabilities. Over the past years Aegon the Netherlands has initiated a number of transactions to hedge this risk via both longevity index derivatives and reinsurance contracts.
36.2 Insurance contracts for general account
2017 | 2016 | |||||||
Life insurance |
98,422 | 105,763 | ||||||
Non-life insurance |
||||||||
- Unearned premiums and unexpired risks |
5,447 | 5,822 | ||||||
- Outstanding claims |
2,206 | 2,226 | ||||||
- Incurred but not reported claims |
830 | 1,018 | ||||||
Incoming reinsurance |
3,913 | 4,739 | ||||||
At December 31 |
110,818 | 119,569 | ||||||
2017 | 2016 | |||||||
Non-life insurance: |
||||||||
- Accident and health insurance |
8,225 | 8,821 | ||||||
- General insurance |
259 | 245 | ||||||
Total non-life insurance |
8,484 | 9,066 |
Annual Report on Form 20-F 2017 |
252 | Notes to the consolidated financial statements Note 36 | |
Annual Report on Form 20-F 2017 |
253 | Notes to the consolidated financial statements Note 37 | |
36.3 Insurance contracts for account of policyholders
Insurance contracts for account of policyholders | 2017 | 2016 | ||||||
At January 1 |
120,929 | 112,679 | ||||||
Portfolio transfers and acquisitions |
(259 | ) | (353 | ) | ||||
Gross premium and deposits existing and new business |
12,144 | 12,931 | ||||||
Unwind of discount / interest credited |
13,349 | 7,085 | ||||||
Insurance liabilities released |
(10,882 | ) | (8,206 | ) | ||||
Fund charges released |
(1,746 | ) | (1,725 | ) | ||||
Changes in valuation of expected future benefits |
100 | 268 | ||||||
Transfer (to) / from insurance contracts |
(135 | ) | (1 | ) | ||||
Transfer (to) / from investment contracts for account of policyholders |
- | (808 | ) | |||||
Transfers to disposal groups |
(1,359 | ) | (1,002 | ) | ||||
Net exchange differences |
(10,289 | ) | 55 | |||||
Other |
317 | 6 | ||||||
At December 31 |
122,168 | 120,929 |
Included in Transfers to disposal groups for 2017 is the sale of Aegon Ireland plc. business which is classified as held for sale per year-end 2017. As a result, the Insurance contracts for account of policyholders are no longer included in the 2017 ending balance. For 2016 the sale of Aegon UKs annuity portfolio was included here. Refer to note 22 Assets and liabilities held for sale and note 51 Business combinations.
Included in Other is the reclassification of the pension contract relating to the personnel of Unirobe Meeùs Groep (UMG) from defined benefit plans to insurance contracts for account of policy holders following the sale of UMG in November 2017.
37.1 Investment contracts for general account
Without discretionary
participation features |
With discretionary
participation features |
Total | ||||||||||
At January 1, 2017 |
19,217 | 355 | 19,572 | |||||||||
Portfolio transfers and acquisitions |
55 | - | 55 | |||||||||
Deposits |
8,432 | - | 8,432 | |||||||||
Withdrawals |
(8,455 | ) | - | (8,455 | ) | |||||||
Investment contracts liabilities released |
- | (64 | ) | (64 | ) | |||||||
Interest credited |
268 | - | 268 | |||||||||
Net exchange differences |
(1,102 | ) | (13 | ) | (1,114 | ) | ||||||
Transfer to/from other headings |
21 | - | 21 | |||||||||
Other |
(1,771 | ) | - | (1,771 | ) | |||||||
At December 31, 2017 | 16,665 | 278 | 16,943 | |||||||||
At January 1, 2016 |
17,260 | 457 | 17,718 | |||||||||
Portfolio transfers and acquisitions |
105 | - | 105 | |||||||||
Deposits |
7,200 | - | 7,200 | |||||||||
Withdrawals |
(6,059 | ) | - | (6,059 | ) | |||||||
Investment contracts liabilities released |
- | (42 | ) | (42 | ) | |||||||
Interest credited |
267 | - | 267 | |||||||||
Net exchange differences |
294 | (61 | ) | 233 | ||||||||
Other |
150 | - | 150 | |||||||||
At December 31, 2016 |
19,217 | 355 | 19,572 |
The value of investment contracts for general account decreased in 2017 mainly due to a paydown of USD 2 billion to the Federal Home Loan Bank visible under other relating to advances on spread products, and due to net exchange differences.
Annual Report on Form 20-F 2017 |
254 | Notes to the consolidated financial statements Note 38 | |
Investment contracts consist of the following: | 2017 | 2016 | ||||||
Institutional guaranteed products |
1,053 | 3,223 | ||||||
Fixed annuities |
5,714 | 6,809 | ||||||
Savings accounts |
9,568 | 8,814 | ||||||
Investment contracts with discretionary participation features |
278 | 355 | ||||||
Other |
331 | 371 | ||||||
At December 31 |
16,943 | 19,572 |
37.2 Investment contracts for account of policyholders
Without discretionary
participation features |
With discretionary
participation features |
Total | ||||||||||
At January 1, 2017 |
42,803 | 41,971 | 84,774 | |||||||||
Gross premium and deposits existing and new business |
5,393 | 1,313 | 6,706 | |||||||||
Withdrawals |
(7,654 | ) | - | (7,654 | ) | |||||||
Interest credited |
4,589 | 4,558 | 9,147 | |||||||||
Investment contracts liabilities released |
- | (9,006 | ) | (9,006 | ) | |||||||
Fund charges released |
(176 | ) | - | (176 | ) | |||||||
Net exchange differences |
(4,272 | ) | (1,570 | ) | (5,842 | ) | ||||||
Transfers to disposal groups |
(3,498 | ) | - | (3,498 | ) | |||||||
Other |
(16 | ) | - | (16 | ) | |||||||
At December 31, 2017 | 37,169 | 37,265 | 74,434 | |||||||||
At January 1, 2016 |
40,365 | 49,754 | 90,119 | |||||||||
Gross premium and deposits existing and new business |
6,553 | 1,724 | 8,277 | |||||||||
Withdrawals |
(6,393 | ) | - | (6,393 | ) | |||||||
Interest credited |
2,649 | 7,280 | 9,929 | |||||||||
Investment contracts liabilities released |
- | (10,841 | ) | (10,841 | ) | |||||||
Fund charges released |
(209 | ) | - | (209 | ) | |||||||
Net exchange differences |
(12 | ) | (6,754 | ) | (6,767 | ) | ||||||
Transfer (to) / from insurance contracts for account of policyholders |
- | 808 | 808 | |||||||||
Other |
(149 | ) | - | (149 | ) | |||||||
At December 31, 2016 |
42,803 | 41,971 | 84,774 |
Transfers to disposal groups relates to the Aegon Ireland plc. business which is classified as held for sale per year-end 2017. As a result, the investment contracts for account of policyholders are no longer included in the 2017 ending balance. Refer to note 22 Assets and liabilities held for sale and note 51 Business combinations.
38 Guarantees in insurance contracts
For financial reporting purposes Aegon distinguishes between the following types of minimum guarantees:
a. | Financial guarantees: these guarantees are treated as bifurcated embedded derivatives, valued at fair value and presented as derivatives (note 2.9 and note 47 Fair value); |
b. | Total return annuities: these guarantees are not bifurcated from their host contracts because they are presented and valued at fair value together with the underlying insurance contracts (note 2.19); |
c. | Life contingent guarantees in the United States: these guarantees are not bifurcated from their host contracts, presented and valued in accordance with insurance accounting together with the underlying insurance contracts (note 2.19); and |
d. | Minimum investment return guarantees in the Netherlands: these guarantees are not bifurcated from their host contracts, valued at fair value and presented together with the underlying insurance contracts (note 2.19 and note 47 Fair value). |
In addition to the guarantees mentioned above, Aegon has traditional life insurance contracts that include minimum guarantees that are not valued explicitly; however, the adequacy of all insurance liabilities, net of VOBA and DPAC, and including all guarantees, are assessed periodically (note 2.19).
a. Financial guarantees
In the United States and in the United Kingdom, a guaranteed minimum withdrawal benefit (GMWB) is offered directly on some variable annuity products Aegon issues and is also assumed from a ceding company. Additionally, Aegon offers guarantees on variable
Annual Report on Form 20-F 2017 |
255 | Notes to the consolidated financial statements Note 38 | |
annuities sold through its joint venture in Japan. Variable annuities allow a customer to provide for the future on a tax-deferred basis and to participate in equity or bond market performance. Variable annuities allow a customer to select payout options designed to help meet the customers need for income upon maturity, including lump sum payment or income for life or for a period of time. This benefit guarantees that a policyholder can withdraw a certain percentage of the account value, starting at a certain age or duration, for either a fixed period or during the life of the policyholder.
In the Netherlands, individual variable unit-linked products have a minimum benefit guarantee if premiums are invested in certain funds. The sum insured at maturity or upon the death of the beneficiary has a minimum guaranteed return (in the range of 3% to 4%) if the premium has been paid for a consecutive period of at least ten years and is invested in a mixed fund and/or fixed-income funds. No guarantees are given for equity investments only.
The following table provides information on the liabilities for financial guarantees for minimum benefits, net of present value of the expected future premiums that are received to cover these guarantees:
2017 | 2016 | |||||||||||||||||||||||||||||||
United
States 1) |
The
Nether- lands 2) |
United
Kingdom |
Total 3) |
United
States 1) |
The
Nether- lands 2) |
United
Kingdom |
Total 3) | |||||||||||||||||||||||||
At January 1 |
405 | 1,555 | 68 | 2,028 | 510 | 1,432 | 56 | 1,998 | ||||||||||||||||||||||||
Incurred guarantee benefits 4) |
(114 | ) | (8 | ) | (37 | ) | (158 | ) | (113 | ) | 123 | - | 10 | |||||||||||||||||||
Paid guarantee benefits |
(1 | ) | - | - | (1 | ) | (1 | ) | - | 12 | 11 | |||||||||||||||||||||
Transfers to disposal groups |
- | - | (30 | ) | (30 | ) | - | - | - | - | ||||||||||||||||||||||
Net exchange differences |
(42 | ) | - | (2 | ) | (44 | ) | 10 | - | - | 10 | |||||||||||||||||||||
At December 31 |
247 | 1,547 | - | 1,794 | 405 | 1,555 | 68 | 2,028 | ||||||||||||||||||||||||
Account value 5) |
33,371 | 8,805 | - | 42,175 | 35,374 | 8,957 | 1,350 | 45,681 | ||||||||||||||||||||||||
Net amount at risk 6) |
94 | 1,737 | - | 1,831 | 222 | 1,972 | 68 | 2,262 |
1 | Guaranteed minimum accumulation and withdrawal benefits. |
2 | Fund plan and unit-linked guarantees. |
3 | Balances are included in the derivatives liabilities on the face of the statement of financial position; refer to note 25 Derivatives. |
4 | Incurred guarantee benefits mainly comprise the effect of guarantees from new contracts, releases related to expired out-of-the-money guarantees and fair value movements during the reporting year. |
5 | Account value reflects the actual fund value for the policyholders. |
6 | The net amount at risk represents the sum of the positive differences between the discounted maximum amount payable under the guarantees and the account value. |
The decrease of incurred guarantee benefits mainly relates to equity markets rising, fair value movements due to increasing interest rates and tightening of treasury swaps spreads.
Aegon Americas mitigates the exposure from the elective guaranteed minimum withdrawal benefit rider issued with a ceding companys variable annuity contracts. The rider is essentially a return of premium guarantee, which is payable over a period of at least 14 years from the date that the policyholder elects to start withdrawals. At contract inception, the guaranteed remaining balance is equal to the premium payment. The periodic withdrawal is paid by the ceding company until the account value is insufficient to cover additional withdrawals. Once the account value is exhausted, Aegon pays the periodic withdrawals until the guaranteed remaining balance is exhausted. At December 31, 2017, the reinsured account value was 2.0 billion (2016: EUR 2.4 billion) and the guaranteed remaining balance was EUR 1.2 billion (2016: EUR 1.5 billion).
The GMWB rider Aegon assumed from the ceding company is accounted for as a derivative and is carried in Aegons statement of financial position at fair value. At December 31, 2017, the contract had a value of EUR 34 million (2016: EUR 50 million). Aegon entered into a derivative program to mitigate the overall exposure to equity market and interest rate risks associated with the reinsurance contract. This program involves selling equity futures contracts and equity total return swap contracts (S&P 500, Midcap, Russell 2000, and the MCSI EAFE index in accordance with Aegons exposure) to mitigate the effect of equity market movement on the reinsurance contract and the purchase of interest rate swaps, treasury futures and treasury forwards to mitigate the effect of movements in interest rates on the reinsurance contracts.
Aegon the Netherlands provides guarantees to its customers on expiry date for certain insurance contracts. In order to mitigate the risks related to the guarantees Aegon the Netherlands has setup a hedging program. Aegon the Netherlands does not use reinsurance in order to mitigate risks related to insurance contracts with a guarantee component. The net amount at risk represents the sum of the
Annual Report on Form 20-F 2017 |
256 | Notes to the consolidated financial statements Note 38 | |
positive differences between the discounted maximum amount payable under the guarantees and the account value, which is the actual fund value of the policyholder.
The guarantees in the United Kingdom relate to the Aegon Ireland plc. business which is classified as held for sale per year-end 2017 and as a result the guarantees are no longer included in the 2017 ending balance.
b. Total return annuities
Total Return Annuity (TRA) is an annuity product in the United States which provides customers with a pass-through of the total return on an underlying portfolio of investment securities (typically a mix of corporate and convertible bonds) subject to a cumulative minimum guarantee. Both the assets and liabilities are carried at fair value, however, due to the minimum guarantee not all of the changes in the market value of the asset will be offset in the valuation of the liability. This product exists for the fixed annuity line of business and represents a closed block.
The fixed annuities product balance as of December 31, 2017, amounted to EUR 270 million (2016: EUR 328 million).
c. Life contingent guarantees in the United States
Certain variable insurance contracts in the United States also provide guaranteed minimum death benefits (GMDB) and guaranteed minimum income benefits (GMIB). Under a GMDB, the beneficiaries receive the greater of the account balance or the guaranteed amount upon the death of the insured. The net amount at risk for GMDB contracts is defined as the current GMDB in excess of the capital account balance at the reporting date.
The GMIB feature provides for minimum payments if the contract holder elects to convert to an immediate payout annuity. The guaranteed amount is calculated using the total deposits made by the contract holder, less any withdrawals and sometimes includes a roll-up or step-up feature that increases the value of the guarantee with interest or with increases in the account value.
The additional liability for guaranteed minimum benefits that are not bifurcated are determined each period by estimating the expected value of benefits in excess of the projected account balance and recognizing the excess over the accumulation period based on total expected assessments. The estimates are reviewed regularly and any resulting adjustment to the additional liability is recognized in the income statement. The benefits used in calculating the liabilities are based on the average benefits payable over a range of stochastic scenarios. Where applicable, the calculation of the liability incorporates a percentage of the potential annuitizations that may be elected by the contract holder.
The following table provides information on the liabilities for guarantees for minimum benefits that are included in the valuation of the host contracts:
2017 | 2016 | |||||||||||||||||||||||
GMDB 1) | GMIB 2) | Total 4) | GMDB 1) | GMIB 2) | Total 4) | |||||||||||||||||||
At January 1 |
531 | 849 | 1,381 | 544 | 816 | 1,359 | ||||||||||||||||||
Incurred guarantee benefits 5) |
(49 | ) | (121 | ) | (171 | ) | 48 | 83 | 130 | |||||||||||||||
Paid guarantee benefits |
(60 | ) | (26 | ) | (86 | ) | (75 | ) | (74 | ) | (148 | ) | ||||||||||||
Net exchange differences |
(58 | ) | (94 | ) | (153 | ) | 15 | 25 | 40 | |||||||||||||||
At December 31 |
364 | 608 | 972 | 531 | 849 | 1,381 | ||||||||||||||||||
GMDB 1) , 3) | GMIB 2) , 3) | GMDB 1) , 3) | GMIB 2) , 3) | |||||||||||||||||||||
Account value 6) |
52,070 | 5,270 | 54,821 | 5,628 | ||||||||||||||||||||
Net amount at risk 7) |
1,309 | 474 | 2,615 | 684 | ||||||||||||||||||||
Average attained age of contract holders |
69 | 70 | 69 | 69 |
1 | Guaranteed minimum death benefit in the United States. |
2 | Guaranteed minimum income benefit in the United States. |
3 | Note that the variable annuity contracts with guarantees may offer more than one type of guarantee in each contract; therefore, the amounts listed are not mutually exclusive. |
4 | Balances are included in the insurance liabilities on the face of the statement of financial position; refer to note 36 Insurance contracts. |
5 | Incurred guarantee benefits mainly comprise the effect of guarantees from new contracts, releases related to expired out-of-the-money guarantees and value changes as a consequence of interest movements during the reporting year. |
6 | Account value reflects the actual fund value for the policyholders. |
7 | The net amount at risk is defined as the present value of the minimum guaranteed annuity payments available to the contract holder determined in accordance with the terms of the contract in excess of the current account balance. |
Annual Report on Form 20-F 2017 |
257 | Notes to the consolidated financial statements Note 38 | |
d. Minimum investment return guarantees in the Netherlands
The traditional life and pension products offered by Aegon in the Netherlands include various products that accumulate a cash value. Premiums are paid by customers at inception or over the term of the contract. The accumulation products pay benefits on the policy maturity date, subject to survival of the insured. In addition, most policies also pay death benefits if the insured dies during the term of the contract. The death benefits may be stipulated in the policy or depend on the gross premiums paid to date. Premiums and amounts insured are established at inception of the contract. The amount insured can be increased as a result of profit sharing, if provided for under the terms and conditions of the product. Minimum interest guarantees exist for all generations of traditional accumulation products written. Older generations contain a 4% guarantee; in 1999 the guarantee decreased to 3% and in 2013 the guarantee decreased to 0%.
The traditional group pension contracts offered by Aegon in the Netherlands include large group insurance contracts that have an individually determined asset investment strategy underlying the pension contract. The guarantee given is that the profit sharing is the maximum of 0% and the realized return on an asset portfolio specified in the policy conditions, adjusted for technical interest rates ranging from 3% to 4%. If the adjusted return is negative, the 0% minimum is effective, but the loss in any given year is carried forward to be offset against any future surpluses within the contract period. In general, a guarantee is given for the life of the underlying employees so that their pension benefit is guaranteed. Large group contracts also share technical results (mortality risk and disability risk). The contract period is typically five years and the premiums are fixed over this period.
These guarantees are valued at fair value and are included as part of insurance liabilities with the underlying host insurance contracts in note 36 Insurance contracts.
The following table provides information on the liabilities for guarantees that are included in the valuation of the host contracts, net of the present value of the expected future premiums that are received to cover these guarantees:
2017 | 2016 | |||||||
GMI 1), 2) | GMI 1), 2) | |||||||
At January 1 |
5,542 | 4,741 | ||||||
Incurred guarantee benefits 3) |
(823 | ) | 801 | |||||
At December 31 |
4,719 | 5,542 | ||||||
Account value 4) |
18,754 | 19,467 | ||||||
Net amount at risk 5) |
4,440 | 5,017 |
1 | Guaranteed minimum investment return in the Netherlands. |
2 | Balances are included in the insurance liabilities on the face of the statement of financial position; refer to note 36 Insurance contracts. |
3 | Incurred guarantee benefits mainly comprise the effect of guarantees from new contracts, releases related to expired out-of-the-money guarantees and fair value movements during the reporting year. |
4 | Account value reflects the liability value of the insurance contracts as a whole. |
5 | The net amount at risk represents the sum of the differences between the guaranteed and actual amount that is credited to the policyholders. For Individual policies only positive differences are included, for Group pensions contracts carry forwards of negative differences are recognized. |
Fair value measurement of guarantees in insurance contracts
The fair values of guarantees mentioned above (with the exception of life contingent guarantees in the United States) are calculated as the present value of future expected payments to policyholders less the present value of assessed rider fees attributable to the guarantees. For further details refer to note 47 Fair value.
For equity volatility, Aegon uses a term structure assumption with market-based implied volatility inputs for the first five years and a long-term forward rate assumption of 25% thereafter. The volume of observable option trading from which volatilities are derived generally declines as the contracts term increases, therefore, the volatility curve grades from implied volatilities for five years to the ultimate rate. The resulting volatility assumption in year 20 for the S&P 500 index (expressed as a spot rate) was 23.1% at December 31, 2017, and 24.0% at December 31, 2016. Correlations of market returns across underlying indices are based on historical market returns and their inter-relationships over a number of years preceding the valuation date. Assumptions regarding policyholder behavior, such as lapses, included in the models are derived in the same way as the assumptions used to measure insurance liabilities.
These assumptions are reviewed at each valuation date, and updated based on historical experience and observable market data, including market transactions such as acquisitions and reinsurance transactions. Disclosure on interest rate risk, including interest rate risk sensitivity is included in note 4 Financial risks.
Annual Report on Form 20-F 2017 |
258 | Notes to the consolidated financial statements Note 39 | |
Aegon utilizes different risk management strategies to mitigate the financial impact of the valuation of these guarantees on the results including asset and liability management and derivative hedging strategies to hedge certain aspects of the market risks embedded in these guarantees.
Guarantees valued at fair value contributed a net loss before tax of EUR 75 million (2016: loss of EUR 61 million) to earnings. The main drivers of this loss before tax are a fair value loss on hedges related to the guarantee reserves of EUR 1.417 million (2016: EUR 325 million gain) and a loss of EUR 243 million related to increasing own credit spread (2016: EUR 404 million gain), partly offset by a gain of EUR 1.147 million related to a increase in equity markets (2016: EUR 671 million gain) positive results related to increases in risk free rates of EUR 169 million (2016: EUR 1.159 million loss) and DPAC offset, a gain of EUR 81 million related to decreases in equity volatilities (2016: EUR 7 million gain) and other contributed a gain of EUR 205 million (2016: EUR 279 million loss).
Guarantee reserves decreased by EUR 1.121 million in 2017 (2016: increase of EUR 863 million).
1 | Measured at fair value. |
2 | Issued by subsidiaries of, and guaranteed by, Aegon N.V. |
These loans are considered senior debt in calculating financial leverage in note 46 Capital management and solvency.
Operational funding
During 2017, the operational funding increased EUR 0.6 billion due to new FHLB advances of EUR 1.3 billion and two covered bond issuances in the Netherlands of EUR 0.5 billion in June and November 2017. This was partly offset by the redemption of Seacure
Annual Report on Form 20-F 2017 |
259 | Notes to the consolidated financial statements Note 39 | |
12 in the Netherlands of EUR 1.0 billion and the redemption of operational funding of EUR 0.4 billion supporting a captive insurance company, which was dissolved following the divestment of a block of life reinsurance business in the Americas. Next to this there was a decrease of EUR 0.5 billion as result of foreign exchange impacts on the US dollar positions as a result of the strengthening of the euro.
During 2016, Aegon redeemed EUR 450 million of ECB LTRO, EUR 225 million of ECB MRO, EUR 737 million of regular borrowings and repurchased the mortgage loans from SAECURE 9 and SAECURE 10 for EUR 1,658 million. In addition, Aegon entered into a USD 3 billion new liquidity program from the Federal Home Loan Bank and issued a EUR 500 million covered bond.
There were no defaults or breaches of conditions during the period.
Annual Report on Form 20-F 2017 |
260 | Notes to the consolidated financial statements Note 40 | |
Other reflects the reclassification of the pension contract relating to the personnel of Unirobe Meeùs Groep (UMG) from defined benefit plans to insurance contracts for account of policyholders following the sale of UMG in November 2017.
Annual Report on Form 20-F 2017 |
261 | Notes to the consolidated financial statements Note 41 | |
The amounts recognized in the statement of financial position are determined as follows:
Annual Report on Form 20-F 2017 |
262 | Notes to the consolidated financial statements Note 41 | |
Movements during the year in plan assets for retirement benefit plans | 2017 | 2016 | ||||||||||||||||||||||||||||||
At January 1 |
3,793 | 3,569 | ||||||||||||||||||||||||||||||
Interest income (based on discount rate) |
121 | 134 | ||||||||||||||||||||||||||||||
Remeasurements of the net defined liability (asset) |
|
283 | 290 | |||||||||||||||||||||||||||||
Contributions by employer |
175 | 261 | ||||||||||||||||||||||||||||||
Benefits paid |
(396 | ) | (336 | ) | ||||||||||||||||||||||||||||
Net exchange differences |
(355 | ) | (125 | ) | ||||||||||||||||||||||||||||
At December 31 |
3,622 | 3,793 | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
2017 | 2016 | |||||||||||||||||||||||||||||||
Breakdown of plan assets for retirement benefit plans |
Quoted | Unquoted | Total |
in % of
total plan assets |
Quoted | Unquoted | Total |
in % of
total plan assets |
||||||||||||||||||||||||
Equity instruments |
127 | 4 | 131 | 4% | 206 | 14 | 219 | 6% | ||||||||||||||||||||||||
Debt instrument |
397 | 411 | 809 | 22% | 570 | 713 | 1,283 | 34% | ||||||||||||||||||||||||
Derivatives |
- | 254 | 254 | 7% | - | 179 | 179 | 5% | ||||||||||||||||||||||||
Investment funds |
5 | 2,027 | 2,032 | 56% | 4 | 1,701 | 1,705 | 45% | ||||||||||||||||||||||||
Structured securities |
- | - | - | 0% | - | 3 | 3 | 0% | ||||||||||||||||||||||||
Other |
25 | 372 | 397 | 11% | 12 | 392 | 405 | 11% | ||||||||||||||||||||||||
At December 31 |
554 | 3,068 | 3,622 | 100% | 792 | 3,001 | 3,793 | 100% |
Defined benefit plans are mainly operated by Aegon USA, Aegon the Netherlands and Aegon UK. The following sections contain a general description of the plans in each of these subsidiaries and a summary of the principal actuarial assumptions applied in determining the value of defined benefit plans.
Aegon USA
Aegon USA has defined benefit plans covering substantially all its employees that are qualified under the Internal Revenue Service Code, including all requirements for minimum funding levels. The defined benefit plans are governed by the Board of Managers of Transamerica Corporation. The Board of Managers has the full power and discretion to administer the plan and to apply all of its provisions, including such responsibilities as, but not limited to, developing the investment policy and managing assets for the plan, maintaining required funding levels for the plan, deciding questions related to eligibility and benefit amounts, resolving disputes that may arise from plan participants and for complying with the plan provisions, and legal requirements related to the plan and its operation. The benefits are based on years of service and the employees eligible annual compensation. The plans provide benefits based on a traditional final average formula or a cash balance formula (which defines the accrued benefit in terms of a stated account balance), depending on the age and service of the plan participant. The defined benefit plans have a deficit of EUR 629 million at December 31, 2017 (2016: EUR 742 million deficit).
Investment strategies are established based on asset and liability studies by actuaries which are updated as they consider appropriate. These studies, along with the investment policy, assist to develop the appropriate investment criteria for the plan, including asset allocation mix, return objectives, investment risk and time horizon, benchmarks and performance standards, and restrictions and prohibitions. The overall goal is to maximize total investment returns to provide sufficient funding for the present and anticipated future benefit obligations within the constraints of a prudent level of portfolio risk and diversification. Aegon believes that the asset allocation is an important factor in determining the long-term performance of the plan. The plan uses multiple asset classes as well as sub-classes to meet the asset allocation and other requirements of the investment policy, which minimizes investment risk. From time to time the actual asset allocation may deviate from the desired asset allocation ranges due to different market performance among the various asset categories. If it is determined that rebalancing is required, future additions and withdrawals will be used to bring the allocation to the desired level.
Aegon USA maintains minimum required funding levels as set forth by the Internal Revenue Code. If contributions are required, the funding would be provided from the Companys general account assets. Pension plan contributions were not required for Aegon USA in 2017 or 2016. However, with the Aegon N.V. Management Board approval of a proposal from Transamerica Corporation, Transamerica Corporation made a pension plan contribution of EUR 89 million in September 2017 (EUR 226 million in September 2016) that was over and above the minimum required funding levels as set forth by the Internal Revenue Code.
Annual Report on Form 20-F 2017 |
263 | Notes to the consolidated financial statements Note 41 | |
Aegon USA also sponsors supplemental retirement plans to provide senior management with benefits in excess of normal retirement benefits. The plans are unfunded and are not qualified under the Internal Revenue Code. The supplemental retirement plans are governed by either Transamerica Corporation, or the Compensation Committee of the Board of Directors of Transamerica Corporation. Transamerica Corporation, or the Compensation Committee of the Board of Directors has the full power and discretion to apply all of the plans provisions, including such responsibilities as, but not limited to, interpret the plan provisions, to make factual determinations under the plan, to determine plan benefits, and to comply with any statutory reporting and disclosure requirements. The benefits are based on years of service and the employees eligible annual compensation. The plans provide benefits based on a traditional final average formula or a cash balance formula (which defines the accrued benefit in terms of a stated account balance), depending on the age and service of the plan participant. The company funds the benefit payments of the supplemental retirement plans from its general account assets. The unfunded amount related to these plans, for which a liability has been recorded, was EUR 257 million (2016: EUR 286 million unfunded).
Aegon USA provides health care benefits to retired employees through continuation of coverage in self funded plans, which are classified as unfunded per IAS 19 financial guidance. The postretirement health care benefits under the Plans are administered by Transamerica Corporation, which has delegated the claims administration to third-party administrators. Aegon USA maintains two plans which provide continuation of coverage for retiree medical benefits. For each plan, Aegon USA has the fiduciary responsibility to administer the plan in accordance with its terms, and decides questions related to eligibility and determines plan provisions and benefit amounts.
Under the Employee Retirement Income Security Act (ERISA), Aegon USA has the fiduciary responsibility to monitor the quality of services provided by the third-party claims administrator and to replace the third-party administrator if needed. In addition, Aegon USA has the fiduciary obligation to interpret the provisions of the plans, and to comply with any statutory reporting and disclosure requirements. Finally, Aegon USA reviews the terms of the plans and makes changes to the plans if and when appropriate. Aegon USA funds the benefit payments of the post-retirement health care plans from its general account assets. The post-retirement health benefit liability amounted to EUR 227 million (2016: EUR 246 million).
The weighted average duration of the defined benefit obligation is 13.2 years (2016: 13.3 years).
The principal actuarial assumptions that apply for the year ended December 31 are as follows:
Actuarial assumptions used to determine defined benefit obligations at year-end | 2017 | 2016 | ||||||
Demographic actuarial assumptions |
||||||||
Mortality |
US mortality table 1) | US mortality table 2) | ||||||
Financial actuarial assumptions |
||||||||
Discount rate |
3.55% | 4.10% | ||||||
Salary increase rate |
3.85% | 3.87% | ||||||
Health care trend rate |
7.40% | 7.25% |
1 | U.S. Society of Actuaries RP2014 mortality table with Scale MP2017. |
2 | U.S. Society of Actuaries RP2014 mortality table with Scale MP2016. |
The principal actuarial assumptions have an effect on the amounts reported for the defined benefit obligation. A change as indicated in the table below in the principal actuarial assumptions would have the following effects on the defined benefit obligation per year-end:
Annual Report on Form 20-F 2017 |
264 | Notes to the consolidated financial statements Note 41 | |
Aegon the Netherlands
Aegon Nederland has a number of defined benefit plans and a small number of defined contribution plans. The defined benefit plans are subject to Dutch Pension regulations and governed by the Board of Directors of Aegon Nederland. The Board of Directors has the full power and discretion to administer the plan including developing investment policy and managing assets for the plans (although these assets do not qualify as plan assets as defined by IFRS), deciding questions related to eligibility and benefit amounts, and any disputes that may arise from plan participants and for complying with the plan provisions, and legal requirements related to the plan and its operation. Aegon Nederland runs, in principle, full actuarial and investment risk regarding the defined benefit plans. This includes the risks of low interest rates, low returns and increased longevity. A part of this risk can be attributed to plan participants by lowering indexation or by increasing employee contributions.
Furthermore, the specific statutory requirements governing the administration of group pension schemes have been laid down in the Pension Act (Pensioenwet / Pw). Insurers are subject to prudential supervision pursuant to the Financial Supervision Act (Wet op het financieel toezicht / Wft).
Investment strategies are established based on asset and liability studies. The overall goal is to maximize total investment returns to provide sufficient funding for the present and anticipated future benefit obligations within the constraints of a prudent level of portfolio risk. These studies use for example return objectives and various investment instruments. Investment restrictions are updated regularly and they result in asset allocation mix and hedges.
The contributions to the retirement benefit plan of Aegon Nederland are paid by both the employees and the employer, with the employer contribution being variable 1 . The benefits covered are retirement benefits, disability, death and survivor pension and are based on an average wage system. The defined benefit plans were unfunded by EUR 2,628 million at December 31, 2017. (2016: EUR 3,121 million). The defined benefit plans are largely backed by investment, although these assets do not qualify as plan assets as defined by IFRS The average remaining duration of the defined benefits obligation is 19.6 years (2016: 19.7 years).
As a consequence of the sale of UMG to Aon Groep Nederland during 2017, the defined benefit obligation (DBO) and the assets backing the DBO related to UMG have been derecognized. This resulted in a decrease of the DBO and insurance contracts for general account of EUR 478 million. On the other hand, the pension contract between UMG and Aegon Levensverzekering N.V. is no longer
1 | Aegon Nederland deducts employee contributions from the total pension expenses. |
Annual Report on Form 20-F 2017 |
265 | Notes to the consolidated financial statements Note 41 | |
eliminated. This resulted in an increase of the insurance contracts for risk of policy holders and investments for account of policy holders of EUR 442 million.
Aegon Nederland also has a post-retirement medical plan that contributes to the health care coverage of employees and beneficiaries after retirement. For this plan, Aegon Nederland has the responsibility to administer the plan in accordance with its terms, and decides on questions related to eligibility and determines plan provisions and benefit amounts. In addition, Aegon Nederland has the obligation to interpret the provisions of the plans, and to comply with any statutory reporting and disclosure requirements. Finally, Aegon Nederland reviews the terms of the plans and makes changes to the plans if and when appropriate. The liabilities related to these other post-employment benefit plans are fully unfunded and amount to EUR 65 million at December 31, 2017 (2016: EUR 68 million). The weighted average duration of the other post-employment benefit plans is 11.9 years (2016: 10.8 years).
Plan amendments
The minimum tax-qualified retirement age for occupational retirement plans in the Netherlands is triggered by an increase in average life expectancy as determined by the Central Bureau of Statistics. Effective January 1, 2018, the tax-qualified retirement age in combination with the maximum annual benefit accrual of 1.875% becomes 68. As a result Aegon has changed the retirement age of its pension plan from 67 to 68 years as from January 1, 2018.
The principal actuarial assumptions that apply for the year-ended December 31 are as follows:
The above sensitivity analysis is based on a change in one assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the defined benefit obligation recognized within the statement of financial position.
Annual Report on Form 20-F 2017 |
266 | Notes to the consolidated financial statements Note 41 | |
Aegon UK
Aegon UK operated a defined benefit pension scheme providing benefits for staff based on final pensionable salary and years of service. The scheme closed to new entrants a number of years ago and closed to future accrual on March 31, 2013. Aegon UK now offers a defined contribution pension scheme to all employees.
The pension scheme is administered separately from Aegon UK and is governed by Trustees, who are required to act in the best interests of the pension scheme members.
The pension scheme Trustees are required to carry out triennial valuations on the schemes funding position, with the latest valuation being as at March 31, 2016. As part of this triennial valuation process, a schedule of contributions is agreed between the Trustees and Aegon UK in accordance with UK pensions legislation and guidance issued by the Pensions Regulator in the UK. The schedule of contributions includes deficit reduction contributions to clear any scheme deficit. Under IAS 19, the defined benefit plan has a deficit of EUR 137 million at December 31, 2017 (2016: EUR 298 million deficit).
The investment strategy for the scheme is determined by the trustees in consultation with Aegon UK. Currently 40% of assets are invested in growth assets (i.e. primarily equities) and 60% are liability driven investments where the investments are a portfolio of fixed interest and inflation-linked bonds and related derivatives, selected to broadly match the interest rate and inflation profile of liabilities.
Under the scheme rules, pensions in payment increase in line with the UK Retail Price Index, and deferred benefits increase in line with the UK Consumer Price Index. The pension scheme is therefore exposed to UK inflation changes as well as interest rate risks, investment returns and changes in the life expectancy of pensioners.
The weighted average duration of the defined benefit obligation is 23.1 years (2016: 23.0 years).
The principal actuarial assumptions that apply for the year ended December 31 are as follows:
The above sensitivity analysis is based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the pension liability recognized within the statement of financial position.
Annual Report on Form 20-F 2017 |
267 | Notes to the consolidated financial statements Note 42 | |
Target allocation of plan assets for retirement
benefit plans for the next annual period is: |
||||
Equity instruments |
29% | |||
Debt instruments |
71% |
All other operating segments
Businesses included in all other operating segments mostly operate defined contribution plans.
2017 | 2016 | |||||||
At January 1 |
64 | 112 | ||||||
Income deferred |
1 | 4 | ||||||
Disposals |
- | (31 | ) | |||||
Release to income statement |
(5 | ) | (6 | ) | ||||
Net exchange differences |
(2 | ) | (14 | ) | ||||
Transfers to disposal groups |
(45 | ) | - | |||||
At December 31 |
13 | 64 |
Transfers to disposal groups relates to the Aegon Ireland plc. business which is classified as held for sale per year-end 2017 and as a result the deferred gains are no longer included in the 2017 ending balance.
2017 | 2016 | |||||||
Deferred tax assets |
79 | 87 | ||||||
Deferred tax liabilities |
1,029 | 2,201 | ||||||
Total net deferred tax liability / (asset) |
950 | 2,113 |
Deferred tax assets comprise temporary differences on: | 2017 | 2016 | ||||||
Financial assets |
(20 | ) | (22 | ) | ||||
Insurance and investment contracts |
(19 | ) | (55 | ) | ||||
Deferred expenses, VOBA and other intangible assets |
(140 | ) | (148 | ) | ||||
Defined benefit plans |
26 | 54 | ||||||
Losses |
176 | 221 | ||||||
Other |
57 | 37 | ||||||
At December 31 |
79 | 87 |
Deferred tax liabilities comprise temporary differences on: | 2017 | 2016 | ||||||
Real estate |
554 | 541 | ||||||
Financial assets |
1,724 | 3,143 | ||||||
Insurance and investment contracts |
(1,806 | ) | (3,042 | ) | ||||
Deferred expenses, VOBA and other intangible assets |
1,752 | 3,150 | ||||||
Defined benefit plans |
(268 | ) | (592 | ) | ||||
Losses |
(120 | ) | (188 | ) | ||||
Other |
(807 | ) | (812 | ) | ||||
At December 31 |
1,029 | 2,201 |
Annual Report on Form 20-F 2017 |
268 | Notes to the consolidated financial statements Note 43 | |
The following table provides a movement schedule of net deferred tax broken-down by those items for which a deferred tax asset or liability has been recognized.
At January 1, 2017 |
541 | 3,165 | (2,988 | ) | 3,298 | (645 | ) | (407 | ) | (850 | ) | 2,113 | ||||||||||||||||||||
Acquisitions / Additions |
- | - | - | 9 | - | (1 | ) | (14 | ) | (6 | ) | |||||||||||||||||||||
Charged to income statement |
37 | 32 | 609 | (1,016 | ) | 120 | 78 | (62 | ) | (202 | ) | |||||||||||||||||||||
Charged to equity |
(9 | ) | (874 | ) | - | - | 174 | - | (5 | ) | (715 | ) | ||||||||||||||||||||
Net exchange differences |
(16 | ) | (270 | ) | 241 | (322 | ) | 57 | 27 | 111 | (172 | ) | ||||||||||||||||||||
Disposal of a business |
- | - | - | 2 | - | - | - | 2 | ||||||||||||||||||||||||
Transfers to disposal groups |
- | - | - | - | - | 8 | - | 8 | ||||||||||||||||||||||||
Transfer to current income tax |
- | - | - | - | - | - | (73 | ) | (73 | ) | ||||||||||||||||||||||
Transfer to/from other headings |
- | (300 | ) | 351 | (79 | ) | - | - | 27 | - | ||||||||||||||||||||||
Other |
- | (9 | ) | - | - | - | - | 2 | (7 | ) | ||||||||||||||||||||||
At December 31, 2017 |
554 | 1,744 | (1,787 | ) | 1,892 | (295 | ) | (296 | ) | (863 | ) | 950 | ||||||||||||||||||||
At January 1, 2016 |
434 | 2,735 | (2,500 | ) | 3,008 | (688 | ) | (500 | ) | (261 | ) | 2,227 | ||||||||||||||||||||
Charged to income statement |
99 | 596 | (380 | ) | 222 | 135 | 57 | (543 | ) | 185 | ||||||||||||||||||||||
Charged to equity |
3 | (264 | ) | (2 | ) | 2 | (85 | ) | - | (2 | ) | (350 | ) | |||||||||||||||||||
Net exchange differences |
5 | 84 | (108 | ) | 69 | (6 | ) | 34 | (45 | ) | 34 | |||||||||||||||||||||
Transfer to current income tax |
- | 16 | - | - | - | - | - | 16 | ||||||||||||||||||||||||
Other |
- | (1 | ) | 2 | (3 | ) | (1 | ) | 1 | 3 | - | |||||||||||||||||||||
At December 31, 2016 |
541 | 3,165 | (2,988 | ) | 3,298 | (645 | ) | (409 | ) | (849 | ) | 2,113 |
The decrease of the United States corporate income tax rate from 35% to 21% as from January 1, 2018 with an impact of total EUR 1,034 million, EUR 554 million through profit and loss and EUR 479 million through other comprehensive income (refer to note 18) is the main cause for the total decrease in the deferred tax liability in 2017 of EUR 1,163 million.
The transfer to current income tax relates to transfers from deferred to current tax, in relation to own equity instruments.
Transfer to/from other headings in 2017 includes transfers between two reporting segments.
In 2016, there were considerable movements in the net deferred tax schedule. The major components consisted of:
◆ | The increase of deferred tax liability primarily related to an increase of unrealised profits in respect of financial assets mainly driven by tightening credit spread |
◆ | The movement in Insurance contracts and Intangible assets mainly related to the reclassification through these categories |
◆ | The increase in Other mainly related to the deferral tax credits in 2016 |
Deferred corporate income tax assets are recognized for tax losses carried forward to the extent that the realization of the related tax benefit through future taxable profits is probable. For an amount of gross EUR 85 million; tax EUR 15 million (2016: gross EUR 505 million; tax EUR 90 million) the realization of the deferred tax asset is dependent on the projection of future taxable profits from existing business in excess of the profits arising from the reversal of existing taxable temporary differences.
Annual Report on Form 20-F 2017 |
269 | Notes to the consolidated financial statements Note 44 | |
For the following amounts, arranged by loss carry forward periods, the deferred corporate income tax asset is not recognized:
Gross amounts 1) |
Not recognized deferred tax assets |
|||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
< 5 years |
89 | 101 | 22 | 26 | ||||||||||||
> 5 10 years |
137 | 130 | 18 | 16 | ||||||||||||
> 10 15 years |
- | 1 | 25 | 33 | ||||||||||||
> 15 20 years |
- | - | - | - | ||||||||||||
Indefinitely |
499 | 396 | 111 | 94 | ||||||||||||
At December 31 |
725 | 628 | 177 | 170 |
1 | The gross value of state tax loss carry forward is not summarized in the disclosure, due to the fact that the United States files in different state jurisdictions with various applicable tax rates and apportionment rules |
Deferred corporate income tax assets in respect of deductible temporary differences are recognized to the extent that the realization of the related tax benefit through future taxable profits is probable. For the following amounts relating to Defined benefit plans and Other items the recognition of the deferred corporate income tax asset is dependent on future taxable profits in excess of the profits arising from the reversal of existing taxable temporary differences:
Gross amounts | Deferred tax assets | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Deferred corporate income tax asset dependent on retaining bonds and similar investments until the earlier of market recovery or maturity 1) |
- | 816 | - | 286 | ||||||||||||
Deferred corporate income tax asset dependent on future taxable profits |
261 | 362 | 46 | 64 | ||||||||||||
At December 31 |
261 | 1,179 | 46 | 350 |
1 | The amendment of IAS 12, relating to deferred tax assets on unrealized losses, changed the qualification by Aegon of holding bonds and similar investments until the earlier of market recovery or maturity from a tax planning opportunity into a source of income with no impact on the figures presented. |
Aegon did not recognize deferred corporate income tax assets in respect of deductible temporary differences relating to Financial assets and Other items for the amount of gross EUR 43 million; tax EUR 8 million (2016: gross EUR 70 million; tax EUR 13 million).
Deferred corporate income tax liabilities have not been recognized for withholding tax and other taxes that would be payable on the unremitted earnings of certain subsidiaries. The unremitted earnings totaled gross EUR 1,771 million; tax EUR 441 million (2016: gross EUR 1,770 million; tax EUR 441 million).
All deferred corporate income taxes are non-current by nature.
2017 | 2016 1) | |||||||
Payables due to policyholders |
1,184 | 1,337 | ||||||
Payables due to brokers and agents |
385 | 428 | ||||||
Payables out of reinsurance |
3,010 | 2,443 | ||||||
Social security and taxes payable |
125 | 125 | ||||||
Investment creditors |
1,228 | 1,437 | ||||||
Cash collateral on derivative transactions |
2,335 | 2,841 | ||||||
Cash collateral on securities lended |
3,277 | 3,633 | ||||||
Cash collateral - other |
43 | 50 | ||||||
Repurchase agreements |
1,373 | 1,489 | ||||||
Commercial paper |
72 | 128 | ||||||
Bank overdrafts |
2 | 1 | ||||||
Other creditors |
2,174 | 3,067 | ||||||
At December 31 |
15,208 | 16,978 | ||||||
Current |
14,992 | 16,101 | ||||||
Non-current |
216 | 877 |
1 | Certain amounts within Other liabilities in 2016 have been reclassified to conform to the current year presentation as certain accounts were previously not mapped correctly to the line items disclosed in this note. These reclassifications are not considered material as these reclassifications had no effect on net income, shareholders equity and earnings per share, nor on the total of other liabilities of EUR 16,978 reported in 2016. Reclassifications affected all items, except for Commercial paper and Bank overdrafts. |
Annual Report on Form 20-F 2017 |
270 | Notes to the consolidated financial statements Note 45 | |
The carrying amounts disclosed reasonably approximate the fair values at year-end, given the predominantly current nature of the other liabilities.
2017 | 2016 | |||||||
Accrued interest |
183 | 131 | ||||||
Accrued expenses |
147 | 106 | ||||||
At December 31 |
329 | 237 |
The carrying amounts disclosed reasonably approximate the fair values as at the year-end.
46 Capital management and solvency
After receiving a confirmation from the Dutch Central Bank (DNB) Aegon started to apply a revised method in calculating the Solvency II contribution of the Aegon US Insurance entities under Deduction & Aggregation (D&A), affecting Aegons tiering of capital in 2017. It includes lowering the conversion factor from 250% to 150% Risk-Based Capital Company Action Level and reducing own funds by a 100% RBC Company Action Level requirement to reflect transferability restrictions. The methodology is subject to annual review. This methodology is consistent with EIOPAs guidance on group solvency calculation in the context of equivalence, and in line with methods applied by other European peer companies. As a consequence, this adjustment improves the comparability to capital positions of European insurance groups with substantial insurance activities in the US. The impact on Available Own Funds in 2016 is included in the table in the Capital quality section below. Aegon manages its available capital on the new basis.
Strategic importance
Aegons approach towards capital management plays a vital role in supporting the execution of its strategy. Next to ensuring adequate capitalization to cover Aegons obligations towards its policyholders, capital management priorities also include the shift of capital to products that offer higher growth and return prospects, the shift from capital intensive spread business to capital light fee business and Aegons aim to provide for a sustainable dividend to shareholders, which can grow over time if the Companys performance so allows.
Management of capital
Disciplined risk and capital management support Aegons decisions in deploying the capital that is generated in the Companys businesses and that is provided for by investors. Aegon balances the funding of new business growth with the funding required to ensure that its obligations towards policyholders and debtholders are always adequately met, and providing for a sustainable dividend to shareholders.
Aegons goal for both its operating units and for the Aegon group as a whole is to maintain a strong financial position and to be able to sustain losses from extreme business and market conditions. The companys overall capital management strategy is based on adequate solvency capital, capital quality, and the use of leverage.
Aegons ERM framework ensures that the Aegon Group and its operating companies are adequately capitalized and that obligations towards policyholders are always adequately met. Firmly embedded in this larger framework, Aegons capital management framework builds on a set of key pillars: the use of internal target capital management zones, an internal target range for the use of gross financial leverage and, supported by robust risk and capital monitoring processes that timely trigger and escalate interventions if needed to ensure that capital is always being managed towards these internal target ranges, and is prevented from falling below the regulatory minimum capital requirements.
Capital adequacy
The capitalization of the Aegon Group and its operating units is managed in relation to the most stringent of local regulatory requirements, rating agency requirements and/or self-imposed criteria. Aegon manages its Solvency II capital in relation to the required capital. Under Aegons capital management framework the own funds are managed such that the Group Solvency II ratio remains within the target range of 150% - 200% even in an adverse event. This target range was updated in the second quarter of 2017 (previous target range: 140% - 170%) in line with a revision of Aegons group capital management policy and the methodology change mentioned above.
Annual Report on Form 20-F 2017 |
271 | Notes to the consolidated financial statements Note 46 | |
Minimum solvency requirements
Insurance laws and regulations in local regulatory jurisdictions often contain minimum regulatory capital requirements. For insurance companies in the European Union, Solvency II formally defines a lower capital requirement, being the Minimum Capital Requirement (MCR). An irreparable breach of the MCR would lead to a withdrawal of the Companys insurance license. Similarly, for the US insurance entities the withdrawal of the insurance license is triggered by a breach of the 100% Authorized Control Level (ACL), which is set at 50% of the Company Action Level (CAL).
With the introduction of Solvency II for EEA countries, Aegon views the higher capital requirement, 100% of the SCR, as the level around which EU supervisors will formally require management to provide regulatory recovery plans. For the US insurance entities this is viewed at 100% Company Action Level (CAL).
During 2017, the Aegon Group and all of its regulated entities that are subject to capital requirements on a solo-level continued to comply with the 100% Solvency II ratio.
Capital quality
Aegons capital consists of 3 Tiers as an indication of its quality, with Tier 1 capital ranking highest. It is to be noted that the Group own funds do not include any contingent liability potentially arising from unit-linked products sold, issued or advised on by Aegon in the Netherlands in the past as the potential liability cannot be reliably quantified at this point. Further, the available own funds is an estimate, has not been filed with the regulator and is subject to supervisory review.
The below table provides the composition of Aegons available own funds across Tiers:
Available own funds |
December 31, 2017
1)
Available own funds |
December 31, 2016
1)
Available own funds |
December 31, 2016
2)
Available own funds |
|||||||||
Unrestricted Tier 1 |
10,428 | 10,081 | 10,656 | |||||||||
Restricted Tier 1 |
3,540 | 3,817 | 3,817 | |||||||||
Tier 2 |
1,213 | 1,291 | 2,008 | |||||||||
Tier 3 |
448 | 768 | 1,638 | |||||||||
Total available own funds |
15,628 | 15,957 | 18,119 |
1 | The tiering information is based on the revised method which was confirmed by the DNB in 2017. |
2 | The 2016 comparative numbers are the final numbers as disclosed in Aegons 2016 Solvency and Financial Condition Report. |
Under the revised methodology Aegons own funds reduced by EUR 2.2 billion at December 31, 2016. This is reflected through eliminating deferred tax balances recorded in Tier 3 for an amount of EUR 0.9 billion and Tier 2 for an amount of EUR 0.7 billion and eliminating unrestricted Tier 1 of EUR 0.6 billion.
As at December 31, 2017, Tier 1 capital accounted for 89% of own funds (2016: 87%; number based on revised method), including EUR 3,047 million of junior perpetual capital securities (2016: EUR 3,309 million) and EUR 493 million of perpetual cumulative subordinated bonds (2016: EUR 508 million) which are both classified as grandfathered restricted Tier 1 capital.
As at December 31, 2017, Tier 2 capital accounted for 8% of own funds (2016: 8%; number based on revised method), including EUR 441 million of non-cumulative subordinated notes (2016: EUR 503 million) and EUR 772 million of fixed floating subordinated notes (2016: EUR 788 million) which are both classified as grandfathered Tier 2 capital. Changes in Tier 2 capital compared to previous year is mainly related to foreign currency movements.
The grandfathered restricted Tier 1 and Tier 2 capital instruments are grandfathered such that they are considered as capital under the Solvency II framework for up to 10 years as from January 1, 2016. For the terms and conditions of these grandfathered instruments refer to note 33 and note 34 to the consolidated financial statements.
It is to be noted that the difference between the amounts mentioned above for junior perpetual capital securities and perpetual cumulative subordinated bonds, and those in note 33 and note 34 to the consolidated financial statements, stem from valuation differences between Solvency II (market value) and IFRS rules (refer to note 2.17 and 2.18).
Tier 3 capital as of December 31, 2017 is comprised of deferred tax assets balances related to Solvency II entities.
Annual Report on Form 20-F 2017 |
272 | Notes to the consolidated financial statements Note 46 | |
IFRS equity compares to Solvency II own funds as follows:
December 31, 2017 1) | December 31, 2016 1) | December 31, 2016 2) | ||||||||||
Shareholders Equity |
20,288 | 20,520 | 20,520 | |||||||||
IFRS adjustments for Other Equity instruments and non controlling interests |
3,813 | 3,821 | 3,821 | |||||||||
Group Equity |
24,102 | 24,341 | 24,341 | |||||||||
Solvency II revaluations |
(5,416 | ) | (5,241 | ) | (5,241 | ) | ||||||
Excess of Assets over Liabilities |
18,685 | 19,100 | 19,100 | |||||||||
Availability adjustments |
(606 | ) | (361 | ) | (361 | ) | ||||||
Fungibility restrictions 2) |
(693 | ) | (619 | ) | (619 | ) | ||||||
Transferability restrictions 3) |
(1,758 | ) | (2,162 | ) | - | |||||||
Available own funds |
15,628 | 15,957 | 18,119 |
1 | The own funds information is based on the revised method which was confirmed by the DNB in 2017. |
2 | Amongst others, this contains the exclusion of Aegon Bank. |
3 | This includes the transferability restriction related to the new RBC CAL conversion methodology. |
4 | The 2016 comparative numbers are the final numbers as disclosed in Aegons 2016 Solvency and Financial Condition Report. |
The Solvency II revaluations of EUR 5,416 million negative (2016: EUR 5,241 million negative) stem from the difference in valuation between IFRS and Solvency II frameworks, which can be grouped into three categories:
◆ | Items that are not recognized under Solvency II. The most relevant examples of this category for Aegon include Goodwill, DPAC and other intangible assets (EUR 2,019 million, 2016: EUR 2,118 million); |
◆ | Items that have a different valuation treatment between IFRS and Solvency II. Solvency II is a market consistent framework hence all assets and liabilities are to be presented at fair value while IFRS also includes other valuation treatments in addition to fair value. The most relevant examples of this category for Aegon Group include Loans and Mortgages, Reinsurance Recoverables, Deferred tax assets balances and Technical provisions. The revaluation difference stemming from this category amounted to EUR (1,416) million (2016: EUR (1,531) million) compared to the IFRS Statement of Financial Position; |
◆ | The Net Asset Value of subsidiaries that are included under the Deduction & Aggregation method (on provisional equivalence or Standard Formula basis) in the Group Solvency II results. The revaluation difference stemming from this category amounted to EUR (6,019) million (2016: EUR (5,828) million) compared to the IFRS Statement of Financial Position. |
The availability adjustments are changes to the availability of own funds of Aegon Group in accordance with Solvency II requirements. Examples include the adjustments for subordinated liabilities, ring-fenced fund, treasury shares and foreseeable dividend (if applicable).
Fungibility restrictions limit the availability of own funds on Aegon Group level as prescribed by Supervisory Authorities. These limitations refer to charitable trusts in the Americas for which the local Supervisory Authority could limit the upstream of capital to the Group, to a temporary restriction in relation to the sale of Aegon Ireland (the difference between the sale price and Aegon Irelands own funds are considered not available at Group level until completion of the sale, expected in the first half of 2018) and Aegon Bank which is under a different regulatory regime but under the same Supervisory Authority and therefore excluded for Solvency II purposes.
Finally, Transferability restrictions reflect the restrictions on US Life Companies DTA and capping of Tier 1 unrestricted own funds as a consequence of the new RBC CAL conversion methodology as described above.
Capital leverage
Aegons total capitalization reflects the capital employed in the business units and consists of shareholders capital and total gross financial leverage. Aegons gross financial leverage ratio is calculated by dividing total financial leverage by total capitalization. Aegon aims to keep total gross financial leverage within a range of 26% to 30% of total capitalization as measured by the gross financial leverage ratio, and a fixed charge coverage in the range of 6-8x the interest payments on financial leverage.
Aegon defines total financial leverage as debt or debt-like funding issued for general corporate purposes and for capitalizing Aegons business units. Total financial leverage includes hybrid instruments, in addition to both subordinated and senior debt. Aegons total capitalization comprises the following components:
◆ | Shareholders equity excluding revaluation reserves and the remeasurement of defined benefit plans, based on IFRS as adopted by the EU; |
◆ | Non-controlling interests and share options not yet exercised; and |
◆ | Total financial leverage. |
Annual Report on Form 20-F 2017 |
273 | Notes to the consolidated financial statements Note 46 | |
As at December 31, 2017, Aegons total capitalization amounted to EUR 24.4 billion (EUR 24.8 billion on December 31, 2016), its gross financial leverage ratio was 28.6% (29.8% on December 31, 2016) and its fixed charge coverage was 8.0x (7.2x on December 31, 2016).
The following table shows the composition of the total capitalization and the calculation of the gross financial leverage ratio:
Note | 2017 | 2016 | ||||||||||
Total shareholders equity - based on IFRS as adopted by the EU |
2 | 20,573 | 20,913 | |||||||||
Non-controlling interests, share options and incentive plans not yet exercised |
33, SOFP 2) | 81 | 88 | |||||||||
Revaluation reserves |
32 | (4,920 | ) | (5,381 | ) | |||||||
Remeasurement of defined benefit plans |
32 | 1,669 | 1,820 | |||||||||
Shareholders capital |
17,401 | 17,440 | ||||||||||
Junior perpetual capital securities |
33 | 3,008 | 3,008 | |||||||||
Perpetual cumulative subordinated bonds |
33 | 454 | 454 | |||||||||
Non-cumulative subordinated notes (Other equity instruments) |
33 | 271 | 271 | |||||||||
Fixed floating subordinated notes |
34 | 695 | 695 | |||||||||
Non-cumulative subordinated notes (Subordinated borrowings) |
34 | 69 | 72 | |||||||||
Trust pass-through securities |
35 | 133 | 156 | |||||||||
Currency revaluation other equity instruments 1) |
40 | 340 | ||||||||||
Hybrid leverage |
4,669 | 4,996 | ||||||||||
Senior debt 3) |
39 | 2,312 | 2,414 | |||||||||
Senior leverage |
2,312 | 2,414 | ||||||||||
Total gross financial leverage |
6,982 | 7,409 | ||||||||||
Total capitalization |
24,383 | 24,849 | ||||||||||
Gross financial leverage ratio |
28.6% | 29.8% |
1 | Other equity instruments that are denominated in foreign currencies are, for purpose of calculating hybrid leverage, revalued to the period-end exchange rate. |
2 | Non-controlling interests are disclosed in the statement of financial position. |
3 | Senior debt for the gross financial leverage calculation also contains swaps for an amount of EUR 31 million (2016: EUR 28 million). |
Aegon N.V. is subject to financial covenants as included in a number of its financial agreements (such as issued debentures, credit facilities and ISDA agreements). Under these financial covenants, an event of default may occur if and when any financial indebtedness of any member of the Group is not paid when due, or not paid within any applicable grace period. The financial agreements may also include a cross-default provision which may be triggered if and when any financial indebtedness of any member of the Group is declared to be or otherwise becomes due and payable prior to its specified maturity as a result of an event of default.
All financial agreements are periodically monitored to assess the likelihood of a breach of any financial covenant and the likelihood thereof in the near future. No breach of any such covenant occurred during 2017.
Aegon N.V. is subject to legal restrictions with regard to the amount of dividends it can pay to its shareholders. Under Dutch law, the amount that is available to pay dividends consists of total shareholders equity less the issued and outstanding capital and the reserves required by law. The revaluation account and legal reserves, foreign currency translation reserve (FCTR) and other reserves, cannot be freely distributed. In case of negative balances for individual reserves legally to be retained, no distributions can be made out of retained earnings to the level of these negative amounts. Total distributable items under Dutch law amounted to EUR 13,749 million as at December 31, 2017 (2016: EUR 11,996 million). The following table shows the composition of the total distributable items:
Distributable items 1) | 2017 | 2016 | ||||||
Equity attributable to shareholders - based on IFRS as adopted by the EU |
20,573 | 20,913 | ||||||
Not distributable items: |
||||||||
Share capital |
(322 | ) | (319 | ) | ||||
Statutory reserves 2) |
(6,502 | ) | (8,598 | ) | ||||
At December 31 |
13,749 | 11,996 |
1 | Distributable items under Dutch law; note that Solvency II ratio also possibly restricts the distribution of dividends. |
2 | Statutory reserves contains legal reserves FCTR, group companies and revaluation account consists of positive revaluations only. |
Annual Report on Form 20-F 2017 |
274 | Notes to the consolidated financial statements Note 47 | |
The ability of Aegons subsidiaries, principally insurance companies, to pay dividends to the holding company is constrained by the requirement for these subsidiaries to remain adequately capitalized to the levels set by local insurance regulations and governed by local insurance supervisory authorities. Based on the capitalization level of the local subsidiary, local insurance supervisors are able to restrict and/or prohibit the transfer of dividends to the holding company. In addition, the ability of subsidiaries to pay dividends to the holding company can be constrained by the requirement for these subsidiaries to hold sufficient shareholders equity as determined by law. The capitalization level and shareholders equity of the subsidiaries can be impacted by various factors (e.g. general economic conditions, capital market risks, underwriting risk factors, changes in government regulations, and legal and arbitrational proceedings). To mitigate the impact of such factors on the ability to pay dividends, the subsidiaries hold additional capital in excess of the levels required by local insurance regulations, as reflected in Aegons target capitalization ranges.
The estimated fair values of Aegons assets and liabilities correspond with the amounts that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When available, Aegon uses quoted market prices in active markets to determine the fair value of investments and derivatives. In the absence of an active market, the fair value of investments in financial assets is estimated by using other market observable data, such as corroborated external quotes and present value or other valuation techniques. An active market is one in which transactions are taking place regularly on an arms length basis. Fair value is not determined based upon a forced liquidation or distressed sale.
Valuation techniques are used when Aegon determines the market is inactive or quoted market prices are not available for the asset or liability at the measurement date. However, the fair value measurement objective remains the same, that is, to estimate the price at which an orderly transaction to sell the asset or to transfer the liability would take place between market participants at the measurement date under current market conditions (i.e. an exit price at the measurement date from the perspective of a market participant that holds the asset or owes the liability). Therefore, unobservable inputs reflect Aegons own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). These inputs are developed based on the best information available.
Aegon employs an oversight structure over valuation of financial instruments that includes appropriate segregation of duties. Senior management, independent of the investing functions, is responsible for the oversight of control and valuation policies and for reporting the results of these policies. For fair values determined by reference to external quotation or evidenced pricing parameters, independent price determination or validation is utilized to corroborate those inputs. Further details of the validation processes are set out below.
Valuation of assets and liabilities is based on a pricing hierarchy, in order to maintain a controlled process that will systematically promote the use of prices from sources in which Aegon has the most confidence, where the least amount of manual intervention exists and to embed consistency in the selection of price sources. Depending on asset type the pricing hierarchy consists of a waterfall that starts with making use of market prices from indices and follows with making use of third-party pricing services or brokers.
Annual Report on Form 20-F 2017 |
275 | Notes to the consolidated financial statements Note 47 | |
Fair value hierarchy
The table below provides an analysis of assets and liabilities recorded at fair value on a recurring basis by level of the fair value hierarchy:
Level I | Level II | Level III | Total 2017 | |||||||||||||
Assets carried at fair value |
||||||||||||||||
Available-for-sale |
||||||||||||||||
Shares |
51 | 151 | 288 | 490 | ||||||||||||
Debt securities |
26,338 | 52,415 | 1,447 | 80,200 | ||||||||||||
Money market and other short-term instruments |
1,664 | 5,026 | - | 6,690 | ||||||||||||
Other investments at fair value |
- | 208 | 583 | 791 | ||||||||||||
28,053 | 57,800 | 2,318 | 88,170 | |||||||||||||
Fair value through profit or loss |
||||||||||||||||
Shares |
226 | 232 | 604 | 1,062 | ||||||||||||
Debt securities |
1,964 | 2,175 | 4 | 4,144 | ||||||||||||
Money market and other short-term instruments |
17 | 102 | - | 119 | ||||||||||||
Other investments at fair value |
1 | 539 | 1,255 | 1,795 | ||||||||||||
Investments for account of policyholders 1) |
115,323 | 76,302 | 1,784 | 193,409 | ||||||||||||
Derivatives |
68 | 5,787 | 57 | 5,912 | ||||||||||||
Investments in real estate |
- | - | 2,147 | 2,147 | ||||||||||||
Investments in real estate for policyholders |
- | - | 655 | 655 | ||||||||||||
117,599 | 85,137 | 6,506 | 209,241 | |||||||||||||
Revalued amounts |
||||||||||||||||
Real estate held for own use |
- | - | 307 | 307 | ||||||||||||
|
-
|
|
|
-
|
|
|
307
|
|
|
307
|
|
|||||
Total assets at fair value |
145,652 | 142,937 | 9,130 | 297,718 | ||||||||||||
Liabilities carried at fair value |
||||||||||||||||
Investment contracts for account of policyholders 2) |
- | 36,950 | 219 | 37,169 | ||||||||||||
Borrowings 3) |
- | 536 | - | 536 | ||||||||||||
Derivatives |
34 | 5,251 | 1,845 | 7,130 | ||||||||||||
Total liabilities at fair value |
34 | 42,738 | 2,064 | 44,835 |
1 | The investments for account of policyholders included in the table above only include investments carried at fair value through profit or loss. |
2 | The investment contracts for account of policyholders included in the table above represents only those investment contracts carried at fair value. |
3 | Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule. |
Note that the investment contracts for account of policyholders previously reported as Level I have been reclassified to Level II, as the value of these liabilities is directly derived from the fair value of the linked investments for account of policyholders. The comparative numbers have been adjusted accordingly. These reclassifications had no effect on net income, shareholders equity or earnings per share.
Annual Report on Form 20-F 2017 |
276 | Notes to the consolidated financial statements Note 47 | |
Level I | Level II | Level III | Total 2016 | |||||||||||||
Assets carried at fair value |
||||||||||||||||
Available-for-sale |
||||||||||||||||
Shares |
119 | 312 | 393 | 824 | ||||||||||||
Debt securities |
29,386 | 69,702 | 1,966 | 101,054 | ||||||||||||
Money market and other short-term instruments |
- | 6,776 | - | 6,776 | ||||||||||||
Other investments at fair value |
- | 453 | 754 | 1,206 | ||||||||||||
29,504 | 77,243 | 3,112 | 109,860 | |||||||||||||
Fair value through profit or loss |
||||||||||||||||
Shares |
288 | 152 | 50 | 490 | ||||||||||||
Debt securities |
27 | 2,082 | 6 | 2,115 | ||||||||||||
Money market and other short-term instruments |
- | 317 | - | 317 | ||||||||||||
Other investments at fair value |
1 | 961 | 1,257 | 2,219 | ||||||||||||
Investments for account of policyholders 1) |
125,997 | 75,202 | 1,726 | 202,924 | ||||||||||||
Derivatives |
41 | 8,169 | 108 | 8,318 | ||||||||||||
Investments in real estate |
- | - | 1,999 | 1,999 | ||||||||||||
Investments in real estate for policyholders |
- | - | 686 | 686 | ||||||||||||
126,355 | 86,883 | 5,831 | 219,069 | |||||||||||||
Revalued amounts |
||||||||||||||||
Real estate held for own use |
- | - | 332 | 332 | ||||||||||||
|
-
|
|
|
-
|
|
|
332
|
|
|
332
|
|
|||||
Total assets at fair value |
155,860 | 164,126 | 9,275 | 329,261 | ||||||||||||
Liabilities carried at fair value |
||||||||||||||||
Investment contracts for account of policyholders 2) |
- | 42,627 | 176 | 42,803 | ||||||||||||
Borrowings 3) |
- | 610 | - | 610 | ||||||||||||
Derivatives |
64 | 6,347 | 2,467 | 8,878 | ||||||||||||
Total liabilities at fair value |
64 | 49,584 | 2,643 | 52,290 |
1 | The investments for account of policyholders included in the table above only include investments carried at fair value through profit or loss. |
2 | The investment contracts for account of policyholders included in the table above represents only those investment contracts carried at fair value. |
3 | Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule. |
Annual Report on Form 20-F 2017 |
277 | Notes to the consolidated financial statements Note 47 | |
Significant transfers between Level I, Level II and Level III
Aegons policy is to record transfers of assets and liabilities between Level I, Level II and Level III at their fair values as of the beginning of each reporting period.
The table below shows transfers between Level I and Level II for financial assets and financial liabilities recorded at fair value on a recurring basis.
Total 2017 | Total 2016 | |||||||||||||||
Transfers Level I
to Level II |
Transfers Level II
to Level I |
Transfers Level I
to Level II |
Transfers Level II
to Level I |
|||||||||||||
Assets carried at fair value |
||||||||||||||||
Available-for-sale |
||||||||||||||||
Shares |
1 | 1 | - | - | ||||||||||||
Debt securities |
12 | - | 5 | 69 | ||||||||||||
Money markets and other short-term instruments |
- | 1,664 | - | - | ||||||||||||
13 | 1,666 | 5 | 69 | |||||||||||||
Fair value through profit or loss |
||||||||||||||||
Shares |
124 | 19 | - | - | ||||||||||||
Investments for account of policyholders |
12 | 30 | 3 | (1 | ) | |||||||||||
136 | 49 | 3 | (1 | ) | ||||||||||||
Total assets at fair value |
149 | 1,714 | 8 | 68 | ||||||||||||
Investment contracts for account of policyholders |
1 | - | - | - | ||||||||||||
Total liabilities carried at fair value |
1 | - | - | - |
Transfers are identified based on transaction volume and frequency, which are indicative of an active market.
Movements in Level III financial instruments measured at fair value
The following table summarizes the change of all assets and liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (Level III), including realized and unrealized gains (losses) of all assets and liabilities and unrealized gains (losses) of all assets and liabilities still held at the end of the respective period.
Annual Report on Form 20-F 2017 |
278 | Notes to the consolidated financial statements Note 47 | |
Assets carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-sale |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
393 | 54 | (46 | ) | 68 | (112 | ) | (35 | ) | (34 | ) | - | - | - | - | 288 | - | |||||||||||||||||||||||||||||||||||
Debt securities |
1,966 | 39 | (2 | ) | 678 | (149 | ) | (890 | ) | (186 | ) | - | 203 | (211 | ) | - | 1,447 | - | ||||||||||||||||||||||||||||||||||
Other investments at fair value |
754 | (112 | ) | (109 | ) | 194 | (48 | ) | (9 | ) | (87 | ) | - | 1 | - | - | 583 | - | ||||||||||||||||||||||||||||||||||
3,112 | (19 | ) | (158 | ) | 939 | (309 | ) | (935 | ) | (307 | ) | - | 205 | (211 | ) | - | 2,318 | - | ||||||||||||||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
50 | (11 | ) | - | 583 | (18 | ) | - | - | - | - | - | - | 604 | (11 | ) | ||||||||||||||||||||||||||||||||||||
Debt securities |
6 | - | - | - | - | - | (1 | ) | - | - | - | - | 4 | 1 | ||||||||||||||||||||||||||||||||||||||
Other investments at fair value |
1,257 | 23 | - | 378 | (350 | ) | - | (162 | ) | - | 341 | (233 | ) | - | 1,255 | 20 | ||||||||||||||||||||||||||||||||||||
Investments for account of policyholders |
1,726 | 11 | - | 671 | (622 | ) | - | (27 | ) | - | 32 | (8 | ) | - | 1,784 | 30 | ||||||||||||||||||||||||||||||||||||
Derivatives |
108 | (33 | ) | - | - | - | - | (2 | ) | (16 | ) | - | - | - | 57 | (21 | ) | |||||||||||||||||||||||||||||||||||
Investments in real estate |
1,999 | 193 | - | 246 | (202 | ) | - | (89 | ) | - | - | - | - | 2,147 | 77 | |||||||||||||||||||||||||||||||||||||
Investments in real estate for policyholders |
686 | 38 | - | 10 | (53 | ) | - | (26 | ) | - | - | - | - | 655 | 38 | |||||||||||||||||||||||||||||||||||||
5,831 | 220 | - | 1,889 | (1,245 | ) | - | (306 | ) | (16 | ) | 374 | (241 | ) | - | 6,506 | 134 | ||||||||||||||||||||||||||||||||||||
Revalued amounts |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Real estate held for own use |
332 | (2 | ) | 8 | (3 | ) | (4 | ) | - | (24 | ) | - | - | - | - | 307 | (3 | ) | ||||||||||||||||||||||||||||||||||
|
332
|
|
|
(2
|
)
|
|
8
|
|
|
(3
|
)
|
|
(4
|
)
|
|
-
|
|
|
(24
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
307
|
|
|
(3
|
)
|
||||||||||||||
Total assets at fair value |
9,275 | 199 | (150 | ) | 2,826 | (1,558 | ) | (935 | ) | (638 | ) | (16 | ) | 578 | (452 | ) | - | 9,130 | 131 | |||||||||||||||||||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment contracts for account of policyholders |
176 | 7 | - | 60 | (21 | ) | - | (12 | ) | - | 10 | (2 | ) | - | 219 | (2 | ) | |||||||||||||||||||||||||||||||||||
Derivatives |
2,467 | (828 | ) | - | - | 300 | - | (75 | ) | 10 | - | - | (30 | ) | 1,845 | (745 | ) | |||||||||||||||||||||||||||||||||||
2,643 | (821 | ) | - | 60 | 279 | - | (87 | ) | 10 | 10 | (2 | ) | (30 | ) | 2,064 | (747 | ) |
1 | Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item Results from financial transactions of the income statement. |
2 | Total gains and losses are recorded in line items: Gains / (losses) on revaluation of available-for-sale investments, (Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments and Changes in revaluation reserve real estate held for own use of the statement of other comprehensive income. |
3 | Total gains / (losses) for the period during which the financial instrument was in Level III. |
Annual Report on Form 20-F 2017 |
279 | Notes to the consolidated financial statements Note 47 | |
Assets carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-sale |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
293 | 27 | (7 | ) | 161 | (92 | ) | (1 | ) | 11 | - | - | - | - | 393 | - | ||||||||||||||||||||||||||||||||||||
Debt securities |
4,144 | 1 | 92 | 443 | (262 | ) | (287 | ) | 39 | - | 651 | (2,854 | ) | - | 1,966 | - | ||||||||||||||||||||||||||||||||||||
Other investments at fair value |
928 | (177 | ) | 20 | 240 | (133 | ) | (141 | ) | 18 | - | - | (1 | ) | - | 754 | - | |||||||||||||||||||||||||||||||||||
5,365 | (150 | ) | 105 | 845 | (487 | ) | (429 | ) | 68 | - | 651 | (2,856 | ) | - | 3,112 | - | ||||||||||||||||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
- | 3 | - | 48 | - | - | - | - | - | - | - | 50 | 3 | |||||||||||||||||||||||||||||||||||||||
Debt securities |
6 | (1 | ) | - | - | - | - | - | - | - | - | - | 6 | - | ||||||||||||||||||||||||||||||||||||||
Other investments at fair value |
1,265 | (44 | ) | - | 178 | (277 | ) | - | 35 | - | 419 | (321 | ) | - | 1,257 | (42 | ) | |||||||||||||||||||||||||||||||||||
Investments for account of policyholders |
1,745 | 22 | - | 469 | (395 | ) | - | (35 | ) | - | 8 | (88 | ) | - | 1,726 | 23 | ||||||||||||||||||||||||||||||||||||
Derivatives |
222 | (285 | ) | - | 75 | 108 | - | (12 | ) | - | - | - | - | 108 | (287 | ) | ||||||||||||||||||||||||||||||||||||
Investments in real estate |
1,990 | 70 | - | 120 | (215 | ) | - | 19 | 15 | - | - | - | 1,999 | 118 | ||||||||||||||||||||||||||||||||||||||
Investments in real estate for policyholders |
1,022 | (26 | ) | - | 81 | (260 | ) | - | (131 | ) | - | - | - | - | 686 | 22 | ||||||||||||||||||||||||||||||||||||
6,250 | (261 | ) | - | 971 | (1,039 | ) | - | (123 | ) | 15 | 427 | (409 | ) | - | 5,831 | (163 | ) | |||||||||||||||||||||||||||||||||||
Revalued amounts |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Real estate held for own use |
338 | (9 | ) | 8 | 5 | - | - | 6 | (15 | ) | - | - | - | 332 | 5 | |||||||||||||||||||||||||||||||||||||
|
338
|
|
|
(9
|
)
|
|
8
|
|
|
5
|
|
|
-
|
|
|
-
|
|
|
6
|
|
|
(15
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
332
|
|
|
5
|
|
||||||||||||||
Total assets at fair value |
11,954 | (420 | ) | 113 | 1,821 | (1,527 | ) | (429 | ) | (49 | ) | - | 1,077 | (3,264 | ) | - | 9,275 | (159 | ) | |||||||||||||||||||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment contracts for account of policyholders |
156 | (14 | ) | - | 45 | (12 | ) | - | 2 | - | - | (2 | ) | - | 176 | 1 | ||||||||||||||||||||||||||||||||||||
Derivatives |
2,104 | 542 | - | - | (207 | ) | - | 28 | - | - | - | - | 2,467 | 562 | ||||||||||||||||||||||||||||||||||||||
2,260 | 528 | - | 45 | (219 | ) | - | 31 | - | - | (2 | ) | - | 2,643 | 563 |
1 | Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item Results from financial transactions of the income statement. |
2 | Total gains and losses are recorded in line items: Gains / (losses) on revaluation of available-for-sale investments, (Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments and Changes in revaluation reserve real estate held for own use of the statement of other comprehensive income. |
3 | Total gains / (losses) for the period during which the financial instrument was in Level III. |
During 2017, Aegon transferred certain financial instruments from Level II to Level III of the fair value hierarchy. The reason for the change in level was that the market liquidity for these securities decreased, which led to a change in market observability of prices. Prior to transfer, the fair value for the Level II securities was determined using observable market transactions or corroborated broker quotes respectively for the same or similar instruments. The amount of assets and liabilities transferred to Level III was EUR 588 million (2016: EUR 1,077 million). Since the transfer, all such assets have been valued using valuation models incorporating significant non market-observable inputs or uncorroborated broker quotes.
Similarly, during 2017, Aegon transferred EUR 454 million (full year 2016: EUR 3,266 million) of financial instruments from Level III to other levels of the fair value hierarchy. The change in level was mainly the result of a return of activity in the market for these securities and that for these securities the fair value could be determined using observable market transactions or corroborated broker quotes for the same or similar instruments.
Annual Report on Form 20-F 2017 |
280 | Notes to the consolidated financial statements Note 47 | |
Valuation techniques and significant unobservable inputs
The table below presents information about the significant unobservable inputs used for recurring fair value measurements for certain Level III financial instruments.
Assets carried at fair
value |
Valuation technique 1) |
Significant
unobservable input 2) |
December 31,
2017 |
Range
(weighted average) |
December 31,
2016 |
Range
(weighted average) |
||||||||||||||||||
Available-for-sale |
||||||||||||||||||||||||
Shares |
Net asset value 3) | n.a. | 231 | n.a. | 262 | n.a. | ||||||||||||||||||
Other | n.a. | 57 | n.a. | 131 | n.a. | |||||||||||||||||||
288 | 393 | |||||||||||||||||||||||
Debt securities |
Broker quote | n.a. | 1,034 | n.a. | 1,389 | n.a. | ||||||||||||||||||
1.04% - 2.72% | 1.30% - 3.37% | |||||||||||||||||||||||
Discounted cash flow | Credit spread | 116 | (2.64%) | 221 | (3.08%) | |||||||||||||||||||
Other | n.a. | 297 | n.a. | 355 | n.a. | |||||||||||||||||||
1,447 | 1,966 | |||||||||||||||||||||||
Other investments at fair value |
||||||||||||||||||||||||
Tax credit investments |
Discounted cash flow | Discount rate | 528 | 5.8% | 676 | 5.6% | ||||||||||||||||||
Investment funds |
Net asset value 3) | n.a. | 31 | n.a. | 45 | n.a. | ||||||||||||||||||
Other |
Other | n.a. | 24 | n.a. | 32 | n.a. | ||||||||||||||||||
583 | 754 | |||||||||||||||||||||||
At December 31 |
2,318 | 3,112 | ||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||
Shares |
Other | n.a. | 604 | n.a. | 50 | n.a. | ||||||||||||||||||
Debt securities |
Other | n.a. | 4 | n.a. | 6 | n.a. | ||||||||||||||||||
609 | 56 | |||||||||||||||||||||||
Other investments at fair value |
||||||||||||||||||||||||
Investment funds |
Net asset value 3) | n.a. | 1,246 | n.a. | 1,252 | n.a. | ||||||||||||||||||
Other |
Other | n.a. | 9 | n.a. | 5 | n.a. | ||||||||||||||||||
1,255 | 1,257 | |||||||||||||||||||||||
Derivatives |
||||||||||||||||||||||||
Longevity swap |
Discounted cash flow | Mortality | 24 | n.a. | 27 | n.a. | ||||||||||||||||||
Longevity swap |
-/- 0.21% - | |||||||||||||||||||||||
Discounted cash flow | Risk free rate | - | - | 73 | 1.67% (1.01%) | |||||||||||||||||||
Other |
Other | n.a. | 30 | n.a. | 4 | n.a. | ||||||||||||||||||
54 | 104 | |||||||||||||||||||||||
Real estate |
||||||||||||||||||||||||
Investments in real estate |
Direct capitalization | Capitalization | 3.0% - 10.0% | 4.8% - 10.5% | ||||||||||||||||||||
technique | rate | 496 | (5.9%) | 568 | (6.3%) | |||||||||||||||||||
Appraisal value | n.a. | 1,495 | n.a. | 1,237 | n.a. | |||||||||||||||||||
Other | n.a. | 155 | n.a. | 193 | n.a. | |||||||||||||||||||
2,147 | 1,999 | |||||||||||||||||||||||
At December 31 |
4,065 | 3,415 | ||||||||||||||||||||||
Revalued amounts |
||||||||||||||||||||||||
Real estate held for own use |
Direct capitalization | Capitalization | 6.0% - 10.0% | 6.5% - 9.5% | ||||||||||||||||||||
technique | rate | 157 | (7.9%) | 178 | (7.9%) | |||||||||||||||||||
Appraisal value | n.a. | 115 | n.a. | 120 | n.a. | |||||||||||||||||||
Other | n.a. | 35 | n.a. | 34 | n.a. | |||||||||||||||||||
At December 31 |
307 | 332 | ||||||||||||||||||||||
Total assets at fair value 4) |
6,689 | 6,859 | ||||||||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||||||||||
Derivatives |
||||||||||||||||||||||||
Embedded derivatives in |
Own credit | 0.2% - 0.3% | 0.4% - 0.5% | |||||||||||||||||||||
insurance contracts |
Discounted cash flow | spread | 1,831 | (0.22%) | 2,083 | (0.4%) | ||||||||||||||||||
Longevity swap |
Discounted cash flow | Mortality | 10 | n.a. | - | n.a. | ||||||||||||||||||
Other |
Other | n.a. | 3 | n.a. | 384 | n.a. | ||||||||||||||||||
Total liabilities at fair value |
1,845 | 2,467 |
1 | Other in the table above (column Valuation technique) includes investments for which the fair value is uncorroborated and no broker quote is received. |
2 | Not applicable (n.a.) has been included when no significant unobservable assumption has been identified. |
3 | Net asset value is considered the best approximation to the fair value of these financial instruments. |
4 | Investments for account of policyholders are excluded from the table above and from the disclosure regarding reasonably possible alternative assumptions. Policyholder assets, and their returns, belong to policyholders and do not impact Aegons net income or equity. The effect on total assets is offset by the effect on total liabilities. Derivatives exclude derivatives for account of policyholders amounting to EUR 3 million (2016: EUR 4). |
Annual Report on Form 20-F 2017 |
281 | Notes to the consolidated financial statements Note 47 | |
For reference purposes, the valuation techniques included in the table above are described in more detail on the following pages.
Effect of changes in significant unobservable assumptions to reasonably possible alternatives
From all significant unobservable inputs, own credit spread as included in the discount rate for embedded derivatives in insurance contracts is considered significant. It is estimated that changing the other significant unobservable inputs to reflect reasonable possible alternatives in valuation would have no significant impact for the Group.
An increase in own credit spread results in lower valuation, while a decrease results in a higher valuation of the embedded derivatives.
The table below presents the impact on a fair value measurement of a change in the own credit spread by 20 basis points included in the discount rate.
December 31,
2017 |
Effect of reasonably
possible alternative assumptions (+/-) |
December 31,
2016 |
Effect of reasonably
possible alternative assumptions (+/-) |
|||||||||||||||||||||
Increase | Decrease | Increase | Decrease | |||||||||||||||||||||
Financial liabilities carried at fair value |
||||||||||||||||||||||||
Embedded derivatives in insurance contracts |
1,831 | 125 | (120 | ) | 2,083 | 205 | (194 | ) |
Fair value information about assets and liabilities not measured at fair value
The following table presents the carrying values and estimated fair values of assets and liabilities, excluding assets and liabilities which are carried at fair value on a recurring basis.
2017 |
Carrying amount
December 31, 2017 |
Estimated fair value hierarchy |
Total estimated fair
value December 31, 2017 |
|||||||||||||||||
Level I | Level II | Level III | ||||||||||||||||||
Assets |
||||||||||||||||||||
Mortgage loans - held at amortized cost |
33,562 | - | - | 38,076 | 38,076 | |||||||||||||||
Private loans - held at amortized cost |
3,642 | - | 64 | 4,117 | 4,181 | |||||||||||||||
Other loans - held at amortized cost |
2,164 | 6 | 1,991 | 166 | 2,164 | |||||||||||||||
Liabilities |
||||||||||||||||||||
Subordinated borrowings - held at amortized cost |
764 | 791 | 162 | - | 953 | |||||||||||||||
Trust pass-through securities - held at amortized cost |
133 | - | 137 | - | 137 | |||||||||||||||
Borrowings held at amortized cost |
13,099 | 2,116 | 28 | 11,355 | 13,499 | |||||||||||||||
Investment contracts - held at amortized cost |
16,665 | - | 9,676 | 7,356 | 17,031 |
2016 |
Carrying amount
December 31, 2016 |
Estimated fair value hierarchy |
Total estimated fair
value December 31, 2016 |
|||||||||||||||||
Level I | Level II | Level III | ||||||||||||||||||
Assets |
||||||||||||||||||||
Mortgage loans - held at amortized cost |
33,696 | - | - | 38,498 | 38,499 | |||||||||||||||
Private loans - held at amortized cost |
3,166 | - | 52 | 3,516 | 3,569 | |||||||||||||||
Other loans - held at amortized cost |
2,441 | - | 2,292 | 148 | 2,441 | |||||||||||||||
Liabilities |
||||||||||||||||||||
Subordinated borrowings - held at amortized cost |
767 | 703 | 140 | - | 844 | |||||||||||||||
Trust pass-through securities - held at amortized cost |
156 | - | 141 | - | 141 | |||||||||||||||
Borrowings held at amortized cost |
12,543 | 2,138 | 31 | 10,766 | 12,935 | |||||||||||||||
Investment contracts - held at amortized cost |
19,217 | - | 8,951 | 10,797 | 19,748 |
Certain financial instruments that are not carried at fair value are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and cash equivalents, short-term receivables and accrued interest receivable, short-term liabilities, and accrued liabilities. These instruments are not included in the table above.
Annual Report on Form 20-F 2017 |
282 | Notes to the consolidated financial statements Note 47 | |
Fair value measurement
The description of Aegons methods of determining fair value and the valuation techniques are described on the following pages.
Shares
When available, Aegon uses quoted market prices in active markets to determine the fair value of its investments in shares. Fair values for unquoted shares are estimated using observations of the price/earnings or price/cash flow ratios of quoted companies considered comparable to the companies being valued. Valuations are adjusted to account for company-specific issues and the lack of liquidity inherent in an unquoted investment. Adjustments for lack of liquidity are generally based on available market evidence. In addition, a variety of other factors are reviewed by management, including, but not limited to, current operating performance, changes in market outlook and the third-party financing environment. Also for unquoted shares the net asset value may be considered the best approximation to the fair value. Net asset value is the value of an entitys assets minus the value of its liabilities and may be the same as the book value or the equity value of the entity.
Available-for-sale shares include shares in a Federal Home Loan Bank (FHLB) for an amount of EUR 204 million (2016:
EUR 237 million), which are reported as part of the line-item Net asset value. A FHLB has implicit financial support from the United States government. The redemption value of the shares is fixed at par and they can only be redeemed by the FHLB.
Investment funds: Real estate funds, private equity funds and hedge funds
The fair values of investments held in non-quoted investment funds are determined by management after taking into consideration information provided by the fund managers. Aegon reviews the valuations each month and performs analytical procedures and trending analyses to ensure the fair values are appropriate. The net asset value is considered the best valuation method that approximates the fair value of the funds.
Debt securities
The fair values of debt securities are determined by management after taking into consideration several sources of data. When available, Aegon uses quoted market prices in active markets to determine the fair value of its debt securities. As stated previously, Aegons valuation policy utilizes a pricing hierarchy which dictates that publicly available prices are initially sought from indices and third-party pricing services. In the event that pricing is not available from these sources, those securities are submitted to brokers to obtain quotes. The majority of brokers quotes are non-binding. As part of the pricing process, Aegon assesses the appropriateness of each quote (i.e. as to whether the quote is based on observable market transactions or not) to determine the most appropriate estimate of fair value. Lastly, securities are priced using internal cash flow modeling techniques. These valuation methodologies commonly use the following inputs: reported trades, bids, offers, issuer spreads, benchmark yields, estimated prepayment speeds, and/ or estimated cash flows.
To understand the valuation methodologies used by third-party pricing services Aegon reviews and monitors the applicable methodology documents of the third-party pricing services. Any changes to their methodologies are noted and reviewed for reasonableness. In addition, Aegon performs in-depth reviews of prices received from third-party pricing services on a sample basis. The objective for such reviews is to demonstrate that Aegon can corroborate detailed information such as assumptions, inputs and methodologies used in pricing individual securities against documented pricing methodologies. Only third-party pricing services and brokers with a substantial presence in the market and with appropriate experience and expertise are used.
Third-party pricing services will often determine prices using recently reported trades for identical or similar securities. The third-party pricing service makes adjustments for the elapsed time from the trade date to the reporting date to take into account available market information. Lacking recently reported trades, third-party pricing services and brokers will use modeling techniques to determine a security price where expected future cash flows are developed based on the performance of the underlying collateral and discounted using an estimated market rate.
Periodically, Aegon performs an analysis of the inputs obtained from third-party pricing services and brokers to ensure that the inputs are reasonable and produce a reasonable estimate of fair value. Aegons asset specialists and investment valuation specialists consider both qualitative and quantitative factors as part of this analysis. Several examples of analytical procedures performed include, but are not limited to, recent transactional activity for similar debt securities, review of pricing statistics and trends and consideration of recent relevant market events. Other controls and procedures over pricing received from indices, third-party pricing services, or brokers include validation checks such as exception reports which highlight significant price changes, stale prices or unpriced securities. Additionally, Aegon performs back testing on a sample basis. Back testing involves selecting a sample of securities trades and comparing the prices in those transactions to prices used for financial reporting. Significant variances between the price used for financial reporting and the transaction price are investigated to explain the cause of the difference.
Annual Report on Form 20-F 2017 |
283 | Notes to the consolidated financial statements Note 47 | |
Credit ratings are also an important consideration in the valuation of securities and are included in the internal process for determining Aegons view of the risk associated with each security. However, Aegon does not rely solely on external credit ratings and there is an internal process, based on market observable inputs, for determining Aegons view of the risks associated with each security.
Aegons portfolio of private placement securities (held at fair value under the classification of available-for-sale or fair value through profit or loss) is valued using a matrix pricing methodology. The pricing matrix is obtained from a third-party service provider and indicates current spreads for securities based on weighted average life, credit rating, and industry sector. Each month, Aegons asset specialists review the matrix to ensure the spreads are reasonable by comparing them to observed spreads for similar bonds traded in the market. Other inputs to the valuation include coupon rate, the current interest rate curve used for discounting and a liquidity premium to account for the illiquid nature of these securities. The liquidity premiums are determined based upon the pricing of recent transactions in the private placements market; comparing the value of the privately offered security to a similar public security. The impact of the liquidity premium for private placement securities to the overall valuation is insignificant.
Aegons portfolio of debt securities can be subdivided in Residential mortgage-backed securities (RMBS), Commercial mortgage-backed securities (CMBS), Asset-backed securities (ABS), Corporate bonds and Government debt. Below relevant details in the valuation methodology for these specific types of debt securities are described.
Residential mortgage-backed securities, commercial mortgage-backed securities and asset-backed securities
Valuations of RMBS, CMBS and ABS are monitored and reviewed on a monthly basis. Valuations per asset type are based on a pricing hierarchy which uses a waterfall approach that starts with market prices from indices and follows with third-party pricing services or brokers. The pricing hierarchy is dependent on the possibilities of corroboration of the market prices. If no market prices are available, Aegon uses internal models to determine fair value. Significant inputs included in the internal models are generally determined based on relative value analyses, which incorporate comparisons to instruments with similar collateral and risk profiles. Market standard models may be used to model the specific collateral composition and cash flow structure of each transaction. The most significant unobservable input is liquidity premium which is embedded in the discount rate.
Corporate bonds
Valuations of corporate bonds are monitored and reviewed on a monthly basis. The pricing hierarchy is dependent on the possibility of corroboration of market prices when available. If no market prices are available, valuations are determined by a discounted cash flow methodology using an internally calculated yield. The yield is comprised of a credit spread over a given benchmark. In all cases the benchmark is an observable input. The credit spread contains both observable and unobservable inputs. Aegon starts by taking an observable credit spread from a similar bond of the given issuer, and then adjust this spread based on unobservable inputs. These unobservable inputs may include subordination, liquidity and maturity differences. The weighted average credit spread used in valuation of corporate bonds has decreased to 2.6% (December 31, 2016: 3.1%).
Government debt
When available, Aegon uses quoted market prices in active markets to determine the fair value of its government debt investments. When Aegon cannot make use of quoted market prices, market prices from indices or quotes from third-party pricing services or brokers are used.
Tax credit investments
The fair value of tax credit investments is determined by using a discounted cash flow valuation technique. This valuation technique takes into consideration projections of future capital contributions and distributions, as well as future tax credits and the tax benefits of future operating losses. The present value of these cash flows is calculated by applying a discount rate. In general, the discount rate is determined based on the cash outflows for the investments and the cash inflows from the tax credits and/or tax benefits (and the timing of these cash flows). These inputs are unobservable in the market place. The discount rate used in valuation of tax credit investments has increased to 5.8% (December 31, 2016: 5.6%).
Mortgage loans, policy loans and private loans ( held at amortized cost )
For private loans, fixed interest mortgage loans and other loans originated by the Group, the fair value used for disclosure purposes is estimated by discounting expected future cash flows using a current market rate applicable to financial instruments with similar yield and maturity characteristics. For fixed interest mortgage loans, the market rate is adjusted for expenses, prepayment rates, lapse assumptions (unobservable inputs), liquidity and credit risk (market observable inputs). An increase in expense spread, prepayment rates and/or prepayment assumptions, would decrease the fair value of the mortgage loan portfolio.
Annual Report on Form 20-F 2017 |
284 | Notes to the consolidated financial statements Note 47 | |
The fair value of floating interest rate mortgage loans, policy loans and private placements used for disclosure purposes is assumed to be approximated by their carrying amount, adjusted for changes in credit risk. Credit risk adjustments are based on market observable credit spreads if available, or managements estimate if not market observable.
Money market and other short-term investments and deposits with financial institutions
The fair value of assets maturing within a year is assumed to be approximated by their carrying amount adjusted for credit risk where appropriate. Credit risk adjustments are based on market observable credit spreads if available, or managements estimate if not market observable.
Derivatives
Where quoted market prices are not available, other valuation techniques, such as option pricing or stochastic modeling, are applied. The valuation techniques incorporate all factors that a typical market participant would consider and are based on observable market data when available. Models are validated before they are used and calibrated to ensure that outputs reflect actual experience and comparable market prices.
Fair values for exchange-traded derivatives, principally futures and certain options, are based on quoted market prices in active markets. Fair values for over-the-counter (OTC) derivative financial instruments represent amounts estimated to be received from or paid to a third party in settlement of these instruments. These derivatives are valued using pricing models based on the net present value of estimated future cash flows, directly observed prices from exchange-traded derivatives, other OTC trades, or external pricing services. Most valuations are derived from swap and volatility matrices, which are constructed for applicable indices and currencies using current market data from many industry standard sources. Option pricing is based on industry standard valuation models and current market levels, where applicable. The pricing of complex or illiquid instruments is based on internal models or an independent third party. For long-dated illiquid contracts, extrapolation methods are applied to observed market data in order to estimate inputs and assumptions that are not directly observable. To value OTC derivatives, management uses observed market information, other trades in the market and dealer prices.
Some OTC derivatives are so-called longevity derivatives. The payout of longevity derivatives is linked to publicly available mortality tables. The derivatives are measured using the present value of the best estimate of expected payouts of the derivative plus a risk margin. The best estimate of expected payouts is determined using best estimate of mortality developments. Aegon determined the risk margin by stressing the best estimate mortality developments to quantify the risk and applying a cost-of-capital methodology. Depending on the duration of the longevity swaps either the projected mortality development or discount rate are the most significant unobservable inputs.
Aegon normally mitigates counterparty credit risk in derivative contracts by entering into collateral agreements where practical and in ISDA master netting agreements for each of the Groups legal entities to facilitate Aegons right to offset credit risk exposure. Changes in the fair value of derivatives attributable to changes in counterparty credit risk were not significant.
Embedded derivatives in insurance contracts including guarantees
Bifurcated guarantees for minimum benefits in insurance and investment contracts are carried at fair value. These guarantees include Guaranteed minimum withdrawal benefits (GMWB) in the United States and United Kingdom which are offered on some variable annuity products and are also assumed from a ceding company; minimum investment return guarantees on insurance products offered in the Netherlands, including group pension and traditional products; variable annuities sold in Europe. Additionally, Aegon offers guarantees on variable annuities sold through its joint venture in Japan.
Since the price of these guarantees is not quoted in any market, the fair values of these guarantees are based on discounted cash flows calculated as the present value of future expected payments to policyholders less the present value of assessed rider fees attributable to the guarantees. Given the complexity and long-term nature of these guarantees which are unlike instruments available in financial markets, their fair values are determined by using stochastic models under a variety of market return scenarios. A variety of factors are considered, including own credit spread, expected market rates of return, equity and interest rate volatility, correlations of market returns, discount rates and actuarial assumptions. The most significant unobservable factor is own credit spread. The weighted average own credit spread used in the valuations of embedded derivatives in insurance contracts decreased to 0.2% (2016: 0.4%).
The expected returns are based on risk-free rates. Aegon added a premium to reflect the credit spread as required. The credit spread is set by using the Credit default swap (CDS) spreads of a reference portfolio of life insurance companies (including Aegon), adjusted to reflect the subordination of senior debt holders at the holding company level to the position of policyholders at the operating
Annual Report on Form 20-F 2017 |
285 | Notes to the consolidated financial statements Note 47 | |
company level (who have priority in payments over other creditors). Aegons assumptions are set by region to reflect differences in the valuation of the guarantee embedded in the insurance contracts.
Aegon extrapolates yield curves beyond market observable maturities. The discount rates converge linearly in 10 years to an Ultimate Forward Rate of 4.25% from the last liquid point. The uniform last liquid point for all Aegons major currencies (EUR, USD and GBP) is set at 30 years.
Since many of the assumptions are unobservable and are considered to be significant inputs to the liability valuation, the liability included in future policy benefits has been reflected within Level III of the fair value hierarchy. Refer to note 38 Guarantees in insurance contracts for more details about Aegons guarantees.
Real estate
Valuations of both investments in real estate and real estate held for own use are conducted in full by independent external appraisers at least every three to five years and reviewed at least once a year by qualified internal appraisers to ensure the value correctly reflects the fair value at the reporting date. Appraisals are different for each specific local market, but are based on market guidelines such as International Valuation Standards, Uniform Standards of Professional Appraisal Practice or guidelines issued by the Investment Property Databank. Valuations are mostly based on active market prices, adjusted for any difference in the nature, location or condition of the specific property. If such information is not available, other valuation methods are applied, considering the value that the propertys net earning power will support, the value indicated by recent sales of comparable properties and the current cost of reproducing or replacing the property. Discount rates used in the valuation of real estate reflect the risk embedded in the projected cash flows for the asset being valued. Capitalization rates represent the income rate for a real estate property that reflects the relationship between a single years net operating income expectancy and the total property price or value. For property held for own use, appraisers consider the present value of the future rental income cash flows that could be achieved had the real estate been rented to a third party.
Investment contracts
Investment contracts issued by Aegon are either carried at fair value (if they are designated as financial liabilities at fair value through profit or loss) or amortized cost (with fair value being disclosed in the notes to the consolidated financial statements). These contracts are not quoted in active markets and their fair values are determined by using valuation techniques, such as discounted cash flow methods and stochastic modeling or in relation to the unit price of the underlying assets. All models are validated and calibrated. A variety of factors are considered, including time value, volatility, policyholder behavior, servicing costs and fair values of similar instruments.
Similar to embedded derivatives in insurance contracts, certain investment products are not quoted in active markets and their fair values are determined by using valuation techniques. Because of the dynamic and complex nature of these cash flows, stochastic or similar techniques under a variety of market return scenarios are often used. A variety of factors are considered, including expected market rates of return, market volatility, correlations of market returns, discount rates and actuarial assumptions.
The expected returns are based on risk-free rates, such as the current London Interbank Offered Rate (LIBOR) swap rates and associated forward rates, the Overnight Index Swap (OIS) curve or the current rates on local government bonds. Market volatility assumptions for each underlying index are based on observed market implied volatility data and/or observed market performance. Correlations of market returns for various underlying indices are based on observed market returns and their inter-relationships over a number of years preceding the valuation date. Current risk-free spot rates are used to determine the present value of expected future cash flows produced in the stochastic projection process.
Assumptions on customer behavior, such as lapses, included in the models are derived in the same way as the assumptions used to measure insurance liabilities.
Trust pass-through securities and subordinated borrowings
Trust pass-through securities and subordinated borrowings are either carried at fair value (if they are designated as financial liabilities at fair value through profit or loss) or amortized cost (with fair value being disclosed in the notes to the consolidated financial statements). For the determination of the fair value of these instruments, the level hierarchy as described by IFRS is used. The preferred method of obtaining the fair value of the fair value option bonds is the quoted price (Level I). In case markets are less liquid or the quoted prices are not available, an internal model is used, based on parameters which are market observable (Level II). Aegon uses a discounted cash flow method including yield curves such as deposit rates, floating rates and 3-month swap rates. In addition, Aegon includes own credit spread based on Aegons credit default swap curve.
Annual Report on Form 20-F 2017 |
286 | Notes to the consolidated financial statements Note 47 | |
Summary of total financial assets and financial liabilities at fair value through profit or loss
The table that follows summarizes the carrying amounts of financial assets and financial liabilities that are classified as at fair value through profit or loss, with appropriate distinction between those financial assets and financial liabilities held for trading and those that, upon initial recognition, were designated as at fair value through profit or loss.
2017 | 2016 | |||||||||||||||
Trading | Designated | Trading | Designated | |||||||||||||
Investments for general account |
78 | 7,042 | 66 | 5,076 | ||||||||||||
Investments for account of policyholders |
- | 193,409 | - | 202,924 | ||||||||||||
Derivatives with positive values not designated as hedges |
5,430 | - | 6,935 | - | ||||||||||||
Total financial assets at fair value through profit or loss |
5,508 | 200,451 | 7,001 | 208,001 | ||||||||||||
Investment contracts for account of policyholders |
- | 37,169 | - | 42,803 | ||||||||||||
Derivatives with negative values not designated as hedges |
6,792 | - | 8,386 | - | ||||||||||||
Borrowings |
- | 536 | - | 610 | ||||||||||||
Total financial liabilities at fair value through profit or loss |
6,792 | 37,705 | 8,386 | 43,413 |
Investments for general account
The Group manages certain portfolios on a total return basis which have been designated at fair value through profit or loss. This includes portfolios of investments in limited partnerships and limited liability companies (primarily hedge funds) for which the performance is assessed internally on a total return basis. In addition, some investments that include an embedded derivative that would otherwise have required bifurcation, such as convertible instruments, preferred shares and credit linked notes, have been designated at fair value through profit or loss.
Investments for general account backing insurance and investment liabilities, that are carried at fair value with changes in the fair value recognized in the income statement, are designated at fair value through profit or loss. The Group elected to designate these investments at fair value through profit or loss, as a classification of financial assets as available-for-sale would result in accumulation of unrealized gains and losses in a revaluation reserve within equity, while changes to the liability would be reflected in net income (accounting mismatch).
Investments for account of policyholders
Investments held for account of policyholders comprise assets that are linked to various insurance and investment contracts for which the financial risks are borne by the customer. Under the Groups accounting policies these insurance and investment liabilities are measured at the fair value of the linked assets with changes in the fair value recognized in the income statement. To avoid an accounting mismatch the linked assets have been designated as at fair value through profit or loss.
In addition, the investment for account of policyholders include with profit assets, where an insurer manages these assets together with related liabilities on a fair value basis in accordance with a documented policy of asset and liability management. In accordance with the Groups accounting policies, these assets have been designated as at fair value through profit or loss.
Investment contracts for account of policyholders
With the exception of the financial liabilities with discretionary participating features that are not subject to the classification and measurement requirements for financial instruments, all investment contracts for account of policyholders that are carried at fair value or at the fair value of the linked assets are included in the table above.
Derivatives
With the exception of derivatives designated as a hedging instrument, all derivatives held for general account and held for account of policyholders are included in the table above.
Borrowings
Borrowings designated as at fair value through profit or loss includes financial instruments that are managed on a fair value basis together with related financial assets and financial derivatives (note 39 Borrowings).
Annual Report on Form 20-F 2017 |
287 | Notes to the consolidated financial statements Note 48 | |
Gains and losses on financial assets and financial liabilities classified at fair value through profit or loss
Gains and losses recognized in the income statement on financial assets and financial liabilities classified as at fair value through profit or loss can be summarized as follows:
2017 | 2016 | |||||||||||||||
Trading | Designated | Trading | Designated | |||||||||||||
Net gains and (losses) |
13,924 | 5,679 | 6,509 | 8,815 |
No loans and receivables were designated at fair value through profit or loss.
Changes in the fair value of investment contracts for account of policyholders designated at fair value through profit or loss were not attributable to changes in Aegons credit spread. There are also no differences between the carrying amounts of these financial liabilities and the contractual amounts payable at maturity (net of surrender penalties).
Refer to note 39 Borrowings for the impact of Aegons own credit spread on the fair value of the borrowings designated at fair value through profit or loss.
48 Commitments and contingencies
Investments contracted
In the normal course of business, the Group has committed itself through purchase and sale transactions of investments, mostly to be executed in the course of 2018. The amounts represent the future outflow and inflow, respectively, of cash related to these investment transactions that are not reflected in the consolidated statement of financial position.
2017 | 2016 | |||||||||||||||
Purchase | Sale | Purchase | Sale | |||||||||||||
Real estate |
196 | 39 | - | 44 | ||||||||||||
Mortgage loans |
3,152 | 69 | 424 | 78 | ||||||||||||
Private loans |
705 | - | 44 | - | ||||||||||||
Other |
2,373 | - | 1,314 | - |
Commitments increased in 2017 as a result of Aegons strategy to generate higher yield on its investments. Aegon has committed itself, through certain subsidiaries, to invest in real estate, private loans, mortgages loans and receivables and investment funds.
Mortgage loans commitments represent undrawn mortgage loan facility provided and outstanding proposals on mortgages. The sale of mortgage loans relates to pre-announced redemptions on mortgage loans. Private loans represents deals on Aegons portfolio of private placement securities that Aegon has committed to, but have not yet settled and funded. Other commitments include future purchases of interests in investment funds and limited partnerships.
Future lease payments
2017 | 2016 | |||||||||||||||||||||||
Future lease payments |
Not later
than 1 year |
1-5 years |
Later than 5
years |
Not later
than 1 year |
1-5 years |
Later than 5
years |
||||||||||||||||||
Operating lease obligations |
74 | 143 | 201 | 88 | 189 | 231 | ||||||||||||||||||
Operating lease rights |
41 | 104 | 27 | 53 | 124 | 32 |
The operating lease obligations relate mainly to office space leased from third parties.
The operating lease rights relate to non-cancellable commercial property leases.
Annual Report on Form 20-F 2017 |
288 | Notes to the consolidated financial statements Note 48 | |
Other commitments and contingencies
2017 | 2016 | |||||||
Guarantees |
483 | 682 | ||||||
Standby letters of credit |
12 | 29 | ||||||
Share of contingent liabilities incurred in relation to interests in joint ventures |
39 | 40 | ||||||
Other guarantees |
16 | 18 | ||||||
Other commitments and contingent liabilities |
32 | 12 |
Guarantees include those guarantees associated with the sale of investments in low-income housing tax credit partnerships in the United States. Standby letters of credit amounts reflected above are the liquidity commitment notional amounts. In addition to the guarantees shown in the table, guarantees have been given for fulfillment of contractual obligations such as investment mandates related to investment funds.
Contractual obligations
An Aegon N.V. indirect US life subsidiary has a net worth maintenance agreement with its subsidiary Transamerica Life (Bermuda) Ltd, pursuant to which Transamerica Life Insurance Company, a US life insurance subsidiary, will provide capital sufficient to maintain a S&P AA financial strength rating and capital sufficient to comply with the requirements of the countries in which its branches are located.
Transamerica Corporation, a wholly-owned subsidiary of Aegon N.V., has provided a parental guarantee to TLIC Riverwood Reinsurance, Inc. (TRRI), an affiliated captive reinsurer, for the cash payments required fulfilling reinsurance payments to Transamerica Life Insurance Company, to the extent that the assets in the captive (TRRI) are not sufficient to cover reinsurance obligations. As of December 31, 2017, this amounted to EUR 1,793 million (2016 EUR: 2,002 million).
Aegon International B.V., a wholly-owned subsidiary of Aegon N.V., has entered into a contingent capital letter for an amount of JPY 6.5 billion (EUR 49 million) to support its joint venture Aegon Sony Life Insurance Company meeting local statutory requirements.
Aegon N.V. has guaranteed and is severally liable for the following:
◆ | Due and punctual payment of payables due under letter of credit agreements applied for by Aegon N.V. as co-applicant with its captive insurance companies that are subsidiaries of Transamerica Corporation and Commonwealth General Corporation. At December 31, 2017, the letter of credit arrangements utilized by captives to provide collateral to affiliates amounted to EUR 3,025 million (2016: EUR 3,720 million); as of that date no amounts had been drawn, or were due under these facilities. Other letter of credit arrangements for subsidiaries amounted to EUR 55 million (2016: EUR 104 million); as of that date no amounts had been drawn, or were due under these facilities; |
◆ | Due and punctual payment of payables due under letter of credit agreements or guarantees provided for subsidiaries of Transamerica Corporation at December 31, 2017 amounted to EUR 3,079 million (2016: EUR 3,563 million). As of that date no amounts had been drawn, or were due under letter of credit facilities. The guarantees partly related to debt amounted to EUR 1,322 million (2016: EUR 1,505 million) and is included in the Operational funding table in note 39 Borrowings of the consolidated financial statements of the Group in the line USD 1.54 billion Variable Funding Surplus Note; |
◆ | Due and punctual payment of payables by the consolidated group companies Transamerica Corporation, Aegon Funding Company LLC and Commonwealth General Corporation with respect to bonds, capital trust pass-through securities and notes issued under commercial paper programs amounted to EUR 585 million (2016: EUR 633 million); and |
◆ | Due and punctual payment of any amounts owed to third parties by the consolidated group company Aegon Derivatives N.V. in connection with derivative transactions. Aegon Derivatives N.V. only enters into derivative transactions with counterparties with which ISDA master netting agreements, including collateral support annex agreements, have been agreed. Net (credit) exposure on derivative transactions with these counterparties was therefore limited as of December 31, 2017. |
Legal and arbitration proceedings, regulatory investigations and actions
Aegon faces significant risks of litigation as well as regulatory investigations and actions relating to its and its subsidiaries insurance, pensions, securities, investment management, investment advisory and annuities businesses as well as Aegons corporate compliance, including compliance with employment, sanctions, anti-corruption and tax regulations.
Aegon subsidiaries regularly receive inquiries from local regulators and policyholder advocates in various jurisdictions, including the United States, the Netherlands, and the United Kingdom. In some cases, Aegon subsidiaries have modified business practices in response to inquiries or findings of inquiries. Regulators may seek fines or penalties, or changes to the way Aegon operates.
Annual Report on Form 20-F 2017 |
289 | Notes to the consolidated financial statements Note 48 | |
Insurance companies and their affiliated regulated entities are routinely subject to litigation, investigation and governmental review involving issues such as, but not limited to, product fees and costs, including transparency and adequacy of disclosure of initial costs, ongoing costs, and costs due on policy surrender as well as changes to costs over time; employment or distribution relationships; operational and internal controls and processes; environmental matters; competition and antitrust matters; data privacy; information security; intellectual property; and anti-money laundering, anti-bribery and economic sanctions compliance.
Many of Aegons products are affected by fluctuations in equity markets as well as interest rate movements, which may prove to be volatile or disappointing to customers. Significant investment risks are often borne by the customer. Disputes and investigations initiated by governmental entities and private parties may lead to orders or settlements including payments or changes to business practices even if Aegon believes the underlying claims are without merit.
The existence of potential claims may remain unknown for long periods of time after the events giving rise to such claims. Determining the likelihood of exposure to Aegon and the extent of any such exposure may not be possible for long periods of time after Aegon becomes aware of such potential claims. Once litigation is initiated, it may be protracted and subject to multiple levels of appeal.
Aegon cannot predict the effect of litigation, investigations or other actions on its businesses or the insurance industry. In some jurisdictions, plaintiffs may seek recovery of very large or indeterminate amounts under claims of bad faith, resulting in punitive or treble damages. Damages alleged may not be quantifiable or supportable, or may have no relationship to economic losses or final awards. Separate from financial loss, litigation, regulatory action, legislative changes or changes in public opinion may require Aegon to change its business practices, which could have a material adverse impact on Aegons businesses, results of operations, cash flows and financial position.
Aegon has defended and will continue to defend itself vigorously when it believes claims are without merit. Aegon has also settled and will seek to settle certain claims, including through policy modifications, as it believes appropriate. While Aegon intends to resist claims, there can be no assurance that claims brought against Aegon will not have a material adverse impact on its businesses, results of operations, and financial position.
Proceedings in which Aegon is involved
The SEC is conducting a formal investigation related to certain investment strategies offered through mutual funds, variable products and separately managed accounts. These strategies used quantitative models developed by one of the former portfolio managers of Aegons US investment management business units. Among other things, the investigation relates to the operation of and/or the existence of errors in the quantitative models in question and related disclosures. The funds and strategies under review were sub-advised, advised or marketed by Aegons US group companies. The models are no longer being used, although some of the funds are still being offered. The quantitative strategies are no longer being offered. Aegon is cooperating fully with the investigation. Aegon believes that the investigation will conclude in 2018, and has taken a provision of EUR 85 million in anticipation of a possible settlement with the SEC. This amount is partly recorded in the Americas (EUR 45 million) and partly in Aegon Asset Management (EUR 40 million). Government investigations, including this one, may result in the institution of administrative, injunctive or other proceedings and/or the imposition of monetary fines, penalties and/or disgorgement, as well as other remedies, sanctions, damages and restitutionary amounts. While Aegon is unable to predict what actions, if any, might be taken and is unable to predict the costs to or other impact on Aegon of any such action, there can be no assurances that this matter or other government investigations will not have a material and adverse effect on Aegons reputation, financial position, results of operations or liquidity.
Aegon and other US insurers have been sued for charging fees on products offered in 401(k) platforms which allegedly were higher than fees charged on other products available in the market. In February 2018, the US Court of Appeals for the Ninth Circuit reversed the District Courts order denying Transamerica companies motion to dismiss and directed the District Court to grant the motion to dismiss and vacated class certification. Plaintiffs may appeal. US insurers, including Aegon subsidiary Transamerica Life Insurance Company (TLIC), have also been named in class actions as well as individual litigation relating to monthly deduction rates increases on universal life products. Plaintiffs generally allege that the rates were increased to recoup past losses rather than to cover the future costs of providing insurance coverage. The class action against TLIC is pending in US federal district court for the Central District of California. In the first phase of one of the individual cases against TLIC to reach trial the jury found that the increase was improper. That case remains ongoing. At this time it is impracticable for Aegon to quantify a range or maximum liability or the timing of the financial impact, if any, of these matters, as the potential financial impacts are dependent both on the outcomes of court proceedings and future developments in financial markets and mortality. If decided adversely to Aegon, these claims could have a material adverse effect on Aegons business, results of operations, and financial position.
Annual Report on Form 20-F 2017 |
290 | Notes to the consolidated financial statements Note 48 | |
Unclaimed property administrators and state insurance regulators performed examinations and multi-state examinations of the life insurance industry in the United States, including certain of Aegons subsidiaries. Aegon subsidiaries, like other major US insurers, entered into resolutions with state treasurers and insurance regulators regarding unclaimed property and claims settlement practices. As of 2017, USD 1.5 million remained in provisions, which is managements best estimate of the still-outstanding exposure. The final amount may vary based on subsequent regulatory review.
Aegons US operations also face employment-related lawsuits from time to time. Aegon recently defended a suit filed by self-employed independent insurance agents associated with one of Aegons financial marketing units who have claimed that they are, in fact, employees of the organization. The court granted Aegons motion to only allow individual claims to move forward and cease collective action proceedings in this case. Management believes that the potential direct financial exposure in this case is not material. This lawsuit was resolved favorably to Aegon.
A former subsidiary of Transamerica Corporation was involved in a contractual dispute with a Nigerian travel broker that arose in 1976. That dispute was resolved in Delaware court for USD 235 thousand plus interest in 2010. The plaintiff took the Delaware judgment relating to the 1976 dispute to a Nigerian court and alleged that it was entitled to approximately the same damages for 1977 through 1984 despite the absence of any contract relating to those years. The Nigerian trial court issued a judgment in favor of the plaintiff of the alleged actual damages as well as pre-judgment interest of approximately USD 120 million. On appeal this decision was reversed on procedural grounds and remanded back to the trial court for further consideration. Aegon has no material assets located in Nigeria.
In Poland, owners of unit-linked policies continue to file claims in civil court against Aegon over fees payable upon purchase or surrender of the product. Plaintiffs claim that these fees are not contractually supported. Aegon faces a significant number of these cases. For reasons of commercial necessity as well as at the instigation of the regulatory authorities, Aegon decided to modify the fee structure. As of 2017, a provision of EUR 20 million remains, which represents managements best estimate of the exposure. The final amount may vary based on regulatory developments and the outcome of litigation.
In the Netherlands, unit linked products (beleggingsverzekeringen) have been controversial and the target of litigation since at least 2005. Allegations include excessive cost, unfair terms, inadequate disclosure, and failure to perform as illustrated. Consumer groups have formed to address these issues and initiate mass claims against insurers. Regulators as well as the Dutch Parliament have been involved ever since, with the principal goal of achieving an equitable resolution. Developments in similar cases against other Dutch insurers currently before regulators and courts may also affect Aegon. In September 2014, consumer interest group Vereniging Woekerpolis.nl filed a claim against Aegon in court. The claim related to a range of unit-linked products that Aegon sold in the past, including Aegon products involved in earlier litigation. The claim challenges a variety of elements of these products, on multiple legal grounds, including allegations made previously. This claim is being vigorously defended. In June 2017, the court issued a verdict which upheld the principle that disclosures must be evaluated according to the standards at the time when the relevant products were placed in force. Most of the claims of Vereniging Woekerpolis.nl were dismissed under this standard, although the court found that Aegon did not adequately disclose certain charges on a limited set of policies. This court decision has been appealed by both parties. Aegon expects the claims and litigation on unit linked products to continue for the foreseeable future. At this time, Aegon is unable to estimate the range or potential maximum liability. There can be no assurances that these matters, in the aggregate, will not ultimately result in a material adverse effect on Aegons business, results of operations and financial position.
Securities leasing products (aandelenlease producten) have also been the subject of litigation in the Netherlands. Although sales of securities leasing products ended more than a decade ago, litigation relating to these products has resurfaced. In 2016, the Dutch Supreme Court ruled on a case involving a securities leasing product sold by one of Aegons competitors. It decided that the financial institution was liable if a broker (remisier) that advised on the sale of the institutions products was not properly licensed. In July 2016, consumer interest group Platform Aandelenlease filed a claim against Aegon Bank regarding securities leasing product Sprintplan. Allegations include, among other things, a lack of a proper license of the brokers involved. Aegon defends itself vigorously against these claims. In October 2017, the district court of The Hague found in favor of Aegon that the Sprintplan liability had been conclusively determined in earlier proceedings and there were no grounds to hold further collective proceedings. The plaintiff appealed. The case is now pending at the court of appeal of The Hague. At this time, Aegon is unable to estimate the range or potential maximum liability. There can be no assurances that this matter will not ultimately result in a material adverse effect on Aegons business, results of operations and financial position.
Annual Report on Form 20-F 2017 |
291 | Notes to the consolidated financial statements Note 49 | |
49 Transfers of financial assets
Transfers of financial assets occur when Aegon transfers contractual rights to receive cash flows of financial assets or when Aegon retains the contractual rights to receive the cash flows of the transferred financial asset, but assumes a contractual obligation to pay the cash flows to one or more recipients in that arrangement.
In the normal course of business Aegon is involved in the following transactions:
◆ | Transferred financial assets that are not derecognized in their entirety: |
◆ | Securities lending; whereby Aegon legally (but not economically) transfers assets and receives cash and non-cash collateral. The transferred assets are not derecognized. The obligation to repay the cash collateral is recognized as a liability. The non-cash collateral is not recognized in the statement of financial position; and |
◆ | Repurchase activities; whereby Aegon receives cash for the transferred assets. The financial assets are legally (but not economically) transferred, but are not derecognized. The obligation to repay the cash received is recognized as a liability. |
◆ | Transferred financial assets that are derecognized in their entirety and Aegon does not have a continuing involvement (normal sale); |
◆ | Transferred financial assets that are derecognized in their entirety, but where Aegon has a continuing involvement; |
◆ | Collateral accepted in the case of securities lending, reverse repurchase agreement and derivative transactions; and |
◆ | Collateral pledged in the case of (contingent) liabilities, repurchase agreements, securities borrowing and derivative transactions. |
The following disclosures provide details for transferred financial assets that are not derecognized in their entirety, transferred financial asset that are derecognized in their entirety, but where Aegon has a continuing involvement and assets accepted and pledged as collateral.
49.1 Transferred financial assets that have not been derecognized in their entirety
The following table reflects the carrying amount of financial assets that have been transferred to another party in such a way that part or all of the transferred financial assets do not qualify for derecognition. Furthermore, it reflects the carrying amounts of the associated liabilities.
2017 | ||||||||||||||||
Available-for-sale financial assets |
Financial assets at fair value through
profit or loss |
|||||||||||||||
Shares | Debt securities | Debt securities |
Investments for
account of policyholders |
|||||||||||||
Carrying amount of transferred assets |
114 | 5.805 | 54 | 384 | ||||||||||||
Carrying amount of associated liabilities |
122 | 5,929 | 55 | 93 |
2016 | ||||||||||||||||
Available-for-sale financial assets |
Financial assets at fair value through
profit or loss |
|||||||||||||||
Shares | Debt securities | Debt securities |
Investments for
account of policyholders |
|||||||||||||
Carrying amount of transferred assets |
226 | 5,298 | 20 | 194 | ||||||||||||
Carrying amount of associated liabilities |
242 | 5,400 | 21 | 204 |
Securities lending and repurchase activities
The table above includes financial assets that have been transferred to another party under securities lending and repurchase activities.
Aegon retains substantially all risks and rewards of those transferred assets, this includes credit risk, settlement risk, country risk and market risk. The assets are transferred in return for cash collateral or other financial assets. Non-cash collateral is not recognized in the statement of financial position. Cash collateral is recorded on the statement of financial position as an asset and an offsetting liability is established for the same amount as Aegon is obligated to return this amount upon termination of the lending arrangement. Cash collateral is usually invested in pre-designated high quality investments. The sum of cash and non-cash collateral is typically greater than the market value of the related securities loaned. Refer to note 49.3 Assets accepted and note 49.4 Assets pledged for an analysis of collateral accepted and pledged in relation to securities lending and repurchase agreements.
Annual Report on Form 20-F 2017 |
292 | Notes to the consolidated financial statements Note 49 | |
49.2 Transferred financial assets that are derecognized in their entirety, but where Aegon has continuing involvement
Aegon has no transferred financial assets with continuing involvement that are derecognized in their entirely as per year-end 2017 and 2016.
49.3 Assets accepted
Aegon receives collateral related to securities lending, reverse repurchase activities and derivative transactions. Non-cash collateral is not recognized in the statement of financial position. To the extent that cash is paid for reverse repurchase agreements, a receivable is recognized for the corresponding amount.
The following tables present the fair value of the assets received in relation to securities lending and reverse repurchase activities:
Securities lending | 2017 | 2016 | ||||||
Carrying amount of transferred financial assets |
4,987 | 4,262 | ||||||
Fair value of cash collateral received |
3,277 | 3,633 | ||||||
Fair value of non-cash collateral received |
1,847 | 1,077 | ||||||
Net exposure |
(138 | ) | (448 | ) | ||||
Non-cash collateral that can be sold or repledged in the absence of default |
1,550 | 991 | ||||||
Non-cash collateral that has been sold or transferred |
- | - |
Reverse repurchase agreements | 2017 | 2016 | ||||||
Cash paid for reverse repurchase agreements |
4,859 | 4,075 | ||||||
Fair value of non-cash collateral received |
4,885 | 4,103 | ||||||
Net exposure |
(25 | ) | (27 | ) | ||||
Non-cash collateral that can be sold or repledged in the absence of default |
4,166 | 3,288 | ||||||
Non-cash collateral that has been sold or transferred |
- | - |
The above items are conducted under terms that are usual and customary to standard securities lending activities, as well as requirements determined by exchanges where the bank acts as intermediary.
In addition, Aegon can receive collateral related to derivative transactions that it enters into. The credit support agreement will normally dictate the threshold over which collateral needs to be pledged by Aegon or its counterparty. Transactions requiring Aegon or its counterparty to post collateral are typically the result of over-the-counter derivative trades, comprised mostly of interest rate swaps, currency swaps and credit swaps. Refer to the credit risk section in note 4 Financial risks for details on collateral received for derivative transactions.
49.4 Assets pledged
Aegon pledges assets that are on its statement of financial position in securities borrowing transactions, in repurchase transactions, in derivative transactions and against long-term borrowings. In addition, in order to trade derivatives on the various exchanges, Aegon posts margin as collateral.
These transactions are conducted under terms that are usual and customary to standard long-term borrowing, derivative and securities borrowing activities, as well as requirements determined by exchanges where the bank acts as intermediary.
Non-cash financial assets that are borrowed or purchased under agreement to resell are not recognized in the statement of financial position.
To the extent that cash collateral is paid, a receivable is recognized for the corresponding amount. If other non-cash financial assets are given as collateral, these are not derecognized.
Annual Report on Form 20-F 2017 |
293 | Notes to the consolidated financial statements Note 50 | |
The following tables present the carrying amount of collateral pledged and the corresponding amounts.
Assets pledged for general account and contingent liabilities | 2017 | 2016 | ||||||
General account (contingent) liabilities |
5,588 | 6,440 | ||||||
Collateral pledged |
6,951 | 8,115 | ||||||
Net exposure |
(1,363 | ) | (1,675 | ) | ||||
Non-cash collateral that can be sold or repledged by the counterparty |
- | - | ||||||
Assets pledged for repurchase agreements | 2017 | 2016 | ||||||
Cash received on repurchase agreements |
1,373 | 1,489 | ||||||
Collateral pledged (transferred financial assets) |
1,370 | 1,477 | ||||||
Net exposure |
3 | 12 |
As part of Aegons mortgage loan funding program in the Netherlands, EUR 6.5 billion (2016: EUR 6.8 billion) has been pledged as security for notes issued (note 39 Borrowings). In addition, in order to trade derivatives on the various exchanges, Aegon posts margin as collateral. The amount of collateral pledged for derivative transactions was EUR 2,234 million (2016: EUR 2,688 million).
50 Offsetting, enforceable master netting arrangements and similar agreements
The following table includes financial instruments that are set off in the statement of financial position. In addition, it includes financial instruments that are subject to a legally enforceable master netting arrangement or similar agreements, not set off in the financial statements. The table provides details relating to the effect, or potential effect, of netting arrangements, including rights to set-off, associated with the entitys recognized financial assets and recognized financial liabilities.
Gross amounts
of recognized financial assets |
Gross amounts
of recognized financial liabilities set off in the statement of financial position |
Net amounts of
financial assets presented in the statement of financial position |
Related amounts not set off in
position |
Net amount | ||||||||||||||||||||
Financial assets subject to
offsetting, enforceable master
netting arrangements and similar
agreements |
Financial
instruments |
Cash collateral
received
|
||||||||||||||||||||||
2017 |
||||||||||||||||||||||||
Derivatives |
5,823 | - | 5,823 | 4,973 | 821 | 30 | ||||||||||||||||||
At December 31 |
5,823 | - | 5,823 | 4,973 | 821 | 30 | ||||||||||||||||||
2016 |
||||||||||||||||||||||||
Derivatives |
8,114 | - | 8,114 | 6,427 | 1,486 | 201 | ||||||||||||||||||
At December 31 |
8,114 | - | 8,114 | 6,427 | 1,486 | 201 |
Annual Report on Form 20-F 2017 |
294 | Notes to the consolidated financial statements Note 51 | |
Gross amounts
of recognized financial liabilities |
Gross amounts
of recognized financial assets set off in the statement of financial position |
Net amounts of
financial liabilities presented in the statement of financial position |
Related amounts not set off in
position |
Net amount | ||||||||||||||||||||
Financial liabilities subject to offsetting, enforceable master netting arrangements and similar agreements |
Financial
instruments |
Cash collateral
pledged (excluding surplus collateral) |
||||||||||||||||||||||
2017 |
||||||||||||||||||||||||
Derivatives |
5,185 | - | 5,185 | 5,145 | 2 | 38 | ||||||||||||||||||
At December 31 |
5,185 | - | 5,185 | 5,145 | 2 | 38 | ||||||||||||||||||
2016 |
||||||||||||||||||||||||
Derivatives |
6,689 | - | 6,689 | 6,570 | 20 | 99 | ||||||||||||||||||
At December 31 |
6,689 | - | 6,689 | 6,570 | 20 | 99 |
Financial assets and liabilities are offset in the statement of financial position when the Group has a legally enforceable right to offset and has the intention to settle the asset and liability on a net basis, or to realize the asset and settle the liability simultaneously. As shown in the second column there are no financial assets and liabilities offset in 2017 and 2016.
The line Derivatives includes derivatives for general account and for account of policyholder.
Aegon mitigates credit risk in derivative contracts by entering into collateral agreements, where practical, and in ISDA master netting agreements for each of the Aegons legal entities to facilitate Aegons right to offset credit risk exposure. The credit support agreement will normally dictate the threshold over which collateral needs to be pledged by Aegon or its counterparty. Transactions requiring Aegon or its counterparty to post collateral are typically the result of over-the-counter derivative trades, comprised mostly of interest rate swaps, currency swaps and credit swaps. These transactions are conducted under terms that are usual and customary to standard long-term borrowing, derivative, securities lending and securities borrowing activities, as well as requirements determined by exchanges where the bank acts as intermediary.
Acquisitions
2017
On January 1, 2017, Aegon completed the acquisition of Cofunds Ltd., following regulatory approval. The purchase of the Cofunds Ltd. business was done through a sale and purchase agreement to acquire all the shares and platform assets. The total consideration of the acquisition amounted to GBP 147 million (EUR 171 million). The fair value of the net assets amounted to GBP 99 million (EUR 116 million), of which GBP 25 million (EUR 29 million) related to customer intangibles, resulting in goodwill of GBP 48 million (EUR 56 million). The value of the transferred customer investments under management as per January 1, 2017 amounted to approximately GBP 82 billion (EUR 96 billion) and is not recognized on Aegons statement of financial position.
On August 2, 2017, Aegon Poland has received approval by the Polish Financial Supervision Authority to take over the management of the Nordea second-pillar pension fund. The value of the transferred net assets of Nordea to Aegon Poland as per June 30, 2017 amounted to approximately PLN 8.1 billion (EUR 1.9 billion).
2016
On May 3, 2016, Aegon announced it has agreed to buy BlackRocks UK defined contribution (DC) platform and administration business. Under the purchase agreement, Aegon will acquire approximately GBP 12 billion (EUR 15 billion) of assets and 350,000 customers from BlackRock, which serves institutional and retail clients. The transaction is subject to a Part VII transfer of the underlying assets and liabilities to Aegon, which is subject to regulatory and court approval.
On August 11, 2016 Aegon announced the acquisition of Cofunds from Legal & General for GBP 140 million (EUR 164 million). The purchase of the Cofunds Ltd business is done through a sale and purchase agreement to acquire all the shares and platform assets. On January 1, 2017 Aegon completed the acquisition of Cofunds, following regulatory approval.
Annual Report on Form 20-F 2017 |
295 | Notes to the consolidated financial statements Note 51 | |
2015
On June 4, 2015 Aegon completed a strategic asset management partnership with La Banque Postale. Under the terms of the agreement, Aegon has acquired a 25% stake in La Banque Postale Asset Management (LBPAM) for a consideration of EUR 117 million.
On September 25, 2015, Aegon announced that it has acquired Mercers US defined contribution record-keeping business. On December 31, 2015, Aegon completed the acquisition after obtaining regulatory approval. The total purchase price amounted to EUR 70 million (USD 78 million), consisting of EUR 64 million (USD 71 million) cash and EUR 6 million (USD 7 million) contingent consideration. Cash position of Mercer amounts to nil on acquisition date.
On December 7, 2015, Aegon announced that it has increased its investment in Aegon Religare Life Insurance Company ARLI from 26 percent to 49 percent. The company has been renamed as Aegon Life Insurance Company Ltd.
Divestments/Disposals
2017
On June 28, 2017, Aegon completed its transaction to divest its two largest run-off businesses in the Americas, the payout annuity business and Bank Owned Life Insurance/ Corporate Owned Life Insurance business (BOLI/COLI). Under the terms of the agreement, Aegons Transamerica life subsidiaries has reinsured USD 14 billion of liabilities. The transaction resulted in a book gain of USD 250 million (EUR 231 million), reported in the line other income in the condensed consolidated income statement. The book gain consisted of a loss on the reinsurance transaction which is more than offset by the reclassification of gains from Other Comprehensive Income following the disposal of assets to fund the transaction.
The loss on the reinsurance transaction amounted to USD 1,813 million (EUR 1,675 million) being the difference of the reinsurance premium paid and the reinsurance asset received related to the insurance liabilities. Upon disposal an amount of USD 979 million (EUR 905 million) and USD 1,018 million (EUR 941 million) respectively related to revaluation reserves and cash flow hedging reserves has been reclassified from Other Comprehensive Income into the income statement. Gains on sale of certain assets carried at amortized cost backing the insurance liabilities amount to USD 94 million (EUR 87 million). Other expenses related to the transaction, including cost of sale, amounted to USD 28 million (EUR 26 million).
On June 30, 2017, following court approval on the Part VII transfer, the sale of the annuity portfolio to Rothesay Life has been completed. On September 22, 2017, following court approval on the Part VII transfer, the sale of the annuity portfolio to Legal & General has been completed.
On August 9, 2017, Aegon agreed to sell Aegon Ireland plc. The sales price will amount to 81% of the Solvency II Own Funds of Aegon Ireland at the end of 2017. This transaction further optimizes its portfolio of businesses. As the transaction is contingent on certain closing and market conditions until closing of the transaction, the book loss is uncertain. This divestment is expected to have an immaterial impact on income before tax and underlying earnings before tax going forward. The transaction is subject to customary regulatory approvals and is expected to close in the first half of 2018.
On November 1, 2017, Aegon completed the sale of Unirobe Meeùs Groep (UMG), an independent financial advisory group, for a total consideration of EUR 295 million. The divestment led to a book gain of EUR 208 million, which was reported in Other income in the fourth quarter. As a consequence of this transaction annual income before tax and underlying earnings before tax will decrease by approximately EUR 20 million going forward from the 2017 level.
On December 28, 2017, Aegon agreed to divest a block of life reinsurance business and to dissolve a related captive insurance company. Under the terms of the agreement, Aegons Transamerica life subsidiaries reinsured approximately USD 750 million of liabilities. The transaction covers approximately half of the life reinsurance business that Transamerica retained after it divested the vast majority of its life reinsurance business to SCOR in 2011.
2016
On January 18, 2016 Aegon Nederland N.V. sold its commercial non-life insurance business, which includes the proxy and coinsurance run-off portfolios. This business has an annual premium volume of approximately EUR 90 million. The total insurance liabilities from this business are EUR 334 million while the consideration paid in cash was EUR 302 million. The transaction was subsequently approved by the Dutch Central Bank (De Nederlandsche Bank) and the Dutch Authority for Consumers and Markets (Autoriteit Consument & Markt). Aegon completed the sale on July 1, 2016, which resulted in a gain of EUR 11 million.
Annual Report on Form 20-F 2017 |
296 | Notes to the consolidated financial statements Note 51 | |
On May 13, 2016, Aegon completed the sale of certain assets of Transamerica Financial Advisors, a full service independent broker-dealer and registered investment adviser, following regulatory approval. The consideration received for the sale consisted of USD 49 million (EUR 44 million) cash and USD 14 million (EUR 13 million) of contingent consideration which is subject to a 12 month earn-out period. The transaction resulted in a pre tax gain of USD 58 million (EUR 52 million) recorded in the second quarter of 2016.
In the second quarter of 2016 Aegon sold its UK annuity portfolio in two parts. On April 11, 2016 Aegon announced the sale of around GBP 6 billion of the portfolio to Rothesay Life. On May 23, 2016 Aegon announced the sale of around GBP 3 billion of the portfolio to Legal & General. Aegon incurred a book loss on the transaction before tax of GBP 530 million (EUR 682 million), reported in the line other charges in the consolidated income statement. The transaction resulted in a tax benefit of GBP 41 million (EUR 53 million). Under the terms of the agreements, Aegon reinsured GBP 6.8 billion of liabilities to Rothesay Life and Legal & General, followed by a Part VII transfer 1 , which were completed in 2017. The loss on the reinsurance transaction is GBP 1.9 billion (EUR 2.4 billion) being the difference of the reinsurance premium paid and the reinsurance asset received related to the insurance liabilities. Upon disposal an amount of GBP 1.4 billion (EUR 1.8 billion) related to a positive revaluation reserve has been reclassified from Other Comprehensive Income into the income statement. Taking into account the results of the sale of the related bonds leads to abovementioned result on the transaction of GBP 530 million. The related net cash outflow amounted to GBP 647 million (EUR 831 million). Expenses related to the transaction, including cost of sale, amount to GBP 13 million (EUR 16 million).
On December 16, 2016, Aegon completed the sale of 100% of its shares of Aegon Life Ukraine to TAS Group, and exited the Ukrainian market. This transaction has no material impact on the consolidated numbers of Aegon.
2015
On March 3, 2015, Aegon completed the sale of its 35% share in La Mondiale Participations following the granting of approval by the French Competition Authority (Autorité de la Concurrence). The agreement to sell Aegons stake in La Mondiale Participations to La Mondiale for EUR 350 million was announced on November 24, 2014. Proceeds from the sale were added to Aegons excess cash buffer, and increased the groups Insurance Group Directive (IGD) solvency ratio by over 4 percentage points at the time of the sale.
On July 31, 2015, Aegon completed the sale of its Canadian life insurance business following regulatory approval. The agreement to sell Aegons Canadian life insurance business for an amount of CAD 600 million (EUR 428 million) was announced on October 16, 2014. The transaction resulted in a book loss of CAD 1,054 million (EUR 751 million) recorded and presented as part of other charges, please refer to Note 17 Other charges. Aegon used the proceeds of this transaction for the redemption of the USD 500 million 4.625% senior bond which was due in December 2015.
The results of the Canadian operations reflect amounts previously recorded in Other Comprehensive Income that were reclassified into the income statement including CAD 178 million (EUR 127 million) release of the foreign currency translation reserve, CAD (72) million (EUR (51) million) release of the net foreign investment hedging reserve and CAD 668 million (EUR 476 million) for the release of the available for sale reserve. The net cash proceeds were CAD 543 million (EUR 387 million) consisting of CAD 600 million (EUR 428 million) cash received and the cash and cash equivalents included in the sale of CAD 57 million (EUR 41 million). Expenses related to the transaction, including cost of sale, amounted to CAD 11 million (EUR 8 million).
On September 1, 2015, Aegon completed the sale of Clark Consulting following regulatory approval. The agreement to sell Clark Consulting for USD 177.5 million (EUR 160 million) was announced on July 10, 2015 and resulted in a gain of USD 8 million (EUR 7 million). The cash and cash equivalents included at the time of the sales amounted to USD 13 million (EUR 12 million).
On September 7, 2015, Aegon completed the sale of its 25.1% share in platform provider and discretionary fund manager Seven Investment Management (7IM) for GBP 19 million (EUR 26 million). This transaction has led to a net gain of GBP 7 million (EUR 10 million). 7IM was recorded as an associate in the books of Aegon.
1 | An insurance business transfer scheme under Part VII of the United Kingdom Financial Services and Markets Act 2000 allows an insurer to transfer policies as at a fixed time and date to another insurer, along with related contracts with other parties (including reinsurance). |
Annual Report on Form 20-F 2017 |
297 | Notes to the consolidated financial statements Note 52 | |
Subsidiaries
The principal subsidiaries of the parent company Aegon N.V. are listed by geographical segment. All are wholly owned, directly or indirectly, unless stated otherwise, and are involved in insurance or reinsurance business, asset management or services related to these activities. The voting power in these subsidiaries held by Aegon is equal to the shareholdings.
Americas
◆ | Transamerica Advisors Life Insurance Company, Little Rock, Arkansas (United States); |
◆ | Transamerica Casualty Insurance Company, Columbus, Ohio (United States); |
◆ | Transamerica Corporation, Wilmington, Delaware (United States); |
◆ | Transamerica Financial Life Insurance Company, Albany, New York (United States); |
◆ | Transamerica Life Insurance Company, Cedar Rapids, Iowa (United States); |
◆ | Transamerica Premier Life Insurance Company, Cedar Rapids, Iowa (United States). |
The Netherlands
◆ | Aegon Bank N.V., The Hague; |
◆ | Aegon Hypotheken B.V., The Hague; |
◆ | Aegon Levensverzekering N.V., The Hague; |
◆ | Aegon Schadeverzekering N.V., The Hague; |
◆ | Aegon Spaarkas N.V., The Hague; |
◆ | Optas Pensioenen N.V., Rotterdam; |
◆ | TKP Pensioen B.V., Groningen; |
◆ | Unirobe Meeùs Groep B.V., The Hague (until November 1, 2017); |
◆ | Aegon PPI B.V., The Hague; |
◆ | CAPPITAL Premiepensioeninstelling B.V., Groningen. |
United Kingdom
◆ | Aegon Investment Solutions Ltd., Edinburgh; |
◆ | Scottish Equitable plc, Edinburgh; |
◆ | Cofunds Limited, London. |
Central & Eastern Europe
◆ | Aegon Magyarország Általános Biztosító Zártkőrűen Működő Részvénytársaság, Budapest (Aegon Hungary Composite Insurance Co.); |
◆ | Aegon Towarzystwo Ubezpieczeń na Życie Spółka Akcyjna, Warsaw (Aegon Poland Life); |
◆ | Aegon Powszechne Towarzystwo Emerytaine Spólka Akcyjna, Warsaw (Aegon Poland Pension Fund Management Co.); |
◆ | Aegon Emeklilik ve Hayat A.Ş., Istanbul (Aegon Turkey); |
◆ | Aegon Pensii Societate de Administrare a Fondurilor de Pensii Private S.A., Cluj (Aegon Romania Pension Administrator Co.); |
◆ | Aegon Pojitovna, a.s., Prague (Aegon Czech Life); |
◆ | Aegon ivotná poistovňa, a.s., Bratislava (Aegon Slovakia Life); |
◆ | Aegon, d.s.s., a.s., Bratislava (Aegon Slovakia Pension Management Co.). |
Spain & Portugal
◆ | Aegon España S.A.U. de Seguros y Reaseguros, Madrid (Spain); |
◆ | Aegon Administracion y Servicios A.I.E., Madrid (Spain); |
◆ | Aegon Activos A.V., S.A., Madrid (Spain); |
◆ | Aegon Mediacion, S.L.U, Madrid (Spain). |
Asia
◆ | Transamerica Life (Bermuda) Ltd., Hamilton (Bermuda); |
◆ | Aegon Insights Limited, Hong Kong (Hong Kong). |
Annual Report on Form 20-F 2017 |
298 | Notes to the consolidated financial statements Note 52 | |
Asset Management
◆ | Aegon Asset Management Holding B.V., The Hague (The Netherlands); |
◆ | Aegon Custody BV, The Hague (The Netherlands); |
◆ | Aegon Asset Management Pan-Europe B.V., The Hague (The Netherlands); |
◆ | Kames Capital plc, Edinburgh (United Kingdom); |
◆ | TKP Investments B.V., Groningen (The Netherlands); |
◆ | Aegon USA Investment Management, LLC, Cedar Rapids (United States); |
◆ | Aegon USA Realty Advisors, LLC, Des Moines (United States); |
◆ | Aegon Magyarország Befektetési Alapkezelő Zártkőrűen Műkődő Részvénytársaság (Aegon Hungary Asset Management Company ZrtA), Budapest (Hungary); |
◆ | Aegon Investment Management B.V, The Hague (The Netherlands). |
The legally required list of participations as set forth in articles 379 and 414 of Book 2 of the Dutch Civil Code has been registered with the Trade Register in The Hague. Aegon N.V. has issued a statement of liability as meant in article 403 of Book 2 of the Dutch Civil Code for its subsidiary company Aegon Derivatives N.V.
Joint ventures
The principal joint ventures are listed by geographical segment. The voting power in these joint ventures is equal to the shareholdings except for Akaan where Aegon has 50% of the voting power.
Americas
◆ | Akaan-Aegon, S.A.P.I. de C.V., Mexico City (Mexico), (99.99%). |
The Netherlands
◆ | AMVEST Vastgoed B.V., Utrecht (50%), property management and development. |
Spain & Portugal
◆ | Santander Generales Seguros y Reaseguros, S.A., Madrid (Spain), (51%); |
◆ | Aegon Santander Portugal Vida Companhia de Seguros de Vida S.A., Lisbon (Portugal), (51%); |
◆ | Aegon Santander Portugal Não Vida Companhia de Seguros S.A., Lisbon (Portugal), (51%); |
◆ | Santander Vida Seguros y Reaseguros, S.A., Madrid (Spain), (51%); |
◆ | Liberbank Vida y Pensiones, Seguros y Reaseguros, S.A., Oviedo (Spain), (50%). |
Asia
◆ | Aegon Sony Life Insurance Co., Tokyo (Japan), (50%); |
◆ | Aegon THTF Life Insurance Co., Ltd., Shanghai (China), (50%); |
◆ | SA Reinsurance Ltd, Hamilton (Bermuda), (50%). |
Asset Management
◆ | Aegon Industrial Fund Management Co., Ltd, Shanghai (China), (49%). |
Refer to note 26 Investments in joint ventures for further details on these investments.
Investments in associates
The principal investments in associates are listed by geographical segment. The voting power in these associates is equal to the shareholdings.
Americas
◆ | Mongeral Aegon, Seguros e Previdencia S.A., Rio de Janeiro (Brazil), (50%). |
Asset Management
◆ | La Banque Postale Asset Management, Paris (France), (25%). |
Refer to note 27 Investments in associates for further details on these investments.
Annual Report on Form 20-F 2017 |
299 | Notes to the consolidated financial statements Note 53 | |
In the normal course of business, Aegon enters into various transactions with related parties. Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial or operating decisions. Related parties of Aegon include, amongst others, its associates, joint ventures, key management personnel and the defined benefit and contribution plans. Transactions between related parties have taken place on an arms length basis. Transactions between Aegon and its subsidiaries that are deemed related parties have been eliminated in the consolidation and are not disclosed in the notes.
Related party transactions include, among others, transactions between Aegon N.V. and Vereniging Aegon.
On December 19, 2017 Aegon N.V. repurchased 13,042,592 common shares B from Vereniging Aegon for the amount of EUR 1,725,169.73 based on 1/40th of the Value Weight Average Price of the common shares of the five trading days preceding this transaction. The repurchase of common shares B was executed to align the aggregate shareholding of Vereniging Aegon in Aegon N.V. with its special cause voting rights of 32.6% following the completion of the Share Buy Back Program, initiated by Aegon N.V. in October 2017 to neutralize the dilutive effect of the distribution of final dividend 2016 in stock and interim dividend 2017 in stock.
On June 23, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 13,042,612 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on June 23, 2017, being the final dividend 2016 in the form of stock dividend.
On May 19, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 1,979,260 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused the issuance of shares on May 19, 2017, in connection with the Long Term Incentive Plans for senior management.
On June 6, 2016 Aegon N.V. repurchased 17,324,960 common shares B from Vereniging Aegon for the amount of EUR 1,968,332, based on 1/40th of the Value Weight Average Price of the common shares of the 5 trading days preceding this transaction. The repurchase of common shares B was executed to align the aggregate shareholding of Vereniging Aegon in Aegon N.V. with its special cause voting rights of 32.6%.
On May 19, 2016 Aegon N.V. repurchased 13,450,835 common shares from Vereniging Aegon for the amount of EUR 58 million being the Value Weight Average Price of the common shares of the 5 trading days preceding this transaction, as part of the EUR 400 million Share Buy Back program, initiated by Aegon N.V. in January 2016 to neutralize the dilutive effect of the cancellation of Aegon N.V.s preferred shares in 2013. Also the amount of EUR 58 million is 14.5% of EUR 400 million, which percentage is equal to the percentage of shares held by Vereniging Aegon in the total number of outstanding and voting shares Aegon N.V. at the time of this transaction.
On November 13, 2015, Vereniging Aegon exercised its options rights to purchase in aggregate 760 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by a correction to Aegons issuance of shares on May 21, 2015, in connection with the Long Term Incentive Plans for senior management.
On May 21, 2015, Vereniging Aegon exercised its options rights to purchase in aggregate 3,686,000 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by issuance of shares on May 21, 2015, in connection with the Long Term Incentive Plans for senior management.
On January 1, 2015, Vereniging Aegon exercised its options rights to purchase in aggregate 9,680 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by issuance of shares on January 1, 2015, in connection with the Long Term Incentive Plans for senior management.
Remuneration of members of the Management Board
The Management Board, which assists the Executive Board in pursuing Aegons strategic goals, is formed by members of the Executive Board, the CEOs of Aegon USA, Aegon Continental Europe, Aegon UK, Aegon Asset Management, Chief Risk Officer, Chief Technology Officer, Global Head HR and General Counsel. In April 2017, the members of the Management Board decreased by one due to the retirement of the CEO of Aegon Central & Eastern Europe.
Annual Report on Form 20-F 2017 |
300 | Notes to the consolidated financial statements Note 53 | |
The total remuneration for the members of the Management Board over 2017 was EUR 19.8 million (2016: EUR 18.6 million; 2015: EUR 15.2 million), consisting of EUR 7.4 million (2016: EUR 7.0 million; 2015: EUR 6.3 million) fixed compensation, EUR 7.8 million variable compensation awards (2016: EUR 6.4 million; 2015: EUR 4.9 million), EUR 0.9 million (2016: EUR 1.9 million; 2015: EUR 1.6 million) other benefits and EUR 3.7 million (2016: EUR 3.4 million; 2015: EUR 2.5 million) pension premiums. Amounts are reflective of time spent on the Management Board.
Expenses as recognized under IFRS in the income statement for variable compensation and pensions differ from the variable compensation awards and pension premiums paid due to the accounting treatment under respectively IFRS 2 and IAS 19. IFRS expenses related to variable compensation amounted to EUR 6.3 million (2016: EUR 6.0 million; 2015: EUR 5.0 million) and EUR 3.7 million (2016: EUR 3.2 million; 2015: EUR 3.4 million) for pensions. Total IFRS expenses for the members of the Management Board over 2017 were EUR 18.3 million (2016: EUR 18.7 million; 2015: EUR 16.8 million). The amount is reflective of time spent on the Management Board.
Additional information on the remuneration and share-based compensation of members of the Executive Board and the remuneration of the Supervisory Board is disclosed in the sections below (all amounts in EUR 000, except where indicated otherwise).
Remuneration of members of the Executive Board
The information below reflects the compensation and various related expenses for members of the Executive Board. Mr. Rider was appointed to the Executive Board for a term of four years by the shareholders on May 19, 2017 as CFO. Amounts and numbers are disclosed for the period Mr. Rider has been part of the Executive Board. Under the current remuneration structure, rewards are paid out over a number of years, or in the case of shares, vest over a number of years. This remuneration structure has made it more relevant to present rewards earned during a certain performance year instead of what was received in a certain year.
Fixed compensation
In EUR thousand | 2017 | 2016 | 2015 | |||||||||
Alex Wynaendts |
1,269 | 1,269 | 1,154 | |||||||||
Matt Rider 1) |
560 | - | - | |||||||||
Darryl Button |
- | 933 | 991 | |||||||||
Total fixed compensation |
1,829 | 2,202 | 2,145 |
1 | Mr. Rider was appointed as CFO and member of Aegons Executive Board per May 19, 2017. Fixed compensation is disclosed for the period that Mr. Rider has been part of the Executive Board. The base salary of Mr Rider is EUR 900 thousand on an annualized basis. |
Conditional variable compensation awards
In EUR thousand | 2017 | 2016 | 2015 | |||||||||
Alex Wynaendts |
1,147 | 1,044 | 923 | |||||||||
Matt Rider 1) |
499 | - | - | |||||||||
Darryl Button 2) |
- | 747 | 784 | |||||||||
Total conditional variable compensation awards |
1,646 | 1,791 | 1,707 |
1 | Mr. Rider was appointed as CFO and member of Aegons Executive Board per May 19, 2017. Conditional variable compensation is disclosed for the period that Mr. Rider has been part of the Executive Board. |
2 | Mr. Button stepped down as CFO and member of Aegons Executive Board on December 1, 2016. Conditional variable compensation is disclosed for the period that Mr. Button has been part of the Executive Board and are reflective of his time with Aegon until December 1, 2016. Amounts are based on USD, converted to EUR, based on annual average exchange rates. Expenses recognized under IFRS accounting treatment in the income statement for Mr. Button for 2016 amount to EUR 1,237 (2015: EUR 995). |
The amounts in the table represent the conditional variable compensation awards earned during the related performance year. Expenses recognized under IFRS accounting treatment in the income statement for conditionally awarded cash and shares differ from the awards. For the performance year 2017 and previous performance years, expenses under IFRS for Mr. Wynaendts amounted to EUR 1,092 (2016: EUR 956; 2015: EUR 900). For Mr. Rider the expenses under IFRS amounted to EUR 293.
2017
Over the performance year 2017, Mr. Wynaendts was awarded EUR 1,147 in total conditional variable compensation. Mr. Rider was awarded EUR 499.
Variable compensation is split 50/50 in a cash payment and an allocation of shares. Of the variable compensation related to performance year 2017, 40% is payable in 2018. Accordingly, Mr. Wynaendts and Mr. Rider will receive a cash payment
Annual Report on Form 20-F 2017 |
301 | Notes to the consolidated financial statements Note 53 | |
of EUR 229 and EUR 100 respectively. The number of shares to be made available in 2018 relating to performance year 2017 is 43,732 and 19,017 for Mr. Wynaendts and Mr. Rider respectively. The vested shares, less the number of shares to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares, are subject to a three year retention (holding) period, before they are at the disposal of the Executive Board members.
The remaining part of variable compensation for the performance year 2017 (60%), for Mr. Wynaendts EUR 344 and 65,598 shares and for Mr. Rider EUR 150 and 28,522 shares, is to be paid out in equal portions in 2019, 2020 and 2021, subject to ex-post assessments, which may result in downward adjustments and may be subject to additional conditions being met. Any payout will be split 50/50 in a cash payment and an allocation of shares vesting. The vested shares, less the number of shares to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares, are subject to a three year retention (holding) period, before they are at the disposal of the Executive Board members.
Mr. Button has not been awarded variable compensation.
2016
Over the performance year 2016, Mr. Wynaendts was awarded EUR 1,044 in total conditional variable compensation. Mr. Button was awarded EUR 747.
Variable compensation is split 50/50 in a cash payment and an allocation of shares. Of the variable compensation related to performance year 2016, 40% is payable in 2017. Accordingly, Mr. Wynaendts and Mr. Button will receive a cash payment of EUR 209 and EUR 149 respectively. The number of shares to be made available in 2017 relating to performance year 2016 is 40,722 and 29,614 for Mr. Wynaendts and Mr. Button respectively. The vested shares, less the number of shares to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares, are subject to a three year retention (holding) period, before they are at the disposal of the Executive Board members.
The remaining part of variable compensation for the performance year 2016 (60%), for Mr. Wynaendts EUR 313 and 61,083 shares and for Mr. Button EUR 224 and 44,424 shares, is to be paid out in equal portions in 2018, 2019 and 2020, subject to ex-post assessments, which may result in downward adjustments and may be subject to additional conditions being met. Any payout will be split 50/50 in a cash payment and an allocation of shares vesting. The vested shares, less the number of shares to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares, are subject to a three year retention (holding) period, before they are at the disposal of the Executive Board members.
2015
Over the performance year 2015, Mr. Wynaendts was awarded EUR 923 in total conditional variable compensation. Mr. Button was awarded EUR 784.
Variable compensation is split 50/50 in a cash payment and an allocation of shares. Of the variable compensation related to performance year 2015, 40% is payable in 2016. Accordingly, Mr. Wynaendts and Mr. Button will receive a cash payment of EUR 185 and EUR 157 respectively. The number of shares to be made available in 2016 relating to performance year 2015 is 30,219 and 23,621 for Mr. Wynaendts and Mr. Button respectively. The vested shares, less the number of shares to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares, are subject to a three year retention (holding) period, before they are at the disposal of the Executive Board members.
The remaining part of variable compensation for the performance year 2015 (60%), for Mr. Wynaendts EUR 277 and 45,330 shares and for Mr. Button EUR 235 and 35,433 shares, is to be paid out in equal portions in 2017, 2018 and 2019, subject to ex-post assessments, which may result in downward adjustments and may be subject to additional conditions being met. Any payout will be split 50/50 in a cash payment and an allocation of shares vesting. The vested shares, less the number of shares to cover for the payment of any applicable taxes, social security premiums and possible other deductions by the government due for which the Company holds a withholding obligation in connection with the vesting of the shares, are subject to a three year retention (holding) period, before they are at the disposal of the Executive Board members.
Annual Report on Form 20-F 2017 |
302 | Notes to the consolidated financial statements Note 53 | |
The table below illustrates all the conditionally awarded cash and shares of the members of the Executive Board, and the years in which each component will be paid out and/or vest, subject to the conditions as mentioned:
Conditional granted
performance related remuneration |
Timing of vesting, subject to targets and conditions | |||||||||||||||||||||||||||||||
Shares by reference period | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |||||||||||||||||||||||||
Alex Wynaendts |
||||||||||||||||||||||||||||||||
2007 |
9,253 8) | - | 9,253 | - | - | - | - | - | ||||||||||||||||||||||||
2011 1) |
17,304 | 17,304 | - | - | - | - | - | - | ||||||||||||||||||||||||
2012 2) |
65,110 | 32,555 | 32,555 | - | - | - | - | - | ||||||||||||||||||||||||
2013 3) |
62,943 | 20,981 | 20,981 | 20,981 | - | - | - | - | ||||||||||||||||||||||||
2014 4) |
67,761 | 27,105 | 13,552 | 13,552 | 13,552 | - | - | - | ||||||||||||||||||||||||
2015 5) |
75,549 | - | 30,219 | 15,110 | 15,110 | 15,110 | - | - | ||||||||||||||||||||||||
2016 6) |
101,805 | - | - | 40,722 | 20,361 | 20,361 | 20,361 | - | ||||||||||||||||||||||||
2017 7) |
109,330 | - | - | - | 43,732 | 21,866 | 21,866 | 21,866 | ||||||||||||||||||||||||
Total number of shares 9) |
509,055 | 97,945 | 106,560 | 90,365 | 92,755 | 57,337 | 42,227 | 21,866 | ||||||||||||||||||||||||
Matt Rider |
||||||||||||||||||||||||||||||||
2017 7) |
47,539 | - | - | - | 19,015 | 9,508 | 9,508 | 9,508 | ||||||||||||||||||||||||
Total number of shares 9) |
47,539 | - | - | - | 19,015 | 9,508 | 9,508 | 9,508 | ||||||||||||||||||||||||
Darryl Button |
||||||||||||||||||||||||||||||||
2013 3) |
28,716 | 9,572 | 9,572 | 9,572 | - | - | - | - | ||||||||||||||||||||||||
2014 4) |
43,258 | 17,302 | 8,652 | 8,652 | 8,652 | - | - | - | ||||||||||||||||||||||||
2015 5) |
59,054 | - | 23,621 | 11,811 | 11,811 | 11,811 | - | - | ||||||||||||||||||||||||
2016 6) |
74,038 | - | - | 29,614 | 14,808 | 14,808 | 14,808 | - | ||||||||||||||||||||||||
2017 7) |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
Total number of shares 9) |
205,066 | 26,874 | 41,845 | 59,649 | 35,271 | 26,619 | 14,808 | - | ||||||||||||||||||||||||
Jan J. Nooitgedagt |
||||||||||||||||||||||||||||||||
2011 1) |
11,250 | 11,250 | - | - | - | - | - | - | ||||||||||||||||||||||||
2012 2) |
44,740 | 22,370 | 22,370 | - | - | - | - | - | ||||||||||||||||||||||||
2013 3) |
26,478 | 8,826 | 8,826 | 8,826 | - | - | - | - | ||||||||||||||||||||||||
Total number of shares 9) |
82,468 | 42,446 | 31,196 | 8,826 | - | - | - | - | ||||||||||||||||||||||||
Cash (in EUR) |
||||||||||||||||||||||||||||||||
Alex Wynaendts |
||||||||||||||||||||||||||||||||
2011 |
81,795 | 81,795 | - | - | - | - | - | - | ||||||||||||||||||||||||
2012 |
203,536 | 101,768 | 101,768 | - | - | - | - | - | ||||||||||||||||||||||||
2013 |
309,489 | 103,163 | 103,163 | 103,163 | - | - | - | - | ||||||||||||||||||||||||
2014 |
456,643 | 182,656 | 91,329 | 91,329 | 91,329 | - | - | - | ||||||||||||||||||||||||
2015 |
461,305 | - | 184,522 | 92,261 | 92,261 | 92,261 | - | - | ||||||||||||||||||||||||
2016 |
522,060 | - | - | 208,824 | 104,412 | 104,412 | 104,412 | - | ||||||||||||||||||||||||
2017 |
573,550 | - | - | - | 229,420 | 114,710 | 114,710 | 114,710 | ||||||||||||||||||||||||
Total cash |
2,608,378 | 469,382 | 480,782 | 495,577 | 517,422 | 311,383 | 219,122 | 114,710 | ||||||||||||||||||||||||
Matt Rider |
||||||||||||||||||||||||||||||||
2017 |
249,390 | - | - | - | 99,756 | 49,878 | 49,878 | 49,878 | ||||||||||||||||||||||||
Total cash |
249,390 | - | - | - | 99,756 | 49,878 | 49,878 | 49,878 | ||||||||||||||||||||||||
CONTINUED > |
Annual Report on Form 20-F 2017 |
303 | Notes to the consolidated financial statements Note 53 | |
Conditional granted
performance related remuneration |
Timing of vesting, subject to targets and conditions | |||||||||||||||||||||||||||||||
Cash (in EUR) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |||||||||||||||||||||||||
Darryl Button |
||||||||||||||||||||||||||||||||
2013 |
140,301 | 46,767 | 46,767 | 46,767 | - | - | - | - | ||||||||||||||||||||||||
2014 |
300,120 | 120,048 | 60,024 | 60,024 | 60,024 | - | - | - | ||||||||||||||||||||||||
2015 |
392,155 | - | 156,862 | 78,431 | 78,431 | 78,431 | - | - | ||||||||||||||||||||||||
2016 |
373,369 | - | - | 149,347 | 74,674 | 74,674 | 74,674 | - | ||||||||||||||||||||||||
2017 |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
Total cash |
1,205,945 | 166,815 | 263,653 | 334,569 | 213,129 | 153,105 | 74,674 | - | ||||||||||||||||||||||||
Jan J. Nooitgedagt |
||||||||||||||||||||||||||||||||
2011 |
53,180 | 53,180 | - | - | - | - | - | - | ||||||||||||||||||||||||
2012 |
139,858 | 69,929 | 69,929 | - | - | - | - | - | ||||||||||||||||||||||||
2013 |
130,188 | 43,396 | 43,396 | 43,396 | - | - | - | - | ||||||||||||||||||||||||
Total cash |
323,226 | 166,505 | 113,325 | 43,396 | - | - | - | - |
1 | The number of shares is based on a volume weighted average price of EUR 4.727. After vesting a 3 year holding period applies to shares vested. |
2 | The number of shares is based on a volume weighted average price of EUR 3.126. After vesting a 3 year holding period applies to shares vested. |
3 | The number of shares is based on a volume weighted average price of EUR 4.917. After vesting a 3 year holding period applies to shares vested. |
4 | The number of shares is based on a volume weighted average price of EUR 6.739. After vesting a 3 year holding period applies to shares vested. |
5 | The number of shares is based on a volume weighted average price of EUR 6.106. After vesting a 3 year holding period applies to shares vested. |
6 | The number of shares is based on a volume weighted average price of EUR 5.128 After vesting a 3 year holding period applies to shares vested. |
7 | The number of shares is based on a volume weighted average price of EUR 5.246 After vesting a 3 year holding period applies to shares vested. |
8 | During the vesting period, dividend payments on these shares are deposited in blocked savings accounts on behalf of the executive members. For active members of the Executive Board 50% of the shares vested in 2012 and 50% vested in 2016. |
9 | The shares that were allocated, vested with the acceptance of the Annual Accounts at the AGM in the year of vesting. The vesting price (in EUR) was: 7.2428 on 21 May 2015, 4.5020 on 20 May 2016, and 4.4230 on May 2017. |
Other benefits
In EUR thousand | 2017 | 2016 | 2015 | |||||||||
Alex Wynaendts |
165 | 178 | 151 | |||||||||
Matt Rider 1) |
59 | - | - | |||||||||
Darryl Button 2) |
- | 739 | 528 | |||||||||
Total other benefits |
224 | 917 | 679 |
1 | Mr. Rider was appointed as CFO and member of Aegons Executive Board per May 19, 2017. Other benefits are disclosed for the period that Mr. Rider has been part of the Executive Board. |
2 | Mr. Button stepped down as CFO and member of Aegons Executive Board on December 1, 2016. Other benefits are disclosed for the period that Mr. Button has been part of the Executive Board and are reflective of his time with Aegon December 1, 2016. These benefits also included expenses related to his expatriation and commuter assignment from the United States to the Netherlands, borne by the Group. |
Other benefits include non-monetary benefits (e.g. company car), social security contributions by the employer, and tax expenses borne by the Group.
Pension contributions
Pension contributions reflect the expenses related to the pension accrual over the financial year disclosed in the table, excluding back service charges.
In EUR thousand | 2017 | 2016 | 2015 | |||||||||
Alex Wynaendts 1) |
1,670 | 1,631 | 1,219 | |||||||||
Matt Rider 2) |
224 | - | - | |||||||||
Darryl Button 3) |
- | 375 | 215 | |||||||||
Total pension contributions |
1,894 | 2,006 | 1,434 |
1 | The increase to the base pay of Mr. Wynaends, resulted in a backservice liability of EUR 1,361 in 2016 which is expensed over 2016-2019 (2016: EUR 416, 2017: EUR 432). |
2 | Mr. Rider was appointed as CFO and member of Aegons Executive Board per May 19, 2017. Pension contributions are disclosed for the period that Mr. Rider has been part of the Executive Board. |
3 | Mr. Button stepped down as CFO and member of Aegons Executive Board on December 1, 2016. Pension contributions are disclosed for the period that Mr. Button has been part of the Executive Board and are reflective of his time with Aegon until December 1, 2016. Expenses recognized under IFRS accounting treatment in the income statement for Mr. Button for 2016 amount to EUR 375 (2015: EUR 215). |
The amounts as presented in the table are the pension contributions in the related book year. The 2017 and 2016 contributions for Mr. Wynaendts to the Aegon pension funds reflect the increase to his fixed salary in 2016 as well as the current low interest rates. Under IFRS, the service cost as recognized in the income statement related to the defined benefit obligation of Mr. Wynaendts amounted to EUR 1,733 (2016: EUR 1,666; 2015: EUR 1,962). Service cost for Mr. Rider amounted to EUR 175 (2016: nil; 2015: nil).
Annual Report on Form 20-F 2017 |
304 | Notes to the consolidated financial statements Note 53 | |
Total
The total amount of remuneration, consisting of the fixed compensation, conditional variable compensation awards, other benefits and pension contributions, for Mr. Wynaendts related to 2017 was EUR 4,683 (2016: EUR 4,538; 2015: EUR 3,446) and for Mr. Rider EUR 1,342. The total remuneration for the members of the Executive Board over 2017 was EUR 6.0 million (2016: EUR 7.3 million; 2015: EUR 6.0 million). Total expenses recognized under IFRS accounting treatment in the income statement for Mr. Wynaendts related to 2017 was EUR 4,258 (2016: EUR 4,086; 2015: EUR 4,167) and for Mr. Rider EUR 1,088 (2016: nil; 2015: nil). Total IFRS expenses for the members of the Executive Board over 2017 was EUR 5.3 million (2016: EUR 8.0 million; 2015: 7.1 million). As a result of the termination of the Board membership of Mr. Button in 2016, an additional Dutch employer wage tax was estimated at EUR 1,394 in 2016. In 2017 it turned out that based on the actual situation and the expected value of the deferred compensations no additional Dutch employer wage tax will be due.
Interests in Aegon N.V. held by active members of the Executive Board
Shares held in Aegon at December 31, 2017 by Mr. Wynaendts amount to 448,601 (2016: 401,948). Mr. Rider was appointed as CFO and member of Aegons Executive Board per May 19, 2017. Mr. Rider held no shares on December 31, 2017. The shares held in Aegon mentioned above do not exceed 1% of total outstanding share capital at the reporting date. At the reporting date no loans with Aegon or outstanding balances such as guarantees or advanced payments exist for either Mr. Wynaendts or Mr. Rider.
Remuneration of active and retired members of the Supervisory Board
In EUR | 2017 | 2016 | 2015 | |||||||||
Robert J. Routs |
134,000 | 140,000 | 143,000 | |||||||||
William L. Connelly (as of May 19, 2017) |
60,125 | - | - | |||||||||
Robert W. Dineen |
104,000 | 115,000 | 121,000 | |||||||||
Mark A. Ellman (as of May 19, 2017) |
70,125 | - | - | |||||||||
Ben J. Noteboom (as of May 20, 2015) |
101,500 | 109,000 | 69,250 | |||||||||
Ben van der Veer |
106,000 | 109,000 | 115,000 | |||||||||
Dirk P.M. Verbeek |
100,000 | 111,000 | 112,125 | |||||||||
Corien M. Wortmann-Kool |
100,750 | 90,000 | 96,000 | |||||||||
Dona D. Young |
115,500 | 113,000 | 121,000 | |||||||||
Total for active members |
892,000 | 787,000 | 777,375 | |||||||||
Leo M. van Wijk (up to May 20, 2015) |
- | - | 38,625 | |||||||||
Irving W. Bailey, II (up to May 20, 2016) |
- | 53,625 | 135,000 | |||||||||
Shemaya Levy (up to May 19, 2017) |
40,375 | 95,250 | 101,000 | |||||||||
Total remuneration |
932,375 | 935,875 | 1,052,000 | |||||||||
VAT liable on Supervisory Board remuneration |
195,799 | 196,534 | 220,920 | |||||||||
Total |
1,128,174 | 1,132,409 | 1,272,920 |
Aegons Supervisory Board members are entitled to the following:
◆ | A base fee for membership of the Supervisory Board. No separate attendance fees are paid to members for attendance at the regular Supervisory Board meetings (2017: 7 meetings; 2016: 8 meetings; 2015: 7 meetings); |
◆ | An attendance fee of EUR 3,000 for each extra Board meeting attended, be it in person or by video and/or telephone conference; |
◆ | A committee fee for members on each of the Supervisory Boards Committees; |
◆ | An attendance fee for each Committee meeting attended, be it in person or through video and/or telephone conference; and |
◆ | An additional fee for attending meetings that require intercontinental travel between the Supervisory Board members home location and the meeting location. |
Not included in the table above is a premium for state health insurance paid on behalf of Dutch Supervisory Board members. There are no outstanding balances such as loans, guarantees or advanced payments
Annual Report on Form 20-F 2017 |
305 | Notes to the consolidated financial statements Note 54 | |
Common shares held by Supervisory Board members
Shares held in Aegon at December 31 | 2017 | 2016 | ||||||
Robert W. Dineen |
10,000 | 10,000 | ||||||
Ben J. Noteboom |
23,500 | 23,500 | ||||||
Ben van der Veer |
1,450 | 1,450 | ||||||
Dirk P.M. Verbeek |
1,011 | 1,011 | ||||||
Dona D. Young |
13,260 | 13,260 | ||||||
Total |
49,221 | 49,221 |
Shares held by Supervisory Board members are only disclosed for the period for which they have been part of the Supervisory Board.
54 Events after the reporting period
On January 11, 2018, Aegon announced that its subsidiary in the Americas, Transamerica, has entered into an agreement with Tata Consultancy Services (TCS) to administer the companys US insurance and annuity business lines. The agreement is expected to be completed by the second quarter of 2018.
The Hague, the Netherlands, March 22, 2018
Supervisory Board | Executive Board | |
Robert J. Routs |
Alexander R. Wynaendts | |
William L. Connelly |
Matthew J. Rider | |
Robert W. Dineen |
||
Mark A. Ellman |
||
Ben J. Noteboom |
||
Ben van der Veer |
||
Dirk P.M. Verbeek |
||
Corien M. Wortmann-Kool |
||
Dona D. Young |
Annual Report on Form 20-F 2017 |
306 | Financial statements of Aegon N.V. | |
Table of contents
Financial statements of Aegon N.V. | ||||||
307 | ||||||
308 | ||||||
Notes to the financial statements | ||||||
1 |
General information | 309 | ||||
2 |
Summary of significant accounting policies | 309 | ||||
3 |
Investment income | 309 | ||||
4 |
Results from financial transactions | 310 | ||||
5 |
Commissions and expenses | 310 | ||||
6 |
Interest charges and related fees | 310 | ||||
7 |
Income tax | 310 | ||||
8 |
Shares in group companies | 310 | ||||
9 |
Loans to group companies | 311 | ||||
10 |
Receivables | 311 | ||||
11 |
Other assets | 311 | ||||
12 |
Share capital | 311 | ||||
13 |
Shareholders equity | 313 | ||||
14 |
Other equity instruments | 316 | ||||
15 |
Subordinated borrowings | 317 | ||||
16 |
Long-term borrowings | 318 | ||||
17 |
Other liabilities | 318 | ||||
18 |
Commitments and contingencies | 318 | ||||
19 |
Number of employees | 318 | ||||
20 |
Accountants remuneration | 318 | ||||
21 |
Events after the reporting period | 319 | ||||
22 |
Proposal for profit appropriation | 319 |
Annual Report on Form 20-F 2017 |
307 | Financial statements of Aegon N.V. | |
Income statement of Aegon N.V.
For the year ended December 31
Amounts in EUR million | Note | 2017 | 2016 | |||||||||
Income |
||||||||||||
Investment Income |
3 | 83 | 121 | |||||||||
Total revenues |
83 | 121 | ||||||||||
Results from financial transactions |
4 | 56 | (68 | ) | ||||||||
Total income |
139 | 53 | ||||||||||
Charges |
||||||||||||
Commissions and expenses |
5 | 82 | 68 | |||||||||
Interest charges and related fees |
6 | 100 | 106 | |||||||||
Total charges
|
|
182
|
|
|
174
|
|
||||||
Income before tax |
(43 | ) | (121 | ) | ||||||||
Income Tax |
7 | 1 | 25 | |||||||||
Income after tax |
(42 | ) | (96 | ) | ||||||||
Net income/(loss) group companies |
2,511 | 533 | ||||||||||
Net income / (loss) |
2,469 | 437 |
Annual Report on Form 20-F 2017 |
308 | Financial statements of Aegon N.V. | |
Statement of financial position of Aegon N.V.
As at December 31
Before profit appropriation, amounts in EUR million | Note | 2017 | 2016 | |||||||||
Non-current assets |
||||||||||||
Financial fixed assets |
||||||||||||
Shares in group companies |
8 | 23,117 | 22,219 | |||||||||
Loans to group companies |
9 | 2,690 | 4,123 | |||||||||
25,807 | 26,342 | |||||||||||
Current assets |
||||||||||||
Receivables |
||||||||||||
Receivables from group companies |
10 | 36 | 80 | |||||||||
Other receivables |
10 | 146 | 219 | |||||||||
Other |
11 | 74 | 140 | |||||||||
Accrued interest and rent |
8 | 15 | ||||||||||
264 | 454 | |||||||||||
Cash and cash equivalents |
||||||||||||
Cash and cash equivalents |
1,068 | 879 | ||||||||||
Total assets |
27,139 | 27,675 | ||||||||||
Shareholders equity |
||||||||||||
Share capital |
12 | 322 | 319 | |||||||||
Paid-in surplus |
13 | 7,731 | 7,873 | |||||||||
Revaluation account |
13 | 5,017 | 5,450 | |||||||||
Remeasurement of defined benefit plans of group companies |
13 | (1,669 | ) | (1,820 | ) | |||||||
Legal reserves foreign currency translation reserve |
13 | (401 | ) | 1,316 | ||||||||
Legal reserves in respect of group companies |
13 | 1,122 | 1,169 | |||||||||
Retained earnings, including treasury shares |
13 | 5,696 | 5,776 | |||||||||
Net income / (loss) |
13 | 2,469 | 437 | |||||||||
20,288 | 20,520 | |||||||||||
Other equity instruments |
14 | 3,794 | 3,797 | |||||||||
Total equity |
24,082 | 24,318 | ||||||||||
Non-current liabilities |
||||||||||||
Subordinated borrowings |
15 | 764 | 767 | |||||||||
Long-term borrowings |
16 | 1,801 | 1,832 | |||||||||
2,565 | 2,599 | |||||||||||
Current liabilities |
17 | |||||||||||
Short term deposits |
73 | 128 | ||||||||||
Loans from group companies |
62 | 62 | ||||||||||
Payables to group companies |
123 | 140 | ||||||||||
Deferred tax liability |
89 | 159 | ||||||||||
Other |
125 | 242 | ||||||||||
Accruals and deferred income |
22 | 29 | ||||||||||
|
494
|
|
|
760
|
|
|||||||
Total liabilities
|
|
3,059
|
|
|
3,359
|
|
||||||
Total equity and liabilities |
27,139 | 27,675 |
Annual Report on Form 20-F 2017 |
309 | Notes to the financial statements of Aegon N.V. Note 1 | |
Notes to the financial statements
Aegon N.V., incorporated and domiciled in the Netherlands, is a public limited liability company organized under Dutch law and recorded in the Commercial Register of The Hague registered under number 27076669 and with its registered address at Aegonplein 50, 2591 TV, The Hague, the Netherlands. Aegon N.V. serves as the holding company for the Aegon Group and has listings of its common shares in Amsterdam and New York.
Aegon N.V. (or the Company) and its subsidiaries (Aegon or the Group) have life insurance and pensions operations in more than 20 countries in the Americas, Europe and Asia and are also active in savings and asset management operations, accident and health insurance, general insurance and to a limited extent banking operations. Headquarters are located in The Hague, the Netherlands. The Group employs over 28,000 people worldwide (2016: over 29,000).
Aegon Funding Company LLC
Aegon Funding Company LLC (AFC) is an indirect wholly owned subsidiary of Aegon that was established as a financing vehicle to raise funds for the US subsidiaries of Aegon. AFC has been fully consolidated in the financial statements of Aegon under IFRS. If AFC issues debt securities, Aegon will fully and unconditionally guarantee the due and punctual payment of the principal, any premium and any interest on those debts securities when and as these payments become due and payable, wheather at maturity, upon redemption or declaration of acceleration, or otherwise. The guarantees of senior debt securities will constitute an unsecured, unsubordinated obligation of Aegon and will rank equally with all other unsecured and unsubordinated obligations of Aegon. The guarantees of subordinated debt securities will constitute an unsecured obligation of Aegon and will be subordinated in right of payment to all senior indebtedness of Aegon.
2 Summary of significant accounting policies
The financial statements have been prepared in accordance with accounting principles in the Netherlands as embodied in Part 9 of Book 2 of the Netherlands Civil Code. In accordance with 2:362.8 of the Dutch Civil Code, the Companys financial statements are prepared based on the accounting principles of recognition, measurement and determination of profit, as applied in the consolidated financial statements. These principles also include the classification and presentation of financial instruments, being equity instruments or financial liabilities.
The group companies are stated at their net asset value, determined on the basis of the consolidated accounting policies as applied in the consolidated financial statements of the Group. For details on the accounting policies applied for the group companies refer to the consolidated financial statements.
Revaluation account includes unrealized gains and losses on available-for-sales assets and the positive changes in value that have been recognized in net income/(loss) relating to investments (including real estate) and which do not have a frequent market listing.
Legal reserves in respect of group companies include net increases in net asset value of subsidiaries and associates since their first inclusion, less any amounts that can be distributed without legal restrictions.
A reference is made to Note 2 Summary of significant accounting policies of the consolidated financial statements for the description of the accounting policies applied.
2017 | 2016 | |||||||
Interest income from intercompany loans |
65 | 104 | ||||||
Interest income from derivatives |
18 | 17 | ||||||
Total Investment Income |
83 | 121 |
Annual Report on Form 20-F 2017 |
310 | Notes to the financial statements of Aegon N.V. Note 4 | |
4 Results from financial transactions
2017 | 2016 | |||||||
Results from financial transactions comprise: |
||||||||
Net fair value change of derivatives |
56 | (68 | ) | |||||
Net foreign currency gains and (losses) |
- | (2 | ) | |||||
Net fair value change on borrowings and other financial liabilities |
- | 2 | ||||||
Total |
56 | (68 | ) |
Net fair value change of derivatives mostly comprises of Fair value changes on derivatives that are designated as economic hedges for which no hedge accounting is applied.
2017 | 2016 | |||||||
Employee expenses |
80 | 80 | ||||||
Administration expenses |
78 | 73 | ||||||
Cost sharing |
(76 | ) | (85 | ) | ||||
Total |
82 | 68 | ||||||
|
|
|||||||
2017 | 2016 | |||||||
Subordinated borrowings |
34 | 34 | ||||||
Borrowings |
62 | 68 | ||||||
Other |
4 | 4 | ||||||
Total |
100 | 106 | ||||||
|
|
|||||||
2017 | 2016 | |||||||
Current Tax |
||||||||
- Current Tax |
1 | 25 | ||||||
Income tax for the period (income) / charge |
1 | 25 | ||||||
Reconciliation between standard and effective tax |
||||||||
Income before tax |
(43 | ) | (121 | ) | ||||
Tax on income |
11 | 30 | ||||||
Differences due to the effect of: |
||||||||
Non deductible expenses |
(11 | ) | (6 | ) | ||||
Total |
1 | 25 | ||||||
|
|
|||||||
2017 | 2016 | |||||||
At January 1 |
22,219 | 23,992 | ||||||
Capital contributions and acquisitions |
1,006 | 210 | ||||||
Divestments and capital repayments |
(698 | ) | (895 | ) | ||||
Dividend received |
(120 | ) | (181 | ) | ||||
Net income / (loss) for the financial year |
2,511 | 533 | ||||||
Revaluations |
(1,799 | ) | (1,440 | ) | ||||
At December 31 |
23,117 | 22,219 |
For a list of names and locations of the most important group companies, refer to note 52 Group companies of the consolidated financial statements of the Group. The legally required list of participations as set forth in article 379 of Book 2 of the Netherlands Civil Code has been registered with the Commercial Register of The Hague.
Annual Report on Form 20-F 2017 |
311 | Notes to the financial statements of Aegon N.V. Note 9 | |
2017 | 2016 | |||||||
Loans to group companies long-term |
||||||||
At January 1 |
1,934 | 3,137 | ||||||
Additions / (repayments) |
(427 | ) | (1,248 | ) | ||||
Transfer to short term |
(829 | ) | - | |||||
Other changes |
(239 | ) | 45 | |||||
At December 31 |
439 | 1,934 | ||||||
Loans to group companies short-term |
||||||||
At January 1 |
2,189 | 1,392 | ||||||
Additions / (repayments) |
(563 | ) | 746 | |||||
Transfer from long term |
829 | - | ||||||
Other changes |
(204 | ) | 51 | |||||
At December 31 |
2,251 | 2,189 | ||||||
Total |
2,690 | 4,123 |
The other changes in 2017 in Loans to group companies mainly relate to currency exchange rate fluctuations.
Receivables from group companies and other receivables have a maturity of less than one year. Other receivables include an income tax receivable of EUR 130 million (2016: EUR 219 million).
Aegon N.V., together with certain of its subsidiaries, is part of a tax grouping for Dutch corporate income tax purposes. The members of the fiscal entity are jointly and severally liable for any taxes receivable or payable by the Dutch tax grouping.
Other assets include derivatives with positive fair values of EUR 70 million (2016: EUR 135 million).
Issued and outstanding capital | 2017 | 2016 | ||||||
Common shares |
251 | 249 | ||||||
Common shares B |
70 | 70 | ||||||
Total share capital |
322 | 319 | ||||||
Common shares | 2017 | 2016 | ||||||
Authorized share capital |
720 | 720 | ||||||
Number of authorized shares (in million) |
6,000 | 6,000 | ||||||
Par value in cents per share |
12 | 12 | ||||||
Common shares B | 2017 | 2016 | ||||||
Authorized share capital |
360 | 360 | ||||||
Number of authorized shares (in million) |
3,000 | 3,000 | ||||||
Par value in cents per share |
12 | 12 |
All issued common shares and common shares B each have a nominal value of EUR 0.12 and are fully paid up. Repayment of capital can only be initiated by the Executive Board, is subject to approval of the Supervisory Board and must be resolved by the General Meeting of Shareholders. Moreover, repayment on common shares B needs approval of the related shareholders. Refer to Other information for further information on dividend rights.
Vereniging Aegon, based in The Hague, the Netherlands, holds all of the issued and outstanding common shares B.
Annual Report on Form 20-F 2017 |
312 | Notes to the financial statements of Aegon N.V. Note 12 | |
On December 19, 2017, Aegon N.V. repurchased 13,042,592 common shares B from Vereniging Aegon for the amount of EUR 1,725,169.73 based on 1/40th of the Value Weight Average Price of the common shares of the five trading days preceding this transaction. The repurchase of common shares B was executed to align the aggregate shareholding of Vereniging Aegon in Aegon N.V. with its special cause voting rights of 32.6% following the completion of the Share Buy Back Program, initiated by Aegon N.V. in October 2017 to neutralize the dilutive effect of the distribution of final dividend 2016 in stock and interim dividend 2017 in stock.
On June 23, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 13,042,612 common shares B at fair value of a common share B (based on 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on June 23, 2017, being the final dividend 2016 in the form of stock dividend.
On May 19, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 1,979,260 common shares B at fair value of a common share B (based on 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused the issuance of shares on May 19, 2017, in connection with the Long Term Incentive Plans for senior management.
In 2016, Vereniging Aegon decided not to exercise its option rights to purchase common shares B, since its special cause voting rights at the time of the issuance of shares in connection with the Long Term Incentive Plans for senior management already exceeded 32.6% due to the execution of the EUR 400 million Share Buyback program. As a consequence, such issuance of shares would not result in dilution of Vereniging Aegons voting rights.
The following table shows the movement during the year in the number of common shares and common shares B:
Common shares | Common shares B | |||||||||||||||
Number of shares
(thousands) |
Total amount |
Number of shares
(thousands) |
Total amount | |||||||||||||
At January 1, 2016 |
2,147,037 | 258 | 585,022 | 70 | ||||||||||||
Dividend |
10,629 | 1 | - | - | ||||||||||||
Shares withdrawn |
(83,117 | ) | (10 | ) | - | - | ||||||||||
At December 31, 2016 |
2,074,549 | 249 | 585,022 | 70 | ||||||||||||
Dividend |
21,099 | 3 | - | - | ||||||||||||
At December 31, 2017 |
2,095,648 | 251 | 585,022 | 70 |
The following table shows the weighted average number of common shares and common shares B:
Weighted
average number of common shares (thousands) |
Weighted
average number of common shares B (thousands) |
|||||||
2016 |
2,129,074 | 585,022 | ||||||
2017 |
2,080,792 | 585,022 |
The shares repurchased by Aegon N.V. during the share-buy-back programs to undo the dilution caused by the distribution of dividend in stock, although included in the issued and outstanding number of shares, are excluded from the calculation of the weighted average number of shares.
Long-term incentive plan, share appreciation rights and share options
For detailed information on the Long Term Incentive Plans, share appreciation rights and share options granted to senior executives and other Aegon employees, refer to note 14 Commissions and expenses to the consolidated financial statements of the Group.
Board remuneration
Detailed information on remuneration of active and retired members of the Executive Board including their share and share option rights, remuneration of active and retired members of the Supervisory Board along with information about shares held in Aegon by the members of the Boards is included in note 53 Related party transactions to the consolidated financial statements of the Group.
Annual Report on Form 20-F 2017 |
313 | Notes to the financial statements of Aegon N.V. Note 13 | |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
At January 1, 2017 |
319 | 7,873 | 5,450 | (1,820 | ) | 1,316 | 1,169 | 5,966 | (190 | ) | 437 | 20,520 | ||||||||||||||||||||||||||||
Net income 2016 retained |
- | - | - | - | - | - | 437 | - | (437 | ) | - | |||||||||||||||||||||||||||||
Net income 2017 |
- | - | - | - | - | - | - | - | 2,469 | 2,469 | ||||||||||||||||||||||||||||||
Total net income / (loss) |
- | - | - | - | - | - | 437 | - | 2,032 | 2,469 | ||||||||||||||||||||||||||||||
Foreign currency translation differences and movement in foreign investment hedging reserves |
- | - | - | 102 | (1,717 | ) | - | - | - | - | (1,615 | ) | ||||||||||||||||||||||||||||
Changes in revaluation subsidiaries |
- | - | (461 | ) | - | - | - | - | - | - | (461 | ) | ||||||||||||||||||||||||||||
Remeasurement of defined benefit plans of group companies |
- | - | - | 49 | - | - | - | - | - | 49 | ||||||||||||||||||||||||||||||
Transfer to legal reserve |
- | - | 28 | - | - | (47 | ) | (1 | ) | - | - | (20 | ) | |||||||||||||||||||||||||||
Other |
- | - | - | - | - | - | 12 | - | - | 12 | ||||||||||||||||||||||||||||||
Other comprehensive income / (loss) |
- | - | (433 | ) | 151 | (1,717 | ) | (47 | ) | 11 | - | - | (2,035 | ) | ||||||||||||||||||||||||||
Shares issued |
3 | - | - | - | - | - | - | - | - | 3 | ||||||||||||||||||||||||||||||
Dividend common shares |
- | (142 | ) | - | - | - | - | (296 | ) | - | - | (438 | ) | |||||||||||||||||||||||||||
Dividend withholding tax reduction |
- | - | - | - | - | - | 2 | - | - | 2 | ||||||||||||||||||||||||||||||
Treasury shares |
- | - | - | - | - | - | 30 | (136 | ) | - | (106 | ) | ||||||||||||||||||||||||||||
Coupons and premium on convertible core capital securities and coupon on perpetual securities, net of tax |
- | - | - | - | - | - | (131 | ) | - | - | (131 | ) | ||||||||||||||||||||||||||||
Repurchased and sold own shares |
- | - | - | - | - | - | 4 | - | - | 4 | ||||||||||||||||||||||||||||||
At December 31, 2017 |
322 | 7,731 | 5,017 | (1,669 | ) | (401 | ) | 1,122 | 6,022 | (325 | ) | 2,469 | 20,288 |
Annual Report on Form 20-F 2017 |
314 | Notes to the financial statements of Aegon N.V. Note 13 | |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
At January 1, 2016 |
328 | 8,059 | 6,551 | (1,532 | ) | 1,264 | 1,048 | 7,423 | (269 | ) | (432 | ) | 22,440 | |||||||||||||||||||||||||||
Net income 2015 retained |
- | - | - | - | - | - | (432 | ) | - | 432 | - | |||||||||||||||||||||||||||||
Net income 2016 |
- | - | - | - | - | - | - | - | 437 | 437 | ||||||||||||||||||||||||||||||
Total net income / (loss) |
- | - | - | - | - | - | (432 | ) | - | 869 | 437 | |||||||||||||||||||||||||||||
Foreign currency translation differences and movement in foreign investment hedging reserves |
- | - | - | 16 | 52 | - | - | - | - | 68 | ||||||||||||||||||||||||||||||
Changes in revaluation subsidiaries |
- | - | (1,090 | ) | - | - | - | - | - | - | (1,090 | ) | ||||||||||||||||||||||||||||
Remeasurement of defined benefit plans of group companies |
- | - | - | (304 | ) | - | - | - | - | - | (304 | ) | ||||||||||||||||||||||||||||
Transfer to legal reserve |
- | - | (11 | ) | - | - | 121 | (97 | ) | - | - | 13 | ||||||||||||||||||||||||||||
Other |
- | - | - | - | - | - | (2 | ) | - | - | (2 | ) | ||||||||||||||||||||||||||||
Other comprehensive income / (loss) |
- | - | (1,101 | ) | (288 | ) | 52 | 121 | (99 | ) | - | - | (1,316 | ) | ||||||||||||||||||||||||||
Shares issued |
1 | - | - | - | - | - | - | - | - | 1 | ||||||||||||||||||||||||||||||
Shares withdrawn |
(10 | ) | - | - | - | - | - | (372 | ) | - | - | (382 | ) | |||||||||||||||||||||||||||
Dividend common shares |
- | (186 | ) | - | - | - | - | (304 | ) | - | - | (490 | ) | |||||||||||||||||||||||||||
Dividend withholding tax reduction |
- | - | - | - | - | - | (2 | ) | - | - | (2 | ) | ||||||||||||||||||||||||||||
Treasury shares |
- | - | - | - | - | - | (106 | ) | 79 | - | (27 | ) | ||||||||||||||||||||||||||||
Coupons and premium on convertible core capital securities and coupon on perpetual securities, net of tax |
- | - | - | - | - | - | (133 | ) | - | - | (133 | ) | ||||||||||||||||||||||||||||
Repurchased and sold own shares |
- | - | - | - | - | - | (9 | ) | - | - | (9 | ) | ||||||||||||||||||||||||||||
At December 31, 2016 |
319 | 7,873 | 5,450 | (1,820 | ) | 1,316 | 1,169 | 5,966 | (190 | ) | 437 | 20,520 |
The balance of the revaluation account, which includes revaluation reserves for real estate and investments that do not have a frequent market listing, consisted of EUR 5,380 million (2016: EUR 6,113 million) of items with positive revaluation and of EUR 363 million (2016: EUR 663 million) of items with negative revaluation.
The revaluation account and legal reserves, foreign currency translation reserve and other, can not be freely distributed. In case of negative balances for individual reserves legally to be retained, no distributions can be made out of retained earnings to the level of these negative amounts.
Certain of Aegons subsidiaries, principally insurance companies, are subject to restrictions on the amounts of funds they may transfer in the form of cash dividends or otherwise to their parent companies. There can be no assurance that these restrictions will not limit or restrict Aegon in its ability to pay dividends in the future.
On the reporting date, Aegon N.V., and its subsidiaries held 65,650,650 of its own common shares (2016: 48,780,045) with a nominal value of EUR 0.12 each. Most of the shares have been purchased to neutralize the dilution effect of issued share dividend and to hedge share based payment plans for executives and employees. Aegon N.V. held 15,345,680 of its own common shares B (2016:17,324,960) with a nominal value of 0.12 each.
Annual Report on Form 20-F 2017 |
315 | Notes to the financial statements of Aegon N.V. Note 13 | |
Movements in the number of treasury common shares of Aegon N.V. were as follows:
2017 | 2016 | |||||||||||||||
Number of shares
(thousands) |
Amount |
Number of shares
(thousands) |
Amount | |||||||||||||
At January 1 |
47,473 | 178 | 42,998 | 257 | ||||||||||||
Transactions in 2017: |
||||||||||||||||
Sale: transactions, average price EUR 3.44 |
(4,085 | ) | (14 | ) | ||||||||||||
Sale: 1 transaction, average price EUR 3.68 |
(26,916 | ) | (99 | ) | ||||||||||||
Sale: 1 transaction, average price EUR 3.77 |
(3,849 | ) | (14 | ) | ||||||||||||
Purchase: 1 transaction, average price EUR 5.09 |
51,865 | 263 | ||||||||||||||
Transactions in 2016: |
||||||||||||||||
Purchase: transactions, average price EUR 4.81 |
83,117 | 400 | ||||||||||||||
Sale: transactions, price average EUR 6.49 |
(6,153 | ) | (40 | ) | ||||||||||||
Sale: 1 transaction, price EUR 6.38 |
(20,137 | ) | (129 | ) | ||||||||||||
Purchase: transactions, average price EUR 3.51 |
29,259 | 103 | ||||||||||||||
Sale: 1 transaction, price EUR 5.11 |
(29,259 | ) | (150 | ) | ||||||||||||
Shares withdrawn: 1 transaction, price EUR 4.60 |
(83,117 | ) | (382 | ) | ||||||||||||
Purchase: transactions, average price EUR 3.84 |
30,765 | 118 | ||||||||||||||
At December 31 |
64,488 | 314 | 47,473 | 178 |
Movements in the number of treasury common shares B of Aegon N.V. were as follows:
2017 | 2016 | |||||||||||||||
Number of shares
(thousands) |
Amount |
Number of shares (thousands) |
Amount | |||||||||||||
At January 1 |
17,325 | 2 | - | - | ||||||||||||
Transactions in 2017: |
||||||||||||||||
Sale: transaction, average price EUR 0.11 |
(1,979 | ) | - | |||||||||||||
Sale: transaction, average price EUR 0.11 |
(13,043 | ) | (1 | ) | ||||||||||||
Purchase: transaction, average price EUR 0.13 |
13,043 | 2 | ||||||||||||||
Transactions in 2016: |
||||||||||||||||
Purchase: transactions, average price EUR 0.11 |
17,325 | 2 | ||||||||||||||
At December 31 |
15,346 | 2 | 17,325 | 2 |
As part of their insurance and investment operations, subsidiaries within the Group also hold Aegon N.V. common shares, both for their own account and for account of policyholders. These shares have been treated as treasury shares and are included at their consideration paid or received.
2017 | 2016 | |||||||||||||||
Number of shares
(thousands) |
Total amount |
Number of shares
(thousands) |
Total amount | |||||||||||||
Common shares |
||||||||||||||||
Held by Aegon N.V. |
64,488 | 314 | 47,473 | 178 | ||||||||||||
Held by subsidiaries |
1,163 | 9 | 1,307 | 10 | ||||||||||||
Common shares B |
||||||||||||||||
Held by Aegon N.V. |
15,346 | 2 | 17,325 | 2 | ||||||||||||
At December 31 |
80,996 | 325 | 66,105 | 190 |
The consideration for the related shares is deducted from or added to the retained earnings.
Annual Report on Form 20-F 2017 |
316 | Notes to the financial statements of Aegon N.V. Note 14 | |
Junior
perpetual capital securities |
Perpetual
cumulative subordinated bonds |
Share options
and incentive plans |
Non-cumula-
tive subordinated notes |
Total | ||||||||||||||||
At January 1, 2017 |
3,008 | 454 | 65 | 271 | 3,797 | |||||||||||||||
Shares granted / Share options cost incurred |
- | - | 26 | - | 26 | |||||||||||||||
Shares vested / Share options forfeited |
- | - | (30 | ) | - | (30 | ) | |||||||||||||
At December 31, 2017 |
3,008 | 454 | 61 | 271 | 3,794 | |||||||||||||||
At January 1, 2016 |
3,008 | 454 | 68 | 271 | 3,801 | |||||||||||||||
Shares granted / Share options cost incurred |
- | - | 13 | - | 13 | |||||||||||||||
Shares vested / Share options forfeited |
- | - | (16 | ) | - | (16 | ) | |||||||||||||
At December 31, 2016 |
3,008 | 454 | 65 | 271 | 3,797 |
Junior perpetual capital securities | Coupon rate |
Coupon date, as of |
Year of next
call |
2017 | 2016 | |||||||||||||||
USD 500 million |
6.50% |
|
Quarterly,
December 15 |
|
2018 | 424 | 424 | |||||||||||||
USD 250 million |
|
floating LIBOR
rate 1) |
|
|
Quarterly,
December 15 |
|
2018 | 212 | 212 | |||||||||||
USD 500 million |
|
floating CMS
rate 2) |
|
|
Quarterly, July
15 |
|
2018 | 402 | 402 | |||||||||||
USD 1 billion |
6.375% |
|
Quarterly, June
15 |
|
2018 | 821 | 821 | |||||||||||||
EUR 950 million |
|
floating DSL
rate 3) |
|
|
Quarterly, July
15 |
|
2018 | 950 | 950 | |||||||||||
EUR 200 million |
6.0% |
|
Annually, July
21 |
|
2018 | 200 | 200 | |||||||||||||
At December 31 |
3,008 | 3,008 |
1 | The coupon of the USD 250 million junior perpetual capital securities is reset each quarter based on the then prevailing three-month LIBOR yield plus a spread of 87.5 basis points, with a minimum of 4%. |
2 | The coupon of the USD 500 million junior perpetual capital securities is reset each quarter based on the then prevailing ten-year US dollar interest rate swap yield plus a spread of ten basis points, with a maximum of 8.5%. |
3 | The coupon of the EUR 950 million junior perpetual capital securities is reset each quarter based on the then prevailing ten-year Dutch government bond yield plus a spread of ten basis points, with a maximum of 8%. |
The interest rate exposure on some of these securities has been swapped to a three-month LIBOR and/or EURIBOR based yield.
The securities have been issued at par. The securities have subordination provisions, rank junior to all other liabilities and senior to shareholders equity only. The conditions of the securities contain certain provisions for optional and required coupon payment deferral and mandatory coupon payment events. Although the securities have no stated maturity, Aegon has the right to call the securities for redemption at par for the first time on the coupon date in the years as specified, or on any coupon payment date thereafter.
Perpetual cumulative subordinated bonds | Coupon rate | Coupon date |
Year of next
call |
2017 | 2016 | |||||||||||||||
EUR 136 million |
5.185% 1), 4) | Annual, October 14 | 2018 | 136 | 136 | |||||||||||||||
EUR 203 million |
4.260% 2), 4) | Annual, March 4 | 2021 | 203 | 203 | |||||||||||||||
EUR 114 million |
1.506% 3), 4) | Annual, June 8 | 2025 | 114 | 114 | |||||||||||||||
At December 31 |
454 | 454 |
1 | The coupon of the EUR 136 million bonds was originally set at 7.25% until October 14, 2008. Subsequently, the coupon has been reset at 5.185% until October 14, 2018. |
2 | The coupon of the EUR 203 million bonds was originally set at 7.125% until March 4, 2011. Subsequently, the coupon has been reset at 4.26% until March 4, 2021. |
3 | The coupon of the EUR 114 million bonds was originally set at 8% until June 8, 2005. Subsequently, the coupon has been reset at 4.156% until 2015 and 1.506% until 2025. |
4 | If the bonds are not called on the respective call dates and after consecutive period of ten years, the coupons will be reset at the then prevailing effective yield of ten-year Dutch government securities plus a spread of 85 basis points. |
Annual Report on Form 20-F 2017 |
317 | Notes to the financial statements of Aegon N.V. Note 15 | |
The bonds have the same subordination provisions as dated subordinated debt. In addition, the conditions of the bonds contain provisions for interest deferral.
Although the bonds have no stated maturity, Aegon has the right to call the bonds for redemption at par for the first time on the coupon date in the year of next call.
Non-cumulative subordinated notes |
Coupon
rate |
Coupon date,
as of |
Year of next
call |
2017 | 2016 | |||||||||||||||
USD 525 million |
8 | % |
|
Quarterly,
February 15 |
|
2018 | 271 | 271 | ||||||||||||
At December 31 |
271 | 271 |
On February 7, 2012, Aegon issued USD 525 million in aggregate principal amount of 8.00% non-cumulative subordinated notes, due 2042, in an underwritten public offering in the United States registered with the US Securities and Exchange Commission. The subordinated notes bear interest at a fixed rate of 8.00% and have been priced at 100% of their principal amount. Any cancelled interest payments will not be cumulative.
The securities are subordinated and rank senior to the junior perpetual capital securities, equally with the perpetual cumulative subordinated bonds and fixed floating subordinated notes, and junior to all other liabilities. The conditions of the securities contain certain provisions for optional and required cancellation of interest payments. The securities have a stated maturity of 30 years, however, Aegon has the right to call the securities for redemption at par for the first time on the first coupon date in August 2017, or on any coupon payment date thereafter.
These notes are recognized as a compound instrument due to the nature of this financial instrument. Compound instruments are separated into an equity component and a liability component. At December 31, 2017, the equity component amounted to EUR 271 million (2016: EUR 271 million), subordinated borrowings amounted to EUR 69 million (2016: EUR 72 million) and a deferred tax liability amounting to EUR 92 million (2016: EUR 106 million).
Refer to note 15 Subordinated borrowings for details of the component classified as subordinated borrowings.
Coupon rate | Coupon date | Year of next call | 2017 | 2016 | ||||||||||||||||
Fixed floating subordinated notes |
||||||||||||||||||||
EUR 700 million |
4% | Annually, April 25 | 2024 | 695 | 695 | |||||||||||||||
Non-cumulative subordinated notes |
||||||||||||||||||||
USD 525 million |
8% | Quarterly, February 15 | 2018 | 69 | 72 | |||||||||||||||
At December 31 |
764 | 767 |
On April 25, 2014, Aegon issued EUR 700 million of subordinated notes, first callable on April 25, 2024, and maturing on April 25, 2044. The coupon is fixed at 4% until the first call date and floating thereafter.
Subordinated borrowings include a liability of EUR 69 million (2016: EUR 72 million) relating to the USD 525 million non-cumulative subordinated notes issued on February 7, 2012. The liability component of the non-cumulative subordinated notes is related to the redemption amount. For further information on the non-cumulative subordinated notes and their subordination refer to note 14 Other equity instruments.
These securities are subordinated and rank senior to the junior perpetual capital securities, equally with the perpetual cumulative subordinated bonds and junior to all other liabilities. The conditions of the securities contain certain provisions for optional and required deferral of interest payments. There have been no defaults or breaches of conditions during the period.
The fair value of these loans amounted to EUR 953 million (2016: EUR 844 million).
Annual Report on Form 20-F 2017 |
318 | Notes to the financial statements of Aegon N.V. Note 16 | |
2017 |
2016 | |||||||
Remaining terms less than 1 year |
500 | 500 | ||||||
Remaining terms 1 - 5 years |
82 | 84 | ||||||
Remaining terms 5 - 10 years |
- | - | ||||||
Remaining terms over 10 years |
1,219 | 1,248 | ||||||
At December 31 |
1,801 | 1,832 |
The repayment periods of borrowings vary from within one year up to a maximum of 22 years. The interest rates vary from 0.000% to 6.625% per annum. The market value of the long-term borrowings amounted to EUR 2,198 million (2016: EUR 2,221 million).
Loans from and payables to group companies have a maturity of less than one year. Other includes derivatives with negative fair values of EUR 97 million (2016: EUR 233 million).
18 Commitments and contingencies
Aegon N.V. has guaranteed and is severally liable for the following:
◆ | Due and punctual payment of payables due under letter of credit agreements applied for by Aegon N.V. as co-applicant with its captive insurance companies that are subsidiaries of Transamerica Corporation and Commonwealth General Corporation. At December 31, 2017, the letter of credit arrangements utilized by captives to provide collateral to affiliates amounted to EUR 3,025 million (2016: EUR 3,720 million); as of that date no amounts had been drawn, or were due under these facilities. Other letter of credit arrangements for subsidiaries amounted to EUR 55 million (2016: EUR 104 million); as of that date no amounts had been drawn, or were due under these facilities; |
◆ | Due and punctual payment of payables due under letter of credit agreements or guarantees provided for subsidiaries of Transamerica Corporation at December 31, 2017 amounted to EUR 3,079 million (2016: EUR 3,563 million) as of that date no amounts had been drawn, or were due under letter of credit facilities. The guarantees partly related to debt amounted to EUR 1,322 million (2016: EUR 1,505 million) and is included in the Operational funding table in note 39 Borrowings of the consolidated financial statements of the Group in the line USD 1.54 billion Variable Funding Surplus Note; |
◆ | Due and punctual payment of payables by the consolidated group companies Transamerica Corporation, Aegon Funding Company LLC and Commonwealth General Corporation with respect to bonds, capital trust pass-through securities and notes issued under commercial paper programs amounted to EUR 585 million (2016: EUR 633 million); and |
◆ | Due and punctual payment of any amounts owed to third parties by the consolidated group company Aegon Derivatives N.V. in connection with derivative transactions. Aegon Derivatives N.V. only enters into derivative transactions with counterparties with which ISDA master netting agreements including collateral support annex agreements have been agreed; net (credit) exposure on derivative transactions with these counterparties was therefore limited as of December 31, 2017. |
There were no employees employed by Aegon N.V. in 2017 (2016:nil).
Of which PricewaterhouseCoopers | ||||||||||||||||
Total remuneration | Accountants N.V. (NL) | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Audit fees | 42 | 27 | 13 | 9 | ||||||||||||
Audit-related fees |
3 | 3 | 1 | 1 | ||||||||||||
Total |
46 | 30 | 14 | 10 |
The total remuneration of the independent auditor has increased compared to last year. This increase is related to a contract renewal and to additional audit work that was provided, related to a model conversion in the US and to the conversion to IFRS 9 in the Netherlands. In addition, the total remuneration for 2016 did not yet include the fees for the audit of the 2016 Solvency II figures, as these fees were invoiced in and booked in 2017.
Annual Report on Form 20-F 2017 |
319 | Notes to the financial statements of Aegon N.V. Note 21 | |
21 Events after the reporting period
There were no events after the reporting period.
22 Proposal for profit appropriation
At the Annual General Meeting of Shareholders on May 18, 2018, the Executive Board will, absent unforeseen circumstances, propose a final dividend for 2017 of EUR 0.14 per common share and EUR 0.0035 per common share B. The final dividend will be paid in cash or stock at the election of the shareholder. The value of the stock dividend will be approximately equal to the cash dividend.
If the proposed dividend is approved by shareholders, Aegon shares will be quoted ex-dividend on May 22, 2018, for the shares listed on the New York Stock Exchange and on May 22, 2018, for shares listed on Euronext. The record date for the dividend will be May 23, 2018. Shareholders can elect to receive a dividend in cash or in shares during the dividend election period, which will run from May 29, 2018 up to and including June 15, 2018. The dividend will be payable as of June 22, 2018.
In order to reflect the prevailing market price of Aegon N.V. common shares fully within the indication provided, the number of dividend coupons that give entitlement to a new common share of EUR 0.12 (nominal value) will be determined on June 15, 2018 after 5.30 p.m. (CET), based on the average share price on Euronext Amsterdam in the five trading days from June 11, 2018 up to and including June 15, 2018.
2017 | 2016 | |||||||
Final dividend on common shares | 286 | 265 | ||||||
Earnings to be retained | 2,183 | 172 | ||||||
Net income attributable to owners of Aegon N.V. |
2,469 | 437 |
The Hague, the Netherlands, March 22, 2018
Supervisory Board | Executive Board | |||
Robert J. Routs | Alexander R. Wynaendts | |||
William L. Connelly | Matthew J. Rider | |||
Robert W. Dineen | ||||
Mark A. Ellman | ||||
Ben J. Noteboom | ||||
Ben van der Veer | ||||
Dirk P.M. Verbeek | ||||
Corien M. Wortmann-Kool | ||||
Dona D. Young |
Annual Report on Form 20-F 2017 |
320 | Other information Profit appropriation | |
Appropriation of profit will be determined in accordance with the articles 31 and 32 of the Articles of Association of Aegon N.V. The relevant provisions read as follows:
1. The General Meeting of Shareholders will adopt the Annual Accounts;
2. If the adopted profit and loss account shows a profit, the Supervisory Board may decide, upon the proposal of the Executive Board, to set aside part of the profit to augment and/or form reserves;
3. The profits remaining after application of 2 above shall be put at the disposal of the General Meeting of Shareholders. The Executive Board, subject to the approval of the Supervisory Board, shall make a proposal for that purpose. A proposal to pay a dividend shall be dealt with as a separate agenda item at the General Meeting of Shareholders;
4. The Executive Board may, subject to the approval of the Supervisory Board, make one or more interim distributions to the holders of common shares and common shares B;
5. Distributions are made in accordance with the principle set forth in article 4 of the Articles of Association of Aegon N.V. that the financial rights attaching to a common share B are one-fortieth (1/40th) of the financial rights attaching to a common share;
6. The Executive Board may, subject to the approval of the Supervisory Board, decide that a distribution on common shares and common shares B shall not take place as a cash payment but as a payment in common shares, or decide that holders of common shares and common shares B shall have the option to receive a distribution as a cash payment and/or as a payment in common shares, out of the profit and/or at the expense of reserves, provided that the Executive Board is designated by the General Meeting to issue shares. Subject to the approval of the Supervisory Board, the Executive Board shall also determine the conditions applicable to the aforementioned choices; and
7. The Companys policy on reserves and dividends shall be determined and can be amended by the Supervisory Board, upon the proposal of the Executive Board. The adoption and thereafter each amendment of the policy on reserves and dividends shall be discussed and accounted for at the General Meeting of Shareholders under a separate agenda item.
Annual Report on Form 20-F 2017 |
321 | Other information Major shareholders | |
General
As of December 31, 2017, Aegons total authorized share capital consisted of 6,000,000,000 common shares with a par value of EUR 0.12 per share and 3,000,000,000 common shares B with a par value of EUR 0.12 per share. At the same date, there were 2,095.648,244 common shares and 585,022,160 common shares B issued. Of the issued common shares, 64,488,094 common shares and 15,345,680 common shares B were held by Aegon as treasury shares and 1,162,556 treasury shares were held by its subsidiaries.
All of Aegons common shares and common shares B are fully paid and not subject to calls for additional payments of any kind. All of Aegons common shares are registered shares. Holders of shares of New York registry hold their common shares in the registered form issued by Aegons New York transfer agent on Aegons behalf. Shares of New York registry and shares of Netherlands registry are exchangeable on a one-to-one basis and are entitled to the same rights, except that cash dividends are paid in US dollars on shares of New York registry.
As of December 31, 2017, 278 million common shares were held in the form of New York Registry shares. As of December 31, 2017, there were approximately 16,966 record holders of Aegons New York Registry shares resident in the United States.
Vereniging Aegon
Vereniging Aegon is the continuation of the former mutual insurer AGO. In 1978, AGO demutualized and Vereniging AGO became the only shareholder of AGO Holding N.V., which was the holding company for its insurance operations. In 1983, AGO Holding N.V. and Ennia N.V. merged into Aegon N.V. Vereniging AGO initially received approximately 49% of the common shares (reduced gradually to less than 40%) and all of the preferred shares in Aegon N.V., giving it voting majority in Aegon N.V. At that time, Vereniging AGO changed its name to Vereniging Aegon.
The purpose of the Association is a balanced representation of the direct and indirect interests of Aegon N.V. and of companies with which Aegon N.V. forms a group, of insured parties, employees, shareholders and other related parties of these companies. Influences that threaten the continuity, independence or identity of Aegon N.V., in conflict with the aforementioned interests will be resisted as much as possible.
In accordance with the 1983 Amended Merger Agreement, Vereniging Aegon had certain option rights on preferred shares to prevent dilution of voting power as a result of share issuances by Aegon N.V. This enabled Vereniging Aegon to maintain voting control at the General Meeting of Shareholders of Aegon N.V. In September 2002, Aegon N.V. effected a capital restructuring whereby Vereniging Aegon, among others, sold 206,400,000 common shares to Aegon N.V. for the amount of EUR 2,064,000,000; Vereniging Aegon contributed these as additional paid-in capital on the then existing Aegon N.V. preferred shares. As a result of this capital restructuring, Vereniging Aegons beneficial ownership interest in Aegon N.V.s common shares decreased from approximately 37% to approximately 12% and its beneficial ownership interest in Aegon N.V.s voting shares decreased from approximately 52% to approximately 33%.
On May 9, 2003, Aegons shareholders approved certain changes to Aegons corporate governance structure. Preferred shares with a nominal value of EUR 0.12 were converted into 211,680,000 new class A preferred shares with a nominal value of EUR 0.25, and class B preferred shares were created with a nominal value of EUR 0.25 each. No class B preferred shares were issued at that time. The voting rights pertaining to the preferred shares were adjusted accordingly to 25/12 vote per preferred share. However, in May 2003, Aegon N.V. and Vereniging Aegon entered into a Preferred Shares Voting Agreement, pursuant to which Vereniging Aegon agreed to exercise one vote only per preferred share, except in the event of a Special Cause, as defined below.
In May 2003, Aegon N.V. and Vereniging Aegon amended the option arrangements under the 1983 Amended Merger Agreement so that, in the event of an issuance of shares by Aegon N.V., Vereniging Aegon could purchase as many class B preferred shares as would enable Vereniging Aegon to prevent or correct dilution to below its actual percentage of voting shares, to a maximum of 33%.
On February 15, 2013, Aegon N.V. and Vereniging Aegon entered into an agreement to simplify the capital structure of Aegon and to cancel all of Aegons preferred shares, of which Vereniging Aegon was the sole owner. The execution of this agreement was subject to the approval of the General Meeting of Shareholders of Aegon N.V. This approval was granted at the Annual General Meeting of Shareholders on May 15, 2013.
The simplified capital structure entailed, but was not limited to, the amendment of the Articles of Association of Aegon N.V., including the conversion of all outstanding 329,773,000 preferred shares A and B, with a nominal value of EUR 0.25 each, into 120,713,389 common shares and 566,313,695 common shares B, with a nominal value of EUR 0.12 each. The financial rights attached to a common share B were determined at 1/40th of the financial rights attached to a common share.
Annual Report on Form 20-F 2017 |
322 | Other information Major shareholders | |
The simplified capital structure also entailed the amendment of the Voting Rights Agreement between Aegon N.V. and Vereniging Aegon, known as the Preferred Shares Voting Agreement before May 2013. As a matter of Dutch corporate law, the shares of both classes offer equal full voting rights, as they have equal nominal values (EUR 0.12). The amended Voting Rights Agreement ensures that under normal circumstances, i.e. except in the event of a Special Cause, Vereniging Aegon will no longer be able to exercise more votes than is proportionate to the financial rights represented by its shares. This means that in the absence of a Special Cause Vereniging Aegon may cast one vote for every common share it holds and one vote only for every 40 common shares B it holds. As Special Cause qualifies the acquisition of a 15% interest in Aegon N.V., a tender offer for Aegon N.V. shares or a proposed business combination by any person or group of persons, whether individually or as a group, other than in a transaction approved by the Executive Board and the Supervisory Board. If, in its sole discretion, Vereniging Aegon determines that a Special Cause has occurred, Vereniging Aegon will notify the General Meeting of Shareholders and retain its right to exercise the full voting power of one vote per common share B for a limited period of six months.
The simplified capital structure also included an amendment to the 1983 Amended Merger Agreement between Aegon N.V. and Vereniging Aegon. Following this 2013 amendment, Vereniging Aegons call option relates to common shares B. Vereniging Aegon may exercise its call option to keep or restore its total stake at 32.6%, irrespective of the circumstances which cause the total shareholding to be or become lower than 32.6%.
In the years 2003 through 2012, 118,093,000 class B preferred shares were issued under these option rights and in the years 2013 and 2014 Vereniging Aegon purchased in aggregate 15,012,025 common shares B under its call option right.
On January 1, 2015, Vereniging Aegon exercised its options rights to purchase in aggregate 9,680 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on January 1, 2015, in connection with the Long Term Incentive Plans for senior management.
On May 21, 2015, Vereniging Aegon exercised its options rights to purchase in aggregate 3,686,000 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on May 21, 2015, in connection with the Long Term Incentive Plans for senior management.
And on November 13, 2015, and with effect of November 13, 2015, Vereniging Aegon exercised its options rights to purchase in aggregate 760 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by a correction to Aegons issuance of shares on May 21, 2015, in connection with the Long Term Incentive Plans for senior management.
On May 19, 2016, Aegon N.V. repurchased 13,450,835 common shares from Vereniging Aegon for the amount of EUR 58,000,000, being the Value Weight Average Price of the common shares of the five trading days preceding this transaction, as part of the EUR 400 million Share Buy Back program, initiated by Aegon N.V. in January 2016 to neutralize the dilutive effect of the cancellation of Aegon N.V.s preferred shares in 2013.
On June 6, 2016, Aegon N.V. repurchased 17,324,960 Common Shares B from Vereniging Aegon for the amount of EUR 1,968,332, based on 1/40th of the Value Weight Average Price of the common shares of the five trading days preceding this transaction. The repurchase of common shares B was executed to align the aggregate shareholding of Vereniging Aegon in Aegon N.V. with its special cause voting rights of 32.6%.
On May 19, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 1,979,260 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused the issuance of shares on May 19, 2017, in connection with the Long Term Incentive Plans for senior management.
On June 23, 2017, Vereniging Aegon exercised its options rights to purchase in aggregate 13,042,612 common shares B at fair value of a common share B (being 1/40th of the market value of a common share in the capital of the Company at the time of issuance) to mitigate dilution caused by Aegons issuance of shares on June 23, 2017, being the final dividend 2016 in the form of stock dividend.
On December 19, 2017, Aegon N.V. repurchased 13,042,592 Common Shares B from Vereniging Aegon for the amount of EUR 1,725,169.73 based on 1/40th of the Value Weight Average Price of the common shares of the five trading days preceding
Annual Report on Form 20-F 2017 |
323 | Other information Major shareholders | |
this transaction. The repurchase of common shares B was executed to align the aggregate shareholding of Vereniging Aegon in Aegon N.V. with its special cause voting rights of 32.6% following the completion of the Share Buy Back Program, initiated by Aegon N.V. in October 2017 to neutralize the dilutive effect of the distribution of final dividend 2016 in stock and interim dividend 2017 in stock.
Development of shareholding in Aegon N.V.
Number of shares held by Vereniging Aegon |
Common | Common B | ||||||
At January 1, 2017 | 279,236,609 | 567,697,200 | ||||||
Exercise option right common shares B - May 2017 | - | 1,979,260 | ||||||
Exercise option right common shares B - June 2017 | - | 13,042,612 | ||||||
Repurchase common shares B - December 2017 | - | (13,042,592) | ||||||
At December 31, 2017 |
279,236,609 | 569,676,480 |
Accordingly, at December 31, 2017, the voting power of Vereniging Aegon under normal circumstances amounted to approximately 14.34%, based on the number of outstanding and voting shares (excluding issued common shares held in treasury by Aegon N.V.). In the event of a Special Cause, Vereniging Aegons voting rights will increase, currently to 32.6%, for up to six months.
At December 31, 2017, the General Meeting of Members of Vereniging Aegon consisted of eighteen members. The majority of the voting rights is with the sixteen members who are not employees or former employees of Aegon N.V. or one of the Aegon Group companies, nor current or former members of the Supervisory Board or the Executive Board of Aegon N.V. The other two members are from the Executive Board of Aegon N.V.
Vereniging Aegon has an Executive Committee consisting of eight members, six of whom are not, nor have ever been, related to Aegon, including the Chairman and the Vice-Chairman. The other two members are also member of the Executive Board of Aegon N.V. Resolutions of the Executive Committee, other than regarding the amendment of the Articles of Association of Vereniging Aegon, are made with an absolute majority of the votes. When a vote in the Executive Committee results in a tie, the General Meeting of Members has the deciding vote. Regarding the amendment of the Articles of Association of Vereniging Aegon, a special procedure requires a unanimous proposal from the Executive Committee, thereby including the consent of the representatives of Aegon N.V. at the Executive Committee. This requirement does not apply in the event of a hostile change of control at the General Meeting of Shareholders of Aegon N.V., in which event Vereniging Aegon may amend its Articles of Association without the cooperation of Aegon N.V. Furthermore, the two members of the Executive Board of Aegon N.V., who are also members of the Executive Committee, have no voting rights on several decisions that relate to Aegon N.V., as set out in the Articles of Association of Vereniging Aegon.
Other major shareholders
In this section below where reference is made to any filings with the Dutch Autoriteit Financiële Markten or the SEC the terms capital issued and votes are used as defined in the Wet op het Financieel Toezicht.
To Aegons knowledge based on the filings made with the Dutch Autoriteit Financiële Markten, the US based investment management firm Dodge & Cox International Stock Fund holds a capital and voting interest in Aegon of over 5%.
Based on its last filing with the Dutch Autoriteit Financiële Markten as at September 22, 2016, Dodge & Cox International Stock Fund stated to hold 134,654,439 common shares, which represent 5.2% of the issued and outstanding capital and of the votes as at December 31, 2017. On February 20, 2018, Dodge & Coxs filing with the US Securities and Exchange Commission (SEC) shows that Dodge & Cox holds 256,029,115 common shares, representing 9.8% of the issued and outstanding capital as at December 31, 2017 and has voting rights for 250,384,686 shares, representing 9.6% of the votes as at December 31, 2017.
Based on its filing with the Dutch Autoriteit Financiële Markten as at May 26, 2017, BlackRock, Inc. stated to hold 59,827,512 shares, representing 2.3 % of the issued and outstanding capital as at December 31, 2017 and 79,077,402 voting rights, representing 3.0% of the votes as at December 31, 2017. On February 20, 2018, BlackRock, Inc.s filing with the SEC shows that BlackRock holds 119,424,291 common shares, representing 4.6% of the issued and outstanding capital as at December 31, 2017, and has voting rights for 107,367,731 shares, representing 4.1% of the votes as at December 31, 2017.
Based on its filing with the Dutch Autoriteit Financiële Markten as at June 10, 2015, Franklin Resources, Inc (FRI). stated to hold 81,510,408 shares, representing 3.1% of the issued and outstanding capital and of the votes as of December 31, 2017. On February 20, 2018, the filing of Franklin Resources, Inc. (FRI), a US based investment management firm, with the SEC shows that FRI holds 156,591,360 common shares and voting rights, representing 6.0% of the issued and outstanding capital, as at December 31, 2017.
Annual Report on Form 20-F 2017 |
324 | Other financial information Schedule I | |
Schedules to the financial statements
Index to schedules
Schedule I | Summary of Investments other than Investments in Related Parties as at December 31, 2017 | |
Schedule II | Condensed Financial Information of Registrant (Parent Company Only) | |
Schedule II | Statement of Financial Position as of December 31, 2017 and 2016 | |
Schedule II | Income Statement (Loss) for the years ended December 31, 2017, 2016 and 2015 | |
Schedule II | Condensed Cash Flow Statement for the years ended December 31, 2017, 2016 and 2015 | |
Schedule II | Dividends from and Capital Contributions to Business Units for the years ended December 31, 2017, 2016 and 2015 | |
Schedule III | Supplementary Insurance Information for the years ended December 31, 2017, 2016 and 2015 | |
Schedule IV | Reinsurance for the years ended December 31, 2017, 2016 and 2015 | |
Schedule V | Valuation and Qualifying Accounts for the years ended December 31, 2017, 2016 and 2015 |
Summary of investments other than investments in related parties
As at December 31, 2017 | ||||||||||||
Amounts in million EUR |
Cost 1) | Fair value | Book value | |||||||||
Shares: |
||||||||||||
Available-for-sale |
436 | 490 | 490 | |||||||||
Fair value through profit or loss |
1,021 | 1,062 | 1,062 | |||||||||
Bonds: |
||||||||||||
Available-for-sale and held-to-maturity: |
||||||||||||
US government |
8,011 | 8,846 | 8,846 | |||||||||
Dutch government |
4,799 | 5,781 | 5,781 | |||||||||
Other government |
11,746 | 12,568 | 12,568 | |||||||||
Mortgage backed |
7,326 | 7,694 | 7,694 | |||||||||
Asset backed |
4,624 | 4,698 | 4,698 | |||||||||
Corporate |
37,168 | 40,613 | 40,613 | |||||||||
Money market investments |
6,690 | 6,690 | 6,690 | |||||||||
Other |
765 | 791 | 791 | |||||||||
Subtotal | 81,130 | 87,681 | 87,681 | |||||||||
Bonds: |
||||||||||||
Fair value through profit or loss |
4,150 | 4,144 | 4,144 | |||||||||
Other investments at fair value through profit or loss |
1,898 | 1,914 | 1,914 | |||||||||
Mortgages |
33,562 | 38,076 | 33,562 | |||||||||
Private loans |
3,642 | 4,181 | 3,642 | |||||||||
Deposits with financial institutions |
139 | 139 | 139 | |||||||||
Policy loans |
1,897 | 1,897 | 1,897 | |||||||||
Other |
127 | 127 | 127 | |||||||||
Subtotal | 39,368 | 44,422 | 39,368 | |||||||||
Real estate: |
||||||||||||
Investments in real estate |
2,147 | 2,147 | ||||||||||
Total |
141,858 | 136,804 |
1 | Cost is defined as original cost for available-for-sale shares and amortized cost for available-for-sale and held-to-maturity bonds |
Annual Report on Form 20-F 2017 |
325 | Other financial information Schedule II | |
Condensed financial information of registrant
Statement of financial position of Aegon N.V.
As at December 31
Before profit appropriation, amounts in EUR million | Note | 2017 | 2016 | |||||||||
Non-current assets |
||||||||||||
Financial fixed assets |
||||||||||||
Shares in group companies |
8 | 23,117 | 22,219 | |||||||||
Loans to group companies |
9 | 2,690 | 4,123 | |||||||||
25,807 | 26,342 | |||||||||||
Current assets |
||||||||||||
Receivables |
||||||||||||
Receivables from group companies |
10 | 36 | 80 | |||||||||
Other receivables |
10 | 146 | 219 | |||||||||
Other |
11 | 74 | 140 | |||||||||
Accrued interest and rent |
8 | 15 | ||||||||||
264 | 454 | |||||||||||
Cash and cash equivalents |
||||||||||||
Cash and cash equivalents |
1,068 | 879 | ||||||||||
Total assets |
27,139 | 27,675 | ||||||||||
Shareholders equity |
||||||||||||
Share capital |
12 | 322 | 319 | |||||||||
Paid-in surplus |
13 | 7,731 | 7,873 | |||||||||
Revaluation account |
13 | 5,017 | 5,450 | |||||||||
Remeasurement of defined benefit plans of group companies |
13 | (1,669 | ) | (1,820 | ) | |||||||
Legal reserves foreign currency translation reserve |
13 | (401 | ) | 1,316 | ||||||||
Legal reserves in respect of group companies |
13 | 1,122 | 1,169 | |||||||||
Retained earnings, including treasury shares |
13 | 5,696 | 5,776 | |||||||||
Net income / (loss) |
13 | 2,469 | 437 | |||||||||
20,288 | 20,520 | |||||||||||
Other equity instruments |
14 | 3,794 | 3,797 | |||||||||
Total equity |
24,082 | 24,318 | ||||||||||
Non-current liabilities |
||||||||||||
Subordinated borrowings |
15 | 764 | 767 | |||||||||
Long-term borrowings |
16 | 1,801 | 1,832 | |||||||||
2,565 | 2,599 | |||||||||||
Current liabilities |
17 | |||||||||||
Short term deposits |
73 | 128 | ||||||||||
Loans from group companies |
62 | 62 | ||||||||||
Payables to group companies |
123 | 140 | ||||||||||
Deferred tax liability |
89 | 159 | ||||||||||
Other |
125 | 242 | ||||||||||
Accruals and deferred income |
22 | 29 | ||||||||||
|
494
|
|
|
760
|
|
|||||||
Total liabilities
|
|
3,059
|
|
|
3,359
|
|
||||||
Total equity and liabilities |
27,139 | 27,675 |
Annual Report on Form 20-F 2017 |
326 | Other financial information Schedule II | |
Income statement of Aegon N.V.
For the year ended December 31
Amounts in EUR million | 2017 | 2016 | 2015 | |||||||||
Net income / (loss) group companies |
2,511 | 533 | (394 | ) | ||||||||
Other income / (loss) |
(42 | ) | (96 | ) | (38 | ) | ||||||
Net income / (loss) |
2,469 | 437 | (432 | ) |
Condensed cash flow statement of Aegon N.V.
For the year ended December 31
Amounts in EUR million | 2017 | 2016 | 2015 | |||||||||
Income / (loss) before tax | 2,468 | 411 | (454 | ) | ||||||||
Adjustments |
(3,676 | ) | (231 | ) | 1,920 | |||||||
Net cash flows from operating activities |
(1,208 | ) | 180 | 1,466 | ||||||||
Dividends and capital repayments of subsidiaries, associates and joint ventures |
700 | 895 | - | |||||||||
Other |
(1 | ) | (2 | ) | (5 | ) | ||||||
Net cash flows from investing activities |
700 | 893 | (5 | ) | ||||||||
Issuance of treasury shares |
2 | - | - | |||||||||
Purchase of treasury shares |
(266 | ) | (623 | ) | (213 | ) | ||||||
Dividends paid |
(294 | ) | (306 | ) | (292 | ) | ||||||
Issuance, repurchase and coupons of perpetual securities |
(138 | ) | (140 | ) | (148 | ) | ||||||
Issuance, repurchase and coupons of non-cumulative subordinated notes |
(37 | ) | (38 | ) | (38 | ) | ||||||
Issuance and repurchase of borrowings |
1,429 | 604 | (1,115 | ) | ||||||||
Net cash flows from financing activities
|
|
696
|
|
|
(503
|
)
|
|
(1,806
|
)
|
|||
Net increase / (decrease) in cash and cash equivalents |
188 | 570 | (346 | ) |
Five-year schedule of maturities of debt
As at December 31
2017 | 2016 | |||||||||||||||
Amounts in million EUR |
Subordi-
nated borrowings |
Long-term
Borrowings |
Subordinated
borrowings |
Long-term
Borrowings |
||||||||||||
Remaining terms less than 1 year |
- | 500 | - | 500 | ||||||||||||
Remaining terms 1 - 2 years |
- | 82 | - | - | ||||||||||||
Remaining terms 2 - 3 years |
- | - | - | 84 | ||||||||||||
Remaining terms 3 - 4 years |
- | - | - | - | ||||||||||||
Remaining terms 4 - 5 years |
- | - | - | - | ||||||||||||
Remaining terms longer than 5 years |
764 | 1,219 | 767 | 1,248 | ||||||||||||
At December 31 |
764 | 1,801 | 767 | 1,832 |
Annual Report on Form 20-F 2017 |
327 | Other financial information Schedule II | |
Dividends from and capital contributions to business units
Aegon received EUR 1.8 billion of dividends from its business units during 2017, mainly from Americas, United Kingdom, Asset Management, Central & Eastern Europe and Spain & Portugal. Capital contributions of EUR 1.1 billion were paid to Aegons businesses, mainly to the Netherlands.
Aegon received EUR 1.1 billion of dividends from its business units during 2016 from the Americas, asset management, Central & Eastern Europe and Spain & Portugal. Aegon spent EUR 0.2 billion on capital contributions.
Aegon received EUR 1.1 billion of dividends from its business units during 2015, almost all of which from the Americas. Aegon spent EUR 0.3 billion on capital contributions and acquisitions.
Annual Report on Form 20-F 2017 |
328 | Other financial information Schedule III | |
Supplementary insurance information
Column A | Column B | Column C | Column D | Column E | Column F | |||||||||||||||
Segment Amounts in million EUR |
Deferred
policy acquisition costs |
Future
policy benefits |
Unearned
premiums |
Other policy
claims and benefits |
Premium
revenue |
|||||||||||||||
2017 | ||||||||||||||||||||
Americas | 8,188 | 171,122 | 5,241 | 1,982 | 9,383 | |||||||||||||||
The Netherlands | 76 | 62,446 | 61 | 932 | 2,208 | |||||||||||||||
United Kingdom | 903 | 65,052 | 14 | 6 | 9,635 | |||||||||||||||
Central & Eastern Europe | 70 | 1,910 | 23 | 86 | 628 | |||||||||||||||
Spain & Portugal | 1 | 796 | - | 15 | 155 | |||||||||||||||
Asia | 490 | 4,969 | 100 | 15 | 816 | |||||||||||||||
Holding and other activities | - | 16 | 8 | - | 1 | |||||||||||||||
Total | 9,729 | 306,311 | 5,447 | 3,036 | 22,826 | |||||||||||||||
2016 | ||||||||||||||||||||
Americas | 8,958 | 185,654 | 5,625 | 2,151 | 9,433 | |||||||||||||||
The Netherlands | 84 | 63,526 | 59 | 977 | 2,491 | |||||||||||||||
United Kingdom | 996 | 69,505 | 11 | 6 | 9,924 | |||||||||||||||
Central & Eastern Europe | 71 | 1,905 | 18 | 75 | 578 | |||||||||||||||
Spain & Portugal | 1 | 799 | - | 12 | 148 | |||||||||||||||
Asia | 832 | 5,558 | 105 | 22 | 882 | |||||||||||||||
Holding and other activities | - | 16 | 4 | - | (2) | |||||||||||||||
Total | 10,942 | 326,964 | 5,822 | 3,244 | 23,453 | |||||||||||||||
2015 | ||||||||||||||||||||
Americas | 8,330 | 177,742 | 4,977 | 1,991 | 9,195 | |||||||||||||||
The Netherlands | 97 | 59,779 | 108 | 1,316 | 2,947 | |||||||||||||||
United Kingdom | 1,264 | 83,417 | 12 | 5 | 8,512 | |||||||||||||||
Central & Eastern Europe | 84 | 1,890 | 15 | 70 | 642 | |||||||||||||||
Spain & Portugal | 1 | 797 | - | 10 | 133 | |||||||||||||||
Asia | 745 | 4,127 | 88 | 20 | 1,494 | |||||||||||||||
Holding and other activities | 9 | 89 | 2 | 1 | 2 | |||||||||||||||
Total |
10,530 | 327,841 | 5,202 | 3,414 | 22,925 |
The numbers included in Schedule III are based on IFRS and excludes the proportionate share in Aegons joint ventures and Aegons associates.
Annual Report on Form 20-F 2017 |
329 | Other financial information Schedule III | |
Deferred policy acquisition costs also include deferred costs of reinsurance.
Column G | Column H | Column I | Column J | Column K | ||||||||||||||||
Amounts in million EUR |
Net
investment income |
Benefits,
claims and losses |
Amortization
of deferred policy acquisition costs |
Other
operating expenses |
Premiums
written |
|||||||||||||||
2017 |
||||||||||||||||||||
Americas |
3,362 | 8,585 | 552 | 2,953 | 6,387 | |||||||||||||||
The Netherlands |
2,173 | 4,430 | 19 | 925 | 2,192 | |||||||||||||||
United Kingdom |
1,516 | 11,796 | 111 | 646 | 9,266 | |||||||||||||||
Central & Eastern Europe |
49 | 416 | 54 | 207 | 614 | |||||||||||||||
Spain & Portugal |
31 | 153 | - | 93 | 150 | |||||||||||||||
Asia |
203 | 153 | 33 | 95 | 778 | |||||||||||||||
Asset Management |
- | - | - | 159 | - | |||||||||||||||
Holding and other activities |
5 | 5 | - | 76 | 8 | |||||||||||||||
Total |
7,338 | 25,537 | 770 | 5,155 | 19,395 | |||||||||||||||
2016 |
||||||||||||||||||||
Americas |
3,711 | 8,913 | 576 | 3,438 | 6,824 | |||||||||||||||
The Netherlands |
2,133 | 3,726 | 24 | 967 | 2,477 | |||||||||||||||
United Kingdom |
1,661 | 12,618 | 148 | 518 | 9,331 | |||||||||||||||
Central & Eastern Europe |
45 | 395 | 59 | 185 | 568 | |||||||||||||||
Spain & Portugal |
36 | 143 | - | 90 | 143 | |||||||||||||||
Asia |
196 | 130 | 31 | 111 | 927 | |||||||||||||||
Asset Management |
- | - | - | 138 | - | |||||||||||||||
Holding and other activities |
6 | 3 | - | 66 | 7 | |||||||||||||||
Total |
7,788 | 25,929 | 837 | 5,513 | 20,277 | |||||||||||||||
2015 |
||||||||||||||||||||
Americas |
3,672 | 8,240 | 593 | 3,357 | 6,643 | |||||||||||||||
The Netherlands |
2,274 | 4,641 | 30 | 1,039 | 2,934 | |||||||||||||||
United Kingdom |
2,331 | 11,541 | 319 | 588 | 8,038 | |||||||||||||||
Central & Eastern Europe |
45 | 563 | 80 | 184 | 631 | |||||||||||||||
Spain & Portugal |
34 | 151 | - | 74 | 128 | |||||||||||||||
Asia |
165 | 119 | 30 | 128 | 1,564 | |||||||||||||||
Asset Management |
- | - | - | 117 | - | |||||||||||||||
Holding and other activities |
4 | 2 | 3 | 57 | 7 | |||||||||||||||
Total |
8,525 | 25,259 | 1,055 | 5,543 | 19,946 |
Annual Report on Form 20-F 2017 |
330 | Other financial information Schedule IV | |
Reinsurance
Amounts in million EUR | Gross amount |
Ceded to
other companies |
Assumed
from other companies |
Net amount |
% of amount
net |
|||||||||||||||
For the year ended December 31, 2017 |
||||||||||||||||||||
Life insurance in force |
863,686 | 709,326 | 525,201 | 679,561 | 77% | |||||||||||||||
Premiums |
||||||||||||||||||||
Life insurance |
18,324 | 3,214 | 1,628 | 16,738 | 10% | |||||||||||||||
Non-life insurance |
2,849 | 217 | 25 | 2,657 | 1% | |||||||||||||||
Total premiums |
21,174 | 3,431 | 1,653 | 19,395 | 9% | |||||||||||||||
For the year ended December 31, 2016 |
||||||||||||||||||||
Life insurance in force |
986,854 | 851,003 | 648,147 | 783,999 | 83% | |||||||||||||||
Premiums |
||||||||||||||||||||
Life insurance |
18,687 | 2,932 | 1,713 | 17,468 | 10% | |||||||||||||||
Non-life insurance |
3,046 | 244 | 7 | 2,808 | 0% | |||||||||||||||
Total premiums |
21,734 | 3,176 | 1,719 | 20,277 | 8% | |||||||||||||||
For the year ended December 31, 2015 |
||||||||||||||||||||
Life insurance in force |
1,008,787 | 961,485 | 658,594 | 705,896 | 93% | |||||||||||||||
Premiums |
||||||||||||||||||||
Life insurance |
17,971 | 2,694 | 1,612 | 16,889 | 10% | |||||||||||||||
Non-life insurance |
3,332 | 286 | 11 | 3,057 | 0% | |||||||||||||||
Total premiums |
21,302 | 2,979 | 1,623 | 19,946 | 8% |
Annual Report on Form 20-F 2017 |
331 | Other financial information Schedule V | |
Valuation and qualifying accounts
Amounts in million EUR | 2017 | 2016 | 2015 | |||||||||
Balance at January 1 |
215 | 249 | 363 | |||||||||
Addition charged to earnings |
40 | 5 | 30 | |||||||||
Amounts written off and other changes |
(37 | ) | (40 | ) | (152 | ) | ||||||
Currency translation |
(5 | ) | 1 | 8 | ||||||||
Balance at December 31 |
213 | 215 | 249 | |||||||||
The provisions can be analyzed as follows: |
||||||||||||
Mortgages |
48 | 40 | 56 | |||||||||
Other loans |
116 | 97 | 86 | |||||||||
Receivables |
48 | 79 | 107 | |||||||||
Total |
213 | 215 | 249 |
Annual Report on Form 20-F 2017 |
332 | Auditors report on the Annual Report on Form 20-F | |
Annual Report on Form 20-F
Report of Independent Registered Public Accounting Firm
To the Supervisory Board, the Executive Board and Shareholders of Aegon N.V.:
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated statement of financial position of Aegon N.V. and its subsidiaries as of December 31, 2017 and 2016, and the related consolidated income statement, statement of comprehensive income, statement of changes in equity and cash flow statement for each of the three years in the period ended December 31, 2017, including the related notes and financial statement schedules of summary of investments other than investments in related parties as of December 31, 2017, of condensed financial information of Aegon N.V. as of December 31, 2017 and 2016 and for the three years in the period ended December 31, 2017, of supplementary insurance information as of December 31, 2017, 2016 and 2015, of reinsurance for the years ended December 31, 2017, 2016 and 2015 and of valuation and qualifying accounts as of December 31, 2017, 2016 and 2015 appearing under the section Other Financial Information (collectively referred to as the consolidated financial statements). We also have audited the Companys internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2017 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Companys management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Managements Annual Report on internal control over financial reporting. Our responsibility is to express opinions on the Companys consolidated financial statements and on the Companys internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance
Annual Report on Form 20-F 2017 |
333 | Auditors report on the Annual Report on Form 20-F | |
regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the companys assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
R. Dekkers RA
PricewaterhouseCoopers Accountants N.V.
Amsterdam, the Netherlands
March 22, 2018
We have served as the Companys auditor since 2014.
Annual Report on Form 20-F 2017 |
334 | Additional information | |
Table of contents
Additional information | ||||
335 | ||||
336 | ||||
356 | ||||
356 | ||||
357 | ||||
358 | ||||
359 | ||||
360 | ||||
360 | ||||
361 | ||||
368 | ||||
Purchases of equity securities by the issuer and affiliated purchasers |
369 | |||
370 | ||||
376 | ||||
377 | ||||
378 | ||||
380 | ||||
381 | ||||
382 | ||||
383 |
Annual Report on Form 20-F 2017 |
335 | Additional information Compliance with regulations | |
Iran Threat Reduction and Syria Human Rights Act
Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 requires Aegon to disclose whether Aegon N.V. or any of its affiliates has engaged during the calendar year in certain Iran-related activities, including any transaction or dealing with the Government of Iran that is not conducted pursuant to a specific authorization of the U.S. government. The amounts in this section are reported in EUR 1 or GBP 1.
In the UK and the Netherlands, Aegon maintained a limited number of plans that are reportable under Section 219. The non-U.S. based subsidiaries of Aegon N.V. do operate in compliance with applicable laws and regulations of the various jurisdictions where they conduct business. Aegon UK had an Individual Personal Pension (IPP) for a UK customer until March 2017 when the benefits were transferred externally to another pension provider. The customer is a UK-based employee of an Iranian bank which appears on OFACs Specially Designated Nationals (SDN) and Blocked Persons List with the identifiers of [SDGT], [IRAN], and [IFSR]. The last contribution to the pension was in November 2016. The customer is not a SDN; the Iranian bank did not own, benefit from, or have any control over the pension. All payments from the Iranian bank were made in UK Pounds from a UK bank account. Her Majestys Treasury (HMT) had previously confirmed that this business activity falls within an acceptable exemption. On October, 22 2016 HMT removed the entity from their consolidated list.
Aegon UK also has six UK resident customers who have one active IPP and are UK-based employees of a British registered charity that appears on the SDN List with the identifier [SDGT]; the charity makes contributions to the pensions. The customers are not SDNs; the charity does not own, benefit from, or have control over the pensions. All payments have been paid in UK Pounds from a UK bank account. The pensions are managed in line with applicable legislation and regulation in the UK and the charity is not subject to sanctions in the UK or EU. The relationships are under close ongoing review. IPP #1 has a value of GBP 9,741 as at January 12, 2018, and regular monthly contributions of GBP 69.41 are being received into this policy. IPP #2 has a value of GBP 4,287as at January 12, 2018, and regular monthly contributions of GBP 18.61 are being received. IPP #3 has a value of GBP 193,694 as at January 12, 2018, and regular monthly contributions of GBP 527.91 are being received. IPP #4 has a value of GBP 8,854 as at January 12, 2018, and no further contributions are being received. IPP #5 has a value of GBP 43,119 as at January 12, 2018, and no further contributions are being received. IPP #6 has a current value of GBP 8,348 as at January 12, 2018, and no further contributions are being received. The related annual net profit arising from these contracts, which is difficult to calculate with precision, is estimated to be no greater than GBP 8,040.
In the Netherlands, Aegon Levensverzekering N.V. has one Dutch resident customer who is a party subject to U.S. sanctions for whom two active IPPs and one individual life investment linked insurance policy are held. This person is on the Foreign Sanctions Evaders List (FSE List) with Regard to Syria and is listed on the SDN and Blocked Persons List. The FSE List includes persons sanctioned pursuant to E.O. 13608 and are identified with the program tags [FSE-IR] and [FSE-SY]. The customer is not subject to sanctions in the Netherlands or EU .
IPP #1 and #2 are lifelong annuity plans which start at the retirement age of 65 (January 2023). The annual pensions benefits as of January 1, 2023 for policy #1 will be EUR 560.64 gross per year and for #2 EUR 34.11 gross per year. The contributions into these policies ended in the 1980s. The related annual net profit arising from these two contracts is negligible.
The individual life investment linked insurance policy has a value of EUR 65,323 as at January 1, 2018, and regular monthly contributions of EUR 198.60 are being received; all contributions have been paid in Euros from a Dutch bank account. The policy is managed in line with applicable legislation and regulation in the Netherlands; the individual is not subject to sanctions in the Netherlands or EU. The end date of this policy is February 1, 2023. The related annual net profit arising from this contract, which is difficult to calculate with precision, is estimated to be EUR 500 per year.
Annual Report on Form 20-F 2017 |
336 | Additional information Risk factors | |
Aegon faces a number of risks, some of which may arise from internal factors, such as inadequate compliance systems and operational change management. Others, may arise from external factors, such as developments in financial markets, the business and/or political environment, economic trends, politics and regulations. These risks, whether internal or external, may affect the Companys operations, its earnings, the value of its investments, or the sale of certain products and services. The market price of Aegon securities could decline due to any of the risks described in this section and investors could lose (part of) the value of their investments. Additional risks of which Aegon is not presently aware could also affect its operations and share price. The business of a multinational insurance company such as Aegon is inherently exposed to risks that may only become apparent with the benefit of hindsight. The next two sections provide a description of risk factors relating to Aegons businesses and Aegons securities, including its common shares. The order in which the risk factors are presented is not indicative of their likelihood of occurrence or the potential magnitude of their financial consequences.
Risks relating to Aegons business
The following covers key risk factors that may affect Aegons businesses and operations, as well as other risk factors that are particularly relevant to Aegon in periods of significant economic uncertainty. Additional risks to which Aegon is subject include, but are not limited to, the factors mentioned under Forward-looking statements, and the risks of Aegons businesses described elsewhere in this Annual Report.
Disruptions in the global financial markets and general economic conditions may affect, and could have materially adverse effects on Aegons businesses, results of operations, cash flows and financial condition.
Aegons results of operations and financial condition may be materially affected from time to time by general economic conditions, such as economic growth, levels of unemployment, consumer confidence, inflation and interest rate levels in the countries in which Aegon operates. The global financial crisis has shown that financial markets can experience extreme volatility and disruption.
Such conditions may result in reduced demand for Aegons products as well as impairments and reductions in the value of the assets in Aegons general account, separate account, and company pension schemes, among other assets. Aegon may also experience a higher incidence of claims and unexpected policyholder behavior such as unfavorable changes in lapse rates. Aegons policyholders may choose to defer or stop paying insurance premiums, which may impact Aegons businesses, results of operations, cash flows and financial condition, and Aegon cannot predict with any certainty whether or when such actions may occur.
Governmental action in the United States, the Netherlands, the United Kingdom, the European Union and elsewhere to address any of the above may impact Aegons businesses. Aegon cannot predict the effect that these or other government actions as well as actions by the ECB or the Federal Reserve may have on the financial markets or on Aegons businesses, results of operations, cash flows and financial condition.
Declines in value and defaults in Aegons debt securities, private placements and mortgage loan portfolios held in Aegons general and separate accounts, or the failure of certain counterparties, may adversely affect Aegons profitability and shareholders equity.
Credit risk is the risk of loss resulting from the default by, or failure to meet contractual obligations of issuers and counterparties. Aegon also considers credit risk to include spread risk that is the value of the bond reduced due to a general widening of credit spreads. For general account products, Aegon typically bears the risk for investment performance equalling the return of principal and interest. Aegon is exposed to credit risk on its general account fixed-income portfolio (debt securities, mortgages and private placements), over-the-counter (OTC) derivatives and reinsurance contracts. In addition, financial institutions acting as a counterparty on derivatives may not fulfil their obligations. Default by issuers and counterparties on their financial obligations may be due to, among other things, bankruptcy, lack of liquidity, market downturns or operational failures, and the collateral or security they provide may prove inadequate to cover their obligations at the time of the default.
Additionally, Aegon is indirectly exposed to credit risk on the investment portfolios underlying separate account liabilities. Changes to credit risk can result in separate account losses, which increase the probability of future loss events. In the United States and the Netherlands separate account products can include guarantees which protect policyholders against some or all of the downside risks in their separate account portfolio. Reduced separate account values also decrease fee income and may accelerate deferred policy acquisition costs (DPAC) amortization. Reconsideration of assumptions might also affect the DPAC amortization schedule. These factors may have a material adverse effect on Aegons results of operations and financial position.
Annual Report on Form 20-F 2017 |
337 | Additional information Risk factors | |
Aegons investment portfolio contains, among other investments, Dutch government bonds, US Treasury, agency and state bonds, other government issued securities and corporate bonds. Especially in a weak economic environment Aegon may incur significant investment impairments due to defaults and overall declines in the capital markets. Further, excessive defaults or other reductions in the value of these securities and loans may have a materially adverse effect on Aegons businesses, results of operations, cash flows and financial condition.
A decline in equity markets may adversely affect Aegons profitability and shareholders equity, sales of savings and investment products, and the amount of assets under management.
Aegon and its customers run the risk that the market value of its equity investments declines. Exposure to equity markets exists in both assets and liabilities. Asset exposure exists through direct equity investment where Aegon bears all or most of the volatility in returns and investment performance risk. Equity market exposure is also present in policyholders accounts for insurance and investment contracts (such as variable annuities, unit-linked products and mutual funds) where funds are invested in equities. Although most of the risk remains with the policyholder, guarantees within certain products may transfer some or all of this risk to Aegon. Lower investment returns also reduce the asset management fee that Aegon earns on the asset balance in these products and prolonged investment under-performance may cause existing customers to withdraw funds and potential customers not to grant investment mandates. Hedging of exposures may change those effects significantly and equity hedges are used extensively to manage the equity market risk of variable annuity investment guarantees. Hedging programs are in place that are designed to manage the risks within the limits as defined as part of the financial risk management policies within Aegon groups risk strategy. The actual impact of the hedging programs is dependent on the real time market movements of equity markets.
Some of Aegons insurance and investment contract businesses have minimum return or accumulation guarantees, which require Aegon to establish reserves to fund these future guaranteed benefits when equity market returns do not meet or exceed these guarantee levels. Aegons reported results under International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS), are also at risk if returns are not sufficient to allow amortization of DPAC, which may impact the reported net income as well as shareholders equity. Volatile or poor market conditions may also significantly reduce the demand for some of Aegons savings and investment products, which may lead to lower sales and net income.
Interest rate volatility or sustained low interest rate levels may adversely affect Aegons profitability and shareholders equity.
Aegon is exposed to interest rate risk as both its assets and liabilities are sensitive to movements in long and short term interest rates as well as to changes in the volatility of interest rates. In periods of rapidly increasing interest rates, policy loans, surrenders and withdrawals may and usually do increase. Premiums in flexible premium policies may decrease as policyholders seek investments with higher perceived returns. This activity may result in cash payments by Aegon requiring the sale of invested assets at a time when the prices of those assets are affected adversely by the increase in market interest rates. This may result in realized investment losses. These cash payments to policyholders also result in a decrease in total invested assets and net income. Early withdrawals may also require accelerated amortization of DPAC, which in turn reduces net income. Hedging against interest rate movements may change these effects significantly. Hedging programs are in place that are designed to manage the risks within the limits defined as part of the financial risk management policies within Aegon groups risk strategy. The actual impact of the hedging programs is dependent on the effectiveness of the design of those programs as well as real time movements of financial markets. If hedging programs are not effective, Aegons results of operation, cash flow and financial position could be materially and adversely affected.
In general, if interest rates rise, there will be unrealized losses on assets carried at fair value that will be recorded in other comprehensive income (available-for-sale investments) or as negative income (investments at fair value through profit or loss) under IFRS. This is inconsistent with the IFRS accounting on much of Aegons liabilities, where corresponding economic gains from higher interest rates do not affect shareholders equity or income in the shorter term. Over time, the short-term reduction in shareholder equity and income due to rising interest rates would be offset in later years, all else being equal.
During periods of decreasing interest rates or sustained low interest rates, as experienced in recent years, Aegon may not be able to preserve margins due to the existence of minimum interest rate guarantees and minimum guaranteed crediting rates provided in policies. Also, investment earnings may be lower because the interest earnings on new fixed-income investments are likely to have declined with the market interest rates. A prolonged low interest rate environment may also result in a lengthening of maturities of the policyholder liabilities from initial estimates, primarily due to lower policy lapses.
Annual Report on Form 20-F 2017 |
338 | Additional information Risk factors | |
In-force life insurance and annuity policies may be relatively more attractive to consumers due to built-in minimum interest rate guarantees, resulting in increased premium payments on products with flexible premium features and a higher percentage of insurance policies remaining in force year-to-year. The majority of assets backing the insurance liabilities are invested in fixed-income securities.
Aegon manages its investments and derivative portfolio, considering a variety of factors, including the relationship between the expected duration of its assets and liabilities. However, if interest rates remain low, the yield earned upon reinvesting interest payments from current investments, or from their sale or maturation, may decline. Reinvestment at lower yields may reduce the spread between interest earned on investments and interest credited to some of Aegons products and accordingly net income may decline. In addition, borrowers may prepay or redeem fixed maturity investments or mortgage loans in Aegons investment portfolio in order to borrow at lower rates. Aegon can lower crediting rates on certain products to offset the decrease in spread. However, its ability to lower these rates may be limited by contractually guaranteed minimum rates or competition.
Depending on economic developments going forward, interest rates at the shorter end of the curve may remain at low or even negative levels for a prolonged period. In such an environment, an anchored expectation of low inflation or deflation could further push down the longer end of the interest rate curve which could have significant implications for Aegons operations and financial results.
The profitability of Aegons spread-based businesses depends in large part upon the ability to manage interest rate risk, credit spread risk and other risks inherent in the investment portfolio. Aegon may not be able to successfully manage interest rate risk, credit spread risk and other risks in the investment portfolio or the potential negative impact of those risks.
The sensitivity of Aegons net income and shareholders equity to a change in interest rates is provided in the notes to the consolidated statements, note 4 Financial risks, section Interest rate risk.
Fluctuations in currency exchange rates may affect Aegons reported results of operations.
As an international group, Aegon is subject to foreign currency translation risk. Foreign currency exposure also exists when policies are denominated in currencies other than Aegons functional currency. Currency risk in the investment portfolios backing insurance and investment liabilities are managed using asset liability matching principles. Assets allocated to equity are kept in local currencies to the extent shareholders equity is required to satisfy regulatory and Aegons self-imposed capital requirements. Therefore, currency exchange rate fluctuations may affect the level of Aegons consolidated shareholders equity as a result of translation of the equity of Aegons subsidiaries into euro, Aegons reporting currency. Aegon holds the remainder of its capital base (capital securities, subordinated and senior debt) in various currencies in amounts that are targeted to correspond to the book value of Aegons business units. This balancing is intended to mitigate currency translation impacts on equity and leverage ratios. Aegon may also hedge the foreign exchange component of expected dividends from its principal business units that maintain their equity in currencies other than the euro
To the extent the foreign exchange component of expected dividends is not hedged or actual dividends vary from expected, Aegons net income and shareholders equity may fluctuate. As Aegon has significant business segments in the Americas and in the United Kingdom, the principal sources of exposure from currency fluctuations are from the differences between the US dollar and the euro and between the UK pound and the euro. Aegon may experience significant changes in net income and shareholders equity because of these fluctuations.
The sensitivity of Aegons net income and shareholders equity to foreign exchange translation risk is provided in the notes to the financial statements, note 4 Financial risks, section Currency exchange risks.
Illiquidity of certain investment assets may prevent Aegon from selling investments at fair prices in a timely manner.
Aegon must maintain sufficient liquidity to meet short term cash demand under normal circumstances, as well as in crisis situations. Liquidity risk is inherent in much of Aegons businesses. Each asset purchased and liability sold has unique liquidity characteristics. Some liabilities can be surrendered, while some assets, such as privately placed loans, mortgage loans, real estate and limited partnership interests, are to some degree illiquid. In depressed markets, Aegon may be unable to sell or buy significant volumes of assets at quoted prices.
Any security Aegon issues in significant volume may be issued at higher financing costs if funding conditions are impaired. The necessity to issue securities can be driven by a variety of factors, for instance Aegon may need liquidity for operating expenses, debt servicing and the maintenance of capital levels of insurance subsidiaries. Although Aegon manages its liquidity position for extreme
Annual Report on Form 20-F 2017 |
339 | Additional information Risk factors | |
events, including greatly reduced liquidity in capital markets, if these conditions were to persist for an extended period of time, Aegon may need to sell assets substantially below prices at which they are currently recorded to meet its insurance obligations.
Aegon makes use of (bilateral and syndicated) credit facilities to support repayment of amounts outstanding under Aegons commercial paper programs and to serve as additional sources of liquidity. An inability to access these credit facilities, for example due to non-compliance with conditions for borrowing or the default of a facility provider under stressed market circumstances, could have an adverse effect on Aegons ability to meet liquidity needs and to comply with contractual and other requirements.
Many of Aegons derivatives transactions require Aegon to pledge collateral against declines in the fair value of these contracts. Volatile financial markets may significantly increase requirements to pledge collateral and adversely affect its liquidity position. Further, a downgrade of Aegons credit ratings may also result in additional collateral requirements and affect its liquidity, or even enable counterparties to terminate such derivative transactions.
Underwriting risk relates to the products sold by Aegon insurance entities. The underwriting process requires, among others, the setting of assumptions. Aegons reported results of operations and financial condition may be affected by differences between actual claims experience and underwriting and reserve assumptions both due to incurred gains/ losses and from potential changes in best estimate assumptions that are used to value insurance liabilities.
There is a risk that the pricing of Aegons products turns out to be inadequate if the assumptions used for pricing do not materialize. Aegons earnings depend significantly upon the extent to which actual claims experience is consistent with the assumptions used in setting the prices for Aegons products and the extent to which the established technical provisions for insurance liabilities prove to be sufficient. If actual claims experience is less favorable than the underlying assumptions used in establishing such liabilities, Aegons income would be reduced. Furthermore, if less favorable claims experience became sustained, Aegon may be required to change its best estimate assumptions with respect to future experience, potentially increasing the technical provisions for insurance liabilities, which may reduce Aegons income. In addition, certain acquisition costs related to the sale of new policies and the purchase of policies already in force have been recorded as assets on the balance sheet and are being amortized into income over time. If the assumptions relating to the future profitability of these policies (such as future claims, investment income and expenses) are not realized, the amortization of these costs may be accelerated and may require write-offs should there be an expectation that the costs are not fully recoverable. This may have a materially adverse effect on Aegons results of operations and financial condition.
Sources of underwriting risk include policyholder behavior (such as lapses or surrender of policies), policy claims (such as mortality and morbidity) and expenses. For some product lines, Aegon is at risk if policy lapses increase, as sometimes Aegon is unable to fully recover up-front sales expenses despite the presence of commission recoveries or surrender charges and fees. In addition, some policies have embedded options which at times are more valuable to the client if they stay (lower lapses) or leave (higher lapses), which may result in losses to Aegons businesses. Aegon sells certain types of policies that are at risk if mortality or morbidity increases, such as term life insurance and accident insurance. Aegon also sells certain other types of policies, such as annuity products, that are at risk if mortality decreases (longevity risk). For example, certain current annuity products, as well as products sold in previous years, have seen their profitability deteriorate as longevity assumptions have been revised upward. If the trend toward increased longevity persists, Aegons annuity products may continue to experience adverse effects due to longer expected benefit payment periods. Aegon is also at risk if expenses are higher than assumed.
The sensitivity of Aegons net income and shareholders equity to changes in various underwriting risks is provided in the notes to the consolidated financial statements, note 36 Insurance contracts.
Valuation of Aegons investments, allowances and impairments is subjective, and discrepant valuations may adversely affect Aegons results of operations and financial condition.
The valuation of many of Aegons financial instruments is based on methodologies, estimations and assumptions that are subject to different interpretations. Changes to investment valuations may have a materially adverse effect on Aegons results of operations and financial condition. In addition, the determination of the amount of allowances and impairments taken on certain investments and other assets is subjective and based on assumptions, estimations and judgments that may not reflect or correspond to Aegons actual experience any of which may materially impact Aegons results of operations or financial position.
Among other things, changes in assumptions, estimations, judgments or in actual experience may require Aegon to accelerate the amortization of DPAC and value of business acquired, establish a valuation allowance against deferred income tax assets, or to recognize impairment of other assets, any of which may materially adversely affect Aegons results and financial condition.
Annual Report on Form 20-F 2017 |
340 | Additional information Risk factors | |
Certain of Aegons products have guarantees that may adversely affect its results, financial condition or liquidity.
Certain products, particularly Aegons variable annuity products, include death benefit guarantees, guarantees of minimum surrender values or income streams for stated periods or for life, which may be in excess of account values. These guarantees are designed, among other things, to protect policyholders against downturns in equity markets and interest rates. As a result, a drop in the value of underlying assets or more volatile markets could result in an increase in the valuation of Aegons liabilities associated with these products. An increase in these liabilities may decrease its net income. Aegon uses a variety of hedging and risk management strategies to mitigate these risks. However, these strategies may not be fully effective and hedging instruments may not fully offset the costs of guarantees or may otherwise be insufficient in relation to its obligations. Estimates and assumptions Aegon makes in connection with hedging activities may fail to fully reflect or correspond to the actual (longer term) exposure in respect of guarantees. Further, unexpected policyholder behavior may cause Aegons hedging to be less effective. The above factors could have a material adverse effect on its results of operations, financial condition or liquidity.
Aegon may be unable to manage Aegons risks successfully through derivatives.
Aegon is exposed to changes in the fair value of its investments, the impact of interest rate, equity markets and credit spread changes, currency fluctuations and changes in mortality and longevity. Aegon uses common financial derivative instruments, such as swaps, options, futures and forward contracts to hedge some of the exposures related to both investments backing insurance products and company borrowings. Aegon may not be able to manage the risks associated with these activities successfully through the use of derivatives. In addition, a counterparty may fail to honor the terms of its derivatives contracts with Aegon and clearing members and clearing houses may terminate their derivatives contracts with Aegon. Aegons inability to manage risks successfully through derivatives, a counterpartys failure to honor Aegons obligations or the systemic risk that failure is transmitted from counterparty to counterparty may each have a material adverse effect on Aegons businesses, results of operations and financial condition.
Currently the possible impact of Brexit on clearing houses located in the United Kingdom is unknown. Aegon uses London Clearing House (LCH) as central counterparty to clear most of its derivatives transactions. If, following Brexit, the system of supervision in the United Kingdom is not considered equivalent to that of the European Union and LCH has not been granted recognition, new and existing derivatives cleared through LCH and executed by EU27 entities, may not comply to EMIR regulations and possibly existing trades may have to be terminated and replaced by new trades to be cleared by an authorized clearing house located in the EU27. This could lead to additional costs and may impair the effectiveness of Aegons hedging programs.
Inaccuracies in econometric, financial or actuarial models, or differing interpretations of underlying methodologies, assumptions and estimates, could have a significant adverse effect on Aegons business, results of operations and financial condition.
Aegon uses econometric, financial and actuarial models to measure and manage multiple types of risk, to price products and to establish and assess key valuations and report financial results. All these functions are critical to Aegons operations. If these models, their underlying methodologies, assumptions and estimates, or their implementation and monitoring prove to be inaccurate, this could have a significant adverse effect on Aegons business, financial condition and results.
Many of Aegons business units offer investment products that utilize quantitative models, algorithms or calculations that could experience errors or prove to be incorrect, incomplete or unsuccessful resulting in losses for clients who have invested in such products and possible regulatory actions and/or litigation against Aegon and/or its affiliates.
Aegons business units may utilize quantitative models, algorithms or calculations (whether proprietary or supplied by third parties) (Models) or information or data supplied by third parties (Data) for the management of, or to assist in the management of, investment products offered to clients. Examples of such investment products include, volatility controlled funds, mutual funds, separately managed accounts, and other types of advisory accounts. Models and Data are used to construct sets of transactions and investments, to provide risk management insights, and may be used to assist in hedging the investments. If Models and Data prove to be incorrect or incomplete, any decisions made, in whole or part, in reliance thereon expose the investment product to additional risks. For example, by utilizing Models or Data, certain investments may be bought at prices that are too high, certain other investments may be sold at prices that are too low, or favorable opportunities may be missed altogether. Similarly, any hedging based on faulty Models and Data may prove to be unsuccessful. The applicable investment product bears the risk that Models or Data used will not be successful and the product may not achieve its investment objective. Models can be predictive in nature. The use of predictive Models has inherent risks. For example, such Models may incorrectly forecast future behavior, leading to potential losses on a cash flow and/or a mark-to-market basis. In addition, in unforeseen or certain low-probability scenarios (often involving a market disruption of some kind), such
Annual Report on Form 20-F 2017 |
341 | Additional information Risk factors | |
Models may produce unexpected results, which can result in losses for an investment product. Furthermore, the success of relying on or otherwise using Models depends on a number of factors, including the validity, accuracy and completeness of the Models development, implementation and maintenance, the Models assumptions, factors, algorithms and methodologies, and the accuracy and reliability of the supplied historical or other Data. Models rely on, among other things, correct and complete Data inputs. If incorrect Data is entered into even a well-founded Model, the resulting information will be incorrect. However, even if Data is input correctly, Model prices may differ substantially from market prices, especially for securities with complex characteristics. Investments selected with the use of Models may perform differently than expected as a result of the design of the Model, inputs into the Model or other factors. There can be no assurance that the use of Models will result in effective investment decisions for an investment product. Additionally, if investment products offered by Aegons affiliates experience Model errors or use erroneous Data, this could result in regulatory actions and/or litigation brought against Aegon and/or its affiliates.
Aegon may be required to increase its technical provisions and/or hold higher amounts of regulatory capital, which may decrease Aegons returns on its products.
Prudential regulatory requirements such as with respect to the calculation of technical provisions, capital requirements, the eligibility of own funds and the regulatory treatment of investments may change, resulting in increased technical provisions, higher amounts of regulatory capital, more stringent requirements with respect to investments and/or the qualification of own funds. Aegon cannot predict specific proposals that might be adopted, or what impact, if any, such proposals or, if enacted, such laws, may have on its businesses, results of operations, or financial condition. For example, the European Union, the National Association of Insurance Commissioners (NAIC) in the US or US state regulators may adopt revisions to applicable risk based capital formulas and local regulators in other jurisdictions in which Aegons subsidiaries operate may increase their capital requirements.
In addition to requirements imposed directly through regulatory requirements and/or supervisory authorities rating agencies may incorporate higher capital thresholds into their quantitative analyses, thus requiring additional capital for Aegons regulated subsidiaries in order for Aegon Group and/or its regulated subsidiaries to maintain their desired credit ratings.
An important example of changed regulatory requirements for insurers originates from the European Commissions Solvency II Directive, which became effective on January 1, 2016, and which imposes, among other things, substantially greater quantitative and qualitative capital requirements on some of Aegons businesses and at the Group level, as well as supervisory and disclosure requirements, and may impact the structure, business strategies, and profitability of Aegons insurance subsidiaries and of the Group. Although the Solvency II Directive became effective on January 1, 2016, the requirements remain subject to change, for instance through reviews by the European Commission of the Solvency II requirements, which are currently taking place. Some of Aegons competitors, who are headquartered outside the European economic area may not be subject to Solvency II requirements and may thereby be better able to compete against Aegon, particularly in the United States and Asia. In particular, the manner in which Aegons United States and Asia insurance businesses are taken into account in the Solvency II group solvency calculation, may have a significant impact on the groups capital position. In that context, the opinion published by EIOPA on January 27, 2016 regarding the application of a combination of accounting methods for the group solvency calculation has offered important additional guidance to Aegon that may help to determine its group solvency position under Solvency II. As is generally the case with respect to the interpretation of regulatory requirements, in the future this guidance, or the manner in which this guidance is applied, may change, which may have, depending on the nature of the change, a significant effect on the outcome of the group solvency calculation. As an illustration, in August 2017, adjustments in the calculation for the US led to an increase in the Group Solvency Ratio. Until June 30, 2017, Aegon used 250% of the local Company Action Level (CAL) RBC as the SCR equivalent. Aegon received approval from the De Nederlandse Bank (DNB) to apply, as of July 1, 2017, a revised methodology that includes lowering the conversion factor from 250% to 150% RBC, and reducing the contribution to own funds by 100% of the local Company Action Level RBC requirement to reflect transferability restrictions. This methodology is subject to annual review and the change enhances comparability with European peers.
In the United States, the National Association of Insurance Commissioners (NAIC) has taken an initiative to better align the Risk-Based Capital charges with the appropriate risk for invested assets. This may lead to higher risk charges for such assets.
Furthermore, the NAIC Model Regulation entitled Valuation of Life Insurance Policies, commonly known as Regulation XXX, requires insurers in the United States to establish additional statutory reserves for term life insurance policies with long-term premium guarantees. In addition, Actuarial Guideline XXXVIII, commonly known as AG38, intended to clarify the regulation on valuation of life insurance policies, requires insurers to establish additional statutory reserves for certain universal life insurance policies with secondary guarantees. Virtually all of Aegons newly issued term and universal life insurance products in the United States are affected by Regulation XXX and AG38, respectively.
Annual Report on Form 20-F 2017 |
342 | Additional information Risk factors | |
Subsequently, the NAIC adopted regulations to monitor and provide transparency for insurer-affiliated captive reinsurers. Captive reinsurance structures have been used to manage economically redundant reserves for term and secondary guarantee universal life policies. It is anticipated that after the enactment of US principle-based reserves, effective January 1, 2017 for new business, new captive reinsurance structures may not be required for these term and secondary guarantee universal life products. The new reserves requirements for US life insurance products are intended by regulators to represent a more economically supported view of the resources required to honor the promises to policyholders. For existing business held in a captive, Aegon may continue to be subject to the risks of adverse publicity and changes in regulations related to captive reinsurance.
In addition, the NAIC is reviewing the use of captives for variable annuity business and is considering actuarial and accounting changes for variable annuities. Aegon utilizes variable annuity captives to align its hedging strategy with capital requirements for a closed block of variable annuities. The NAIC also continues to consider changes to corporate governance and insurers use of captives.
Aegon utilizes affiliated captive insurance companies to manage risks of various insurance policies, including universal life with secondary guarantees, level term life insurance and variable annuity policies. Through these structures, Aegon finances certain required regulatory reserves at a lower cost. To the extent that state insurance departments restrict Aegons use of captives and regulatory reserve requirements remain unchanged, this could increase costs, limit the ability to write these products in the future or lead to increased prices to consumers on those products. The NAIC continues to consider changes to corporate governance and insurers use of captives. Due to the uncertainty of the proposals it is not possible to provide an estimate of the effects at this time.
As a further example, Aegon and the Aegon Group may be impacted by further changes to the capital adequacy requirements it is subject to as a result of the development of the Insurance Capital Standard (ICS) as part of the Common Framework for the Supervision of Internationally Active Insurance Groups (ComFrame) (a set of international regulatory standards focusing on the effective group-wide supervision of internationally active insurance groups (IAIGs)). Since November 3, 2015 Aegon is classified as a Global Systematically Important Insurer (G-SII). While the qualification is reviewed by the Financial Stability Board (FSB) yearly, the FSB, in consultation with the International Association of Insurance Supervisors (IAIS) and national authorities, decided not to publish a new list of G-SIIs for 2017. The policy measures set out in the FSBs 2016 communication on G-SIIs will continue to apply to the firms listed in the 2016 communication. Continued enhancement of the Entity Based Approach (EBA) for the assessment of systemic risk has been suspended in favour of an Activities Based Approach to managing systemic risk. In this respect, the development of ComFrame as well as any additional requirements or standards applicable to either systemic entities or activities could lead to enhanced capital requirements applicable to IAIGs. This could adversely affect Aegons ability to compete with other insurers that are not subject to those capital requirements. These requirements may lead Aegon to engage in transactions that affect capital, repurchase own shares or constrain Aegons ability to pay dividends. Furthermore, such requirements may constrain Aegons ability to provide guarantees and increase the cost to Aegon of offering certain products resulting in price increases, discontinuance of offering of certain products or reducing the amount of risk Aegon takes on. Aegon may consider structural and other business alternatives in light of its G-SII designation, of which the impact on shareholders cannot be predicted.
Regulatory restrictions and failure to comply with regulations may impact Aegons ability to do business, its financial position or financial results.
Aegon may not be able to comply fully with, or obtain appropriate exemptions from, the wide variety of laws and regulations applicable to insurance companies, holding companies, groups of insurance companies and/or other financial undertakings and/or financial conglomerates. Failure to comply with or to obtain appropriate exemptions under any applicable laws may result in restrictions on Aegons ability to do business in one or more of the jurisdictions in which Aegon operates and may result in fines and other sanctions, which may have a materially adverse effect on Aegons businesses, financial position or results of operations.
Restrictions on underwriting criteria and the use of data may affect Aegons ability to do business, its financial position or financial results.
Some countries impose restrictions on particular underwriting criteria, such as gender, or use of genetic test results, for determination of premiums and benefits of insurance products. To date, Aegon has not observed negative financial or business impact due to these restrictions. However, future restrictions could adversely impact Aegons operations or financial results. Further developments in underwriting, such as automation and use of additional data, may also be affected by future regulatory developments regarding privacy and use of personal data.
Annual Report on Form 20-F 2017 |
343 | Additional information Risk factors | |
A downgrade in Aegons ratings may increase policy surrenders and withdrawals, adversely affect relationships with distributors, and negatively affect Aegons results.
Claims-paying ability and financial strength ratings are factors in establishing the competitive position of insurers. A rating downgrade (or a change in outlook indicating the potential for such a downgrade) of Aegon or any of its rated insurance subsidiaries may, among other things, materially increase the number of policy surrenders and withdrawals by policyholders of cash values from their policies. These withdrawals may require the sale of invested assets, including illiquid assets, at a price that may result in realized investment losses. These cash payments to policyholders would result in a decrease in total invested assets and a decrease in net income. Among other things, early withdrawals may also cause Aegon to accelerate amortization of deferred policy acquisition costs (DPAC), reducing net income.
Aegon has experienced downgrades and negative changes to its outlook in the past, and may experience rating and outlook changes in the future. A downgrade or potential downgrade, including changes in outlook, may result in higher funding costs and/or affect the availability of funding in the capital markets. In addition, a downgrade may adversely affect relationships with broker-dealers, banks, agents, wholesalers and other distributors of Aegons products and services, which may negatively impact new sales and adversely affect Aegons ability to compete. A downgrade of Aegons credit ratings will have the small effect of increased fees on credit facilities but may result in higher funding costs on future long term debt funding transactions and its ability to obtain reinsurance contracts at reasonable prices or at all.
Aegon cannot predict what actions rating agencies may take, or what actions Aegon may take in response to the actions of rating agencies. As with other companies in the financial services industry, Aegons ratings may be downgraded at any time and without notice by any rating agency.
Changes in government regulations in the countries in which Aegon operates may affect profitability.
Aegons regulated businesses, such as insurance, banking and asset management, are subject to comprehensive regulation and supervision, specific to these businesses. The primary purpose of such regulation is to protect clients of these operating companies, (e.g. policyholders), not holders of Aegon capital securities. Changes in existing laws and regulations may affect the way in which Aegon conducts its businesses, the profitability of its businesses and the products offered. Additionally, the laws or regulations adopted or amended from time to time may be more restrictive or may result in higher costs than currently the case, such as with regard to the calculation of capital needs, treatment of own funds, rules or guidance with respect to the modelling of insurance, investment and other risks.
Regulatory changes include or may include capital standards and prudential standards for non-bank companies deemed to be systemically important financial institutions (SIFIs) that are more stringent than the standards applicable to non-SIFIs. Aegon has not been designated a SIFI in the United States. In addition, US state insurance regulators are developing group capital standards. The scope of application of these standards has not yet been determined. The current US administration announced plans to review aspects of the Dodd-Frank Act. This review may result in changes in laws and regulations that may impact US or global operations.
In the United States, the Patient Protection and Affordable Care Act (PPACA) was enacted in 2011 and upheld, with the exception of the Medicaid expansion mandate, by the US Supreme Court in 2012. PPACA significantly changed the regulation of health insurance in the United States, including in certain respects the regulation of supplemental health insurance products. The current US Presidential administration and US Congress have repealed certain provisions of the PPACA and additional changes in laws or regulations that may impact US health insurance industry are possible. The extent to which employers or individuals may discontinue their purchase of supplemental health insurance products as a result of these changes may significantly impact Aegon USAs supplemental health insurance products business. The extent of the expected changes or impact on Aegon USAs supplemental health insurance business cannot be determined at this time.
Solvency II became effective in EU member states as per January 1, 2016. Elements of the Solvency II framework may change going forward. This may affect the way Aegon implements the Solvency II framework, including Aegons financial position under Solvency II. Pursuant to Solvency II, Aegon is required to calculate a solvency ratio (own funds divided by the required solvency, the latter referred to as the Group SCR), for the Aegon Group at the level of Aegon which should be at least equal to 100%. Under Solvency I, EU supervisors usually required insurance and reinsurance undertakings to maintain a substantial percentage of own funds above the statutory minimum requirements. Under Solvency II, the DNB leaves the decision as to whether to hold a buffer of own funds in excess of the Group SCR or the SCR to the Aegon Group and the insurance and reinsurance undertakings in the Aegon Group. As the prudential supervisor, the DNB nonetheless monitors Aegons capital management policies. Aegon applies its own capital management policies
Annual Report on Form 20-F 2017 |
344 | Additional information Risk factors | |
that determine the Companys risk tolerances on the basis of self-imposed criteria. These policies result in Aegon, at its own election, but supervised by the DNB, maintaining a buffer of own funds in addition to those required according to Solvency II requirements. Aegons maximum risk tolerance for capital adequacy in the operating units is to maintain capitalization ratios above at least 100% SCR until after the occurrence of statistical 1-in-10 year equivalent stress scenarios. However, Aegon aspires to consistently maintain higher capital levels and targets local capitalisation levels in the operating units to support sustainable capital generation and stable dividends also until after the occurrence of statistical 1- in-10 year equivalent stress scenarios. These scenarios do not only reflect narrow statistical events, but can also include a broader range of stress scenarios such as economic, operational, regulatory and political events. Pursuant to these self-imposed criteria, Aegon currently aims to hold a buffer in excess of the 100% minimum Group Solvency Ratio of 50 to 100%. The calculation of the Group Solvency Ratio in accordance with Solvency II is further described in the section Regulation and Supervision.
In the Netherlands, the Dutch Central Bank provided guidance with regard to assumptions underlying Aegons factor for the loss absorbing capacity of deferred taxes (LAC-DT). Reduction of this factor would impact the Group Solvency II ratio. From June 30, 2017 to year-end, the factor of LAC-DT taken into account in Aegon the Netherlands Solvency II ratio remained unchanged at 75%. The factor is reassessed quarterly. The Solvency II sensitivity for a 25-percentage points change in the factor is given in the section Capital and liquidity management. The treatment of LAC-DT under the Solvency II framework is also one of the elements of the Solvency II review being conducted by the European Commission. The review was work in progress as per year-end 2017. The outcomes of this review and potential changes to the relevant regulations, guidelines or opinions, or their application by national supervisory authorities may have an impact on the determination of the LAC-DT that may be taken into account by Aegon going forward.
The United States Department of Labor (DOL) issued a Conflict of Interest or Fiduciary rule in April 2016 (the DOL Rule) that substantially broadens the definition of fiduciary with respect to retirement savings and investment plans and products (qualified assets). The final rule would, with limited exemptions and carve-outs, make agents and brokers who provide recommendations on qualified assets, subject to a best interest/fiduciary standard. The DOL Rule best interest standard becomes effective with additional requirements and exemptions as of July 1, 2019. The DOL announced that it would further review the DOL Rule and propose additional changes before the DOL Rule becomes fully applicable. In addition the SEC has announced that it will propose a harmonized standard of care for broker dealers and investment advisers. Finally, New York and several other states have proposed or are expected to propose a heightened standard of care for financial professionals in their state and/or relating to the sale of life insurance as well as retirement savings and investment products.
The DOL Rule could have a material adverse impact from a prospective sales perspective both as to Aegon USAs retirement plan and annuity businesses, and could create other challenges to the operating model of these businesses. In addition, the SEC or the United States promulgation or enactment, respectively, of an enhanced standard of care could similarly have a material adverse impact on Aegon USAs business. In late 2017, the additional requirements applicability date was extended to July 1, 2019. It is expected that the DOL will propose changes to the rule later this year. The final results of the review and the impact on Aegon USAs retirement plan and annuity business will not be known until after the changes to the rule are finalized by 2018-2019.
Changes in pension and employee benefit regulation, social security regulation, financial services regulation, taxation and the regulation of securities products and transactions may adversely affect Aegons ability to sell new policies or claims exposure on existing policies. For example, in Hungary, the mandatory pension business has been nationalized and therefore Aegon in Hungary has liquidated its mandatory pension business. Similarly, in December 2013, the Polish parliament approved legislation to overhaul the existing state pension system, which was a reason for Aegon to write down its intangible assets.
Other initiatives, such as by the International Association of Insurance Supervisors, may lead to regulations that would increase capital needs and other requirements that would not be applicable to all carriers and create an uneven competitive playing field.
In general, changes in laws and regulations may materially increase Aegons direct and indirect compliance costs and other ongoing business expenses and have a materially adverse effect on Aegons businesses, results of operations or financial condition.
An abandonment of the euro currency by one or more members of the European Monetary Union may affect Aegons results of operations in the future.
It is possible that the euro may be abandoned as a currency in the future by countries that have already adopted its use. This may lead to the re-introduction of individual currencies in one or more European Monetary Union member states, or in more extreme circumstances, the dissolution of the European Monetary Union. It is not possible to predict the effect on the European and global economies of a potential dissolution of the European Monetary Union or the exit of one or more European Union member states from
Annual Report on Form 20-F 2017 |
345 | Additional information Risk factors | |
the European Monetary Union. Any such event may have a materially adverse effect on Aegons future financial condition and results of operations.
The United Kingdom (UK) leaving the European Union (Brexit), potentially followed by more countries, may affect Aegons results and financial condition.
On June 23, 2016 the United Kingdom voted in a national referendum to withdraw from the European Union. With the negotiations underway, the implications of Brexit remain unclear, with respect to the European integration process, the relationship between the UK and the European Union, and the impact on economies and businesses. Aegon could be adversely impacted by related market developments such as increased exchange rate movements of the UK pound versus the euro and higher financial market volatility in general due to increased uncertainty, any of which could reduce the value or results of Aegons operations in the United Kingdom. Aegon could also be adversely impacted should Brexit result in the UK moving away from agreed and implemented EU legislation like, but not limited to, Solvency II regulations.
More countries could potentially follow the UK in leaving the European Union. This could also result in the mentioned possible abandonment of the euro currency by one or more countries. The topic could be raised in elections and referenda. Any uncertainty, volatility or negative impacts created by these political events could have a material adverse effect on Aegons results of operations, cash flows or financial position.
Risks of application of to the Dutch Intervention Act
In June 2012, the Dutch Intervention Act (Wet bijzondere maatregelen financiële ondernemingen) came into force in the Netherlands, with retroactive effect from 20 January 2012. The Dutch Intervention Act grants far-reaching powers to the Dutch Central Bank (De Nederlandsche Bank N.V., DNB) and the Dutch Minister of Finance to intervene in situations where an institution, including a financial group such as Aegon, faces financial difficulties or where there is a serious and immediate risk to the stability of the Dutch financial system caused by an institution in difficulty. The Dutch Intervention Act has been amended in respect of, inter alia, banks as a result of the entry into force of the EU Directive on the recovery and resolution of credit institutions and investments firms, which was approved by the European Parliament on 15 April 2014 and of which the final text was published in the Official Journal of the European Union on 12 June 2014 (the Bank Recovery and Resolution Directive). The Bank Recovery and Resolution Directive also contains provisions that apply to mixed financial holding companies such as Aegon N.V., including the right of bail-in of creditors. Under the Dutch Intervention Act, substantial powers have been granted to the DNB and the Dutch Minister of Finance enabling them to deal with ailing Dutch insurance companies as well as holding companies of insurance companies and financial conglomerates prior to insolvency. The measures allow them to commence proceedings which may lead to (a) the transfer of all or part of the business of an ailing insurance company to a private sector purchaser, (b) the transfer of all or part of the business of an ailing insurance company to a bridge entity, (c) the transfer of the shares in an ailing insurance company to a private sector purchaser or a bridge entity, (d) immediate interventions by the Dutch Minister of Finance concerning an ailing insurance company, and (e) public ownership (nationalization) of (i) all or part of the business of an ailing insurance company or (ii) all or part of the shares or other securities issued by an ailing insurance company or its holding company. The Dutch Intervention Act also contains measures that limit the ability of counterparties to invoke contractual rights (such as contractual rights to terminate or to invoke a right of set-off or to require security to be posted) if the right to exercise such rights is triggered by intervention of the DNB or the Dutch Minister of Finance based on the Dutch Intervention Act or by a circumstance which is the consequence of such intervention. There is a risk that the exercise of powers, or any perceived exercise of powers, by the DNB or the Dutch Minister of Finance under the Dutch Intervention Act could have a material adverse effect on the performance by the failing institution, including Aegon, of its obligations (of payment or otherwise) under contracts of any form, including the expropriation, write-off, write-down or conversion of securities such as shares and debt obligations issued by the failing institution. Furthermore, the terms of contracts, including debt obligations may be varied (e.g. the variation of maturity of a debt instrument). The Dutch Intervention Act and the Bank Recovery and Resolution Directive aim to ensure that financial public support will only be used as a last resort after having assessed and exploited, to the maximum extent practicable, the resolution tools, including the bail-in tool. The Dutch Ministry of Finance has published a proposal of law at the end of 2017 on recovery and resolution of insurers, and potentially other entities belonging to insurance groups, based in the Netherlands. The act is currently under review in Parliament. If and when formally adopted, this act will replace and complement the provisions of the Dutch Intervention Act. The risks related to this new act are comparable to the risks related to the Dutch Intervention Act described immediately above. In addition, the new act will allow the resolution authority (the DNB) to require a Dutch insurance or reinsurance company or a group to remove, ex ante, impediments to effective resolution of a Dutch insurance or reinsurance undertaking (such as the revision of financing arrangements, the reduction of exposures, the transfer of assets, the termination or limitation of business activities, or the prohibition to start certain business activities, change the legal or operational structure of the
Annual Report on Form 20-F 2017 |
346 | Additional information Risk factors | |
group, securing certain critical business lines). The use of this tool may adversely affect Aegons business, results of operations and financial position.
Legal and arbitration proceedings and regulatory investigations and actions may adversely affect Aegons business, results of operations and financial position.
Aegon faces significant risks of litigation as well as regulatory investigations and actions relating to its and its subsidiaries insurance, pensions, securities, investment management, investment advisory and annuities businesses as well as Aegons corporate compliance, including compliance with employment, sanctions, anti-corruption and tax regulations.
Aegon subsidiaries regularly receive inquiries from local regulators and policyholder advocates in various jurisdictions, including the United States, the Netherlands, and the United Kingdom. Regulators may seek fines or penalties, or changes to the way Aegon operates. In some cases, Aegon subsidiaries have modified business practices in response to inquiries.
Insurance companies and their affiliated regulated entities are routinely the subject of litigation, investigation and regulatory activity by various governmental and enforcement authorities, individual claimants and policyholder advocate groups, involving issues such as, but not limited to, employment or distribution relationships; operational and internal controls and processes; disclosures; environmental matters; competition and antitrust matters; data privacy; information security; intellectual property; and anti-money laundering, anti-bribery and economic sanctions compliance. For example with respect to employment relationships, Aegon recently faced a suit in the state of Georgia filed by self-employed independent insurance agents associated with one of Aegons financial marketing units who claimed to be employees of the organization. This lawsuit was resolved favorably to Aegon. The SEC is conducting a formal investigation related to certain investment strategies offered through mutual funds, variable products and separately managed accounts. These strategies used quantitative models developed by one of the former portfolio managers of Aegons US investment management business unit. Among other things, the investigation relates to the operation of and/or the existence of errors in the quantitative models in question and related disclosures. The funds and strategies under review were sub-advised, advised or marketed by Aegons US group companies. The models are no longer being used although some of the funds are still being offered. The quantitative management strategies are no longer being offered. Aegon is cooperating fully with the investigation. Aegon believes that the investigation will come to a conclusion in 2018, and has taken a provision in anticipation of a possible settlement with the SEC.
Government investigations, including this one, may result in the institution of administrative, injunctive or other proceedings and/ or the imposition of monetary fines, penalties and/or disgorgement as well as other remedies, sanctions, damages and restitutionary amounts. While we are unable to predict what actions, if any, might be taken and are unable to predict the costs to or other impact on us of any such action, there can be no assurances that this matter or other government investigations will not have a material and adverse effect on Aegons reputation, financial position, results of operations or liquidity.
In addition, insurance companies and their affiliated regulated entities are routinely subject to litigation, investigation and governmental review concerning product fees and costs, including transparency and adequacy of disclosure of initial costs, ongoing costs, and costs due on policy surrender as well as changes to costs over time. Disputes and investigations initiated by governmental entities and private parties may lead to orders or settlements including payments or changes to business practices even if Aegon believes the underlying claims are without merit. Aegon and other US insurers have been sued for charging fees on products offered in 401(k) platforms which allegedly were higher than fees charged on other products available in the market. Several US insurers, including an Aegon subsidiary, have also been named in class actions as well as individual litigation relating to increases in monthly deduction rates on universal life products. Plaintiffs generally allege that the increases were made to recoup past losses rather than to cover the future costs of providing insurance coverage. The class action against Aegons subsidiary is pending in the US federal district court for the Central District of California. In the first phase of one of the individual cases against Aegons subsidiary to reach trial, the jury found that the increase was improper. That case and others remain ongoing. In the Netherlands, unit linked products (beleggingsverzekeringen) have been controversial and the target of litigation since 2005. Allegations include excessive cost, unfair terms, inadequate disclosure, and failure to perform as illustrated. Consumer groups have formed to address these issues and initiate mass claims against insurers. Regulators as well as the Dutch Parliament have been involved ever since, with the principal goal of achieving an equitable resolution. Aegon has made improvements across its product lines, including after settlements reached in 2009 with Stichting Woekerpolis and Stichting Verliespolis. In 2013 Aegon took a charge of EUR 25 million after the Dutch Supreme Court ruled adversely in litigation concerning premium amounts charged in the KoersPlan product. Some of the unit linked products are still involved in ongoing litigation. In March 2014, consumer interest group Vereniging Woekerpolis.nl filed a claim against Aegon in court. The claim related to a range of unit linked products that Aegon sold in the past, including Aegon products involved in the earlier litigation. In June 2017, the court issued a verdict which upheld the principle that disclosures must be evaluated according to the standards at the time when the relevant products were placed in-force. Most of the claims of Vereniging Woekerpolis.nl were dismissed
Annual Report on Form 20-F 2017 |
347 | Additional information Risk factors | |
under this standard, although the court found that Aegon did not adequately disclose certain charges on a limited set of policies. This court decision has been appealed by both parties. Aegon expects the claims and litigation on unit linked products to continue for the foreseeable future. Developments in similar cases against other Dutch insurers currently before regulators and courts may also affect Aegon. Lawsuits have also been brought against providers of securities leasing products (aandelenlease producten). Although sales of securities leasing products ended more than a decade ago, litigation relating to these products has resurfaced. In 2016, the Dutch Supreme Court ruled on a case involving a securities leasing product sold by one of Aegons competitors. It decided that the financial institution was liable if a broker (remisier) that advised on the sale of the institutions products, was not properly licensed. In July 2016, consumer interest group Platform Aandelenlease filed a class action claim against Aegon Bank regarding securities leasing product Sprintplan. Allegations include, among other things, a lack of a proper license of the brokers involved. There can be no assurances that this matter will not ultimately result in a material adverse effect on Aegons business, results of operations and financial position. In October 2017, the district court of The Hague ruled in favor of Aegon that the Sprintplan liability had been conclusively determined in earlier proceedings and there were no grounds to hold further collective proceedings. The plaintiff appealed. The case is now pending at the court of appeal of The Hague. There can be no assurances that this matter will not ultimately result in a material adverse effect on Aegons business, results of operations and financial position. In Poland, owners of unit-linked policies continue to file claims in civil court against Aegon over fees payable upon purchase or surrender of the product. Plaintiffs claim that these fees are not contractually supported. For reasons of commercial necessity as well as at the instigation of regulatory authorities, Aegon decided to modify the fee structure.
Many of Aegons products are affected by fluctuations in equity markets as well as interest rate movements, which may prove to be volatile or disappointing to customers. Significant investment risks are often borne by the customer.
The existence of potential claims may remain unknown for long periods of time after the events giving rise to such claims. Determining the likelihood of exposure to Aegon and the extent of any such exposure may not be possible for long periods of time after Aegon becomes aware of such potential claims. Once litigation is initiated, it may be protracted and subject to multiple levels of appeal.
Aegon cannot predict the effect of litigation, investigations or other actions on its businesses or the insurance industry. In some jurisdictions, plaintiffs may seek recovery of very large or indeterminate amounts under claims of bad faith, resulting in punitive or treble damages. Damages alleged may not be quantifiable or supportable, or may have no relationship to economic losses or final awards. Separate from financial loss, litigation, regulatory action, legislative changes or changes in public opinion may require Aegon to change its business practices, which could have a material adverse impact on Aegons businesses, results of operations, cash flows and financial position.
Aegons risk management policies and processes may leave the Company exposed to unidentified or unanticipated risk events, adversely affecting its businesses, results and financial condition.
Aegon has devoted significant resources to the implementation and maintenance of a comprehensive enterprise risk management framework in all aspects of the business. Nevertheless, its risk measurements make use of historic and public data that may be inaccurate or may not predict future exposures. Further, operational and legal risks involve high volumes of transactions and are affected by frequent changes in Aegons businesses and their environments, and the risk management framework may not evolve at the same pace. As a result, there is a chance that risks present in its business strategies and initiatives may not be fully identified, monitored and managed.
State statutes and regulators may limit the aggregate amount of dividends payable by Aegons subsidiaries and Aegon N.V., thereby limiting Aegons ability to make payments on debt obligations.
Aegons ability to make payments on debt obligations and pay some operating expenses is dependent upon the receipt of dividends from subsidiaries. Some of these subsidiaries have regulatory restrictions that can limit the payment of dividends. In addition, local regulators, acting to represent the interests of local policyholders, are taking an increasingly restrictive stance with respect to permitting dividend payments, which may affect Aegons ability to satisfy its debt obligations or pay its operating expenses.
Changes in accounting standards may affect Aegons reported results, shareholders equity and dividend.
Since 2005, Aegons financial statements have been prepared and presented in accordance with IFRS. Any future changes in these accounting standards may have a significant impact on Aegons reported results, financial condition and shareholders equity. This includes the level and volatility of reported results and shareholders equity. New accounting standards that are likely to have a significant impact on Aegons reported results, financial condition and shareholders equity include but are not limited to IFRS 9
Annual Report on Form 20-F 2017 |
348 | Additional information Risk factors | |
Financial Instruments and IFRS 17 Insurance Contracts. On July 24, 2014, the IASB issued the fourth and final version of its new standard on financial instruments accounting IFRS 9 Financial Instruments. Application of IFRS 9 is required for annual periods beginning on or after January 1, 2018. IFRS 17 Insurance Contracts was issued on May 18, 2017 with an effective date of January 1, 2021. However, the IASB has also issued an amendment related to IFRS 4 Insurance Contracts. The objective of the amendment is to address the temporary accounting consequences of the different effective dates of IFRS 9 and IFRS 17. The amendment permits entities whose predominant activities are connected with insurance, to defer the application of IFRS 9 until 2021 (the temporary exemption); and permit all issuers of insurance contracts to recognize in other comprehensive income, rather than profit or loss, the volatility that could arise when IFRS 9 is applied before the new insurance contracts Standard is issued (the overlay approach). Aegon has decided to make use of the temporary exemption to defer the application of IFRS 9 until 2021, as it meets the underlying qualifying criteria for doing so. As Aegon is able to defer the application of IFRS 9 until 2021, the full impact of both IFRS 9 and IFRS 17 is not yet clear. Initial impact assessments on both standards resulted in the expectation that it will have a significant impact on reported results, shareholders equity and disclosures.
Further details are provided in the notes to the consolidated financial statements, note 2 Summary of significant accounting policies.
Tax law changes may adversely affect Aegons profitability, as well as the sale and ownership of Aegons products.
Aegon is subject to the substance and interpretation of tax laws in all countries in which Aegon operates or invests. Tax risk is the risk associated with changes in tax laws, or the interpretation of tax laws, later jurisprudence or case law, or the introduction of new taxes or tax laws. This tax risk includes for example the risk of changes in tax rates, changes in loss carry-over rules and new rules restricting the tax deductibility of interest expenses.
Tax risk also includes the risk of consequences arising from failure to comply with procedures required by tax authorities. Failure to manage tax risks may lead to increased tax charges, including financial or operating penalties. This tax risk may have a direct materially adverse effect on Aegons profits, capital and financial condition.
Any changes in tax laws, interpretation of tax laws, later jurisprudence or case law, or the introduction of new taxes or tax laws in all countries in which Aegon operates or invests, which affects Aegons products, may also have a materially adverse effect on Aegons businesses, results of operations, capital and financial condition.
Most insurance products enjoy certain tax advantages, particularly in the United States, the United Kingdom and the Netherlands, which permit the tax deferred accumulation of earnings on the premiums paid by the holders of annuities and life insurance products under certain conditions and within certain limits. Taxes on this inside build-up of earnings may not be payable at all and, if payable, generally are due only when the earnings are actually paid.
The US Congress has, from time to time, considered possible legislation that may make Aegons products less attractive to consumers, including legislation that would reduce or eliminate the deferral of taxation on the accretion of value within certain annuities and life insurance products. This may have an impact on insurance products and sales in the United States.
The US Government, as well as state and local governments, also consider from time to time tax law changes that may increase the amount of taxes that Aegon pays. Effective January 1, 2018 the Tax Cuts and Jobs Act lowered US corporate tax to 21%, reducing the amount of tax that Aegon pays. Also significant changes were made to the computation of tax reserves, capitalized policy acquisition costs and the dividends received deduction available to life insurance companies, increasing the amount of tax that Aegon pays.
Competitive factors may adversely affect Aegons market share.
Competition in Aegons business segments is based on service, product features, price, commission structure, financial strength, claims paying ability, ratings and name recognition. Aegon faces intense competition from a large number of other insurers, as well as non-insurance financial services companies such as banks, broker-dealers and asset managers, for individual customers, employers, other group customers, agents and other distributors of insurance and investment products. Consolidation in the global financial services industry can enhance the competitive position of some of Aegons competitors by broadening the range of their products and services, and increasing their distribution channels and their access to capital. In addition, development of alternative distribution channels for certain types of insurance and securities products, including through the internet, may result in increasing competition as well as pressure on margins for certain types of products. Traditional distribution channels are also challenged by the ban on sales- based commissions in some countries. These competitive pressures may result in increased pricing pressures on a number of products and services, particularly as competitors seek to win market share. This may harm Aegons ability to maintain or increase profitability
Annual Report on Form 20-F 2017 |
349 | Additional information Risk factors | |
Adverse market and economic conditions can be expected to result in changes in the competitive landscape. Financial distress experienced by financial services industry participants as a result of weak economic conditions and newly imposed regulation may lead to acquisition opportunities. Aegons ability or that of Aegons competitors to pursue such opportunities may be limited due to lower earnings, reserve increases, capital requirements or a lack of access to debt capital markets and other sources of financing. Such conditions may also lead to changes by Aegon or Aegons competitors in product offerings and product pricing that may affect Aegon and Aegons relative sales volumes, market shares and profitability. Additionally, the competitive landscape in which Aegon operates may be affected by government-sponsored programs or actions taken in response to, for instance, dislocations in financial markets.
Aegon may be unable to adapt to and apply new technologies
New technologies are transforming the insurance industry. New technologies include, but are not limited to, communication channels, robotization, artificial intelligence, data analytics and blockchain. These technologies are changing the way insurance is sold. They are also changing the way insurers manage their businesses and the skills they need in their workforces. Furthermore, the new technologies are influencing customer demands. They want speed, ease of use and accessibility. Technology makes it easier to move into new markets. This increases competition, not just among peers, but also from new competitors and disruptors. Inability to quickly enough adapt and apply these new technologies may impact Aegons competitive position, its ability to maintain profitability and adversely affect Aegons future financial condition and results of operations.
Aegon may experience difficulties in distributing and marketing products through its current and future distribution channels.
Although Aegon distributes its products through a wide variety of distribution channels, Aegons ability to market its products could be affected if key relationships would be interrupted. Distributors may elect to reduce or terminate their distribution relationship with Aegon due to adverse developments in its business. Further, key distribution partners may also merge, change their business models in ways that affect how Aegons products are sold, or new distribution channels could emerge and adversely impact the effectiveness of its current distribution efforts.
When Aegons products are distributed through unaffiliated firms, Aegon may not always be able to monitor or control the manner of their distribution despite its significant training and compliance programs. If Aegons products would be distributed by such firms in an inappropriate manner, or to customers for whom they are unsuitable, Aegon may suffer reputational and other harm to its business.
The default of a major market participant may disrupt the markets and may affect Aegons business, financial condition, liquidity, operations and prospects.
The failure of a sufficiently large and influential financial institution, or other market participant including a government issuer, may disrupt securities markets or clearing and settlement systems in Aegons markets. This may cause market declines or volatility. Such a failure may lead to a chain of defaults that may adversely affect Aegon and Aegons contract counterparties. In addition, such a failure may impact future product sales as a potential result of reduced confidence in the insurance industry. The default of one or more large international financial institutions, which may result in disruption or termination of their cash, custodial or and administrative services, may also have a material adverse impact on Aegons ability to run effective treasury and asset management operations.
Even the perceived lack of creditworthiness of a government or financial institution (or a default by any such entity) may lead to market- wide liquidity problems and losses or defaults by Aegon or by other institutions. This risk is sometimes referred to as systemic risk and may adversely affect financial intermediaries, such as clearing members or futures commissions merchants, clearing houses, banks, securities firms and exchanges with whom Aegon interacts on a daily basis and financial instruments of governments which Aegon holds. Systemic risk could have a material adverse effect on Aegons ability to raise new funding and on its business, financial condition, results of operations, liquidity and/or prospects. In addition, such distress or failure could impact future product sales as a potential result of reduced confidence in the financial services industry.
Aegon may be unable to retain personnel who are key to the business.
As a global financial services enterprise, Aegon relies, to a considerable extent, on the quality of local management and personnel in the various countries in which Aegon operates. The success of Aegons operations is dependent, among other things, on Aegons ability to attract and retain highly qualified professional personnel. Competition for key personnel in most countries in which Aegon operates is intense. Aegons ability to attract and retain key personnel, in particular senior officers, experienced
Annual Report on Form 20-F 2017 |
350 | Additional information Risk factors | |
portfolio managers, mutual fund managers and sales executives, is very much dependent on the competitiveness of the compensation package for employees in the market in which it competes. As a part of the governmental response in Europe and, to a certain extent, the United States to the financial crisis in 2008, there have been various legislative initiatives that have sought to give guidance or regulate the structure of remuneration for personnel, in particular senior management, with a focus on performance- related remuneration and limiting severance payments. With differences in interpretation of these regulations by local regulators on how the guidelines need to be applied, as well as to the question of whether they apply to insurance industries at all, these restrictions create an uncertain playing field and may adversely affect Aegons ability to compete for qualified employees, as well as Aegons ability to transfer employees between regions.
Reinsurers to whom Aegon has ceded risk may fail to meet their obligations.
Aegons insurance subsidiaries cede premiums to other insurers under various agreements that cover individual risks, group risks or defined blocks of business, on a co-insurance, yearly renewable term, excess or catastrophe excess basis. The purpose of these reinsurance agreements is to spread the risk and minimize the effect of losses. The amount of each risk retained depends on an evaluation of the specific risk, which is subject, in certain circumstances, to maximum limits based on the characteristics of coverage. Under the terms of the reinsurance agreements, the reinsurer agrees to reimburse for the ceded amount in the event a covered claim is paid. However, Aegons insurance subsidiaries remain liable to their policyholders for ceded insurance if any reinsurer fails to meet the obligations assumed by it. A bankruptcy or insolvency or inability of any of Aegons reinsurance counterparties to satisfy its obligations may have a materially adverse effect on Aegons financial position and results of operations. Refer to Schedule IV for a table showing life insurance in force amounts and premiums on a direct, assumed and ceded basis.
Reinsurance may not be available, affordable or adequate to protect Aegon against losses.
As part of Aegons overall risk and capital management strategy, Aegon purchases reinsurance for certain risks underwritten by Aegons various business segments. Market conditions beyond Aegons control determine the availability and cost of the reinsurance protection Aegon purchases. In addition, interpretations of terms and conditions may differ over time as contracts extend for decades. Accordingly, Aegon may be forced to incur additional expenses for reinsurance or may not be able to obtain or enforce sufficient reinsurance on acceptable terms, which may adversely affect Aegons ability to write future business and realize planned value for current business.
Aegon may have difficulty managing its expanding operations, and Aegon may not be successful in acquiring new businesses or divesting existing operations.
In recent years, Aegon has made a number of acquisitions and divestitures around the world and it is possible that Aegon may make further acquisitions and divestitures in the future. Growth by acquisition involves risks that may adversely affect Aegons operating results and financial condition. These include: the potential diversion of financial and management resources from existing operations; difficulties in assimilating the operations, technologies, products and personnel of the acquired company; significant delays in completing the integration of acquired companies; the potential loss of key employees or customers of the acquired company; potential losses from unanticipated litigation, and tax and accounting issues. In addition, expansion into new and emerging markets may involve heightened political, legal and regulatory risks, such as discriminatory regulation, nationalization or expropriation of assets, price controls and exchange controls.
Aegons acquisitions may result in additional indebtedness, costs, contingent liabilities and impairment expenses related to goodwill and other intangible assets. In addition, they may divert managements attention and other resources. Divestitures of existing operations may result in Aegon assuming or retaining certain contingent liabilities. All of these may adversely affect Aegons businesses, results of operations and financial condition. Future acquisitions may also have a dilutive effect on the ownership and voting percentages of existing shareholders. There can be no assurance that Aegon will successfully identify suitable acquisition candidates or that Aegon will properly value acquisitions made. Aegon is unable to predict whether or when any prospective acquisition candidate will become available, or the likelihood that any acquisition will be completed once negotiations have commenced.
Catastrophic events, which are unpredictable by nature, may result in material losses and abruptly and significantly interrupt Aegons business activities.
Aegons operating results and financial position may be adversely affected by volatile natural and man-made disasters such as hurricanes, windstorms, earthquakes, terrorism, riots, fires and explosions, pandemic disease and other catastrophes. Over the past several years, changing weather patterns and climatic conditions have added to the unpredictability and frequency of natural disasters
Annual Report on Form 20-F 2017 |
351 | Additional information Risk factors | |
in certain parts of the world and created additional uncertainty as to future trends and exposure. Generally, Aegon seeks to reduce its exposure to these events through individual risk selection, monitoring risk accumulation, and purchasing reinsurance. However, such events may lead to considerable financial losses to Aegons businesses. Furthermore, natural disasters, terrorism, civil unrest, military actions and fires may disrupt Aegons operations and result in significant loss of property, key personnel and information about Aegon and its clients. If its business continuity plans have not included effective contingencies for such events, Aegon may experience business disruption and damage to corporate reputation and financial condition for a substantial period of time.
Aegon regularly develops new financial products to remain competitive in its markets and to meet the expectations of its customers. If customers do not achieve expected returns on those products, Aegon may be confronted with legal claims, advocate groups and negative publicity.
Aegon may face claims from customers, both individual claimants as well as policyholder advocate groups, and negative publicity if Aegons products result in losses or fail to result in expected gains, regardless of the suitability of products for customers or the adequacy of the disclosure provided to customers by Aegon and by the intermediaries who distribute Aegons products. New products that are less well understood and that have less of a historical performance track record may be more likely to be the subject of such claims. Any such claims may have a materially adverse effect on Aegons results of operations, corporate reputation and financial condition.
Aegon may not be able to protect its intellectual property and may be subject to infringement claims.
Aegon relies on a combination of contractual rights with third parties and copyright, trademark, patent and trade secret laws to establish and protect Aegons intellectual property. Third parties may infringe on or misappropriate Aegons intellectual property, and it is possible that third parties may claim that Aegon has infringed on or misappropriated their intellectual property rights. Any resulting proceedings in which Aegon would have to enforce and protect its intellectual property, or defend itself against a claim of infringement of a third-partys intellectual property, may require significant effort and resources and may not prove successful. As a result of any proceeding in which Aegon would have to enforce and protect its intellectual property, Aegon may lose intellectual property protection, which may have a materially adverse effect on Aegons businesses, results of operation, financial condition and Aegons ability to compete. As a result of any proceeding in which Aegon would have to defend itself against a claim of infringement of a third-partys intellectual property, Aegon may be required to pay damages and provide injunctive relief, which may have a materially adverse effect on Aegons businesses, results of operations and financial condition.
Inadequate or failed processes or systems, human factors or external events may adversely affect Aegons profitability, reputation or operational effectiveness.
Operational risk is inherent in Aegons businesses and may manifest itself in many ways, including business interruption, poor vendor performance, information systems malfunctions or failures, regulatory breaches, processing errors, modelling errors, and/or internal and external fraud. These events may result in financial loss, harm Aegons reputation, or hinder Aegons operational effectiveness. Further, employee error, unethical behavior and/or misconduct may be difficult to detect and prevent under all circumstances and may result in significant losses.
Aegons management maintains a well-controlled environment and sound (conduct) policies and practices to control these risks and keep operational risk at appropriate levels. Notwithstanding these control measures, however, operational risk is part of the business environment in which Aegon operates, and is inherent in Aegons size and complexity, as well as Aegons geographic diversity, and the scope of the businesses Aegon operates. Aegons risk management activities cannot anticipate every circumstance, and economic and financial outcome, or the specifics and timing of such outcomes. Furthermore, if the contractual arrangements put in place with any third-party service providers are terminated, including contractual arrangements with providers of information technology, administrative or investment management services, Aegon may not be able to find an alternative provider on a timely basis or on equivalent terms. Aegon may incur significant losses due to these types of risks.
As Aegon continues to focus on reducing expenses necessary to support its business, a key part of its operating strategy has been to outsource certain services that are important to its business. Aegon outsources certain information technology, finance and actuarial services, investment management services and policy administration operations to third-party providers and may do so increasingly in the future. If Aegon fails to maintain an effective outsourcing strategy or if third-party providers do not provide the core administrative, operational, financial, and actuarial services Aegon requires and anticipates, or perform as contracted, such as compliance with applicable laws and regulations, suffers a cyber-attack or other security breach, Aegon may not realize the productivity improvements or cost efficiencies, nor find an alternate provider on the same terms and conditions, and instead experience
Annual Report on Form 20-F 2017 |
352 | Additional information Risk factors | |
financial loss, reputational harm, operational difficulties, increased costs, a loss of business and other negative consequences, all of which could have a material adverse effect on Aegons results of operations. In addition, Aegons reliance on third-party providers does not relieve Aegon of its responsibilities and requirements. Any failure or negligence by such third-party providers in carrying out their contractual duties may result in Aegon being subjected to liability and litigation. Any litigation relating to such matters could be costly, expensive and time-consuming, and the outcome of which is uncertain. Moreover, any adverse publicity arising from such litigation, even if the litigation is not successful, could adversely affect Aegons reputation and distribution of its products. Finally, Aegons ability to receive services from third-party providers based in different countries might be impacted by political instability, cultural differences, unanticipated regulatory requirements or policies inside or outside of the countries within which Aegon has operations. As a result, Aegons ability to conduct its business might be adversely affected.
In January 2018, in connection with the transformation of Aegons US business and its long term strategy, Aegon entered into a multi-year third party administration arrangement for the administration of certain US based in-force policies currently administered on up to 25 systems and for new US based insurance business. As part of this arrangement Aegon will modernize the systems upon which it administers its insurance business whereby at least 20 of the systems will be consolidated into a new policy administration system hosted by the third party administrator. Aegon may further reduce the remaining in-scope systems in the future. If Aegon does not effectively develop, implement and monitor its outsourcing relationships, or if third-party providers do not perform as anticipated or if Aegon experiences technological or other problems with transition from Aegon or its other third party providers, Aegon may not realize productivity improvements or cost efficiencies and may experience operational difficulties, increased costs and a loss of business that may have an adverse effect upon on Aegons operations or financial condition.
Aegons operations support complex transactions and are highly dependent on the proper functioning of information technology and communication systems. Any failure of Aegons information technology or communications systems may result in a material adverse effect on Aegons results of operations and corporate reputation.
While systems and processes are intended to support complex transactions and avoid systems failure, fraud, information security failures, processing errors and breaches of regulation, any failure may lead to a materially adverse effect on Aegons results of operations and corporate reputation. In addition, Aegon must commit significant resources to maintain and enhance its existing systems in order to keep pace with industry standards and customer preferences. If Aegon fails to keep up-to-date information systems, Aegon may not be able to rely on information for product pricing, risk management and underwriting decisions. In addition, even though back-up and recovery systems and contingency plans are in place, Aegon cannot assure investors that interruptions, failures or breaches in security of these processes and systems will not occur, or if they do occur, that they can be adequately addressed. The occurrence of any of these events may have a materially adverse effect on Aegons businesses, results of operations and financial condition.
A computer system failure or security breach may disrupt Aegons business, damage Aegons reputation and adversely affect Aegons results of operations, financial condition and cash flows.
Changes towards more sophisticated internet technologies, the introduction of new products and services, changing customer needs and evolving applicable standards increase the dependency on internet, secure systems and related technology. Introducing new technologies, computer system failures, cyber-crime attacks or security breaches may disrupt Aegons business, damage Aegons reputation and adversely affect Aegons results of operations, financial condition and cash flows.
Cyber risk is predominantly determined by the risk of malicious outside forces using public networks to attack the Companys systems, but also includes inside threats, both malicious and accidental. In recent years this risk has increased sharply due to a number of developments in how information systems are used by companies such as Aegon, but also by society in general. Threats have increased as hackers get more organised and employ more sophisticated techniques. At the same time companies increasingly unlock information systems through the internet to customers and business partners expanding the attack surface hackers can exploit. Furthermore, the nature of Aegons business increasingly becomes more data driven.
To date the highest impact of cyber security incidents Aegon was exposed to were caused by phishing attacks targeted at business partners and customers. Although these historic events were far from material, Aegon has prepared for more significant cyberattacks would they occur. Aegon has taken cyber insurance to decrease the impact of such an event and at the same time continues to focus on strengthening cyber resilience to mitigate the likelihood and impact of significant events.
Annual Report on Form 20-F 2017 |
353 | Additional information Risk factors | |
A breach of data privacy and security obligations may disrupt Aegons business, damage Aegons reputation and adversely affect financial conditions and results of operations.
Pursuant to applicable laws, various government agencies and independent administrative bodies have established rules protecting the privacy and security of personal information. A number of Aegons subsidiaries are also subject to contractual restrictions with respect to the information of our clients and business partners. Aegon, and numerous of its systems, employees and business partners have access to, and routinely process, the personal information of consumers. Aegon relies on various processes and controls to protect the confidentiality of personal information and other confidential information that is accessible to, or in the possession of, Aegon, its systems, employees and business partners. It is possible that an Aegon employee, business partner or system could, intentionally or unintentionally, inappropriately disclose or misuse personal or confidential information. Aegons data or data in its possession could also be the subject of a cybersecurity attack. If Aegon fails to maintain adequate processes and controls or if Aegon or its business partners fail to comply with relevant laws and regulations, policies and procedures, misappropriation or intentional or unintentional inappropriate disclosure or misuse of personal information or other confidential information could occur. Such control inadequacies or non-compliance could cause disrupted operations and misstated or unreliable financial data, materially damage Aegons reputation or lead to civil or criminal penalties, which, in turn, could have a material adverse effect on Aegons business, financial condition and results of operations. In addition, Aegon analyzes personal information and customer data to better manage its business, subject to applicable laws and regulations and other restrictions. It is possible that additional regulatory or other restrictions regarding the use of such techniques may be imposed. Additional privacy and security obligations are likely to be imposed. Such limitations could have material impacts or Aegons business, financial conditions and/or results of operations.
Judgments of US courts are not enforceable against Aegon in Dutch courts.
There is no treaty between the United States and the Netherlands providing for the reciprocal recognition and enforcement of judgments (other than arbitration awards) in civil and commercial matters. Judgments of US courts, including those predicated on the civil liability provisions of the US federal securities laws, may not be enforceable in Dutch courts. Therefore, Aegons investors that obtain a judgment against Aegon in the United States may not be able to require Aegon to pay the amount of the judgment unless a competent court in the Netherlands gives binding effect to the judgment. It may, however, be possible for a US investor to bring an original action in a Dutch court to enforce liabilities against Aegon, Aegons affiliates, directors, officers or any expert named therein who resides outside the United States, based upon the US federal securities laws.
Risks relating to Aegons common shares
Aegons share price could be volatile and could drop unexpectedly, and investors may not be able to resell Aegons common shares at or above the price paid.
The price at which Aegons common shares trade is influenced by many factors, some of which are specific to Aegon and
Aegons operations, and some of which are related to the insurance industry and equity markets in general. As a result of these factors, investors may not be able to resell their common shares at or above the price paid for them. In particular, the following factors, in addition to other risk factors described in this section, may have a material impact on the market price of Aegons common shares:
◆ | Investor perception of Aegon as a company; |
◆ | Actual or anticipated fluctuations in Aegons revenues or operating results; |
◆ | Announcements of intended acquisitions, disposals or financings, or speculation about such acquisitions, disposals or financings; |
◆ | Changes in Aegons dividend policy, which may result from changes in Aegons cash flow and capital position; |
◆ | Sales of blocks of Aegons shares by significant shareholders, including Vereniging Aegon; |
◆ | A downgrade or rumored downgrade of Aegons credit or financial strength ratings, including placement on credit watch; |
◆ | Potential litigation involving Aegon or the insurance industry in general; |
◆ | Changes in financial estimates and recommendations by securities research analysts; |
◆ | Fluctuations in capital markets, including foreign exchange rates, interest rates and equity markets; |
◆ | The performance of other companies in the insurance sector; |
◆ | Regulatory developments in the United States, the Netherlands, the United Kingdom, and other countries in which Aegon operates; |
◆ | International political and economic conditions, including the effects of terrorist attacks, military operations and other developments stemming from such events, and the uncertainty related to these developments; |
◆ | News or analyst reports related to markets or industries in which Aegon operates; and |
◆ | General insurance market conditions. |
Annual Report on Form 20-F 2017 |
354 | Additional information Risk factors | |
Aegon and its significant shareholders may offer additional common shares in the future, and these and other sales may adversely affect the market price of the outstanding common shares.
Aegon may decide to offer additional common shares in the future, for example, to strengthen Aegons capital position in response to regulatory changes or to support an acquisition.
In 2016, Vereniging Aegon entered into a three year term and revolving facilities agreement with a consortium of banks. Under this agreement, Aegons common shares in the possession of Vereniging Aegon are pledged to the consortium of banks. If Vereniging Aegon were to default under the facilities agreement in force at that time, the lenders may dispose of Aegons common shares held by them as collateral in order to satisfy amounts outstanding.
An additional offering of common shares by Aegon, the restructuring of Aegons share capital, the sales of common shares by significant shareholders or by lenders to Vereniging Aegon, or the public perception that an offering or such sales may occur, may have an adverse effect on the market price of Aegons common shares.
As of December 31, 2017, there were 2,095,648,244 common shares and 585,022,160 common shares B issued. Of these, Vereniging Aegon held 279,236,609 common shares and 569,676,480 common shares B. All of Aegons outstanding common shares are freely tradable, and all shareholders, including large shareholders such as Vereniging Aegon, are free to resell their common shares at any time.
Vereniging Aegon, Aegons major shareholder, holds a large percentage of the voting shares and therefore has significant influence over Aegons corporate actions.
Prior to September 2002, Vereniging Aegon beneficially owned approximately 52% of the voting shares and thus held voting control over Aegon. In September 2002, Vereniging Aegon reduced its beneficial ownership to approximately 33% of the voting shares (excluding issued common shares held in treasury by Aegon). In 2003, Aegon and Vereniging Aegon amended the 1983 Merger Agreement, resulting in a right for Vereniging Aegon, upon issuance of shares by Aegon, to purchase as many class B preferred shares existing at that time as would enable it to prevent or offset a dilution to below its actual voting power percentage of 33%. In 2013, Aegon N.V. and Vereniging Aegon entered into an agreement to simplify the capital structure of Aegon and to cancel all of Aegons preferred shares, of which Vereniging Aegon was the sole owner. The execution of this agreement was approved by the General Meeting of Shareholders of Aegon N.V. on May 15, 2013. For details on the simplification of the corporate structure, please see the section Major shareholders on pages 321-323.
The simplified capital structure included an amendment to the 1983 Amended Merger Agreement between Aegon N.V. and Vereniging Aegon. Following this 2013 amendment, Vereniging Aegons call option relates to common shares B. Vereniging Aegon may exercise its call option to keep or restore its total stake at 32.6%, irrespective of the circumstances which cause the total shareholding to be or become lower than 32.6%.
The simplification of the capital structure also entailed the amendment of the Voting Rights Agreement between Aegon N.V. and Vereniging Aegon. As a matter of Dutch corporate law, the shares of both classes offer equal full voting rights, as they have equal nominal values (EUR 0.12). The financial rights attached to a common share B are 1/40th of the financial rights attached to a common share. The amended Voting Rights Agreement ensures that under normal circumstances, i.e. except in the event of a Special Cause, Vereniging Aegon will no longer be able to exercise more votes than is proportionate to the financial rights represented by its shares. This means that in the absence of a Special Cause Vereniging Aegon may cast one vote for every common share it holds and one vote only for every 40 common shares B. A Special Cause includes the acquisition of a 15% interest in Aegon N.V., a tender offer for Aegon N.V. shares or a proposed business combination by any person or group or persons, whether individually or as a group, other than in a transaction approved by the Executive Board and the Supervisory Board. Accordingly, at December 31, 2017, the voting power of Vereniging Aegon under normal circumstances amounted to approximately 14.34%, based on the number of outstanding and voting shares (excluding issued common shares held in treasury by Aegon N.V.). In the event of a Special Cause, Vereniging Aegons voting rights will increase to 32.6% for up to six months.
Consequently, Vereniging Aegon may have substantial influence on the outcome of corporate actions requiring shareholder approval, including:
◆ | Adopting amendments to the Articles of Association; |
◆ | Adopting the Annual Accounts; |
◆ | Approving a consolidation or liquidation; |
◆ | Approving a tender offer, merger, sale of all or substantially all of the assets, or other business combination; and |
Annual Report on Form 20-F 2017 |
355 | Additional information Risk factors | |
◆ | In particular, during the periods when Vereniging Aegon is entitled to exercise its increased voting rights, it will generally have sufficient voting power to veto certain decisions presented to the General Meeting of Shareholders, including any proposal relating to the following matters: |
◆ | Rejecting binding Supervisory Board nominations for membership to the Supervisory Board and Executive Board; |
◆ | Appointing an Executive Board or Supervisory Board member other than pursuant to Supervisory Board nomination; and |
◆ | Suspending or removing an Executive Board or Supervisory Board member other than pursuant to a Supervisory Board proposal. |
Currency fluctuations may adversely affect the trading prices of Aegons common shares and the value of any cash distributions made.
Since Aegons common shares listed on Euronext Amsterdam are quoted in euros and Aegons common shares listed on NYSE New York are quoted in US dollars, fluctuations in exchange rates between the euro and the US dollar may affect the value of Aegons common shares. In addition, Aegon declares cash dividends in euros, but pays cash dividends, if any, on Aegons shares of New York registry in US dollars based on an exchange rate set the business day following the shareholder meeting approving the dividend. As a result, fluctuations in exchange rates may affect the US dollar value of any cash dividends paid.
Convertible securities (or other securities that permit or require Aegon to satisfy its obligations by issuing common shares) that Aegon may issue could influence the market price for Aegons common shares.
In the future, Aegon may issue convertible securities or other securities that permit or require Aegon to satisfy obligations by issuing common shares. Those securities would likely influence, and be influenced by, the market for Aegons common shares.
For example, the price of Aegons common shares may become more volatile and may be depressed by investors anticipation of the potential resale in the market of substantial amounts of Aegons common shares received at maturity. Aegons common shares may also be depressed by the acceleration of any convertible securities (or other such securities) that Aegon has issued by investors who view such convertible securities (or other such securities) as a more attractive means of participation in Aegons equity. Negative results may also be produced by hedging or arbitrage trading activity that may develop involving such convertible securities (or other such securities) and Aegons common shares. Any such developments may negatively affect the value of Aegons common shares.
Annual Report on Form 20-F 2017 |
356 | Additional information Property, plant and equipment | |
In the United States, Aegon owns many of the buildings that the Company uses in the normal course of its business, primarily as offices. Aegon owns 16 offices located throughout the United States with a total square footage of 2 million. Aegon also leases space for various offices located throughout the United States under long-term leases with a total square footage of 1 million. Aegons principal offices are located in Little Rock, AR; Denver, CO; Cedar Rapids, IA; St. Petersburg, FL; Atlanta, GA; Louisville, KY; Baltimore, MD; Harrison, NY; Exton, PA; and Plano, TX.
Other principal offices owned by Aegon are located in The Hague, the Netherlands and Budapest, Hungary. Aegon owns its headquarters and leases other offices in the Netherlands (Hoofddorp, Leeuwarden and Groningen), in the United Kingdom and in Spain under long-term leases. Aegon believes that its properties are adequate to meet its current needs.
At the end of 2017, Aegon had 28,318 employees. Approximately 39% are employed in the Americas, 35% in Europe, 21% in Asia and 5% in Asset Management. Note that employees of the Holding are included in Europe.
All of Aegons employees in the Netherlands, other than senior management, are covered by the collective labor agreement of Aegon NL. Aegon, the unions and the Dutch Central Works Council are working closely together in the co-creation steering group to come to new agreements. The current collective agreement has a duration of three years. Aegon has experienced no significant strike, work stoppage or labor dispute in recent years.
Under Dutch law, members of the Central Works Council responsible for Aegon in the Netherlands are elected by Aegon the Netherlands employees. The Central Works Council has certain defined powers at the level of the Dutch subsidiary company Aegon Nederland N.V., including the right to make non-binding recommendations for appointments to its Supervisory Board and the right to enter objections against proposals for appointments to that Supervisory Board.
A break-down of the number of employees is provided below:
2017 | 2016 | 2015 | ||||||||||
Americas |
10,951 | 11,943 | 12,701 | |||||||||
The Netherlands |
3,460 | 4,794 | 4,802 | |||||||||
United Kingdom |
3,435 | 2,673 | 2,478 | |||||||||
Central & Eastern Europe |
2,337 | 2,317 | 2,470 | |||||||||
Spain & Portugal |
610 | 600 | 534 | |||||||||
Asia |
6,025 | 5,579 | 7,163 | |||||||||
Asset Management |
1,500 | 1,474 | 1,382 | |||||||||
28,318 | 29,380 | 31,530 | ||||||||||
Of which Aegons share of employees in joint ventures and associates |
6,497 | 5,944 | 7,499 |
See note 14 Commissions and expenses of the Notes to the consolidated financial statements of this Annual Report for a description of employee expenses.
Annual Report on Form 20-F 2017 |
357 | Additional information Dividend policy | |
Under Dutch law and Aegons Articles of Association, holders of Aegons common shares are entitled to dividends paid out of the profits remaining, if any, after the creation of a reserve account. Aegons Executive Board may determine the dividend payment date and the dividend record date for the common shares, which may vary for the various kinds of registered shares. Aegons Executive Board, with the approval of Aegons Supervisory Board, may also determine the currency or currencies in which the dividends will be paid. Aegon may make one or more interim distributions to the holders of common shares.
Aegon aims to pay out a sustainable dividend to allow equity investors to share in Aegons performance, which can grow over time if Aegons performance so allows. After investment in new business to generate organic growth, capital generation in Aegons operating subsidiaries is available for distribution to the holding company, while maintaining a capital and liquidity position in the operating subsidiaries in line with Aegons capital management and liquidity risk policies.
Aegon uses cash flows from its operating subsidiaries to pay holding expenses, including funding costs. The remaining cash flow is available to execute Aegons strategy and to fund dividends on its shares, subject to maintaining holding company targeted capital. Depending on circumstances, future prospects and other considerations, Aegons Executive Board may elect to deviate from this target. Aegons Executive Board will also take capital position, financial flexibility, leverage ratios and strategic considerations into account when declaring or proposing dividends on common shares.
Under normal circumstances, Aegon would expect to declare an interim dividend when announcing Aegons first half year results and to propose a final dividend at the Annual General Meeting of Shareholders for approval. Dividends would normally be paid in cash or stock at the election of the shareholder. The relative value of cash and stock dividends may vary. Stock dividends paid may, subject to capital management and other considerations, be repurchased in order to limit dilution.
When determining whether to declare or propose a dividend, Aegons Executive Board has to balance prudence versus offering an attractive return to shareholders, for example in adverse economic and/or financial market conditions. Also, Aegons operating subsidiaries are subject to local insurance regulations which could restrict dividends to be paid to the Company. There is no requirement or assurance that Aegon will declare and pay any dividends.
Holders of common shares historically have been permitted to elect to receive dividends, if any, in cash or in common shares. For dividends, which holders may elect to receive in either cash or common shares, the value of the stock alternative may differ slightly from the value of the cash option. Aegon pays cash dividends on shares of New York registry in US dollars through Citibank, N.A., Aegons NYSE paying agent, based on the foreign exchange reference rate (WM/Reuters closing spot exchange rate fixed at 5.00 pm Central European Summer Time (CEST)) on the US-ex dividend day.
Annual Report on Form 20-F 2017 |
358 | Additional information The offer and listing | |
The principal market for Aegons common shares is Euronext Amsterdam. Aegons common shares are also listed on NYSE New York.
The table below sets forth, for the calendar periods indicated, the high and low sales prices of Aegons common shares on Euronext Amsterdam and NYSE New York as reported by Bloomberg and is based on closing prices.
Euronext Amsterdam (EUR) | NYSE New York (USD) | |||||||||||||||
High | Low | High | Low | |||||||||||||
2013 |
6.86 | 4.23 | 9.48 | 5.76 | ||||||||||||
2014 |
6.96 | 5.75 | 9.46 | 7.27 | ||||||||||||
2015 |
7.70 | 4.87 | 8.35 | 5.41 | ||||||||||||
2016 |
5.65 | 3.01 | 6.09 | 3.37 | ||||||||||||
2017 |
5.49 | 4.26 | 6.35 | 4.73 | ||||||||||||
2015 |
||||||||||||||||
First quarter |
7.70 | 5.87 | 8.35 | 6.97 | ||||||||||||
Second quarter |
7.65 | 6.37 | 8.22 | 7.24 | ||||||||||||
Third quarter |
7.22 | 4.87 | 7.93 | 5.51 | ||||||||||||
Fourth quarter |
5.94 | 4.93 | 6.38 | 5.41 | ||||||||||||
2016 |
||||||||||||||||
First quarter |
5.65 | 4.04 | 6.00 | 4.59 | ||||||||||||
Second quarter |
5.41 | 3.47 | 6.09 | 3.91 | ||||||||||||
Third quarter |
3.98 | 3.00 | 4.37 | 3.37 | ||||||||||||
Fourth quarter |
5.32 | 3.38 | 5.72 | 3.84 | ||||||||||||
2017 |
||||||||||||||||
First quarter |
5.49 | 4.65 | 5.84 | 5.10 | ||||||||||||
Second quarter |
5.04 | 4.26 | 5.40 | 4.73 | ||||||||||||
Third quarter |
5.38 | 4.50 | 6.06 | 5.20 | ||||||||||||
Fourth quarter |
5.42 | 4.72 | 6.35 | 5.50 | ||||||||||||
Sep-17 |
5.03 | 4.63 | 5.94 | 5.50 | ||||||||||||
Oct-17 |
5.18 | 4.72 | 6.02 | 5.50 | ||||||||||||
Nov-17 |
5.42 | 5.03 | 6.24 | 5.83 | ||||||||||||
Dec-17 |
5.41 | 5.13 | 6.35 | 6.08 | ||||||||||||
2018 |
||||||||||||||||
January 2018 |
5.76 | 5.26 | 7.02 | 6.32 | ||||||||||||
February 2018 |
5.77 | 5.19 | 7.02 | 6.30 | ||||||||||||
March 2018 (through March 7, 2018) |
5.71 | 5.36 | 6.91 | 6.62 |
On Euronext Amsterdam only Euronext registered shares may be traded, and on NYSE New York only New York Registry Shares may be traded.
Annual Report on Form 20-F 2017 |
359 | Additional information Memorandum and Articles of Association | |
Memorandum and Articles of Association
Aegon is registered under number 27076669 in the Commercial Register of the Chamber of Commerce and Industries for Haaglanden, The Hague, the Netherlands.
Certain provisions of Aegons current Articles of Association are discussed below.
Objects and purposes
◆ | The objects of Aegon are to incorporate, acquire and alienate shares and interests in, to finance and grant security for commitments of, to enter into general business relationships with, and to manage and grant services to legal entities and other entities, in particular those involved in the insurance business, and to do all that is connected therewith or which may be conducive thereto, all to be interpreted in the broadest sense; and |
◆ | In achieving the aforesaid objects due regard shall be taken, within the scope of sound business operations, to provide fair safeguards for the interests of all the parties directly or indirectly involved in Aegon. |
Provisions related to directors
For information with respect to provisions in the Articles of Association relating to members of the Supervisory Board and Executive Board, refer to the Governance section (see pages 131 - 135).
Description of Aegons capital stock
Aegon has two types of shares: common shares (par value EUR 0.12) and common shares B (par value EUR 0.12).
Common characteristics of the common shares and common shares B
◆ | All shares are in registered form; |
◆ | All shares have dividend rights except for those shares (if any) held by Aegon as treasury stock. Dividends which have not been claimed within five years lapse to Aegon; |
◆ | Each currently outstanding share is entitled to one vote except for shares held by Aegon as treasury stock. There are no upward restrictions; |
◆ | However, under normal circumstances, i.e. except in the event of a Special Cause, based on the Voting Rights Agreement 1 , Vereniging Aegon will no longer be able to exercise more votes than is proportionate to the financial rights represented by its shares. This means that in the absence of a Special Cause, Vereniging Aegon may cast one vote for every common share it holds and one vote only for every 40 common shares B it holds. As Special Cause qualifies the acquisition of a 15% interest in Aegon N.V., a tender offer for Aegon N.V. shares or a proposed business combination by any person or group of persons, whether individually or as a group, other than in a transaction approved by the Executive Board and the Supervisory Board. If, in its sole discretion, Vereniging Aegon determines that a Special Cause has occurred, Vereniging Aegon will notify the General Meeting of Shareholders and retain its right to exercise the full voting power of one vote per common share B for a limited period of six months; |
◆ | All shares have the right to participate in Aegons net profits. Net profits is the amount of profits after contributions, if any, to a reserve account; |
◆ | In the event of liquidation, all shares have the right to participate in any remaining balance after settlement of all debts; |
◆ | The General Meeting of Shareholders may, at the proposal of the Executive Board, as approved by the Supervisory Board, resolve to reduce the outstanding capital either by (i) repurchasing shares and subsequently canceling them, or (ii) by reducing their nominal share value; |
◆ | There are no sinking fund provisions; |
◆ | All issued shares are fully paid-up; so there is no liability for further capital calls; and |
◆ | There are no provisions discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares. |
Differences between common shares and common shares B
◆ | The common shares are listed; the common shares B are not listed; |
◆ | The financial rights attaching to a common share B are one-fortieth (1/40th) of the financial rights attaching to a common share; and |
◆ | A repayment on common shares B needs approval of the holders of common shares B. |
1 | The Voting Rights Agreement is published on Aegons corporate website. |
Annual Report on Form 20-F 2017 |
360 | Additional information Memorandum and Articles of Association | |
Actions necessary to change the rights of shareholders
A change to the rights of shareholders would require an amendment to the Articles of Association. The General Meeting of Shareholders (Annual General Meeting or extraordinary General Meeting) may only pass a resolution to amend the Articles of Association pursuant to a proposal of the Executive Board with the approval of the Supervisory Board. The resolution requires a majority of the votes cast at the meeting in order to pass. The actual changes to the text of the Articles of Association will be executed by a civil law notary.
Furthermore, a resolution of the General Meeting of Shareholders to amend the Articles of Association which has the effect of reducing the rights attributable to holders of a specific class shall be subject to the approval of the meeting of holders of such class.
Conditions under which meetings are held
Annual General Meetings and extraordinary General Meetings of Shareholders shall be convened by public notice. Notice must be given no later than 42 days prior to the date of the meeting. The notice must contain a summary agenda and indicate the place where the complete agenda together with the documents pertaining to the agenda may be obtained. The agenda is also sent to shareholders registered with the Company Register. New York Registry shareholders or their brokers receive a proxy solicitation notice.
For admittance to and voting at the meeting, shareholders must produce evidence of their shareholding as of the record date. The Dutch law determines that the record date is 28 days prior to the General Meeting of Shareholders. Shareholders must notify Aegon of their intention to attend the meeting.
Limitation on the right to own securities
There are no limitations, either under the laws of the Netherlands or in Aegons Articles of Association, on the rights of non-residents of the Netherlands to hold or vote Aegon common shares or common shares B.
Provisions that would have the effect of delaying a change of control
A resolution of the General Meeting of Shareholders to suspend or dismiss a member of the Executive Board or a member of the Supervisory Board, other than pursuant to a proposal by the Supervisory Board, shall require at least two-thirds of the votes cast representing more than one-half of the issued capital.
In the event a Special Cause occurs (such as the acquisition of 15% of Aegons voting shares, a tender offer for Aegons shares or a proposed business combination by any person or group of persons, whether individually or as a group, other than in a transaction approved by the Executive Board and Supervisory Board), Vereniging Aegon will be entitled to exercise its full voting rights of one vote per each common share B for up to six months per Special Cause, thus increasing its current voting rights to 32.6%.
Threshold above which shareholder ownership must be disclosed
There are no such provisions in the Articles of Association. Dutch law requires public disclosure with the Authority for Financial Markets with respect to the ownership of listed shares when the following thresholds are met: 3%, 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 75% and 95%.
Material differences between Dutch law and US law with respect to the items above
Reference is made to the paragraph Differences in company law practices for domestic companies included in the Corporate Governance section of this Annual Report (see page 136).
Special conditions governing changes in the capital
There are no conditions more stringent than what is required by law.
There are no material contracts.
There are no legislative or other legal provisions currently in force in the Netherlands or arising under Aegons Articles of Association restricting remittances to holders of Aegons securities that are not resident in the Netherlands. Cash dividends payable in euros on Aegons common shares may be officially transferred from the Netherlands and converted into any other convertible currency.
Annual Report on Form 20-F 2017 |
361 | Additional information Taxation | |
i Certain Netherlands tax consequences for holders of shares
The following section outlines certain material Netherlands tax consequences of the acquisition, holding, redemption and disposal of Aegon common shares, but does not purport to be a comprehensive description of all Netherlands tax considerations that may be relevant. This section is intended as general information only and each prospective investor should consult a professional tax adviser with respect to the tax consequences of an investment in Aegon common shares.
This section is based on tax legislation, published case law, treaties, regulations and published policy, in each case as in force as of the date hereof, and it does not take into account any developments or amendments thereof after that date whether or not such developments or amendments have retroactive effect.
This section does not address the Netherlands corporate and individual income tax consequences for:
i. | Investment institutions (fiscale beleggingsinstellingen) ; |
ii. | Pension funds, exempt investment institutions (vrijgestelde beleggingsinstellingen) or other entities that are exempt from Netherlands corporate income tax; |
iii. | Corporate holders of Aegon common shares, the shareholding of which qualifies for the participation exemption (deelnemingsvrijstelling) of the Netherlands Corporate Income Tax Act 1969 (Wet op de vennootschapsbelasting 1969) or would qualify for the participation exemption had the corporate holders of the Aegon common shares been resident in the Netherlands. Generally speaking, a shareholding is considered to qualify as a participation for the participation exemption if it represents an interest of 5% or more of the nominal paid-up share capital; |
iv. | Holders of Aegon common shares holding a substantial interest (aanmerkelijk belang) or deemed substantial interest (fictief aanmerkelijk belang ) in Aegon and holders of Aegon common shares of whom a certain related person holds a substantial interest in Aegon. Generally speaking, a substantial interest in Aegon arises if a person, alone or, where such person is an individual, together with his or her partner (statutory defined term), directly or indirectly, holds or is deemed to hold (i) an interest of 5% or more of the total of capital issued by Aegon or 5% or more of the issued capital of a certain class of Aegon shares, (ii) rights to acquire, directly or indirectly, such interest or (iii) certain profit-sharing rights in Aegon; |
v. | Persons to whom the Aegon common shares and the income from the Aegon common shares are attributed based on the separated private assets (afgezonderd particulier vermogen) provisions of the Netherlands Income Tax Act 2001 (Wet inkomstenbelasting 2001) ; |
vi. | Entities which are resident in Aruba, Curacao or Sint Maarten that have an enterprise which is carried on through a permanent establishment or a permanent representative on Bonaire, Sint Eustatius or Saba, to which permanent establishment or permanent representative the Aegon common shares are attributable; |
vii. | Holders of Aegon common shares which are not considered the beneficial owner (uiteindelijk gerechtigde) of these shares or of the benefits derived from or realised in respect of the Aegon common shares; and |
viii. | Individuals to whom Aegon common shares or the income therefrom are attributable to employment activities which are taxed as employment income in the Netherlands. |
Where this section refers to the Netherlands, such reference is restricted to the part of the Kingdom of the Netherlands that is situated in Europe and the legislation applicable in that part of the Kingdom.
Dividend withholding tax
Withholding requirement
Aegon is required to withhold 15% Netherlands dividend withholding tax in respect of dividends paid on its common shares.
Netherlands dividend withholding tax will be withheld from the gross dividends paid on the Aegon common shares. In the Netherlands Dividend Withholding Tax Act 1965 ( Wet op de dividendbelasting 1965), dividends are defined as the proceeds from shares, which include:
i. | Direct or indirect distributions of profit, regardless of their name or form; |
ii. | Liquidation proceeds, proceeds on redemption of Aegon common shares and, as a rule, the consideration for the repurchase of its own common shares by Aegon in excess of the average paid-in capital recognised for Netherlands dividend withholding tax purposes, unless a particular statutory exemption applies; |
iii. | The nominal value of new common shares issued to a holder of Aegon common shares or an increase of the nominal value of Aegon common shares, except insofar as the (increase in the) nominal value of Aegon common shares is funded out of its paid-in capital as recognized for Netherlands dividend withholding tax purposes; and |
iv. | Partial repayments of paid-in capital recognised for Netherlands dividend withholding tax purposes, if and to the extent there are qualifying profits ( zuivere winst ), unless Aegons General Meeting of Shareholders has resolved in advance to make such repayment and provided that the nominal value of Aegon common shares concerned has been reduced by an equal amount by way of an amendment of the Articles of Association. The term qualifying profits includes anticipated profits that have yet to be realized. |
Annual Report on Form 20-F 2017 |
362 | Additional information Taxation | |
Residents of the Netherlands
If a holder of Aegon common shares is a resident, or deemed to be a resident of the Netherlands for Netherlands corporate or individual income tax purposes, Netherlands dividend withholding tax which is withheld with respect to proceeds from Aegon common shares will generally be creditable for Netherlands corporate income tax or Netherlands income tax purposes.
Non-residents of the Netherlands
If a holder of Aegon common shares is a resident of a country other than the Netherlands and if a treaty for the avoidance of double taxation with respect to taxes on income is in effect between the Netherlands and that country, and such holder is a resident for the purposes of such treaty, such holder may, depending on the specific terms of that particular treaty, qualify for full or partial relief at source or for a refund in whole or in part of the Netherlands dividend withholding tax.
A refund of Netherlands withholding dividend tax is available to an entity resident in another EU member state, Norway, Iceland, or Liechtenstein if (i) this entity is not subject to corporate income tax there and (ii) this entity would not be subject to Netherlands corporate income tax, if this entity would be tax resident in the Netherlands for corporate income tax purposes and (iii) this entity is not comparable to an investment institution (fiscale beleggingsinstelling) or exempt investment institution (vrijgestelde beleggingsinstelling) . Furthermore, a similar refund of Netherlands dividend withholding tax may be available to an entity resident in another country, under the additional conditions that (i) the Aegon common shares are considered portfolio investments for purposes of article 63 (taking into account article 64) of the Treaty on the functioning of the European Union and (ii) the Netherlands can exchange information with this other country in line with the international standards for the exchange of information.
A (partial) refund of Netherlands dividend withholding tax is available to a holder of Aegon common shares resident in another EU member state, Norway, Iceland or Liechtenstein if (i) this holder of Aegon common shares is not subject to Netherlands individual income tax or Netherlands corporate income tax with respect to the income from the Aegon common shares and (ii) such Netherlands dividend withholding tax is higher than the Netherlands individual income tax or Netherlands corporate income tax would have been had this holder of Aegon common shares been tax resident in the Netherlands, after taking into account a possible refund based on the Netherlands Dividend Withholding Tax Act 1965 ( Wet op de dividendbelasting 1965) or a refund based on a treaty for the avoidance of double taxation with respect to taxes on income, and (iii) no credit based on a treaty for the avoidance of double taxation with respect to taxes on income is granted in the state in which the holder of Aegon common shares is tax resident, for the full amount of Netherlands dividend withholding tax withheld, and (iv) this holder of Aegon common shares does not have a similar function as an investment institution ( fiscale beleggingsinstelling) or exempt investment institution ( vrijgestelde beleggingsinstelling) . Furthermore, a similar refund of Netherlands dividend withholding tax may be available to a holder of Aegon common shares resident in another country, under the additional conditions that (i) the Aegon common shares are considered portfolio investments for purposes of article 63 (taking into account article 64) of the Treaty on the functioning of the European Union and (ii) the Netherlands can exchange information with this other country in line with the international standards for the exchange of information.
US-residents
Residents of the United States that qualify for, and comply with the procedures for claiming benefits under, the Convention between the Kingdom of the Netherlands and the United States of America for the avoidance of double taxation and the prevention of fiscal evasion with respect to taxes on income 1992 (the US/NL Income Tax Treaty) may, under various specified conditions, be eligible for a reduction of the Netherlands dividend withholding tax rate from 15% to 5% if the resident of the United States is a company which holds directly at least 10% of the voting power in Aegon. The US/NL Income Tax Treaty provides, subject to certain conditions, for a complete exemption from, or refund of, Netherlands dividend withholding tax for dividends received by exempt pension trusts and exempt organizations, as defined therein.
Beneficial owner
A recipient of proceeds from Aegon common shares will not be entitled to any exemption, reduction, refund or credit of Netherlands dividend withholding tax if such recipient is not considered to be the beneficial owner of such proceeds. The recipient will not be considered the beneficial owner of these proceeds, if, in connection with such proceeds, the recipient has paid a consideration as part of a series of transactions in respect of which it is likely:
◆ | That the proceeds have in whole or in part accumulated, directly or indirectly, to a person or legal entity that would: (i) as opposed to the recipient paying the consideration, not be entitled to an exemption from dividend withholding tax; or (ii) in comparison to the recipient paying the consideration, to a lesser extent be entitled to a reduction or refund of dividend withholding tax; and |
◆ | That such person or legal entity has, directly or indirectly, retained or acquired an interest in Aegon common shares or in profit- sharing certificates or loans, comparable to the interest it had in similar instruments prior to the series of transactions being initiated. |
Annual Report on Form 20-F 2017 |
363 | Additional information Taxation | |
Netherlands dividend withholding tax upon redistribution of foreign dividends
Aegon must pay to the Dutch tax authorities all Netherlands dividend withholding tax it withholds on dividends it distributed with respect to the Aegon common shares. Provided certain conditions are met, Aegon may apply a reduction with respect to the withholding tax that it has to pay to the Dutch tax authorities. This reduction can be applied if Aegon distributes dividends that stem from dividends Aegon itself has received from certain qualifying non-Netherlands subsidiaries, provided these dividends received by Aegon are exempt from Netherlands corporate income tax and were subject to a withholding tax of at least 5% upon distribution to Aegon. The reduction is applied to the Netherlands dividend withholding tax that Aegon must pay to the Netherlands tax authorities and not to the amount of the Netherlands dividend withholding tax that Aegon must withhold. The reduction is equal to the lesser of:
i. | 3% of the amount of the dividends distributed by Aegon that are subject to Netherlands dividend withholding tax; and |
ii. | 3% of the gross amount of the dividends received during a certain period from the qualifying non-Netherlands subsidiaries. |
The amount of the above mentioned reduction of the withholding tax will be reduced on a pro rata basis to the extent that Aegon distributes dividends to entities that are entitled to a refund of the Netherlands dividend withholding tax. This reduction does not apply in respect of dividends paid to entities that own less than 5% of the nominal paid-up capital of Aegon.
Corporate and individual income tax
Residents of the Netherlands
If a holder of Aegon common shares is a resident or deemed to be a resident of the Netherlands for Netherlands corporate income tax purposes and is fully subject to Netherlands corporate income tax or is only subject to Netherlands corporate income tax in respect of an enterprise to which Aegon common shares are attributable, income derived from Aegon common shares and gains realized upon the redemption or disposal of Aegon common shares are generally taxable in the Netherlands (at up to a maximum rate of 25%) under the Netherlands Corporate Income Tax Act 1969 (Wet op de vennootschapsbelasting 1969) .
If an individual is a resident or deemed to be a resident of the Netherlands for Netherlands individual income tax purposes, income derived from Aegon common shares and gains realized upon the redemption or disposal of Aegon common shares are taxable at progressive rates (at up to a maximum rate of 51,95%) under the Netherlands Income Tax Act 2001 (Wet inkomstenbelasting 2001) if :
i. | The individual is an entrepreneur ( ondernemer ) and has an enterprise to which Aegon common shares are attributable or the individual has, other than as a shareholder, a co-entitlement to the net worth of an enterprise ( medegerechtigde ), to which enterprise Aegon common shares are attributable; or |
ii. | Such income or gains qualify as income from miscellaneous activities ( resultaat uit overige werkzaamheden ), which includes but is not limited to activities with respect to Aegon common shares that exceed regular, active portfolio management ( normaal, actief vermogensbeheer ). |
If neither condition (i) nor condition (ii) above applies to the holder of the Aegon common shares, taxable income with regard to the Aegon common shares must be determined on the basis of a deemed return on income from savings and investments (sparen en beleggen), rather than on the basis of income actually received or gains actually realized. This deemed return on income from savings and investments is fixed at percentage of the individuals yield basis ( rendementsgrondslag ) at the beginning of the calendar year (1 January), insofar as the individuals yield basis exceeds a certain threshold ( heffingsvrij vermogen) . The individuals yield basis is determined as the fair market value of certain qualifying assets held by the holder of Aegon common shares less the fair market value of certain qualifying liabilities on 1 January. The fair market value of Aegon common shares will be included as an asset in the individuals yield basis. The deemed return percentage to be applied to the yield basis increases progressively depending on the amount of the yield basis. The deemed return on income from savings and investments is taxed at a rate of 30%
Non-residents of the Netherlands
If a person is neither a resident nor is deemed to be a resident of the Netherlands for Netherlands corporate or individual income tax purposes, such person is not subject to Netherlands income tax in respect of income derived from Aegon common shares and gains realized upon the redemption or disposal of Aegon common shares, except if:
i. | The person is not an individual and (1) has an enterprise that is, in whole or in part, carried on through a permanent establishment or a permanent representative in the Netherlands to which permanent establishment or a permanent representative Aegon common shares are attributable, or (2) is, other than by way of securities, entitled to a share in the profits of an enterprise or a co-entitlement to the net worth of an enterprise, which is effectively managed in the Netherlands and to which enterprise Aegon common shares are attributable. This income and these gains are subject to Netherlands corporate income tax at up to a maximum rate of 25%; |
ii. | The person is an individual that (1) has an enterprise or an interest in an enterprise that is, in whole or in part, carried on through a permanent establishment or a permanent representative in the Netherlands to which permanent establishment or permanent |
Annual Report on Form 20-F 2017 |
364 | Additional information Taxation | |
representative Aegon common shares are attributable, or (2) realises income or gains with respect to Aegon common shares that qualify as income from miscellaneous activities ( resultaat uit overige werkzaamheden) in the Netherlands which include activities with respect to Aegon common shares that exceed regular, active portfolio management ( normaal , actief vermogensbeheer), or (3) is, other than by way of securities, entitled to a share in the profits of an enterprise that is effectively managed in the Netherlands and to which enterprise Aegon common shares are attributable. Income and gains derived from Aegon common shares as specified under (1) and (2) by an individual are subject to individual income tax at up to a maximum rate of 51,95%. Income derived from a share in the profits of an enterprise as specified under (3) that is not already included under (1) or (2) will be taxed on the basis of a deemed return on income from savings and investments (as described above under Residents of the Netherlands). The fair market value of the share in the profits of the enterprise (which includes Aegon common shares) will be part of the individuals Netherlands yield basis.
Gift and inheritance tax
Residents of the Netherlands
Generally, gift tax ( schenkbelasting ) or inheritance tax ( erfbelasting ) will be due in the Netherlands in respect of the acquisition of Aegon common shares by way of a gift by, or on behalf of, or on the death of, a holder of Aegon common shares that is a resident or deemed to be a resident of the Netherlands for the purposes of the Netherlands Gift and Inheritance Tax Act 1956 ( Successiewet 1956 ) at the time of the gift or his or her death. A gift made under a condition precedent is for the purposes of the Netherlands Gift and Inheritance Tax Act 1956 deemed to be made at the time the condition precedent is fulfilled and is subject to gift tax if the donor is, or is deemed to be, a resident of the Netherlands at that time.
A holder of Netherlands nationality is deemed to be a resident of the Netherlands for the purposes of the Netherlands Gift and Inheritance Tax Act 1956 if he or she has been resident in the Netherlands and dies or makes a gift within ten years after leaving the Netherlands. A holder of any other nationality is deemed to be a resident of the Netherlands for the purposes of the Netherlands Gift and Inheritance Tax Act 1956 if he or she has been resident in the Netherlands and makes a gift within a twelve-month period after leaving the Netherlands. The same twelve-month rule may apply to entities that have transferred their seat of residence out of the Netherlands.
Non-residents of the Netherlands
No gift or inheritance tax will arise in the Netherlands in respect of the acquisition of Aegon common shares by way of a gift by, or as a result of the death of, a holder that is neither a resident nor deemed to be a resident of the Netherlands for the purposes of the Netherlands Gift and Inheritance Tax Act 1956. However, inheritance tax will be due in the case of a gift of Aegon common shares by, or on behalf of, a holder who at the date of the gift was neither a resident nor deemed to be a resident of the Netherlands for the purposes of the Netherlands Gift and Inheritance Tax Act 1956, but such holder dies within 180 days after the date of the gift, and at the time of his or her death is a resident or deemed to be a resident of the Netherlands for the purposes of the Netherlands Gift and Inheritance Tax Act 1956. A gift made under a condition precedent is deemed to be made at the time the condition precedent is fulfilled.
The proposed financial transactions tax
The European Commission has published a proposal for a Directive for a common financial transactions tax (FTT) in Belgium, Germany, Estonia, Greece, Spain, France, Italy, Austria, Portugal, Slovenia and Slovakia (the participating Member States). However, Estonia has stated that it will not participate.
The proposed FTT has a very broad scope and could, if introduced in its current form, apply to certain dealings in Aegon common shares (including secondary market transactions) in certain circumstances.
Under the current proposals, the FTT could apply in certain circumstances to persons both within and outside of the participating Member States. Generally, it would apply to certain dealings in Aegon common shares where at least one party is a financial institution, and at least one party is established in a participating Member State. A financial institution may be, or be deemed to be, established in a participating Member State in a broad range of circumstances, including (1) by transacting with a person established in a participating Member State or (2) where the financial instrument which is subject to the dealings is issued in a participating Member State.
However, the FTT proposal remains subject to negotiation between participating Member States and is subject to legal challenge. It may therefore be altered prior to any implementation, the timing of which remains unclear. Additional EU Member States may decide to participate. Prospective holders of Aegon common shares are advised to seek their own professional advice in relation to the FTT.
Annual Report on Form 20-F 2017 |
365 | Additional information Taxation | |
Value added tax
In general, no value added tax will arise in respect of payments in consideration for the issue of Aegon common shares or in respect of a cash payment made under Aegon common shares, or in respect of a transfer of Aegon common shares.
Other taxes and duties
No registration tax, customs duty, transfer tax, stamp duty, capital tax or any other similar documentary tax or duty will be payable in the Netherlands by a holder of Aegon common shares in respect of or in connection with the subscription, issue, placement, allotment, delivery or transfer of the Aegon common shares.
ii Taxation in the United States
This section describes certain US Federal income tax consequences to beneficial holders of common shares that are held as capital assets. This section does not address all US Federal income tax matters that may be relevant to a particular holder. Each investor should consult their tax advisor with respect to the tax consequences of an investment in the common shares. This section does not address tax considerations for holders of common shares subject to special tax rules including, without limitation, the following:
◆ | Financial institutions; |
◆ | Insurance companies; |
◆ | Dealers or traders in securities or currencies; |
◆ | Tax-exempt entities; and |
◆ | Regulated investment companies; |
◆ | Persons that will hold the common shares as part of a hedging or conversion transaction or as a position in a straddle or as part of a synthetic security or other integrated transaction for US Federal income tax purposes; |
◆ | Holders that own (or are deemed to own for US Federal income tax purposes) 10% or more of the voting shares of Aegon; |
◆ | Partnerships or pass-through entities or persons who hold common shares through partnerships or other pass-through entities; and |
◆ | Holders that have a functional currency other than the US dollar. |
Further, this section does not address alternative minimum tax consequences or the indirect effects on the holders of equity interests in a holder of common shares. This section also does not describe any tax consequences arising under the laws of any taxing jurisdiction other than the Federal income tax laws of the US Federal government.
This section is based on the US Internal Revenue Code of 1986, as amended, US Treasury regulations and judicial and administrative interpretations, in each case as in effect and available on the date of this Annual Report. All of the foregoing is subject to change, which change could apply retroactively and could affect the tax consequences described below.
For the purposes of this section, a US holder is a beneficial owner of common shares that is, for US Federal income tax purposes:
◆ | A citizen or individual resident of the United States; |
◆ | A corporation created or organized in or under the laws of the United States or any state of the United States (including the District of Columbia); |
◆ | An estate, the income of which is subject to US Federal income taxation regardless of its source; or |
◆ | A trust, if a court within the United States is able to exercise primary supervision over its administration and one or more US persons have the authority to control all of the substantial decisions of such trust. |
A non-US holder is a beneficial owner of common shares that is not a US holder.
Tax consequences to US holders
Distributions
The gross amount of any distribution (including any amounts withheld in respect of Dutch withholding tax) actually or constructively received by a US holder with respect to common shares will be taxable to the US holder as a dividend to the extent of Aegons current and accumulated earnings and profits as determined under US Federal income tax principles. Such dividends will not qualify for the dividends received deduction otherwise allowable to corporations. Distributions in excess of current and accumulated earnings and profits are treated under US tax law as non-taxable return of capital to the extent of the US holders adjusted tax basis in the common shares. Distributions in excess of earnings and profits and such adjusted tax basis will generally be taxable to the US holder as capital gain from the sale or exchange of property. However, Aegon does not maintain calculations of its earnings and profits under US Federal income tax principles. Therefore, US holders of Aegon shares will generally be taxed on all distributions as dividends, even if some portion of the distributions might otherwise be treated as a non-taxable return of capital or as capital gain if the amount
Annual Report on Form 20-F 2017 |
366 | Additional information Taxation | |
of US earnings and profits was known. The amount of any distribution of property other than cash will be the fair market value of that property on the date of distribution.
Certain qualified dividend income received by individual US holders is taxed at a maximum income tax rate of 20% under current law. Only dividends received from US corporations or from a qualified foreign corporation and on shares held by an individual US holder for a minimum holding period (generally, 61 days during the 121-day period beginning 60 days before the ex-dividend date) can qualify for this reduced rate. Aegon is eligible for benefits under the comprehensive income tax treaty between the Netherlands and the US; therefore, Aegon should be considered a qualified foreign corporation for this purpose. Accordingly, dividends paid by Aegon to individual US holders on shares held for the minimum holding period may qualify for a reduced income tax rate. Each US holder should consult their tax advisor regarding the applicable tax rate.
In addition, US holders receiving dividends may be subject to a net investment income tax (NIIT). The NIIT is a 3.8% tax on the lesser of net investment income or the amount of modified adjusted gross income (MAGI) that is over a threshold amount based on filing status (USD 250,000 for married taxpayers filing jointly). Each US holder should consult their tax advisor regarding applicability of the NIIT.
Distributions paid in currency other than US dollars (a foreign currency), including the amount of any withholding tax thereon, must be included in the gross income of a US holder in an amount equal to the US dollar value of the foreign currency calculated by reference to the exchange rate in effect on the date of receipt. This is the case regardless of whether the foreign currency is converted into US dollars. If the foreign currency is converted into US dollars on the date of receipt, a US holder generally should not be required to recognize foreign currency gain or loss in respect of the dividend. If the foreign currency received in the distribution is not converted into US dollars on the date of receipt, a US holder will have a basis in the foreign currency equal to its US dollar value on the date of receipt. Any gain or loss on a subsequent conversion or other disposition of the foreign currency will be treated as ordinary income or loss.
Dividends received by a US holder with respect to common shares will be treated as foreign source income for foreign tax credit limitation purposes. Subject to certain conditions and limitations, any Dutch income tax withheld on dividends may be deducted from taxable income or credited against a US holders Federal income tax liability. The limitation on foreign taxes eligible for the US foreign tax credit is calculated separately with respect to passive category income and general category income. Dividends distributed by Aegon generally will constitute passive category income, or, in the case of certain US holders, financial services income, which is treated as general category income. Each US holder should consult their tax advisor regarding the availability of the foreign tax credit under their particular circumstances.
The amount of the qualified dividend income paid by Aegon to a US holder that is subject to the reduced dividend income tax rate and that is taken into account for purposes of calculating the US holders US foreign tax credit limitation must be reduced by the rate differential portion of such dividend (which, assuming a US holder is in the highest income tax bracket, would generally require a reduction of the dividend amount by approximately 45.95% under current law). Each US holder should consult their tax advisor regarding the implications of the rules relating to qualified dividend income on the calculation of US foreign tax credits under their particular circumstances.
In general, upon making a distribution to shareholders, Aegon is required to remit all Dutch dividend withholding taxes to the Dutch tax authorities. The full amount of the taxes so withheld should (subject to certain limitations and conditions) be eligible for the US holders foreign tax deduction or credit as described above. Investors are urged to consult their tax advisors regarding the general creditability or deductibility of Dutch withholding taxes.
Aegon generally affords shareholders an option to receive dividend distributions in cash or in stock. A distribution of additional common shares to US holders with respect to their common shares that is made pursuant to such an election will generally be taxable in the same manner as a cash dividend under the rules described above.
Sale or other disposition of shares
Upon the sale or exchange of common shares, a US holder will generally recognize gain or loss for US Federal income tax purposes on the difference between the US dollar value of the amount realized from such sale or exchange and the tax basis in those common shares. This gain or loss will be a capital gain or loss and will generally be treated as from sources within the United States. Investors should consult their tax advisors with respect to the treatment of capital gains (which may be taxed at lower rates than ordinary income for taxpayers who are individuals, trusts or estates that have held the common shares for more than one year) and capital losses (the deductibility of which is subject to limitations).
Annual Report on Form 20-F 2017 |
367 | Additional information Taxation | |
In addition, US holders with capital gains may be subject to a NIIT. The NIIT is a 3.8% tax on the lesser of net investment income or the amount of modified adjusted gross income (MAGI) that is over a threshold amount based on filing status (USD 250,000 for married taxpayers filing jointly). Each US holder should consult their tax advisor regarding applicability of the NIIT.
If a US holder receives foreign currency upon a sale or exchange of common shares, gain or loss, if any, recognized on the subsequent sale, conversion or disposition of such foreign currency will be ordinary income or loss, and will generally be income or loss from sources within the United States for foreign tax credit limitation purposes. However, if such foreign currency is converted into US dollars on the date received by the US holder, the US holder generally should not be required to recognize any gain or loss on such conversion.
Passive foreign investment company considerations
Based on the nature of Aegons gross income, the average value of Aegons gross assets, and the active conduct of Aegons insurance business, Aegon does not believe that it could be classified as a Passive Foreign Investment Company (PFIC). If Aegon were treated as a PFIC in any year during which a US holder owns common shares, certain adverse tax consequences could apply. Investors should consult their tax advisors with respect to any PFIC considerations.
Tax consequences to non-US holders
A non-US holder generally will not be subject to US Federal income tax on dividends received on common shares or on any gain realized on the sale or exchange of common shares unless the gain is connected with a trade or business that the non-US holder conducts in the United States or unless the non-US holder is an individual, such holder was present in the United States for at least 183 days during the year in which such holder disposes of the common shares, and certain other conditions are satisfied. Non-US holders should consult their tax advisors with respect to the US Federal income tax consequences of dividends received on, and any gain realized from the sale or exchange of, the common shares.
Backup withholding and information reporting
Backup withholding and information reporting requirements may apply to certain payments on the common shares and to proceeds of a sale or redemption of the common shares to US holders made within the United States. Aegon, its agent, a broker, or any paying agent, as the case may be, may be required to withhold tax from any payment that is subject to backup withholding if a US holder fails to furnish the US holders taxpayer identification number, fails to certify that such US holder is not subject to backup withholding, or fails to otherwise comply with the applicable requirements of the backup withholding rules. Certain US holders are not subject to the backup withholding and information reporting requirements.
Non-US holders that provide the required tax certifications of exempt or foreign status will generally be exempt from US information reporting requirements and backup withholding. However, sales proceeds a non-US holder receives on a sale of common shares through a broker may be subject to information reporting and backup withholding if the non-US holder is not eligible for an exemption.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a US holder or a non-US holder generally may be claimed as a credit against such holders US Federal income tax liability provided that the required information is furnished to the US Internal Revenue Service (IRS). Investors should consult their tax advisors as to their qualification for exemption from backup withholding and the procedure for obtaining an exemption. Non-US holders should consult their tax advisors concerning the applicability of the information reporting and backup withholding rules.
Individual US holders may be required to report to the IRS certain information with respect to their beneficial ownership of certain foreign financial assets, such as the common shares, if the aggregate value of such assets exceeds USD 50,000 and the assets are not held through a US financial institution. US holders who fail to report required information could be subject to substantial penalties. Prospective investors should consult their own tax advisors concerning the application of the information reporting rules to their particular circumstances.
Annual Report on Form 20-F 2017 |
368 | Additional information Principal accountant fees and services | |
Principal accountant fees and services
PricewaterhouseCoopers Accountants N.V. (PwC) has served as Aegons independent public accountant for each of the years in the three-year period ended December 31, 2017, for which audited financial statements appear in this Annual Report.
The following table presents the aggregate fees for services rendered by PwC in 2017, 2016 and 2015.
Fees independent public accountant
In million EUR | 2017 | 2016 | 2015 | |||||||||
Audit fees |
42 | 27 | 20 | |||||||||
Audit-related fees |
3 | 3 | 2 | |||||||||
46 | 30 | 22 |
Audit fees consist of fees billed for the annual financial statement audit (including required quarterly reviews), subsidiary audits, equity investment audits and other procedures required to be performed by the independent auditor to be able to form an opinion on Aegons consolidated financial statements. These other procedures include information systems and procedural reviews and testing performed in order to understand and place reliance on the systems of internal control, and consultations relating to the audit or quarterly review. They also include fees billed for other audit services, which are those services that only the external auditor reasonably can provide, and include statutory audits or financial audits for subsidiaries or affiliates of the Company and services associated with SEC registration statements, periodic reports and other documents filed with the SEC or other documents issued in connection with securities offerings.
Audit-related fees consist of fees billed for audit-related services including assurance and related services that are reasonably related to the performance of the audit or review of Aegons financial statements or that are traditionally performed by the independent auditor. Audit-related services include, among others, assurance services to report on internal controls for third parties, due diligence services pertaining to potential business acquisitions/dispositions; accounting consultations related to accounting, financial reporting or disclosure matters not classified as Audit services; assistance with understanding and implementing new accounting and financial reporting guidance from rulemaking authorities; financial audits of employee benefit plans; agreed-upon or expanded audit procedures related to accounting and/or billing records required to respond to or comply with financial, accounting or regulatory reporting matters; and assistance with internal control reporting requirements.
All other fees include fees billed for permissible non-audit services that Aegon believes are routine and recurring services, would not impair the independence of the auditor and are consistent with the SECs rules on auditor independence.
Audit Committee pre-approval policies and procedures
Aegons Audit Committee is responsible, among other matters, for the oversight of the external auditor. The Audit Committee has adopted a policy regarding pre-approval of audit and permissible non-audit services provided by Aegons independent auditors (the Pre-approval Policy).
Under the Pre-approval Policy, proposed services either:
◆ | May be pre-approved by the Audit Committee without consideration of specific case-by-case services (general pre-approval); or |
◆ | Require the specific pre-approval of the Audit Committee (specific pre-approval). Appendices to the Pre-approval Policy (that are adopted each year) set out the audit, audit-related, tax and other services that have received general pre-approval of the Audit Committee. All other audit, audit-related, tax and other services must receive specific pre-approval from the Audit Committee. |
For the period 2015 to 2017, all services provided to Aegon by its independent public accountant were pre-approved by the Audit Committee in accordance with the Pre-approval Policy.
Annual Report on Form 20-F 2017 |
369 | Additional information Purchases of equity securities by the issuer and affiliated purchasers | |
Purchases of equity securities by the issuer and affiliated purchasers
Period |
Total number of shares
purchased 1) |
Average price paid per
share in EUR |
Total number of shares
purchased as part of publicly announced plans or programs |
Maximum number of
shares that may yet be purchased under the plans or programs at end of month |
||||||||||||
January 1 - 31, 2017 |
691 | 6.52 | - | - | ||||||||||||
February 1 - 28, 2017 |
642 | 6.66 | - | - | ||||||||||||
March 1 - 31, 2017 |
598 | 6.67 | - | - | ||||||||||||
April 1 - 30, 2017 |
804 | 5.67 | - | - | ||||||||||||
May 1 - 31, 2017 |
756 | 5.66 | - | - | ||||||||||||
June 1 - 30, 2017 |
1,387 | 5.62 | - | - | ||||||||||||
July 1 - 31, 2017 |
671 | 6.64 | - | - | ||||||||||||
August 1 - 31, 2017 |
502 | 6.73 | - | - | ||||||||||||
September 1 - 30, 2017 |
1,035 | 6.73 | - | 51,864,626 | ||||||||||||
October 1 - 31, 2017 |
19,073,434 | 4.94 | 19,072,946 | 32,791,680 | ||||||||||||
November 1 - 30, 2017 |
23,573,736 | 5.15 | 23,573,233 | 9,218,447 | ||||||||||||
December 1 - 31, 2017 |
9,218,858 | 5.25 | 9,218,447 | - | ||||||||||||
Total |
51,873,114 | 51,864,626 |
1 | The shares have been purchased as part of a share purchase program, to neutralize the dilution effect of issued stock dividends and agent-related incentive programs. Excluding Aegon shares purchased by index funds controlled by Aegon. Such purchases are made to the extent necessary to maintain a basket of securities within the relevant fund reflecting the underlying index. Please refer to note 20 Dividend per common share and to the section Major shareholders in the Other information. |
Annual Report on Form 20-F 2017 |
370 | Additional information Glossary | |
Accounting Consolidation is the default method for calculating the Group solvency position. With this consolidation method, diversification benefits in the calculation of capital requirements are allowed.
Acquisition date is the date on which the acquirer effectively obtains control of the acquiree. In most cases this includes at least the transfer of risks and rewards related to the acquired business or assets/liabilities.
Actuarial funding enables a life insurance company to reduce the size of the unit reserves it holds for unit-linked business to reflect some or all of the unit-linked charges it expects to receive in the future from the units nominally allocated. Actuarial funding is used on those contracts that have surrender penalties and the Company will hold a minimum of the surrender value at all times.
Actuarial gains and losses relate to the accounting for post-employment benefit plans. They comprise the effects of experience adjustments and changes in assumptions used to determine the cost of a plan.
Alt-A mortgages relates to a type of US residential mortgage which are securitized home equity loans. Typical Alt-A borrower has a credit score high enough to obtain an: Astanding. Alt-A mortgages are primarily backed by loans with fixed interest rates for the entire term of the loan.
Aggregation is the methodology by which capital requirements are calculated across different risk groupings, allowing for diversification benefit between the groupings.
Amortized cost is the amount at which the financial asset or liability is measured at initial recognition minus principal repayments, plus or minus the cumulative amortization using the effective interest rate method of any difference between that initial amount and the maturity amount and minus any reduction (directly or through the use of an allowance account) for impairment or uncollectability.
Asset-Backed Securities (ABS) are securities whose value and income payments are derived from and collateralized (or backed) by a specified pool of underlying assets.
Assets held by long-term employee benefit funds are part of plan assets. These are assets (other than non-transferable financial instruments issued by the reporting entity) that:
◆ | Are held by an entity that is legally separate from the reporting entity and exists solely to pay or fund employee benefits; and |
◆ | Are available to be used only to pay or fund employee benefits and are not available to the reporting entitys own creditors. |
Authorised Control Level (ACL) is the level regulators are permitted to seize control of a company.
Bifurcation is the measurement and presentation of embedded derivatives separate from the host contracts, as if they were stand-alone derivative financial instruments.
Binomial option pricing model uses a binomial lattice that represents possible paths that might be followed by the underlying assets price over the life of the option, for a given number of time steps between valuation date and option expiration. Each node in the lattice represents a possible price of the underlying asset, at a particular point in time. The valuation process is iterative; it starts at each final node and then works backwards through the lattice to the first node, which is the valuation date, where the calculated result is the value of the option.
Business combination is the bringing together of separate entities or operations of entities into one reporting entity. This can be realized through a purchase transaction or by means of a merger. A business combination involving entities (or operations of entities) under common control is a business combination in which all of the combining entities (or operations of entities) ultimately are controlled by the same party or parties both before and after the combination, and that control is not transitory.
Company Action Level (CAL) is the regulatory intervention level at which a company has to submit a plan to its state regulators for the Aegon Americas segment. It is 200% of the Authorised Control Level (ACL) - the level regulators are permitted to seize control of a company. It is a requirement and the most pertinent for measuring risk-based capital (RBC).
Capital funding includes debt securities that are issued for general corporate purposes and for capitalizing our business units. Capital funding is part of the Companys total capitalization that is used for financing our subsidiaries and the cash held at the holding company.
Capitalization is the recognition of a cost as part of the cost of an asset on the statement of financial position.
Cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Cedant is the policyholder under a reinsurance contract.
Claims settlement expenses are costs incurred in settling a claim. These costs include internal administration and payout costs, but also such items as attorneys fees and investigation expenses.
Annual Report on Form 20-F 2017 |
371 | Additional information Glossary | |
Collateral is an asset pledged by a borrower to secure a loan and is subject to seizure in the case of default.
Collateralized Debt Obligation (CDO) isa type of asset-backed security which provides investors exposure to the credit risk of a pool of fixed income assets.
Commercial Mortgage-Backed Securities (CMBS) is a type of mortgage-backed security that is secured by the loan on a commercial property.
Compound financial instruments are financial instruments that, from the issuers perspective, contain both a liability and an equity element.
Constructive obligation is an obligation that derives from an entitys actions whereby an established pattern of past practice, published policies or a sufficiently specific current statement, the entity has indicated to other parties that it will accept certain responsibilities, and as a result, the entity has created a valid expectation on the part of those other parties that it will discharge those responsibilities.
Contingent liability is a possible obligation dependent on the occurrence of an uncertain future event or a present obligation for which payment is not probable or the amount cannot be measured reliably.
Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss.
Currency exchange rate risk is a market risk, namely the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates.
Debt securities are interest-paying bonds, debentures, notes, or money market instruments that are issued by governments or corporations. Debt securities are issued with a promise of repayment on a certain date at a specified rate of interest.
Deduction & Aggregation is the alternate method for calculating group solvency that aggregates an entity without allowing for diversification between the entity that is aggregated using D&A and those that are aggregated using Accounting Consolidation.
Deferred tax assets are amounts of income taxes recoverable in future periods in respect of deductible temporary differences; the carryforward of unused tax losses; and the carryforward of unused tax credits.
Deferred tax liabilities are amounts of income taxes payable in future periods in respect of taxable temporary differences.
Defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods.
Defined benefit plans are post-employment benefit plans other than defined contribution plans.
Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods.
Deferred Policy Acquisition Cost (DPAC) - are the variable costs related to the acquisition or renewal of insurance contracts and investment contracts with discretionary participation features.
Deposit accounting method includes amounts charged and paid to customers directly into the financial liability and not through the income statement as premium income and claims.
Derecognition is the removal of a previously recognized asset or financial liability from an entitys statement of financial position.
Derivatives are financial instruments whose value changes in response to an underlying variable, that require little or no net initial investment and are settled at a future date.
Discretionary participation feature is a contractual right to receive, as a supplement to guaranteed benefits, additional benefits:
◆ | That are likely to be a significant portion of the total contractual benefits; |
◆ | Whose amount or timing is contractually at the discretion of the issuer; and |
That are contractually based on:
◆ | The performance of a specified pool of contracts or a specified type of contract; |
◆ | Realized and/or unrealized investment returns on a specified pool of assets held by the issuer; or |
◆ | The profit or loss of the Company, fund or other entity that issues the contract. |
Diversification is the general concept of reducing the total risk of a portfolio of assets and/or liabilities by spreading it across a mix of different risk exposures. Risk reduction occurs due to the less than perfect correlation among the individual risk exposures in the portfolio, meaning risks will not materialize all at the same time.
Annual Report on Form 20-F 2017 |
372 | Additional information Glossary | |
Effective interest rate method is a method of calculating the amortized cost of a financial asset or liability and of allocating the interest income or expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments or receipts through the expected life of the financial instrument or, when appropriate, a shorter period to the net carrying amount of the financial asset or liability.
Embedded derivative is a component of a hybrid instrument that also includes a non-derivative host contract, with the effect that some of the cash flows of the combined instrument vary in a way similar to a derivative.
Equity instruments are financial instruments issued by the Group that are classified as equity if they evidence a residual interest in the assets of the Group after deducting all of its liabilities.
Equity method is a method of accounting whereby the investment is initially recognized at cost and adjusted thereafter for the post-acquisition change in the investors share of net assets of the investee. The profit or loss of the investor includes the investors share of the profit or loss of the investee.
Equity volatility is the relative rate at which the price of equity changes.
Excess cash in the holding, which is rather a measure of Holdings liquidity, can be defined as the sum of the Holding company assets, less capital investments, less matched short term assets, less other adjustments. Aegons internal policy for the management of excess cash in the holding is based on a similar approach as the management of the Group and Local Unit capitalization, using a range approach and a ladder of intervention to trigger timely conversations and escalating management actions.
Exchange differences are differences resulting from translating a given number of units of one currency into another currency at different exchange rates.
Fee-based earnings refers to the excess of fees earned over expenses. This is typically associated with pensions business, asset management business, distribution business, variable annuities and unit linked products.
Finance lease is a lease that transfers substantially all the risks and rewards incident to ownership of an asset.
Financial asset is any asset that is:
◆ | Cash; |
◆ | An equity instrument of another entity; |
◆ | A contractual right to receive cash or another financial asset from another entity or to exchange financial instruments with another party under conditions that are potentially favorable; or |
◆ | A contract that will or may be settled in the entitys own equity instruments; and is |
◆ | A non-derivative for which the entity is or may be obliged to receive a variable number of the entitys own equity instruments; or |
◆ | A derivative that will or may be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entitys own equity instruments. |
Financial instrument is any contract that gives rise to both a financial asset of one entity and a financial liability or equity instrument of another entity.
Financial liability is any liability that is:
◆ | A contractual obligation to deliver cash or another financial asset to another entity or to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavorable to the entity; or |
◆ | A contract that will or may be settled in the entitys own equity instruments; and is |
◆ | A non-derivative for which the entity is or may be obliged to deliver a variable number of the entitys own equity instruments; or |
◆ | A derivative that will or may be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entitys own equity instruments. |
Financial risks are risks of a possible future change in one or more of the following variables: a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index or prices or rates, credit rating or credit index or other variable, provided in the case of a non-financial variable, that the variable is not specific to a party to the contract.
Firm commitment is a binding agreement for the exchange of a specified quantity of resources at a specified price on a specified future date or dates.
Fixed charge coverage is a measure of the Aegons ability to service its financial leverage. It is calculated as the sum of underlying earnings before tax and interest expenses on financial leverage divided by interest payments on financial leverage. The fixed charge coverage includes the impact of interest rate hedging.
Foreign currency is a currency other than the functional currency of an entity within the Group.
Foreign currency translation reserve (FCTR) is part of shareholdersequity, and is the reserve for the exchange differences recognized from the financial statements of the
Annual Report on Form 20-F 2017 |
373 | Additional information Glossary | |
group entities. On the consolidation, the financial statements of group entities with a foreign functional currency are translated to euro, the currency in which the consolidated financial statements are presented. Assets and liabilities are translated at the closing rates on the reporting date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. The resulting exchange differences are recognized in the FCTR.
Foreign operation is an entity that is a subsidiary, associate, joint venture or branch of a reporting entity within the Group, the activities of which are based or conducted in a country or currency other than those of the reporting entity.
Functional currency is the currency of the primary economic environment in which an entity within the Group operates.
Fungibility & Transferrability is the ability to up-stream and transfer capital between jurisdictions. This ability differs between jurisdictions as it depends on the legal framework of each jurisdiction.
General account investments are investments of which the financial risks are not borne by the policyholder.
Goodwill is the amount of future economic benefits arising from assets that are not capable of being individually identified and separately recognized as an asset in a business combination.
Government exposures relates to government issued securities including Dutch Government bonds and US Treasury, agency and state bonds.
Guaranteed benefits are payments or other benefits to which a particular policyholder or investor has an unconditional right that is not subject to the contractual discretion of the issuer.
Guaranteed minimum death benefits are benefits that guarantee that the beneficiary, as named in the contract, will receive a death benefit if the annuitant dies. The benefit received differs among contracts and may be greater than the current account value.
Guaranteed minimum income benefits are a type of option that annuitants can purchase for their retirement annuities. When the annuity is annuitized, this specific option guarantees that the annuitant will receive a minimum values worth of payments, regardless of the current level of the account value.
Guaranteed minimum withdrawal benefits are a type of option that annuitants can purchase for their retirement annuities. This specific option gives annuitants the ability to protect their retirement investments against downside market risk by allowing the annuitant the right to withdraw a percentage
of their withdrawal base each year, regardless of how markets have performed
Hedge effectiveness is the degree to which changes in the fair value or cash flows of the hedged item that are attributable to a hedged risk are offset by changes in the fair value or cash flows of the hedging instrument.
Incremental cost is one that would not have been incurred if the entity had not acquired, issued or disposed of a financial instrument.
Insurance asset is an insurers contractual right under an insurance contract.
Insurance contract is a contract under which one party (the insurer) accepts significant insurance risk from another party (the policyholder) by agreeing to compensate the policyholder if a specified uncertain future event (the insured event) adversely affects the policyholder.
Insurance liability is an insurers contractual obligation under an insurance contract.
Insurance risk is a risk, other than financial risk, transferred from the holder of a contract to the issuer.
Interest rate risk is a market risk, namely the risk that the value of a financial instrument will fluctuate due to changes in market interest rates.
Joint control is the contractually agreed sharing of control over an economic activity, which exists when the strategic and operating decisions relating to the activity require the unanimous consent of the parties sharing control.
Liability adequacy testing is an assessment of whether the carrying amount of an insurance liability needs to be increased (or the carrying amount of related deferred policy acquisition costs or related intangible assets decreased) based on a review of future cash flows.
Liquidity risk is the risk that an entity will encounter difficulty in raising funds to meet commitments associated with financial instruments.
Loss absorbing capacity of deferred taxes is a loss compensating effect of taxes taken into account in the solvency capital requirement.
Master netting agreement is an agreement providing for an entity that undertakes a number of financial instrument transactions with a single counterparty to make a single net settlement of all financial instruments covered by the agreement in the event of default on, or termination of, any contract.
Annual Report on Form 20-F 2017 |
374 | Additional information Glossary | |
Matching adjustment will adjust the discount rate applied in the valuation of predictable liabilities which are cashflow matched using fixed income assets. The predictability of the portfolio means that matching assets can be held to maturity and that the insurer is consequently not exposed to price movements, only to the risk of default.
Minimum capital requirement is the absolute minimum level of capital an insurance company must hold in excess of its Technical Provisions under Solvency II.
Monetary items are units of currency held and assets and liabilities to be received or paid in a fixed or determinable number of units of currency.
Monoline insurer is an insurance company which issues types of insurance for securities and bonds to cover the interest and principal when an issuer defaults.
Negative amortization mortgages are loans whereby the payment made by the borrower may be less than the accrued interest due and the difference is added to the loan balance. When the accrued balance of the loan reaches the negative amortization limit (typically 110% to 125% of the original loan amount), the loan recalibrates to a fully amortizing level and a new minimum payment amount is determined.
Non-controlling interests are that portion of the profit or loss and net assets of a subsidiary attributable to equity interests that are not owned, directly or indirectly through subsidiaries, by the parent.
Onerous contracts are contracts in which the unavoidable costs of meeting the obligations under the contract exceed the economic benefits expected to be received under it.
Operational funding includes debt securities that are issued for the financing of dedicated pools of assets. These assets are either legally segregated or tracked as separate portfolios.
Operating expenses are all expenses associated with selling and administrative activities (excluding commissions) after reallocation of claim handling expenses to benefits paid.
Partial Internal Model is a combination of a Standard Formula and Internal Model, used to calculated the Solvency II capital requirement.
Past service cost is the increase in the present value of the defined benefit obligation for employee service in prior periods, resulting in the current period from the introduction of, or changes to, post-employment benefits.
Plan assets are assets held by a long-term employee benefit fund and qualifying insurance policies.
Policy acquisition costs are the expenses incurred in soliciting and placing new business as well as renewal of existing business. It includes agents commissions, underwriting expenses, medical and credit report fees, marketing expenses and all other direct and indirect expenses of the departments involved in such activities.
Policyholder is a party that has a right to compensation under an insurance contract if an insured event occurs.
Presentation currency is the currency in which the financial statements are presented.
Price risk is a market risk, namely the risk that the value of a financial instrument will fluctuate as a result of changes in market prices.
Private loan is a non-derivative financial asset with a fixed interest rate and a maturity date, which is not bought in an active market but negotiated between the two parties involved. Private loans are not embodied in securities. When a private loan takes the form of a private placement of bonds or other investments directly to an institutional investor like an insurance company, it has more the character of a bond loan and such financial instruments are classified as available-for-sale investments rather than as loans and receivables.
Projected unit credit method is an actuarial valuation method that sees each period of service as giving rise to an additional unit of benefit entitlement and measures each unit separately to build up the final obligation.
Qualifying insurance policies are a component of plan assets. These are insurance policies issued by an insurer that is not a related party of the reporting entity, if the proceeds of the policies:
◆ | Can be used only to pay or fund employee benefits under a defined benefit plan; and |
◆ | Are not available to the reporting entitys own creditors. |
Real estate investments foreclosed are real estate investments purchased through foreclosure on the mortgage. Such purchases are not accounted for as mortgages, but as real estate investments until they can be sold at a better price than at the foreclosure. Meanwhile they yield a rental income.
Realizable value is the amount of cash or cash equivalents that could currently be obtained by selling an asset in an orderly disposal.
Recognition is the process of incorporating in the statement of financial position or income statement an item that meets the
Annual Report on Form 20-F 2017 |
375 | Additional information Glossary | |
definition of an element and satisfies the following criteria for recognition:
◆ | It is probable that any future economic benefit associated with the item will flow to or from the entity; and |
◆ | The item has a cost or value that can be measured with reliability. |
Reinsurance assets are a cedants net contractual rights under a reinsurance contract.
Reinsurance contract is an insurance contract issued by one insurer to compensate another insurer for losses on one or more contracts issued by the cedant.
Renewal of a contract is when a policyholder takes whatever action is required, typically payment of a premium, in order to maintain benefits under the contract.
Repurchase agreement is a sale of securities with an agreement to buy back the securities at a specified time and price.
Residential Mortgage Backed Security (RMBS) is an asset-backed security that is secured by a mortgage or collection of mortgages.
Return on plan assets is the investment income derived from plan assets, together with realized and unrealized gains and losses on the plan assets less any costs of administering the plan and less any tax payable by the plan itself.
Reverse repurchase agreement is a purchase of securities with the agreement to resell them at a later specified date and price.
Risk Based Capital Company Action Level is designed primarily for US regulators to identify poorly capitalized companies whose continued operations may be hazardous to policyholders. The insurers RBC solvency ratio is determined as its total adjusted capital divided by authorized control level risk based capital. (ACL) However, it is industry and rating agency convention to complete and communicate the RBC solvency ratio relative to the Company Action Level Risk Based Capital, which is twice the authorized control level.
Security lending involves a loan of a security from one party to another.
Settlement date is the date that a financial asset is delivered to the entity that purchased it.
Solvency II is the fundamental reform of European insurance legislation.
Solvency capital requirement is the level of capital an insurance company must hold in excess of its Technical Provisions under Solvency II.
Spot exchange rate is the exchange rate for immediate delivery.
Spread is the difference between the current bid and the current ask or offered price of a given security.
Spread earnings is the difference between the interest earned on investments and the interest credited to policyholders. This is typically associated with traditional type business.
Standard Formula is a risk-based approach to the calculation of an insurers solvency capital requirement, prescribed by the regulator.
Stochastic modeling is a statistical process that uses probability and random variables to predict a range of probable investment performances.
Temporary differences are differences between the carrying amount of an asset or liability in the statement of financial position and its tax base that will reverse over time.
Trade date is the date that an entity commits itself to purchase or sell an asset.
Transaction costs are incremental costs that are directly attributable to the acquisition, issue or disposal of a financial asset or liability.
Transitional measures allow EEA entities to gradually move to a full implementation of Solvency II over a period of time.
Trust Pass-Through securities (TRUPS) are securities through which the holders participate in a trust. The assets of these trusts consist of debentures issued by an Aegon Group company.
Unlocking of DPAC and VOBA refers to the process of updating the DPAC or the VOBA amortization schedule to reflect changes between the past and current expectations of key assumptions used in the projection of future gross profits.
Value of Business Acquired (VOBA) the difference between the fair value and the carrying amount of the insurance liabilities recognized when a portfolio of insurance contracts is acquired (directly from another insurance company or as part of a business combination).
Volatility adjustment is a volatility adjustment to the discount rates for calculating technical provisions aims at avoiding pro-cyclical investment behavior of insurers when bond prices deteriorate owing to low liquidity of bond markets or exceptional expansion of credit spreads. The adjustment has the effect of stabilizing the capital resources of insurers and will be calculated by EIOPA.
Annual Report on Form 20-F 2017 |
376 | Additional information Abbreviations | |
AFM Authority for the Financial Markets
ALCO Asset & Liability Management Committee
ALM Asset Liability Management
BCR Basic Capital Requirement
CEE Central & Eastern Europe
DNB Dutch Central Bank
DOL Department of Labour
EFRAG European Financial Reporting Advisory Group
FSB Financial Stability Board
GICs Guaranteed Investment Contracts
GMDB Guaranteed Minimum Death Benefits
GMIB Guaranteed Minimum Income Benefits
GMWB Guaranteed Minimum Withdrawal Benefits
G-SII Global Systematically Important Insurer
HLA Higher Loss Absorbing Capacity
IAIS International Association of Insurance Supervisors
ICS Insurance Capital Standard
ORSA Own Risk and Solvency Assessment
PPI Premium Pension Institution
SEC United States Securities and Exchange Commission
Annual Report on Form 20-F 2017 |
377 | Additional information References | |
1. From 2018, Aegon is required to publish a non-financial statement as part of its Annual Report. This is in compliance with the Dutch Civil Code and EU directive 2014/95/EU. The statement should address the Companys non-financial performance, as well as its management of social and environmental issues. In addition, recent changes to the Dutch Corporate Governance Code require companies also to explain their strategy and approach to value creation and corporate culture.
2. License to operate refers to the general acceptance or approval by stakeholders for a company to continue its business operations in their community or communities.
3. More information on Aegons materiality exercise (both methodology and findings) may be found in the Companys Review.
4. Based on the International Integrated Reporting Councils six capitals: financial, human, intellectual, natural, manufactured and social & relationship. Each of these capitals represents a store of value, which companies use and transform through their business activities. Its important to remember that, during this process, capitals may increase or be depleted in value. For the purposes of reporting, Aegon has chosen the four capitals most relevant to its businesses (financial, human, intellectual and social & relationship).
5. When restructuring, Aegon takes steps to keep redundancies to a minimum. In Europe and Asia, the Company works through trade unions. Where possible, staff are reassigned within the Company. Those leaving Aegon are offered support, advice and training. As part of restructuring in the US, for example, Transamerica is outsourcing administration of approximately 10 million insurance and annuities policies to Tata Consultancy Services. All employees affected will be offered position with TCS.
6. Aegon has set up, for example, a dedicated Aegon Analytics Academy, covering financial, customer and risk analytics. The Company also has a Digital Marketing course in Europe, and organizes two-day Digital Acceleration programs to bring management up to speed with latest technologies.
7. Information on Aegons governance system may be found in this report on pages 131-135.
8. Aegon Ireland is accounted on a held for sale basis.
9. Source: MABISZ, http://www.mabisz.hu/hu/piaci-adatok-jelentesek.html. Webpage visited November 14, 2017.
10. Source: KNF, https://www.knf.gov.pl/en/REPORTS_AND_ ANALYSIS/Pension_system/Monthly_data_pension_funds_ market. Webpage visited November 14, 2017.
11. Source: MABISZ, http://www.mabisz.hu/images/stories/ docs-eng/publications/yearbook-2017-english.pdf. Webpage visited November 14, 2017.
12. Source: MABISZ, http://www.mabisz.hu/hu/piaci-adatok-jelentesek.html. Webpage visited November 14, 2017.
13. Source: Insurance Association of Turkey, https://www.tsb. org.tr/official-statistics.aspx?pageID=1003. Webpage visited November 14, 2017.
14. Source: MNB, Aranykönyv, 2016, http://www.mnb. hu/felugyelet/idosorok/v-aranykonyv. Webpage visited November 14, 2017.
15. Source: ADSS, http://www.adss.sk/zhodnotenie-vo-fondoch?year=2017#documents.Webpage visited January 23, 2018.
16. Source: KNF, https://www.knf.gov.pl/en/REPORTS_AND_ ANALYSIS/Pension_system/Monthly_data_pension_funds_ market. Webpage visited November 14, 2017.
17. Source: APAPR, http://www.apapr.ro/statistics.html. Webpage visited January 23, 2018.
18. Note that on a consolidated group level Aegon Bank is not included in the calculation of the Solvency II ratio.
19. On December 14, 2017, Aegon announced that Rob Routs, Chairman of the Supervisory Board, decided to step down, after 10 years of service, at the Annual General Meeting of Shareholders on May 18, 2018.
20. On February 15, 2018, Aegon announced that Dirk Verbeek, member of the Supervisory Board, decided to step down after 10 years of service, at the General Meeting of Shareholders on May 18, 2018.
21. Mr. Rider was appointed as CFO and member of Aegons Executive Board on May 19, 2017. Conditional variable compensation is disclosed on an annualized basis for Mr. Rider.
22. A Part VII transfer is a court-sanctioned legal transfer of some or all of the policies of one company to another governed by Part VII of the Financial Services and Markets Act 2000.
Annual Report on Form 20-F 2017 |
378 | Additional information Disclaimer | |
Cautionary note regarding non-IFRS measures
This document includes the following non-IFRS financial measures: underlying earnings before tax, income tax and income before tax. These non-IFRS measures are calculated by consolidating on a proportionate basis Aegons joint ventures and associated companies. The reconciliation of these measures to the most comparable IFRS measure is provided in note 5 Segment information of this report. Aegon believes that these non-IFRS measures, together with the IFRS information, provide meaningful supplemental information about the underlying operating results of Aegons business including insight into the financial measures that senior management uses in managing the business.
Currency exchange rates
This document contains certain information about Aegons results, financial condition and revenue generating investments presented in USD for the Americas and Asia, and in GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. None of this information is a substitute for or superior to financial information about Aegon presented in EUR, which is the currency of Aegons primary financial statements.
Forward-looking statements
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:
◆ | Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; |
◆ | Changes in the performance of financial markets, including emerging markets, such as with regard to: |
◆ | The frequency and severity of defaults by issuers in Aegons fixed income investment portfolios; |
◆ | The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and |
◆ | The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of government exposure that Aegon holds; |
◆ | Changes in the performance of Aegons investment portfolio and decline in ratings of Aegons counterparties; |
◆ | Consequences of a potential (partial) break-up of the euro; |
◆ | Consequences of the anticipated exit of the United Kingdom from the European Union; |
◆ | The frequency and severity of insured loss events; |
◆ | Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegons insurance products; |
◆ | Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations; |
◆ | Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; |
◆ | Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; |
◆ | Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; |
◆ | Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; |
◆ | Changes in laws and regulations, particularly those affecting Aegons operations ability to hire and retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers; |
◆ | Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which Aegon operates; |
◆ | Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII); |
◆ | Changes in customer behavior and public opinion in general related to, among other things, the type of products Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations; |
◆ | Acts of God, acts of terrorism, acts of war and pandemics; |
◆ | Changes in the policies of central banks and/or governments; |
◆ | Lowering of one or more of Aegons debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegons ability to raise capital and on its liquidity and financial condition; |
◆ | Lowering of one or more of insurer financial strength ratings of Aegons insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries; |
Annual Report on Form 20-F 2017 |
379 | Additional information Disclaimer | |
◆ The effect of the European Unions Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain; ◆ Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business; ◆ As Aegons operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegons business, damage its reputation and adversely affect its results of operations, financial condition and cash flows; ◆ Customer responsiveness to both new products and distribution channels; ◆ Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegons products; ◆ Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegons reported results and shareholders equity; ◆ Aegons projected results are highly sensitive to complex mathematical models of financial markets, mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future performance will vary from projected results; |
◆ The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegons ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; ◆ Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegons business; ◆ Aegons failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving and excess cash and leverage ratio management initiatives; and ◆ This press release contains information that qualifies or may qualify as inside information within the meaning of Article 7 (1) of the EU Market Abuse Regulation (596/2014).
Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegons expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. |
Annual Report on Form 20-F 2017 |
380 | Additional information Contact | |
Headquarters
Aegon N.V.
Aegonplein 50
2591 TV The Hague
The Netherlands
Telephone: +31 (0) 70 344 32 10
aegon.com
Investor Relations
Telephone: +31 (0) 70 344 83 05
or toll free (US only): 877-548 96 68
E-mail: ir@aegon.com
Media Relations
Telephone: +31 (0) 70 344 89 56
E-mail: gcc@aegon.com
Agent for service in the United States of America
Name: Jay Orlandi
Telephone: +1 443 475 3836
E-mail: jay.orlandi@transamerica.com
Colophon |
||||
Consultancy and design |
DartGroup, Amsterdam (NL) | |||
Editing and production |
Aegon Corporate Communications (NL) | |||
Typesetting |
DartGroup, Amsterdam (NL) |
Annual Report on Form 20-F 2017 |
381 | Additional information Documents on display | |
Aegon files annual reports with and furnishes other information to the Securities and Exchange Commission. You may read and copy any document filed with or furnished to the SEC by Aegon at the SECs public reference room at 450 Fifth Street, N.W., Washington, D.C. 20549. Aegons SEC filings are also available to the public through the SECs web site at www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room in Washington D.C. and in other locations.
The SEC allows Aegon to incorporate by reference information into this Annual Report on Form 20-F, which means that:
◆ | Incorporated documents are considered part of this Annual Report on Form 20-F; and |
◆ | Aegon can disclose important information to you by referring you to those documents. |
Those documents contain important information about Aegon and its financial condition. You may obtain copies of those documents in the manner described above. You may also request a copy of those documents (excluding exhibits) at no cost by contacting us (refer to page 380).
Annual Report on Form 20-F 2017 |
382 | Additional information Index to Exhibits | |
Exhibits
1 | Articles of Association. (1) | |||
2 | Any instruments defining the rights of security holders and / or long-term debt holders. Pursuant to the requirement of this | |||
item, we agree to furnish to the SEC upon request a copy of any instrument defining the rights of holders of long-term debt | ||||
of us or of our subsidiaries for which consolidated or unconsolidated financial statements are required to be filed. | ||||
4.1 | 1983 Amended Merger Agreement. (2) | |||
4.2 | Voting Rights Agreement. (3) | |||
4.3 | Board Agreement between A.R. Wynaendts and Aegon N.V. (4) | |||
4.4 | Aegon N.V. Long-term Incentive Plan Rules. (5) | |||
4.5 | Aegon Group Executive Board Variable Compensation Plan Rules 2013. (6) | |||
4.6 | Aegon Group Executive Board Variable Compensation Plan Rules 2014. (7) | |||
4.7 | Aegon Group Executive Board Variable Compensation Plan Rules 2015. (8) | |||
7 | Ratio of earnings to fixed charges. | |||
8 | List of Subsidiaries of Aegon N.V. - Incorporation by reference to Note 52 of this Annual Report. | |||
12.1 | Certification of the Chief Executive Officer pursuant to Rule 13A-14 or 15D-14 of the Securities Exchange Act of 1934. | |||
12.2 | Certification of the Chief Financial Officer pursuant to Rule 13A-14 or 15D-14 of the Securities Exchange Act of 1934. | |||
13 | Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350. | |||
15 | Consent of independent registered public accounting firm. | |||
101.INS | XBRL Instance Document | |||
101.SCH | XBRL Taxonomy Schema Linkbase Document | |||
101.CAL | XBRL Taxonomy Calculation Linkbase Document | |||
101.DEF | XBRL Taxonomy Definition Linkbase Document | |||
101.LAB | XBRL Taxonomy Labels Linkbase Document | |||
101.PRE | XBRL Taxonomy Presentation Linkbase Document | |||
(1) | Incorporated by reference to Form 6K (0001104659-13-046533) filed with the SEC on June 4, 2013. | |||
(2) | Incorporated by reference Exhibit 4.1 to Form 20-F 2013 filed with the SEC on March 21, 2014. | |||
(3) | Incorporated by reference Exhibit 4.2 to Form 20-F 2013 filed with the SEC on March 21, 2014. | |||
(4) | Incorporated by reference Exhibit 4.4 to Form 20-F 2015 filed with the SEC on March 25, 2016. | |||
(5) | Incorporated by reference Exhibit 4.13 to Form 20-F 2004 filed with the SEC on March 31, 2005. | |||
(6) | Incorporated by reference Exhibit 4.14 to Form 20-F 2013 filed with the SEC on March 21, 2014. | |||
(7) | Incorporated by reference Exhibit 4.8 to Form 20-F 2014 filed with the SEC on March 20, 2015. | |||
(8) | Incorporated by reference Exhibit 4.9 to Form 20-F 2015 filed with the SEC on March 25, 2016. |
The company agrees to furnish to the Securities and Exchange Commission upon request copies of instruments with respect to long-term debt of the company and its consolidated subsidiaries.
Annual Report on Form 20-F 2017 |
383 | Additional information Signatures | |
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.
Aegon N.V. |
/s/ Matthew J. Rider |
|
Matthew J. Rider |
Chief Financial Officer |
Date: March 23, 2018 |
Annual Report on Form 20-F 2017 |
384 | Additional information Signatures | |
Exhibit 7
RATIO OF EARNINGS TO FIXED CHARGES
Year ended December 31, | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||
Earnings: |
||||||||||||||||||||
Income before taxes |
2,534 | 610 | (514 | ) | 916 | 1,236 | ||||||||||||||
Add: Fixed charges included in earnings |
1,570 | 1,530 | 1,643 | 1,542 | 1,746 | |||||||||||||||
(A) Total Earnings |
4,104 | 2,140 | 1,129 | 2,458 | 2,981 | |||||||||||||||
Fixed charges: |
||||||||||||||||||||
Interest |
435 | 347 | 412 | 371 | 355 | |||||||||||||||
Interest on fixed annuities, investment contracts and savings accounts |
1,135 | 1,183 | 1,232 | 1,171 | 1,391 | |||||||||||||||
Sub-total fixed charges included in earnings |
1,570 | 1,530 | 1,643 | 1,542 | 1,746 | |||||||||||||||
Dividend on preferred shares |
- | - | - | - | 24 | |||||||||||||||
Coupons on perpetual capital securities |
138 | 140 | 148 | 171 | 194 | |||||||||||||||
Coupons on Non-Cumulative Subordinated Notes |
37 | 38 | 38 | 32 | 28 | |||||||||||||||
(B) Total fixed charges |
1,745 | 1,708 | 1,829 | 1,744 | 1,992 | |||||||||||||||
Ratio: (A) / (B) |
2.4 | 1.3 | 0.6 | 1.4 | 1.5 | |||||||||||||||
Ratio excluding interest on fixed annuities, investment contracts and savings accounts |
4.9 | 1.8 | (0.2 | ) | 2.2 | 2.6 |
Annual Report on Form 20-F 2017 |
385 | Additional information Signatures | |
Exhibit 12.1
CERTIFICATION
PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934
I, Alexander R. Wynaendts, certify that
◆ | I have reviewed this Annual Report on Form 20-F of Aegon N.V.; |
◆ | Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
◆ | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; |
◆ | The Companys other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: |
◆ | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
◆ | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
◆ | Evaluated the effectiveness of the Companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
◆ | Disclosed in this report any change in the Companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting; and |
◆ | The Companys other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Companys auditors and the audit committee of the Companys board of directors (or persons performing the equivalent functions): |
◆ | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Companys ability to record, process, summarize and report financial information; and |
◆ | Any fraud, whether or not material, that involves management or other employees who have a significant role in the Companys internal control over financial reporting. |
Date: March 22, 2018 |
/s/ Alexander R. Wynaendts |
|
Alexander R. Wynaendts |
Chief Executive Officer |
Annual Report on Form 20-F 2017 |
386 | Additional information Signatures | |
Exhibit 12.2
CERTIFICATION
PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934
I, Mathew J. Rider, certify that
◆ | I have reviewed this Annual Report on Form 20-F of Aegon N.V.; |
◆ | Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
◆ | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; |
◆ | The Companys other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: |
◆ | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
◆ | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
◆ | Evaluated the effectiveness of the Companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
◆ | Disclosed in this report any change in the Companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting; and |
◆ | The Companys other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Companys auditors and the audit committee of the Companys board of directors (or persons performing the equivalent functions): |
◆ | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Companys ability to record, process, summarize and report financial information; and |
◆ | Any fraud, whether or not material, that involves management or other employees who have a significant role in the Companys internal control over financial reporting. |
Date: March 22, 2018 |
/s/ Matthew J. Rider |
|
Matthew J. Rider |
Chief Financial Officer |
Annual Report on Form 20-F 2017 |
387 | Additional information Signatures | |
Exhibit 13
CERTIFICATION
In connection with this Annual Report on Form 20-F of Aegon N.V. (the Company) for the period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the Report), we, Alexander R. Wynaendts, the Chief Executive Officer of the Company and Matthew J. Rider, the Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
◆ | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
◆ | The information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of the Company. The information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 22, 2018 |
/s/ Alexander R. Wynaendts |
|
Alexander R. Wynaendts |
Chief Executive Officer |
/s/ Matthew J. Rider |
|
Matthew J. Rider |
Chief Financial Officer |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Aegon and will be retained by Aegon and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished solely pursuant to 18 U.S.C. section 1350 and is not being filed as part of the Report or as a separate disclosure document.
Annual Report on Form 20-F 2017 |
388 | Additional information Signatures | |
Exhibit 15
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
1) | Registration Statement (Form F-3 No. 333-220276) pertaining to Aegon Funding Company LLC, |
2) | Registration Statement (Form F-3 No. 333-222212) pertaining to Transamerica Corporation Producers Stock Purchase Plan, |
3) | Registration Statement (Form S-8 No. 333-196156) pertaining to Aegon Group Identified Staff Variable Compensation Plan - 2012, Aegon Group Long-Term Variable Compensation Plan for Other Staff - 2012, Aegon Group Identified Staff Variable Compensation Plan - 2013 and Aegon Group Long-Term Variable Compensation Plan for Other Staff - 2013, |
4) | Registration Statement (Form S-8 No. 333-183176) pertaining to Aegon N.V. LTIC Plan for Executive Board, Management Board, Senior Management and Other Managers - 2010, Aegon Group Identified Staff Variable Compensation Plan - 2011 and Aegon Group Long-Term Variable Compensation Plan for Other Staff - 2011, |
5) | Registration Statement (Form S-8 No. 333-157843) pertaining to Aegon USA, LLC Profit Sharing Plan (now known as Transamerica 401(k) Retirement Savings Plan), and |
6) | Registration Statement (Form S-8 No. 333-150774) pertaining to Aegon USA, Inc. Profit Sharing Plan (now known as Transamerica 401(k) Retirement Savings Plan). |
of Aegon N.V. of our report dated March 22, 2018 relating to the consolidated financial statements and the other financial statement schedules and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers Accountants N.V.
Amsterdam, The Netherlands
March 22, 2018
Annual Report on Form 20-F 2017 |
aegon.com